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Abstract 
 
The human genome sequence can be thought of as an instruction manual for our species, written 
and rewritten over more than a billion of years of evolution. Taking a complete inventory of our 
genome, dissecting its genes and their functional components, and elucidating how these genes are 
selectively used to establish and maintain cell types with markedly different behaviors, are key 
challenges of modern biology. In this thesis we present contributions to our understanding of the 
structure, function and evolution of the human genome. We rely on two complementary approaches.  
 
First, we study signatures of evolutionary processes that have acted on the genome using 
comparative sequence analysis. We generate high quality draft genome sequences of the 
chimpanzee, the dog and the opossum. These species share a last common ancestor with humans 
approximately 6 million, 80 million and 140 million years ago, respectively, and therefore provide 
distinct perspectives on our evolutionary history. We apply computational methods to explore the 
functional organization of the genome and to identify genes that contribute to shared and species-
specific traits.  
 
Second, we study how the genome is bound by proteins and packaged into chromatin in distinct cell 
types. We develop new methods to map protein-DNA interactions and DNA methylation using 
single-molecule based sequencing technology. We apply these methods to identify new functional 
sequence elements based on characteristic chromatin signatures, and to explore the relationship 
between DNA sequence, chromatin and cellular state. 
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The completion of the Human Genome Project 1,2 at the beginning of this decade represents a major 
milestone in the human scientific endeavor. The DNA sequence generated by the project can be 
thought of as an instruction manual for our species, written and rewritten over more than a billion 
years of evolution. Genes encoded by the sequence specify the synthesis of the molecular building 
blocks necessary to create, sustain and propagate human life. Interactions of these genes with each 
other and their environment control the process of development, in which a single fertilized egg 
gives rise to daughter cells that progressively divide, differentiate and organize into the assembly of 
trillions of specialized cells that make up the human body. Taking a complete inventory of our 
genome, dissecting its genes and their functional components, and elucidating how these genes are 
selectively used to establish and maintain cell types with markedly different behaviors, are key 
challenges of modern biology. 
In this thesis we present contributions to our understanding of the structure, function and 
evolution of the human genome. We rely on two complementary approaches. First, we study 
signatures of evolutionary processes that have acted on the genome using comparative sequence 
analysis. We generate high quality draft genome sequences of the chimpanzee, the dog and the 
opossum. These species share a last common ancestor with humans approximately 6 million, 80 
million and 140 million years ago, respectively, and therefore provide distinct perspectives on our 
evolutionary history. We apply computational methods to explore the functional organization of the 
genome and to identify genes that contribute to shared and species-specific traits. Second, we study 
how the genome is bound by proteins and packaged into chromatin in distinct cell types. We 
develop new methods to map protein-DNA interactions and DNA methylation using single-
molecule based sequencing technology. We apply these methods to identify new functional 
sequence elements based on characteristic chromatin signatures, and to explore the relationship 
between DNA sequence, chromatin and cellular state. 
 To provide context, we begin by reviewing relevant literature on genome and chromatin 
biology pre-dating the inception of this thesis (fall 2004). Readers with limited background in 
biological sciences might also find it useful to refer to general textbooks on molecular and cellular 
biology 3,4, development 5, epigenetics 6, evolutionary theory 7-9 and genomics 10. Next , we briefly 
review advances in DNA sequencing, which is an enabling technology for this thesis. Finally, we 
summarize our specific contributions. 
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Genome biology 
Genome biology is the study of the information content and global properties of the genetic material 
of living organisms. The basic unit of heredity is a gene. The physical manifestation of a gene is a 
set of nucleotide sequences (DNA in all cellular organisms) that specify (i) the synthesis of one or 
more gene products (RNA or proteins) and (ii) under what conditions these products are to be 
produced. A chromosome is a linear or circular DNA polymer that contains physically linked genes, 
potentially interspersed among nucleotide sequences that are inherited but are functionally inert or 
do not contribute to organismal traits. A genome is the complete set of chromosomes in a living cell 
(because eukaryotic cells carry two copies of each chromosome, we usually refer to their genomes 
as the complete haploid set of chromosomes). Major questions in the field follow three related 
themes: 
 Content: A key step in understanding a genome is to comprehensively identify the 
biological information encoded in its nucleotide sequence. How much of the total sequence encodes 
genes? Where is each gene located? What are their RNA or protein products? How are the coding 
and regulatory components of each gene organized? Are there other classes of biologically active or 
inert sequence features? Do chromosomes, or regions of chromosomes, differ significantly in their 
gene content or physical properties? 
 Regulation: Only a subset of the genes in a genome is expressed in any given cell type or 
state. How is regulatory information encoded in the genome? Are genes regulated independently, or 
does the genome structure facilitate coordinated regulation of multiple genes? How are differential 
gene expression patterns maintained through cell division and development? 
 Evolution: Understanding why a genome is organized and regulated the way it is requires 
understanding its evolutionary history. What is the nature of the evolutionary processes acting on a 
genome? How do these processes constrain or enable molecular and organismal change? What is 
the relative importance of genetic drift and natural selection? How rapidly do ancestral genes 
change or disappear? How do new gene products and regulatory elements emerge?  
 Answers to these questions would greatly inform future genetic and functional analyses of 
human development, physiology, disease and evolutionary history. We note that genome content, 
regulation and evolution can vary dramatically between species from different taxonomic 
kingdoms, phyla and classes. Here, we focus on the genomes of mammals, the class of vertebrate 
animals to which the human species belongs.  
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Sanger (dideoxy) sequencing 
Efficient methods for the determination of the nucleotide sequence of a DNA polymer was first 
demonstrated in the mid-1970s when Maxam, Gilbert and Sanger independently published 
descriptions of sequencing methods that relied on gel electrophoresis to resolve DNA fragments 
that encoded sequence information at base pair resolution 11-13. While Maxam-Gilbert sequencing 
initially became the most widely used methodology, the Sanger sequencing method based on 
dideoxy chain termination eventually proved to be more practical and has been used in the vast 
majority of genome sequencing projects. 
Initially a labor intensive process that yielded at most a few hundred bases of sequence 
information per experiment, dideoxy sequencing has been successfully scaled to a level where it has 
become feasible to read all nucleotides in the human genome many times over. Getting to this point 
involved extensive modification of the original chemistry to make it more amenable to automation. 
In particular, introduction of fluorescently labeled dideoxy terminators 14 and engineered DNA 
polymerases 15 proved to be key innovations. Replacing traditional slab gel electrophoresis with 
capillary electrophoresis 16 greatly reduced reagent and labor costs. Large investments have also 
been made in parallelized and robotic sample preparation 17,18. 
Because the dideoxy sequencing process is in practice limited to reading less than 1,000 bp 
from any one template, indirect strategies are required to infer the contiguous sequence of larger 
naturally occurring DNA polymers, such as each chromosome in a genome. The fundamental 
strategy for genome sequencing over the last three decades have been shotgun sequencing 19-22. In 
this approach, a long DNA template is fragmented by mechanical shearing or enzyme digestion. 
Resulting DNA fragments are selected at random, ligated into a common sequencing vector, 
amplified by bacterial cloning, and sequenced using universal primers. The initial template is 
reconstructed computationally by searching for overlap between the sequenced fragments. Simple 
mathematical analysis can predict the expected number of gaps in the resulting sequence as a 
function of fragment coverage 23. Such gaps can be filled in by targeted sequencing as required. 
 The first DNA genome to be fully sequenced was the 5.4 kb genome of the bacteriophage 
phi-X174 24. Gradual improvements to sequencing and computational methods eventually led to 
sequencing of the first genome of a free-living organism, the bacterium Haemophilus influenzae 
(1.8 Mb), in 1995 25. The genome sequences of a variety of model organisms quickly followed, 
including the yeast Saccharomyces cerevisiae (12 Mb) 26, the roundworm Caenorhabditis elegans 
(97 Mb) 27 and the fruit fly Drosophila melanogaster (120 Mb) 28. 
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To obtain complete coverage of the 3,000 Mb human genome, the Human Genome Project 
employed a common variation of the shotgun strategy known as hierarchical shotgun sequencing. 
This two-step process begins with cloning large 100-200 kb fragments of the human genome into 
bacterial or P1-derived artificial chromosome (BAC/PAC) vectors. Overlapping BAC/PAC clones 
are shotgun sequenced individually and then combined into a largely contiguous whole genome 
sequence.  
In a parallel commercial effort, Celera attempted to generate a human genome sequence 
using whole genome shotgun (WGS) sequencing 29, which skips the BAC/PAC subcloning step 30. 
At present, WGS is the dominant strategy for genome sequencing. Generating 20-40 million 
shotgun sequence reads, ideally from both ends of fragments of several known sizes (paired end-
sequencing), is sufficient to infer the contiguous sequence of a mammalian genome using whole 
genome assembly software such as ARACHNE 31,32 and PCAP 33. 
 
The human genome sequence 
Gradual advances in DNA sequencing technology allowed targeted sequencing of genomic regions 
of increasing size, from the 48kb growth hormone locus 34 and the 106 kb FosB/ERCC1 locus 35, to 
the 685 kb beta T cell receptor locus 36, and eventually the two smallest autosomes, chromosome 21 
(25 Mb 37) and chromosome 22 (33.4 Mb 38). These early studies provided anecdotal insights into 
sequence composition, gene structure and evolution. The initial draft sequence of the whole human 
genome provided the first opportunity to asses the generality of these insights and to generate a 
comprehensive map. Here, we review some of its large-scale features. 
 Nucleotide composition. 41% of human DNA consists of GC base pairs, while AT base 
pairs make up the remainder. In the 1970s, density gradient separation studies revealed significant 
variation in GC content between large genomic fragments 39,40. Analysis of the complete genome 
sequence confirmed these studies and showed that the GC content of 20 kb intervals varies from 
~30%-60%, a 15-fold higher spread than expected from uniform random fluctuations alone. 
Notably, several genomic properties, such as ‘dark’ and ‘light’ cytogenetic bands, repetitive element 
composition, gene density and recombination rate are strongly correlated with GC content, 
suggesting that GC-rich and GC-poor regions of the genome may have different functions 41-43. 
 A key question is therefore whether the large-scale variation in GC content is the direct 
product of natural selection, or simply a consequence of variation in neutral evolutionary processes 
acting across the genome 44. Bernardi and colleagues have proposed that variation in GC content 
reflects natural selection on thermal stability in species with high body temperatures, because GC-
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rich DNA tends to be more stable than AT-rich DNA 45. Alterative mechanisms that do not invoke 
selection include variation in base misincorporation patterns during DNA replication due to changes 
in the free nucleotide pool during the cell cycle 46; variable cytosine deamination rates (see below) 
in GC-rich and AT-rich DNA 47; and ‘biased gene conversion’, where heterozygous sites are 
preferentially repaired to GC during homologous recombination 48 and would therefore lead to 
variation in GC content as a consequence of variation in recombination rates 49,50. A better 
understanding of mammalian genome evolution is needed to differentiate between these hypotheses. 
 CpG islands. So-called ‘CpG islands’ are smaller sequence features related to GC content 
51. CpG dinucleotides in the human genome are generally methylated on the cytosine base. 
Spontaneous deamination of C residues gives rise to uracil residues that are recognized and repaired 
by the cell, whereas deamination of methyl-C residues gives rise to T residues. CpG dinucleotides 
therefore steadily mutate to TpG nucleotides, leading to a scarcity of CpGs across the genome. 
However, small ‘islands’ of relatively high CpG density, usually spanning less than a thousand base 
pairs, can be found throughout the genome. CpGs in these islands are generally unmethylated. 
Many, but not all, known genes have CpG islands at their 5’ ends, suggesting that CpG islands are 
involved in regulation of gene expression and might be useful markers for the identification of 
novel genes 51-54. Approximately 29,000 CpG islands have been identified across the non-repetitive 
fraction of the human genome. They are unevenly distributed across each chromosome, in a pattern 
that correlates with gene density. The human genome also harbors tens of thousands of copies of 
transposons that meet the classic definition of a CpG island 53. These transposon associated CpG 
islands tend to be shorter that gene-associated islands and are generally thought to not have any 
biological role 55, although there is little direct evidence for this distinction. 
 Repetitive elements. Approximately half of the human genome sequence can be 
recognized as copies, or relics, of transposable elements, parasitic sequence elements that have 
copied and inserted themselves throughout the genome 56,57. The vast majority of transposable 
elements can be assigned to one of four major categories, based on their sequence composition and 
replication strategies: Long interspersed elements (LINEs), short interspersed elements (SINEs), 
long terminal repeat (LTR) retroposons and DNA transposons. 
LINEs are 6-8 kb autonomous sequence elements that contain an internal promoter and two 
ORFs. LINE RNA transcripts associate with their encoded proteins and are translocated back to the 
nucleus, where they are reverse transcribed directly into the genome. Reverse transcription is 
inefficient, leading to large numbers of truncated, nonfunctional insertions. Approximately 21% of 
the human genome is clearly derived from insertions of each of three distantly related LINE 
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families: LINE1, LINE2 and LINE3. Only LINE1 is thought to remain active. LINEs tend to be 
clustered in AT-rich, gene-poor regions of the genome. 
 SINEs are 100-400 bp non-autonomous sequence elements that contain an internal 
promoter but no ORFs. They are though to use their 3’ ends to ‘hijack’ the LINE machinery for 
transposition 58,59. Approximately 13% of the human genome can be recognized as being derived 
from SINE insertions. The Alu element is the most abundant, with one million recognizable copies, 
and remains active in modern humans. SINEs tend to be clustered in GC-rich, gene-rich regions of 
the genome. 
 LTR retroposons are flanked by direct repeats that contain promoter activity. Autonomous 
LTR elements (retrotransposons) contain gag and pol genes that enable reverse transcription in a 
cytoplasmic virus-like particle and subsequent integration into the genome. LTR insertions have 
contributed at least 8% of the human genome sequence. The majority of these insertions have lost 
their internal coding sequences due to homologous recombination between the flanking repeats. 
LTR activity is thought to be on the brink of extinction in the human genome. 
 DNA transposons contain one ORF flanked by inverted repeats. It encodes a protein that 
binds near the flanking repeats and moves the transposon to a new location through a ‘cut-and-
paste’ mechanism. DNA transposons in the human genome can be grouped into at least seven major 
families with apparently independent origins. They have contributed at least 3% of the genome 
sequence, but appear to have become completely inactive over the last ~50 million years. 
Copies of transposable element insertions gradually diverge as they age, until they 
degenerate into sequences that bear no resemblance to their parental elements. Simulations suggest 
that the mutation rate of the human genome (see below) is sufficient to obscure the origin of any 
insertion older than ~150-200 million years 60. Because transposable elements similar to those found 
in the human genome are known to be substantially older than this, it is likely that much of the 
remaining ‘unique’ sequence of the human genome are also derived from them 56. 
A key question surrounding transposable elements is how these ‘selfish’ pieces of DNA 
affect the fitness and evolution of their hosts. Transposons were first described by McClintock in 
the 1950s as mobile ‘controlling elements’ that could both induce chromosome breaks and affect 
the expression of nearby genes in maize 61,62. In the 1960s, Britten and colleagues showed that about 
half of the genomes of mammals had to consist of families of repetitive sequences, based on the 
reassociation kinetics of DNA fragments obtained from them 63,64. Since then, a number of 
researchers have proposed key roles for transposable elements in the evolution of higher organisms, 
for example as templates for organization of chromatin, as sources of genetic variation due to 
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insertion mutagenesis and homologous recombination, as vehicles for copying existing functional 
elements to new locations, and as sources of proteins and regulatory elements that can be exapted 
and modified for the benefit of their host 65-72. Individual examples of most of these models have 
been identified. Homologous recombination between Alu elements has been shown to cause 
chromosomal rearrangements the human genome 73-76. A small number of functional ‘retrogenes’ 
are thought to have been generated by LINE-mediated reverse transcription of non-LINE RNA 
transcripts 77,78. About fifty human protein-coding sequences 56,79 and a few dozen known regulatory 
elements 77,80 clearly originate from exaptation of  transposon sequences. It remains to be 
determined whether these examples were isolated incidents or represent major sources of innovation 
in our evolutionary history. 
Segmental duplications. The human genome contains numerous instances of two or more 
~1-200 kb intervals with very high nucleotide sequence similarity (>90%) that are not copies of 
transposable elements 81-83. The initial draft genome sequence showed that such ‘segmental 
duplications’ cover at least ~3.6% of the genome sequence, although recent duplications can be 
difficult to assemble correctly from shotgun sequencing data. The estimate was later revised up to at 
least 5.3% based on a more complete version of the sequence 2. Duplications can occur both within 
a chromosome and between non-homologous chromosomes, and their distribution varies 
significantly between different chromosomes and chromosomal regions. Interchromosomal 
duplications are particularly common in pericentromeric and subtelomeric regions, apparently due 
to a steady bombardment of insertional translocations 84. Interchromosomal duplications often occur 
in clusters and are predisposed to recurrent deletions or rearrangements due to paralogous 
recombination. Such events have been associated with a variety of genetic diseases, including 
Prader-Willi/Angelman, DiGeorge and Williams’ syndromes 85-88. Segmental duplications have also 
been shown to harbor novel gene families evolving under strong positive selection 89, suggesting 
that they may provide a useful substrate for evolutionary innovation. 
 Gene content. Genes can generally be divided into protein-coding and non-coding RNA 
genes based on the functional form of the products they specify. Protein-coding sequences can 
easily be identified in the genomes of simple organisms, such as bacteria and yeast, based on long 
open reading frames (ORFs). The task is much more difficult in the genomes of complex organisms 
such as humans, because their protein-coding sequences make up only a small fraction of the total 
genomic sequence, and because most functional ORFs are split into multiple short exons separated 
by longer, non-coding introns that are spliced out before translation. This creates a signal-to-noise 
problem, because the number of potential ORFs in the genomic sequence is much higher than the 
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number of ORFs that are ever transcribed, spliced and translated into proteins in the organism. 
Efforts to create a complete catalog of human genes have therefore relied on the indirect strategy of 
first isolating and identifying gene products through cDNA or amino acid sequencing, and then 
aligning these products to the genome to identify the genes which specified them or novel genes 
with similar structures or protein domains. 
Various attempts were made at estimating the total number of protein-coding genes prior to 
completion of the human genome sequence. Extrapolation from early work on messenger RNA 
reassociation kinetics suggested about 40,000 distinct genes 90. Extrapolation from the number of 
CpG islands and the frequency with which they are associated with genes suggested about 70,000-
80,000 91. Different analyses of expressed sequence tags (ESTs 92) led to predictions ranging from 
35,000 to 120,000 93,94.  
 With the availability of the genome sequence, computational methods were used to identify 
any potential coding sequences in the genome based on sequence similarity to any known EST, 
messenger RNA, protein sequence or domain from any species. This effort led to a set of ~32,000 
predicted genes. These predictions were then merged with ~15,000 well-characterized human 
transcripts and proteins known at the time. Various considerations on the accuracy of the prediction 
algorithms and the completeness of the initial draft sequence led to the estimate that ~24,000 of the 
predicted genes would turn out to be real, and that the genome contains an additional 5,000-10,000 
protein-coding genes, for a total of 30,000-35,000. Subsequent corrections to, and increased 
coverage of, the genome sequence, improved computational methods and expanded cDNA 
collections have led to downward adjustments to this estimate, down to 19,600-25,000 at present 2. 
The lower bound is the number of currently known genes. The upper bound is likely to be 
conservative, based on the low number of novel genes having been discovered despite 
comprehensive cDNA sequencing efforts. In total, the known and predicted protein-coding 
sequences make up ~1.5% of the human genome. 
The genome also contains a variety of non-coding genes that specify RNA molecules that 
contribute directly to cellular processes, rather than being translated into proteins 95-97. So far 1,000-
2,000 non-coding genes with known or putative functions have been identified in the genome, 
including transfer RNAs, ribosomal RNAs, small nucleolar RNAs, spliceosomal RNAs, regulatory 
micro RNAs, and a small number of idiosyncratic long RNAs associated with imprinting or X 
inactivation, such as XIST 98. Unlike protein-coding genes, which are transcribed into messenger 
RNAs that all share a common primary structure and grammar (the genetic code), non-coding 
RNAs exist in a wide variety of sizes and structures. It is therefore difficult to estimate the 
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completeness of the current non-coding gene catalog. Chromosome-wide surveys of transcriptional 
activity suggest that the genome gives rise to a large number of currently unclassified RNA 
transcripts 99, but to what extent these represent functional gene products or reproducible 
transcriptional noise remains unclear. 
 Locating the regulatory sequence elements that specify when and where each gene product 
is to be synthesized is considerably more challenging than locating the sequences that specify the 
product itself. In contrast to the genomes of many simple organisms where regulatory elements are 
generally located near transcription start sites, human regulatory elements can be located far from 
the sequences which transcription they control. For example, the Shh gene is controlled in part by a 
regulatory element situated over a million nucleotides away from its protein-coding sequence, 
within an intron of a different protein-coding gene 100. Moreover, analysis of known regulatory 
elements have so far failed to uncover characteristic patterns that make them clearly stand out 
against the vast background of non-functional sequences. Alternative approaches are required to 
construct a parts list of the human genome that include comprehensive coverage of both non-coding 
genes and regulatory elements. 
 
Comparative analysis of genome sequences 
Comparative analysis has emerged as a promising tool for studying genome evolution and for 
locating functional information encoded in DNA sequences. This approach relies on evolutionary 
theory and the principle of common descent. As genetic information is passed from generation to 
generation, individuals acquire mutations through errors in DNA replication or repair. Each 
mutation has a small chance of spreading throughout a population and becoming a fixed part of a 
species’ genome. Mutations that happen to change functional sequence information might have 
positive or negative effects on the fitness of the individuals that carry them. Natural selection will 
act on such mutations to increase or decrease their chance of fixation, respectively. As evolution 
ceaselessly tinkers with gene pools over millions of years, new species form and diverge from 
common ancestors. Comparing the genomes of related species to identify sequences that have 
changed less than would be expected in the absence of selection should therefore help pinpoint 
shared genes. Sequences that have changed more than expected might also help pinpoint genes 
responsible for the emergence of novel traits. 
 Comparative analysis of genomic sequences dates to at least 1975, when Pribnow and 
Schaller identified the -10 RNA polymerase recognition site, an essential part of prokaryotic 
promoters, in part by comparing promoter sequences from bacteriophages and E. coli 101,102. In one 
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of the first applications to mammalian biology, Tagle and colleagues used ‘phyogenetic 
footprinting’ of the galago, rabbit and mouse ε and γ globulin loci to identify conserved regulatory 
elements likely to control their expression in primates 103. They also noted that the transition from 
embryonic to fetal γ globulin expression in primates correlates with an elevated non-synonymous 
substitution rate.  
The first comparative analysis of extended genomic regions between human and other 
mammals involved the rat γ-crystallin locus 104 and the mouse β-globin cluster 105. Both analyses 
found low overall sequence similarity outside of the orthologous ORFs, in part due to insertions of 
large numbers of lineage-specific transposable elements, but noted the presence of small conserved 
non-coding sequences of unknown function. In contrast, comparative analysis of the 100 kb human 
and mouse α/δ T cell receptor loci showed extensive organizational and non-coding sequence 
conservation, suggesting that this region either contains a large number of regulatory sequence 
elements or has an unusually low mutation rate 106. In 1997, Oeltjen and colleagues demonstrated 
that conserved non-coding sequences identified by comparison of the human and mouse Bruton’s 
tyrosine kinase (BTK) loci possessed regulatory activities in transient transfection experiments 107. 
Similar findings were later made in, for example, orthologous interleukin 108 and Hox 109 gene 
clusters. These results led to a growing appreciation of the value of sequencing additional 
mammalian and vertebrate genomes to facilitate detection of novel coding and regulatory sequences 
in the human genome 110,111. 
The utility of whole-genome comparative analysis for identification of protein-coding 
sequences, non-coding RNAs and regulatory elements, as well as for gaining insight into genome 
evolution, has been conclusively demonstrated for model systems such as yeast 112-115 and worm 116. 
Here, we review lessons learned from comparative genome analysis of mammals and more 
distantly-related vertebrates. 
 
Comparison of the human and murid genomes 
Sequencing of the mouse genome 60, and later the rat genome 117, launched the era of mammalian 
comparative genomics. The mammalian lineages leading to modern humans and murids diverged 
approximately 75 million years ago, while the lineages leading to mice and rats diverged 12-24 
million years ago 118,119. Thus, human-murid and mouse-rat comparisons provided two different 
perspectives on mammalian evolution. Here, we review key lessons from the whole-genome 
analyses. 
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Synteny. The human and murid genomes have each been repeatedly shuffled by 
chromosomal rearrangements after their lineages separated. The rate of these rearrangements have 
been low enough, however, that local gene order generally remains the same. Early evidence of 
conserved gene order in mammals came from the observation that the albino and pink-eye dilution 
mutants were closely linked in both mouse and rat 120,121. Consistent with this, comparison of the 
mouse and rat genome sequences show that they can be divided into ~100 orthologous segments 
with largely intact gene order. Extrapolating from linkage and cytogenetic data for 83 loci, Nadeau 
and Taylor estimated that the human and mouse genomes could be parsed into ~180 syntenic 
segments 122. Analysis of the complete genome sequences identified ~300 syntenic segments 
varying in length from 1 to 65 Mb, which covers >90% of each genome. A cytogenetic analysis 
that included outgroups suggested that the rate of rearrangement was significantly higher in the 
lineage leading to the murids 123.  
A question arising from the analysis of mammalian synteny is whether the chromosomal 
breaks involved in large-scale rearrangements occur randomly across the genome. In 1973, Ohno 
postulated the random breakage model of genome evolution 124, which implies that the number of 
breakpoints can be used as a measure of genetic distance and that significant deviation from random 
breakage can be used as a test for selection on gene order. Genomic synteny maps of human and 
mouse genomes were at first deemed to be consistent with this model 60. However, based on 
analysis of human, mouse and rat, Pevzner and colleagues have argued that breakage might be 
biased towards structurally unstable ‘hotspots’ 125,126. High resolution synteny analysis involving 
additional mammals should help resolve this issue. 
Shared and lineage-specific genes. Catalogs of known and predicted genes in the mouse 
and rat genomes have been generated by computational analysis of cDNA and protein evidence (see 
above). Both genomes are predicted to contain 20,000-25,000 protein-coding genes and ~1,000 
known non-coding RNA genes. Similar to human, substantial evidence of additional non-coding 
transcription of largely unknown function has also been found in mouse 127. 
The vast majority (>99%) of known and predicted mouse and rat protein-coding genes have 
clear homologs in the human genome, which is consistent with the notion that duplication of 
ancestral genes, rather than de novo evolution from non-coding sequences, is the most common 
mechanism for generating new genes 128. The fraction of human protein-coding genes that have 
single, unambiguous (1:1) orthologs in each of the murid genomes is estimated to be 80-90% (after 
accounting for shortcomings in the genome assembly). This is similar to the fraction of 1:1 
orthologs between mouse and rat (86-94%), despite the difference in divergence times.  
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Protein-coding genes that are not part of 1:1 ortholog pairs are frequently found in clusters 
of lineage-specific duplications in one or more of the species, usually within syntenic segments. The 
largest such clusters involve olfactory receptor genes and the cytochrome P450 gene family, which 
is involved in xenobiotic metabolism. Both of these gene families have undergone parallel 
duplication, expansion and gene loss in both the human and murid lineages. Interestingly, the 
majority of lineage-specific duplications in these and other families appear to be of very recent 
origin, based on their high synonymous sequence similarities. One possible interpretation of this 
pattern is that many lineage-specific genes represent transient duplication events that are destined for 
deletion due to lack of functional benefit. The functional proteome of humans and murids might 
therefore be even more similar than ~90% 1:1 orthology suggests.  
 An emerging theme from the field of evolutionary developmental biology is that changes in 
gene regulation rather than gene products might be the most important driver of evolution of 
morphological diversity, such as that seen across the class of mammalian species 129,130. As early as 
1975, Wilson and colleagues argued that the substitution rate between known human and 
chimpanzee proteins were too low and symmetrical to account for the accelerated anatomical 
evolution evident in modern humans 131,132. Comparing the rates of evolutionary innovation in coding 
and regulatory sequences is not feasible, however, without a much better understanding of the 
identity and evolution of the latter. 
Nucleotide divergence. Approximately 40% of the human genome can be aligned to the 
murid genomes at the nucleotide level. The remaining 60% is thought to be accounted for by 
insertion of lineage-specific transposable elements and turnover of ancestral sequence. Using 
orthologous transposable element relics as a proxy for neutrally evolving sequence, the substitution 
rate between human and mouse genomic DNA has on average been ~0.5 per site, with the absolute 
rate being approximately twice as high on the murid lineage compared to human. The rates of small 
insertion and deletion events (not related to transposable elements) have been ~9 and ~21 per kb, 
respectively. These rates all vary significantly across the genome, in a pattern that shows complex 
correlations with sequence properties such as GC and transposable element content. The source of 
this variation is not fully understood, but may include reduction in genetic diversity due to natural 
selection 133, biased gene conversion 134 or transcription associated mutagenesis 135. Gaining a better 
understanding of substitution rate variation is critical to any genomic analysis that relies on accurate 
detection of signals of positive or negative selection, such as phylogenetic footprinting. 
Proportion of the genome under negative selection. Sequencing of the mouse genome 
provided the first opportunity to estimate how much of the human genome has been evolving under 
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negative selection since our last common ancestor, and therefore presumably contains functional 
sequence elements. Waterston and colleagues estimated this fraction by measuring human-mouse 
sequence similarity across short (50 or 100 bp) intervals of aligned, orthologous sequence 60. They 
then compared the resulting distribution of sequence similarities to the distribution expected under 
neutral evolution, as estimated from relics of ancestral transposable elements. Variations on this 
method consistently showed a ~5% excess of intervals with high sequence similarity.  
The 5% estimate came as something of a surprise because it is three times larger than what 
can be accounted for by protein-coding sequences alone, suggesting that the majority of functional 
information in mammalian genomes have other roles. Some conserved non-coding sequences 
overlap promoters, enhancers and untranslated regions of protein-coding genes, but many are not 
associated with any known gene. In fact, there appears to be no simple spatial correlation between 
conserved coding and non-coding sequences, and conserved non-coding sequences are frequently 
found in long ‘gene deserts’ 136. The strength of negative selection also appears to vary significantly 
between different sequence elements. At one extreme, Bejarano and colleagues have identified 
several hundred ‘ultraconserved elements’ associated with developmental genes that show perfect 
nucleotide identity between human, mouse and rat over at least 200 bp 137. Such high levels of 
constraint have been difficult to explain, because degeneracy in the genetic code and in transcription 
factor binding preferences suggests that at least some sites is both protein-coding and regulatory 
elements should have little functional impact. 
How accurate the 5% estimate is remains an open question. It critically depends on 
assumptions made about how mammalian genomes change in the absence of selection. It is difficult 
to assess how general these assumptions are from analysis of only three complete genome 
sequences. For example, hypothetical mutational ‘cold spots’ could yield a high rate of false 
positives. Moreover, in contrast to early optimism 110, comparison of the human and murid genomes 
does not provide sufficient statistical power to accurately identify most individual sequence 
elements under selection, which limits opportunities for follow-up studies. Comparing the human 
genome to that of more distantly related species, such as chicken 138 and fish 139, have yielded higher 
specificity (but lower sensitivity) and helped to accurately predict new regulatory elements 140,141. 
While most human protein-coding sequences have conserved orthologs in these species, 
significantly less conserved non-coding elements can be found (2-3 fold less with chicken, >100 
fold less with fish). Due to the high background substitution rate (>1.7 per site for human-chicken), 
it is difficult to say whether this stems from failure to align orthologous elements, lack of specificity 
in the human-murid comparisons, or evolutionary innovation in mammals. Sequencing of additional 
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mammalian genomes should help inform these issues and unlock the full power of comparative 
analysis for understanding human biology. 
 How close the 5% estimate is to the fraction of the human genome that is functional at 
present is also unclear. If lineage-specific loss or gain of regulatory or other non-coding elements is 
common, as a comparison of limited sequences from eight mammals has suggested 142, many would 
have been missed altogether by the human-murid analysis. Additional mammals might help identify 
ancestral elements that have been lost in the murids. Identification of new elements specific to the 
human lineage is difficult, however, because comparative analysis of closely related species has less 
statistical power. Complementary approaches that do not rely on sequence conservation might 
therefore be required to compile a comprehensive catalog of functional elements in the human 
genome. 
 
Chromatin 
In higher organisms, the genome exists in the cell nucleus as part of a complex combination of 
DNA, RNA and proteins referred to as chromatin 3. X-ray diffraction and electron-microscopy 
studies in the early 1970s suggested that chromatin might be organized into a repeating, “spheroid” 
structure 143,144. In 1974, Kornberg and Thomas demonstrated that the fundamental repeating unit of 
chromatin is the nucleosome, which consists of ~147 base pairs of DNA wrapped around an 
octamer of different histone proteins (H2A, H2B, H3, H4). Nucleosomes are connected by 20-100 
bp of free linker DNA. Each nucleosome is stabilized by several hundred protein-DNA interactions 
145.  
Cellular processes that utilize genetic information, such as gene activation or replication, 
require temporary disruption of nucleosome interactions to gain access to the DNA sequence. Early 
studies of eukaryotic gene regulation showed that active genes and functional elements tend to be 
associated with less compact chromatin than silent genes, as measured by nuclease accessibility 
146,147. “Open” chromatin can therefore be thought of as a signature of active genes or regulatory 
elements in a given cell type or state. Indeed, mapping sequences that are hypersensitive to DNAse 
I digestion has been shown to be an effective and specific method for identification of active 
promoters and other regulatory elements 148. For example, the locus control region (LCR) which 
regulates β-globin expression during erythroid development was identified and dissected using 
nuclease hypersensitivity mapping 149,150.  
The open chromatin structure observed at active genes is not simply an indirect 
consequence of non-histone proteins interacting with the DNA sequence. In the late 1980s, 
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pioneering experiments by Han and Grunstein demonstrated that histone depletion lead to 
widespread transcriptional initiation in vivo 151. In the early 1990s, genetic and biochemical 
experiments showed that sequence-specific transcription factors mediated gene activation in part 
through recruitment of ATP-dependent chromatin remodeling complexes 152-154. These observations 
imply that the nucleosome structure contributes directly to gene repression. Controlling chromatin 
compaction might provide a mechanism for controlling which parts of the information encoded in 
the genome is accessible at any given time and therefore help stabilize lineage commitment and cell 
state 155.  
Modulation of DNA accessibility is mediated by chromatin remodeling complexes, but 
often involves covalent modifications of histones or the DNA itself. Various evidence from model 
organisms suggest that these modifications might provide highly informative signatures of different 
processes involved in genome regulation. 
Histone modifications. Histones are globular proteins with flexible N-terminal tails. 
Biochemical studies have revealed that specific residues on these tails can be subject to a variety of 
post-translational covalent modifications, including acetylation, methylation, phosphorylation, 
ubiquination and ADP-ribosylation 156. Pioneering experiments in yeast showed that the N-terminal 
tail of histone H4 is required for stable repression of the silent mating type loci 157. The same group 
later showed that acetylation of specific residues in the H4 tail are required for transcriptional 
activation 158.  
Histone acetylation was at first thought to mediate its activating function primarily by 
removing positive charge from lysine resides and therefore decrease the strength of electrostatic 
interactions with the negatively charged DNA backbone. Eventually, it became clear that acetylated 
residues could also directly block interactions with repressive chromatin remodeling proteins 
SIR3/4 159 and serve as recognition sites for a protein domain found in a variety of transcriptional 
co-activators 160. Searches for additional proteins that interact with histone modifications soon 
revealed that methylation of H3 lysine 9 (H3K9me) serves as a recognition mark for a different 
class of repressive proteins (HP1/Swi6) 161,162.  
It quickly became clear that multiple pathways converge on the histones and use covalent 
tail modifications as anchoring points for regulatory enzymes. A growing number of histone tail 
modifications have been associated activating and repressive protein complexes, primarily from 
studies in model systems such as yeast and fly. For example: H3 lysine 4 methylation (H3K4me) 
has been associated with transcriptional initiation, potentially due to interactions between the 
initiating form of RNA polymerase and H3K4 methyl-transferases 163-165; H3K27me has been 
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shown to be catalyzed and recognized by repressive Polycomb group (PcG) proteins 166-168; H3 
lysine 36 methylation (H3K36me) has also been shown to mediate transcriptional repression, but 
appears to be associated with the elongating form of RNA polymerase in vivo, potentially to prevent 
aberrant initiation in active gene bodies 169. H4 lysine 20 methylation (H4K20me) has been 
associated with heterochromatin formation 170. 
The potential for combinatorial modification patterns led to the formulation of the ‘histone 
code’ hypothesis, which states that different histone modifications can influence each other and 
have synergistic or antagonistic effects on gene activity or related processes 171. A better 
understanding of the genomic distribution and functional role of histone modifications will be 
required to test this hypothesis. 
DNA methylation. As alluded to above, cytosines in CpG dinucleotides are frequently 
methylated in vertebrate and mammalian genomes. In 1975, Riggs and Holliday suggested that this 
covalent chromatin modification might have a role in regulating gene expression 172,173. The 
discovery that promoter-associated CpG islands were strongly represented in the unmethylated 
fraction of the mouse genome provided anecdotal support for this hypothesis 51,52. Direct evidence 
for a causal role came from studies showing that DNA methylation can directly interfere with 
transcription factor binding 174-176, and from the discovery of methyl-CpG binding domain proteins 
that target repressive nucleosome remodeling complexes to methylated sequences 177-181. 
Genetic evidence suggests that a single enzyme, DNMT1 182, is responsible for maintaining 
DNA methylation patterns in mammalian cells 183,184. Two additional enzymes, DNMT3A and 
DNMT3B, possess de novo methyltransferase activities, are highly expressed in developing 
embryos and are responsible for establishing global DNA methylation patterns following 
implantation 184,185. DNMT1 shows strong preference for hemi-methylated over unmethylated 
CG/GC base pairs. This preference provides a clear mechanism for faithful transmission of 
established DNA methylation patterns through mitosis. After DNA replication, unmethylated 
CG/GC pairs give rise to two unmethylated copies while symmetrically methylated CG/GC pairs 
give rise to two hemi-methylated copies. DNMT1 then ‘completes’ the methylation of the hemi-
methylated copies. Interestingly, experiments by Jones and Taylor have demonstrated that transient 
inhibition of DNMT1 methylation in differentiated cells using small molecules appear to revert 
cultured fibroblasts to a more pluripotent state in a cell-cycle dependent manner 186,187. Thus, DNA 
methylation appears to play a key role in maintaining differentiated cell states. DNA methylation 
has also been implicated in repression of transposable elements, genomic imprinting and X 
inactivation 188. 
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Chromatin state and cell state. Lineage-commitment and cellular differentiation lie at the 
core of animal development. As embryonic cells grow and divide, they organize into anatomical 
structures and take on specialized states. These states are associated with differential gene 
expression patterns that can be remarkably stable, even after the signals that established them are no 
longer present. Seminal experiments by Hadorn and colleagues demonstrated the concept of 
‘cellular memory’ 189: clusters of cells from fly embryos that were destined to give rise to particular 
adult structures were isolated and made to proliferate substantially longer than they would during 
normal development. When reintroduced into embryos, these cells still differentiated into the 
anatomical structures and appendages they were initially programmed for. Understanding the 
molecular basis of this memory is a key challenge in developmental biology. 
It has long been speculated that differentiated cells retain the genetic material necessary to 
control all of development 190. Cloning and nuclear reprogramming experiments in amphibians and 
mammals 191-195 eventually proved that this was the case. All nucleated cells contain the same 
genetic information as the totipotent zygote (with a few exceptions, such as mature B and T cells 
due to recombination of the immunoglobulin loci). Thus, lineage-commitment and cell state must 
be maintained though cell division by ‘epigenetic’*  mechanisms. There are two known molecular 
systems that appear contribute to epigenetic inheritance: DNA methylation (see above) and the 
Polycomb/Trithorax system 188,196. Both systems are closely related to chromatin state. 
The Polycomb/Trithorax system was first described in Drosophila melanogaster 197. The 
Polycomb group (PcG) proteins were named after mutations in 18 different genes that cause ectopic 
sex combs on the legs of male flies. The phenotype is caused by failure to repress expression of 
Hox genes, which are transcriptional regulators that specify anatomical patterns in the embryo. The 
Trithorax group (TrxG) proteins are named after mutations in 17 different genes that act as 
supressors of the ectopic sex comb phenotype. Biochemical purification and analysis of the PcG 
and TrxG proteins show that they are components of large complexes that interact with and modify 
histone tails. As noted above, the recruitment and repressive activity of PcG proteins have been 
closely linked to tri-methylation of H3 lysine 27 (H3K27me3). The activity of TrxG proteins is less 
understood, but appears to be associated with methylation of H3 lysine 4 (H3K4me) 198. PcG and 
TrxG activites are thought to initially be recruited to target loci through sequence-specific binding 
to Polycomb Response Elements (PREs) scattered throughout the fly genome 199. 
                                                 
* The term ‘epigenetic’ has a variety of proposed definitions. Here, we adapt the recent definition of Bird 221 
as “the structural adaptation of chromosomal regions so as to register, signal or perpetuate altered activity 
states”.  
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 Human and other mammalian genomes contain highly conserved homologs of most of the 
PcG and TrxG proteins identified in fly 196. Recent experiments in mice have shown that PcG 
proteins are involved in maintaining the pluripotent state of embryonic stem cells, are required for 
successful embryonic development and contribute to X chromosome inactivation in differentiated 
female cells 200-202. Few mammalian PcG/TrxG targets are known, however, and no homologs of fly 
PREs have so far been identified. Unlike DNA methylation, the molecular basis for mitotic 
inheritance of PcG-mediated repression is also not yet understood 196.  
 
Mapping chromatin state 
Mapping the location of histone tail modifications and DNA methylation at high resolution might 
be a highly informative approach to identify functional elements, particularly activating and 
repressive regulatory elements. Gaining a better understanding of the distribution of epigenetic 
marks should also be helpful for exploring the relationship between DNA sequence, chromatin state 
and differentiation. To date, virtually nothing is known about the distribution of histone 
modifications and DNA methylation across mammalian genomes. 
Accurate assays have been developed for mapping protein-DNA interactions, including 
histone tail modifications at single sequence elements or genes. The most practical assay is 
chromatin immunoprecipitation (ChIP), in which an antibody is used to enrich DNA from genomic 
regions carrying a specific epitope. 203-205. The level of enrichment relative to the expected 
background can be measured by quantitative PCR. The ‘gold standard’ assay for DNA methylation 
is bisulfite sequencing, which involves chemical conversion of unmethylated cytosines to uracils 206. 
Bisulfite treated fragments can be amplified by PCR and sequenced to reveal DNA methylation 
patterns at nucleotide resolution. The major challenge to generating genome-wide chromatin state 
maps lies in scaling the existing assays to allow profiling of multiple chromatin modifications 
across large mammalian genomes in multiple cell types without incurring prohibitive labor or 
reagent costs.  
 Proof-of-principle experiments have recently demonstrated the feasibility of mapping 
chromatin state across small genomes using microarray and sequencing technologies. Several 
groups have used microarrays containing amplified intergenic regions and ORFs to assay the 
distribution of H3K4 methylation, H3/H4 acetylation and related enzymes across the yeast genome 
164,207,208. A variation of the serial analysis of gene expression (SAGE) method 209 has also been used 
to directly sequence ChIP fragments from the yeast genome to identify acetylated regions 210. 
Scaling these methods to mammals, which genomes are two orders of magnitude larger than yeast, 
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and which utilize a significantly larger array of cell types and states, would be cost-prohibitive 
using either microarrays or Sanger sequencing, however. New technologies are therefore needed to 
meet this challenge. 
 
Single molecule-based sequencing 
Initially motivated by the Human Genome Project, tremendous effort has been expended into 
developing cost-efficient, high-throughput instruments capable of decoding any collection of DNA 
sequences. Similar to the production of semiconductors, the cost of dideoxy sequencing has 
decreased exponentially over the last two decades 211. However, with the stated post-Human 
Genome Project goal of sequencing a complete human genome for USD $1,000, the consensus in 
the DNA sequencing community has been that an entirely new generation of sequencing technology 
has to be developed. 
Various non-Sanger sequencing instruments have recently been developed and 
commercialized. These instruments are based on the unifying principle of cyclic array sequencing. 
They achieve increased throughput and decreased costs by using a single reagent volume to 
simultaneously infer the sequence of millions (potentially billions) of DNA features immobilized on 
a surface. Each DNA feature may be a single molecule or an ensemble of identical molecules in 
close spatial proximity. Sequencing takes place in progressive cycles where in each cycle an 
enzymatic process is used to interrogate one or more nucleotide position from all of the DNA 
features in parallel. The outcome of each cycle is reported by light or fluorescence signals and 
captured using CCD imaging of the array. After multiple sequencing cycles, the location and 
composition of each DNA feature are inferred from the resulting series of images. The details of 
DNA feature generation, deposition and interrogation differ significantly between instruments 
designs. 
Pyrosequencing of emulsion PCR features. In this approach, a collection of DNA 
templates are fitted with common adapters. Emulsion PCR 212 is used to generate DNA features 
consisting of a large number of identical copies of each template immobilized on the surface of 
micrometer-scale paramagnetic beads. These beads are deposited across millions of picoliter-scale 
wells etched into the surface of a fiber optic bundle. The concentration of beads is titrated to 
maximize throughput while minimizing the number of wells expected to contain multiple beads. 
Sequence interrogation is done using the pyrosequencing method 213. In each cycle, one of the four 
DNA nucleotides is introduced into the common reaction volume and polymerase-mediated 
incorporation events are detected by monitoring luciferase-based light generation upon 
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pyrophosphate release. Parallel incorporation across identical templates on a single bead amplifies 
the signal for robust detection. Unincorporated nucleotides are removed and the process is repeated. 
A commercial implementation of this method by 454 Life Sciences can generate >100 bp sequence 
reads at a cost per read that is roughly an order of magnitude lower than for capillary Sanger 
sequencing. 
Sequencing of emulsion PCR features by ligation. In this approach, DNA features are 
also prepared by bead-based emulsion PCR. The amplified beads are then randomly distributed on a 
glass slide and immobilized by a thin layer of polyacrylamide gel or by direct covalent attachment 
to the surface. Sequencing is achieved by sequence-specific ligation rather than polymerase-based 
extension [214]. In each cycle, an anchor primer is first hybridized to a universal adapter on each 
DNA template. Next, the slide is exposed to a population of fluorescently labeled degenerate 
nonamers (single-stranded 9 bp DNA sequences). The nonamer population is designed such that the 
attached fluorophore identifies the base at one particular position within it. The ligase discriminates 
for sequence complementarity up to some distance from the ligation site, ensuring that nonamers 
with one of the fluorophores are preferentially ligated to each DNA feature. After ligation, the array 
is imaged in four colors. Then the ligation products of the anchor primers and 9-mers are stripped 
from the beads, and the process is repeated. A commercial implementation of this method by 
Applied Biosystems can generate short (25-35 bp) reads at a cost per read that is roughly two 
orders of magnitude lower than for capillary Sanger sequencing.  
Sequencing of bridge PCR features by synthesis. In this approach, DNA features are 
generated directly on a glass slide by bridge PCR 215. Two universal primers are first immobilized to 
the glass  surface. The primers are complementary to adaptors ligated onto each DNA template and 
serve to capture the fragments on the surface. Upon thermal cycling with all non-DNA reagents 
moving freely in the aqueous phase, DNA features corresponding to a cluster of ~1,000 identical 
DNA templates are “grown” on the surface. After amplification, one of the two primers is released 
from the slide, resulting in only one of the two amplicon strands remaining in each cluster. 
Sequencing is achieved by cyclic polymerase-based incorporation of fluorescently labeled 
nucleotides, starting from a universal sequencing primer. Reversible terminators ensure that only 
one nucleotide is incorporated in each cycle. After removal of unincorporated nucleotides, the array 
is imaged in four colors, allowing identification of the identity of one base in each cluster. The 
reversible terminator group is subsequently cleaved off the clusters, and the process is repeated by 
extending the previous synthesis products, allowing interrogation of the next base. A commercial 
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implementation of this method by Solexa can generate short (25-50 bp) sequence reads, at a cost per 
read that is also roughly two orders of magnitude lower than for capillary Sanger sequencing. 
Sequencing of single molecule features by synthesis. The ultimate realization of high-
density cyclic array sequencing is interrogation of single molecule DNA features. In one version of 
this approach, adapter flanked DNA templates are first immobilized on a quartz slide. Fluorescently 
labeled universal primers are then hybridized to the templates and imaged to identify the location of 
each DNA feature. In the subsequent cyclic steps, fluorescently labeled nucleotides are incorporated 
by a polymerase, imaged, and then inactivated by photobleaching. Observations of single molecule 
fluorescence are made with a conventional microscope equipped with total internal reflection 
illumination, which reduces background fluorescence. In addition, single-pair fluorescence 
resonance energy transfer (spFRET) is used to minimize noise. The first incorporated nucleotide is 
labeled with a donor fluorophore (Cy3) and the subsequent nucleotides by an acceptor (Cy5). 
Excitation of the donor leads to fluorescence from acceptors within a limited spatial range that 
avoids unincorporated nucleotides on the slide. Photobleaching of the incorporated acceptors does 
not affect the donor flurophore, rendering it active for the next cycle. An implementation of this 
method by Helicos 216 is currently being adapted for commercialization. 
The DNA sequencer as a general-purpose laboratory tool. The launch and continued 
improvement of commercial and academic next-generation sequencing instruments have generated 
tremendous excitement in the DNA sequencing field. New applications that were effectively out of 
reach with traditional dideoxy sequencers are continually being developed and explored. 
Importantly, the promise of next-generation sequencing technologies extends far beyond deeper and 
more comprehensive cataloguing of genomes and genetic variation. Automated sequencing can in 
principle be used to capture the result of any assay for which the end product is a collection of DNA 
molecules that encode its outcome. It does not matter whether the DNA is naturally occurring or 
the product of a designed enzymatic process. As long as sequence reads are long enough to capture 
the information encoded in each DNA molecule, and throughput is sufficient to sample the collection 
to the required depth, a sequencing instrument can provide a high resolution, digital measurement of 
the assay result.  
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Contributions of this thesis 
We begin by describing a comparative analysis of the chimpanzee and human genomes (Chapter 2). 
The chimpanzee is the first non-human primate to be sequenced. We generate a nearly complete 
catalog of genetic changes that have occurred since our last common ancestor, and use this catalog 
to explore the magnitude and variation in mutational and selective forces acting on our genomes. 
We show that patterns of evolution in human and chimpanzee protein-coding genes are highly 
correlated, and dominated by the fixation of neutral and slightly deleterious alleles, as predicted by 
the nearly neutral theory of evolution 217. We find evidence of human-specific positive selection in 
genes encoding transcription factors and in regions devoid of protein-coding genes, which is 
consistent with the hypothesis that the accelerated anatomical evolution in the human lineage was 
driven by changes in gene regulation 132. 
 We next describe a comparative analysis of the dog genome with those of human and 
mouse (Chapter 3). We characterize patterns of gene and genome evolution in eutherian (placental) 
mammals, and provide strong support for the previous estimate 60 that 5% of the human genome has 
evolved under purifying selection since the last common ancestor of eutherian mammals, and that 
the majority of these sequences do not encode proteins. We show that the majority of highly 
conserved non-coding elements are clustered in large gene deserts surrounding a few hundred genes 
encoding developmental transcription factors, signaling molecules and axon guidance receptors. 
This suggests a model of mammalian genome organization where a large fraction of the highly 
conserved regulatory elements control a small set of key regulatory genes. 
 We next describe a comparative analysis of the opossum genome with those of human, 
mouse and dog (Chapter 4). As the first metatherian (marsupial) species to be sequenced, the 
opossum provides a much closer outgroup to the eutherian mammals than previously sequenced 
vertebrates. Our analysis reveals a sharp difference in evolutionary innovation between protein-
coding and non-coding elements. Lineage-specific differences in protein-coding gene content are 
rare and appear to be largely due to diversification and rapid turnover in gene families involved in 
environmental interactions. By contrast, one-fifth of the non-coding elements conserved in 
eutherian mammals are recent inventions that postdate the split from metatherians. A substantial 
proportion of these recent elements arose from sequence inserted by transposable elements, 
including tens of thousands of elements surrounding key regulatory genes, pointing to transposons 
as a major creative force in the evolution of mammalian gene regulation. 
 In order to uncover which bits of genomic information are utilized in a particular cell state, 
and to gain clues about their functions, we turn to biochemical analysis of proteins that interact with 
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and package DNA in the cell nucleus. We first develop a method for identifying proteins that 
recognize specific DNA sequences in vitro using affinity capture and mass spectrometry. Using this 
method, we discover sequence- and context-specific recruitment of proteins involved in chromatin 
remodeling to highly conserved non-coding elements (Chapter 5). We next characterize the 
chromatin state of selected loci enriched for highly conserved non-coding elements and key 
regulatory genes in pluripotent and differentiated cells using chromatin immunoprecipitation and 
microarray (ChIP-Chip) technology (Chapter 6). We describe a novel chromatin pattern, termed 
“bivalent domains”, which is associated with regulatory genes expressed at low levels and might 
contribute to maintaining embryonic stem (ES) cells in a pluripotent state. Moreover, we find a 
strong correlation between genome sequence and chromatin state in undifferentiated cells that 
become notably weaker upon differentiation. These results highlight the importance of DNA 
sequence in establishing the epigenomic landscape during development. 
 To facilitate more comprehensive analyses of chromatin state, we next develop methods for 
mapping protein-DNA interactions using chromatin immunoprecipitation and single-molecule 
based sequencing technology (ChIP-Seq; Chapter 7). We apply these methods to generate the first 
genome-wide maps of histone methylation patterns in undifferentiated and differentiated mouse 
cells. We identify three broad categories of promoters in the mouse genome based on their sequence 
composition and histone methylation patterns in ES cells, and show that lineage commitment is 
accompanied by characteristic chromatin changes that parallel changes in gene expression and 
transcriptional competence. We also demonstrate the potential for using characteristic histone 
methylation patterns to identify active genomic elements such as promoters, transcribed protein-
coding and non-coding genes, transposons, imprinting control regions and other distal regulatory 
elements.  
 To complement our studies of protein-DNA interactions, we next develop efficient methods 
for mapping DNA methylation across mammalian genomes using high-throughput reduced 
representation bisulfite sequencing (RRBS; Chapter 8). We show that DNA methylation is a 
dynamic chromatin modification that is closely correlated with histone methylation patterns and that 
undergoes extensive change during cellular differentiation, particularly in regulatory elements outside 
of core promoters. We also show that the majority of differences in DNA and histone methylation 
between cell types are found outside of promoters and protein coding-sequences, which provides 
additional support for the notion that the majority of functional elements in mammalian genomes do 
not encode proteins 60. Finally, we show that while developmentally regulated methylation of 
promoters is largely limited to imprinted and germ line-specific genes, extended culture of cells in 
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vitro can induce aberrant methylation of specific regulatory genes in a pattern similar to that 
observed in some primary tumors. 
 Finally, we explore direct reprogramming of somatic cells to an undifferentiated state using 
ectopic expression of transcription factors 218-220. We generate histone methylation, DNA 
methylation and gene expression profiles of mouse cells at different stages of this reprogramming 
process (Chapter 9). Our data suggest that cells may become trapped in partially reprogrammed 
states owing to incomplete repression of key regulatory genes, and that DNA de-methylation is an 
inefficient step in the transition to pluripotency. We show that inhibition of DNA methyltransferase 
can improve the efficiency of the reprogramming process, which supports the notion that chromatin 
modifications contribute to the stabilization of differentiated cell states. 
 Our results provide strong experimental support for some previous theories about genome 
evolution and function, and generate several novel hypotheses. In addition, our methods provide a 
technological framework for characterization of chromatin state across diverse mammalian cell 
populations. Insights from our studies are already guiding multiple large-scale efforts to 
comprehensively annotate the human genome, as well as the genomes of model organisms, and to 
further explore the relationship between chromatin and cellular state in development and disease. 
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Chapter 2: The chimpanzee genome 
 
In this chapter, we describe the first comprehensive comparative analysis of the human and 
chimpanzee genome sequences. 
This work was first published as  
The Chimpanzee Sequencing and Analysis Consortium (Mikkelsen, T. S. et al.). Initial sequence of 
the chimpanzee genome and comparison with the human genome. Nature 437, 69-87 (2005). 
This publication is attached as Appendix 1. Supplementary notes can be found at the end of the 
chapter. Supplementary data is available online from http://www.nature.com/nature 
The text was co-authored with analysis section leaders LaDeana W. Hillier (Genome Sequencing 
and Assembly), Evan E. Eichler (Insertions and Deletions, Transposable Element Insertions, Large-
scale rearrangements), Michael C. Zody (Human Population Genetics), with significant input from 
many members of the analysis consortium. 
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We present a draft genome sequence of the common chimpanzee (Pan troglodytes).  Through 
comparison with the human genome, we generate a largely complete catalog of the genetic 
differences that have accumulated since the human and chimpanzee species diverged from 
our common ancestor, constituting approximately 35 million single-nucleotide changes, 5 
million insertions and deletions, and various chromosomal rearrangements. We use this 
catalog to explore the magnitude and regional variation of mutational forces shaping these 
two genomes, and the strength of positive and negative selection acting on their genes. In 
particular, we find that the patterns of evolution in human and chimpanzee protein coding 
genes are highly correlated, and dominated by the fixation of neutral and slightly deleterious 
alleles. We also use the chimpanzee genome as an outgroup to investigate human population 
genetics and to identify signatures of selective sweeps in recent human evolution.   
More than a century ago Darwin1and Huxley2 posited that humans share recent common 
ancestors with the African great apes.  Modern molecular studies have spectacularly confirmed this 
prediction and have refined the relationships, showing that the common chimpanzee (Pan 
troglodytes) and bonobo (Pan paniscus or so-called pygmy chimpanzee) are our closest living 
evolutionary relatives3. Chimpanzees are thus especially suited to teach us about ourselves, both in 
terms of their similarities and differences with human. For example, Goodall’s pioneering studies 
on the common chimpanzee revealed startling behavioral similarities such as tool use and group 
aggression4,5. By contrast, other features are obviously specific to human including habitual 
bipedality, a greatly enlarged brain and complex language5. Important similarities and differences 
have also been noted for the incidence and severity of several major human diseases6. 
Genome comparisons of human and chimpanzee can help to reveal the molecular basis for 
these traits as well as the evolutionary forces that have molded our species, including underlying 
mutational processes and selective constraints. Early studies sought to draw inferences from sets of 
a few dozen genes 7-9, while recent studies have examined larger datasets such as protein-coding 
exons 10, random genomic sequences 11,12, and an entire chimpanzee chromosome13.  
Here, we report a draft sequence of the genome of the common chimpanzee, and undertake 
comparative analyses with the human genome. This comparison differs fundamentally from recent 
comparative genomic studies of mouse, rat, chicken and fish 14-17. Because the latter species have 
diverged substantially from the human lineage, the focus in such studies is on accurate alignment of 
the genomes and recognition of regions of unusually high evolutionary conservation to pinpoint 
functional elements. Because the chimpanzee lies at such a short evolutionary distance, nearly all of 
the bases are identical by descent and sequences can be readily aligned except in recently derived, 
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large repetitive regions. The focus thus turns to differences rather than similarities. An observed 
difference at a site nearly always represents a single event, not multiple independent changes over 
time. Most of the differences reflect random genetic drift, and thus they hold extensive information 
about mutational processes and negative selection that can be readily mined with current analytical 
techniques. Hidden among the differences is a minority of functionally important changes that 
underlie the phenotypic differences between the two species. Our ability to distinguish such sites is 
currently quite limited, but the catalog of human-chimpanzee differences opens this issue to 
systematic investigation for the first time. We would also hope that, in elaborating the few 
differences that separate the two species, we will increase pressure to save chimpanzees and other 
great apes in the wild. 
Our results confirm many earlier observations, but notably challenge some previous claims 
based on more limited data. The genome-wide data also allow some questions to be addressed for 
the first time. (Here and throughout, we refer to chimpanzee-human comparison as representing 
hominids and mouse-rat comparison as representing murids. Of course, each pair covers only a 
subset of the clade). The key findings include: 
• Single-nucleotide substitutions occur at a mean rate of 1.23% between copies of the human 
and chimpanzee genome, with 1.06% or less corresponding to fixed divergence between the 
species.  
• Regional variation in nucleotide substitution rates is conserved between the hominid and 
murid genomes, but rates in subtelomeric regions are disproportionately elevated in the hominids. 
• Substitutions at CpG dinucleotides, which constitute a quarter of all observed substitutions, 
occur at more similar rates in the male and female germ-lines than non-CpG substitutions. 
• Insertion and deletion (indel) events are fewer in number than single-nucleotide 
substitutions, but result in ~1.5% of the euchromatic sequence in each species being lineage-
specific.  
• There are notable differences in the rate of transposable element insertions: SINEs have 
been three-fold more active in humans, while chimpanzees have acquired two new families of 
retroviral elements. 
• Orthologous proteins in human and chimpanzee are extremely similar, with ~29% being 
identical and the typical ortholog differing by only two amino acids, one per lineage. 
• The normalized rates of amino acid altering substitutions in the hominid lineages are 
elevated relative to the murid lineages, but close to that seen for common human polymorphisms, 
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implying that positive selection during hominid evolution accounts for a smaller fraction of protein 
divergence than suggested in some previous reports.  
• The substitution rate at silent sites in exons is lower than the rate at nearby intronic sites, 
consistent with weak purifying selection on silent sites in mammals.  
• Analysis of the pattern of human diversity relative to hominid divergence identifies several 
loci as potential candidates for strong selective sweeps in recent human history. 
In this paper, we begin with information about the generation, assembly and evaluation of the 
draft genome sequence. We then explore overall genome evolution, with the aim of understanding 
mutational processes at work in the human genome. We next focus on the evolution of protein-
coding genes, with the aim of characterizing the nature of selection. Finally, we briefly discuss 
initial insights into human population genetics.  
In recognition of its strong community support, we will refer to chimpanzee chromosomes 
using the orthologous numbering nomenclature proposed by McConkey 18, which renumber the 
chromosomes of the great apes from the ICSN (1978) standard to directly correspond to their 
human orthologs, using the terms 2A and 2B for the two ape chromosomes corresponding to human 
chromosome 2. 
 
Genome Sequencing and Assembly 
We sequenced the genome of a single male chimpanzee (“Clint”; Yerkes pedigree number C0471), 
a captive-born descendant of chimpanzees from the West Africa sub-species (Pan troglodytes 
verus), using a whole-genome shotgun (WGS) approach 19,20. The data were assembled using both 
the PCAP and ARACHNE programs 21,22 (see Supplementary Information).  The former was a 
de novo assembly, while the latter made limited use of human genome sequence (NCBI build 34) 
23,24 to facilitate and confirm contig linking. The ARACHNE assembly has slightly greater 
continuity (Table 1) and was used for analysis in this paper. The draft genome assembly, generated 
from ~3.6-fold sequence redundancy of the autosomes, and ~1.8-fold redundancy of both sex 
chromosomes, covers ~94% of the chimpanzee genome with >98% of the sequence in high-quality 
bases. 50% of the sequence (N50) is contained in contigs of length greater than 15.7 kb and 
supercontigs of length greater than 8.6 Mb. The assembly represents a consensus of two haplotypes, 
with one allele from each heterozygous position arbitrarily represented in the sequence.  
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Table 1: Chimpanzee Assembly Statistics  
Assembler PCAP ARACHNE 
Major contigs1 400,289 361,782 
Contig length (N50)2 13.3 Kb 15.7 Kb 
Supercontigs 67,734 37,846 
Supercontig length (N50) 2.3 Mb 8.6 Mb 
Sequence redundancy: all bases (Q20) 5.0x (3.6x) 4.3x (3.6x) 
Physical redundancy 20.7 19.8 
Consensus bases 2.7 Gb 2.7 Gb 
1Contigs > 1 kb. 2N50 length is the size x such that 50% of the assembly is in units of length at least x. 
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Assessment of Quality and Coverage 
The chimpanzee genome assembly was subjected to rigorous quality assessment, based on 
comparison to finished chimpanzee BACs and to the human genome (see Supplementary Notes). 
Nucleotide-level accuracy is high by several measures. About 98% of the chimpanzee 
genome sequence has quality scores 25 of at least 40 (Q40), corresponding to an error rate of ≤ 10-4. 
Comparison of the WGS sequence to 1.3 Mb of finished BACs from the sequenced individual is 
consistent with this estimate, giving a high-quality discrepancy rate of 3 x 10-4 substitutions and 2 x 
10-4 indels, which is no more than expected given the heterozygosity rate (see below) since 50% of 
the polymorphic alleles in the WGS sequence will differ from the single-haplotype BACs. 
Comparison of protein coding regions aligned between the WGS sequence, the recently published 
sequence of chromosome 21 13 (formerly chromosome 22 18) and the human genome, also revealed 
no excess of substitutions in the WGS sequence (see Supplementary Notes). Thus, by restricting our 
analysis to high-quality bases, the nucleotide-level accuracy of the WGS assembly is essentially 
equal to that of ‘finished’ sequence.   
Structural accuracy is also high based on comparison with finished BACs from the primary 
donor and other chimpanzees, although the relatively low level of sequence redundancy limits local 
contiguity. Based on comparisons with the primary donor, some small supercontigs (most < 5kb) 
have not been positioned within large supercontigs (~1 event per 100 kb); these are not strictly 
errors but nonetheless affect the utility of the assembly. There are also small, undetected overlaps 
(all < 1kb) between consecutive contigs (~1.2 events per 100 kb) and occasional local misordering 
of small contigs (~0.2 events per 100 kb). No misoriented contigs were found. Comparison with the 
finished chromosome 21 sequence yielded similar discrepancy rates (see Supplementary 
Information). 
The most problematic regions are those containing recent segmental duplications. Analysis of 
BAC clones from duplicated (n=75) and unique (n=28) regions showed that the former tend to be 
fragmented into more contigs (1.6-fold) and more supercontigs (3.2-fold). Discrepancies in contig 
order are also more frequent in duplicated than unique regions (~0.4 vs. ~0.1 events per 100 kb). 
The rate is two-fold higher in duplicated regions with the highest sequence identity (>98%). If we 
restrict the analysis to older duplications (<=98% identity) we find fewer assembly problems: 72% 
of those that can be mapped to the human genome are shared as duplications in both species. These 
results are consistent with the described limitations of current WGS assembly for regions of 
segmental duplication 26.  
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Chimpanzee Polymorphisms  
The draft sequence of the chimpanzee genome also facilitates genome-wide studies of genetic 
diversity among chimpanzees, extending recent work 27-30.  We analyzed sequence reads from the 
primary donor, four other western and three central chimpanzees (Pan troglodytes troglodytes) to 
discover polymorphic positions within and between these individuals (see Supplementary 
Information).  
A total of 1.66 million (M) high-quality single nucleotide polymorphisms (SNPs) were 
identified, of which 1.01 M are heterozygous within the primary donor, Clint. Heterozygosity rates 
were estimated to be 9.5 x 10-4 for Clint, 8.0 x 10-4 among western chimpanzees and 17.6 x 10-4 
among central chimpanzees, with the variation between western and central chimpanzees being 19.0 
x 10-4. The diversity in western chimpanzees is similar to that seen for human populations 31, while 
the level for central chimpanzees is roughly twice as high.  
The observed heterozygosity in Clint is broadly consistent with western origin, although there 
are a small number of regions of distinctly higher heterozygosity. These may reflect a small amount 
of central ancestry, but more likely reflect undetected regions of segmental duplications present 
only in chimpanzees. 
 
Genome Evolution 
We set out to study the mutational events that have shaped the human and chimpanzee genomes 
since their last common ancestor. We explored changes at the level of single nucleotides, small 
insertions and deletions, interspersed repeats and chromosomal rearrangements. The analysis is 
nearly definitive for the smallest changes, but is more limited for larger changes, particularly 
lineage-specific segmental duplications, owing to the draft nature of the genome sequence.   
 
Nucleotide Divergence  
Best reciprocal nucleotide-level alignments of the chimpanzee and human genomes cover ~2.4 Gb 
of high quality sequence, including 89 Mb from chromosome X and 7.5 Mb from chromosome Y. 
Genome-wide rates. We calculate the genome-wide nucleotide divergence between human 
and chimpanzee to be 1.23%, confirming recent results from more limited studies 12,32,33. The 
differences between one copy of the human genome and one copy of the chimpanzee genome 
include both the sites of fixed divergence between the species and some polymorphic sites within 
each species. By correcting for the estimated coalescence times in the human and chimpanzee  
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Figure 1. Human-chimpanzee divergence in 1 Mb segments across the genome. 
(a) Distribution of divergence of the autosomes (blue), the X chromosome (red) 
and the Y chromosome (green). (b) Distribution of variation by chromosome, 
shown as a box plot; the edges of the box correspond to quartiles; the notches to 
the standard error of the median; and the whiskers to the range. The X and Y 
chromosomes are clear outliers, but there is also high local variation within 
each of the autosomes.
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populations (see Supplementary Information), we estimate that polymorphism accounts for 14-22% 
of the observed divergence rate and thus that the fixed divergence is ~1.06% or less.  
Nucleotide divergence rates are not constant across the genome, as has been seen in 
comparisons of the human and murid genomes 16,17,24,34,35. The average divergence in 1 Mb 
segments fluctuates with a standard deviation of 0.25% (coefficient of variation, CV = 0.20), which 
is much greater than the 0.02% expected assuming a uniform divergence rate (Figure 1a; Figure 2). 
Regional variation in divergence could reflect local variation in either mutation rate or other 
evolutionary forces. Among the latter, one important force is genetic drift, which can cause 
substantial differences in divergence time across loci when comparing closely related species, since 
the divergence time for orthologs is the sum of two terms: t1, the time since speciation, and t2, the 
coalescence time for orthologs within the common ancestral population 36. While t1 is constant 
across loci (~6-7 Mya 37), t2 is a random variable that fluctuates across loci (with a mean that 
depends on population size and here may be on the order of 1-2 million years 38). However, because 
of historical recombination, the characteristic scale of such fluctuations will be on the order of tens 
of kb, which is too small to account for the variation observed for 1 Mb regions39 (see 
Supplementary Notes). Other potential evolutionary forces are positive or negative selection. While 
it is more difficult to quantify the expected contributions of selection in the ancestral population 40-
42, it is clear that the effects would have to be very strong to explain the large-scale variation 
observed across mammalian genomes 16,43. There is tentative evidence from in-depth analysis of 
divergence and diversity that natural selection is not the major contributor to the large-scale patterns 
of genetic variability in humans 44-46. For these reasons, we suggest that the large-scale variation in 
the human-chimpanzee divergence rate primarily reflect regional variation in mutation rate. 
Chromosomal variation in divergence rate. Variation in divergence rate is evident even at 
the level of whole chromosomes (Figure 1b). The most striking outliers are the sex chromosomes, 
with a mean divergence of 1.9% for chromosome Y and 0.94% for chromosome X.  The likely 
explanation is a higher mutation rate in the male vs. female germline 47. Indeed, the ratio of the 
male-female mutation rates (denoted α) can be estimated by comparing the divergence rates among 
the sex chromosomes and the autosomes and correcting for ancestral polymorphism as a function of 
population size of the most recent common ancestor (MRCA; see Supplementary Notes. Estimates 
for α range from 3-6, depending on the chromosomes compared and the assumed ancestral 
population size. This is significantly higher than recent estimates of α in the murids (~1.9) 17and 
resolves a recent controversy based on smaller datasets 12,24,48,49. 
Figure 2. Distribution of observed (blue) and Poisson expectation (red)
standard deviations of human-chimpanzee divergence over different
window sizes. The observed variation is consistently larger than expected,
but sample variance starts to increase rapidly in windows less than
~250 kb.  
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The higher mutation rate in the male germline is generally attributed to the 5-6-fold higher 
number of cell divisions undergone by male germ cells 47. We reasoned that this would affect 
mutations resulting from DNA replication errors (the rate should scale with the number of cell 
divisions) but not mutations resulting from DNA damage such as deamination of methyl CpG to 
TpG (the rate should scale with time). Accordingly, we calculated α separately for CpG sites, 
obtaining a value of ~2 from the comparison of rates between autosomes and chromosome X. This 
intermediate value is a composite of the rates of CpG loss and gain, and is consistent with roughly 
equal rates of CpG to TpG transitions in the male and female germ-line 50,170. 
Significant variation in divergence rates is also seen among autosomes (Figure 1b; p < 3 x 10-
15, Kruskal-Wallis test over 1 Mb windows), confirming earlier observations based on low-coverage 
WGS sampling 12. Additional factors thus influence the rate of divergence between chimpanzee and 
human chromosomes. These factors are likely to act at length scales significantly shorter than a 
chromosome, because the standard deviation across autosomes (0.21%) is comparable to the 
standard deviation seen in 1 Mb windows across the genome (0.13-0.35%). We therefore sought to 
understand local factors that contribute to variation in divergence rate. 
Contribution of CpG dinucleotides. Sites containing CpG dinucleotides in either species 
show a substantially elevated divergence rate of 15.2% per base; they account for 25.2% of all 
substitutions while constituting only 2.1% of all aligned bases. The divergence at CpG sites 
represents both the loss of ancestral CpGs and the creation of new CpGs. The former process is 
known to occur at a rapid rate per base due to frequent methylation of cytosines in a CpG context 
and their frequent deamination 51,52, whereas the latter process likely proceeds at a rate more typical 
of other nucleotide substitutions. Assuming that loss and creation of CpG sites are close to 
equilibrium, the mutation rate for bases in a CpG dinucleotide must be 10-12-fold higher than for 
other bases (see Supplementary Notes and ref. 50).  
Because of the high rate of CpG substitutions, regional divergence rates would be expected to 
correlate with regional CpG density. CpG density indeed varies across 1 Mb windows (mean = 
2.1%, CV = 0.44 vs. 0.0093 expected under a Poisson distribution), but only explains 4% of the 
divergence rate variance. In fact, regional CpG and non-CpG divergence is highly correlated (r = 
0.88; Figure 3), suggesting that higher-order effects modulate the rates of two very different 
mutation processes (see also ref. 46).  
Figure 3. Co-variation of the divergence rate of different sequence classes
in sliding 1 Mb windows. CpG and non-CpG divergence is highly correlated.
As is repetitive and non-repetitive sequence divergence. 
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Increased divergence in distal regions. The most striking regional pattern is a consistent 
increase in divergence towards the ends of most chromosomes (Figure 4).  The terminal 10 Mb of 
chromosomes (including distal regions and proximal regions of acrocentric chromosomes) averages 
15% higher divergence than the rest of the genome (pMW < 10-30), with a sharp increase towards the 
telomeres. The phenomenon correlates better with physical distance than relative position along the 
chromosomes and may partially explain why smaller chromosomes tend to have higher divergence 
(Figure 5; see also ref. 15). These observations suggest that large-scale chromosomal structure, 
directly or indirectly, influences regional divergence patterns. The cause of this effect is unclear, but 
these regions (~15% of the genome) are notable in having high local recombination rate, high gene 
density and high GC content. 
Correlation with chromosome banding. Another interesting pattern is that divergence 
increases with the intensity of Giemsa staining in cytogenetically-defined chromosome bands, with 
the regions corresponding to Giemsa dark bands (G-bands) showing 10% higher divergence than 
the genome-wide average (pMW < 10-14) (e.g. Figure 4). In contrast to terminal regions, these regions 
(17% of the genome) tend to be gene-poor, GC-poor and low in recombination53,54. The elevated 
divergence seen in two such different types of regions suggests that multiple mechanisms are at 
work, and that no single known factor, such as GC content or recombination rate, is an adequate 
predictor of regional variation in the mammalian genome by itself (Figure 6). Elucidation of the 
relative contributions of these and other mechanisms will be important in formulating accurate 
models for population genetics, natural selection, divergence times and the evolution of genome-
wide sequence composition 55. 
Correlation with regional variation in the murid genome. Given that sequence divergence 
shows regional variation in both hominids (human-chimpanzee) and murids (mouse-rat), we asked 
whether the regional rates are positively correlated between orthologous regions. Such a correlation 
would suggest that the divergence rate is driven, in part, by factors that have been conserved over 
the ~75 Myr since rodents, humans and apes shared a common ancestor. Comparative analysis of 
the human and murid genomes has suggested such a correlation 56-58, but the chimpanzee sequence 
provides the first direct opportunity to compare independent evolutionary processes between two 
mammalian clades. 
We compared the local divergence rates in hominids and murids across major orthologous 
segments in the respective genomes (Figure 7). For orthologous segments that are non-distal in both 
hominids and murids, there is a strong correlation between the divergence rates (r = 0.5, p < 10-11). 
In contrast, orthologous segments that are centered within 10 Mb of a hominid telomere have  
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Figure 4. Regional variation in divergence rates. Human-chimpanzee 
divergence (blue), GC content (green) and human recombination rates [169] 
(red) in sliding 1 Mb windows for human and chimpanzee chromosome 1. 
Divergence and GC content is noticeably elevated near the 1p telomere, a 
trend that holds for most subtelomeric regions (see text). Internally on the 
chromosome, regions of low GC content and high divergence often 
correspond to the dark G-bands.
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disproportionately high divergence rates and GC content relative to the murids (pMW < 10-11 and 
pMW < 10-4), implying that the elevation in these regions is, at least partially, lineage-specific. The 
same general effect is observed (albeit less pronounced) if CpG dinucleotides are excluded (Figure 
8). Increased divergence and GC content might be explained by “biased gene conversion” 59 due to 
the high hominid recombination rates in these distal regions. Segments that are distal in murids do 
not show elevated divergence rates, which is consistent with this model, because the recombination 
rates of distal regions are not as elevated in mouse and rat 60.   
Taken together, these observations suggest that sequence divergence rate is influenced by 
both conserved factors (stable across mammalian evolution) and lineage-specific factors (such as 
proximity to the telomere or recombination rate, which may change with chromosomal 
rearrangements). 
 
Insertions and Deletions 
We next studied the indel events that have occurred in the human and chimpanzee lineage by 
aligning the genome sequences to identify length differences. We will refer below to all events as 
insertions relative to the other genome, although they may represent insertions or deletions relative 
to the genome of the common ancestor. 
The observable insertions fall into two classes: (i) ‘completely covered’ insertions, 
occurring within continuous sequence in both species, and (ii) ‘incompletely covered’ insertions, 
occurring within sequence containing one or more gaps in the chimpanzee, but revealed by a clear 
discrepancy between the species in sequence length. Somewhat different methods are needed for 
reliable identification of modest-size insertions (1 base to 15 kb) and large insertions (>15 kb), with 
the latter only being reliably identifiable in the human genome (see Supplementary Information). 
The analysis of modest-sized insertions reveals ~32 Mb of human-specific sequence and 
~35 Mb of chimpanzee-specific sequence, contained in ~5 M events in each species (Supplementary 
Notes and Figure 9). Nearly all of the human insertions are completely covered, whereas only half 
of the chimpanzee insertions are completely covered. Analysis of the completely covered insertions 
shows that the vast majority are small (45% of events cover only 1 bp, 96% are < 20 bp, and 98.6% 
are <80 bp), but that the largest few contain the majority of the sequence (with the ~70,000 indels 
larger than 80 bp comprising 73% of the affected bp) (Figure 10). The latter indels >80 bp fall into 
three categories: about one-quarter are newly inserted transposable elements; more than a third are 
due to microsatellite and satellite sequences; and the remainder are assumed to be mostly deletions 
in the other genome. 
Figure 5. Correlation between human-chimpanzee divergence and distance
to the closest telomere for 1 Mb windows on metacentric (a) or acrocentric (b)
chromosomes. Each dot corresponds to a unique 1 Mb window. The colors of 
the dots represent their mean recombination rate (red = highest, dark blue =
lowest).
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The analysis of larger insertions (>15 kb) identified 163 human regions, containing 8.3 Mb of 
human-specific sequence (Figure 11). These cases include 34 regions that involve exons from 
known genes, which are discussed in a subsequent section. Although we have no direct measure of 
large insertions in the chimpanzee genome, it appears likely that the situation is similar. 
Based on this analysis, we estimate that the human and chimpanzee genomes each contain 
40-45 Mb of species-specific euchromatic sequence, and the indel differences between the genomes 
thus total ~90 Mb. This difference corresponds to ~3% of both genomes and dwarfs the 1.23% 
differences resulting from nucleotide substitution; this confirms and extends several recent studies 
61-64,65. Of course, the number of indel events is far fewer than the number of substitution events (~5 
million vs. ~35 million). 
 
Transposable Element Insertions  
We next used the catalog of lineage-specific transposable element copies to compare the activity of 
transposons in the human and chimpanzee lineages (Table 2).  
Endogenous Retroviruses. Endogenous retroviruses (ERVs) have become all but extinct in 
the human lineage, with only a single retrovirus (HERV-K) still active24. HERV-K was found to be 
active in both lineages, with at least 73 human-specific insertions (7 full length and 66 solo LTRs) 
and at least 44 chimpanzee-specific insertions (1 full length and 44 solo LTRs). A few other ERV 
classes persisted in the human genome beyond the human-chimpanzee split, leaving ~9 human-
specific insertions (all solo LTRs, including five HERV9) before dying out.  
Against this background, it was surprising to find that the chimpanzee genome has two active 
retroviral elements (PtERV1, PtERV2) that are unlike any older elements in either genome; these 
must have been introduced by infection of the chimpanzee germline. The smaller family (PtERV2) 
has only a few dozen copies, which nonetheless represent multiple (~5-8) invasions, because the 
sequence differences among reconstructed subfamilies is too great (~8%) to have arisen by mutation 
since divergence from human. It is closely related to a baboon endogenous retrovirus (BaEV, 88% 
ORF2 product identity) and a feline endogenous virus (ECE-1, 86% ORF2 product identity). The 
larger family (PtERV1) is more homogeneous and has over 200 copies. While older ERVs, like 
HERV-K above, are primarily represented by solo LTRs, resulting from LTR-LTR recombination, 
more than half of the PtERV1 copies are still full-length, likely reflecting the young age of the 
elements. PtERV1-like elements are present in the rhesus monkey, olive baboon and African great 
apes but not in human, orangutan or gibbon, suggesting separate germline invasions in these 
species66. 
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Figure 6. Divergence rates vs. GC content for 1 Mb segments across the 
autosomes.  Conditional on recombination rate, the relationship between 
divergence and GC content varies. In regions with recombination rates less 
than 0.8 cM/Mb (blue), there is an inverse relationship, where high divergence 
regions tend to be GC-poor and low divergence regions tend to be GC-rich.  
In regions with recombination rates greater than 2.0 cM/Mb, whether within 10 
Mb (red) or proximal (green) of chromosome ends, both divergence and GC-
content are uniformly high.
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Table 2: Transposable element activity in the human and chimpanzee lineages 
Element Chimpanzee1 Human1 
Alu 2340  (0.7 Mb)  7082  (2.1 Mb) 
LINE1 1979  ( >5 Mb)  1814  (5.0 Mb) 
SVA  757   ( >1 Mb)    970   (1.3 Mb) 
ERV class 1  234   ( >1 Mb) 2        5   (    8 kb) 3 
ERV class 2    45   (   55 kb) 4      77  ( 130 kb) 4 
(Micro)satellite 7054  (4.1 Mb) 11101  (5.1 Mb) 
 
1 Number of lineage-specific insertions (total size of inserted sequences) in the aligned parts of the genomes. 2 
PtERV1 and PtERV2. 3 HERV9. 4 Mostly HERV-K. 
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Figure 7. Disproportionately elevated divergence and GC content near 
hominid telomeres. Scatter plot of the ratio of human-chimpanzee divergence 
over mouse-rat divergence vs. the ratio of human GC-content over mouse 
GC-content across 199 syntenic blocks for which more than 1 Mb of sequence 
could be aligned between all four species.  Blocks whose center is within 10 Mb 
of a telomere in hominids only (green) or in hominids and murids (magenta), 
but not in murids only (light blue), show a significant trend towards higher ratios 
than internal blocks (blue). Blocks on the X chromosome (red) tend to show a 
lower divergence ratio than autosomal blocks, consistent with a smaller difference 
between autosomal and X divergence in murids than in hominids (lower α). 
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Higher Alu activity in humans. SINE (Alu) elements have been three-fold more active in 
humans than chimpanzee (~7000 vs. ~2300 lineage-specific copies in the aligned portion), refining 
the rather broad range (2-7-fold) estimated in smaller studies 13,65,67 .  Most chimpanzee-specific 
elements belong to a subfamily (AluYc1) that is very similar to the source gene in the common 
ancestor. By contrast, most human-specific Alus belong to two new subfamilies (AluYa5 and 
AluYb8) that have evolved since the chimpanzee-human divergence and differ substantially from 
the ancestral source gene 67. It seems likely that the resurgence of Alu elements in humans is due to 
these potent new source genes. However, based on an examination of finished sequence, the baboon 
shows a 1.6 fold higher Alu activity relative to human new insertions, suggesting that there may 
also have been a general decline in activity in the chimpanzee 65. 
Some of the human-specific Alus are highly diverged (92 with > 5% divergence), which 
would seem to suggest that they are much older than the human-chimpanzee split. Possible 
explanations include: gene conversion by nearby older elements; processed pseudogenes arising 
from a spurious transcription of an older element; precise excision from the chimpanzee genome; or 
high local mutation rate. In any case, the presence of such anomalies suggests that caution is 
warranted in the use of single repeat elements as homoplasy-free phylogenetic markers. 
New Alus target AT-rich DNA in human and chimpanzee genomes. Older SINE elements 
are preferentially found in gene-rich, GC-rich regions whereas young SINE elements are found in 
gene-poor AT-rich regions where LINE-1 (L1) copies also accumulate24,68. The latter distribution is 
consistent with the fact that Alu retrotransposition depends on L1 proteins69. Murid genomes 
revealed no change in SINE distribution with age17.  
The human pattern could reflect either preferential retention of SINEs in GC-rich regions, 
due to selection or mutation bias, or a recent change in Alu insertion preferences. With the 
availability of the chimpanzee genome, it is possible to classify the youngest Alu copies more 
accurately and thus to begin to distinguish these possibilities. 
Analysis shows that lineage-specific SINEs in both human and chimpanzee are biased toward 
AT-rich regions, as opposed to even the most recent copies in the MRCA (Figure 12). This strongly 
favors that SINEs are indeed preferentially retained in GC-rich DNA, but comparison with a more 
distant primate is required to formally rule out that the insertion bias of SINEs did not change just 
prior to speciation. 
Figure 8. The ratio of human-chimpanzee non-CpG divergence over mouse-
rat divergence vs. the ratio of human GC-content over mouse GC-content across
199 syntenic blocks greater than 1 Mb. Hominid-specific acceleration in 
subtelomeric blocks is evident even when ignoring CpG sites.
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Equal activity of L1 in both species. The human and chimpanzee genomes both show 
~2000 lineage-specific L1 elements, contrary to previous estimates based on small samples that L1 
activity is 2-3-fold higher in chimpanzee 70 .  
Transcription from L1 source genes can sometimes continue into 3’ flanking regions, which 
can then be co-transposed 71,72 . Human-chimpanzee comparison revealed that ~15% of the species-
specific insertions appear to have carried with them at least 50 bp of flanking sequence (followed by 
a polyA tail and a target site duplication). In principle, incomplete reverse transcription could result 
in insertions of the flanking sequence only (without any L1 sequence) mobilizing gene elements 
such as exons, but we found no evidence of this. 
Retrotransposed gene copies. The L1 machinery also mediates retrotransposition of host 
mRNAs, resulting in many intron-less (processed) pseudogenes in the human genome 73-75. We 
identified 163 lineage-specific retrotransposed gene copies in human and 246 in chimpanzee. 
Correcting for incomplete sequence coverage of the chimpanzee genome, we estimate that there are 
~200 and ~300 processed gene copies in human and chimpanzee, respectively. Processed genes thus 
appear to have arisen at a rate of ~50 per Myr since the divergence of human and chimpanzee; this 
is lower than the estimated rate for early primate evolution 73, perhaps reflecting the overall 
decrease in L1 activity. As expected 76, ribosomal protein genes constitute the largest class in both 
species.  The second largest class in chimpanzee corresponds to zinc finger C2H2 genes, which are 
not a major class in the human genome. 
The retroposon SVA and distribution of CpG islands by transposable elements. The 
third most active element since speciation has been SVA, which created about 1000 copies in each 
lineage. SVA is a composite element (~1.5-2.5 kb) consisting of two Alu fragments, a tandem 
repeat and a region apparently derived from the 3’ end of a HERV-K transcript; it is likely 
mobilized by L177,78. This element is of particular interest because each copy carries a sequence that 
satisfies the definition of a CpG island79 and contains potential transcription factor binding sites; the 
dispersion of 1000 SVA copies could therefore be a source of regulatory differences between 
chimpanzee and human. At least three human genes contain SVA insertions near their promoters, 
one of which have been found to be differentially expressed between the two species 80 81, but 
additional investigations will be required to determine if the SVA insertion directly caused this 
difference. 
Homologous recombination between interspersed repeats. Human-chimpanzee 
comparison also makes it possible to study homologous recombination between nearby repeat 
elements as a source of genomic deletions. We found 612 deletions (totaling 2Mb) in the human  
Figure 9. Length distribution of small indels (< 15 kb) detected within scaffolds
(a and d) or contigs only (b and c). For chimpanzee “insertions”, the former is an
over-estimate of the number of actual indels due to assembly artifacts, whereas
the latter is an under-estimate, due to the small contig size.
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genome that appear to have resulted from recombination between two nearby Alus present in the 
common ancestor and 914 such events in the chimpanzee genome. (The events are not biased to 
AT-rich DNA and thus would not explain the preferential loss of Alus in such regions discussed 
above). Similarly, we found 26 and 48 instances involving adjacent L1 copies and 8 and 22 
instances involving retroviral LTRs in human and chimpanzee, respectively. None of the repeat 
mediated deletions removed an orthologous exon of a known human gene in chimpanzee. 
The genome comparison allows one to estimate the dependency of homologous 
recombination on divergence and distance. Homologous recombination appears to occur between 
quite (>25%) diverged copies (Figure 13), while the number of recombination events (n) varies 
inversely with the distance (d, in bases) between the copies (as n ≈ 6 x 106 d-1.7; r2 = 0.9). 
 
Large Scale Rearrangements 
Finally, we examined the chimpanzee genome sequence for information about large-scale genomic 
alterations. Cytogenetic studies have shown that human and chimpanzee chromosomes differ by 
one chromosomal fusion, at least nine pericentric inversions, and in the content of constitutive 
heterochromatin 82.  Human chromosome 2 resulted from a fusion of two ancestral chromosomes 
that remained separate in the chimpanzee lineage (chromosomes 2A and 2B in the revised 
nomenclature 18 , formerly chimpanzee chromosomes 12 and 13); the precise fusion point has been 
mapped and its duplication structure described in detail 83,84. In accord with this, alignment of the 
human and chimpanzee genome sequences shows a break in continuity at this point.   
We searched the chimpanzee genome sequence for the precise locations of the 18 breakpoints 
corresponding to the 9 pericentric inversions.  By mapping paired-end sequences from chimpanzee 
large insert clones to the human genome, we were able to identify 13 of the breakpoints within the 
assembly from discordant end alignments. The positions of five breakpoints (on chromosomes 4, 5, 
and 12) were tested by FISH analysis and all were confirmed. Also, the positions of three 
previously mapped inversion breakpoints (on chromosomes 15 and 18) matched closely those found 
in the assembly 85,86. The paired-end analysis works well in regions of unique sequence, which 
constitute the bulk of the genome, but is less effective in regions of recent duplication due to 
ambiguities in mapping of the paired-end sequences. Beyond the known inversions, we also found 
suggestive evidence of many additional smaller inversions, as well as older segmental duplications 
(< 98% identity). However, both smaller inversions and more recent segmental duplications will 
require further investigations. 
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Figure 10. Length distribution of small insertion-deletion events (<15 kb), as 
determined using bounded sequence gaps. Sequences present in chimpanzee 
but not in human (blue) or present in human but not in chimpanzee (red) are 
shown. The prominent spike around 300 nucleotides corresponds to SINE
insertion events. The vast majority of indels are smaller than 20 bp, but larger 
indels account for the bulk of lineage-specific sequence in the two genomes.
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Gene Evolution 
We next sought to use the chimpanzee sequence to study the role of natural selection in the 
evolution of human protein coding genes. Genome-wide comparisons can shed light on many 
central issues, including: the magnitude of positive and negative selection; the variation in selection 
across different lineages, chromosomes, gene families and individual genes; and the complete loss 
of genes within a lineage.    
We began by identifying a set of 13,454 pairs of human and chimpanzee genes with 
unambiguous 1:1 orthology for which it was possible to generate high-quality sequence alignments 
covering virtually the entire coding region (see Supplementary Notes). The list contains a large 
fraction of the entire complement of human genes, although it underrepresents gene families that 
have undergone recent local expansion (such as olfactory receptors and immunoglobins). To 
facilitate comparison with the murid lineage, we also compiled a set of 7,043 human, chimpanzee, 
mouse and rat genes with unambiguous 1:1:1:1 orthology and high-quality sequence alignments.  
 
Average Rates of Evolution 
To assess the rate of evolution for each gene, we estimated Ka, the number of coding base 
substitutions that result in amino acid change as a fraction of all such possible sites (the non-
synonymous substitution rate). Because the background mutation rate varies across the genome, it is 
crucial to normalize Ka for comparisons between genes. A striking illustration of this variation is the 
fact that the mean Ka is 37% higher in the rapidly diverging distal 10 Mb of chromosomes than in 
the more proximal regions. Classically, the background rate is estimated by Ks, the synonymous 
substitution rate (coding base substitutions that because of codon redundancy do not result in amino 
acid change). Because a typical gene has only a few synonymous changes between humans and 
chimpanzees, and not infrequently is zero, we exploited the genome sequence to estimate the local 
intergenic/intronic substitution rate, Ki, where appropriate. Ka and Ks were also estimated for each 
lineage separately using mouse and rat as outgroups (Figure 14). 
The Ka/Ks ratio is a classical measure of the overall evolutionary constraint on a gene, where 
Ka/Ks << 1 indicates that a substantial proportion of amino acid changes must have been eliminated 
by purifying selection. Under the assumption that synonymous substitutions are neutral, Ka/Ks > 1 
implies, but is not a necessary condition for, adaptive or positive selection. The Ka/Ki ratio has the 
same interpretation. The ratios will sometimes be denoted below by ω with an appropriate subscript 
(for example, ωhuman) to indicate the branch of the evolutionary tree under study. 
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Table 3: Comparison of Ka/Ks for divergence and human diversity 
 ∆A ∆S Ka/Ks % excess1 CI2 
Human-chimpanzee divergence 38773 61737 0.23 - - 
HapMap (European ancestry)3      
Rare derived alleles (< 15%) 1614 1540 0.39 67 [ 59, 75] 
Common alleles 1199 1907 0.23 0 [  -5,  6] 
Frequent derived alleles (> 85%) 209 356 0.22 -7 [-19,  7] 
HapMap (African ancestry)3      
Rare derived alleles (< 15%) 849 842 0.36 61 [ 50, 72] 
Common alleles 495 803 0.22 -2 [-10,  7] 
Frequent derived alleles (> 85%) 59 82 0.26 15 [-11, 48] 
Affymetrix 120K (Multi-ethnic)4      
Rare derived alleles (< 15%) 74 82 0.33 44 [ 14, 80] 
Common alleles 77 137 0.21 -11 [-28, 12] 
Frequent derived alleles (> 85%) 10 15 0.25 6 [-42, 95] 
∆A = Number of observed non-synonymous substitutions. ∆S = Number of observed synonymous 
substitutions. 1 A negative fraction indicates excess of non-synonymous divergence over 
polymorphism. 2 95% confidence intervals assuming non-synonymous substitutions are Poisson 
distributed. 3 Source: http://www.hapmap.org (Public Release #13). 4 Source: 
http://www.affymetrix.com 
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Figure 12. Correlation of Alu age and distribution by GC content.  Alu elements 
that inserted after human-chimpanzee divergence are densest in the GC-poor 
regions of the genome (peaking at 36-40% GC), whereas older copies, common 
to both genomes, crowd GC-rich regions. The figure is similar to Figure 23 of ref. 24, 
but the use of chimpanzee allows improved separation of young and old elements, 
leading to a sharper transition in the pattern.
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Evolutionary constraint on amino acid sites within hominid lineage. Overall, human and 
chimpanzee genes are extremely similar, with the encoded proteins identical in the two species in 
29% of cases. The median number of non-synonymous and synonymous substitutions per gene are 
2 and 3, respectively. About 5% of the proteins show in-frame indels, but these tend to be small 
(median = 1 codon) and to occur in regions of repeated sequence. The close similarity of human and 
chimpanzee genes necessarily limits the ability to make strong inferences about individual genes, 
but there is abundant data to study important sets of genes.  
 The Ka/Ks ratio for the human-chimpanzee lineage (ωhominid) is 0.23. The value is much 
lower than some recent estimates based on limited sequence data (ranging as high as 0.63 7), but is 
consistent with an estimate (0.22) from random EST sequencing44. Similarly, Ka/Ki was also 
estimated as 0.23.  
Under the assumption that synonymous mutations are selectively neutral, the results imply 
that 77% of amino acid alterations in hominid genes are sufficiently deleterious as to be eliminated 
by natural selection. Because synonymous mutations are not entirely neutral (see below), the actual 
proportion of amino acid alterations with deleterious consequences may be higher. Consistent with 
previous studies 8, we find that Ka/Ks of human polymorphisms with frequencies up to 15% is 
significantly higher than that of human-chimpanzee differences and more common polymorphisms 
(Table 3), implying that at least 25% of the deleterious amino acid alterations may often attain 
readily detectable frequencies and thus contribute significantly to the human genetic load. 
Evolutionary constraint on synonymous sites within hominid lineage. We next explored 
the evolutionary constraints on synonymous sites, specifically four-fold degenerate sites. Because 
such sites have no effect on the encoded protein, they are often considered to be selectively neutral 
in mammals.  
We re-examined this assumption by comparing the divergence at four-fold degenerate sites 
with the divergence at nearby intronic sites. Although overall divergence rates are very similar at 
four-fold degenerate and intronic sites, direct comparison is misleading because the former have a 
higher frequency of the highly mutable CpG dinucleotides (9% vs. 2%). When CpG and non-CpG 
sites are considered separately, we find that both CpG sites and non-CpG sites show dramatically 
lower divergence in exonic synonymous sites than in introns (~50% and ~30% lower, respectively). 
This result resolves recent conflicting reports based on limited datasets 44,87 by showing that such 
sites are indeed under constraint. 
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Figure 13. Dependency of homologous recombination between Alu elements on 
divergence and distance. (a) While homologous recombination occurs between 
quite divergent (Smith-Waterman score < 1000), closely spaced copies, more 
distant recombination seems to favor a better match between the recombining 
repeats. (b) The frequency of Alu-Alu mediated recombination falls dramatically 
as a function of distance between the recombining copies. The first three points 
(magenta) involve recombination between left or right arms of one Alu inserted 
into another.  The high number of occurrences at a distance of 300-400 
nucleotides is due to the preference of integration in the A-rich tail; exclusion of 
this point does not change the parameters of the equation.
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The constraint does not appear to result from selection on the usage of preferred codons, 
which has been detected in lower organisms, 88 such as bacteria 89, yeast 90 and flies 91. In fact, 
divergence at four-fold degenerate sites increases slightly with codon usage bias (Kendall’s τ = 
0.097, p<10-14).  Alternatively, the observed constraint at synonymous sites might reflect 
‘background selection’ – that is, the indirect effect of purifying selection at amino acid sites causing 
reduced diversity and thereby reduced divergence at closely linked sites 41. Given the low rate of 
recombination in hominid genomes (a 1 kb region experiences only ~1 crossover per 100,000 
generations or 2 M years), such background selection should extend beyond exons to include 
nearby intronic sites 92. However, when the divergence rate is plotted relative to exon-intron 
boundaries, we find that the rate jumps sharply within a short region of ~7 bp at the boundary 
(Figure 15). This pattern strongly suggests that the action of purifying selection at synonymous sites 
is direct rather than indirect, suggesting other signals, e.g. those involved in splice site selection, 
may be embedded in the coding sequence and therefore constrain synonymous sites. 
Comparison with murids. An accurate estimate of Ka/Ks makes it possible to study how 
evolutionary constraint varies across clades. Ohta 93 predicted more than thirty years ago that 
selection against deleterious mutations would depend on population size, with mutations being 
strongly selected only if they reduce fitness by s >> 1/4N (where N is effective population size). 
This would predict that genes would be under stronger purifying selection in murids than hominids, 
owing to their presumed larger population size. Initial analyses (involving fewer than 50 genes 94) 
suggested a strong effect, but the wide variation in estimates of Ka/Ks in hominids 7 8,95  and murids 
96  has complicated this analysis 44. 
Using the large collection of 7,043 orthologous quartets, we calculated mean Ka/Ks values for 
the various branches of the four-species evolutionary tree (Figure 14). The Ka/Ks ratio for hominids 
is 0.20. (This is slightly lower than the value of 0.23 obtained with all human-chimpanzee 
orthologs, probably reflecting slightly greater constraint on the class of proteins with clear orthologs 
across hominids and murids). 
The Ka/Ks ratio is strikingly lower for murids than for hominids (ωmurid~0.13 vs. ωhominid~0.20) 
(Figure 14). This implies that there is a ~35% excess of the amino acid changing mutations in the 
two hominids, relative to the two murids. Excess amino acid divergence may be explained by either 
increased adaptive evolution or relaxation of evolutionary constraints. As shown in the next section, 
the latter appears to be the principal explanation. 
Relaxed constraints in human evolution. The Ka/Ks ratio can be used to make inferences 
about the role of positive selection in human evolution 97,98. Because alleles under positive selection  
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Figure 14. Human-chimpanzee-mouse-rat tree with branch specific Ka/Ks (ω) 
values. (a) Evolutionary tree. The branch lengths are proportional to the absolute 
rates of amino acid divergence. (b) Maximum-likelihood estimates of the rates of 
evolution in protein-coding genes for humans, chimpanzees, mice and rats. In the 
text, ω[hominid] is the Ka/Ks of the combined human and chimpanzee branches 
and ω[murid] of the combined mouse and rat branches. The slight difference 
between ω[human] and ω[chimp] is not statistically significant; masking of some 
heterozygous bases in the chimpanzee sequence may contribute to the observed 
difference (see Supplementary Notes).
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spread rapidly through a population, they will be found less frequently as common human 
polymorphisms than as human-chimpanzee differences 8. Positive selection can thus be detected by 
comparing the Ka/Ks ratio for common human polymorphisms with the Ka/Ks ratio for hominid 
divergence. Fay and colleagues8 estimated these ratios as ωpolymorphism ~0.20 based on an initial 
collection of common SNPs in human genes and ωdivergence ~ 0.34 based on comparison of human 
and Old World monkey genes. They thus inferred the proportion of amino acid changes attributable 
to positive selection to be ~ 35%. This would imply a huge quantitative role for positive selection in 
human evolution.  
 With the availability of extensive data for both human polymorphism and human-
chimpanzee divergence, we repeated this analysis (using the same set of genes for both estimates). 
We find that ωpolymorphism ~0.21-0.23 and ωdivergence ~0.23 are statistically indistinguishable (Table 3). 
Although some of the amino acid substitutions in human and chimpanzee evolution must surely 
reflect positive selection, the results indicate that the proportion of changes fixed by positive 
selection appears to be much lower than the previous estimate8. (Because the previous results 
involved comparison to Old World monkeys, it is possible that they reflect strong positive selection 
earlier in primate evolution. However, we suspect that they reflect the fact that relatively few genes 
were studied and that different genes were used to study polymorphism and divergence).  
Relaxed negative selection pressures thus primarily explain the excess amino acid divergence 
in hominid genes relative to murids. Moreover, since both ωhuman and ωchimpanzee are similarly 
elevated this explanation applies equally to both lineages.  
We next sought to study variation in the evolutionary rate of genes within the hominid 
lineage, by searching for unusually high or low levels of constraint for genes and sets of genes. 
 
Rapid evolution in individual genes.  
We searched for individual genes that have accumulated amino acid substitutions faster than 
expected given the neutral substitution rate, as potentially being under strong positive selection. A 
total of 585 of the 13,454 human-chimpanzee orthologs (4.4%) have observed Ka/Ki > 1 (see 
Supplementary Information). However, given the low divergence, the Ka/Ki statistic has large 
variance. Simulations show that estimates of Ka/Ki > 1 would be expected to occur simply by 
chance in at least 263 cases, if purifying selection is allowed to act non-uniformly across genes 
(Figure 16). 
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Figure 15. Purifying selection on synonymous sites. Mean divergence around exon 
boundaries at non-CpG exonic four-fold degenerate sites and intronic sites, relative 
to the closest mRNA splice junction. The divergence rate at exonic four-fold 
degenerate sites is significantly lower than at nearby intronic sites (p[MW] < 10^-27), 
suggesting that purifying selection limits the rate of synonymous codon substitutions.
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Nonetheless, this set of 585 may be enriched for genes that are under positive selection. The 
most extreme outliers include glycophorin C, which mediates one of the P. falciparum invasion 
pathways in human erythrocytes 99; granulysin, which mediates antimicrobial activity against 
intracellular pathogens such as M. tuberculosis 100; as well as genes that have previously been 
shown to be undergoing adaptive evolution, such as the protamines and semenogelins involved in 
reproduction 101 and the Mas-related gene family involved in nociception 102. With similar follow up 
studies on candidates from this list, one may be able to draw conclusions about positive selection on 
other individual genes. In subsequent sections, we examine the rate of divergence for sets of related 
genes with the aim of detecting subtler signals of accelerated evolution.  
 
Variation in Evolutionary Rate Across Physically Linked Genes 
We explored how the rate of evolution varies regionally across the genome. Several studies of 
mammalian gene evolution have noted that the rate of amino acid substitution shows local 
clustering, with proteins encoded by nearby genes evolving at correlated rates 16,103-105.  
Variation across chromosomes. Navarro and Barton 106 recently reported, based on the 
analysis of ~100 genes, that the normalized rate of protein evolution is greater on the nine 
chromosomes that underwent major structural rearrangement during human evolution 
(chromosomes 1, 2, 5, 9, 12, 15, 16, 17, 18); they suggested that such rearrangements led to reduced 
gene flow and accelerated adaptive evolution. A subsequent study of a collection of chimpanzee 
ESTs gave contradictory results 107,108. With our larger data set, we re-examined this issue and found 
no evidence of accelerated evolution on chromosomes with major rearrangements, even if we 
considered each rearrangement separately. 
Among all chromosomes, the most extreme outlier is chromosome X with a mean Ka/Ki of 
0.32. The higher mean appears to reflect a skewed distribution at both high and low values, with the 
median value (0.17) being more in line with other chromosomes (0.15). The excess of low values 
may reflect greater purifying selection at some genes, owing to the hemizygosity of chromosome X 
in males. The excess of high values may reflect increased adaptive selection also resulting from 
hemizygosity, if a considerable proportion of advantageous alleles are recessive 109. Interestingly, 
the higher Ka/Ki on X versus autosomes is largely restricted to genes expressed in testis81. 
Variation in local gene clusters. We next searched for genomic neighborhoods with an 
unusually high density of rapidly evolving genes. Specifically, we calculated the median Ka/Ki for 
sliding windows of 10 orthologs and identified extreme outliers (p < 0.001 compared to random 
ordering of genes; see Supplementary Information). A total of 16 such neighborhoods were found,  
Figure 16. Cumulative distribution of Ka/Ki values for 13,454 orthologs as
observed (blue), as expected if all orthologs evolved at Ka/Ki = 0.23 (green)
and as expected if 23% of codons evolved at Ka/Ki = 1 and the rest at
Ka/Ki = 0 (red). There is a small excess of ortholgos with Ka/Ki > 1 in the 
observed distribution, possibly indicating an enrichment of genes under
strong positive selection.
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Table 4 Rapidly diverging gene clusters in human and chimpanzee 
Location 
(HSA) Cluster 
Median
Ka/Ki1 
1q21 Epidermal differentiation complex 1.46 
6p22 Olfactory receptors and HLA-A 0.96 
20p11 Cystatins 0.94 
19q13 Pregnancy-specific glycoproteins 0.94 
17q21 Hair keratins and keratin associated proteins 0.93 
19q13 CD33-related Siglecs 0.90 
20q13 WAP domain protease inhibitors 0.90 
22q11 Immunoglobin lambda/Breakpoint Critical Region 0.85 
12p13 Taste receptors, type 2 0.81 
17q12 Chemokine (C-C motif) ligands 0.81 
19q13 Leukocyte-associated Ig-like receptors 0.80 
5q31 Protocadherin-beta 0.77 
1q32 Complement component 4-binding proteins 0.76 
21q22 Keratin associated proteins and uncharacterized ORFs 0.76 
1q23 CD1 antigens 0.72 
4q13 Chemokine (C-X-C motif) ligands 0.70 
 
1 Maximum median Ka/Ki if the cluster stretched over more than one window of 10 genes.   
Figure 17. Median Ka/Ki over sliding 10 gene windows across chromosome 1.
Three peaks, corresponding to rapidly evolving gene clusters, are visible.
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 which greatly exceeds random expectation (Table 4). Repeating the analysis with larger windows 
(25, 50 and 100 orthologs) did not identify additional rapidly diverging regions. 
In nearly all cases, the regions contain local clusters of phylogenetically and functionally 
related genes. The rapid diversification of gene families, postulated by Ohno (1970), can thus be 
readily discerned even at the relatively close distance of human-chimpanzee divergence. Most of 
the clusters are associated with functional categories such as host defense and chemosensation (see 
below). Examples include the epidermal differentiation complex encoding proteins that help form 
the cornified layer of the skin barrier (Figure 17), the WAP-domain cluster encoding secreted 
protease inhibitors with antibacterial activity and the Siglec cluster encoding CD33-related genes. 
Rapid evolution in these clusters does not appear to be unique to either human or chimpanzee 110,111. 
 
Variation in Evolutionary Rate Across Functionally Related Genes 
We next studied variation in the evolutionary rate of functional categories of genes, based on the 
Gene Ontology (GO) classification 112.   
Rapidly and slowly evolving categories within the hominid lineage.  We started by 
searching for sets of functionally related genes with exceptionally high or low constraint in humans 
and chimpanzees. For each of the 809 categories with at least 20 genes, Ka/Ks was calculated by 
concatenating the gene sequences. The category-specific ratios were compared to the average across 
all orthologs to identify extreme outliers using a metric based on the binomial test (see 
Supplementary Information). The numbers of observed outliers below a specific threshold (test 
statistic < 0.001) were then compared to the expected distribution of outliers given randomly 
permuted annotations. 
A total of 98 categories showed elevated Ka/Ks ratios at the specified threshold (Table 5). 
Only 30 would be expected by chance, indicating that most (but not all) of these categories undergo 
significantly accelerated evolution relative to the genome-wide average (p < 10-4). The rapidly 
evolving categories within the hominid lineage are primarily related to immunity and host defense, 
reproduction and olfaction, which are the same categories known to be undergoing rapid evolution 
within the broader mammalian lineage, as well as more distantly related species 15,16,113. Hominids 
thus appear to be typical of mammals in this respect (but see below). 
A total of 251 categories showed significantly low Ka/Ks ratios (versus ~32 expected by 
chance; p < 10-4). These include a wide range of processes including intracellular signaling, 
metabolism, neurogenesis and synaptic transmission, which are evidently under stronger-than-
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average purifying selection. More generally, genes expressed in the brain show significantly 
stronger average constraint than genes expressed in other tissues 81.  
Differences between hominid and murid lineages. Having found gene categories that show 
substantial variation in absolute evolutionary rate within hominids, we next examined variation in 
relative rates between murids and hominids. The Ka/Ks of each of the GO categories are highly 
correlated between the hominid and murid ortholog pairs, suggesting that the selective pressures 
acting on particular functional categories have been largely proportional in recent hominid and 
recent murid evolution (Figure 18). However, there are several categories with significantly 
accelerated non-synonymous divergence on each of the lineages, which could represent functions 
that have undergone lineage-specific positive selection or a lineage-specific relaxation of constraint 
(Supplementary Notes).  
A total of 59 categories (versus 11 expected at random, p < 0.0003) show evidence of 
accelerated non-synonymous divergence in the murid lineage. These are dominated by functions 
and processes related to host defense, such as immune response and lymphocyte activation. 
Examples include genes encoding interleukins and various T-cell surface antigens (CD4, CD8, 
CD80). Combined with the recent observation that genes involved in host defense have undergone 
gene family expansion in murids16,17, this suggests that the immune system has undergone extensive 
lineage-specific innovation in murids. Additional categories that also show relative acceleration in 
murids include chromatin-associated proteins and proteins involved in DNA repair. These 
categories may have similarly undergone stronger adaptive evolution in murids or, alternatively, 
they may contain fewer sites for mutations with slightly deleterious effects (with the result that the 
Ka/Ks ratios are less affected by the differences in population size94,114).   
Another 58 categories (versus 14 expected at random, p < 0.0005) show evidence of 
accelerated evolution in hominids, with the set dominated by genes encoding proteins involved in 
transport (e.g. ion transport), synaptic transmission, spermatogenesis and perception of sound 
(Table 6). Notably, some outliers include genes with brain related functions, compatible with a 
recent finding 115. However, as above, it is possible that these categories could have more sites for 
slightly deleterious mutations and thus be more affected by population size differences. Sequence 
information from more species and from individuals within species will be necessary to distinguish 
between the possible explanations. 
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Table 5 GO categories with the highest divergence rates in hominids 
 N AA Ka/Ks 
GO:0007606 Sensory perception of chemical stimulus 59 0.018 0.590 
GO:0007608 Perception of smell 41 0.018 0.521 
GO:0006805 Xenobiotic metabolism 40 0.013 0.432 
GO:0006956 Complement activation 22 0.013 0.428 
GO:0042035 Regulation of cytokine biosynthesis 20 0.011 0.402 
GO:0007565 Pregnancy 34 0.014 0.384 
GO:0007338 Fertilization 24 0.010 0.371 
GO:0008632 Apoptotic program 36 0.010 0.358 
GO:0007283 Spermatogenesis 80 0.008 0.354 
GO:0000075 Cell cycle checkpoint 27 0.006 0.354 
AA = Amino acid divergence. N = number of orthologs. Listed are the 10 categories in the taxonomy 
‘biological process’ with the highest Ka/Ks ratios, which are not significant solely due to significant 
subcategories.
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Figure 18. Hominid and murid Ka/Ks (ω) in GO categories with more than 20 
analyzed genes. GO categories with putatively accelerated (test statistic < 0.001; 
see Methods) non-synonymous divergence on the hominid lineages (red) and on 
the murid lineages (orange) are highlighted. Due to the hierarchical nature of GO, 
the categories do not all represent independent data points. A non-redundant list of 
significant categories is provided in Table 8.
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Table 6: GO categories with accelerated divergence rates in hominids relative to 
murids 
 N 
AA 
hominids
AA 
murids 
Ka/Ks 
hominids 
Ka/Ks 
murids 
GO:0007283 Spermatogenesis 43 0.0075 0.054 0.323 0.188 
GO:0006869 Lipid transport 22 0.0081 0.051 0.306 0.120 
GO:0006865 Amino acid transport 24 0.0058 0.033 0.218 0.084 
GO:0015698 Inorganic anion transport 29 0.0061 0.027 0.195 0.072 
GO:0006486 Protein amino acid glycosylation 50 0.0056 0.040 0.166 0.100 
GO:0019932 Second-messenger-mediated 
signaling 58 0.0049 0.036 0.159 0.083 
GO:0007605 Perception of sound 28 0.0052 0.033 0.158 0.085 
GO:0016051 Carbohydrate biosynthesis 27 0.0047 0.028 0.147 0.067 
GO:0007268 Synaptic transmission 93 0.0040 0.025 0.126 0.069 
GO:0006813 Potassium ion transport 65 0.0035 0.022 0.113 0.056 
AA = Amino acid divergence. N = number of orthologs. Listed are the 10 categories in the taxonomy 
biological process with the strongest evidence for accelerated evolution in hominids relative to 
murids, which are not significant solely due to significant subcategories. 
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Figure 19. Human and chimpanzee Ka/Ks (ω) in GO categories with more than 20 
analyzed genes. GO categories with putatively accelerated (test statistic < 0.001; 
see Methods) non-synonymous divergence on the human lineage (red) and on 
the chimpanzee lineage (orange) are highlighted. The variance of these estimates 
are larger that seen in the hominid-murid comparison due to the small number of 
lineage-specific substitutions. Due to the hierarchical nature of the GO ontology, 
the categories do not all represent independent data points.
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Differences between human and chimpanzee lineage. One of the most interesting 
questions is perhaps whether certain categories have undergone accelerated evolution in humans 
relative to chimpanzees, since such genes might underlie unique aspects of human evolution. 
As was done for hominids and murids above, we compared non-synonymous divergence for 
each category to search for relative acceleration in either lineage (Figure 19). Seven categories show 
signs of accelerated evolution on the human lineage relative to chimpanzee, but this is only slightly 
more than the 4 expected at random (p < 0.22). Intriguingly, the single strongest outlier is 
‘transcription factor activity’, with the 348 human genes studied having accumulated 47% more 
amino acid changes than their chimpanzee orthologs. Genes with accelerated divergence in human 
include homeotic, forkhead and other transcription factors that play key roles in early development. 
However, given the small number of changes involved, additional data will be required to confirm 
this trend. There was no excess of accelerated categories on the chimpanzee lineage. 
We also compared human genes with and without disease associations, including mental 
retardation, for differences in mutation rate when compared to chimpanzee.  Briefly, no significant 
differences were observed in either the background mutation rate or in the ratio of human-specific 
changes to chimpanzee specific amino acid changes (see Supplemental Notes).  
We thus find minimal evidence of acceleration unique to either the human or chimpanzee 
lineage across broad functional categories. This is not entirely due to general lack of power 
resulting from the small number of changes since the divergence of human and chimpanzee, 
because one can detect acceleration of categories in either hominid relative to either murid. For 
example, 29 accelerated categories versus 9 expected at random (p < 0.02) can be detected on the 
human lineage, and 40 categories versus 11 expected at random (p < 0.007) on the chimpanzee 
lineage, relative to mouse. But the outliers are largely the same for both human and chimpanzee, 
indicating that the fraction of amino acid mutations that have contributed to human- and 
chimpanzee-specific patterns of evolution must be small relative to the fraction that have 
contributed to a common hominid and, to a large extent, mammalian pattern of evolution. 
Clark and colleagues10 recently reported that numerous gene categories (including signal 
transduction, ion transport and hearing) are under accelerated positive selection in the human 
lineage relative to the chimpanzee lineage. Their analysis used a likelihood approach to detect 
codons under positive selection in human or chimpanzee coding sequences, using mouse as an 
outgroup. However, this approach may be highly sensitive to false positives in the presence of 
relaxed constraints in the hominid lineages116, or potential alignment artifacts. As shown above, 
with the potential exception of some developmental regulators, the categories that Clark et al. 
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reported as showing the strongest evidence of human-specific positive selection are among those 
that show the highest accelerated divergence in both human and chimpanzee. This suggests that 
their results may be enriched for false positives due to relaxed constraints, rather than human-
specific positive selection. Additional data may enhance the statistical power of such analysis, but, 
at present, strong evidence of positive selection unique to the human lineage is limited to a handful 
of genes 117. 
Our analysis above largely omitted genes belonging to large gene families, because gene 
family expansion makes it difficult to define 1:1:1:1 orthologs across hominids and murids. One of 
the largest such family, the olfactory receptors, is known to be undergoing rapid divergence in 
primates. Directed study of these genes in the draft assembly has suggested that more than a 
hundred functional human olfactory receptors are likely to be under no evolutionary constraint 118. 
Our analysis also omitted the majority of very recently duplicated genes due to their lower coverage 
in the current chimpanzee assembly. However, recent human-specific duplications can be readily 
identified from the finished human genome sequence, and have previously been shown to be highly 
enriched for the same categories found to have high absolute rates of evolution in 1:1 orthologs 
here, i.e. olfaction, immunity and reproduction23. 
 
Gene disruptions in Human and Chimpanzee 
Whereas most genes have undergone only subtle substitutions in their amino acid sequence, a few 
dozen have suffered more drastic changes. We found a total of 53 known or predicted human genes 
that are either deleted entirely (36) or partially (17) in chimpanzee. We have so far tested and 
confirmed 15 of these cases by PCR or Southern blotting. An additional 8 genes have sustained 
large deletions (>15 kb) entirely within an intron. Some genes may have been missed in this count, 
owing to limitations of the draft genome sequence. In addition, some genes may have suffered chain 
termination mutations or altered reading frames in chimpanzee, but accurate identification of these 
will require higher-quality sequence. The sensitivity of the reciprocal analysis of genes disrupted in 
human is currently limited by the small number of independently predicted gene models for the 
chimpanzee 119. Some of the gene disruptions may be related to interesting biological differences 
between the species, as discussed below. 
 
Genetic Basis for Human- and Chimpanzee-specific Biology 
Given the substantial number of neutral mutations, only a small subset of the observed gene 
differences is likely to be responsible for the key phenotypic changes in morphology, physiology 
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and behavioral complexity between humans and chimpanzees. Determining which differences are in 
this evolutionarily important subset and inferring their functional consequences will require 
additional types of evidence, including information from clinical observations and model systems 
120. We describe some novel examples of genetic changes for which plausible functional or 
physiological consequences can be suggested. 
Apoptosis. Mouse and human are known to differ with respect to an important mediator of 
apoptosis, caspase-12121,122 123. The protein triggers apoptosis in response to perturbed calcium 
homeostasis in mice, but humans appear to lack this activity owing to several mutations in the 
orthologous gene that together affect the protein produced by all known splice forms; the mutations 
include a premature stop codon and a disruption of the SHG box required for enzymatic activity of 
caspases. By contrast, the chimpanzee gene encodes an intact open-reading frame and SHG box, 
indicating that the functional loss occurred in the human lineage. Intriguingly, loss-of-function 
mutations in mice confer increased resistance to amyloid-induced neuronal apoptosis without 
causing obvious developmental or behavioral defects 124. The loss-of-function in humans may 
contribute to the human-specific pathology of Alzheimer’s disease, which involves amyloid-
induced neurotoxicity and deranged calcium homeostasis. 
Inflammatory Response. Human and chimpanzee show a notable difference with respect 
to important mediators of immune and inflammatory response. Three genes (IL-1F7, IL-1F8 and 
ICEBERG) that act in a common pathway involving caspase-1 all appear to be deleted in 
chimpanzee. ICEBERG is thought to repress caspase-1 mediated generation of pro-inflammatory 
IL-1 cytokines, and its absence in chimpanzee may point to species-specific modulation of the 
interferon-gamma and lipopolysaccharide-induced inflammatory response 125.  
Parasite resistance. Similarly, we found that two members of the primate-specific APOL 
gene cluster (APOL1 and APOL4) have been deleted from the chimpanzee genome. The Apol1 
protein is associated with the high-density lipoprotein fraction in serum and has recently been 
proposed to be the lytic factor responsible for resistance to certain subspecies of Trypanosome 
brucei, the parasite that causes human sleeping sickness and the veterinary disease nagana126. The 
loss of the APOL1 gene in chimpanzees could thus explain the observation that human, gorilla and 
baboon possess the trypanosome lytic factor, whereas the chimpanzee does not 127. 
Sialic acid biology-related proteins. Sialic acids are cell surface sugars that mediate many 
biological functions 128.  Of 54 genes involved in sialic acid-biology, 47 were suitable for analysis.  
We confirmed and extended findings on several that have undergone human-specific changes, 
including disruptions, deletions and domain-specific functional changes 110,119,129.  Human- and 
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chimpanzee-specific changes were also found in otherwise evolutionarily conserved sialyl motifs in 
four sialyl transferases (ST6GAL1, ST6GALNAC3, ST6GALNAC4, and ST8SIA2), suggesting 
changes in donor and/or acceptor binding129. Lineage-specific changes were found in a complement 
factor H (HF1) sialic acid domain binding associated with human disease 130. Human 
SIGLEC11 has undergone gene conversion with a nearby pseudogene, which correlates with the 
acquisition of human-specific expression and binding properties 171. 
 
Human disease alleles 
We next sought to identify putative functional differences between the species by searching for 
instances in which a human disease-causing allele appears to be the wild-type allele in the 
chimpanzee. Starting from 12,164 catalogued disease variants in 1,384 human genes, we identified 
16 cases in which the altered sequence in a disease allele matched the chimpanzee sequence, and 
had plausible support in the literature (Table 7). Upon resequencing in seven chimpanzees, 15 cases 
were confirmed homozygous in all individuals, whereas one (PON1 I102V) appears to be a shared 
polymorphism. 
Six cases represent de novo human mutations associated with simple Mendelian disorders. 
Similar cases have also been found in comparisons of more distantly related mammals131, as well as 
between insects132, and have been interpreted as a consequence of a relatively high rate of 
compensatory mutations. If compensatory mutations are more likely to be fixed by positive 
selection than by neutral drift132, then the variants identified here might point towards adaptive 
differences between humans and chimpanzees. For example, the ancestral Thr29 allele of cationic 
trypsinogen (PRSS1) causes autosomal dominant pancreatitis in humans 133, suggesting that the 
human-specific Asn29 allele may represent a digestion-related molecular adaptation 134. 
The remaining 10 cases represent common human polymorphisms that have been reported as 
associated with complex traits, including coronary artery disease and diabetes mellitus. In all of 
these cases, we confirmed that the disease-associated allele in humans is indeed the ancestral allele 
by showing that it is carried not only by chimpanzee but also by outgroups such as the macaque. 
These ancestral alleles may thus have become human-specific risk factors due to changes in human 
physiology or environment, and the polymorphisms may represent ongoing adaptations. For 
example, PPARG Pro12 is the wild-type allele in chimpanzee but has been clearly associated with 
increased risk of type 2 diabetes in human135. It is tempting to speculate that this allele may 
represent an ancestral ‘thrifty’ genotype 136. 
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Table 7 Candidate human disease variants found in chimpanzee 
Gene Variant1 Disease association Ancestral2 Freq. 3 
AIRE P252L155 Autoimmune syndrome  Unresolved 0 
MKKS R518H156 Bardet-Biedl syndrome Wildtype 0 
MLH1 A441T157 Colorectal cancer Wildtype 0 
MYOC Q48H158 Glaucoma Wildtype 0 
OTC T125M159 Hyperammonemia Wildtype 0 
PRSS1 N29T133 Pancreatitis Disease 0 
ABCA1 I883M160 Coronary artery disease Unresolved 0.136 
APOE C130R161 Coronary artery disease and 
Alzheimer's disease 
Disease 0.15 
DIO2 T92A162 Insulin resistance Disease 0.35 
ENPP1 K121Q163 Insulin resistance Disease 0.17 
GSTP1 I105V164 Oral cancer Disease 0.348 
PON14 I102V165 Prostate cancer Wildtype 0.016 
PON1 Q192R166 Coronary artery disease Disease 0.3 
PPARG A12P135 Type 2 Diabetes Disease 0.85 
SLC2A2 T110I167 Type 2 Diabetes Disease 0.12 
UCP1 A64T168 Waist-to-hip ratio Disease 0.12 
1 Benign variant, codon, disease/chimpanzee variant. 2 Ancestral variant as inferred from closest 
available primate outgroups (Supplementary Information). 3 Frequency of the disease allele in 
human study population. 4 Polymorphic in chimpanzee. 
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The current results must be interpreted with caution, because few complex disease 
associations have been firmly established. The fact that the human disease allele is the wild-type 
allele in chimpanzee may actually indicate that some of the putative associations are spurious and 
not causal. However, this approach can be expected to become increasingly fruitful as the quality 
and completeness of the disease mutation databases improve. 
 
Human Population Genetics 
The chimpanzee plays a special role in informing studies of human population genetics, a field that 
is undergoing rapid expansion and acquiring new relevance to human medical genetics 137. The 
chimpanzee sequence allows recognition of those human alleles that represent the ancestral state 
and the derived state. It also allows estimates of local mutation rates, which serve as an important 
baseline in searching for signs of natural selection. 
Ancestral and derived alleles. Of ~7.2 M SNPs mapped to the human genome in the current 
public database, we could assign the alleles as ancestral or derived in 80% of the cases according to 
which allele agrees with the chimpanzee genome sequence 138 (see Supplementary Notes). In 
remaining cases, no assignment could be made because the orthologous chimpanzee base differed 
from both human alleles (1.2%); was polymorphic in the chimpanzee sequences obtained (0.4%); or 
could not be reliably identified with the current draft sequence of the chimpanzee (18.8%), with 
many of these occurring in repeated or segmentally duplicated sequence.  The first two cases arise 
presumably because a second mutation occurred in the chimpanzee lineage. It should be possible to 
resolve most of these cases by examining a close outgroup such as gorilla or orangutan. 
 Mutations in the chimpanzee may also lead to the erroneous assignment of human alleles as 
derived alleles.  This error rate can be estimated as the probability of a second mutation resulting in 
the chimpanzee sequence matching the derived allele (see Supplementary Notes). The estimated 
error rate for typical SNPs is 0.5%, owing to the low nucleotide substitution rate. The exceptions 
are those SNPs for which the human alleles are CpG and TpG and the chimpanzee sequence is TpG. 
For these, a non-negligible fraction may have arisen by two independent deamination events within 
an ancestral CpG dinucleotide, which are well known mutational hotspots 50 (also see above). 
Human SNPs in a CpG-context for which the orthologous chimpanzee sequence is TpG account for 
12% of the total, and have an estimated error rate of 9.8%. Across all SNPs, the average error rate, 
ε, is thus estimated to be ~1.6%.  
We compared the distribution of allele frequencies for ancestral and derived alleles, using a 
database of allele frequencies for ~120,000 SNPs (see Supplementary Notes). As expected, 
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ancestral alleles tend to have much higher frequencies than derived alleles. Nonetheless, a 
significant proportion of derived alleles have high frequencies: 9.1% of derived alleles have 
frequency ≥ 80%.  
An elegant result in population genetics states that, for a randomly interbreeding population 
of constant size, the probability that an allele is ancestral is equal to its frequency 139. We explored 
the extent to which this simple theoretical expectation fits the human population.  We tabulated the 
proportion pa(x) of ancestral alleles for various frequencies of x and compared this with the 
prediction pa(x) = x (Figure 20).  
The data lie near the predicted line, but the observed slope (0.83) is substantially less than 1. 
One explanation for this deviation is that some ancestral alleles are incorrectly assigned (an error 
rate of ε would artificially decrease the slope by a factor of 1-2ε). However, with ε estimated to be 
only 1.6%, errors can only explain a small part of the deviation. The most likely explanation is the 
presence of bottlenecks during human history, which tend to flatten the distribution of allele 
frequencies. Theoretical calculations indicate that a recent bottleneck would decrease the slope by a 
factor of (1-b), where b is the inbreeding coefficient induced by the bottleneck. This suggests that 
measurements of the slope in different human groups may shed light on population-specific 
bottlenecks. Consistent with this, preliminary analyses of allele frequencies in several regions for 
SNPs obtained by systematic uniform sampling indicate that the slope is significantly lower than 1 
in European and Asian samples and close to 1 in an African sample (see Supplementary Notes).  
Signatures of strong selective sweeps in recent human history. The pattern of human 
genetic variation holds substantial information about selection events that have shaped our species. 
Strong positive selection creates the distinctive signature of a ‘selective sweep’, whereby a rare 
allele rapidly rises to fixation and carries the haplotype on which it occurs to high frequency (the 
‘hitchhiking’ effect). The surrounding region should show two distinctive signatures: (i) a 
significant reduction of overall diversity and (ii) an excess of derived alleles with high frequency in 
the population, owing to hitchhiking of derived alleles on the selected haplotype (see 
Supplementary Information). The pattern might be detectable up for 250,000 years after a selective 
sweep has ended140. Notably, the chimpanzee genome provides crucial baseline information 
required for accurate assessment of both signatures. 
The size of the interval affected by a selective sweep is expected to scale roughly with s, the 
selective advantage due to the mutation. Simulations can be used to study the distribution of the 
interval size (see Supplementary Notes). With s = 1%, the interval over which heterozygosity falls 
by 50% has modal size of 600kb and a probability of greater than 10% of exceeding 1Mb. 
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We undertook an initial scan for large regions (> 1 Mb) with the two signatures suggestive of 
strong selective sweeps in recent human history. We began by identifying regions in which the 
observed human diversity rate was much lower than the expectation based on the observed 
divergence rate with chimpanzee. The human diversity rate was measured as the number of 
occurrences from a database of 1.92 M SNPs identified by shotgun sequencing in a panel of 
African-American individuals (see Supplementary Information).  The comparison with the 
chimpanzee eliminates regions in which low diversity simply reflects a low mutation rate in the 
region. Regions were identified based on a simple statistical procedure (see Supplementary Notes). 
Six genomic regions stood out as clear outliers that show significantly reduced diversity relative to 
divergence (Table 8).  
We next tested whether these six regions show a high proportion of SNPs with high-
frequency derived alleles (defined here as alleles with frequency ≥ 80%). Within each region, we 
focused on the 1 Mb interval with the greatest discrepancy between diversity and divergence and 
compared it to 1 Mb regions throughout the genome. For the database of 120,000 SNPs with allele 
frequencies discussed above, the typical 1 Mb region in the human genome contains ~40 SNPs and 
the proportion ph of SNPs with high-frequency derived alleles is ~9.1%. All six regions identified 
by our scan for reduced diversity have a higher than average fraction of high frequency derived 
alleles; all six fall within the top 10% genome-wide and three fall within the top 1%. Although this 
is not definitive evidence for any particular region, the joint probability of all six regions randomly 
scoring in the top 10% is 10-6. The results suggest the six regions as candidates for strong selective 
sweeps during the past quarter-million years140. The regions differ notably with respect to gene 
content, ranging from one containing 57 annotated genes (chromosome 22) to another with no 
annotated genes whatsoever (chromosome 4). We have no evidence to implicate any individual 
functional element as a target of recent selection at this point, but the regions contain a number of 
interesting candidates for follow-up studies. Intriguingly, the chromosome 4 gene desert, which is 
conserved across vertebrates 15, has been implicated in two independent studies as being associated 
with obesity141,142.  
In addition to the six regions, one further genomic region deserves mention: an interval of 7.6 
Mb on chromosome 7q (see Supplementary Notes). The interval contains several regions with high 
scores in the diversity-divergence analysis (including the seventh highest score overall) as well as in 
the proportion of high-frequency derived alleles. The region contains the FOXP2 and CFTR genes. 
The former has been the subject of much interest as a possible target for selection during human 
evolution143 and the latter as a target of selection in European populations 144.  
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Convincing proof of past selection will require careful analysis of the precise pattern of 
genetic variation in the region and the identification of a likely target of selection. Nonetheless, our 
findings suggest that the approach outlined here may help to unlock some of the secrets of recent 
human evolution through a combination of within-species and cross-species comparison.  
 
 
 
Table 8 Human regions with strongest signal of selection based on diversity 
relative to divergence 
Chr Start(Mb) End(Mb) Score 
Skew p-
value Genes 
1 48.58 52.58 103.3 0.071 14 known genes from ELAVL4 to GPX7 
2 144.35 148.47 84.8 0.074 ARHGAP15 (partial), GTDC1, and ZFHX1B
22 36.15 40.22 81.8 0.00022 57 known genes from CARD10 to PMM1 
12 84.69 89.01 80.9 0.031 10 known genes from PAMCI to ATP2B1 
8 34.91 37.54 76.9 0.00032 UNC5D and FKSG2 
4 32.42 35.62 55.9 0.00067 No known genes or Ensembl predictions 
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Figure 20. The observed fraction of ancestral alleles in 1% bins of observed 
frequency. The solid line shows the regression (b = 0.83). The dotted line shows 
the theoretical relationship pa(x) = x. Note that because each variant yields a 
derived and an ancestral allele, the data are necessarily symmetric about 0.5.
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Discussion 
Our knowledge of the human genome is greatly advanced by the availability of a second hominid 
genome. Some questions can be directly answered by comparing the human and chimpanzee 
sequences, including estimates of regional mutation rates and average selective constraints on gene 
classes. Other questions can be addressed in conjunction with other large datasets, such as issues in 
human population genetics for which the chimpanzee genome provides crucial controls. For still 
other questions, the chimpanzee genome simply provides a starting point for further investigation. 
The hardest such question is: what makes us human? The challenge lies in the fact that most 
evolutionary change is due to neutral drift. Adaptive changes comprise only a small minority of the 
total genetic variation between two species. As a result, the extent of phenotypic variation between 
organisms is not strictly related to the degree of sequence variation. For example, gross phenotypic 
variation between human and chimpanzee is much greater than between the mouse species M. 
musculus and M. spretus, although the sequence difference in the two cases is similar. On the other 
hand, dogs show considerable phenotypic variation despite having little overall sequence variation 
(~0.15%). Genomic comparison dramatically narrows the search for the functionally important 
differences between species, but specific biological insights will be needed to sift the still-large list 
of candidates to separate adaptive changes from neutral background.  
Our comparative analysis suggests that the patterns of molecular evolution in the hominids 
are typical of a broader class of mammals in many ways, but distinctive in certain respects. As with 
the murids, the most rapidly evolving gene families are those involved in reproduction and host 
defense. In contrast to the murids, however, hominids appear to experience substantially weaker 
negative selection; this likely reflects their smaller population size. Consequently, hominids 
accumulate deleterious mutations that would be eliminated by purifying selection in murids. This 
may be both an advantage and a disadvantage. Although decreased purifying selection may tend to 
erode overall fitness, it may also allow hominids to ‘explore’ larger regions of the fitness landscape 
and thereby achieve evolutionary adaptations that can only be reached by passing through 
intermediate states of inferior fitness146,147.  
Although the analyses presented here focus on protein-coding sequences, the chimpanzee 
genome sequence also allows systematic analysis of the recent evolution of gene regulatory 
elements for the first time. Initial analysis of both gene expression patterns and promoter regions 
suggest that their overall patterns of evolution closely mirror that of protein-coding regions. In a 
companion paper 81 , we show that the rates of change in gene expression among different tissues in 
human and chimpanzee correlate with the nucleotide divergence in the putative proximal promoters 
  105
and even more interestingly with the average level of constraint on proteins in the same tissues. 
Keightley and colleagues145 have similarly used the chimpanzee sequence described here to show 
that gene promoter regions are also evolving under dramatically less constraint in hominids than in 
murids.  
 The draft chimpanzee sequence here is sufficient for initial analyses, but it is still imperfect 
and incomplete. Definitive studies of gene and genome evolution – including pseudogene 
formation, gene family expansion and segmental duplication – will require high-quality finished 
sequence. In this regard, we note that efforts are already underway to construct a BAC-based 
physical map and to increase the shotgun sequence coverage to ~6-fold redundancy.  The added 
coverage alone will not impact the analysis greatly, but plans are in place to produce finished 
sequence for difficult and important segments of the genome. 
 Finally, our close biological relatedness to chimpanzees not only allows unique insights 
into human biology, it also creates ethical obligations. Although the genome sequence was acquired 
without harm to chimpanzees, the availability of the sequence may increase pressure to use 
chimpanzees in experimentation. We strongly oppose reducing the protection of chimpanzees and 
instead advocate the policy positions suggested by Gagneux and colleagues elsewhere in this issue 
148. Furthermore, the existence of chimpanzees and other great apes in their native habitats is 
increasingly threatened by human civilization.  More effective policies are urgently needed to 
protect them in the wild. We hope that elaborating how few differences separate our species will 
broaden recognition of our duty to these extraordinary primates who stand as our siblings in the 
family of life. 
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Methods 
 
Sequencing and assembly. Approximately 22.5 million sequence reads were derived from both 
ends of inserts (paired end reads) from 4, 10, 40 and 180 kb clones, all prepared from primary blood 
lymphocyte DNA. Genomic resources available from the source animal include a lymphoid cell line 
(S006006) and genomic DNA (NS06006) at Coriell Cell Repositories (http://locus.umdnj.edu/ccr/), 
as well as a BAC library (CHORI-251) 149 (see also Supplementary Notes).  
Genome alignment. BLASTZ150 was used to align non-repetitive chimpanzee regions against 
repeat-masked human sequence. BLAT151 was subsequently used to align the more repetitive 
regions. The combined alignments were chained152 and only best reciprocal alignments were 
retained further analysis. 
Insertions and deletions. Small insertion/deletion events (<15kb) were parsed directly from the 
BLASTZ genome alignment by counting the number and size of alignment gaps between bases 
within the same contig. Sites of large-scale insertion/deletion (indels >15kb) were detected from 
discordant placements of paired sequence reads against the human assembly. Size thresholds were 
obtained from both human fosmids alignments on human sequence (40 +/- 2.58 kb), and 
chimpanzee plasmid alignments against human chromosome 21 (4.5 +/-1.84 kb). Indels were 
inferred by two or more pairs surpassing these thresholds by more than two standard deviations and 
the absence of sequence data within the discordancy. 
Gene annotation. A total of 19,277 human RefSeq transcripts153, representing 16,045 distinct 
genes, were indirectly aligned to the chimpanzee sequence via the genome alignment. After 
removing low quality sequences and likely alignment artifacts, an initial catalog containing 13,454 
distinct 1:1 human-chimpanzee orthologs was created for the analyses described here. A subset of 
7,043 of these genes with unambiguous mouse and rat orthologs were realigned using Clustal W 154 
for the lineage specific analyses. Updated gene catalogs can be obtained from www.ensembl.org.  
Rates of divergence. Nucleotide divergence rates were estimated using baseml with the REV 
model. Non-CpG rates were estimated from all sites that did not overlap a CG dinucleotide in either 
human or chimpanzee. Ka and Ks were estimated jointly for each ortholog using codeml with the 
F3x4 codon frequency model and no additional constraints, except for the comparison of divergent 
and polymorphic substitutions where Ka/Ks for both was estimated as (∆A/Na)/(∆S/Ns) with Ns/Na, 
the ratio of synonymous to non-synonymous sites, estimated as 0.36 from the ortholog alignments. 
Unless otherwise specified, Ka/Ks for a set of genes was calculated by summing the number of 
substitutions and the number of sites to obtain Ka and Ks for the concatenated set before taking the 
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ratio. Hominid and murid pair-wise rates were estimated independently from codons aligned across 
all four species. Human and chimpanzee lineage specific Ka and Ks were estimated on an unrooted 
tree with both mouse and rat included. Lineage-specific rates were also estimated by parsimony, 
with essentially identical results (see Supplementary Notes). Ki was estimated from all interspersed 
repeats within 250kb of the midpoint of each gene.  
Accelerated evolution in GO categories. The binomial probability of observing X or more non-
synonymous substitutions, given a total of X + Y substitutions and the expected proportion x from 
all orthologs, was calculated by summing substitutions across the orthologs in each GO category. 
For the absolute rate test, Y = the number of synonymous substitutions in orthologs in the same 
category. For the relative rate tests, Y = the number of non-synonymous substitutions on the 
opposite lineage. Note that this binomial probability is simply a metric designed to identify 
potentially accelerated categories, it is not a p-value that can be used to directly reject the null 
hypothesis of no acceleration in that particular category. For each test, the observed number of 
categories with a binomial probability less than 0.001 was compared to the expected distribution of 
such outliers by repeating the procedure 10,000 times on randomly permuted GO annotations. The 
significance of the number of observed outliers n was estimated as the proportion of random trials 
yielding n or more outliers. 
Detection of selective sweeps. The observed number of human SNPS, ui, human bases, mi, human-
chimpanzee substitutions, vi, and chimpanzee bases, ni, within each set of non-overlapping 1 Mb 
windows along the human genome were used to generated two random numbers, xi (adjusted human 
diversity) and yi (adjusted human-chimpanzee divergence), from the distributions: 
   xi ~ Beta(ui + a, mi – ui + b) 
   yi ~ Beta(vi + c, ni – vi + d) 
where a = 1, b = 1000, c = 1, and d = 100. These numbers were then fit to a linear regression: 
   x|y ~ N(α0 + α1y, β2) 
A p-value for each window was calculated for each window based on (xi, yi) and the regression line. 
This was repeated 100 times and the average of the p-values taken as the p-value for diversity given 
divergence in each window. Overlapping windows with p < 0.1 containing at least one window of p 
< 0.05 were coalesced and scored as the sum of their –log(p) scores.
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Supplementary Notes: Genome Sequencing and Assembly 
 
The chimpanzee genome sequence was generated from native DNA derived from Clint, a captive-
born male chimpanzee from the Yerkes Primate Research Center (Atlanta, USA). Whole genome 
shotgun libraries were constructed in plasmid pOT4. Protocols are available from the Washington 
University website (genome.wustl.edu/tools/protocols).  
ARACHNE Assembly (Jaffe 2003). The ARACHNE assembly was created using reads 
from the primary donor only, except as noted below. Human genome sequence (NCBI build 34) 
was also used in a limited fashion. We created two distinct assemblies, one called the modified 
de novo assembly (MDN) and the other called the validated chimpanzee-on-human assembly 
(VCH). We then performed a partial merger to obtain the final assembly described by the 
Consortium.  
The MDN assembly started with a partially formed ARACHNE assembly, constructed 
without reference to human genome data. This assembly was iteratively modified using several 
procedures, some of which exploited human data in the following capacities:  
1. We normally require two read pairs to join supercontigs, but if we had a single read pair 
which landed consistently on human sequence (implying that the pair was not 
chimeric), we allowed a join based on it.  
2. Joins were broken in contigs having the following characteristics:  
there was a weak sequence link holding the contig together, and  
there was no link across the join (within the contig), and  
there was no link from both sides to a common contig, and 
the reads abutting the juncture did not align consistently to the human sequence 
through the region.  
3. The calculated gap size between two consecutive contigs in a supercontig was replaced 
with the corresponding gap size in human sequence if:  
these contigs aligned to human sequence, and  
if the gap size on human was within two standard deviations of the assembly gap 
size, as predicted from insert characteristics.  
The VCH assembly started with alignments of chimpanzee reads to the human build. We 
utilized only those reads whose placement was unique, or for which unique placement could be 
inferred from pairing. These were formed into overlapping “piles”, based on relative positions 
inferred from human sequence and confirmed by chimpanzee-chimpanzee overlap. Piles were 
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assembled into contigs, which were then “validated” by requiring that SNPs between reads within a 
given contig were consistent with the presence of no more than two haplotypes. These validated 
contigs were formed into the VCH assembly.  
The MDN and VCH assemblies were then aligned using shared reads to seed the 
alignments. A merged assembly was formed by importing sequence from VCH into MDN, but only 
in cases where the two assemblies were consistent. This merged assembly was then iteratively 
modified, as the MDN had been.  
At this stage we temporarily inserted non-Clint reads into the assembly, without changing 
the sequence in the contigs. Supercontigs where then merged, where possible, after which the non-
Clint reads were removed. Those supercontigs that were thereby disconnected were allowed to fall 
apart. As a final step, prior to release, we manually identified and removed two global 
misassemblies.  
PCAP Assembly As described in (Huang 2003).  
Assembly Statistics. Sequence coverage is calculated on the basis of assuming a 3 Gb 
euchromatic genome size. An additional 2.1 million chimpanzee SNP reads were used as input and 
later excised from the ARACHNE assembly, as described above.  
Genome Alignment. We evaluated three independent methods for aligning chimpanzee 
contigs to human genome sequence. The first utilized BLASTZ (Schwartz 2003) to align and score 
non-repetitive chimpanzee regions against repeat-masked human sequence and BLAT (Kent 2002) 
to process the more repetitive regions. Alignment chains differentiated between orthologous and 
paralogous alignments (Kent 2003) and only “reciprocal best” alignments were retained in the 
alignment set.  
In the second method, each contig was aligned to human sequence with a hashing procedure 
based on affine Smith-Waterman calculations for locally refining alignments without repeat 
masking (D. Jaffe and T.S. Mikkelsen, unpublished). Each alignment was assigned a confidence 
value based on alignment strength and frequency.  
The last method split chimp contigs into 1 kb segments and aligned them to human 
sequence with BLAT. This step was followed by re-alignment using cross_match (P. Green, 
personal communication) to exploit base quality values and tagging of unique alignments.  
Results of the three alignment methods were compared using detailed analyses of local 
regions using finished chimpanzee sequence, and quality of human RefSeq alignments to the 
chimpanzee genome when applying the chimp-human alignments. Coverage and consistency with 
respect to human sequence was also considered. For example, in comparing to a 1.3 Mb region of 
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finished chimp sequence, less than 0.25% of the aligned bases came from alignments that were 
clearly spurious. There were 3.068 Gb of scaffold length where all three methods agreed upon 
chromosomal placement and 3.087 Gb where are least two of the methods concurred. Only 9.9 Mb 
showed disagreement between all three methods, but in 98% of these cases less than 2 kb of the 
scaffold could be uniquely placed. There was disagreement as to where 3.8 Mb belonged on specific 
chromosomes. Of that, only 293 kb had more than 1 kb uniquely mapped.  
Creation of Chimp AGP Files. The 37,931 chimpanzee scaffolds comprise 2.73 Gb of 
sequence and span 3.109 Gb of the genome. Of these, a total of 33,180 (2.70 Gb of sequence 
spanning 3.077 Gb) scaffolds had significant alignments to the human genome. The process of 
constructing a path of scaffolds designed to represent the chimpanzee genome was as follows.  
All alignments completely contained within other alignments were first removed from the 
alignment set. Next, alignments where more than 90% of the scaffold length aligned to the human 
genome in a single chain were examined. When a subregion of such an alignment also aligned to 
another region of the genome, the alignment was removed. The next step involved examining the 
subset of scaffolds for which more than 5% of the scaffold content aligned elsewhere in the 
genome. If the alternate alignments were within 3 kb of the main (90%) alignment, the alignments 
were merged. If the alternate alignments were each less than 100 bp in length, they were also 
removed. If the 5% was aligned on the same chromosome but in the random portion, then only the 
main 90% portion was retained. Only those alignments determined to be chimeric were removed, all 
others were retained. 
All alignments were retained where at least 60% of the scaffold length was aligned to one 
``region'' of the genome. For remaining alignments, when all alignments were to the same 
chromosome they were assigned to their respective chromosomes, but to the random drawer. When 
alignments were to various chromosomes, they were assigned to chrUn_random.  
All alignments in the >90% and >60% categories were examined if the chimp scaffold 
spanned more than 1.5 times its counterpart in the human genome. When the offending supercontig 
only subsumed other supercontigs less than 1.5 kb, they were retained. For those that would 
completely overlap large contigs, the alignments were manually reviewed to determine if the 
alignment should be broken.  
At this point scaffolds spanning a total of 2.85 Gb were anchored to the human genome 
sequence (excluding those in the _random bins). All scaffolds that were completely overlapped by 
another scaffold based on the human position were then removed. Also removed were the smaller of 
two neighboring contigs when there was an overlap of 60% (based on human) between neighboring 
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scaffolds. The total anchored sequence after these steps dropped to 2.74 Gb (2.41 Gb of actual 
contig length), or 88% of the total chimpanzee sequence. An additional span of 280 Mb (240 Mb of 
actual sequence) was assigned to a chromosome, but in the _random portion, and the final 91 Mb 
was unassigned. For gaps between supercontigs, sizes were estimated using the alignments to the 
human genome.  
Centromeres were introduced into the chimp at the positions of the centromeres in the 
human chromosomes. An additional centromere was introduced in Chromosome 2B (formerly 
PTR13) at the site of the 30 kb of alpha-satellite. Finally, nine documented/known human 
inversions (Yunis 1982) were introduced into the ordering as was the fusion of human chromosome 
2 from chimpanzee chromosomes 2A and 2B (formerly PTR12 and PTR13).  
Detailed Assessment of Assemblies. We sought to evaluate the consistency of the 
assemblies by examining pairing rates and read depths and by comparing assemblies to various data 
sets. In terms of pairing rates, 90% of the read pairs in the PCAP assembly fell within the distance 
of their nominal insert sizes. We also examined regions of the assembly that appeared to be 
collapsed repetitive data by examining local depth of coverage. For example, only 910 kb of the 
PCAP assembly fell in areas where the depth of coverage exceeded 20 reads. Using a Poisson 
model for independently and identically distributed sequence with a rate of 4, i.e. for 4x nominal 
coverage, such regions would have a probability on the order of 10-8 of occurring by mere chance. 
Therefore, they are very likely collapsed repeat regions. Examination of the content of these regions 
revealed four times fewer simple repeats and low complexity masked regions as compared to the 
genome as a whole, but 26 times more satellite sequences. About 34% of these bases were masked 
as interspersed repeats as compared to 42% for the genome as a whole.  
As a measure of accuracy of the assembly, we examined the alignments between the 
chimpanzee assembly and the finished chimpanzee clones for interweaving of supercontigs and 
mis-ordering of contigs within a supercontig. Both assemblies had some issues arise as a result of 
the moderate level of coverage, although the ARACHNE assembly had fewer overall. There were 
cases in both assemblies where overlaps were suggested by human sequence, but which were not 
recognized by the assemblers. The lengths of these provisional overlaps were always less than 1000 
bp.  
We also assessed the assemblies by more direct comparisons with the human genome. For 
example, none of the final assemblies contained any global misjoins. These were defined as regions 
of at least 50 kb having cross-over or consecutive alignment to more than one human chromosome. 
Human mRNAs and oriented ESTs were also used to assess coverage of the assemblies. Both 
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assembly methods performed similarly with respect to percentages of human mRNAs and ESTs 
aligned.  
Absolute values are not of interest for certain comparisons between the chimpanzee and 
human genome, since many of these cases are true chimpanzee/human differences. However, 
relative numbers of inter- and intrachromosomal differences were used to compare performance of 
each assembler. For example, we considered  
1. numbers of supercontigs with orientation issues with respect to the human genome  
2. numbers of supercontigs where successive pieces of the alignments jumped more than 
300 kb in human coordinates  
3. numbers of supercontigs where individual contigs within them seemed to be out of 
order with respect to the human genome. 
We specifically examine only supercontigs larger than 150 kb. PCAP had fewer orientation 
and ``jumps'' along the human genome, although both assemblies had a similar number of ordering 
anomalies. In particular, about 73% of those supercontigs exhibited at least one of the above issues, 
confirming the complex relationship between the chimp and human genomes.  
We also examined the assemblies in terms of several additional quantities for which 
finished BAC sequences were available. These BACs were determined to be either unique or 
duplicated, based on segmental duplication analysis of the human genome (NCBI build 34). 
Overall, the mean number of aligned bases is reduced by 30% in duplicated regions (determined by 
merging Blast (Altschul 1990) alignments where neighboring HSPs were within 80 bp and 
sequence contigs were in the same orientation). The number of supercontigs and the number of 
discordances, or disruptions in the linear relationship of adjacent contigs within a supercontig, 
increases by 3 to 4 times.  
We estimate the genome coverage to be about 94%, based on comparison to 12 finished 
CHORI-251 BAC clones. These clones collectively comprise a total of 1,265,617 bases of 
sequence. ARACHNE covers 1,186,774 bases, or 93.8% of the clones, while PCAP covers 
1,189,836 bases, or 94.0% of the clones.  
Comparison with the finished chromosome 21 sequence. We also sought to evaluate the 
contiguity of the WGS assembly by comparing it to the BAC-sequenced chromosome 21 
(Watanabe, 2004). Using the same alignment procedure as described above, a total of 3,462 contigs 
could be unambiguously aligned to cover 95% of the finished sequence. 57% of this sequence is 
contained in a single 17.8 Mb supercontig, 90% is contained in the 10 largest supercontigs, and the 
remainder is contained in 201 smaller supercontigs, often interwoven within the larger ones (~0.6 
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events per 100 kb). There are 371 undetected contig overlaps with a median length of 101 bp (~1.2 
events per 100 kb). With the exception of 88 linked contig pairs that could not be unambiguously 
ordered in the assembly (~0.3 events per 100 kb), there were no ordering or orientation conflicts 
between the WGS supercontigs and the finished sequence. These discrepancy rates are nearly 
identical to the same source BAC comparison. Because chromosome 21 is particularly duplication 
poor (only ~ 650 kb of segmental duplications) and the pericentromeric region appears to be 
underrepresented in the finished sequence, these rates may still underestimate the number of 
discrepancies in highly duplicated/repetitive regions. 
Because the error rate at high quality bases in the WGS assembly is significantly lower than 
the polymorphism rate in the chimpanzee population, the substitution rate between the WGS 
sequence and the finished chromosome 21 sequence is not informative for accurately determining 
this error rate (the Q20 substitution rate is 1.2x10-3, which is within 10-4 of the expected 
heterozygosity given than the mutation rate of chromosome 21 is approximately 20% higher than 
the genome mean). However, by comparing both to the orthologous human sequence, we can 
determine whether there is any bias in the WGS analysis. We therefore constructed a gene catalog 
for each of the two chromosome sequences using the same approach as used globally in the 
manuscript. Using the UCSC Browser knownGenes track for human chromosome 21, orthologous 
chimpanzee coding regions were extracted for 493 transcripts using the uniquely placed contig 
alignments, and then filtered for alignment/sequence artifacts. The finished chromosome 21 
sequence yielded a mean base coverage of the human coding regions of 95.6%, and had 68 
transcripts with frame-shifts or premature stop codons. Manual inspection suggested that the 
majority of these artifacts are likely due to problems with the human gene predictions (errors in the 
cDNA evidence, see below). The WGS chromosome 21 sequence yielded a mean base coverage of 
the human coding regions of 89.3%, and had 95 transcripts with frame-shifts or premature stop 
codons. Manual inspection suggested that the majority of the 27 artifacts that were not also present 
in the finished sequence were caused by 1-2 bp indels in the chimpanzee WGS sequence. After 
removing all but the longest transcript from each gene, a total of 219 unique, artifact free coding 
region alignments could be extracted from the finished sequence, and 196 from the WGS sequence. 
We counted the number of substitutions between the two chimpanzee sequences and the 
human sequence in the aligned coding regions at all unmasked sites in the WGS assembly. The 
number of differences between the WGS and finished sequences is 3.88x10-4, well within the range 
expected from heterozygosity. Both chimpanzee sequences were also roughly equidistant from the 
human sequence, indicating no detectable excess of substitutions in the WGS sequence.  
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We also counted the number of substitutions between the finished chimpanzee sequence 
and the human sequence after including those sites which were masked as low quality in the WGS 
sequence, shown in the last column on the table below. Including these sites increase the observed 
substitution rate for the finished sequence by 2.6x10-4, 50% of which is contributed by only 2.5% of 
the compared genes. This may indicate a slight bias against inclusion of highly diverged regions in 
the WGS sequence (most likely by mistaking true SNPs for sequencing errors). As described 
elsewhere, a bias may contribute to the slightly higher number of substitutions observed on the 
human lineage compared to the chimpanzee lineage, but this would not affect any conclusions in the 
manuscript. Alternatively, low quality regions may not be independent in the WGS and finished 
sequences, and including sites corresponding to masked bases in the WGS assembly may slightly 
increase the error rate of the finished sequence. 
Human-chimpanzee ortholog alignments. In order to build a first-generation chimpanzee 
gene catalog we aligned human RefSeq cDNA sequences to the human genome (NCBI build 34) 
and in turn transferred those alignments to the chimpanzee sequence. Discrepancies between the 
cDNA and human genome sequence were carefully flagged (see below). Each gene alignment was 
transferred to the chimpanzee genome sequence by identifying the orthologous chimpanzee bases of 
the aligned cDNA via the whole-genome BLASTZ alignments (see above). Discrepancies between 
the human and chimpanzee sequences were also noted. 
Proofreading the Human Genome. As mentioned above, not all apparent discrepancies 
between human gene predictions and the chimpanzee sequence are due to errors in the latter. A 
significant source of such problems may in fact be discrepancies between the human genome 
sequence and the transcript evidence on which the gene prediction was based.  
We used the chimpanzee alignment to examine such discrepancies among existing human 
genomic data. As described above, we first identified the positions of each alignment gap between 
the cDNAs and the human genome by searching for indels in the alignment descriptions, and then 
determining how far we could slide them in either direction without introducing a mismatch or 
merging the gap with another gap. This allowed us to find all equivalent instances of the alignment 
that have the same score under an affine gap scoring scheme. So for example, for the BLAT 
alignment  
           01234  56 7  
   refseq  CGTAT--AT-C  
   genome  CGTATATATGC  
           01234567891  
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we would report each gap in the format “<rmin>  <rmax> <rinsert> <gmin> <gmax> 
<ginsert>” and the leftmost gap would be described as ``1 6 0 1 8 2'', meaning that there is a 
2 bp insertion in between positions 1 and 8 in the genome, and a corresponding 2 bp gap between 
positions 1 and 6 in the RefSeq sequence.  
Next, we looked at the alignment of the human genome to the chimpanzee genome. So for 
example, if the BLASTZ genome alignment showed  
            01234567891  
   human    CGTATATATGC  
   chimp    CG--TATATGC  
            01  2345678  
we would report that the chimpanzee genome supported the RefSeq at this 2 bp discrepancy, and 
that it supported the human genome at the other 1 bp discrepancy.  
 Limiting our analysis to gaps < 10 bp in size, we identified 11,986 unique UTR gaps and 
2,582 unique CDS gaps in 6,216 gapped cDNAs alignments. The gaps occurring in the cDNAs are 
rarely disruptive to the annotated RefSeq CDS. They tend to be close to the end of the CDS, and 
often have compensating frameshifts nearby, for example: 
   human_cdna          GTTGGCCGCGG-CTGCGAGGACGGGTGCCC  
   human               GT-GGCCGCGGCCTGCGAGGACGGGTGCCC  
   chimp               GT-GGCCGCGGCCTGCGAGGACGAGTGCCC  
   qual                44 555555555555444333333444455  
The gaps occurring in the genome sequence tend to be more randomly distributed, and are rarely 
compensated for, e.g.:  
   human_cdna          GATGGGCTCGTCCGCGGAGGACGCGTTGAC  
   human               GATGGGCTCG-CCGCGGAGGACGCGTTGAC  
   chimp               GATGGGCTCGTCCGCGGAGGACGCGTTGAC  
   qual                444444444444444444444444444444  
The nature of these inconsistencies (over-representation in UTRs and small effects on the RefSeq 
annotated CDSs) suggests that they are due mainly to sequencing errors in cDNAs. Disruptive 
indels are likely to have been filtered out of RefSeq, but probably would not have been discovered 
in the genomic sequencing/assembly process. Such errors can now be corrected appropriately. On 
the other hand, it is possible that at least some of these inconsistencies are actual polymorphisms in 
human sequence. We genotyped 90 CDS indels in the 24-individual NIH diversity panel (Collins 
1998). Of 87 successful assays, the chimpanzee sequence correctly predicted the human sequence in 
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all but three cases. The predicted sequence was found to be monomorphic in the sample in 90% of 
cases and polymorphic in the remainder. This strongly suggests that ~90% of observed 
discrepancies between current human cDNAs and the human genome sequence represent errors in 
the cDNAs, or deleterious mutations aquired by the source cell lines, which is consistent with the 
conclusions of a similar EST-based analysis (Furey 2004).   
Chimpanzee Polymorphisms. Sequences for SNP discovery were generated from three 
western and three central chimpanzees, Pan troglodytes verus and Pan troglodytes troglodytes, 
respectively. For the chimpanzees other than Clint, 4 kb libraries were constructed and ~0.5x 
whole-genome shotgun reads were generated. The western chimpanzees were captive-born 
descendants of chimpanzees shipped from Sierra Leone and the central chimpanzees were wild 
born, confiscated by customs and brought to a primate center in Gabon. BAC clones from two other 
(putative) western chimpanzees, ``Donald'' and ``Gon'' provided an additional end sequences. For 
more discussion on chimpanzee nucleotide diversity, see Kaessmann (1999), Deinard (2000), and 
Yu (2003).  
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Divergence rate estimates. Regional divergence rates were estimated over all bases in a chosen 
segment/window that passed the relaxed NQS(30,25) quality filter (quality score 30 at the compared 
base, 25 at the five flanking bases on each side, and any number of flanking substitutions allowed), 
using the baseml program of PAML (Yang 1997) with the REV substitution model. Due to the low 
level of divergence, the REV model estimate and the observed divergence rate (diverged bases/total 
bases) was always highly similar. 
CpG and non-CpG divergence rates. We observe a rate of divergence at sites in CpG 
context of 15.2%, compared to a rate of 0.92% in other contexts. The simple assumption would be 
that the CpG to non-CpG mutation ratio is 16.5. However, some number of these mutations are into, 
rather than out of, the CpG context, and are in fact normal, not CpG mutations. We can, however, 
calculate the real ratio, which we define as X, the ratio of CpG mutations to non-CpG mutations 
(note that X is not the rate of deamination events, so CpG mutations consist of (X-1)/X caused by 
deamination and 1/X resulting from normal replication error). Separating observed mutations into 
loss and gain requires the assumption that the total fraction of CpG in the genome is roughly in 
equilibrium (Sved 1990), which seems valid given the high rate of CpG loss, the long history of 
primate evolution, and the fact that both humans and chimpanzees have almost identical counts of 
CpGs. As we note, some CpGs may be gained through non-mutational methods such as mobile 
elements rich in CpG, like Alu or SVA, but the total number of CpGs added to either genome by 
this method is no more than 500 k, at most 2% of the approximately 25 M CpGs in the aligned 
portion of either genome. 
 To calculate the true ratio, we reassign some of the observed CpG mutations to be non-CpG 
and recalculate the denominators. If we observe a fraction of bases currently in CpG context in one 
or both genomes, we can break this down into the number of ancestral CpGs plus those gained by 
mutation into CpG less those lost in both genomes and now classified (with equal probability) as 
two non-CpG mutations or a non-CpG apparently unchanged base (if the same base mutated in both 
copies). Assuming that the number of CpGs created equals the number destroyed, this yields a 
quadratic equation which can be solved to get a true rate of CpG mutation of 4.7% (per genome), 
with an ancestral fraction of CpGs of 1.78%. The rate of non-CpG mutation increases (because we 
reassigned more than half of the CpG mutations as non-CpG while only slightly increasing the 
number of such sites) to 0.535%, (per genome, or ~1.07% divergence) for a ratio of X = 8.8. 
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 This is the observed, rather than the instantaneous, rate, although at this divergence they are 
approximately equal. However, several other factors could influence the estimate. First, the 
chimpanzee genome is a heterozygous draft, and the CpG context bases are ~10 fold more likely to 
be polymorphic, which would result in lowered quality scores, and they might be excluded from 
analysis, which might underestimate the fraction of CpG positions (in fact, human build 34 has 
1.98% of its bases in CpG context compared to our estimate of 1.78% estimated in the chimp-
human ancestor). Also, this rate assumes that all CpGs are equally susceptible to deamination 
events. However, approximately 7% of all CpGs are in CpG islands, and presumably protected from 
methylation (in fact, their mutation rate is only ~0.8%), which would imply a larger mutation ratio 
at the remaining sites (althought the globally observed rate per site remains constant regardless of 
fraction methylated). In the end, this question could be illuminated further by the sequence of a 
close outgroup, such as orangutan, baboon, or macaque, which could determine the ancestral 
human-chimp base at high confidence. 
Proportion of fixed differences. Assuming constant mutation rates and no selection, the 
proportion of observed divergent sites that are non-polymorphic in both the human and chimpanzee 
populations is 1 – (TH+TC)/(2*THC) where TH is the mean time to the most recent common 
ancestor (TMRCA) of a chromosomal segment in the human population, TC is the TMRCA in the 
chimpanzee population and THC is the TMRCA of humans and chimpanzees. From coalescence 
theory (Rosenberg 2002), the expected TMRCA in the human and chimpanzee populations is 
4*Ne*g, where Ne is the effective population size (10,000 for humans, 10,000-20,000 for 
chimpanzees) and g is the generation time (assumed to be 25 years), giving TH = 1 Myr and TC = 
1-2 Myr (see also Excoffier 2002). Assuming THC = 7 Myr, we get a fixed proportion of 0.78-0.86. 
Expected variation in divergence due to variation in Time to the Most Recent 
Common Ancestor. In order to estimate a conservative upper bound on divergence variation due to 
TMRCA variation, we assumed that 2/3rds of the observed divergence has accumulated since the 
human-chimpanzee split; that TMRCA is exponentially distributed with a mean of 1/3 times the 
observed divergence (a conservative upper bound) and that blocks of constant TMRCA are on 
average 10 kb long (approximately the length of linkage disequilibrium blocks in African 
populations (Reich 2001) and a likely overestimate for the larger human-chimpanzee ancestral 
population) and randomly distributed across the autosomes. We estimated the expected standard 
deviation as 0.07% (roughly one-quarter of the observed standard deviation) from a simulated 
ensemble of 2,000 random windows of 1 Mb length, assuming constant mutation rates and no 
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sample variance, repeated 1,000 times. Given that this should be a conservative upper bound, the 
majority of the variation observed at the megabase scale is unlikely to be due to drift. 
 Male mutation rate bias for CpGs and non-CpGs. After masking ampliconic regions in 
Y, pseudoautosomal regions in X and Y, and segmental duplications in all chromosomes, we 
estimated alpha from the three possible comparisons between X and Y, X and autosomes and Y and 
autosomes (Taylor 2006). Since the divergence between human and chimpanzee is low and the 
effective population size is different for X, Y and the autosomes, alpha estimates should be 
corrected for the effects of pre-existing polymorphism in the ancestral human-chimpanzee 
population (Makova 2002). Assuming a similar effective population size as contemporary 
chimpanzees, which is twice as high as contemporary humans (Fischer 2004; Yu 2003), corrected 
alpha estimates range between 3-6, depending on the pair-wise comparison. The X/A comparisons 
are likely to be the most accurate because the Y chromosome data is scarce (particularly for 
diversity on Y - and we need this for correction), and challenging to align correctly. If the relative 
time spent in the male and female germlines is the dominant factor leading to differences among 
rates on X, Y, and autosomes, then alpha estimated from the three comparisons should be similar. 
This can be achieved if we assume a three times higher population size for the human-chimpanzee 
ancestral population compared with that in contemporary humans and leads to alpha ~5.  
 However, alpha seems to be not the same for all types of mutations: Intriguingly, alpha 
estimated at CpG dinucleotides is lower than at all sites. This is consistent with the expectation that 
CpG to TpG transitions caused by spontaneous deamination of methylated cytosines are time-
dependent, rather than dependent on the number of germline cell divisions (Nachman 2000). A 
close outgroup will be required to separate mutations that create CpGs (and are expected to be 
replication-dependent) from those that eliminate CpGs (and are expected to be time-dependent). 
Detection of Deletions within Bounded Alignments: Small insertion/deletion events 
(<15kb) were parsed directly from the BLASTZ genome alignment by counting the number and 
size of alignment gaps between bases within the same scaffold (“scaffold-based indels”) or contig 
(“contig-based indels”). The size distributions of the bounded indels are given in Figure 9. Missed 
contig overlaps in the draft assembly create artificial chimpanzee “insertions”, leading to a slight 
overestimate of the number of unalignable chimpanzee bases from the scaffold-based indels (35.18 
Mb total sequence). On the other hand, the relatively small contig sizes lead to an underestimate of 
small indels in the contig-based set (17.45 Mb total sequence). Together, these sets provide 
conservative upper and lower bounds on the number of chimpanzee “insertions” in the aligned draft 
sequence. 
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Detection of Deletions by Paired-end Placement: Sites of large-scale insertion/deletion 
(indels >15kb) were detected by optimal placement of paired sequence reads (8.94M fosmid pairs 
[1788427 reads]), 6.88M plasmid pairs [WASHU: 7339999 reads, MIT:  6420133 reads] and 
0.084M BAC pairs [RIKEN:  45828, WASHU:  122614 reads]) against the human assembly (April 
2003, build33). Our detection methodology utilizes only high quality read pair alignments to the 
finished human genome, thereby circumventing false-positives  which may be detected by  using 
the draft chimpanzee assembly alone (method in preparation). The distance between the reads of a 
single clone should reflect the size of the cloned insert (concordant read pair).  If the pairs do not 
place in the correct orientation, or define a region smaller/larger than the expected it is considered 
discordant. Indels (>15kb) were identified by two or more discordant placement from the same 
vector, with support from at least one plasmid; macro events (>100kb) are defined by BAC 
discordant placements. Size thresholds were obtained from read pair distribution of both human 
fosmids alignments on human sequence (X=40kb;SD:+/-2.58kb), and chimpanzee plasmid 
alignments against human chromosome 21 (X=4.5kb; SD: +/-1.84kb). Size discrepancies were 
determined to fall within two standard deviations from mean distribution.  By identifying read pairs 
which surpass our thresholds we are able to detect both chimpanzee deletion and potential insertion 
events in respect to the human genome. Three events were required before considering an indel: 
each indel must be defined by two or more discordant pairs and the absence of sequence data within 
the discordancy. This eliminates potential cloning artifacts from further consideration. Other 
confounding sequence properties (recent duplications, retroelements, etc.) were also considered 
during this analysis.  
Unmapped Chimpanzee Sequence: Roughly 90% of the scaffolds that did not align to the 
human genome at all contained previously characterized repeats (~5.9 Mb of total sequence). As 
expected, satellite repeats were largely represented in set. Subterminal satellite repeats, found in 
many chromosome arms in the chimpanzee and gorilla, represents the largest percentage of 
identified repeats (62% of all masked bases in unplaced scaffolds) (Royle 1994).  Centromeric 
satellite repeats were also detected, with over 2.1Mb (19% of all masked bases) of sequence 
consisting of alpha satellite  repeat (ALR) and 1.2 Mb of sequence (10.8% of all masked basepairs) 
of beta satellite repeat (BSR). Only ~1% of all masked bases were due to complex and simple 
repeats (0.132 Mb; 1.2% all masked bases). HERV and LTR sequences comprise 2.5% of all 
masked bases (271274 bp). 
Estimate of indel basepairs: The total number of insertion/deletion bases between 
chimpanzee and human was estimated as follows. The number of unaligned bases (“insertions” < 15 
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kb) within sequence scaffolds was 31.78 Mb (2347812 events) and 35.18 Mb (2741577 events) for 
human and chimpanzee respectively. The number of chimpanzee deletions >15 kb was estimated by 
paired-end sequence to be 8.2 Mb (163 events). 5.9 Mb of chimpanzee sequence could not be 
mapped back to human using low sequence threshold cutoffs.  We estimate a similar amount of 
such sequence for human.  In total, we estimate 95.2 Mb (31.78+35.18+5.9 *2 + 8.2*2) or 3.2% 
difference between chimp and human.   
Processed Pseudogene Analysis.  Based on a divergence time of 6 million years and the 
number of processed pseudogenes reported in the paper, we estimate a minimum rate of 
retrotransposition as 40 and 60 events per million years. This is significantly reduced when 
compared to a constant rate of retrotransposition after the human-mouse split. We estimate 17,000 
human processed pseudogenes have emerged since the human-mouse divergence with a 
concomitant rate of 170 events (17,000/100) per My (Torrents 2003). 
New repeat-derived CpG islands in humans: Some interspersed repeat elements contain 
CpG-rich regions that could theoretically become functional CpG-islands if inserted in the promoter 
region of a host gene.. At least 3 of ~1000 human-specific CpG islands have been inserted in the 
promoter region of known genes, but additional data will be required to determine whether these 
insertions have led to changes in gene expression patterns. 
Repeat-mediated homologous recombination: We curated the results by hand to 
eliminate assembly artifacts in chimpanzee and cases of expansion or contractions of tandem 
duplications. We limited the analysis to those indels with breakpoints well within the repeat 
elements. This removes duplications that simply have an element on one site, but also results in an 
underestimate by missing those recombination events with breakpoints on the edge of repeats. 
Detection of large-scale Inversions: Optimal BAC read pair (32,826) placements against 
the human genome (build33) were evaluated for large discordant placement (greater than 2Mb) to 
identify sites of inversion. Reads pairs which are incorrectly orientated and lack concordant read 
pair placement within breakpoints may identify sites of rearrangement. Large-scale inversions 
(>2Mb) were initially determined by 2 or more discordant BACs spanning the same region.  
Plasmid and fosmid discordant placements were then used to refine the breakpoints and increase 
confidence in a potential rearrangement. Breakpoints supported by 2 or more fosmids, plasmids, 
and BAC discordant read pair placement were selected for experimental validation. We utilized a 
previously described method (Nickerson 1998) to validate breakpoints. Two or more probes were 
selected in the human genome that mapped on either side of the breakpoint region identified by our 
study. Two-color FISH experiments (or single FISH experiment if the region was unique) were then 
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performed with each pair of BAC probes. True inversions in the chimpanzee lineage will appear as 
separate FISH foci/ split signal within a chimpanzee metaphase chromosomes as opposed to a 
merged/single signals within the human genome (Nickerson 1998)    
Segmental Duplication Analysis. Segmental duplication is very difficult to analyze on the 
basis of draft genome sequence, because sequence from duplicated regions may be collapsed 
together and sequence from a single region may fail to be assembled together (resulting, 
respectively, in under- and over-estimates of the extent of duplication). With near-complete 
sequence, it is now possible to estimate that ~5.3% (150.8 Mb) of the human genome resides in 
regions of segmental duplications (defined as stretches of >1 kb in length matching other regions 
with >90% identity (IHGSC 2004, She 2004). The chimpanzee genome assembly shows a lower 
amount of segmental duplication (136.7 Mb), with greater fragmentation and more regions with 
>99% identity. However, these apparent differences from the human are likely predominantly to 
reflect limitations of the draft genome assembly (She 2004).  Like the human genome, the 
chimpanzee assembly shows both extensive interchromosomal and intrachromosomal duplication; 
in contrast, the mouse and rat genomes have predominantly intrachromosomal duplications (Bailey 
2004, Tuzun 2004, Cheung 2003).  
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Ka, Ks, Ki. The Ka and Ks rates are estimated jointly by PAML (Yang 1997) from all aligned 
bases with quality score > 20 in orthologous coding regions, using the F3x4 codon frequency model 
and the REV substitution matrix. Lineage specific rates were estimated using an unrooted tree 
including human, chimpanzee, mouse and rat. Ki is estimated by PAML as substitutions per 
nucleotide for all aligned, orthologous nucleotides that passed the relaxed NQS(30,25) filter (any 
number of flanking substitutions allowed) in non-coding, interspersed repeats (not low-complexity) 
within 250kb, centered on each gene.  
We note that CpG dinucleotides are not explicitly modeled, which leads to bias in the rate 
estimates due to differential sequence content. On average, Ks appears to be more sensitive to CpG 
content than Ka, which again is more sensitive than Ki. For example, genes in GC-rich regions 
appear to have lower mean Ka/Ks values and higher Ka/Ki values than genes in GC-poor regions. 
To the best of our knowledge, none of the results presented in this work are directly affected by this 
apparent bias, but we caution that for applications where absolute rate estimates are crucial, more 
sophisticated evolutionary models should be used. Models that explicitly incorporate context-
dependent mutation rates are currently under development (e.g. Hwang 2004, Siepel 2004). 
Bias due to quality masked chimpanzee SNPs. The apparent slight excess of amino acid 
and synonymous substitutions on the human lineage in the hominid-murid comparison may be 
partly explained by a data artifact. Because the human assembly is a tiling of single haplotypes, 
whereas the chimpanzee assembly is a consensus of two haplotypes, some heterozygous positions in 
the chimpanzee WGS reads are effectively masked as low quality positions. This may lead to a 
slightly disproportionate contribution of human diversity to the human divergence rate. Additional 
high quality sequence will be required to robustly test for small differences in the human and 
chimpanzee substitution rates. 
Ka/Ks of polymorphism. Polymorphisms from the HapMap or Affymetrix datasets that 
overlapped one of the aligned 13,454 orthologs were classified as synonymous or nonsynonymous 
according to whether they changed the overlapped amino acid when the flanking bases were fixed 
as the human and chimpanzee references sequences. The Ka/Ks of the polymorphisms is calculated 
as (∆A/Na)/(∆S/Ns) where Na and Ns are the number of nonsynonymous and synonymous sites 
sampled from, and ∆A and ∆S are the number of observed nonsynonymous and synonymous 
differences. Ns/Na was estimated as ~0.36 from the aligned orthologs. The % excess of 
nonsynonymous substitutions were calculated as 1 – (∆Adiversity / ∆Sdiversity) / (∆Adivergence / ∆Sdivergence). 
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The confidence interval for this fraction was estimated by assuming that both ∆A counts were 
Poisson distributed and both ∆S fixed, and calculating a likelihood-based 95% confidence interval 
for a ratio of two rates (Graham 2003).  
Simulation of expected Ka/Ki distributions. The expected distribution of observed Ka/Ki 
values over 13,454 orthologs under the null hypothesis of no positive selection were simulated by 
randomly redistributing the observed number of non-synonymous substitutions between the 
orthologs under the constraints that (i) the actual (not observed) Ka/Ki = 0.23 for all genes, or (ii) 
23% of the non-synonymous sites, distributed between genes according to a beta distribution, 
evolved at Ka/Ki = 1, and the remaining at Ka/Ki = 0, and that the number of orthologs with 
observed Ka/Ki > 0 were equal to the observed fraction (~29%). The mean numbers of orthologs 
with observed Ka/Ki > 1 over 100 trials were (i) 0 and (ii) 263. Note that this does not guarantee 
that the apparent excess of genes with observed Ka/Ki > 1 is due to positive selection, 263 is simply 
a lower bound on the number of cases that can be explained by stochastic fluctuations. 
Identification of rapidly diverging gene clusters. We ordered all aligned human-
chimpanzee orthologs by their genomic positions and calculated the median Ka/Ki ratio for sliding 
windows over 10 genes, with a step size of 2, across the autosomes (because X chromosome Ka/Ki 
are not directly comparable for this purpose). We estimated the distribution of Ka/Ki under the null 
hypothesis of no clustering by repeating the same procedure 1,000 times on the same orthologs in 
random orderings. Empirical P-values were calculated by comparing the observed Ka/Ki to this null 
distribution, and windows with a P-value of less than 0.001 where reported. Approximately 13,000 
orthologs were scanned, implying that approximately 1,300 independent tests were performed, we 
therefore calculated the significance of seeing 16 clusters with P-value less than 0.001 from a 
binomial distribution with n=1,300 and p=0.001. When multiple, overlapping windows 
corresponded to the same gene cluster, only the most significant window was kept. The list of top 
clusters also remained highly similar when the procedure was repeated using Ka only. Repeating 
the analysis with larger window sized did not identify any regions that could not be explained by 
the inclusion of one or more of these original clusters. 
No accelerated evolution in rearranged chromosomes. Navarro et al. (2003) proposed 
that orthologs within one or more of the pericentric inversions between human and chimp might 
show higher Ka/Ks than the genome-wide average. We re-evaluated this hypothesis on our 
considerably larger dataset, using a binomial test for increased Ka/Ks relative to genes on the 
collinear chromosomes. All P-values are corrected for multiple hypothesis testing. A few of the 
regions contained few or no aligned orthologs. 
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 Only the HSA4 and HSA5 inversions show a significant increase in Ka/Ks, but it is 
significantly smaller than the 2.2-fold increase observed on the smaller dataset in (Navarro 2003), 
and it is primarily due to low Ks, rather than the overall accelerated divergence that is predicted by 
the model of Navarro et al. Furthermore, there is no increase is Ka/Ki. However, we note that 
because of the numerous confounding factors, such as differences in gene content and sequence 
composition, it is difficult to directly compare the rates of protein evolution between relatively 
small genomic regions. Thus, our negative findings do not necessarily disprove the chromosomal 
speciation model described by Navarro et al. per se, just the huge quantitative signal implied by 
their initial report. 
Identification of rapidly and slowly evolving categories.  Unique LocusLink identifiers 
(June 2004) of 13438 human-chimpanzee mRNA alignments GO categories (May 2004) were 
assigned to 9205 orthologs via GenMapper (Do 2004). We used the following approach to identify 
GO categories that have a Ka/Ks ratio significantly above or below average.  
First, the ‘concatenated’ ka and ks for all genes in a GO taxonomy T were calculated as  
  
where ni and Ni are the numbers of non-synonymous substitutions and sites, and si and Si are the 
numbers of synonymous substitutions and sites in gene i, as estimated by PAML, respectively.  
The expected proportion of non-synonymous substitutions pA in a GO category C was then 
estimated as: 
  
Finally, for a given category, the probability pc of observing an equal or higher number of 
non-synonymous substitutions, conditional on the total number of observed substitutions, was 
calculated assuming a binominal distribution: 
  
where aC and sC are the total number of non-synonymous and synonymous substitutions in GO 
category C, respectively.  
  134
 Defined in this manner, pC, is a statistic whose expected value has two relevant properties: 
(1) given a fixed number of substitutions, its value decreases monotonically as the category Ka/Ks 
increases relative to the GO taxonomy average and (2) given a fixed Ka/Ks ratio, its value decreases 
monotonically as the total number of substitutions in a category grows. A GO category with a low 
pC value is therefore more likely to be rapidly evolving relative to all other genes than a GO 
category with a high pC value. However, because of the large number of categories tested and the 
unknown variance of pC, it is not a conservative p-value for category specific acceleration. 
Slowly evolving categories was detected correspondingly by calculating the probability that 
a category contains equal or less non-synonymous substitutions, conditional on the total number of 
observed substitutions. 
 To determine whether a subset of the categories are evolving under significantly high (low) 
constraints we first computed the number of GO categories with at least 20 orthologs and pC less 
than a threshold value (0.05, 0.01 or 0.001). We then repeated this procedure 10,000 times on the 
same dataset after randomly permuting the GO annotations (all GO categories assigned to a specific 
gene are kept together in order to preserve the hierarchical structure of the GO categories). Finally, 
we tested the null hypothesis that the number of biologically meaningful categories with pC below 
the chosen threshold is no more than expected from randomly composed categories by counting 
how many of the latter have more low pC values. A rejection of this null hypothesis implies that the 
level of constraint is significantly higher (lower) than average in some biologically meaningful 
categories. The average number of categories with pC below the threshold identified in the 
randomized datasets is the expected number of false positives among the putatively rapidly (slowly) 
evolving categories. 
Since categories are overlapping, the list of significant categories can contain redundant 
information. Therefore we used a ‘refinement’ algorithm to generate the non-redundant Table 5. 
This algorithm removes parent categories that do not have pC values below the chosen threshold 
after the genes in their child categories with low pC have been removed. 
 As an alternative to the binomial statistics described above, we also used a non-parametric 
approach to test for categories with a significantly high or low median Ka/Ki ratio. For this purpose, 
we first used a Wilcoxon two-sample test with a correction for ties as implemented in the R package 
(http://www.r-project.org) to calculate the probability of equal medians, and then repeated the 
permutation test as described above to estimate the significance of this statistic. The results are 
largely similar to the binomial approach, but with slightly more outliers and a lower expected false 
positive rate, potentially due to the lower variance of Ki compared to Ks. However, the lack of 
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lineage-specific Ki estimates, combined with the large number orthologs with observed Ka or Ks = 
0 between human and chimpanzee make rank sum statistics ill-suited for the relative rate tests 
described below. 
  Identification of lineage-specific acceleration in GO categories. Unique LocusLink 
identifiers (June 2004) of the 7043 human, chimpanzee, mouse, rat mRNA alignments were used to 
assign GO categories (May 2004) to 4805 genes via GenMapper (Do 2004).  
We used a similar approach to the binomial test described above to identify GO categories 
that have an excess of non-synonymous changes on one lineage (e.g. between mouse and rat or on 
the human lineage) than on another lineage (e.g. between human and chimpanzee or on the 
chimpanzee lineage). Instead of calculating the expected proportion of non-synonymous to total 
substations, we calculate the genome-wide proportion of non-synonymous changes on one linage 
over the total number of non-synonymous changes between the two compared lineages:   
  
where xi and yi are the numbers of non-synonymous changes on lineages x and y for gene i, 
respectively. For the hominid vs. murid tests, the numbers of substitutions were estimated 
independently from pair-wise comparisons of human-chimpanzee or mouse-rat alignments across 
the same codons. For the human vs. chimpanzee and human vs. mouse tests, the numbers of 
lineage-specific substitutions were estimated jointly with mouse and rat as outgroups using PAML 
as described above.  
  
As described for the absolute rate tests, we then computed this statistic for every GO category with 
more than 20 orthologs, as well as for every category in 10,000 randomly permuted data sets. The 
top 10 non-redundant categories from the hominid vs. murid comparison were reported in Table 6. 
 In order to rule out any estimation bias due to using PAML to estimate lineage-specific 
rates from relatively little sequence information, we repeated the relative rate tests using the number 
of observed amino acid changes only. For the homind vs. murid tests, the observed numbers of 
amino acids between each of the two species pairs were counted. For the human vs. chimpanzee and 
human/chimpanzee vs. mouse tests, only the amino acid changes that could be unambiguously 
assigned to one of the three lineages using mouse as the outgroup were counted. The results are 
essentially identical to those from the non-synonymous rate estimates.  
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As shown in the paper, there is a significant correlation between synonymous and non-
synonymous substitution rates across orthologs. In order to test whether any category-dependent 
non-synonymous acceleration is due to systematic changes in mutation rate we repeated the relative 
rate analysis for synonymous substitutions. Although there is a trend towards an excess of 
synonymous substitutions in some categories between hominids and murids, the variation is 
significantly less than for non-synonymous substitutions. The strongest outliers are cell surface 
receptors and adhesion related genes, which have previously been noted to be biased towards 
mutational hotspots in the human genome (Chuang 2004). 
Human Disease Genes: Overall substitution rate. We downloaded all available 1116 
OMIM disease genes using EnsMart (www.ensembl.org) and could find a human-chimpanzee 
cDNA alignment for 882 of them. We compared Ka, Ks, Ki Ka/Ks and Ka/Ki between disease 
genes and non-disease genes and used a Mann-Whitney test to estimate the significance of the 
observed differences. 
Recent studies (Huang 2004, RGSC 2004) have reported that human disease genes show an 
elevated synonymous substitution rate (Ks) in human-rat comparisons. The authors suggest that 
disease genes may tend to be located in genomic regions with elevated mutation rates. We re-
examined this question using the chimpanzee sequence, which allows us to study both Ks and Ki. 
Disease genes indeed show higher Ks (0.0138 vs. 0.0126, pMW < 0.001), but no elevation in Ki. This 
indicates that the effect is not due to known disease genes being located in regions with higher 
overall mutation rates. In fact, the elevated Ks in disease genes appears to be explained by a higher 
proportion or rate of substitution of CpGs at silent sites and because these CpGs have a higher 
substitution rate, the effect disappears when only non-CpG sites are considered. 
We also tested whether there were more amino acid changes on the human lineage than on 
the chimpanzee lineage in disease genes and in mental retardation genes (Inlow 2004) using the 
binominal test described above. We do not find a significant difference in the ratio of human-
specific changes to chimpanzee-specific amino acid changes between these two classes and genes 
that have no disease association. This is also true for genes on the X-chromosome, which does not 
support the hypothesis that mental retardation genes on the X-chromosome would have contributed 
particularly to the evolution of human cognition as proposed by Zechner et al (2001). 
Human Disease Genes: Specific disease alleles. We downloaded all amino acid variants 
annotated as “disease” variants in SWISS-PROT (www.expasy.org) and all amino acid variants 
annotated in HGMD (www.celeradiscoverysystem.com), mapped them to their corresponding 
position in human-chimpanzee mRNA alignments and filtered out positions of low sequence quality 
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(Q<20 in at least one codon position). This resulted in a combined list of 12164 disease variants at 
10886 amino acid positions in 1384 different genes. At 46 positions in 41 different genes the 
chimpanzee variant was identical to the human disease variant. We manually screened the literature 
for these variants to confirm a plausible causative association of the variant with the disease and 
excluded 30 variants. We also checked the chimpanzee trace archive to confirm the chimpanzee 
sequence and excluded one variant. For the remaining 15 variants in 14 different genes, we 
confirmed the ancestral state by genotyping them across a panel of primate samples. One additional 
variant (PPARG) was manually added due to the wrong allele being assigned as the disease allele in 
HGMD. 
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Supplementary Notes: Human Population Genetics 
 
Alignment of Reads and Variant Calling. Human reads from the Baylor African-American 
diversity panel (International HapMap Consortium, 2003) consisting of pooled DNA from 4 male 
and 4 female African-American donors generated at the Whitehead Institute/MIT Center for 
Genome Research and the Baylor College of Medicine Human Genome Sequencing Center were 
downloaded from the NCBI trace repository (http://www.ncbi.nlm.nih.gov/Traces).  A total of 
5,316,404 reads were downloaded and quality screened to eliminate reads which did not have: 
length ≥ 500 bp, ≥ 60% of length at Phred score ≥ 20, and at least 100 (for WIBR) and 50 (for 
BCM) passing reads on their sequencing plate. The reads were aligned to Build 34 of the human 
genome using the alignment portion of the Arachne assembler (Jaffe 2003). Reads were discarded at 
this phase if they were not uniquely placed or were not placed consistently with their annotated 
paired end. SNPs were called using the neighborhood quality standard (Altshuler 2000) with a 
window size of 11, minimum score for the variant base of 30, minimum flank score of 25, 
maximum mismatches within the window 2, and maximum indels in the window 0. We discarded 
any alignments, which yielded fewer than 200 NQS bases at that threshold or a SNP rate greater 
than 1%. This resulted in 3,497,810 read alignments covering 1.945 billion NQS bases and yielding 
1,924,196 discrepancies vs the reference sequence (average heterozygosity of 9.9x10-4). 
 For human-chimpanzee divergence, we started with 23,021,928 chimpanzee reads 
sequenced at the Whitehead Institute/MIT Center for Genome Research, Washington University 
Genome Sequencing Center, The Institute for Genomic Research, and RIKEN (Fujiyama  2002). 
We applied similar criteria to the reads, modified as follows: only 50% of raw bases ≥ Phred 20 
were required, and the reads had to have 30% of bases matching only the quality portion of NQS 
prior to alignment and at least 200 such bases (because these trimmed reads were also being used 
for chimpanzee-chimpanzee comparisons at the read level, we needed screens which were 
independent of the human reference genome). These reads were then aligned to the human genome 
and variants called as above, with the exception that we placed no upper bound on divergence rate. 
We estimate the genome-wide average divergence to be 1.23%. An alternative analysis not applying 
the mismatch/indel restriction on the NQS windows raises the estimate slightly to 1.27%. 
Assignment of Ancestral Alleles. We started with the most recent build of NCBI’s dbSNP, 
which had been mapped to build 34 of the human genome (from http://genome.ucsc.edu). In order 
to assign ancestral alleles, we used the same chimpanzee read alignments to human that were used 
to call chimpanzee SNPs. Repetitive or segmentally duplicated regions of the human genome were 
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not covered by this method. This yields calls for 79.6% of human SNPs, with 1.2% having a chimp 
base that agrees with neither human allele and 0.4% being polymorphic in chimpanzee. If we then 
use the draft assembly alignment to human to augment the coverage, we can cover an additional 6-
10% of SNPs (depending on quality threshold on the chimp assembly base) with a rate of chimp 
bases matching neither human allele which is slightly higher than the uninformative calls for the 
original alignment. 
Estimating Error Rate of Ancestral Allele Assignments. We estimated the rate of error 
in the assignment of ancestral bases as the probability that the chimp base matches one of the two 
human alleles, but not the one that is ancestral in the human population. There are two simple cases 
in which this could happen, first where the chimp base has mutated to the same base as the derived 
human allele and second where the human base has experienced a fixed mutation at some point in 
the past and then experienced a reversion mutation that is still segregating. Cases involving more 
mutations are possible but are at least two orders of magnitude less likely than these. Since most 
segregating variants are <1 Mya, we take the probability of a prior fixed change in human to be 
about equal to the probability of a change in chimp, so in the general case, both of these events have 
equal probability: 
Perror = (Pchange)(1 – Pchange)(Psame) + (1-Pchange)(Pchange)(Psame) 
Pchange is ~ half the observed divergence, or 0.00615. Psame is the probability that both mutations are 
identical, which is 0.5, given a 2:1 transition:transversion ratio. This is all contingent on the human 
base currently being polymorphic, so we take Phs-poly = 1 and drop it. This makes Perror 0.6%. 
Breaking these sites down into CpG and non-CpG reveals a more complex story. 
Polymorphic sites in the human genome that are not in a CpG context for either allele will 
essentially follow the equation above, with Pchange reduced to our estimated non-CpG mutation rate, 
0.00535, for Perror of 0.5%. A small number of these sites may have ancestrally been CpG, which 
would create a higher error rate (see below), but we estimate only 0.16% of the genome was 
ancestrally CpG and has mutated out, so the effect will be negligible. 
However, for sites which are in a CpG context for one of their alleles in human, we need to 
consider more seriously the possibility of multiple mutations. Because of the high frequency 
nutation of CpG to TpG, CpG context alleles in human whose chimp alignment is to ApG or GpG 
will have the CpG as the derived variant in human 85-95% of the time and thus be only slightly 
more likely to be erroneously estimated than in the non-CpG case. Similarly, mutants in the human 
which are [C/X]pG and X ≠ T will rarely (<20%) be ancestrally CpG. Thus, we limit our analysis to 
those mutations where the human is [C/T]pG and the chimp is CpG or TpG. (The former case, 
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chimp CpG, will stand as illustrative for all the cases not explicitly calculated that the CpG effect on 
error is small given that observation.) 
For each observed state, human = [C/T]pG and chimp = CpG or TpG, we define prior 
probabilities of observing each of the four likely combinations of ancestral states of the human 
chimp ancestor, HCA = C or T, and the most recent common human ancestor (the ancestral human 
allele), MRCA = C or T as follows: 
P(HCA = X, MRCA = X | Pt = X) = PXpG • (1-PXpG-ch)2 • PXpG-p 
P(HCA = X, MRCA = Y | Pt = X) = PXpG • (1-PXpG-ch) • PXpG>YpG • PYpG-p 
P(HCA = Y, MRCA = X | Pt = X) = PYpG • PYpG>XpG2 • PXpG-p 
P(HCA = Y, MRCA = Y | Pt = X) = PYpG • PYpG>XpG • (1-PYpG-ch) • PYpG-p 
Where: 
P[X/Y]pG = probability that the ancestral sequence was [X/Y]pG at any base 
  PCpG = 0.0178, PTpG = 0.145 
P[X/Y]pG-ch = probability that an ancestral [X/Y]pG has changed at all 
  PCpG-ch = 0.047, PTpG-ch = 0.00535 
PXpG>YpG = probability that an ancestral XpG will mutate to YpG 
  PCpG>TpG = (0.047)(8.45/8.8) = 0.045, PTpG>CpG = (0.00535)(.65) = 0.003 
P[X/Y]pG-p = relative probability that a given human site will become a C/T variant 
The base rate of polymorphism will divide out, so we take this as 0.65 for TpG and 
8.45 for CpG 
Cases 1 and 3, where MRCA = Pt, will yield correct inferences of the human ancestral allele, while 
2 and 4, MRCA ≠ Pt, will yield errors. The ratio of the sum of the latter two to the total will give the 
error rate. For Pt = C, this gives us Perror = 0.6%, as suggested, only slightly different than the non-
CpG case. However, when Pt = T, we get Perror = 9.8%, thus these bases will be a significant source 
of error. 
Effect of Bottlenecks on Ancestral Allele Probabilities.   We estimated the effect of a 
bottleneck on ancestral allele frequencies as follows. Using a diffusion approximation for how the 
frequency of an allele changes with time, one can show that, under the simplest demographic 
assumptions, the probability density that a derived allele has frequency f (for 0 < f < 1) is 
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where K(x,y;t) is the transition probability that an allele initially at frequency x is at frequency y 
after time t (Patterson 2005). From a diffusion perspective, a genetic bottleneck is a time interval in 
which the allele frequencies diffuse, but no new mutations occur. In essence, ‘genetic time’ is 
stretched. For a bottleneck with inbreeding coefficient b, the corresponding time interval has length 
  
After a bottleneck of inbreeding coefficient b, the frequency distribution of derived alleles will be 
given by 
  
where the range of integration starts before the bottleneck. As no new mutations are introduced 
during the bottleneck, the low frequency alleles after the bottleneck will be overrepresented in the 
population by alleles of previously higher frequency (and larger probability of being ancestral) that 
drifted downward in frequency during the bottleneck. The above equation can be evaluated 
numerically. The slope following a bottleneck decreases from 1 to roughly (1-b). 
Allele Frequency Dataset. The genome-wide dataset that we analyze here (from 
Affymetrix: (www.affymetrix.com/support/technical/sample_data/genotyping_data.affx) is 
composed of a collection of individuals from multiple populations (6 Venezuelan, 6 Chinese, 6 
African-American, 12 Caucasian, and 24 of unknown origin); accordingly the effect of recent 
bottlenecks on the distribution of ancestral probabilities is a mixture reflecting the various 
subpopulations. We have also analyzed a much smaller set of data, generated across several of the 
ENCODE regions, for which we have separate results for European, Asian, and West African 
HapMap samples. These show that the European and Asian slopes are well below 1, consistent with 
the effects of an out of Africa bottleneck, while the West African population has a slope close to 1. 
Excess of Derived Alleles After Selective Sweep. Within the immediate region (i.e., in the 
absence of recombination during the sweep) of an advantageous allele under selection, ancestral 
variation will be completely removed. Distant from the selected allele (i.e., where recombination 
has removed association), there will be no effect. Within the region where recombination occurs, 
but rarely, during the sweep, some alleles will be swept to high frequency while others will be 
driven to low frequency. The probability that an allele exists on the selected background is given by 
its frequency f, while the number of derived alleles at frequency f is proportional to 1/f. As a result, 
the distribution of pre-sweep allele frequencies after the sweep is uniform across pre-sweep allele 
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frequencies, meaning that high frequency alleles are equally likely to be derived or ancestral, 
creating a large excess of high frequency derived alleles (Fay 2000). This signal is highly specific 
for selection, but not especially sensitive, especially at long times past the end of the sweep, as high 
frequency derived alleles created by the sweep move to fixation and all new low frequency alleles 
introduced by mutation during and after the sweep are at low frequency, rapidly restoring the 
balance of high frequency ancestral alleles (Przeworski 2002). 
Expected Width of Reduction of Diversity in Selected Regions. We performed 
simulations with the program cosi (Schaffner 2005) using median values for human recombination 
(1 cM/Mb) and selective sweeps of s = 0.005, 0.01, and 0.02 ending 5000 generations (~125,000 
yrs) ago, we found that the probability that region over which heterozygosity is reduced to below 
50% of the average value exceeds 1 Mb is 6.3%, 13.9%, and 40.6%, respectively.  
Scoring of Low Diversity Relative to Divergence Regions. We identified regions in 
which the observed human diversity rate was much lower than the expectation based on the 
observed divergence rate with chimpanzee.  
We compared the human diversity to the chimpanzee divergence to eliminate regions in 
which low diversity simply reflects a low mutation rate in the region.  In order to capture the 
uncertainly in diversity and divergence estimates within each window, we looked at each set of non-
overlapping windows (since the window step is 1/100 the size, there are 100 such sets). Within each 
window, we took the observed number of human SNPS, ui, human NQS bases, mi, human-
chimpanzee substitutions, vi, and chimpanzee NQS bases, ni, and generated two random numbers 
from the distributions: 
  
where a = 1, b = 1000, c = 1, and d = 100. We then took xi as the human diversity and yi as the 
human-chimp divergence for each window i and fit a linear regression 
  
A p-value for each window was then calculated for each window based on (xi, yi) and the regression 
line. This was repeated 100 times and the average of the p-values taken as the p-value for diversity 
given divergence each window. The window was assigned a score proportional to –log(p-value). 
Because we were looking for a signal where diversity was low relative to divergence, we 
were concerned that regions where divergence might be artificially high would preferentially appear 
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in our analysis. In order to avoid finding such regions, which might be true but were deemed likely 
to be enriched in artifacts, we aggressively screened the windows. The –log(p-value) score was set 
to 0 for any window matching any of the following: low human or chimpanzee NQS coverage 
(NQS bases ≤ 0.5 max NQS coverage), in the highest quartile of human chimpanzee divergence, 
within 3 Mbp of a human centromere or telomere, or within 1 Mbp of a large gap in the human 
genome. 
After filtering, we coalesced regions as the maximal overlapping windows with p < 0.1 
containing at least one window of p < 0.05 and scored them as the sum of their –log(p-value) 
scores, thus weighting for both length and strength. 
FOXP2 – CFTR Region. The genomic region on 7q containing both FOXP2 and CFTR 
stands out as unusual, although no specific part of it scores exceptionally high in the diversity-
divergence test.  The region is 7.58 Mb long and is covered by 3 separate regions, running from 
112.88 to 114.41, 114.83 to 117.15, and 117.77 to 120.46 Mb, and covering 6.55 Mb of the 
extended region. Were these regions merged into a single region, their combined div-div score 
would be 94.4, ranking it as the second highest scoring region. Two of the three regions show large 
windows of severe derived allele frequency skew, but only in the central region does it come close 
to overlapping the highest diversity-divergence score. Intriguingly, well outside this region and 
flanking it, at 106 to 108 and 121 to 123 Mb are two other large regions of severe derived allele 
frequency skew. It is tempting to speculate that since the hitchhiking model posits the derived allele 
skew in the flanks of the region, this may be the relic of a very powerful sweep affecting the entire 
extended region, although such an observation would require a selective coefficient on the order of 
0.1-0.2. Alternatively, an undetected inversion of the region combined with positive selection could 
also have led to these results.  Although our data fail to strongly confirm prior evidence of positive 
selection in recent human history, the region clearly bears more detailed examination. 
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Chapter 3: The dog genome 
 
In this chapter, we describe the first comprehensive comparative analysis of the dog, human and 
mouse genome sequences. 
This work was first published as part of 
Lindblad-Toh, K., Wade, C. M., Mikkelsen, T. S. et al. Genome sequence, comparative analysis 
and haplotype structure of the domestic dog. Nature 438, 803-819 (2005). 
The full publication is attached as Appendix 2. Supplementary notes can be found at the end of 
the chapter. Supplementary data is available online from http://www.nature.com/nature 
The text in this chapter was written with significant contributions from members of the analysis 
consortium. 
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We report a high-quality draft sequence of the domestic dog. The dog is of particular 
interest to the field of comparative genomics because the species provides key evolutionary 
information and because existing breeds display extraordinary phenotypic diversity for 
morphological, physiological and behavioral traits. Sequence comparison with the primate 
and rodent lineages sheds light on the structure and evolution of genomes and genes. 
Notably, the majority of the most highly conserved non-coding sequences in mammalian 
genomes are clustered near a small subset of genes with key roles in development.  
Man’s best friend, Canis familiaris, occupies a special niche in genomics. The unique 
breeding history of the domestic dog provides an unparalleled opportunity to explore the genetic 
basis of disease susceptibility, morphological variation and behavioral traits. The dog’s position 
within the mammalian evolutionary tree also makes it an important guide for comparative 
analysis of the human genome.  
The history of domestic dogs traces back at least 15,000 and possibly over 100,000 years 
to their original domestication from the gray wolf in East Asia 1-4. Dogs evolved in a mutually 
beneficial relationship with humans, sharing living space and food sources. In recent centuries 
humans have selectively bred dogs that excel at herding, hunting, and obedience, and, in the 
process, created breeds rich in behaviors that both mimic our own and support our needs. 
Similarly, dogs were bred for desired physical characteristics such as size, skull shape, coat color 
and texture 5, producing breeds with closely delineated morphologies. This evolutionary 
experiment has produced the most diverse domestic species, harboring more morphological 
diversity than exists within the remainder of the family Canidae 6. 
As a consequence of these stringent breeding programs and periodic population 
bottlenecks during, for example, the world wars, many of the ~400 modern dog breeds also 
exhibit high prevalence of specific diseases, including cancers, blindness, heart disease, cataracts, 
epilepsy, hip dysplasia and deafness 7, 8. The majority of these diseases are also commonly seen in 
the human population, and clinical manifestations in the two species are often similar 9. The high 
prevalence of specific diseases within certain breeds, suggest that a limited number of loci 
underlie each disease, making their genetic dissection potentially more tractable in dogs than in 
humans 10.  
Genetic analysis of traits in dogs is enhanced by the close relationship between humans 
and canines in modern society. Through the efforts of the American Kennel Club (AKC), and 
similar organizations worldwide, extensive genealogies are easily accessible for most purebred 
dogs. With the exception of human, dog is the most intensely studied animal in medical practice, 
with detailed family history and pathology data often available 8. Using genetic resources 
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developed over the last 15 years 11-16, researchers have already identified mutations in genes 
underlying ~25 Mendelian diseases17, 18. There are also growing efforts to understand the genetic 
basis of phenotypic variation, such as skeletal morphology 10, 19 . 
The dog is similarly important for comparative analysis of mammalian genome biology 
and evolution. The four mammalian genomes that have been intensely analyzed to date (human 20 
21, 22, chimpanzee 23, mouse 24 and rat 25) represent only one of the four clades of placental 
mammals (Euarchontoglires). The dog represents the neighboring clade, Laurasiatheria 26. It thus 
serves as an outgroup to the Euarchontoglires and increases the total branch length of the current 
tree of fully sequenced mammals, thereby providing additional statistical power to search for 
conserved functional elements in the human genome 24, 27-33; it helps us draw inferences about the 
common ancestor of the two clades, called the boreoeutherian ancestor; and it provides a bridge 
to the two remaining clades (Afrotheria and Xenarthra) that will be helpful for anchoring low-
coverage sequence currently being produced from such species as elephant and armadillo 28. 
Here, we report a high-quality draft sequence of the dog genome covering ~99% of the 
euchromatic genome. The completeness, nucleotide accuracy, sequence continuity and long-range 
connectivity are extremely high; these quality measures exceed those for the recent draft 
sequence of the mouse genome 24, reflecting improved algorithms, higher quality data, deeper 
coverage and intrinsic genome properties.  
We have analyzed these data to study genome structure, gene evolution, haplotype 
structure and phylogenetics of the dog. The key findings include: 
• The evolutionary forces molding the mammalian genome differ among lineages, with 
the average transposon insertion rate being lowest in dog, the deletion rate being highest in mouse 
and the nucleotide substitution rate being lowest in human. 
• Human-dog comparison shows that ~5.3% of the human genome contains functional 
elements that have been under purifying selection in both lineages. Nearly all of these elements 
are confined to regions that have been retained in mouse, indicating that they represent a common 
set of functional elements across mammals. 
• Fully 50% of the most highly conserved non-coding sequence in the genome shows 
striking clustering in ~200 gene-poor regions, most of which contain genes with key roles in 
establishing or maintaining cellular identity, such as transcription factors or axon guidance 
receptors.  
• Sets of functionally related genes show highly similar patterns of evolution in the 
human and dog lineages. This suggests caution about interpreting accelerated evolution in human 
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relative to mouse as representing human-specific innovations (such as in genes involved in brain 
development), because comparable acceleration is often seen in the dog lineage.  
 
Generating a draft genome sequence 
We sequenced the genome of a female Boxer using the whole-genome shotgun (WGS) approach 
22, 24 (see Methods).  A total of 31.5 million sequence reads, providing ~7.5-fold sequence 
redundancy, were assembled with an improved version of the ARACHNE program 34, resulting in 
an initial assembly (CanFam1.0) used for much of the analysis below and an updated assembly 
(CanFam2.0), with minor improvements (Table 1). 
 Genome assembly. The recent genome assembly spans a total distance of 2.41 Gb, 
consisting of 2.38 Gb of nucleotide sequence with the remaining 1% in captured gaps.  The 
assembly has extremely high continuity. The N50 contig size is 180 kb (that is, half of all bases 
reside in a contiguous sequence of 180 kb or more) and the N50 supercontig size is 45.0 Mb 
(Table 1). In particular, this means that the majority of genes should contain no sequence gaps 
and that most canine chromosomes (mean size 61 Mb) have nearly all of their sequence ordered 
and oriented within one or two supercontigs. Notably, the sequence contigs are ~50-fold larger 
than the earlier survey sequence of the Standard Poodle 16. 
The assembly was anchored to the canine chromosomes using data from both RH and 
cytogenetic maps 11, 13, 14. Roughly 97% of the assembled sequence was ordered and oriented on 
the chromosomes, showing an excellent agreement with the two maps. There were only three 
discrepancies, which were resolved by obtaining additional FISH data from the sequenced Boxer. 
The 3% of the assembly that could not be anchored consists largely of highly repetitive sequence, 
including eight supercontigs of 0.5-1.0 Mb composed almost entirely of satellite sequence. 
The nucleotide accuracy and genome coverage of the assembly is high. Of the bases in 
the assembly, 98% have quality scores exceeding 40, corresponding to an error rate of less than 
10-4 and comparable to the standard for finished human sequence 35. When we directly compared 
the assembly to 760 kb of finished sequence (in regions where the Boxer is homozygous to 
eliminate differences due to polymorphisms; see below), we found that the draft genome 
sequence covers 99.8% of the finished sequence and that bases with quality scores exceeding 40 
have an empirical error rate of 2 x 10-5. 
Explaining the high sequence continuity. The dog genome assembly has superior 
sequence continuity (180 kb) than the WGS assembly of the mouse genome (25 kb) obtained 
several years ago 24. At least three factors contribute to the higher connectivity of the dog 
assembly (see Supplementary Notes). First, a new version of ARACHNE with improved  
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Table 1: Assembly statistics for CanFam1.0 and 2.0 
 
 CanFam1.0 CanFam2.0 
N50 contig size 123 kb 180 kb 
N50 supercontig size 41.2 Mb 45.0 Mb 
Assembly size, total bases 2.360 Gb 2.385 Gb 
Number of anchored supercontigs 86 87 
Portion of genome in anchored supercontigs 96% 97% 
Sequence in anchored bases 2.290 Gb 2.309 Gb 
Portion of assembly in gaps 0.9% 0.8 % 
Estimated genome size: anchored bases, spanned gaps 
(21Mb and18Mb respectively) and centromeric sequence 
(3Mb each) 
2.411 Gb 2.445 Gb 
Portion of assembly in ‘certified regions’,  
     without assembly inconsistency  99.3% 99.6% 
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Figure 1. Conserved synteny between the human, dog, mouse and rat genomes. 
(a) Diagram of syntenic blocks (>500 kb) along dog chromosomes 15, 16 and 3, 
with colors indicating the chromosome containing the syntenic region in other 
species. Synteny breakpoints were assigned to one of five lineages: dog (D), 
human (H), mouse (M), rat (R) or the common rodent ancestor (Ro). (b) Lineage-
specific intrachromosomal and interchromosomal breaks displayed on phylogenetic 
trees. Intrachromosomal breaks are seen more frequently in the human lineage 
than in mouse and rat, while interchromosomal breaks are somewhat more common 
in dog and considerably more common in rodents.
     
algorithms was used. Assembling the dog with the previous software decreases N50 contig size 
from 180 kb to 61 kb, while assembling the mouse with the new version increased it from 25 kb 
to 35 kb.  Second, the amount of recently duplicated sequence is roughly two-fold lower in dog 
than mouse; this improves contiguity because sequence gaps in both organisms tend to occur in 
recently duplicated sequence. Third, the dog sequence data has both higher redundancy (7.5 vs. 
6.5-fold) and higher quality (in terms of read length, pairing rate and tight distribution of insert 
sizes). The contig size for dog drops by about 32% when the data redundancy is decreased from 
7.5- to 6.5-fold. A countervailing influence is that the dog genome contains polymorphism, while 
the laboratory mouse is fully inbred . 
 
Genome landscape and evolution 
Our understanding of the evolutionary processes that shape mammalian genomes has greatly 
benefited from the comparative analysis of primate 21, 23, and rodent 24, 25 genomes sequenced to 
date. However, the rodent genome is highly derived relative to that of the common ancestor of the 
eutherian mammals. The dog genome, as the first extensive sequence from an outgroup to the 
clade including primates and rodents, therefore offers a fresh perspective on mammalian genome 
evolution. Accordingly, we examined the rates and correlations of large-scale rearrangement, 
transposon insertion, deletion, and nucleotide divergence across three major mammalian orders 
(primates, rodents and carnivores). 
Conserved synteny and large-scale rearrangements. We created multi-species synteny 
maps from anchors of unique, unambiguously aligned sequences (see Supplementary Notes), 
showing regions of conserved synteny among dog, human mouse and rat. Roughly 94% of the 
dog genome lies in such regions of conserved synteny with the three other species. 
Given a pair of genomes, we refer to a ‘syntenic segment’ as a region that runs 
continuously without alterations of order and orientation and a ‘syntenic block’ as a region that is 
contiguous in two genomes but may have undergone internal rearrangements. The syntenic 
breakpoints between blocks thus primarily reflect interchromosomal exchanges, while 
breakpoints between syntenic segments reflect intrachromosomal rearrangements. In the analysis 
below, we focus on syntenic segments of at least 500 kb. 
We identified a total of 391 syntenic breakpoints across dog, human, mouse and rat 
(Figure 1). With data for multiple species, it is possible to assign events to specific lineages. We 
counted the total number of breakpoints along the human, dog, mouse and rat lineages, with the 
values for each rodent lineage reflecting all breakpoints since the common ancestor with human. 
The total number of breakpoints in the human lineage is substantially smaller than in dog, mouse 
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or rat lineages (83 vs. 100, 161 and 176). However, there are more intrachromosomal breakpoints 
in the human lineage than in dog (52 vs 33).  
Although the overall level of genomic rearrangement has been much higher in rodent 
than in human, comparison with dog shows that there are regions where the opposite is true. In 
particular, of the many intrachromosomal rearrangements previously observed between human 
chromosome 17 and the orthologous mouse sequence 24, the majority has occurred in the human 
lineage (see Supplementary Notes). Human chromosome 17 is rich in segmental duplications and 
gene families 21, which may contribute to its genomic fragility 37, 38. 
Genomic insertion and deletion. The dog has a smaller euchromatic genome than 
mouse and human by ~150 Mb and ~500 Mb, respectively. The smaller total size is reflected at 
the local level, with 100 kb blocks of conserved synteny in dog corresponding to regions whose 
median size is  ~3% larger in mouse and ~15% larger in human.  
To understand the balance of forces that determine genome size, we studied the 
alignments of the human, mouse and dog genomes (Figure 2). In particular, we identified the 
lineage-specific interspersed repeats within each genome, consisting of particular families of 
SINE, LINE and other transposable elements that are readily recognized by sequence analysis. 
The remaining sequence was annotated as ‘ancestral’, consisting of both ancestral unique 
sequence and ancestral repeat sequence; these two categories were combined because the power 
to recognize ancient transposon-derived sequences degrades with repeat age, particularly in the 
rapidly diverging mouse lineage 24. 
This comparative analysis indicates that different forces account for the smaller genome 
sizes in dog and mouse relative to human. The smaller size of the dog genome is primarily due to 
the presence of substantially less lineage-specific repeat sequence in dog (334 Mb) than in human 
(609 Mb) or mouse (954 Mb). This reflects a lower activity of endogenous retrovirus and DNA 
transposons (~26,000 extant copies in dog vs. ~183,000 in human), as well as the fact that the 
SINE element in dog is smaller than in human (although similar to that in mouse). As a 
consequence, the total proportion of repetitive elements (both lineage-specific and ancestral) 
recognizable in the genome is lower for dog (34%) than for mouse (40%) and human (46%). By 
contrast, the smaller size of the mouse genome is primarily due to a higher deletion rate.  
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Figure 2. Venn diagram showing the total length (Mb) of alignable and unique 
sequences in the euchromatic portions of the dog, human and mouse genomes, 
as inferred from genome-wide BLASTZ alignments (see Methods and 
Supplementary Notes). Overlapping partitions represent orthologous ancestral 
sequences. Each lineage-specific partition is further split into the total length of 
sequence classified as either lineage-specific interspersed repeats (red) or non-
repetitive sequence (black). The latter is assumed to primarily represent ancestral 
sequences deleted in the two other species.
     
Specifically, the amount of extant ‘ancestral sequence’ is much lower in mouse (1474 Mb) than in 
human (2216 Mb) or dog (1997 Mb). Assuming an ancestral genome size of 2.8 Gb 24 and that 
deletions occur continuously, this suggests that the rate of genomic deletion in the rodent lineage 
has been approximately two and a half times higher than in the dog and human lineages (see 
Supplementary Notes). As a consequence, the human genome shares ~650 Mb more ancestral 
sequence with dog than with mouse, despite our more recent common ancestor with the latter.  
Active SINE family. Despite its relatively low proportion of transposable element-
derived sequence, the dog genome contains a highly active carnivore-specific SINE family 
(defined as SINEC_Cf;  RepBase release 7.11) 16.  The element is so active that many insertion 
sites are still segregating polymorphisms that have not yet reached fixation. Of ~87,000 young 
SINEC-Cf elements (defined by low divergence from the consensus sequence), nearly 8% are 
heterozygous within the draft genome sequence of the Boxer. Moreover, comparison of genome 
sequence between Boxer and Standard Poodle reveals more than 10,000 insertion sites that are 
bimorphic, with thousands more certain to be segregating in the dog population 16, 39. By contrast, 
the number of polymorphic SINE insertions in the human genome is estimated to be fewer than a 
thousand 40.  
The biological impact of these segregating SINE insertions is unknown. SINE insertions 
can be mutagenic through direct disruption of coding regions, as well as indirect effects on 
regulation and processing of mRNAs 39. Such SINE insertions have already been shown to be 
responsible for two diseases; narcolepsy and centronuclear myopathy in dog 41, 42. It is 
conceivable that the genetic variation resulting from these segregating SINE elements has 
provided important raw material for the selective breeding programs that produced the wide 
phenotypic variations among modern dog breeds 16, 43.  
Sequence composition. The human and mouse genomes differ significantly in sequence 
composition, with the human having slightly lower average G+C content (41% vs. 42%) but 
much greater variation across the genome. The dog closely resembles the human in its 
distribution of G+C content (Figure 3a; Spearman’s rho = 0.85 for dog-human and 0.76 for dog-
mouse), even if we consider only nucleotides that can be aligned across all three species. The 
wider distribution of G+C content in human and dog is thus likely to reflect the boreoeutherian 
ancestor 44, 45, with the more homogeneous composition in rodents having arisen primarily by 
lineage-specific changes in substitution patterns 46, 47 rather than deletion of sequences with 
extreme G+C content. 
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Figure 3. Sequence composition and divergence rates. a, Distribution of G+C content 
in 10 kb windows across the genome in dog (green), human (red) and mouse (blue). 
b, Median lineage-specific substitution rates based on analysis of ancestral repeats 
aligning across all three genomes. Analysis was performed in non-overlapping 1 Mb-
windows across the dog genome containing at least 2 kb of aligned ancestral repeat 
sequence (median 8.8 kb). The tree was rooted with the consensus sequences from 
the ancestral repeats. Numbers in parentheses give the 20th and 80th percentiles 
across the windows studied.
     
 
 
 
Table 2: Substitution rates and evolutionary constraint (Ka/Ks) for 1:1:1 
orthologs among dog, mouse and human 
 
Median  and 20/80 percentiles Spearman’s rho 
 
Dog* Mouse Human Dog Human 
Dog 
Mouse 
Human 
Mouse 
Ks 0.210 (0.138-0.322) 
0.416 
(0.310-0.558) 
0.139 
(0.0928-0.214) 0.47 0.50 0.52 
Ka 0.021 (0.006-0.051) 
0.038 
(0.013-0.087) 
0.017 
(0.005-0.040) 0.87 0.87 0.86 
Ka/Ks 0.095 (0.030-0.221) 
0.088 
(0.031-0.197) 
0.112 
(0.034-0.272) 0.80 0.85 0.82 
 
* Estimates are based on unrooted tree. Dog branch thus includes the branch from the 
boreoeutherian ancestor to the primate-rodent split.  
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Rate of nucleotide divergence. We estimated the mean nucleotide divergence rates in 1 
Mb windows along the dog, human and mouse lineages based on alignments of all ancestral 
repeats, using the consensus sequence for the repeats as a surrogate outgroup (Figure 3b; 
Supplementary Notes).  
The dog lineage has diverged more rapidly than the human lineage (median relative rate 
of 1.18, longer branch length in 95% of windows), but at only half the rate of the mouse lineage 
(median relative rate of 0.48, longer branch length in 100% of windows). The absolute 
divergence rates are somewhat sensitive to the evolutionary model used and the filtering of 
alignment artifacts, but the relative rates appear to be robust and are consistent with estimates 
from smaller sequence samples with multiple outgroups 28, 48, 49. The lineage-specific divergence 
rates (human < dog < mouse) are likely explained by differences in metabolic rates 50, 51 or 
generation times 52, 53, although the relative contributions of these factors remain unclear 49. 
Correlation in nucleotide divergence. As seen in other mammalian genomes 23-25, the 
average nucleotide divergence rate across 1 Mb windows varies significantly across the dog 
genome (coefficient of variation = 0.11, versus 0.024 expected under a uniform distribution). This 
regional variation shows significant correlation in orthologous windows across the dog, human 
and mouse genomes, but the strength of the correlation appears to decrease with total branch 
length (pair-wise correlation for orthologous 1 Mb windows: Spearman’s rho = 0.49 for dog-
human and 0.24 for dog-mouse). Lineage-specific variation in the regional divergence rates may 
be coupled with changes in factors such as sequence composition or chromosomal position 23, 54. 
Consistent with this, the ratios of lineage-specific divergence rates in orthologous windows are 
positively correlated with the ratios of current G+C content in the same windows (dog-human: 
Spearman’s ρ = 0.16; dog-mouse: ρ = 0.24).  
Male mutation bias. Comparison of autosomal and X chromosome substitution rates can 
be used to estimate the relative mutation rates in the male and female germ lines (α), because the 
X chromosome resides in females twice as often as in males. Using the lineage-specific rates 
from ancestral repeats, we estimate α as 4.8 for the lineage leading to human, and 2.8 for the 
lineages leading to both mouse and dog. These values are intermediate between recent estimates 
from murids 24, 25 and from hominids 23, and suggests that male mutation bias may have increased 
in the lineage leading to humans. 
Mutational hotspots and chromosomal fission. Genome comparison of human with 
both chicken 55 and chimpanzee 23 have previously revealed that sequences close to a telomere 
tend to have elevated divergence rates and G+C content relative to interstitial sequences. It has 
been unclear whether this subtelomeric elevation is an inherent characteristic of the sequence  
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Figure 4. Dependence between divergence, (G+C) content and human-dog
synteny breakpoints. a, distribution of divergence on the dog-lineage (as estimated
from ancestral repeats) for all 1 Mb non-overlapping windows, windows centered on a
non-telomeric synteny break, and windows within 1 Mb of a telomere. (Red line =
median, box = upper and lower quartiles, whiskers = range of data) b, distribution of
(G+C) content in the dog genome for all 1 Mb non-overlapping windows, windows
within 1 Mb of a non-telomeric synteny break, and windows within 1 Mb of a telomere.
     
itself or a derived characteristic causally connected with its chromosomal position. We find a 
similar elevation in both divergence (median elevation = 15%, pMann-Whitney < 10-5) and G+C 
content (median elevation = 9%, pMann-Whitney < 10-9) for subtelomeric regions along the dog 
lineage, with a sharp increase towards the telomeres (Figure 4).  
This phenomenon is manifested at other synteny breaks, not only those at telomeres. We 
also observed a significant elevation in divergence and G+C content in interstitial regions that are 
sites of syntenic breakpoints 54, 56. This indicates that these properties are correlated with 
susceptibility of regions to chromosomal breakage.  
 
Proportion of genome under purifying selection  
One of the striking discoveries that emerged from the comparison of the human and mouse 
genomes 21, 24 was the inference that ~5.2% of the human genome shows greater-than-expected 
evolutionary conservation (compared to the background rate seen in ancestral repeat elements, 
which are presumed to be non-functional). This proportion greatly exceeds the 1-2% that can be 
explained by protein coding regions alone. The extent and function of the large fraction of non-
coding conserved sequence remain unclear 57, but it is likely to include regulatory elements, 
structural elements and RNA genes.  
Low turnover of conserved elements. We repeated the analysis of conserved elements 
based on the human and dog genomes. Briefly, the analysis involves calculating a conservation 
score SHD, normalized by the regional divergence rate, for every 50 bp-window in the human 
genome that can be aligned to dog. The distribution of conservation scores for all genomic 
sequences is compared to the distribution in ancestral repeat sequences (which are presumed to be 
diverging at the local neutral rate), showing a clear excess of sequences with high conservation 
scores. By subtracting a scaled neutral distribution from the total distribution, one can estimate 
the distribution of conservation scores for sequences under purifying selection. Moreover, for a 
given sequence with conservation score SHD, one can also assign a probability, pselection(SHD), that 
the sequence is under purifying selection (see 24 and Supplementary Notes). 
The human-dog comparison indicates that ~5.3% of the human genome is under 
purifying selection (Figure 5a), which is equivalent to the proportion estimated from human-
rodent analysis. The obvious question is whether the bases conserved between human and dog 
coincide with the bases conserved between humans and rodents25, 58. Because the conservation 
scores do not unambiguously assign sequences as either selected or neutral (but rather only assign 
probability scores for selection), we cannot directly compare the conserved bases. We therefore 
devised the following alternative approach.  
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Figure 5. Conservation of orthologous sequence between human and dog. 
a, Histogram of conservation scores, S, for all windows of 50-bp across the human 
genome with at least 20 bases of orthologous sequence aligning to the dog genome, 
for all aligning sequences (red) and for ancestral repeat sequence only (blue). 
b, Conservation scores for the subset of window that also have at least 20 bases of 
orthologous sequence aligning to the mouse genome. c, Conservation scores of the 
complementary subset of windows lacking such orthologous sequence in mouse.
     
We repeated the human-dog analysis, dividing the 1462 Mb of orthologous sequence 
between human and dog into those regions with (812 Mb) or without (650 Mb) orthologous 
sequence in mouse (Figure 2). The first set shows a clear excess of conservation relative to 
background, corresponding to ~5.2% of the human genome (Figure 5b). In contrast, the second 
set shows little or no excess conservation, corresponding to at most 0.1% of the human genome 
(Fig 6c). This implies that hardly any of the functional elements conserved between human and 
dogs have been deleted in the mouse lineage (see Supplementary Notes). 
The results strongly suggest that there is a common set of functional elements across all 
three mammalian species, corresponding to ~5% of the human genome (~150 Mb).  These 
functional elements reside largely within the 812 Mb of ancestral sequence common to human, 
mouse and dog. If we eliminate ancestral repeat elements within this shared sequence as largely 
non-functional, the majority of functional elements can be localized to 634 Mb and constitute, 
perhaps, 24% of this sequence. 
It should be noted that the estimate of ~5% pertains to conserved elements across 
distantly related mammals. It is possible that there are additional weakly constrained or recently 
evolved elements within narrow clades (for example, primates) that can only be detected by 
sequencing more closely related species 29. 
Clustering of highly conserved non-coding elements. We next explored the distribution 
of conserved non-coding elements (CNEs) across the mammalian genomes. For this purpose, we 
calculated a conservation score SHMD based on simultaneous conservation across all three species. 
We defined highly conserved non-coding elements (HCNEs) to be 50-bp windows that do not 
overlap coding regions and for which pselection(SHMD), the probability of being under purifying 
selection given the conservation score, is at least 95%. We identified ~140,000 such windows 
(6.5 Mb total sequence), comprising ~0.2% of the human genome and representing the most 
conserved ~5% of all mammalian CNEs.  
The density of HCNEs show striking peaks, when plotted in 1 Mb windows across the 
genome (Figure 6), with fully 50% lying in 204 regions that span less than 14% of the human 
genome. These regions are generally gene-poor, together containing only ~6% of all protein 
coding sequence. 
The genes contained within these gene-poor regions are of particular interest. At least 182 
of the 204 regions contain genes with key roles in establishing or maintaining cellular ‘state’. At 
least 156 of the regions contain one or, in a few cases, several transcription factors involved in 
differentiation and development 59. Another 26 regions contain a gene important to neuronal 
specialization and growth, including several axon guidance receptors. The proportion of  
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Figure 6.  Density of the top 5% most conserved 
50 bp windows aligned between human and 
chicken (HC), where the conservation score SHC 
is calculated as described in the supplementary 
notes, but without the AR normalization term. 
Density of the top 1% most conserved 50 bp 
windows out of all aligned windows between human
and dog (HD) or mouse (HM), or between human, 
mouse and dog (HMD), and density of known genes, 
both in 1 Mb sliding windows across human 
chromosomes (blue).
     
developmental regulators is far greater than expected by chance (P < 10-31; see Supplementary 
Notes). 
We tested whether the HCNEs within these regions tend to cluster around the genes 
encoding development regulators. Analysis of the density of HCNEs in the intronic and intergenic 
sequences flanking every gene in the 204 regions revealed that the 197 genes encoding 
developmental regulators show an average of ~10-fold enrichment for HCNEs relative to the full 
set of 1285 genes in the regions (Figure 7). The enrichment sometimes extends into the 
immediately flanking genes. 
We note that the 204 regions include nearly all of the recently identified clusters of 
conserved elements between distantly-related vertebrates, such as chicken and pufferfish 55 59-62. 
For example, they overlap 56 of the 57 large intervals containing conserved non-coding sequence 
identified between human and chicken 55. The mammalian analysis, however, detects vastly more 
CNEs (>100-fold more sequence than with pufferfish 59 and 2-3-fold more than with chicken) and 
identifies many more clusters. The limited sensitivity of these more distant vertebrate 
comparisons may reflect the difficulty of aligning short orthologous elements across such large 
evolutionary distances or the emergence of mammal-specific regulatory elements. In any case, 
mammalian comparative analysis may be a more powerful tool for elucidating the regulatory 
controls across these important regions. 
Although the function of conserved non-coding elements is unknown, it seems likely 
based on recent studies 59, 63-66 that many are likely to regulate gene expression.  If so, the results 
above suggest that ~50% of all mammalian HCNEs may be devoted to regulating ~1% of all 
genes. In fact, the distribution may be even more skewed, as there are additional genomic regions 
with only slightly lower HCNE density than the 204 studied above. All of these regions clearly 
merit intensive investigation to assess indicators of regulatory function. We speculate that these 
regions may also harbor characteristic chromatin structure and modifications, potentially involved 
in establishment or maintenance of cellular state. 
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Figure 7. Enrichment of HCNEs in the immediate neighborhood of genes encoding 
developmental regulators in the 204 highly conserved regions (see text). 
Histograms show the median number of (a) total bases, (b) HCNE bases and (c)
HCNE density in the intronic and surrounding intergenic sequence, for the 197 known or
putative development regulators (indicated by top of red bar) and for all of the 1,285
genes (blue bar). The histogram is centered at the 5’-end of the gene and each bin
corresponds to half of the normalized distance to the flanking upstream or downstream
gene, as indicated. The sequences surrounding the developmental genes are typically
longer, have more HCNE sequence and have a higher density of HNCE sequence than
other genes in the regions. This suggests that they represent the primary targets of
regulation in the regions.
     
Genes 
Accurate identification of the protein-coding genes in mammalian genomes is essential for 
understanding the human genome, including cellular components, regulatory controls and 
evolutionary constraints. The number of human protein-coding genes has been a topic of 
considerable debate, with estimates steadily falling from ~100,000 to 20-25,000 over the past 
decade 21, 22, 67-70. We analyzed the dog genome to elucidate the human gene complement and to 
assess the evolutionary forces shaping mammals. (Below, ‘gene’ refers only to a protein-coding 
gene.) 
 Gene predictions in dog and human. We generated gene predictions for the dog 
genome using an evidence-based method (see Supplementary Notes). The resulting collection 
contains 19,300 dog gene predictions, with nearly all being clear homologs of known human 
genes.  
The dog gene count is substantially lower than in the ~22,000 gene models in the current 
human gene catalog (EnsEMBL build 26). For many predicted human genes, we find no 
convincing evidence of a corresponding dog gene. Much of the excess in the human gene count is 
due to spurious gene predictions in the human genome 121.  
Gene duplications. Gene duplication is thought to contribute substantially to functional 
innovation 69, 71. We identified 216 gene duplications that are specific to the dog lineage and 574 
that are specific to the human lineage, using the synonymous substitution rate KS as a distance 
metric while taking care to discard likely pseudogenes. (The CanFam 2.0 assembly contains 
roughly two dozen additional gene duplications, mostly olfactory receptors.) Human genes are 
thus 2.7-fold more likely to have undergone duplication than are dog genes over the same time 
period.  This may reflect increased repeat-mediated segmental duplication in the human lineage 
72.    
 Although gene duplication has been less frequent in dog than human, the affected gene 
classes are very similar. Prominent among the lineage-specific duplication are genes that function 
in adaptive immunity, innate immunity chemosensation and reproduction, as has been seen for 
other mammalian genomes 24, 25, 69, 71 . Reproductive competition within the species and 
competition against parasites have thus been major driving forces in gene family expansion. 
The two families with the largest numbers of dog-specific genes are the histone H2Bs and 
the α-interferons, which cluster in monophyletic clades when compared to their human homologs. 
This is particularly notable for the α-interferons, where the gene families within the 6 species 
(human, mouse, rat, dog, cat and horse) are apparently monophyletic. This may be due either to  
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Figure 8. Correlation of Ka/Ks rank-sum z-scores for 4,950 gene sets
between human and dog (top) and between mouse and dog (bottom).
     
coincidental independent gene duplication in each of the 6 lineages or ongoing gene conversion 
events that have homogenized ancestral gene duplicates 73.  
Evolution of orthologous genes across three species. The dog genome sequence allows 
us for the first time to characterize the large-scale patterns of evolution in protein-coding genes 
across three major mammalian orders. We focused on a subset of 13,816 human-mouse-dog 1:1:1 
orthologs. For each, we inferred the number of lineage-specific synonymous (Ks) and non-
synonymous (Ka) substitutions along each lineage and calculated the Ka/Ks ratio (Table 2), a 
traditional measure of the strength of selection (both purifying and directional) on proteins 74.  
The median Ka/Ks differs sharply across the three lineages (pMW < 10-44), with the dog 
lineage being intermediate between mouse and human. Population genetic theory predicts 75 that 
the strength of purifying selection should increase with effective population size (Ne). The 
observed relationship (mouse < dog < human) is thus consistent with the evolutionary prediction, 
given the expectation that smaller mammals tend to have larger effective population sizes76.  
We next searched for particular classes of genes showing deviations from the expected 
rate of evolution for a species. Such variation in rate (heterotachy) may point to lineage-specific 
positive selection or relaxation of evolutionary constraints 77. We developed a statistical method, 
similar to the recently-described Gene Set Enrichment Analysis (GSEA) 78-80 to detect evidence 
of heterotachy for sets of functionally related genes (see Supplementary Notes). Briefly, the 
approach involves ranking all genes by Ka/Ks ratio, testing whether the set is randomly 
distributed along the list and assessing the significance of the observed deviations by comparison 
with randomly permuted gene sets. In contrast to previous studies focused on small numbers of 
genes with prior hypotheses of selection, this approach detects signals of lineage-specific 
evolution in a relatively unbiased manner and can provide context to the results of more limited 
studies. 
A total of 4,950 overlapping gene sets were studied, defined by such criteria as biological 
function, cellular location or co-expression. Overall, the deviations between the three lineages are 
small, and median Ka/Ks ratios for particular gene sets are highly correlated for each pair of 
species (Figure 8). However, there is notably greater relative variation in human-mouse and dog-
mouse comparisons than in human-dog comparisons (Figure 9).  
This suggests that observed heterotachy between human and mouse must be interpreted 
with caution. For example, there is a great interest in the identification of genetic changes 
underlying the unique evolution of the human brain. A recent study 81 highlighted 24 genes 
involved in brain development and physiology that show signs of accelerated evolution in the 
lineage leading from ancestral primates to humans when compared to their rodent orthologs. We  
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Figure 9. Histogram of observed z-scores for accelerated evolution in 4,950 gene 
sets (red), and the expected distribution based on 10,000 randomized trials (blue) 
for human relative to mouse (a), dog relative to mouse (b) and human relative to 
dog (c). Note that the comparison between human and dog fits the expected 
distribution significantly better than either comparison involving mouse, possibly 
due to murid-specific changes in sequence composition or evolutionary constraints.
     
observe the same trend for the 18 human genes that overlap with the genes studied here, but find 
at least as many genes with higher relative acceleration in the dog lineage (see Supplementary 
Notes). Heterotachy relative to mouse therefore does not appear to be a distinctive feature of the 
human lineage. It may reflect decelerated evolution in the rodent lineage or, perhaps, independent 
adaptive evolution in the human and dog lineages 82. 
A small number of gene sets show evidence of significantly accelerated evolution on the 
human lineage, relative to both mouse and dog (32 sets at z ≥ 5.0 versus 0 sets expected by 
chance, p < 10-4; Figure 10a). These sets fall into two categories: genes expressed exclusively in 
testis and (nuclear) genes encoding subunits of the mitochondrial electron transport chain (ETC) 
complexes. The former are believed to undergo rapid evolution as a consequence of sperm 
competition across a wide range of species 83-85 and lineage-specific acceleration suggests that 
sexual selection may have been a particularly strong force in primate evolution. The selective 
forces acting on the latter set are less obvious. Because of the importance of mitochondrial ATP 
generation for sperm motility 86 and the potentially antagonistic co-evolution of these genes with 
maternally inherited mtDNA-encoded subunits 87, we propose that sexual selection may also be 
the primary force behind the rapid evolution of the primate ETC genes. Given the ubiquitous role 
of mitochondrial function, however, such sexual selection may have led to profound secondary 
effects on physiology 88. 
 We found no sets with comparably strong evidence for dog-specific accelerated 
evolution. There is, however, a small excess of sets with moderately high acceleration scores (19 
sets at z ≥ 3.0 versus 5 sets expected by chance, p < 0.02; Figure 10b). These sets, which are 
primarily related to metabolism, may contain promising candidates for follow-up studies of 
molecular adaptation in carnivores. 
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Figure 10. Genes sets showing accelerated evolution along the human and dog 
lineages. a, Distribution of acceleration scores along the human lineage relative to 
both mouse and dog, observed for 4,950 gene sets (red) and expected based on 
10,000 randomized trials (blue). The dotted line shows the acceleration score for 
which the probability of observing even a single set by random chance (out of the 
4,950 sets tested) is less than 1%. In fact, 32 sets show acceleration scores on the 
human lineage exceeding this threshold. b, The observed (red) and expected (blue) 
distribution of acceleration scores for dog, relative to both human and mouse.
     
Conclusion  
Genome comparison is a powerful tool for discovery. It can reveal unknown – and even 
unsuspected – biological functions, by sifting the records of evolutionary experiments that 
occurred over 100 million years or over only 100 years. The dog genome sequence illustrates the 
range of information that can be gleaned from such studies.  
Mammalian genome analysis is providing the first global picture of gene regulation in the 
human genome. Initial comparison with rodents revealed that ~5% of the human genome is under 
purifying selection and that the majority of this sequence is not protein-coding. The dog genome 
is now further clarifying this picture, as our data suggest that this ~5% represents functional 
elements common to all mammals. The distribution of these elements relative to genes is highly 
heterogeneous, with roughly half of the most highly conserved non-coding elements apparently 
devoted to regulating ~1% of human genes; these genes play key roles in development, and 
understanding the extraordinary regulatory clusters that surround them may reveal how cellular 
states are established and maintained. In recent papers 32, 108, the dog genome sequence has been 
used to greatly expand the catalog of mammalian regulatory motifs in promoters and 3’-
untranslated regions. The dog genome sequence is also being used to substantially revise the 
human gene catalog. Despite these advances, it is clear that mammalian comparative genomics is 
still in its early stages. Progress will be dramatically accelerated by the availability of many 
additional mammalian genome sequences, initially with light coverage 28 but eventually with 
near-complete coverage.  
 Beyond its role in studies of mammalian evolution, the dog has a special role in genomic 
studies because of the unparalleled phenotypic diversity among closely related breeds. The dog is 
a testament to the power of breeding programs to select naturally occurring genetic variants with 
the ability to shape morphology, physiology and behavior. Genome comparison within and across 
breeds can reveal the genes that underlie such traits, informing basic research on development 
and neurobiology. It can also identify disease genes that were carried along in breeding programs; 
the potential benefits include insights into disease mechanism, as well as the possibility of clinical 
trials in affected dogs to accelerate new therapeutics to improve health in both species. The SNP 
map of the dog genome generated in a related analysis confirms that dog breeds show the long-
range haplotype structure expected from intensive breeding. Moreover, analysis shows that the 
current collection of ~2.5 million SNPs should be sufficient to allow association studies of nearly 
any trait in any breed. Realizing the full power of dog genetics now only awaits the development 
of appropriate genotyping tools, such as multiplex ‘SNP chips’ 109; this is already underway.  
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 For millennia, dogs have accompanied humans on their travels. It is only fitting that the 
dog should be a valued companion on our journeys of scientific discovery as well.    
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Methods 
 
WGS sequencing and assembly. Approximately 31.5 million sequence reads were derived from 
both ends of inserts (paired end reads) from 4-, 10-, 40- and 200-kb clones, all prepared from 
primary blood lymphocyte DNA from a single female Boxer. The assembly was carried out using 
an interim version of ARACHNE2+ (www.broad.mit.edu/wga/). The particular individual was 
chosen for sequencing because it has the lowest heterozygosity rate among ~120 dogs tested at a 
limited set of loci; subsequent analysis showed that the genome-wide heterozygosity rate is not 
substantially different than other breeds91.  
Genome alignment and comparison. Synteny maps were generated using standard methods24 
from pair-wise alignments of repeat masked assemblies using PatternHunter110 on CanFam2.0. 
All other comparative analyses were performed on BLASTZ/MULTIZ111, 112 genome-wide 
alignments obtained from the UCSC genome browser (genome.ucsc.edu) based on CanFam1.0. 
Known interspersed repeats were identified and dated using RepeatMasker and DateRepeats 113. 
The numbers of orthologous nucleotides were counted directly from the alignments using human 
(hg17) as the reference sequence for all overlaps except the dog-mouse overlap, where pair-wise 
(CanFam1.0, mm5) alignments were used. 
Divergence rate estimates. Orthologous ancestral repeats were excised from the genome 
alignment and realigned with the corresponding RepBase consensus using ClustalW. Nucleotide 
divergence rates were estimated from concatenated repeat alignments using baseml with the REV 
substitution model 114. Orthologous coding regions were excised from the genome alignments 
using the annotated human CDS from Ensembl and the UCSC browser Known Genes track (Oct. 
2004) as reference. KA and KS were estimated for each ortholog triplet using codeml with the 
F3x4 codon frequency model and no additional constraints.  
Detection and clustering of sequence conservation. Pair-wise conservation scores and the 
fraction of orthologous sequences under purifying selection were estimated as in 24. The three-
way conservation score SHMD was defined as 
 SHMD = (p – u) / √(u(1 – u) / n) 
where n is the number of nucleotides aligned across all three genomes for each non-overlapping 
50-bp window with more than 20 aligned bases, p is the fraction of nucleotides identical across 
all three genomes, and u is the mean identity of ancestral repeats within 500kb of the window. 
HCNEs were defined as windows with SHMD > 5.4 that did not overlap a coding exon, as defined 
by the UCSC Known Genes track, and HCNE clusters were defined as all runs of overlapping 
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1Mb intervals (50kb step size) across the human genome with HCNE densities in the 90th 
percentile. 
Gene set acceleration scores. Gene annotation was performed on CanFam1.0. A set of 13,816 
human, mouse and dog orthologous genes were identified and compiled into 4950 gene sets 
containing genes related by functional annotations or microarray gene expression data. For each 
gene set S, the acceleration score A(S) along a lineage is defined by (i) ranking all genes based on 
Ka/Ks within a lineage; (ii) calculating the rank-sum statistic for the set along each lineage 
(denoted adog(S), amouse(S), ahuman(S)); (iii) calculating the rank-sum for the lineage minus the 
maximum rank-sum the other lineages (for example, ahuman(S) – max(adog(S), amouse(S))) and (iv) 
converting this rank-sum difference to a z-score by comparing it to the mean and standard 
deviation observed in 10,000 random sets of the same size. The expected number of sets at a 
given z-score threshold were estimated by repeating steps (i)-(iv) 10,000 times for groups of 
4,950 randomly permuted gene sets. 
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Supplementary notes: Generating a draft genome sequence 
 
Data generation. We sequenced the genome of a female boxer, using a whole genome shotgun 
approach. A female dog was selected to obtain equal coverage of the X chromosome and the 
autosomes. 
In order to facilitate the assembly process, we sought to identify a highly homozygous 
individual. Breed Clubs, Veterinary schools, and specific breeders were contacted via web sites, 
as well as by direct communiqué, to obtain potentially useful DNA samples. We estimated mean 
heterozygosity for each of 185 candidate dogs by resequencing 19,860 base pairs representing 60 
unlinked loci [1]. A female boxer was selected based on the presence of only one heterozygous 
base pair within this sample. However, large scale data now shows that, after accounting for 
sample variance, this is within the expected rate of heterozygosity for the majority of dogs. 
DNA was isolated from the chosen dog via peripheral blood samples. A BAC library was 
made by CHORI and 4 kb, 10 kb Fosmid libraries were made at the Broad Institute of Harvard 
and MIT. Both BAC and Fosmid clones can be ordered from the BACPAC Resource center at 
CHORI (http://bacpac.chori.org/). Sequence reads were generated from all four libraries. The 
BAC end reads were generated at Agencourt Biosciences. All other reads were generated at the 
Broad Institute of Harvard and MIT. A total of 35 million reads were attempted with 31.5 million 
passing reads used as input to the assembly process, resulting in ~7.5x coverage of the 2.4 Gb 
genome.  
Genome assemblies. The most recent genome assembly (CanFam2.0) spans a total 
distance of 2.41 Gb, consisting of 2.38 Gb of nucleotide sequence with the remaining 1% in 
captured gaps. The assembly was carried out using an interim version of ARACHNE2+ [2]. 
Two consecutive assemblies were performed, the initial assembly CanFam1.0 was 
released in July 2004 and the CamFam2.0 assembly was released in May 2005. CanFam1.0 was 
used for the analyses described in this paper, unless otherwise specified. 
Both assemblies were anchored to the canine chromosomes using data from RH and 
cytogenetic maps [3-5]. After comparisons to the maps, further algorithmic improvements 
resulted in an improved CanFam1.0 assembly. For this improved version only four discrepancies 
suggesting errors in the assembly were identified between CanFam1.0 and the RH map. These 
discrepancies were resolved using FISH [3-5] prior to the generation of CanFam2.0. Twenty-
three BAC clones from four groups, each comprising four-seven clones that mapped to four 
different “problematic” regions of CFA 9, 11 and 16 were mapped. DNA for each of the 23 
clones was prepared by routine alkaline lysis and then labeled for FISH with one of five 
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spectrally resolvable fluors according to previous methods [4]. To exclude any structural 
cytogenetic anomalies unique to the sequenced boxer, all groups were hybridized to chromosome 
preparations and interphase nuclei prepared from peripheral lymphocytes of the sequenced boxer 
and two other (mixed breed) dogs. All FISH techniques were as previously described [4]. 
Images were acquired using a semi-automated multicolor FISH workstation driven by 
SmartCapture2.3 software (Digital Scientific, Cambridge, UK). The cytogenetic location and 
order of all probes within each group were determined from metaphase and interphase analysis of 
no fewer than 20 cells and a consensus order derived.  
Assessing base quality. We assessed base accuracy by comparing the CanFam2.0 
assembly to finished sequence. Nine BACs, where both ends had passing reads, were randomly 
selected and finished using the standard finishing pipeline[6]. Only sequence from homozygous 
regions of the boxer genome, comprising in total 4 BACs (0.76 Mb), from the total of 9 BACs 
(1.65 Mb) were compared to the assembly. We did not use the heterozygous regions because the 
finished sequence represented only one of the two haplotypes seen intermingled in the assembly.  
Explaining the high sequence continuity. The CanFam2.0 assembly has dramatically 
greater sequence continuity (180 kb) than the WGS assembly of the mouse genome (25 kb) 
obtained several years ago. Several factors contribute to the higher connectivity of the dog 
assembly: 
1. Increased redundancy: We examined the influence of coverage by approximating 
the continuity of a 6.5X dog assembly by removing reads from the 7.5X assembly, understanding 
that somewhat lesser continuity would be expected for a de novo assembly having less reads. The 
6.5X assembly had the same N50 of supercontig size (45 Mb), but lower N50 of contig size (122 
kb) than the full 7.5X assembly. 
2. Less duplication: We examined dog and mouse reads for the fraction of all observed k-
mers that are represented more than n x c times in the sequence reads, where c is the assembly 
coverage level. Based on presence of overrepresented k-mers, the mouse genome appears to have 
roughly twice as much recently duplication sequence as dog. The contribution to these fractions 
arising from sampling variability of the reads (assuming random DNA) is negligible relative to 
the observed fractions (≤ 0.005%). 
3. Improved data quality: We examined the data quality for the mouse and dog data sets. 
The read length increased from 560 base pairs to 700 base pairs, the read pairing rate from 85% 
to 96% and the library spread (the standard deviation of insert length as a fraction of insert length 
for 4 kb plasmid libraries) decreased from 20% to 9%. 
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4. Algorithmic improvement: A comparison was made between the improved version of 
ARACHNE used for dog and the old version used to assemble the published mouse genome. 
Assembling the dog with the previous software decreases contig size from 180 kb to 61 kb, while 
assembling the mouse with the new version increased it from 25 kb to 35 kb. 
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Supplementary Notes: Genome landscape and evolution 
 
Conserved synteny and large-scale rearrangements. We generated pair-wise synteny maps 
between dog (CanFam2.0) and human (hg17), mouse (mm5) and rat (rn3) using standard methods 
[7]. First, we aligned repeat masked assemblies using the PatternHunter program [8]. Next, we 
identified runs of alignments with well-defined order and orientation. These clusters of 
alignments were then merged hierarchically to create syntenic segments larger than a specified 
minimum size. Segments retain the dominant orientation of the alignments on which they are 
based. Finally, we defined syntenic blocks by merging adjacent syntenic segments that were 
contiguous in both genomes (orientation was ignored). For this reason, a local rearrangement of 
the segments within a syntenic block does not change the block boundaries. Different minimum 
segment sizes were used and yield different numbers of syntenic blocks and segments. 
To assign breakpoints to particular lineages we created a four-way synteny map from the 
individual pair-wise maps as follows. We compiled a list of the locations in dog of all the pair-
wise discontinuities. We then generated finer pair-wise maps to define orthologous segments in 
other genomes for each dog interval in this list (Figure 2). Breakpoints were assigned to particular 
branches of the evolutionary tree based on coincidence in the fourway synteny map. To simplify 
the nomenclature we called all breakpoints falling within syntenic segments “all breakpoints”, 
those falling within syntenic blocks were caller “interchromosomal breakpoints” and the 
breakpoints not present among the interchromosomal breaks but present in the all breaks group 
were called “intrachromosomal breaks”. It is important to note that events identified as 
“coincident “ in two lineages by this approach need not be any closer together in the genomic 
sequence than the minimum size allowed in the syntenic maps. 
Similar results are obtained when monodelphis is used as outgroup to dog, human, mouse 
and rat. We created pair-wise synteny maps at resolutions of 1,000, 500, 300 and 100 kb using a 
preliminary intermediate assembly of Monodelphis Domesticata as the reference genome. 
Because the scaffolds of this Monodelphis assembly are not yet anchored to chromosomes and we 
have not yet fully characterized the completeness and coverage properties of this assembly, we 
sought merely to confirm the overall trends in the assignment of breakpoints to lineages seen in 
the DHMR four-way analysis. In particular, we confirm that the human lineage has experienced a 
greater number of intrachromosomal breaks within syntenic blocks than the dog lineage. 
Furthermore, this tendency grows stronger for smaller segment size cutoffs. 
Genomic insertion and deletion. The analysis of shared and lineage-specific sequence 
content across dog, human and mouse are based on BLASTZ whole-genome alignments 
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(http://genome.ucsc.edu) and RepeatMasker output. Nucleotides in the three genomes were first 
classified as belonging to lineage-specific interspersed repeats or ‘other’ sequence. The dog 
(canFam1), human (hg17) and mouse (mm5) assemblies were masked for known interspersed 
repeats using RepeatMasker [08/03/2002 library: RepBase Update 8.12, RM database version 
20040306]. The final CanFam2.0 assembly was also masked with an updated repeat library 
[RepeatMasker 3.0.8 library: RepBase Update 9.04, RM database version 20040702]. The repeats 
were then subdivided into ancestral and lineage-specific instances based on the DateRepeats 
script and the presences or absence of orthologous sequences. Approximately 1-5% of repeat 
sequences classified as lineage-specific by DateRepeats in one of the genomes were aligned to at 
least one of the other species, although some of these alignments may be spurious. As noted 
previously [7], the activity of repeats in all classes except DNA transposons appears to have been 
distinctly higher in mouse relative to human. The average rates of SINE and LINE insertions have 
been similar in the human and dog lineages, but have contributed more sequence overall to the 
human genome, and the activity of DNA transposons and endogenous retrovirus have been 
significantly higher in human. The total amount of lineage-specific repeats may be a slight 
underestimate for each species as lineage-specific repeats inserted close after the mammalian 
radiation may be conservatively classified as ancestral. 
The numbers of shared and lineage-specific nucleotides, as presented in Figure 1, were 
then counted directly from the BLASTZ alignments. The intersection between the human and the 
other genomes were computed from alignments using human as the reference sequence. The 
intersection between dog and mouse were computer from alignments using dog as the reference 
sequence. We note that asymmetries in the genome-wide alignment procedure leads to slight 
differences (on the order of ~50 Mb) in the estimated size of human-dog overlap depending on 
whether human or dog were used as the reference sequence. We also note that the size of the 
genome intersections depends on whether or not bases overlapping small indels within an 
otherwise orthologous sequence are counted as aligned. The numbers described in the main text 
count only bases present in all three genomes as aligning between all three species. If small indels 
are included as aligned, the number of lineage-specific bases fall by approximately 60 Mb per 
lineage, and the orthologous intersections increase correspondingly. This does not impact any 
conclusion presented in the main text. 
We can obtain a rough estimate of lineage-specific deletion rates by assuming that 
ancestral nucleotides (other than the common, presumed functional 150 Mb) are deleted 
continuously and independently. Give the amount of extant ancestral sequence (X), total ancestral 
genome size (T), and divergence time (t), we have  
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X = T e-kt 
where k is the rate of deletion. Assuming T = 2,800 Mb – 150 Mb and t = 75 Myr [7], we get k = 
0.0024 Myr-1 for human and 0.0078 Myr-1 for mouse. And assuming t = 90 Myr (based on 
divergence rates the length of the BEA to rodent-primate branch is ~10% of the subsequent 
primate and rodent branches, i.e. 7.5 Myr which must be multiplied by 2 given the unrooted tree), 
we get k = 0.0031 Myr-1 for dog, suggesting that the relative rate of deletion between the three 
lineages are roughly proportional to the relative rates of substitutions. Similar estimates can be 
made for insertions, but transposon-derived insertions are unlikely to approximate a continuous 
process [9]. 
Active SINE family: RepeatMasker (3.0.8, RepBase Update 9.04, RM database version 
20040702) identification of the dog-specific SINE element SINEC_Cf found 377,453 copies in 
the canFam2.0 assembly. To study only the most recent copies of SINEC_Cf, we restricted our 
analysis to those copies which matched the SINEC_Cf consensus from end to end with at most 10 
mismatches and 20 indels, obtaining approximately 87,000 elements. Comparison of overlapping 
sequence reads within the assembly identified 8% of these as polymorphic within the sequenced 
boxer.  
Rate of nucleotide divergence. Regional neutral divergence rates for the dog, mouse and 
human branches were estimated from alignments of ancestral repeat (AR) sequences (which are 
presumed to be largely non-functional), as classified by RepeatMasker and RepeatDater 
(http://repeatmasker.org), using the same approach as described previously [10]. The ancient L2 
and L3 subclasses were excluded as inspection revealed a high frequency of apparent alignment 
artifacts, but the relative rates reported in the main text are robust to inclusion of these sequences. 
The orthologous sequences for each AR fragment were extracted from the genome-wide 
alignment and realigned to the corresponding repeats consensus using ClustalW [11]. Branch-
specific divergence rates were then estimated on a tree rooted by the AR consensus using PAML 
(http://abacus.gene.ucl.ac.uk/software/paml.html) with the REV model for all aligned sequences 
within each 1 Mb interval. Only intervals with more than 2,000 nucleotides aligned across all 
three species were used for estimates reported in the main text. 
Male mutation bias. Given that autosomes spend equal time, and the X chromosome 
twice as long, in the female germ-line as in the male germ-line, the autosomal divergence rate 
(A), the X chromosome divergence rate (X), the male mutation rate (μm) and the female mutation 
rate (μf) are related by 
A = 1/2 μm + 1/2 μf 
X = 1/3 μm + 2/3 μf 
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which leads to 
μm / μf = (4A – 3X)/(3X – 2A) 
Taking A and X as the median lineage-specific divergence rates for each lineage from ancestral 
repeats in 1 Mb windows gives 0.193 and 0.162 for the dog lineage; 0.373 and 0.138 for the 
mouse lineage; and 0.138 and 0.108 for the human lineage; yielding μ = μm / μf = 2.8, 2.8 and 
4.6 for the dog, mouse and human lineages, respectively. Using the mean divergence rate, or 
changing the window size or the threshold for number of aligned bases per window, leads to 
correlated estimates in the 2.5-3.5 range on the dog and mouse lineages and in the 4.5-5.7 range 
on the human lineage. 
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Supplementary Notes: Proportion of genome under purifying selection 
 
Low turnover of ancestral conserved elements. We estimated the fraction of ortholgous 
sequence under selection from the excess of conservation observed in all sequence, relative to 
that seen in ancestral repeats only. The initial description and variations to this approach can be 
found in references [7, 12, 13]. Briefly, the human-dog conservation score for a 50 bp window 
(SHD) is defined as  
SHD = (p – u) / !(u(1 – u) / n) 
where n is the number of aligned nucleotides between human and dog within the window, p is the 
fraction of identical nucleotides and u is the fraction of identical, aligned nucleotides in ancestral 
repeats in a 1 Mb interval centered on the window. SHD was computed for all 50 bp windows with 
n > 20 (giving the distribution Sgenome), and separately for the subset of such windows that 
completely overlap an ancestral repeat sequence (giving the distribution Sar). The genome-wide 
distribution was then decomposed into selected (Sselected) and neutral (Sneutral) components defined 
by 
Sneutral = p0 Sar 
Sselected = Sgenome - Sneutral 
where the scaling coefficient p0 is conservatively taken to be the minimum ratio between 
Sselected(SHD) and Sar(SHD) for all values of SHD. The probability that a particular window in under 
selection, given its conservation score 
Pselection(SHD) = 1 – p0 Sneutral(SHMD)/Sgenome(SHMD). 
We first estimated the fraction of all windows under selection between human and dog. When all 
50 bp windows for which human and dog align at ≥ 20 bp are selected, a total of 32.5 million 
windows are covered and p0 = 10.2% and corresponding to 5.3% of all 50 bp windows along the 
human genome. When all windows where human, dog and mouse align at ≥ 20 bp are selected, 
19.9 million windows are covered and p0 = 16%, corresponding to 5.2% of the human genome. 
For the remaining 12.6 million windows where mouse aligns over < 20 bp (the results are 
insensitive to this threshold, data not shown), p0 = 1%, corresponding to 0.1% of the human 
genome. This suggests that the vast majority of selected sequence between human and dog has 
also been retained in mouse. 
We also devised a second approach by computing a combined human-mouse-dog 
conservation score SHMD for each window along the human genome with orthologous sequence in 
both mouse and dog. SHMD is defined as SHD, but with n as the number of nucleotides aligned 
across all three genomes within the window, and p and the proportion of aligned nucleotides 
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identical across all three genomes. Repeating that analysis above on the 19.9 million eligible 
windows yields p0 = 18%, corresponding to 5.7% of the human genome. In principle, this 
estimate might not be directly comparable to the pairwise estimates from dog and mouse because 
the combined score may have increased power to detect weaker selection. However, the similarity 
of the combined and pair-wise estimates, taken together with the retention bias described above, 
strongly suggests that ~5% conserved bases between human-dog and between human-mouse are 
largely the same. 
Distribution of highly conserved elements across the genome. We defined highly 
conserved elements as 50 bp windows on the human genome with more then 20 bp aligned 
sequence to both mouse and dog, and for which Pselection(SHMD) ≥ 95%. We then computed the 
density of such windows across sliding 1 Mb windows (step size = 50 kb). 
A cluster of highly conserved elements were defined as a run of one or more overlapping 
1Mb windows with densities in the 90th percentile, a criteria chosen to identify all major peaks 
evident by visual analysis (Figure 6). 
Potential regulatory targets were identified through manual inspection of functional 
annotations and related literature. Incomplete functional annotations prevent a fully automated 
significance test of the developmental gene enrichment in these clusters (the candidate genes 
were in several cases picked based on literature references and annotations of mouse orthologs 
that were reflected in the human databases). However, repeating the manual analysis of 100 
randomly selected regions of the genome with a similar size distribution yielded putative 
developmental genes in only 26% of cases, compared with 92% of the highly conserved clusters 
(p < 10-31 by Fisher’s exact test). 
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Supplementary Notes: Genes 
 
Gene predictions in dog and human. A dog gene set was produced based largely around the 
results of the Ensembl genebuild pipeline (CanFam1.0). The Ensembl set was augmented by 
additional, evidence based, genes from the Broad annotation pipeline and Goodstadt and 
Ponting's orthology pipeline [15]. Using this dog gene set and the Ensembl gene set for human 
(hg17), we used synteny relationships to establish clear 1-1 orthology relationship for ~14,500 
genes. All other genes were further studied with a variety of tools as well as visual examination to 
confirm the presence or absence of genes in both human and dog. The exact methodology is 
described in [14]. 
Gene duplications. In order to distinguish genes duplicated in the dog or human lineage, 
since their common ancestor, we reconstructed the phylogeny of all Ensembl transcript sequences 
using the synonymous substitution rate KS as a distance metric (see [15]). This allowed 
predictions of gene orthology and paralogy, and of conserved synteny (gene order), whilst 
highlighting likely processed pseudogenes as predictions with multiple frameshift disruptions (as 
indicated by intron sizes less than, or equal to, 10bp) or else those in non-syntenic locations that 
also contain a single disruption or are single exon predictions. 
Evolution of orthologous genes across three species. We compiled alignments of 
human-mouse-dog orthologs by extracting the orthologous sequences of human coding regions, 
as annotated by Ensembl and the UCSC “known genes” track (both downloaded December 30th 
2004), from mouse and dog via MultiZ alignments of the human (hg17), mouse (mm5) and dog 
(canFam1) genomes (genome.ucsc.edu) after filtering out nonsyntenic alignment blocks. We 
removed all alignments with less than 80% coverage of the annotated coding regions or with one 
or more frame-shifting indels. If more than one transcript variant of a particular gene remained, 
we removed all but the longest such alignment, yielding 13,816 unique coding regions. Lineage-
specific Ka and Ks were then estimated for each ortholog triplet on an unrooted tree using codeml 
from PAML with the F3x4 codon frequency model.  
Gene sets. We compiled 4950 gene sets containing genes related by functional 
annotations or microarray gene expression data. For functional annotations, we used gene 
ontology (GO) to generate gene sets for each GO term based on annotations from Ensembl. We 
also used sets of genes involved in known metabolic and regulatory pathways 
(www.broad.mit.edu/gsea/molsigdb/molsigdb_index.html). For gene expression data, we used the 
tissue expression compendium containing gene expression profiles in 75 human tissues generated 
by Novartis [16]. From the compendium, we generated 75 tissue-specific gene sets containing 
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genes that were specifically expressed in certain tissues. We also extracted sets of genes that 
share similar expression profiles across this compendium to each of 2271 putative transcriptional 
regulators from TRANSFAC (www.gene-regulation.com), using Pearson correlation as the 
similarity measure. Finally, we included 1445 gene sets curated by [17]. The complete collection 
of gene sets used is available upon request. 
Acceleration scores for gene sets. We adapted the Gene Set Enrichment Analysis 
approach (www.broad.mit.edu/gsea/) to search for sets enriched for genes with elevated Ka/Ks on 
one of the three branches, relative to the others. First, we ranked all considered orthologs by 
Ka/Ks on each branch. Second, for each set, we computed the rank sum of the constituent genes, 
rH, rM and rD, for the human, mouse and dog branches, respectively. Figure 8 shows that these 
rank sums are highly correlated. Third, we computed the difference between each pair of rank 
sums for pair-wise comparisons (e.g. rH-rD to identify sets accelerated in human relative to dog), 
and the difference between one rank sum and the maximum of the remaining two for three-way 
comparisons (e.g. rH max[rM,rD] to identify sets accelerated in human relative to both dog and 
mouse). Fourth, we converted the rank sum difference into a z-score using the mean and standard 
deviation observed from 10,000 random gene sets of the same size as the considered gene set.  
In order to assess the significance of the observed acceleration scores we repeated the 
above procedure 10,000 times for the same collection of gene sets by randomly permuting the 
gene names (while keeping the three lineage-specific Ka/Ks ratios for each gene together and 
preserving the structure of the gene set intersections). For a given acceleration score threshold we 
then estimated the significance (p-value) of the observed number of gene sets above that 
threshold as the fraction of random trials yielding equal or more sets at the same threshold. We 
also estimated a conservative p-value for each individual gene set as the fraction of random trials 
yielding one or more gene sets at or above its acceleration score (the p < 0.01 threshold is shown 
in Figure 10). Sets related to testis-specific expression and the electron transport chain are 
significantly accelerated in humans according to both p-value definitions. 
Comparisons of the observed distributions of pair-wise acceleration scores and the 
expected distributions are shown in Figure 9. There is a notably higher variance in the two 
comparisons involving mouse, whereas the human-dog distribution is highly symmetrical. This is 
reflected in the slight skew towards negative acceleration scores in Figure 10, and may signal 
more similar selective pressures or mutation biases on the human and dog lineages. 
Acceleration in brain-related genes relative to rodents. Our database of gene sets 
contains multiple sets of genes expressed uniquely or non-uniquely in fetal and adult brains. Most 
showed weak positive acceleration scores for human or dog relative to mouse, but none were 
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significant. We therefore focused specifically on the 24 genes reported to show significantly 
faster evolution in primates relative to rodents in Table 1 of [18]. 18 of the genes were contained 
in our dataset (MCPH1, CASP3, OPRM1, NRCAM, SHH, PYNX1, DRD2, GRIK4, CHRM5, 
CHRNA5, NTRK3, GRIN2A, PAFAH1B, LHX1, AANAT, ADCYAP1, TTRAP, CSPG3). The 
median Ka/Ks estimated for these genes were 0.123, 0.0774 and 0.080, for the human, mouse and 
dog branches, respectively. This is 25% acceleration over the expected ratio for all orthologs on 
the human branch relative to the mouse branch, and 30% acceleration relative to the dog branch. 
This enrichment for non-synonymous substitutions is somewhat lower than reported by 
[18], which is consistent with the expectation that positive selection on these genes increased 
during the more recent portion of branch leading to humans. Also consistent with [18], genes 
showing comparable acceleration on the mouse branch relative to the human branch appear to be 
relatively rare. However, it is simple to identify at least 18 genes in our brain-related gene sets 
showing strong acceleration on the dog branch (MEIS2, DLG3, LHX2, NRXN1, NRXN2, 
NEUROD2, SH3GLB1, NAV2, NAV3, RTN1, LDB2, CDH10, DBN1, CSPG3, FOXP2, OLIG1, 
RBM9, INA). The median Ka/Ks estimated for these genes were 0.0306, 0.0314 and 0.0546 for 
the human, mouse and dog branches, respectively. This is 110% acceleration over the expected 
ratio for all orthologs on the dog branch relative to the human branch, and 61% relative to the 
mouse branch. 
Several of these genes are thought to be critical for nervous system development, 
suggesting that acceleration in the non-synonymous substitution rate of such genes is not unique 
to the lineage leading to humans. 
 
 
 195
     
 196
References for Supplementary Notes 
 
1. Parker, H.G., et al., Genetic structure of the purebred domestic dog. Science, 2004. 304(5674): p. 1160-
4. 
2. Jaffe, D.B., et al., Whole-genome sequence assembly for mammalian genomes: Arachne 2. Genome Res, 
2003. 13(1): p. 91-6. 
3. Breen, M., et al., Chromosome-specific single-locus FISH probes allow anchorage of an 1800-marker 
integrated radiation-hybrid/linkage map of the domestic dog genome to all chromosomes. Genome Res, 
2001. 11(10): p. 1784-95. 
4. Breen, M., et al., An integrated 4249 marker FISH/RH map of the canine genome.BMC Genomics, 2004. 
5(1): p. 65. 
5. Hitte, C., et al., Opinion: Facilitating genome navigation: survey sequencing and dense radiation-hybrid 
gene mapping. Nat Rev Genet, 2005. 
6. Consortium, I.H.G.S., Finishing the euchromatic sequence of the human genome. Nature, 2004. 
431(7011): p. 931-45. 
7. Waterston, R.H., et al., Initial sequencing and comparative analysis of the mouse genome. Nature, 2002. 
420(6915): p. 520-62. 
8. Ma, B., J. Tromp, and M. Li, PatternHunter: faster and more sensitive homology search. Bioinformatics, 
2002. 18(3): p. 440-5. 
9. Liu, G., et al., Analysis of primate genomic variation reveals a repeat-driven expansion of the human 
genome. Genome Res, 2003. 13(3): p. 358-68. 
10. Kirkness, E.F., et al., The dog genome: survey sequencing and comparative analysis. Science, 2003. 
301(5641): p. 1898-903. 
11. Thompson, J.D., et al., The CLUSTAL_X windows interface: flexible strategies for multiple sequence 
alignment aided by quality analysis tools. Nucleic Acids Res, 1997. 25(24): p. 4876-82. 
12. Chiaromonte, F., et al., The share of human genomic DNA under selection estimated from human-
mouse genomic alignments. Cold Spring Harb Symp Quant Biol, 2003. 68: p. 245-54. 
13. Roskin, K.M., M. Diekhans, and D. Haussler, Score functions for determining regional conservation in 
two-species local alignments. J Comput Biol, 2004. 11(2-3): p. 395-411. 
14. Clamp, M., et al., Distinguishing protein-coding and noncoding genes in the human genome. Proc Natl 
Acad Sci U S A 2007. 104(49): p. 19428-33. 
15. Goodstadt, L. and C.P. Ponting,  Analysis of gene orthology in the dog. PLoS Comput Biol, 2006. 2(9): 
e133 
16. Su, A.I., et al., A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad 
Sci U S A, 2004. 101(16): p. 6062-7. 
17. Segal, E., et al., A module map showing conditional activity of expression modules in cancer. Nat 
Genet, 2004. 36(10): p. 1090-8. 
18. Dorus, S., et al., Accelerated evolution of nervous system genes in the origin of Homo sapiens. Cell, 
2004. 119(7): p. 1027-40. 
 
  
 
  
Chapter 4: The opossum genome 
 
In this chapter, we describe the first comprehensive comparative analysis of placental and marsupial 
genome sequences. 
This work was first published as 
Mikkelsen, T. S. et al. Genome of the marsupial Monodelphis domestica reveals innovation in non-
coding sequences. Nature 447, 167-177 (2007). 
The full publication is attached as Appendix 3. Supplementary notes can be found at the end of the 
chapter. Supplementary data is available online from http://www.nature.com/nature 
The text in this chapter was written with significant contributions from members of the analysis 
consortium. 
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 We report a high-quality draft of the genome sequence of the grey, short-tailed opossum 
(Monodelphis domestica). As the first metatherian (‘marsupial’) species to be sequenced, the 
opossum provides a unique perspective on the organization and evolution of mammalian 
genomes. Distinctive features of the opossum chromosomes provide support for recent 
theories about genome evolution and function, including a strong influence of biased gene 
conversion on nucleotide sequence composition and a relationship between chromosomal 
characteristics and X inactivation. Comparison of opossum and eutherian genomes also 
reveals a sharp difference in evolutionary innovation between protein-coding and non-coding 
functional elements. True innovation in protein-coding genes appears to be relatively rare, 
with lineage-specific differences being largely due to diversification and rapid turnover in 
gene families involved in environmental interactions. By contrast, about 20% of eutherian 
conserved non-coding elements (CNEs) are recent inventions that postdate the divergence of 
Eutheria and Metatheria. A substantial proportion of these eutherian-specific CNEs arose 
from sequence inserted by transposable elements, pointing to transposons as a major creative 
force in the evolution of mammalian gene regulation.  
Metatherians (‘marsupials’) comprise one of the three major groups of modern mammals 
and represent the closest outgroup to the eutherian (‘placental’) mammals (Figure 1). Metatherians 
and eutherians diverged ~180 million years ago (Mya), long before the radiation of the extant 
eutherian clades ~100 Mya 1,2. Although the metatherian lineage originally radiated from North 
America, only one extant species can be found there (the Virginia opossum), while all other species 
are found in South America (including more than 65 species of opossums and shrew opossums) and 
Australasia (~200 species, including possums, kangaroos, koalas and many small insectivores and 
carnivores) 3.  
All sequenced mammalian genomes to date have come from eutherian species. Although 
metatherians and eutherians (together, ‘therians’) share many ancient mammalian characteristics, 
they have each evolved distinctive morphological and physiological traits. Metatherians are 
particularly noted for the birth of young at a very early stage of development, followed by a lengthy 
and complex lactational period. Genomic analysis will help reveal the genetic innovations that 
underlie the distinctive traits of each lineage 4-6. 
Equally important, metatherian genomes can shed light on the human genome. Comparative 
analysis of eutherians has greatly improved our understanding of the architecture and functional 
organization of mammalian genomes 7-10. Identification of sequence elements under purifying 
selection, based on cross-species sequence conservation, has led to increasingly refined inventories  
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Figure 1. Simplified phylogeny of amniotes. Infraclass Eutheria is represented by 
human (H), mouse, (M), rat (R) and dog (D). Infraclass Metatheria is divided into 
two extant lineages: the Australasian and the American, represented by wallaby (W) 
and opossum (O), respectively. Infraclass Prototheria is represented by platypus (P). 
Aves is represented by chicken (C). The two dashed lines indicate major lineages 
that are not yet represented by complete genome sequences.
 of protein-coding genes 11,12, proximal and distal regulatory elements 13,14 and putative RNA genes 
15. Yet, we still know relatively little about the evolutionary dynamics of these and other functional 
elements. How stable is the complement of protein-coding genes? How rapidly do regulatory 
sequences appear and disappear? From what substrate do they evolve?  
Comparison of the human genome to genomes from distant outgroups such as birds (~310 
Mya) or fish (~450 Mya) has provided valuable information. When similarity between sequences 
from such distantly-related genomes can be detected, it surely signals functional importance. But 
the high specificity 16 is offset by dramatically reduced sensitivity 10,17,18. Simulations have shown 
that the feasibility of aligning orthologous genomic sequences declines rapidly once their mean 
genetic distance exceeds one substitution per site 19. The genome of chicken, the most closely 
related non-mammalian amniote genome available, is separated from the human genome by 
approximately 1.7 substitutions per site in orthologous, neutrally evolving sequences 20. Even 
moderately constrained functional elements may therefore be difficult to detect. By contrast, 
metatherian mammals are well positioned for addressing this issue; because unconstrained regions 
of their genomes are separated from human by only ~1 substitution per site (see below), most 
orthologous, constrained sequence should be readily aligned. 
Here, we report the first high-quality draft of a metatherian genome sequence, which was 
derived from a female grey, short-tailed opossum, Monodelphis domestica. The species was chosen 
chiefly on the availability and utility of the organism for research purposes. M. domestica, is a small 
rapidly-breeding South American species that has been raised in pedigreed colonies for more than 
25 years and developed as one of only two laboratory bred metatherians 21,22. M. domestica is being 
actively used as a model system for investigations in mechanisms of imprinting 23-25, 
immunogenetics 26-28, neurobiology, neoplasia, and developmental biology (reviewed in 6). For 
example, newborn opossums are remarkable in that they can heal complete transections of the 
spinal cord 29. Elucidation of the molecular mechanisms underlying this ability promise important 
insights relevant to regenerative medicine for spinal cord or peripheral nerve injuries. Other than 
human, M. domestica is also the only mammal known in which ultraviolet radiation is a complete 
carcinogen for malignant melanoma 30, which has led to its establishment as a unique neoplasia 
model. All of these investigations will directly benefit from the development of genomic resources 
for this species.   
Below, we describe the generation of the draft sequence of the opossum genome, analyze 
its large-scale characteristics, and compare it to previously sequenced amniote genomes. Our key 
findings include:  
 200
 • The distinctive features of the opossum genome provide an informative test of current 
models of genome evolution and supports the hypothesis that biased gene conversion plays 
a key role in determining overall nucleotide composition. 
• The evolution of random X inactivation in eutherians correlates with acquisition of XIST, 
elevation in LINE/L1 density and suppression of large-scale rearrangements. 
• The opossum genome appears to contain 18,000-20,000 protein-coding genes, the vast 
majority of which have eutherian orthologs. Lineage-specific genes largely originate from 
expansion and rapid turnover in gene families involved in immunity, sensory perception 
and detoxification. 
• Identification of orthologs of highly divergent immune genes and a novel T-cell receptor 
isotype challenge previous claims that metatherians posses a ‘primitive’ immune system. 
• Of the non-coding sequences conserved among eutherians, ~20% appear to have evolved 
after the divergence from metatherians. Of protein-coding sequences conserved among 
eutherians, only ~1% appear to be absent in opossum. 
• At least 16% of eutherian-specific conserved non-coding elements are clearly derived from 
transposons, implicating these elements as an important creative force in mammalian 
evolution. 
Extensions to these findings, as well as additional topics, are reported in a series of companion 
papers 31-41. 
 
Genome assembly and SNP discovery 
We sequenced the genome of a partially inbred female opossum using the whole-genome shotgun 
(WGS) method 7,42. The resulting WGS assembly has total length of 3,475 Mb, consistent with size 
estimates based on flow cytometry (~3.5-3.6 Gb;, Supplementary Notes S1-S2). Approximately 
97% of the assembled sequence has been anchored to eight large autosomes and one sex 
chromosome based on genetic markers mapped by linkage analysis 38 or fluorescence in situ 
hybridization 43 (FISH; Supplementary Note S3). The draft genome sequence has high continuity, 
coverage and accuracy (Table 1; Supplementary Note S4).  
To enable genetic mapping studies of opossum, we also created a large catalog of candidate 
single nucleotide polymorphisms (SNPs). We identified ~775,000 heterozygous SNPs within the 
sequenced individual by analyzing assembled sequence reads. We identified an additional ~510,000 
SNPs by generating and comparing ~300,000 sequence reads from three individuals from distinct, 
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 partially outbred laboratory stocks maintained at the Southwest Foundation for Biomedical 
Research (SFBR; San Antonio, TX) 22,44 (Supplementary Note S5). The SNP rates between the 
different stocks range from 1/360 to 1/140 bases and correlate with the distance between their 
geographical origins. 
 
 
 
 
 
 
Table 1: Genome assembly characteristics 
 
WGS assembly (monDom5)  
   Number of sequence reads 38.8 million 
   Sequence redundancy (Q20 bases) 6.8x 
   N50 contig size 108 kb 
   N50 scaffold size 59.8 Mb 
   Total anchored bases in the assembly 3,412 Mb 
   Total estimated euchromatic genome sizea 3,475 Mb 
Integration of physical mapping data  
   Scaffolds anchored on chromosomes 216 
   Fraction of genome in anchored and oriented scaffolds 91% 
   Fraction of genome in anchored, but unoriented, scaffolds 6% 
Quality control  
   Bases with quality score ≥ 40 98% 
   Empirical error rate for bases with quality score ≥ 40b 3 ×10-5 
   Empirical euchromatic sequence coverageb 99% 
   Bases in regions with low probability of structural errorc 98% 
N50 is the size x such that 50% of the bases reside in contigs/scaffolds of length ≥ x. 
a Includes anchored sequence and spanned gaps (~2%).  
b Based on comparison with 1.66 Mb of finished BAC sequence. 
c Based on ARACHNE assembly certification (see Supplementary Note S4). 
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Figure 2. Sequence composition in the opossum genome. Distribution of (G+C)-
content in 10-kb windows across the genome in opossum (blue), human (red), 
mouse (black), dog (green) and chicken (purple).
 Genome landscape 
The opossum genome has certain unusual properties that provide an opportunity to test recent 
models of genome evolution. The opossum autosomes are extremely large: they range from 257 Mb 
to 748 Mb, with the smallest being larger than the largest chromosome previously sequenced in any 
amniote (human chromosome 1). In contrast, the X chromosome is only ~76 Mb long; this is 
substantially less than the size of the X chromosome in any sequenced eutherian. Studies of G-
banding and chromosome painting have also shown that karyotypes and basic chromosomal 
organization are extraordinarily conserved throughout Metatheria, even between the distantly 
related American and Australasian lineages (~55-80 Mya) 5,45.  
Sequence composition. Recent analyses have uncovered two major trends in the evolution 
of sequence composition in amniote genomes: First, most modern lineages appear to be 
experiencing a gradual decline in total (G+C)-content relative to their common ancestors 46. Second, 
the local rate of recombination is positively correlated with local (G+C) content and, even more 
strongly, with the local density of CpG dinucleotides 20,47. These observations have led to a 
proposed model 48 whereby sequence composition reflects the balance between a genome-wide, 
AT-biased mutation process and a localized recombination-mediated GC-biased gene conversion 
(BGC) process. This model predicts that the sequence composition of a genomic region is a 
function of its historical rate of recombination, with the frequency of hypermutable CpG 
dinucleotides being a particularly sensitive indicator. 
 The opossum genome fits the predictions of this model well (see also 34,35). Current linkage 
data 38 show that the average recombination rates for the autosomes (~0.2-0.3 cM/Mb) are lower 
than in other sequenced amniotes (0.5 to more than 3 cM/Mb). Consistent with the proposed model, 
the mean autosomal (G+C)-content (37.7%) is also lower than in other sequenced amniotes (40.9-
41.8%), and in particular, the mean autosomal density of CpGs (0.9%) is two-fold lower than in 
other amniotes (1.7-2.2%). Because large-scale patterns of recombination appear to be relatively 
stable in the absence of chromosomal rearrangements 49,50, the stability of the opossum karyotype 
suggests that the majority of the genome has experienced low recombination rates over an extended 
period. Consistent with this, the sequence composition is also more homogenous than seen in other 
amniotes (Figure 2).  
The subtelomeric regions of autosomes are notable outliers with respect to sequence 
composition in the opossum genome, providing additional support for the BGC hypothesis. 
Cytological studies in opossum 51,52 suggest that the rate of chiasmata formation (and hence meiotic 
recombination) is relatively uniform across each autosome in males, while it is strongly biased to 
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Figure 3. Sequence composition in the opossum genome. Distribution of (G+C)-
content (upper) and CpG density (lower) in 1-Mb sliding windows across opossum 
chromosome 1. The centromere is indicated by the dotted red line. Increased 
(G+C)-content and CpG densities are evident in the subtelomeric regions.
  
 
 
 
Table 2: Comparative analysis of genome landscape in opossum and other 
amniotes 
 
 Opossum Human Mouse Dog Chicken 
Euchromatic genome size (Mb) 3475 2880 2550 2330 1050 
Karyotype      
   Haploid number 9 23 20 39 33 
   Autosomal size range (Mb) 258-748 47-247 61-197 27-125 5-201 
   X chromosome size (Mb) 76 155 167 127 NA 
Segmental duplications      
   Autosomal (%) 1.7 5.2 5.3 2.5 10.4 
   Intrachromosomal duplications (%) 76 46 84 ND ND 
   Median length between duplications 
(Mb) 
0.18 2.2 1.6 0.33 0.03 
   X chromosome  (%) 3.3 4.1 13 1.7 NA 
Interspersed repeats (%)      
   Total 52.2 45.5 40.9 35.5 9.4 
   LINE/non-LTR retrotransposon 29.2 20.0 19.6 18.2 6.5 
   SINE 10.4 12.6 7.2 10.2 NA 
   Endogenous retrovirus 10.6 8.1 9.8 3.7 1.3 
   DNA transposon 1.7 2.8 0.8 1.9 0.8 
G+C content (%)      
   Autosomal 37.7 40.9 41.8 41.1 41.5 
   X chromosome 40.9 39.5 39.2 40.2 NA 
CpG content (%)      
   Autosomal 0.9 2.0 1.7 2.2 2.1 
   X chromosome 1.4 1.7 1.2 1.9 NA 
Recombination rate (cM/Mb)       
   Autosomal ~0.2-0.3 1-2 0.5-1 
1.3-
3.4b 2.5-21 
   X chromosomec ≥0.44d 0.8 0.3 ND NA 
NA, not applicable. ND, no or insufficient data. 
a Range of chromosome-averaged recombination rates.  
b http://www.vgl.ucdavis.edu/research/canine/projects/linkage_map/data/ 
c Estimated as 2/3 of the female rate. 
d See text. 
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Figure 4. Opossum-human synteny map at 500 kb resolution. Segments on opossum 
chromosomes 1-8 and X are colored by their orthologous chromosomes in human. 
Diagonal lines show the extent of collinear syntenic segments. Large gaps in the map 
(white) typically correspond to extensive gene clusters where synteny is difficult to 
ascertain. Centromeres are indicated by the opposing red triangles. The estimated 
size of each chromosome is given on its right. The chromosomal assignments and 
size estimates reflect all available FISH data (assembly version monDom5). 
 subtelomeric regions in females. Consistent with a higher sex-averaged rate of recombination, mean 
(G+C)-content (41.6%) and CpG density (1.9%) are significantly elevated within ~10 Mb of the 
chromosome ends (Figure 3).  
Similarly, the very short X chromosome also supports the BGC hypothesis. Although few 
linkage data are currently available for opossum X chromosome, the average effective 
recombination rate must be at least 0.44 cM/Mb, and thus larger than for the autosomes. (This 
estimate follows from the requirement of at least one meiotic crossover per bivalent in the female 
germ-line 53,54). The mean (G+C)-content (40.9%) and CpG density (1.4%) of the X chromosome 
are substantially higher than for any of the autosomes. The opossum pattern is thus the opposite of 
that seen in eutherians, in which the X chromosome has low recombination and low (G+C)-content 
and CpG density (Table 2).  
Segmental duplication. In human and other eutherians, segmental duplications (defined as 
pairs of regions with ≥90% sequence similarity over ≥1 kb) are associated with chromosomal 
fragility and syntenic breakpoints 55,56. The relative karyotypic stability of metatherians therefore 
suggests that they might have a low proportion of segmental duplications.  
The overall proportion of segmental duplication in opossum (1.7%) was indeed 
substantially lower than in other sequenced amniotes (2.5-5.3%). The segmental duplications are 
also relatively short: only 22 exceed 100 kb in opossum as compared to 483 in human. Additionally, 
the segmental duplications are more locally distributed: 76% are intrachromosomal (vs. 46% for 
human) and the median distance between related duplications is 175 kb (vs. 2.2 Mb for human). We 
find no indication that correction for over-collapsed duplications in the assembly would 
significantly alter these estimates (Supplementary Note S6). 
Transposable elements. Metatherian transposable elements (TEs) largely belong to 
families also found in eutherians, but can be divided into more than 500 subfamilies, many of which 
are lineage-specific (catalogued in Repbase 57). At least 52% of the opossum genome can be 
recognized as TEs and other interspersed repeats (Table 2) 33,35, which is more than in any of the 
other sequenced amniotes (34-43%). Notably, the opossum genome is significantly enriched in non-
LTR retrotransposons (LINEs), with over 29% of the genome sequence comprising copies of 
various LINE subfamilies. Given the low abundance of segmental duplications,  accumulation of 
TEs appears to be the primary reason for the relatively large opossum genome size. The total 
euchromatic sequence not recognized as TEs is rather similar in opossum and human (1638 Mb vs 
1568 Mb). The enrichment of LINEs may be related to the overall low recombination rate in 
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 opossum, inasmuch as studies of eutherian genomes have shown that LINEs occur at elevated 
densities in regions with low local recombination rates 47. 
 
Conserved synteny  
Identification of syntenic segments between related genomes can facilitate reconstruction of 
chromosomal evolution and identification of orthologous functional elements. Starting from 
nucleotide-level, reciprocal-best alignments (‘synteny anchors’), we found that the opossum and 
human genomes can be subdivided (at a resolution of 500 kb) into 510 collinear segments with an 
N50 size of 19.7 Mb, which cover 93% of the opossum genome (Figure 4). If local rearrangements 
are disregarded, these segments can be further grouped into of 372 blocks of large-scale, conserved 
synteny.  
Extending this analysis to additional eutherians (mouse, rat and dog), with chicken as an 
additional outgroup, we created a high-resolution synteny map that reveals 616 blocks of conserved 
synteny across the five fully sequenced mammals (Supplementary Note S7). Because the majority 
of synteny breakpoints between human, mouse, rat and dog are clearly lineage-specific (see also 10), 
genomic regions that were probably contiguous in the last common boreoeutherian ancestor can be 
inferred by parsimony (Supplementary Note S8). We found that the mammalian synteny blocks can 
be used to define 43 connected groups in the ancestral boreoeutherian genome (Figure 5). In fact, 
the largest 30 groups cover 95% of the human genome (see also 58).  
The resulting synteny map can be used to clarify chromosomal rearrangements during early 
mammalian evolution. For example, limited comparative mapping previously revealed that the 
eutherian X chromosome contains an ‘X-conserved region’ (XCR) that corresponds to the ancestral 
therian X chromosome, and an ‘X-added region’ (XAR), which was translocated from an autosome 
after the split from Metatheria 59,60. The exact extent of the XCR has been unclear, however, due to 
unclear synteny to non-mammalian out-groups at its boundary 61. Using our high-resolution synteny 
map we can now confidently map the XAR-XCR fusion point to 46.85 Mb on human Xp11.3 
(Figure 6). 
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Figure 5. Reconstructed boreoeutherian synteny groups. All 42 ancestral synteny 
groups are shown sorted by size. For each group, the corresponding chromosomal 
assignments for mouse (M), rat (R), human (H), dog (D), opossum (O) and chicken 
(C) are shown.
 X inactivation 
In opossum and other metatherian mammals, dosage compensation for X-linked genes is achieved 
through inactivity of the paternally derived X chromosome in females 62. In contrast, eutherian 
dosage compensation involves inactivation of the paternal X chromosome at spermatogenesis, 
reactivation in the early embryo, followed by random and clonally stable inactivation of one of the 
two X chromosomes in each cell of female embryos 63. The random inactivation step is controlled 
by a complex locus known as the X inactivation center (XIC). In the early female embryo, the non-
coding XIST gene is transcribed from the XIC and coats one chromosome in cis to initiate silencing 
of the majority of its genes. It has been proposed that paternal X inactivation represents the 
ancestral therian dosage compensation system, and that random X inactivation is a recent 
innovation in the eutherian lineage 64,65. The opossum genome sequence provides the first 
opportunity to test major hypotheses about the evolution of this system. 
No XIST homolog in opossum. We searched all assembled and unassembled opossum 
WGS sequence for homology to the human and mouse XIC non-coding genes but, in agreement 
with a recent report 66, did not find any significant alignments. (In particular, we found no match to 
the highly conserved 150 bp region overlapping the critical exon 4 of XIST; this region is so 
strongly conserved in Eutheria that it should be readily detectable if present 40). Analysis of synteny 
in the regions surrounding the eutherian XIC also revealed that it has been disrupted by large-scale 
rearrangements (Figure 6) 40,41. In eutherians, the XIC is flanked by the ancient protein-coding 
genes CDX4-CHIC1 on one side and SLC16A2-RNF12 on the other side. In both chicken and frog 
these four genes are clustered in autosomal XIC Homologous Regions (which do not contain 
homologs of the XIC non-coding genes 66). On the opossum X chromosome, however, these two 
pairs of genes are separated by ~29 Mb (compared to ~750 Kb in human). Taken together, the 
evidence strongly suggests that XIST is specific to eutherians 40,41,66. 
 The Lyon repeat hypothesis.  LINE/L1 elements are of particular interest to the study of X 
inactivation. These TEs have been proposed to act as “boosters” for the spread of X inactivation in 
cis from the XIC (reviewed in 67). This hypothesis is supported in part by the observation that in 
human, LINE/L1 density is significantly elevated in the XCR (33%) where nearly all genes are 
inactivated, but approximates the autosomal density in the XAR (19%) where many genes escape 
inactivation (Figure 7) 61,68. In mouse, we found that the LINE/L1 density is elevated in both the 
XCR (35%) and the XAR (32%), which is consistent with the observation that genes that escape 
inactivation on the human XAR are often inactivated in mouse 69. As previously observed in 
human68, the LINE/L1 elevation in mouse is particularly dramatic among recent, lineage-specific 
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Figure 6. Opossum-human synteny for chromosome X. The dot plot shows 
correspondence between the human X chromosome and opossum at a resolution 
of 300 kb. Expanded views, at a resolution of 50-kb, of the XAR-XCR fusion and 
the XIC are shown on the bottom left and right, respectively. In the XIC region, the 
closest contig on the distal flank (*) was not anchored in the monDom5 assembly, 
but has been subsequently mapped near UPRT (opossum chromosome X ~55 Mb) 
by FISH [40].
  subfamilies (Figure 8). 
In contrast to human and mouse, the LINE/L1 density on the opossum X chromosome 
(22%) is significantly lower than in the eutherian XCR, and in fact slightly less than in the 
autosomal regions homologous to the eutherian XAR (23%). This difference between metatherian 
and eutherian X chromosomes is not readily explained by any simple correlation between LINE/L1 
density, recombination or mutation rates. We therefore conclude that LINE/L1 density is unlikely to 
be a critical factor for X inactivation in the metatherian lineage, and that the approximately 2-fold 
increase on the eutherian X chromosome may be directly related to the acquisition of XIST and 
random X inactivation. 
 Suppression of large-scale rearrangements. Comparative analyses have revealed that the 
structure of the human X chromosome has remained essentially unchanged since the eutherian 
radiation 10,20,61. A possible reason is that the requirement for XIST to spread across the chromosome 
from a central location has led to selection against structural rearrangements. For example, 
translocation of LINE/L1-poor XAR segments into the XCR could potentially disrupt inactivation 
at more distal loci. Consistent with this hypothesis, our synteny map reveals that the XAR and XCR 
homologous regions have experienced several major rearrangements both in the opossum lineage 
(~15 lineage-specific synteny breakpoints) and in the eutherian lineage prior to the eutherian 
radiation (~9 lineage-specific breakpoints). The low rate of rearrangements in the human lineage is 
therefore unlikely to be due to functions or sequences that were present on the ancestral therian X 
chromosome, or in early eutherian evolution. 
We note that unlike in human, the mouse X chromosome has experienced several 
rearrangements (with 15 lineage-specific synteny breakpoints), such that the XAR and XCR are no 
longer two separate segments. This would be consistent with the more comprehensive inactivation 
in the mouse imposing weaker constraints on rearrangement. Although little is known about the 
extent of X inactivation in dog or rat, their X chromosomes are also consistent with this hypothesis. 
The dog X chromosome is collinear with human and is enriched for LINE/L1 only in the XCR 
(33.4% vs. 16.8% for the XAR). The rat X chromosome has accumulated ~4 lineage-specific 
synteny breakpoints after the divergence from mouse 61, and is similarly enriched for LINE/L1 in 
both the XCR (36.7%) and the XAR (34.5%). 
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 Genes 
The gene content of metatherian and eutherian genomes provides key information about biological 
functions. We analyzed the gene content of the opossum genome and compared it with that of the 
human genome. We focused on instances of rapid divergence and duplication of protein-coding 
genes, which have led to lineage-specific gene complements 70.  
Gene catalog. We generated an initial catalogue of 18,648 predicted protein-coding genes 
and 946 non-coding genes (primarily snRNA, snoRNA, miRNA and rRNA) in opossum 34 
(Supplementary Note S9).  
We next characterized orthology and paralogy relationships between predicted protein-
coding genes in opossum and human 11 (Table 3). We could identify unambiguous human orthologs 
for 15,320 (82%) of the opossum predicted genes, with 12,898 cases having a single copy in each 
species (1:1 orthologs). Notably, we identified orthologs of key T cell lineage markers such as CD4 
and CD8, which had not been successfully identified by cloning in metatherian species 39. Most 
(2,704) of the remaining genes are homologous to human genes, but could not be assigned to 
orthologous groups with certainty.  
  A small number (624) of predicted opossum genes have no clear homolog among the 
human gene predictions. Inspection revealed that most of these are short (median length = 120 
amino acids, compared to 445 for 1:1 orthologs) and probably originate from pseudogenes or 
spurious open reading frames. Only 8 currently have strong evidence of representing functional 
genes without homologs in humans. These include CPD-photolyase, which is part of an ancestral 
photorepair system still active in opossum 71, malate synthase 72 and inosine/uridine hydrolase. The 
latter two are ancient genes not previously identified in a mammalian species. 
Conversely, approximately ~1,100 current gene predictions from human have no clear 
homolog in the initial opossum catalog. Of these, ~620 can be at least partially aligned to the 
opossum genome and may not have been annotated as genes due to imperfections in the draft 
assembly or high sequence divergence. In particular, manual re-annotation identified orthologs of 
several rapidly evolving cytokines 39. The remaining predictions are dominated by gene families 
known to have undergone expansion and rapid evolution in the human lineage, such as beta-
defensins and cancer-testis antigens. Based on our comparison, the opossum genome likely contains 
~18,000-20,000 protein-coding genes with the vast majority having eutherian orthologs. 
Divergence rates among orthologs. We calculated the synonymous substitution rate (KS) 
of 1:1 opossum-human orthologs to estimate the unconstrained divergence rate between the 
species7,10. The median value of KS is 1.02. Consistent with expectation, this value is substantially 
 216
M
ed
ia
n 
de
ns
ity
 in
 5
00
-k
b 
w
in
do
w
s
0.04
0.035
0.03
0.025
0.02
0.015
0.01
0
5 15 25 35 45
a
b
 
0 10 20 30 40
0.005
Divergence from subfamily consensus (%)
M
ed
ia
n 
de
ns
ity
 in
 5
00
-k
b 
w
in
do
w
s
0.035
0.03
0.025
0.02
0.015
0.01
0
5 15 25 35 450 10 20 30 40
0.005
XAR
Autosomes
XCR
XAR
Autosomes
XCR
Divergence from subfamily consensus (%)
Figure 8. LINE/L1 density in human and mouse by approximate age of insertion. 
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is particularly strong for relatively recent insertions. The XAR enrichment unique to 
mouse extends almost as far back as the XCR enrichment.
  
 
 
Table 3: Opossum and human gene predictions and projected gene counts 
 
Protein-coding genes Opossum 
Initial predictions 18,648 
Orthologs in human a 15,320 
   1:1 12,898 
   Many:1 1,016 
   1:Many 451 
   Many:Many 582 
Homologs in human, but unclear orthologyb 2,704 
No predicted homologs in human 624 
Projected total c 18,000-20,000
 
a Includes some cases where multiple transcripts have inconsistent phylogenies, or where the 
predicted ortholog is a putative pseudogene. 
b Includes members of highly duplicated gene families. 
c Accounting for missed annotations in opossum and removal of probable pseudogenes. 
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 smaller than the chicken-human KS value (1.7), with the ratio being very close to the ratio of prior 
estimates of the divergence times for the two lineages (~180 Mya for opossum and ~310 Mya for 
chicken). 
Notably, the median KS for orthologs located on the XCR is significantly elevated relative 
to orthologs located on autosomes in both species (1.2 vs. 1.0; p < 10-3) (see also 34,35). This is 
opposite of what is observed within Eutheria 10, but is consistent with the expectation that the higher 
(G+C)-content and recombination rate on the opossum X chromosome relative to its autosomes 
implies a higher rate of mutation 47. A similar elevation can also be detected in subtelomeric regions 
34. 
Innovation and turnover in gene families. We next studied the evolution of gene family 
expansions in the metatherian lineage. The opossum gene catalog contains 2,743 (15%) genes that 
have probably been involved in one or more duplication or gene conversion event since the last 
common ancestor with eutherian mammals, as inferred from low KS between the copies (median = 
0.41). The number of duplications is one-third fewer than the number of human lineage-specific 
duplications (4037; 20%), which may reflect the lower rate of segmental duplication in the opossum 
genome.  
We found a large number of lineage-specific copies of genes involved in sensory 
perception, such as the γ-crystallin family of eye lens proteins 73, and taste, odorant 74 and 
pheromone receptors. Other major lineage-specific duplications were found in the rapidly evolving 
KRAB zinc-finger family, and in genes related to toxin degradation and dietary adaptations, 
including cytochrome P450 and various gastric enzymes (see also 34).  
Innovation in the innate and adaptive immune systems is visible through substantial 
duplication or gene conversion involving the leukocyte receptor and natural killer complexes, 
immunoglobulins, type I interferons and defensins 32,39. The opossum genome also contains a new 
T-cell receptor (TCR) isotype that is expressed early in ontogeny, prior to conventional TCR and 
may provide early immune function in the altricial young 37.  
The opossum also shows some surprising gene family expansions that are without 
precedent in other vertebrates. Notable among these are multiple duplications of the nonsense 
mediated decay factors SMG5 and SMG6, and the pre-mRNA splicing factors, CWC22 and PRP18. 
The opossum genome also harbors two adjacent paralogous copies of DNA (cytosine-5)-
methyltransferase 1 (DNMT1), which catalyses methylation of CpG dinucleotides. It will be 
interesting to discover if specialized functions have been adopted by these paralogous genes.  
 220
 The patterns of evolution among duplicated genes largely mirror those observed in 
eutherians 34,70. The set of opossum paralogs is strongly biased towards recent duplications (KS < 
0.1) and in general have accumulated a disproportionately high number of nonsynonymous 
mutations (Figure 9). The median intra-species ratio of nonsynonymous to synonymous substitution 
rates  (KA / KS) between paralogs is 0.51, which is six-fold higher than the inter-species ratio seen 
for 1:1 orthologs (0.086). This is consistent with the rapid gene birth and death model 75, which 
predicts that duplicated genes either undergo functional divergence in response to positive selection 
or rapidly degenerate due to lack of evolutionary benefit. 
 
Conserved sequence elements 
The most surprising discovery to emerge from comparative analyses of eutherian genomes is the 
finding that the majority of evolutionarily conserved sequence does not represent protein-coding 
genes, but rather are conserved non-coding elements (CNEs) 7,10. The opossum genome provides a 
well-positioned outgroup to study the origin and evolution of these elements. 
For simplicity, we will refer to sequence elements as ‘amniote conserved elements’ if they 
are conserved between chicken and at least one of opossum or human; ‘eutherian conserved 
elements’ if they are conserved between human and at least one of mouse, rat or dog; and 
‘eutherian-specific elements’ if they are eutherian conserved sequence absent from both opossum 
and chicken. (‘Metatherian-specific elements’ surely also exist, but cannot be identified without 
additional metatherian genomes). 
Loss of amniote conserved elements in mammals. We first studied the extent to which 
amniote conserved elements have been lost in the human lineage. We focused on ~133,000 
conserved intervals between opossum and chicken (68 Mb), ~50% of which overlap protein-coding 
regions. 
Nearly all (97.5%) of these amniote conserved elements can be aligned to the human 
genome (Figure 10a). We reasoned that some of the remainder might be orthologous to sequence 
that lies within gaps in the current human assembly, or which had been missed by the initial 
genome-wide alignment. We therefore repeated the analysis, focusing only on amniote elements 
present in opossum and occurring in ‘ungapped intervals’ (that is, syntenic intervals between human 
and opossum that have no sequence gaps whatsoever); the ungapped intervals contain 63% of all 
conserved elements.  
We found that 99.0% of amniote elements in ungapped intervals could be unambiguously 
aligned to the human genome. The remaining 1.0% of amniote elements could not be found even by 
 221
 a more sensitive alignment algorithm (Figure 10b), and thus appears to have been lost in the human 
lineage.  
We also performed the converse analysis, by aligning the human and chicken genomes to 
identify amniote conserved elements potentially lost in opossum. The results were similar, with 
99.4% of elements in ungapped intervals being readily aligned to opossum.  
We conclude that the vast majority of amniote conserved elements encode such 
fundamental functions that they cannot be lost in either eutherians or metatherians. Nonetheless, the 
small fractions that have been lost correspond to more than 1,400 elements in total; it will be 
interesting to investigate their function and the consequence of their loss. Notably, although protein-
coding sequence comprises 50% of all amniote conserved elements, they comprise only 4% of the 
elements lost in one of the lineages. 
Eutherian-specific conserved elements. We next explored the appearance of novel 
conserved elements in the lineage leading from the common therian ancestor to the boreoeutherian 
ancestor, which could shed light on the origin of such elements in general. We identified a 
collection of eutherian conserved elements that cover 104 Mb (3.7%) of the human genome, ~29% 
of which overlap protein-coding sequence. 
Only a small proportion of human conserved protein-coding sequences could not be aligned 
to the opossum genome (1.1% in ungapped regions; Figure 10c). By contrast, a much larger 
proportion of human non-coding elements appear to be eutherian-specific (20.5% in ungapped 
regions). Taking the results from ungapped syntenic intervals as a conservative estimate for the 
proportion of total innovation, we conclude that approximately 14.8 Mb (1.1% of 30 Mb of coding 
sequence and 20.5% of 74 Mb of CNEs) of the eutherian conserved elements are eutherian-specific.  
The amount of apparent innovation is highest among short and moderately conserved 
elements (median length = 37 bp; median log2-odds score = 22), probably reflecting that shorter 
elements may more readily diverge beyond recognition (see also 36,76). Nonetheless, substantial 
innovation is apparent even among elements that are relatively long and unambiguously conserved 
within Eutheria. For example, the proportion of eutherian-specific elements is 8.1% among CNEs 
with phylo-HMM log2-odds score ≥ 60 (pnominal~10-18), which have a median length of 197 bp 
(Figure 10d).  
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Figure 10. Lineage-specific conserved sequence elements.  a, Phylogenetic 
distribution of  amniote conserved elements. b, Distribution for alignment scores of 
amniote elements, represented by opossum (human), to ungapped syntenic intervals 
in the human (opossum) genome, for shared (purple) and lineage-specific (orange) 
elements, and randomly permuted sequences of the same length and base 
composition (green). Ungapped syntenic intervals are flanked by two synteny anchors 
(white) and contain no assembly gaps (insert). c, Phylogenetic distribution of eutherian 
conserved elements. d, Distribution of alignment scores for eutherian CNEs (log2-odds 
≥ 60), represented by human, to ungapped syntenic intervals in the opossum genome, 
for shared (blue) and eutherian-specific (red) elements, and randomly permuted 
sequences of the same length and base composition (green). The bimodal distribution 
of scores confirm that highly conserved eutherian-specific elements have no significant 
homology in the syntenic opossum sequence. e, The miRNA hsa-mir-194-1 corresponds 
to an amniote CNE lost in opossum (orange). It is flanked by an unrelated amniote 
miRNA that is present in opossum (purple). f, A eutherian-specific CNE in the intron of 
BCL2 (red) overlaps a DNase hypersensitive site in human lymphocytes (black).
 Lineage-specific CNEs correspond to functional elements. To establish the biological 
relevance of lineage-specific CNEs, we examined the overlap of eutherian and amniote CNEs with 
two disparate sets of experimentally identified functional elements. If the eutherian-specific CNEs 
were enriched for false positive predictions, we would expect them to be substantially 
underrepresented among these functional elements. 
We first considered a set of known human miRNAs 77. Of the 51 miRNAs that overlap 
amniote CNEs, only one (hsa-mir-194-1 78) appears to have been lost in opossum (Figure 10e). (The 
mature form of this miRNA is identical to a second conserved miRNA, hsa-mir-194-2, which does 
have an opossum ortholog; this apparent redundancy may have made it more susceptible to lineage-
specific loss). Of the 183 miRNAs that overlap eutherian CNEs in ungapped syntenic regions, 27 
(15%) correspond to eutherian-specific elements. An example is an 87 bp eutherian-specific CNE 
corresponding to hsa-mir-28; it has previously been detected by Northern blot analysis in human 
and mouse, but not in any non-mammalian species 79.  
We next considered a genome-wide set of DNase hypersensitive sites from human 
lymphocytes, which represent a variety of putative regulatory elements 80. Of the 290 sites that 
overlap amniote CNEs present in human, none overlap instances that are absent in opossum. Of the 
2,041 sites that overlap eutherian CNEs in ungapped syntenic regions, 407 (20%) exclusively 
overlap eutherian-specific elements. An example is a 269 bp eutherian-specific CNE in intron 2 of 
the apoptosis regulator BCL2, which overlaps a DNase hypersensitive site, suggesting it has a cis-
regulatory function (Figure 10f).  
The fraction of eutherian CNEs overlapping DNase hypersensitive sites that are eutherian-
specific is strikingly similar to the fraction of all conserved non-coding sequence that is eutherian-
specific (20.5%). The fraction of miRNAs that correspond to eutherian-specific CNEs is slightly 
lower (15%), which is consistent with their higher average conservation scores. In particular, the 
results provide strong evidence that the majority of eutherian-specific CNEs are likely to be genuine 
functional elements.  
Lineage-specific CNEs associated with key developmental genes. We next explored the 
distribution of lineage-specific CNEs across the human genome. Overall, there is a strong regional 
correlation between the density of eutherian CNEs shared with opossum and the density of 
eutherian-specific CNEs (Spearman’s ρ = 0.82 for 1 Mb windows; Figure 11). The densities of 
amniote CNEs present or lost in opossum are also positively correlated (Spearman’s ρ = 0.30). 
Previous studies have shown that both eutherian and amniote CNEs are enriched in certain 
large, gene-poor regions surrounding genes that play key roles in development, primarily encoding 
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 transcription factors, morphogens and axon guidance receptors 10,81,82. For example, 35% of all 
eutherian CNEs and 49% of all amniote CNEs (in ungapped syntenic regions) lie within the 204 
largest clusters of CNEs in the human genome (described in 10). The ~240 key developmental genes 
in these regions have relatively low rates of amino acid divergence (median KA/KS = 0.03) and show 
little evidence of lineage-specific loss or duplications. In contrast, we found that the rate of gain and 
loss of CNEs in the same regions is only moderately (~30%) lower than elsewhere in the genome. 
Indeed, we identified more than 37,000 lineage-specific CNEs in these developmentally important 
regions.  
Because experimental studies of CNEs in these regions have frequently uncovered cis-
regulatory functions affecting the nearby developmental genes 16,82-85, the substantial innovation in 
these regions are candidates for genetic changes underlying differential morphological and 
neurological evolution in mammalian lineages. This pattern would be consistent with the notion that 
modification of regulatory networks has been a major force in the evolution of animal diversity 86-88.  
Eutherian-specific CNEs derived from transposable elements. In general, each 
eutherian-specific element must have arisen by one of three mechanisms: (i) divergence of an 
ancestral functional element to such an extent that it is no longer detectably similar to its ortholog in 
other clades; (ii) duplication of an ancestral functional element giving rise to an element without a 
1:1 ortholog in other clades; or (iii) evolution of a novel functional element from sequence that was 
absent or non-functional in the ancestral genome. 
The first mechanism is not likely to account for most of the eutherian-specific CNE 
sequence, at least among those with high conservation scores: if an ancient functional element 
underwent such rapid divergence at some point in the eutherian lineage that it is no longer 
detectable, then there should be concomitant ‘loss’ of an amniote conserved element. But, lineage-
specific loss appears to be relatively rare for both amniote elements, as shown above, and for 
eutherian elements 10.Tthe majority of eutherian-specific conserved elements therefore likely arose 
after the metatherian divergence, either by adaptive evolution of new or previously non-functional 
sequence, or by duplication of ancestral elements. 
One intriguing source for eutherian-specific CNEs is transposable elements (TEs). A 
number of researchers have argued that TEs offer an obvious and ideal substrate for the evolution of 
lineage-specific functions 89-93. TEs contain a variety of functional subunits that can be exapted and 
modified by the host genome 89,91, and they can mediate duplication of existing CNEs to distant 
genomic locations through transduction or chimerism 92. Individual instances of CNEs derived from 
TEs have been described previously 14,94,95. However, these cases together comprise only a trivial 
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 fraction of the CNEs in the human genome. It has thus been unclear whether the evolution of CNEs 
from TEs represents a general mechanism or a rare exception.  
When we examined the set of eutherian-specific CNEs, we found a striking overlap with 
TEs. In ungapped syntenic intervals, at least 16% of eutherian-specific CNEs overlap currently 
recognized TEs in human. The fraction is similar (14%) if we focus only on the most highly 
conserved elements (phylo-HMM log2-odds ≥ 60, see above). The overlapping TEs originate from 
most major transposon families found in eutherians (Table 4), and are not clearly differentiated 
from other CNEs in terms of distribution across the genome. This implies that TE-mediated 
evolution has been a significant creative force in the emergence of recent CNEs. The fact that 
sequences from TEs themselves can be identified within these CNEs also implies that exaptation of 
at least a portion of the TE, rather than simply incidental transduction of adjacent sequence, has 
been a frequent occurrence. 
In contrast, the eutherian CNEs that are present in opossum (and thus are more ancient) 
only rarely show overlap with recognizable TEs (~0.7%). We speculate that many of these CNEs 
also arose from TEs, but that they are difficult to recognize as such owing to substantial divergence. 
In fact, three large families of ancient paralogous CNEs have recently been discovered that were 
clearly distributed around the genome as part of TEs 96-98. In each case, only a minority of the 
family members still retain evidence of transposon-like features. We also previously described ~100 
smaller CNE families that pre-date the eutherian radiation, but which had no members associated 
with known TEs 98. For all but two of these families, we can find orthologs in the opossum genome 
for the majority of their members (Supplementary Note S10 and Figure 12). Moreover, closer 
inspection reveals previously unrecognized transposon-like features in several of these and other 
ancient CNE families 33. 
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Figure 11. Lineage-specific CNEs near key developmental genes. The densities of 
eutherian CNEs present (blue) or absent (red) in opossum are plotted in 1 Mb sliding 
windows across human chromosome 3. Peaks in the distributions often correspond 
to key developmental genes. The expanded view shows positions of amniote CNEs 
(purple), eutherian CNEs not overlapping amniote CNEs (blue) and eutherian-specific 
CNEs (orange) across a 500-kb gene desert surrounding the SOX2 transcription factor. 
One amniote CNE present in human has been lost in opossum (orange).
  
 
 
Table 4: Eutherian-specific conserved non-coding elements derived from 
transposons. 
 
 All Log2-odds ≥ 60 
Transposon family 
Number of 
CNEsa 
Overlapped 
length (kb)b 
Number of 
CNEsa 
Overlapped  
length (kb)b 
SINE/MIR 9,617 364 363 49 
LINE/L1 6,619 286 194 36 
LINE/L2 7,616 303 290 47 
LINE/CR1 2,520 136 203 36 
LINE/RTE 867 48 56 11 
LTR/MaLR 1,995 65 25 3.7 
LTR/ERV1 140 5.1 1 0.2 
LTR/ERVL 992 36 12 2.8 
DNA/Tip100 242 9.3 2 0.6 
DNA/MER1_type 2,427 93 54 9 
DNA/MER2_type 113 5.3 4 0.9 
DNA/Tc2 162 8.5 6 1.4 
DNA/Mariner 250 14.6 20 3.3 
DNA/AcHobo 151 5.1 3 0.3 
Unknown (MER121) 49 4 10 1.6 
Total 33,760 1,383 1,243 203 
Fraction of overlapped CNEs 16% 14% 
 
a Number of eutherian-specific CNEs in ungapped syntenic regions overlapping annotated TEs. 
b Total length of annotated TE sequence overlapping the CNEs (this is less than the total length of 
CNEs overlapping TE sequence). 
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Figure 12. Phylogenetic distribution of paralogous CNE families with 4 or more 
members in human. a, The observed distribution of the fraction of members of 
eutherian CNE families with identifiable orthologs in opossum (red) is significantly 
biased towards 0 and 1, compared to the distribution expected if the presence 
and absence of opossum orthologs was uniformly distributed between the families 
(black). b, Discounting completely eutherian-specific CNE families, the observed 
distribution of the fraction of members of eutherian CNE families with identifiable 
orthologs in chicken is also significantly biased towards 0 and 1.
 Strikingly, the proportion of eutherian-specific CNEs recognizable as TE-derived (16%) is 
very similar to the proportion of the total aligned sequence between the human, mouse and dog 
genomes recognizable as ancestral TEs (~17% of ~812 Mb; the vast majority of which is inactive) 
10. It is widely suspected that the latter proportion is a significant underestimate due to the difficulty 
of recognizing TEs that inserted more than ~100-200 Mya 7,33. In cases where the TE-related 
sequence hallmarks are not essential to the subsequent CNE, or where evolution of a new function 
did not follow immediately after the TE insertion, exapted sequences would be expected to have 
diverged to the point that they can no longer be readily recognized at a rate similar to inactive 
insertions. Since this appears to have occurred for most of the families of ancient CNEs described 
above, it is likely that the proportion of all eutherian (not just eutherian-specific) CNEs derived 
from TEs is substantially higher than the observed proportion of 16%. 
 
Conclusions  
The generation of the first complete genome sequence for a marsupial, Monodelphis domestica, 
provides an important resource for genetic analysis in this unique model organism, as well as the 
first reference sequence for metatherian mammals. Our initial results demonstrate the utility of this 
sequence for comparative analyses of the architecture and functional organization of mammalian 
genomes. 
The relationship of sequence composition, segmental duplications and transposable element 
density with the large and stable karyotype of the opossum genome has provided new support for an 
emerging, general model of chromosome evolution in mammals. In addition, comparison of the 
opossum and eutherian X chromosomes revealed that the evolution of random X inactivation 
correlate with acquisition of XIST, elevation in LINE/L1 density and suppression of large-scale 
rearrangements. 
Comparative analysis of protein-coding genes showed that the eutherian complement is 
largely conserved in opossum. Lineage-specific genes appear to be largely limited to gene families 
that are rapidly turning over in all mammals, although improved annotations that do not rely on 
homology to distant species will be required to complete the opossum gene catalog. Identification 
of a wide array of both conserved and lineage-specific immune genes is particularly notable because 
limited success in isolating these genes by cloning has led to claims that the metatherian immune 
system is relatively ‘primitive’. Availability of the genome sequence facilitates generation of 
species-specific reagents, which can be used to gain a better understanding of the metatherian 
immune response 39. 
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 At time-scales longer than the characteristic time of loss for gene duplications, it is clear 
that innovation in non-coding elements has been substantially more common relative to protein-
coding sequences, at least during eutherian evolution. The opossum genome sequence has provided 
the first estimate of the genome-wide rate of CNE innovation in eutherian evolution, as well as 
identification of tens of thousands of lineage-specific elements. It has also provided evidence that 
exaptation of TEs plays a much greater role in the evolution of novel CNEs than has been 
previously realized. 
Sequencing of additional metatherian genomes would be helpful for extending our results 
by allowing detection of metatherian-specific coding and non-coding elements. In addition, 
sampling of both the American and Australasian lineages would allow the reconstruction of the 
genome of their common ancestor, which would complement ongoing efforts for the boreoeutherian 
ancestral genome 58. The shorter genetic distance between the ancestral metatherian and 
boreoeutherian genomes (~0.6-7 substitutions per site) would facilitate a more comprehensive 
analysis of short and weakly conserved functional elements, for which the phylogenetic distribution 
and evolutionary origins are still difficult to ascertain. 
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 Methods 
 
WGS sequencing and assembly. Approximately 38.8 million high-quality sequence reads were 
derived from paired-end reads of 4- and 10-kb plasmids, fosmid and BAC clones, prepared from 
primary tissue DNA from a single female opossum. The reads were assembled using an interim 
version of ARACHNE2+ (http://www.broad.mit.edu/wga/). No comparative data was used in the 
assembly process. An intermediate assembly (monDom4) was used for the majority of the analyses 
reported here. The most recent version (monDom5) has identical sequence content and scaffold 
structure, but includes additional FISH data as described in Supplementary Note S2.  
SNP discovery. The SNP discovery was performed using ARACHNE by comparison of the two 
haplotypes derived from the opossum assembly using only high-quality discrepancies supported by 
two or more reads each. Sequence reads from three additional individuals were also aligned to the 
reference assembly, and SNPs were discovered using SSAHA-SNP 99. Linkage disequilibrium was 
assessed using Haploview 100. 
Genome alignment and comparisons. The assembly versions used in all comparative analyses 
were hg17 or hg18 (human), mm8 (mouse), rn4 (rat), canFam2 (dog), monDom4 or monDom5 
(opossum) and galGal3 (chicken). The number of aligned nucleotides was counted directly from 
unfiltered, pairwise BLASTZ alignments (obtained from http://genome.ucsc.edu). Synteny maps 
were generated using standard methods 7,10, starting from 320,000 reciprocal-best syntenic anchors 
identified by PatternHunter 104 (see Supplementary Note S7). Reconstruction of the 
boreoeutherian ancestral karyotype is described in Supplementary Note S8. 
Gene prediction and phylogeny. Opossum protein-coding and non-coding RNA genes were 
predicted using a modified version of the Ensembl genebuild pipeline 101, followed by several 
rounds of refinement using Exonerate 102 and manual curation. Orthology and paralogy were 
inferred using the PhyOP pipeline with all predicted opossum and human (Ensembl v40) gene 
transcripts as input and KS as the distance metric 11,34. Coding regions were aligned according to 
their amino acid sequences using BLASTP. KA and KS were estimated using the codeml program 
105, with default settings and the F3X4 codon frequency model. Functional categories were 
identified using the Gene Ontology 106. 
Conserved element prediction. Amniote conserved elements were inferred directly from pairwise 
BLASTZ alignments of chicken to opossum or human. Every alignment block with more than 75% 
identity for ≥100 bp was classified as an amniote conserved element. Eutherian conserved elements 
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 were inferred using phastCons 14 on BLASTZ/MULTIZ 107,108 alignments of human to mouse, rat 
and dog. The nonconserved model was fitted using phyloFit and the REV model on four-fold 
degenerate sites from 15,900 human RefSeqs projected onto the same alignments. A separate model 
was fitted for chromosome X. The scaling parameter for the conserved model was estimated by 
phastCons. Target coverage and expected element length were set to 0.125 and 12, respectively. 
Predicted eutherian conserved elements that did not fall within a 10-kb or longer synteny ‘net’ 103 
between human, mouse and dog were ignored. The coding status of each element was inferred from 
≥ 1 nucleotide overlap with entries in the UCSC human ‘known genes’ track 109. Proportions are 
reported out of the total length of the elements considered. TE-derived eutherian CNEs were 
inferred from more than 20% nucleotide overlap (median = 100% for all elements, 54% for 
elements with log2-odds ≥ 60) with human RepeatMasker annotations. 
Phylogeny of conserved elements. For amniote conserved elements, pair-wise best-in-genome 
BLASTZ alignments of opossum to human and vice versa were used to infer their phylogenetic 
distributions. For eutherian conserved elements, concomitant BLASTZ/MULTIZ alignments to 
opossum and chicken were used. A conserved element was called absent from a species if it was not 
covered by a single aligned nucleotide in the relevant BLASTZ alignment. 
Correction for assembly gaps and initial alignment artifacts. A conserved element was 
considered to be in an ungapped syntenic interval if it was flanked by two PatternHunter 
synteny anchors within 200-kb of each other on the same contigs in both the human and opossum 
assemblies. All conserved elements (represented by human or opossum, as appropriate) in ungapped 
syntenic intervals were realigned to the unmasked genome sequence (in opossum or human) using 
the water program (http://emboss.sourceforge.net) with default parameters and a gap extension 
penalty of 4. A randomly permuted version of each element was also realigned. For amniote 
conserved elements, only the longest interval with ≥ 75% identity from within the originating 
alignment block (see above) was realigned. Amniote elements were called lost, and eutherian 
elements were called eutherian-specific if their Smith-Waterman realignment score, divided by the 
length of the element, did not exceed the corresponding score for the permuted element plus one. 
(Conservatively calling an element found if its score simply exceeded the score of the permuted 
element resulted in 15% of eutherian CNEs in ungapped regions and 8% of those with log2-odds ≥ 
60 being called eutherian-specific). Putatively eutherian-specific elements, including XIST, were 
also searched against all opossum sequencing reads using discontiguous MegaBLAST. 
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 Supplementary Notes 
 
S1 BAC library construction 
A BAC library was constructed for the purpose of end-sequencing and subsequent anchoring of the 
WGS shotgun assembly. From the same partially inbred female that was selected for sequencing, a 
15X coverage BAC library (384,000 total clones, 175 kb average insert size) was constructed using 
EcoRI partial digests of agarose-embedded DNA. This library was designated VMRC18.  
For BAC library construction, nuclei were isolated from brain tissue using a Dounce 
homogenizer and sequential centrifugation steps. Nuclei were then embedded in Incert agarose and 
high molecular weight DNA was prepared in situ in the agarose. Generation of the library closely 
followed the cloning approach developed in P. de Jong’s laboratory 1. DNA fragments from the 
appropriate size fraction were cloned into the pCC1BAC vector (Epicentre Technologies). The 
ligation products were then transformed into DH10B (T1 resistant) electro-competent cells 
(Invitrogen). The library was arrayed into 1000 384-well microtiter dishes. Analysis of 120 
randomly selected BACs via pulsed field gel electrophoresis of NotI-digested DNA indicated that 
the average insert size was around 175 kb.   
This library and a previously constructed 10X coverage BAC library (VMRC6) from a male 
Monodelphis domestica specimen are available through the BACPAC Resources Center at the 
Children’s Hospital Oakland Research Institute (http://bacpac.chori.org/).   
 
S2 Assembly versions 
Starting in October 2004, a series of draft assemblies were made publicly available by the Broad 
Institute. The monDom4 assembly (January 2006), provided the basis for many of the analyses 
described in the main manuscript, while an updated version was subsequently released as 
monDom5 (October 2006). All versions can be accessed from GenBank using NCBI whole-genome 
shotgun project accession ID AAFR00000000, and from 
http://www.broad.mit.edu/ftp/pub/assemblies/mammals/monodelphis/. 
Both monDom4 and monDom5 have the same sequence content and contig/scaffold 
structure, but monDom5 incorporated additional FISH data (see S3), which increased the 
percentage of genome in anchored scaffolds from 94.6% to 96.5%. Three scaffolds were reassigned 
to different chromosomes: Scaffolds 141 (2.0 Mb) and 151 (1.8 Mb), which were erroneously 
mapped to chromosomes 4 and 7, respectively, in monDom4, were reassigned to chromosome X in 
monDom5. Scaffold 108 (4.1 Mb) was reassigned from chromosome 5 to chromosome 8. Nine 
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 additional scaffolds that were unanchored in monDom4 could be anchored in monDom5: 1 to 
chromosome 3, 1 to chromosome 4, 1 to chromosome 6, and 6 to chromosome X. In addition there 
was minor shuffling of scaffold order and orientation within all chromosomes.  
 
S3 Anchoring scaffolds 
The assembly was anchored using primarily FISH mapping data. The linkage map data (200 
SSLPs) was integrated with the FISH data and used to further order and orient supercontigs and to 
confirm the FISH data. For FISH mapping, two BAC clones were selected from every scaffold ≥ 1 
Mb in size, and one clone each from scaffolds ≥ 500 kb. Additional clones were selected if the 
initial selections did not give unambiguous order and orientation.  
In total, 402 BAC probes were prepared, hybridized and visualized using previously 
described protocols 2. Metaphase chromosomes were prepared by mitotic stimulation of peripheral 
lymphocytes from each of two male and two female Monodelphis domestica. The precise 
cytogenetic band location of each probe was determined from analysis of no fewer than 10 
metaphase spreads (20 chromosomes). Cytogenetic assignments were made according to the 
chromosome nomenclature of Pathak et al. 3.  
Of the 395 clones mapped by FISH, 384 (97.2%) had a unique cytogenetic location and 
were assigned to cytogenetic band. The remaining 11 (2.8%) clones mapped to more than one 
cytogenetic location. To order clones that mapped within each band, the FISH analysis was repeated 
using groups of five clones. Clones that demonstrated overlapping signal in metaphase FISH were 
also analyzed using interphase FISH to resolve the precise clone order where possible. The full 
details of the cytogenetic anchoring of the monDom5 genome assembly and detailed cytogenetic 
BAC map is published elsewhere 4.  
In addition, the assembly was compared to the fingerprint map generated in the laboratory 
of M. A. Marra. The order of BAC end read placement in the assembly was compared to the 
ordering of clone in the fingerprint map (no analysis of individual fingerprint bands was 
performed). The main purpose was to validate the order of BACs within scaffolds and to look for 
regions where a single fingerprint contig would contain multiple assembly scaffolds thereby 
enabling further ordering and orientation of the assembly scaffolds. No additional sequence could 
be ordered and oriented in this way. 
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 S4 Assembly quality control 
Several quality control steps were incorporated into the assembly process to ensure optimal 
continuity, structural integrity and nucleotide accuracy. 
The continuity of the assembly is reflected in the large uninterrupted sequence ‘contigs’ 
(N50 length = 108 kb), which are joined into much larger ‘scaffolds’ (N50 length = 59.8 Mb). The 
high degree of continuity implies that the majority of genes should be present without sequence 
gaps. The coverage of the euchromatic genome is estimated to be ~98%, based on the small 
proportion of the assembly residing within spanned gaps. 
The structural integrity of the assembly was assessed with a substantially revised version of 
the certification process first developed for the dog genome 5. As before, internal inconsistencies in 
the assembly were used as evidence, but unlike the previous process which classified regions as 
either ‘certified’ (essentially equivalent to finished sequence) or ‘uncertified’ (containing assembly 
errors), the new process allows regions that are highly likely to be misassembled to be distinguished 
from those which are merely possibly incorrect. 
The new certification model converts multiple forms of evidence into probabilities for the presence 
of different types of assembly errors across the genome: structural problems, where different 
regions of the genome have been joined (A simplified measure of this is the fraction of reads that 
are placed consistently with their partner. In the monDom5 genome assembly, 94.9% of reads have 
a consistent placement, which is similar to the 96.5% or reads with consistent placement in the dog 
genome.); local deletions and insertions, where either portions of the genome are missing or 
sequence from a different region has been inserted, but the overall structure is correct; and high 
quality base errors, where isolated bases are wrong, but reported as having a quality score of 50 or 
higher. 
Approximately 87% of the opossum sequence resides in regions that are certified to be free 
of structural assembly errors in the monDom5 assembly. The remaining 13% are declared as 
‘uncertified’, but only 2% of the genome is labeled as having a significant probability of containing 
an error. Of these latter regions, half reside in unanchored sequences. For comparison, by the new 
methodology 89% of the dog genome resides in certified regions in the most recent canFam2 
assembly, while only 3% have a significant probability of error.  
To assess nucleotide level accuracy, 11 finished BACs (1.66 Mb) from the sequenced 
opossum were obtained from Genbank. As each finished BAC contains only one haplotype, while 
the assembled genome contains a mixture of two haplotypes, we restricted the comparison to 
homozygous regions in the assembly. Such regions were located by grouping the SNPs identified 
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 from the two assembled haplotypes (see S5) into consecutive blocks of either ≥ 0.3 SNP/kb, or ≤ 
0.01 SNP/kb. Blocks of less than 100 kb were ignored, as were blocks with over 50% of the bases 
excluded due to gaps or uncertified sequences. Those blocks with rates ≤ 0.01 SNP/kb were 
considered homozygous and span 900-kb. The finished BACs were aligned to the assembly using 
an alignment tool built into ARACHNE. Those alignments falling within regions declared 
homozygous (0.9 Mb) were accepted for the base accuracy estimate. A somewhat higher error rate 
can be expected in polymorphic regions of the genome. 
 
S5 Single Nucleotide Polymorphism discovery 
SNPs were discovered in the Monodelphis domestica genome sequence as a standard part of the 
ARACHNE assembly process. Such SNPs represent cases where the single individual (I-1438) 
sequenced was heterozygous. Assembly SNPs were only called within certified regions (see S4), 
and if each allele were observed at least twice, implying that ≥ 4 separate shotgun reads aligned to 
the base containing the putative SNP.  
Additional SNPs were discovered by low-coverage shotgun sequencing of three stocks 
frequently used in laboratory research: B5539 (SFBR Population 1; 104,042 passing reads), D3508 
(SFBR Population 2; 100,000 reads), and C5181 (SFBR Population 5; 99,212 reads). Sequencing 
reads were trimmed to include only intervals of 250 bp or longer with a running 20 bp average 
quality score of at least 20. These intervals were aligned to the monDom4 assembly and SNPs were 
discovered using SSAHA-SNP 6 with a window size of 500bp and a ceiling of 0.02 SNP/bp in any 
single comparison. SNPs were required to have a Phred quality score of 23 or higher with a 
minimum quality score of 15 for each of five bases either side 7. SNPs are available at 
http://www.broad.mit.edu/mammals/opossum/ and have been submitted to dbSNP. 
To estimate the validation rate of the discovered SNPs, ten 200 kb regions (two regions 
each on chromosome 1 and 2 and one each on chromosome 3-8 and X) were chosen randomly from 
regions that included at least 40 SNPs and were more than 1 Mb away from a telomere. Within each 
region, 20 SNPs were selected for genotyping, with individual SNPs given preference if their source 
population was under-represented in the region. On the X chromosome, most available SNPs 
originated from the assembly. Validation genotyping was performed on a Sequenom Mass 
Spectrometry system. After removal of SNPs with low call rate (<75%), 126 SNPs remained. The 
average validation rate for the autosomes was 94.9% (n = 118). On chromosome X the validation 
rate was only 62% (n = 8), but this was likely due to an unfortunate choice of region, which turned 
out to be highly repetitive. The applicability of the SNP set for different laboratory stocks was 
 243
 assessed using representatives from SFBR Populations 1, 2, 3 and 5. The polymorphism rates 
within Populations 1 and 2 were 75% and 60% respectively, suggesting that SNPs can be randomly 
selected for mapping purposes within these populations. It should be noted, however, that of 18 
representatives of Population 2, twelve had some Population 1 admixture (<25%) and in the six 
pure Population 2 individuals, the polymorphism rate was 42%. The two parentals from each of 
Population 3 and 5 were genotyped, capturing the entire polymorphism rate within those lines 
(Population 3 at 10% and Population 5 at 4%). Note, however, that SNPs identified from Population 
5 are likely to be useful for crosses generated between it and either Population 1 or 2. 
We assessed linkage disequilibrium by calculating r2 across the 200kb regions both within 
and across populations, using Haploview 8. SNPs with a minor allele frequency of less than 0.04 
were excluded and SNPs at all distances were subjected to association analysis. The markers 
analyzed vary among populations, as Haploview automatically removes markers that are 
monomorphic within the group of individuals. Markers with a call rate of less than 75% were 
excluded. Linkage disequilibrium (r2 > 0.5) extended less than 15 kb across populations. 
 
S6 Representation of segmental duplications in the assembly 
To elucidate the effect of any bias in the analysis due to the draft nature of the opossum assembly, 
we first examined its overall read coverage landscape to try to locate trace “pile-ups”. Such pile-ups 
might suggest an over-collapsed region in the assembly that concealed segmental duplication. The 
largest “pile-ups” are due to the incorporation of mitochondrial sequence into the assembly. 
However, excluding these, even if one assumed that every over-sampled base was actually part of 
an over-collapsed duplication (surely a conservative upper bound), the overall duplication rate 
would be boosted by less than half (to < 2.6%)- leaving it well under the duplication rate for human. 
We next analyzed all traces that were omitted from the assembly. ~10% of the 38.8 million 
reads left after low quality and contaminating reads were not placed in the assembly. This is a 
similar fraction to that seen in other draft assemblies. The “Improved” ARACHNE WGS assembly 
of the mouse genome (see below) left ~13% of reads unplaced, and the most recent dog assembly 
(canFam2) left ~6% unplaced. For comparison, assembly of the highly repetitive and polymorphic 
fungus Puccinia graminis left 30-40% of reads unplaced (E. Mauceli, unpublished data). The 
opossum genome is therefore unlikely to contain large, euchromatic segmentally duplicated regions 
that completely failed to assemble. 
Finally, we examined a historical series of mouse assemblies to chart how our ability to 
discover segmental duplications changes with the quality of an assembly. The MGSCv3 assembly 
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 of the mouse genome 9 was primarily derived from whole genome shotgun traces, though it had a 
tiny amount of directed sequencing incorporated as well. This assembly was done with an older 
version of the ARACHNE software. An “Improved” assembly was done with the newer 
ARACHNE version that was used to assemble opossum, using the same whole genome shotgun 
traces as the MGSCv3 assembly, but omitting all directed sequencing data. Finally, we analyzed the 
most recent finished assembly available for mouse, mm8 (NCBI Build 36; February 2006), which 
benefits from several rounds of directed sequencing and finishing work. Improvements made to the 
ARACHNE assembler allow for better recognition of segmental duplications, even without any 
finishing. 5.3% of the finished mm8 mouse assembly is covered by segmental duplication, as 
compared to only 3.5% in the “Improved” assembly most comparable to the current opossum 
assembly. Even if there were a roughly similar inflation of segmental duplication coverage in a 
finished opossum assembly (from 1.7% in the current assembly to 2.6% in a speculative finished 
assembly), opossum would remain far less duplicated than either mouse or human. 
 
S7 Synteny maps and assignment of breakpoints to lineages 
We performed full genomic alignments of repeat masked sequence from the opossum genome 
(monDom5) against the human (hg18), dog (canFam2), mouse (mm8), rat (rn4) and chicken 
(galGal3) genomes using PatternHunter 10.  
We sought to align the opossum genome sequence with the human genome. We found that 
~10% (338 Mb) of the nucleotides can be directly aligned to the human sequence. This is much 
lower than for eutherians such as mouse (40%) or dog (~57%), likely reflecting both actual turnover 
of genomic sequence and some difficulty in detecting neutrally evolving segments due to nucleotide 
divergence 11,12. 
Following established methods 5,9, we identified collinear clusters of the identified synteny 
anchors, which were used to form larger syntenic segments in a hierarchical fashion. Segments that 
are larger than a given size in both genomes, and are comprised of at least 4 anchors at a given stage 
in the merging process, define a resolution-dependent, pair-wise synteny map between the two 
genomes.  
We next merged and reconciled the pair-wise synteny maps to create a 5-way multi-species 
map. We identified the locations along the opossum genome (the reference genome) where any of 
the four pair-wise maps indicated a synteny breakpoint, and then, from the opossum locations, 
identified the corresponding locations in each of the four non-reference genomes. This allowed each 
genomic interval in opossum bracketed by synteny breakpoints to be associated with, and oriented 
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 with respect to, a genomic interval in each of the four non-reference genomes. The resulting multi-
species synteny map represent blocks of homologous sequence that are present and contiguous in all 
five species. 
The multi-species synteny map can be represented as a graph: each block is represented by 
two nodes (- and +). Each pair of nodes have exactly one incoming and one outgoing edge for each 
species, which connect to the previous and next neighboring block edge in that species, 
respectively, as defined by their species-specific genomic ordering. This representation greatly 
simplifies the bookkeeping needed to relate breakpoints to evolutionary events. 
At a resolution of 500 kb, our 5-way maps consist of 616 blocks, representing 1,232 
synteny breakpoints. Most (75%) of these breakpoints are simple cases where the outgoing (or 
incoming) edges connect to only one or two neighboring blocks (chromosomal ends are not 
counted, so if the end of a block is the most distal segment of a chromosome in one or more species, 
there may be only one neighboring block). In these cases, synteny breakpoints can be 
unambiguously associated with a lineage, using the principle of parsimony. The remaining 
breakpoints connected to either three (19%) or more than three (6%) neighboring blocks. At higher 
resolutions, we observe more breakpoints (2,126 at 100 kb), but also a higher percentage of simple 
breakpoints (80%). 
We next focused specifically on the subset of simple cases involving purely internal 
breakpoints, i.e. those that do not involve a chromosome end in any of the five species (and 
therefore exactly two neighboring blocks). These represent 65% of all breakpoints in the 500 kb 
maps and 74% in the 100 kb maps. This subset is clearly associated with translocations and 
inversions (but not chromosome fusions or fissions), and can be unambiguously assigned to 
branches in the phylogenetic tree. This subset provides perhaps the most reliable estimate of the 
relative rates of such rearrangements between the eutherian lineages at any given resolution. Our 5-
way synteny map largely confirms the trends reported previously 5 and, in particular, the 
observation that although the human and dog lineages have generally experienced a similar number 
of rearrangements, the human lineage appears to have experienced a greater number of smaller 
rearrangements. We also confirm that most of the larger rearrangements (≥ 500 kb) that have 
occurred in the mouse and rat lineages appear to have occurred in their last common ancestor. 
Finally, we verified that these trends are qualitatively unchanged when internal breakpoints with 3 
alternative neighboring blocks are included (as multiple events). 
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 S8 Reconstruction of the ancestral boreoeutherian karyotype 
Much of the structure of the ancestral eutherian karyotype can be inferred from syntenic 
relationships among extant mammals. Given that most of the synteny breakpoints in our 5-way map 
were clearly lineage-specific, we reasoned that it would be possible to reconstruct genomic regions 
that  were once contiguous in the boroeutherian ancestor (ancestral to dog, human, mouse and rat) 
by joining syntenic blocks into larger groups by following their links in a hierarchical fashion that is 
consistent with the phylogenetic tree. 
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Chapter 5: Proteomic analysis of conserved non-coding elements 
 
In this chapter, we describe experiments designed to identify proteins that bind in a sequence-
specific manner to mammalian conserved non-coding sequences. 
Parts of this work has been published in 
Xie, X., Mikkelsen, T. S. et al. Systematic discovery of regulatory motifs in conserved regions 
of the human genome, including thousands of CTCF insulator sites. Proc Natl Acad Sci U S A 104, 
7145-7150 (2007) 
This publication is attached as Appendix 4. Supplementary data is available online from 
http://www.pnas.org 
The bait design and affinity capture protocols were initially formulated by Andreas Gnirke. The 
CNE motif discovery analysis was performed by Xiaohui Xie. 
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Conserved noncoding elements (CNEs) constitute the majority of sequences under purifying 
selection in the human genome, yet their function remains largely unknown. Experimental 
evidence suggests that many of these elements play regulatory roles, but little is known about 
regulatory motifs contained within them or the proteins that interact with them. Here, we 
describe hypothesis-generating experiments designed to identify proteins that bind specifically 
to CNEs or sequence motifs within them using in vitro DNA affinity capture and mass 
spectrometry.  
 Purification of proteins that recognize specific DNA sequences was first achieved by 
development of DNA affinity chromatography in the late 1980s 1-3. This led to the purification and 
subsequent cloning of abundant regulatory factors, such as Sp1 2-4. Recent advances in mass 
spectrometry has made it feasible to directly identify captured proteins. In 2004 Himeda and 
colleagues successfully identified Six4 as a regulator of the muscle creatine kinase enhancer using 
quantitative mass spectrometry and follow-up screening 5. Öztürk and colleagues similarly 
identified AP2γ as a rat placental lactogen II trophoblast cell-specific enhancer binding protein 6. 
 We have developed a variation of the DNA affinity chromatography method that relies on 
biotinylated DNA baits, streptavidin-coated magnetic beads and liquid-chromatography mass 
spectrometry (LCMS; see Methods). Composition of the capture buffer was at first optimized to 
reliably isolate recombinant cro protein using a lambda phage operator sequence and to capture 
sequence-specific transcription factors from ~1mg of nuclear extract using a human 
cytomegalovirus (CMV) promoter sequence (Table 1; A. Gnirke, unpublished). Here, we describe 
two experiments that relied on this method to gain insights into the putative functions of conserved 
non-coding sequences. 
 
Proteins binding to ultraconserved non-coding elements 
Ultraconserved elements (UCEs) are > 200 bp sequence elements with 100% nucleotide similarity 
between human, mouse and rat 7. Although they are clearly critical elements in the genome, little is 
known about their functions. 
 In order to obtain clues about the possible functions of UCEs, we arbitrarily selected 6 
ultraconserved elements that do not overlap known transcripts in the human or mouse genomes 
(Table1). We generated ~200-400 bp double-stranded DNA baits containing the full sequence of 
these elements by genomic PCR with 5’ biotinylated primers. We also generated a control bait pool  
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Table 1: Baits for DNA affinity capture using highly conserved non-coding 
elements 
 
Element Genome coordinates (hg18) Primers 
UC47 chr2:7692005-7692429 F: CTCGCATTAGACATGTGC 
R: GCTTGCCTCAGTCATACC 
UC191 chr6:51184719-51185009 F: AGGATGGATACAGAAACC 
R: CCAGCCTAGTTTCAGCGA 
UC249 chr9:8085650-8086080 F: GTGCCTTCTAAGGTGGAC 
R: TGTTAACAGCCAACTCTG 
UC320 chr11:8274340-8274781 F: ACAGCGTCCTTACCCTCT 
R: TGGAGTGAATTTCCCAAAC 
UC337 chr12:40035411-40035716 F: ATGGGCCCTACCCTTTTC 
R: GTATCAATGTTCTTGGTTTAC 
UC405 chr16:58132770-58133103 F: GGGAGGGGTAAAACTATTG 
R: AATAAGCCTTTAATAAAATCAG 
AT1 chr16:58133721-58134073 F: CCTTTATCTGCGTGGACCAT 
R: TGTGCTACTGCCACACATCA 
AT2 chr16:58146205-58146475 F: GGGGTAAATTGTTCCTGAAGC 
R: TGGTGAACAATTGAAAGACTGTG
AT3 chr13:55090168-55090564 F: AAGTTGCTCTGCTGCTAAGG 
R: TGAACCTTCAAGTCAGGAACC 
AT4 chr13:55088735-55089255 F: TGTGGGTAACATAACTGCTGCT 
R: TTGCTCAATGCACAAAGTCA 
AT5 chr13: 89192977-89193491 F: GCAACAATTCTGCAACTCTGA 
R: TTGGGAAGTTTCTCACTTGGA 
AT6 chr3:22251022-22251544 F: ACTGAAAAGCATCCCACCAT 
R: CCTTAGTGGCTCCACTTGAAA 
CMV promoter N/A F: CGGGGTCATTAGTTCATAG 
R: CCACCGTACACGCCTACCGCC 
 
UC, ultraconserved; AT, non-conserved AT-rich; CMV cytomegalovirus  
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by adding 5’ biotin to sheared total human genomic DNA. Affinity capture experiments in HeLa 
nuclear extract, using each bait pool and mass spectrometric identification of bound proteins, were 
performed as described in Methods.  
 Table 2 shows proteins for which at least two different peptides were identified in the eluate 
from at least one of the six UCE baits, but not in the eluate from either the sheared total DNA 
control or a no-bait control. Each of the UCE baits captured a distinct set of sequence-specific and 
non-specific DNA binding proteins. Several of these interactions are consistent with the known 
sequence specificity of individual factors and the sequence of the individual baits. For example, 
UC320 captured a protein corresponding to ‘Ets variant gene 6’, also known as ETV6 or TEL. This 
transcription factor is known to bind to the sequence motif [C/T]TTCC[T/G] 8. UC320 contains 
three exact matches to this motif, while only 2 of the other 5 UCE baits contain a single match each.  
 All 6 UCE baits captured many peptides corresponding to the CHD4 protein, also known as 
Mi2-β. CHD4 is a 218 kD protein that belongs to the SNF2/RAD54 helicase-like family. It contains 
a helicase/ATPase domain, a putative chromatin-binding chromodomain , and two PHD zing finger 
domains thought to be involved in protein-protein interactions 9 It is the major component of the 
abundant Mi2/NURD protein complex, which contains repressive chromatin remodeling and 
histone deacetylase activities 10 (we note that none of the other subunits of the complex were 
identified in the experiment). Two interchangeable components of the Mi2/NURD complex, MBD2 
and MBD3, appear to mediate recruitment to cytosine-methylated and sequence-specific targets, 
respectively. Notably, mouse embryonic stem (ES) cells lacking MBD3 show deficiencies in 
lineage-commitment when induced to differentiate 11,12. Because UCEs appear to be associated with 
the regulation of key developmental regulatory genes, we decided to further characterize the 
CHD4/UCE interaction. 
 In order to confirm the CHD4/UCE interaction we repeated the affinity capture experiment 
and probed resulting eluates with anti-CHD4 antibodies (Figure 1a). Because we noted that the 
UCE baits were relatively AT-rich (range: 59-72%) compared to the human genome sequence 
(mean: 58%), we also generated 6 control baits with similar AT-content from non-conserved 
regions of the human genome to rule out non-specific binding to AT-rich sequences (Table 1). 
Western blotting showed the presence of CHD4 in the HeLa nuclear extract and strong, specific 
bands from 3 out of 6 UCE baits (UC191, UC337, UC405). Weaker bands were also visible in 
eluates from the other 3 UCE baits, but only from 1 of the 6 AT-rich control baits (AT3), and not 
from the sheared total human DNA bait pool.  
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Figure 1. Sequence- and context-specific capture of CHD4 by ultraconserved 
elements in vitro. a, Anti-CHD4 Western blot in HeLa nuclear extract 
(NE) and eluates from affinity capture using ultraconserved (UC), non-conserved 
AT-rich (AT) or sheared total human DNA (STH) baits in HeLa NE.UC191, UC337 
and UC405 show strong bands, and UC47, UC249 and UC320 show weak 
bands consistent with specific CHD4 capture. b, CHD4 is detected in NE from 
HeLa and mouse embryonic stem (ES) cells, but capture occurs only in HeLa NE, 
suggesting that a secdonary factor is involved. Western blot of a non-specific 
protein (PARP) is shown for comparison. AT1-6 were pooled into one AT-rich 
control.
 Table 2: Proteins captured by UCE/CMV baits in HeLa nuclear extract 
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19
1 
U
C
24
9 
U
C
32
0 
U
C
33
7 
U
C
40
5 
C
M
V Unique 
Peptides Annotation 
++   +       ++ 7 CCAAT/enhancer binding protein beta 
++ +++ + + ++ +  54 CHD4 protein 
++           +++ 8 Transcription factor ATF-a 
+ ++   +   3 Unnamed protein product 
  +++   + +++ ++   47 AT motif-binding factor 1 
 ++ +++ +  +  24 BTB and CNC homology 1 
  ++ ++ ++       9 Purine-rich element binding protein B 
 ++ +     5 MAFF Transcription Factor 
  ++   + ++ ++   6 AT-rich interactive domain-containing protein 3A 
 ++  ++ ++ +  3 LIM domain binding 1 
  ++     + +   5 T-box 3 protein isoform 1 
 +   + +  3 POU2F1 protein 
  +           2 Hypothetical protein 
 +      2 Unnamed protein product 
    ++++   ++ ++   84 CUTL1 protein 
  ++    +++ 19 Regulatory factor X1 
    +     +   4 Replication protein A1, 70kDa 
  + ++    2 Unnamed protein product 
    + +       2 Novel protein similar to annexin A2 
   ++  ++  6 RNA-binding protein AUF1 
      ++       5 Ets variant gene 6 
   ++    3 Zinc finger protein 148 
      ++       3 Gag-Pro-Pol protein 
   ++    2 Nucleolar phosphoprotein p130 
      + +     4 GTF2I 
   +    2 LGALS7 protein 
      +       2 Homeobox protein A10 
    ++  +++ 14 Nuclear factor 1 C-type 
        +     2 ISL2 transcription factor 
     ++  5 Splicing factor proline/glutamine rich 
          +   10 Transcription factor AP-2 alpha 
      ++ 10 Nuclear receptor subfamily 2, group F, member 1 
            ++ 9 Orphan nuclear receptor TR4 
      ++ 7 Nuclear factor, interleukin 3 regulated 
            ++ 6 Jun B proto-oncogene 
      ++ 4 v-fos 
            ++ 3 CREB 
      ++ 3 FOS-like antigen 2 
            ++ 3 CCCTC-binding factor (zinc finger protein) 
      ++ 2 C-Rel proto-oncogene 
 
+,++,+++ indicates three (qualitative) degrees of protein abundance, from weak to strong. 
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In order to determine whether CHD4 capture was context-specific, we repeated the affinity 
capture experiment using three UCE baits, a pooled AT-rich control (AT1-AT6) and sheared total 
human DNA in nuclear extracts from both HeLa cells and mouse ES cells (Figure 1b). We again 
detected specific capture of CHD4 by the UCE baits from HeLa extracts. In contrast, while CHD4 
could be detected in mouse ES cell nuclear extract, it was not captured by any of the baits. 
 We conclude that the chromatin remodeling protein CHD4 can be recruited to 
ultraconserved non-coding elements in a sequence- and context-specific manner. Due to the lack of 
specific DNA binding domains in CHD4 itself, we speculate that the recruitment is mediated by a 
second factor that may not be present in mouse ES cells. Additional studies will be required to 
understand the relevance of these findings to the functions of UCEs in vivo. 
 
Proteins binding to conserved sequence motifs 
It seems likely that conserved non-coding elements spanning all levels of constraint are involved in 
gene regulation, and transgenic experiments have identified some CNEs that are capable of driving 
highly specific spatiotemporal gene expression patterns 13-16. However, little is known about 
regulatory motifs contained within CNEs or proteins that recognize these motifs. 
We have used the recent availability of sequences of 12 mammalian genomes to search for 
motifs that are enriched in CNE regions relative to the rest of the genome 17. We focused 
specifically on long regulatory motifs, between 12 and 22 bp, which provide a strong signal for 
motif discovery. We began by identifying k-mers (for k ≥ 12) that occur at a significantly higher 
frequency in the CNE sequences than in the remainder of the genome. We focused only on 
relatively long k-mers, because the expected number N of random occurrences in the entire CNE 
database is small (for example, n < 8 for k = 12). We identified a total of 69,810 enriched k-mers. 
An example is 5′-GTTGCCATGGAAAC-3′, which appears 698 times in the CNE data set, whereas 
only 27 sites are expected based on its genome-wide frequency (26-fold enrichment). We noticed 
that many of the enriched k-mers were closely related; therefore, we clustered them based on 
sequence similarity. The 69,810 enriched k-mers collapsed into 233 distinct groups, denoted LM1, 
LM2, etc. for “long motif.” For each of these motifs we derived a positional weight matrix (PWM) 
representation reflecting the distribution of 4 nucleotides at each position. The enrichment of each 
motif in the CNE data set was expressed in an enrichment score. The top 10 motifs are shown in 
Table 3. 
 For each of the 233 discovered motifs, we searched the entire human genome to identify 
conserved instances; that is, we identified all human sites matching the PWM and then found those  
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elorpfitoMDI
No. of
conserved
instances
False
positive
rate*
Conservation
rate, † %
Fold increase
in
conservation
rate ‡
Correlation between
cross-species
conservation and
motif prole
Positional
bias
around
TSS§
LM1 5,332 0.050 29.3 9.5 0.92
LM2 7,549 0.048 29.4 14.0 0.91
LM3 844 0.048 40.1 14.3 0.94
LM4 1,877 0.046 20.3 13.5 0.89 20.3
LM5 224 0.042 19.4 16.3 0.87
LM6 79 0.026 20.1 10.1 0.81 25.5
LM7 6,302 0.048 21.6 10.3 0.72
LM8 608 0.047 17.2 9.6 0.68
LM9 1,443 0.039 11.8 8.4 0.90 6.1
LM10 5,914 0.050 14.5 6.6 0.77
*The proportion of conserved instances expected to have occurred by chance.
†The proportion o nstances detected in human that are also conserved in orthologous regions of other mammals.
‡Compared to the conservation rates of control motifs.
§Fold enrichment on the number of motif sites located within 1 kb of TSS over those for control motifs. Only motifs with fold enrichment above 4 are shown.
Table 3: Properties of top 10 motifs discovered in conserved 
non-coding sequences
sites that show clear cross-species conservation. We found a total of 60,019 conserved instances, 
with roughly half residing within the CNE data set and roughly half in the remainder of the genome. 
Importantly, the approach of focusing on motifs enriched in the CNE data set identified many motif 
instances elsewhere in the genome. 
The number of conserved instances is highly uneven across the motifs (range 37-7,549, 
with mean of 266 and median of 61). Most motifs (67%) have <100 conserved instances. But, 
remarkably, the two motifs with the highest enrichment scores, LM1 and LM2, both have >5,000 
conserved instances in the human genome, suggesting a widespread functional role for these 
elements. We therefore focused on characterizing these two motifs. 
LM1 defines RFX1 binding sites. The most highly enriched motif LM1 is similar to the 
X-box motif, which has been extensively studied in yeast and nematodes 18,19. In yeast, more than 
three dozen X-box sites have been identified, and these sites have been shown to be bound by the 
Crt1 protein, an effector of the DNA damage checkpoint pathway 20. In Caenorhabditis elegans, 
>700 X-box sites have been computationally predicted, and several dozen of these sites have been 
demonstrated to be recognized by the DAF-19 protein, which is known to regulate genes involved 
in the development of sensory cilia 18. 
Individual instances of the X-box motif in vertebrates have been reported, but no systematic 
survey of X-box motifs in the human genome has been conducted. Approximately three dozen such 
sites have been reported to be bound by RFX family proteins, which are homologous to both Crt1 
and DAF-19 and contain a highly conserved winged helix DNA binding domain. The biochemically 
characterized consensus sequence for RFX binding shows similarity to the LM1 motif 21, although it 
contains less information. 
To identify proteins that bind LM1, we performed an affinity capture experiment. A 
biotinylated double-stranded DNA probe containing multiple copies of the LM1 motif and a 
degenerate control bait (see Methods) were incubated with HeLa nuclear extract. Table 4 shows the 
proteins for which at least 2 peptides were identified specifically in the LM1 eluate. RFX1 
(Regulatory factor X1) was the only known sequence-specific transcription factor captured in each 
of two independent experiments. Western blots with anti-RFX1 on an independent eluate confirmed 
that the protein indeed specifically binds LM1 (Figure 2a). 
 LM2 defines a common insulator site across the human genome. The most interesting 
case among the 233 discovered motifs is LM2. It has the largest number of conserved instances  
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TCTCCACCAGATGGCAGCA
TCCAGCAGGTGGCGCTGTC
CTGACCACCAGGTGGTGCGTT
TCTCTACCACATTGCAGCA
TCGAGCATGTAGCGCTGTC
CTGACTACCAAGTCGTGCGTT
Figure 2. Confirmation of CTCF and RFX1 binding by in vitro affinity capture.
a, CTCF was specifically captured by probes LM2a and LM2b constructed for 
the LM2 motif, wheras RFX1 was specifically captured by probes LM1a and 
LM1b constructed for the LM1 motif. b, The binding of CTCF to LM2, LM7 and
LM23 (left), but not to their corresponding mutant motifs with three core bases
altered (right).
(7,549) in the genome, with the vast majority being located far from TSSs. The LM2 motif is 19 
bases in length and does not match the reported consensus sequence of any known motif. 
 To obtain a hint regarding the possible function of the LM2 motif, we again performed an 
affinity capture experiment. A biotinylated double-stranded DNA probe containing multiple copies 
of the LM2 motif and a degenerate control bait (see Methods) were incubated with HeLa nuclear 
extract. Table 4 shows the proteins for which at least 2 peptides were identified specifically in the 
LM2 eluate. CTCF (CCCTC-binding factor) was the only known sequence-specific transcription 
factor captured in each of two independent experiments.  
CTCF, a protein containing 11 zinc-finger domains, is a major factor implicated in 
vertebrate insulator activities 22-24. An insulator is a DNA sequence element that prevents a 
regulatory protein binding to the control region of one gene from influencing the transcription of 
neighboring genes. When placed between an enhancer and a promoter, an insulator can block the 
interaction between the two. Several dozen insulator sites have been characterized, and almost all 
have been shown to contain CTCF binding sites. In some cases, the CTCF site has been directly 
shown to be both necessary and sufficient for enhancer blocking activities in heterologous settings. 
The known CTCF sites show considerable sequence variation, and no clear consensus sequence has 
been derived 23. The well studied CTCF sites in the IGF2/H19 locus show similarity to the LM2 
motif 25, although the similarity score is below our threshold used for detecting LM2 sites. 
To confirm that CTCF binds the LM2 motif we repeated the affinity capture experiment 
and probed the captured material with anti-CTCF antibodies. The results confirmed that CTCF does 
indeed bind the LM2 motif (Figure 2a). By contrast, mutation of the three core positions with the 
highest information content (positions 5, 10, and 13 of LM2; Figure 2b) completely abolished the 
binding of the CTCF protein. 
Given the sequence diversity among reported CTCF sites, we searched for additional motifs 
in our catalog that show substantial similarity to LM2. The motifs LM7 and LM23 are nearly 
identical in their first 14 positions, diverging only in the last four or five bases. The two additional 
motifs also have an unusually large number of conserved instances (6,302 for LM7 and 3,758 for 
LM23). Affinity-capture experiments using probes containing copies of the LM7 and LM23 motifs 
demonstrated that both motifs bind CTCF, whereas mutation of the three core positions with the 
highest information content completely abolish binding (Figure 2b). The three motifs, LM2, LM7, 
and LM23, will be referred to as a “supermotif,” LM2*. 
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Table 3: Proteins captured by LM motif baits in HeLa nuclear extract in two 
independent affinity capture experiments 
 
LM
1 
(1
) 
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(2
) 
LM
2 
(1
) 
LM
2 
(2
) 
Unique 
Peptides Annotation 
++++ ++ ++++   25 Unknown protein 
+++   +++   27 GTBP-N protein 
    +++ ++ 23 Bloom syndrome protein 
++   +++ ++ 16 SMARCA3 
++++ ++ +++ + 16 RecQ protein-like isoform 1 
+++ ++ +++   17 XRCC1 
++++ ++     12 Regulatory factor X1 
    +++   13 Topoisomerase (DNA) III alpha 
+++ ++ ++ ++ 11 DNA topoisomerase 
  ++   + 10 Heterogenous nuclear ribonucleoprotein U  
++   +++   8 C9orf76 
+++       7 Polynucleotide kinase-3'-phosphatase 
    ++   5 KIAA1596 
++       5 Werner syndrome protein 
    +++   5 DNA-directed RNA polymerase III largest subunit 
    ++ + 4 Dermcidin 
    +++ ++ 4 CCCTC-binding factor (zinc finger protein) 
        4 Heterogeneous nuclear ribonucleoprotein D, 
    +++   3 TPA: keratin 1b 
      + 2 polymerase (RNA) III (DNA directed) polypeptide B  
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Figure 3. Genes separated by predicted CTCF sites are less correlated in gene
expression. Correlation coefficients between neighboring gene pairs is shown in
terms of a probability density (a) and a cumulative distribution (b). Green line, 
correlation between all neighboring genes; red line, correlation between genes
separated by at least one CTCF site; gray shading, correlation between randomly
chosen gene pairs.
Altogether the LM2* motif has 14,987 conserved instances in the human genome (which is 
20-fold higher than for the corresponding control motifs). Strikingly, this comprises approximately 
one-fourth of the 60,019 sites for the complete catalog of 233 motifs. We propose that the vast 
majority of these sites are CTCF-binding sites and function as insulators. 
Although the predicted CTCF sites tend to be located far from gene starts, they are not 
randomly distributed across the genome. Instead, their distribution closely follows the distribution 
of genes, with a correlation coefficient of 0.6.  
We sought to test whether the predicted CTCF sites actually serve as functional insulators. 
Although it is possible to perform insulator assays on individual instances in a heterologous context, 
we were interested to assess the function of many CTCF sites in their natural context. If the 
predicted CTCF sites actually function as insulators, we reasoned that the presence of a CTCF site 
between two genes might “decouple” their gene expression. 
It is known that divergent gene pairs, transcribed in opposite directions with transcription 
start sites close to each other, tend to show correlated gene expression patterns 26,27. We therefore 
assembled a data set of 963 divergent gene pairs with intergene distance <20 kb and with expression 
values measured across 75 human tissues 28. As expected, the divergent gene pairs are more closely 
correlated in gene expression than randomly chosen gene pairs (Figure 3). When the cases are 
divided into gene pairs separated by a CTCF site (CTCF pairs, 80 cases) and those not separated by 
a CTCF site (non-CTCF pairs, 883 cases), the former show correlations that are essentially 
equivalent to the random background. Overall, 37% of non-CTCF pairs are strongly correlated 
(correlation coefficient ρ > 0.3). This proportion is 2-fold higher than the proportion of random 
genes pairs (12%) showing similarly strong correlation. By contrast, the proportion of CTCF pairs 
with similarly strong correlation is 16%, which is close to that seen for random gene pairs. This 
difference persists after correcting for small difference in the lengths of CTCF-containing and 
CTCF-non-containing intergenic regions. This provides strong evidence that the majority of the 
predicted CTCF sites do indeed function as insulators. 
 
Discussion 
Our results show that DNA affinity capture followed by mass spectrometry can be an effective 
approach to hypothesis-generating identification of proteins that interact with conserved non-coding 
elements or motifs. We have identified sequence- and context-specific interactions between six 
UCEs and CHD4, a component of the Mi2/NURD chromatin remodeling complex, suggesting a 
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possible role for UCEs in epigenetic regulation. Moreover, we have identified thousands of 
conserved CTCF binding sites with putative insulator functions in the human genome.  
 The sensitivity and versatility of this method can be expected to increase as new proteomic 
technologies are developed and adapted. For example, performing affinity capture experiments in 
nuclear extracts obtained from stable isotope labeling of amino acids in culture (SILAC) 29 should 
yield a more quantitative representation of differential capture by target and control baits. 
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Methods 
 
CNE motif analysis. Performed as described in 17. 
Baits. UCE and AT-rich baits were generated by genomic PCR from total human DNA using 
5’biotinylated primers (Table 1; Operon, Huntsville, AL). Sheared total human DNA control baits 
were generated by mechanical shearing, size-selection to 200-400 bp, end-repair and 5’ 
biotinylation. CNE motif baits were generated by synthesizing, annealing and extending two 
5’biotinylated oligos containing two instances of the motif and an overlapping M13 F site (Operon, 
Huntsville, AL). Probe sequences were as follows: LM1, TGTTGCTTAGCAACA; LM2, 
CCACTAGATGGCAGTGTT; degenerate control, NNNNNNNNNNNNN (each position in each 
molecule contains a random nucleotide). For Western blot validation, probe sequences are as 
follows: LM1a, GCTGTTGCCATGGAAACCAG; LM1b, TGTTGCTTAGCAACA; LM2a, 
CCACCAGGTGGCAGCAGA; LM2b, CCACTAGATGGCAGTGTT. For testing the binding of 
CTCF to LM2, LM7, and LM23 and their mutants we used the following probes: LM2, 
TCTCCACCAGATGGCAGCA; LM2 mutant, TCTCTACCACATTGCAGCA; LM7, 
TCCAGCAGGTGGCGCTGTC; LM7 mutant, TCGAGCATGTAGCGCTGTC; LM23, 
CTGACCACCAGGTGGTGCTGTT; LM23 mutant, CTGACTACCAAGTCGTGCTGTT. 
Affinity capture. In all experiments, 1 pmol of 5’-biotinylated bait was mixed with 1.4 mg of HeLa 
(Promega, Madison, WI) or mouse ES cell nuclear extract in binding buffer (50 mM Tris pH 8, 150 
mM NaCl, 0.25 mM EDTA, 0.5 mM DTT, 0.1% Tween-20, 0.5 mg/mL BSA, 200 μg/mL poly-
dI/dC) in a total volume of 700 μl. Mixtures were incubated for 1 hour at room temperature on a 
rotator. Ten μl of Streptavidin-coated magnetic beads (Dynal, Carlsbad, CA) was added to each 
tube, and the mixture was further incubated for 30 min at room temperature on a rotator. Beads 
were spun for 5 s at 1000g and then captured using a magnetic pull-down system. Beads were 
washed 3 X 700 μL in binding buffer without poly-dI/dC and then 4 X 700 μl in binding buffer 
without poly-dI/dC or BSA. The supernatant was discarded and proteins were eluted by boiling in 
Laemmli buffer (+10 mM DTT). 
Mass spectrometry. Proteins were purified by non-resolving SDS-PAGE. The gel band between 
the loading well and the visible buffer/oligonucleotide fraction was cut out, reduced, alkylated, 
digested with trypsin according to standard proteomics practices 30, and the resulting peptides were 
analyzed by LCMS on an Orbitrap (ThermoFisher) mass spectrometer as described in 31. Database 
searching was performed by the Mascot software package against the REFSEQ database of human 
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or mouse proteins. Reported hits were required to have at least 2 distinct peptide matches in the 
target bait eluate and none from the control or no-bait eluates. 
Immunodetection. Captured proteins were eluted by boiling in XT reducing loading buffer 
(BioRad), separated by SDS/PAGE, and assayed by colorimetric Western blots using polyclonal 
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) for CHD4 (sc-11378), RFXI (sc-10652) or 
CTCF (sc-5916). 
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Chapter 6: Maps of histone methylation at  
key developmental loci 
 
In this chapter, we describe the first ChIP-chip analysis of histone H3 lysine 4 and 27 tri-
methylation across developmental loci in pluripotent and differentiated cells. 
This work was first published as part of 
Bernstein, B. E., Mikkelsen, T. S. et al. A Bivalent Chromatin Structure Marks Key Developmental 
Genes in Embryonic Stem Cells. Cell 125, 315-326 (2006). 
The full publication is attached as Appendix 5. Supplementary data is available online from 
http://www.cell.com 
The text in this chapter was primarily written by Bradley E. Bernstein. Contributions from this 
thesis work includes experimental design and selection of target regions, analysis of 
H3K4me3/H3K27me3 overlap with transcription factors, CpG islands and transposable elements, 
and analysis of correlations between expression levels and chromatin state. 
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 The most highly conserved non-coding elements (HCNEs) in mammalian genomes cluster 
within regions enriched for genes encoding developmentally important transcription factors 
(TFs). This suggests that HCNE-rich regions may contain key regulatory controls involved in 
development. We explored this by examining histone methylation patterns in mouse 
embryonic stem (ES) cells across 56 large HCNE-rich loci. Here, we report the discovery of a 
novel chromatin modification pattern, termed ‘bivalent domains’, consisting of large regions 
of H3 lysine 27 methylation harboring smaller regions of H3 lysine 4 methylation. In ES cells, 
bivalent domains tend to coincide with TF genes expressed at low levels. Few bivalent 
domains are retained in differentiated cells. We propose that bivalent domains silence 
developmental genes in ES cells while keeping them poised to be activated upon 
differentiation. We also found a striking correspondence between genome sequence and 
histone methylation patterns in ES cells, which becomes notably weaker in differentiated cells. 
Together, these results highlight the importance of DNA sequence in defining the initial 
epigenetic landscape, and suggest a novel chromatin-based mechanism for maintaining 
pluripotency. 
Epigenetic regulation of gene expression is mediated in part by post-translational 
modifications of histone proteins, which in turn modulate chromatin structure (Jenuwein and Allis, 
2001; Margueron et al., 2005). The core histones H2A, H2B, H3 and H4 are subject to dozens of 
different modifications, including acetylation, methylation and phosphorylation. Histone H3 lysine 
4 and lysine 27  tri-methylation (H3K4me3/H3K27me3) are of particular interest as these 
modifications are catalyzed, respectively, by trithorax- and polycomb-group proteins, which 
mediate mitotic inheritance of lineage-specific gene expression programs and have key 
developmental functions (Ringrose and Paro, 2004). H3K4me3 positively regulates transcription by 
recruiting nucleosome remodeling enzymes and histone acetylases (Pray-Grant et al., 2005; Santos-
Rosa et al., 2003; Sims et al., 2005; Wysocka et al., 2005), while H3K27me3 negatively regulates 
transcription by promoting a compact chromatin structure (Francis et al., 2004; Ringrose et al., 
2004). 
 Various observations suggest that chromatin undergoes important alterations during 
mammalian development (Delaval and Feil, 2004; Margueron et al., 2005; Sado and Ferguson-
Smith, 2005). Embryonic stem (ES) cell differentiation is accompanied by changes in chromatin 
accessibility at several key developmental genes, including a large-scale opening of the HoxB locus 
(Chambeyron and Bickmore, 2004; Perry et al., 2004). Furthermore, polycomb-group proteins play 
an essential role in maintaining the pluripotent state of ES cells and show markedly reduced 
  271
 expression upon differentiation (O'Carroll et al., 2001; Silva et al., 2003; Valk-Lingbeek et al., 
2004). However, little is known about the overall structure of ES cell chromatin, how it is 
established, or how it contributes to the maintenance of pluripotency (Szutorisz and Dillon, 2005). 
Large-scale studies of mammalian chromatin have recently become possible with the 
combination of chromatin immunoprecipitation (ChIP) and DNA microarrays. Initial studies in 
primary fibroblasts revealed thousands of genomic sites associated with H3K4me3 (Bernstein et al., 
2005; Kim et al., 2005). The vast majority show a ‘punctate’ pattern, typically occurring at sites of 
~1-2 kb near promoters of active genes. H3K27me3 is implicated in X-chromosome inactivation 
and imprinting (Plath et al., 2003; Umlauf et al., 2004). However, little is known about the overall 
genomic distribution of this repressive mark. Gene-specific and limited microarray studies have 
reported that H3K27me3 tends to occur at punctate sites near promoters of repressed genes (Cao 
and Zhang, 2004; Kimura et al., 2004; Kirmizis et al., 2004; Koyanagi et al., 2005). Based on such 
studies, the distributions of H3K4me3 and H3K27me3 have been thought to be non-overlapping. 
A notable exception to the punctate pattern of histone modifications is evident at the Hox 
gene clusters: these loci contain large, cell type-specific H3K4me3 regions, up to 60 kb in length, 
that overlay multiple Hox genes (Bernstein et al., 2005; Guenther et al., 2005). These regions likely 
reflect accessible chromatin domains established during embryonic development to maintain Hox 
gene expression programs (Chambeyron and Bickmore, 2004). However, the extent to which large 
domains of chromatin modifications represent a general feature of mammalian genomes remains 
unclear. 
Recent studies have revealed that the most highly conserved non-coding elements (HCNEs) 
in mammalian genomes cluster within ~200 HCNE-rich genomic loci, which include all four Hox 
clusters (Bejerano et al., 2004; Lindblad-Toh et al., 2005; Nobrega et al., 2003; Woolfe et al., 
2005). These regions tend to be gene-poor, but are highly enriched for genes encoding transcription 
factors (TFs) implicated in embryonic development. 
These findings suggested that the HCNE-rich regions or the TF genes within them may 
contain key epigenetic regulatory controls involved in development.  We explored this by mapping 
histone methylation patterns in mouse ES cells across 61 large regions (~2.5% of the genome). The 
results reveal a novel chromatin modification pattern that we term ‘bivalent domains’, consisting of 
large regions of H3K27me3 harboring smaller regions of H3K4me3. In ES cells, bivalent domains 
frequently overlay developmental TF genes expressed at very low levels. Bivalent domains tend to 
resolve during ES cell differentiation and, in differentiated cells, developmental genes are typically 
marked by broad regions selectively enriched for either H3K27me3 or H3K4me3. We suggest that 
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 bivalent domains silence developmental genes in ES cells while keeping them poised for activation. 
Finally, we analyzed the relationship between histone methylation patterns and the underlying DNA 
sequence in both ES and differentiated cells. This analysis suggests that DNA sequence largely 
defines the initial epigenetic state in ES cells, which is subsequently altered upon differentiation, 
presumably in response to lineage-specific gene expression programs and environmental cues. 
 
Bivalent domains in ES cells contain repressive and activating histone modifications 
H3K4me3 and H3K27me3 patterns in ES cells were examined across a subset of HCNE-rich loci 
using a combination of ChIP and tiling oligonucleotide arrays. The arrays tile 61 large genomic 
regions, totaling 60.3 Mb, at a density of approximately one probe per 30 bases. The regions consist 
of the four Hox clusters (1.3 Mb encoding 43 genes), 52 additional HCNE-rich regions (55 Mb 
encoding 169 genes) and five ‘control’ regions that do not show high HCNE density (4 Mb 
encoding 95 genes). We isolated genomic DNA associated with either H3K4me3 or H3K27me3 by 
immunoprecipitating cross-linked chromatin, and hybridized these DNA fractions to the tiling 
arrays (see Methods). We identified regions of H3K4me3 or H3K27me3 by comparing these 
hybridization results to those obtained for total genomic DNA. Experiments were performed in 
duplicate and analyzed using previously validated criteria (Bernstein et al., 2005). The resulting 
maps of ES cell chromatin (Figure 1) show a number of important features, many of which were 
unexpected.  
We found a total of 343 sites of H3K4me3, ranging in size from 1 kb to 14 kb with a 
median size of 3.4 kb. Of these, 63% correspond to transcription start sites (TSSs) of known genes. 
Conversely, 80% of the TSSs are covered by H3K4me3 sites. Because H3K4me3 sites and TSSs 
each cover only ~2% of the genomic regions, this concordance is highly significant. We and others 
have previously noted a global concordance between H3K4me3 methylated sites and TSSs in 
differentiated mammalian cells (Bernstein et al., 2005; Kim et al., 2005).  
We also found 192 H3K27me3 sites across these regions. These tend to affect much larger 
genomic regions than the H3K4me3 sites. The median H3K27me3 site is smaller in the control 
regions (5 kb), but is twice as large in the HCNE-rich regions (10 kb) and still larger in the Hox 
regions (18 kb). Overall, 75% of H3K27me3 sites are larger than 5 kb. We will refer to these large 
regions as ‘H3K27me3 domains’. There are 123 in the HCNE regions, 14 in the Hox regions and 7 
in the control regions.  
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Figure 1. Representative views of histone methylation patterns across HCNE-rich 
regions in ES and differentiated cells. (a) Dlx1-Dlx2 gene cluster (Region 47, 112 kb). 
For each cell type, tracks show regions associated with H3K27me3 (red), H3K4me3 
(green) or both modifications (yellow). For ES cells only, the raw p-value signals for 
H3K27me3 and H3K4me3  are also shown. Genes (TSSs indicated by long vertical 
lines; exons indicated as dark), CpG islands, HCNEs (Lindblad-Toh et al., 2005), and 
transposable elements are also shown. (b) En2, Shh, Hlxb9 (Region 48, 1.5 Mb). 
Expanded views show 75 kb around En2, Shh and Hlxb9. (c) Ebf1 (Region 31, 497 kb). 
Note expansive H3K27me3 methylated region in the Neuro2a cells.
 Comparison of the two datasets revealed many instances of a previously undescribed 
pattern of chromatin modifications: three-quarters of the H3K27me3 domains contain H3K4me3 
sites within them. These regions thus harbor both a ‘repressive’ and an ‘activating’ chromatin 
modification; we therefore termed them ‘bivalent domains’. There are 95 in the HCNE regions, 9 in 
the Hox regions and 5 in the control regions.  
 
Bivalent domains overlay developmentally-important TF genes in HCNE-rich regions  
Roughly three-quarters of the bivalent domains in the HCNE regions (69/95) overlap TSSs of 
known genes, with the H3K4me3 sites typically positioned directly at the TSS. Of these, a full 93% 
(64/69) occur at genes that encode TFs, including Sox, Fox, Pax, Irx and Pou gene family members, 
even though TF genes make up only half of the genes in the regions examined (Figure 2). The 26 
bivalent domains that do not occur at known TSSs are also of interest: four occur at the 3’-ends of 
developmental genes (Npas3, Meis2, Pax2 and Wnt8b), and ten occur in locations that show strong 
evidence of encoding transcripts (including the presence of mRNA transcripts, CpG islands and 
high levels of sequence conservation). Among the non-TF genes associated with bivalent domains 
are genes implicated in neural development, such as Fgf8 and Prok1. In the Hox regions, the 
observed bivalent domains are especially large and overlap multiple TSSs of known genes, all of 
which are TFs. The 5 bivalent domains in the control regions are quite short; they all overlap gene 
starts, although these genes do not encode TFs. 
The chromatin analysis thus reveals that ES cells contain many bivalent domains. In 
HCNE-rich regions, these domains are particularly large and highly enriched at developmentally 
important genes that establish cell identity. The bivalent nature of this novel epigenetic pattern 
raises the possibility that the associated genes are poised in a bipotential state, which may be 
resolved differently in different cell lineages. This hypothesis predicts that differentiated cells 
would contain few, if any, bivalent domains.  
 
In differentiated cells, TF genes are marked by either repressive or activating modifications  
We next examined H3K4me3 and H3K27me3 patterns across these same regions in a collection of 
differentiated cell types, including mouse embryonic fibroblasts (MEFs), mouse primary lung 
fibroblasts (MLFs), C2C12 myoblasts and Neuro2a neuroblastoma cells. We identified multiple 
H3K4me3 and H3K27me3 sites in each cell type, many of which are large. However, in marked 
contrast to the ES cell data, we found few bivalent domains in the differentiated cells (6 in MEFs, 1 
in MLFs, 13 in myoblasts, 12 in the neuroblastoma cells).  
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Figure 2. Histone methylation status of transcription start sites (TSSs). Methylation 
status of chromatin associated with each of the 332 known TSSs in the 61 examined 
regions in ES cells, C2C12 myoblasts, Neuro2a neuroblastoma cells, mouse embryonic 
fibroblasts (MEF), and mouse lung fibroblasts (MLF). Yellow indicates the presence of a 
bivalent domain, red indicates K27me3 only, green indicates K4me3 only, and black 
indicates no detected methylation. Blue rows in the three rightmost columns indicate 
which TSSs correspond to TF genes, contain CpG islands or coincide with transposon-
exclusion zones (TEZs). This figure shows the strong correlation among bivalent 
domains, transcription factors, CpG islands and TEZs.
 Thus, the majority of TSSs that show bivalent domains in ES cells do not show bivalent 
domains in the differentiated cells. The vast majority of these (93/97) instead show either a 
H3K27me3 or a H3K4me3 site in at least one of the differentiated cell types (Figure 2). These 
‘monovalent’ sites tend to be large, with median sizes of 19.4 kb and 7.4 kb for H3K27me3 and 
H3K4me3, respectively (compared to 6.7 kb and 3.4 kb over all sites in the differentiated cells). 
Thus, bivalent domains appear largely specific to ES cells and, in differentiated cells, 
developmental genes are instead frequently organized within expansive regions showing either 
repressive or activating modifications. 
 
Bivalent modification patterns in ES cells confirmed by alternate techniques 
Given the novel nature of the bivalent domains, we sought to confirm our results using completely 
different reagents and protocols (see Methods). Specifically, we used an independent source of ES 
cells with a different genotype; we refer to the first source as ES1 and the second as ES2. We also 
used an alternative ChIP procedure carried out on micrococcal nuclease-digested nucleosomes that 
had not been subjected to cross-linking, and performed the immunoprecipitation with antisera from 
different sources. This alternative ChIP technique controls for nucleosome occupancy and is not 
subject to potential artifacts of cross-linking and sonication (O'Neill and Turner, 2003). The ES2 
data also show a large number of bivalent domains, and these correspond closely to those seen in 
the ES1 data. Importantly, 94 of the 95 bivalent domains in the ES2 data correspond to bivalent 
domains in the ES1 cells.  
We next sought to test whether the observed bivalent domain structure truly reflects the 
simultaneous presence of both H3K4me3 and H3K27me3 methylation on the same physical 
chromosomes. It is formally possible that the bivalent domains could instead reflect the presence of 
either two subpopulations with distinct character, or one population alternating between two states. 
To rule out this possibility, we carried out a sequential ChIP in which ES cell chromatin was 
immunoprecipitated first with H3K27me3 antibody and second with H3K4me3 antibody. This 
sequential purification is designed to retain only chromatin that concomitantly carries both kinds of 
modifications. Using real-time PCR, we tested three TSSs associated with bivalent domains (Irx2, 
Dlx1 and Hlxb9). Each was significantly enriched relative to the controls (genes enriched for only 
H3K27me3 or only H3K4me3; Figure 3; Methods). For example, Irx2 is enriched ~10-fold in the 
primary (H3K27me3) ChIP and further enriched >30-fold (relative to control) in the secondary 
(H3K4me3) ChIP. This shows that a large proportion of Irx2 chromatin that contains H3K27me3 
methylation also contains H3K4me3 – at least 30-fold more than the control. (Of course, the  
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Figure 3. Characterization of the Irx2 bivalent domain. ChIP and sequential ChIP 
were used to examine the methylation status of the Irx2 TSS (bivalent), the Tcf4 
TSS (H3K4me3 only) and a site upstream of HoxA3 (H3K27me3 only). (a) Real-
time PCR ratios reflect the enrichment of indicated sites when ES cells are 
subjected to ChIP with H3K4me3 or H3K27me3 antibodies. (b) Corresponding 
data for mouse lung fibroblasts. (c) Real-time PCR ratios reflect the relative 
enrichment of indicated sites after sequential immunoprecipitations with H3K27me3 
antibody and then H3K4me3 antibody (see Methods). (d) PCR products amplified 
from control (input) DNA, H3K27me3 ChIP DNA and H3K27me3-H3K4me3 
sequential ChIP DNA are shown; the same samples were used as real-time 
PCR template in (c). The sequential chip results indicate that, in ES cells, the 
Irx2 TSS is associated with chromatin marked by both H3K27me3 and H3K4me3.
 technique cannot prove that 100% of all Irx2 species in ES cells carry both modifications). We also 
tested the Irx2 TSS by repeating the sequential ChIP with the order of the immunoprecipitations 
reversed, and again found significant enrichment (see Methods). Together, the experiments above 
suggest that the bivalent domains accurately represent the epigenetic state at many TF genes in ES 
cells. 
 
Bivalent domains are associated with low levels of gene expression 
To gain insight into the functional significance of bivalent domains, we examined gene expression 
patterns across the three cell types with at least 10 bivalent domains (ES cells, C2C12, Neuro2a) 
(Mogass et al., 2004; Perez-Iratxeta et al., 2005; Tomczak et al., 2004). Within each cell type, we 
found that genes marked by H3K4me3 tend to be expressed at significantly higher levels than those 
associated with H3K27me3 (Figure 4). A good example is the Ebf1 gene, which encodes a TF 
implicated in multiple differentiation pathways: in MEFs, MLFs and myoblasts it is expressed at 
relatively high levels (Koli et al., 2004; Schraets et al., 2003) and is associated with relatively large 
H3K4me3 sites (> 5 kb), while in neuroblastoma cells it is expressed at an essentially undetectable 
level and is associated with an expansive H3K27me3 domain. 
We next examined the expression levels of genes marked by bivalent domains. These show 
low levels of expression, with the overall distribution being similar to that for genes marked by 
H3K27me3 alone (Figure 4). Thus, the presence of H3K4me3 at a TSS is typically associated with 
high gene activity when it occurs in the absence of H3K27me3, but with low gene activity when it 
occurs together with H3K27me3 (that is, the repressive effect of H3K27me3 appears to be epistatic 
to the activating effect of H3K4me3 in a bivalent domain). These results raise the possibility that 
bivalent domains function to silence developmental genes in ES cells while keeping them poised for 
induction upon initiation of specific developmental pathways. 
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Figure 4. Gene expression as a function of histone methylation status. Box plot 
showing 25th, 50th and 75th percentile expression levels in ES cells, myoblasts 
and neuroblastoma cells for genes associated with no histone methylation, 
H3K27me3, bivalent domains or H3K4me3. Whiskers show 2.5th and 97.5th 
percentiles. Expression data (y-axis) were determined from published 
expression profiles (Mogass et al., 2004; Perez-Iratxeta et al., 2005; 
Tomczak et al., 2004), uniformly normalized to a mean of 0 and a standard 
deviation of 1 for all probes on each array.
 Resolution of bivalent domains during ES cell differentiation 
Our analysis of ES cells and four differentiated cell types suggests that bivalent domains are 
characteristic of pluripotent cells, that they silence developmental genes while keeping them poised, 
and that they tend to resolve upon ES cell differentiation into H3K4me3 or H3K27me3, in 
accordance with associated changes in gene expression. We sought to study whether the resolution 
of bivalent domains can be observed soon after ES cell differentiation, by examining a 
differentiated cell type obtained directly from ES cells. Specifically, we differentiated ES cells 
along a neural pathway in serum-free culture and generated a homogenous population of 
multipotent neural precursor cells maintained in FGF2- and EGF-containing media, as described 
previously (Conti et al., 2005). We focused on seven genes associated with bivalent domains in ES 
cells (Figure 5). These include three genes that are markedly induced during differentiation (Nkx2-
2, Sox21 and Zfpm2), one that is weakly induced (Dlx1), and three that are not induced (Pax5, 
Lbx1h, and Evx1). Using ChIP and real-time PCR, we first confirmed that the TSS of each gene is 
indeed associated with both H3K4me3 and H3K27me3 in the original ES cells, and then examined 
the methylation status of these genes in the neural precursor cells. For the three genes whose 
expression is markedly induced, the TSS becomes specifically associated with H3K4me3 in these 
differentiated cells. For the three genes that are not induced, the TSS becomes specifically 
associated with H3K27me3. Interestingly, the TSS of the weakly induced gene, Dlx1, remains 
associated with both methylation marks in the neural precursor cells, although the H3K4me3 signal 
is significantly stronger. These data support a model in which bivalent domains are largely specific 
to ES cells and tend to resolve upon ES cell differentiation according to pathway-specific gene 
expression programs. 
 
Epigenetic modifications in ES cells strongly correlate with underlying DNA sequence 
Because the H3K4me3 and H3K27me3 sites in ES cells seem to represent important initial 
conditions for development, we searched for DNA sequence features that might underlie or predict 
the establishment of these epigenetic marks across the genome.  
We found a strong positive correlation between the presence of H3K4me3 in ES cells and 
the density of CpG dinucleotides in the underlying DNA sequence (median 8% vs. 2% expected; 
Figure S2). Strikingly, 95% of TSSs with H3K4me3 sites have CpG islands, and 91% of TSSs with 
CpG islands also have H3K4me3 sites (rphi = 0.73 see Methods). Moreover, the lengths of the two 
features are significantly correlated where they overlap (r = 0.50). By contrast, the correlation is 
weaker in the differentiated cells; this is primarily due to loss of H3K4me3 at 20-35% of CpG  
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Figure 5. Resolution of bivalent domains during ES cell differentiation. ES cells 
were differentiated along a neural pathway in serum-free culture, and a 
homogenous population of multipotent neural precursor cells were maintained 
in FGF2- and EGF-containing media, as described (Conti et al., 2005). Several
loci showing bivalent domains in ES cells were examined in the differentiated 
cells. (a) Expression levels (relative to Gapdh) were determined by RT-PCR for 
the indicated genes in ES cells and in neural precursors. The methlyation states 
of the indicated genes were determined by ChIP and real-time PCR in ES cells 
(b) and in neural precursors (c). The data suggest that bivalent domains tend to 
resolve during ES cell differentiation in accordance with associated changes 
in gene expression.
 islands (rphi = 0.40 for MLFs). We note that a recent genome-wide study (Roh et al., 2005) of 
histone H3 acetylation in T-cells observed a correlation with CpG islands, at a similar level to that 
seen in the differentiated cells examined here. 
We also found that H3K27me3 methylated regions in ES cells show a strikingly low 
density of transposon-derived sequence (median 6% vs. 22% expected; Figures 6, 7). The most 
extreme example is found at the Hox clusters, which are known to have the lowest density of 
transposon-derived sequence in the mouse and human genomes (Lander et al., 2001; Waterston et 
al., 2002) and which have the largest H3K27me3 domains (up to 141 kb) in our sample. Most of the 
H3K27me3 domains contain long stretches (>10 kb) with little or no identifiable transposon-derived 
sequence. We defined such regions as ‘transposon exclusion zones’ (TEZs; see Methods). Within 
the loci examined here, 89% of TSSs with a TEZ have a H3K27me3 domain in ES cells, and 73% 
of TSSs with a H3K27me3 domain have a TEZ (rphi = 0.69). The lengths of these two features are 
significantly correlated where they overlap (r = 0.78). Interestingly, we note that the small number 
of H3K27me3 domains found only in differentiated cells do not appear to overlap particularly 
transposon-poor sequence (e.g., Figure 1c). 
We tested if the TEZs represent conserved genomic features by examining the orthologous 
sequence in the human and dog genome. The frequency of lineage-specific repeats provides an 
independent test of whether transposons are tolerated in these regions. The TEZs show a clear 
deficit of lineage-specific repeats in both human (1.3% vs. 15.2% expected) and dog (1.0% vs. 
9.1% expected), confirming that this property is strongly conserved across mammals. 
We then searched for TEZs across the entire mouse genome. We identified 710 TEZs, of 
which 328 overlap TSSs of known genes. Strikingly, the vast majority of these genes encode 
developmental and tissue-specific TFs (189), proteins involved in axon guidance and neuronal 
function (65), and other cell signaling-related proteins such as growth factors (25), including Fgf8, 
Fgf10, Fgf14 and the imprinted gene Igf2. Notably, they include ~70% of the developmental 
regulators previously identified within 204 HCNE-rich loci (Lindblad-Toh et al., 2005). We predict 
that most of these genes will harbor H3K27me3 domains or bivalent domains in ES cells. 
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Figure 6. Cumulative distributions of density of CpG dinucleodites within H3K4me3
sites in ES cells (a), transposon-derived nucleotides within H3K27me3 domains in
ES cells (b) and HCNE nucleotides within H3K27me3 domains in ES cells (c). The
clue curves gives the observed distributions. The red solid curves give the median,
and the dotted red cureves give the 2.5th and 97.5th percentiles over 10,000
randomized sites/domains.
 Co-localization of bivalent domains with Oct4 and Nanog 
Finally, we examined the relationship of bivalent domains to the reported binding sites of certain 
pluripotent TFs. A recent genomic analysis in human ES cells found that Oct4, Nanog and Sox2 are 
frequently associated with developmentally-important genes (Boyer et al., 2005). We mapped the 
Oct4, Nanog and Sox2 binding sites reported in that study to orthologous positions in the mouse 
genome and examined their overlap with bivalent domains. About 50% of bivalent domains 
coincide with binding sites of at least one of the pluripotent TFs, a highly significant 
correspondence (p < 10-9). The correlation is primarily due to Oct4 and Nanog, and actually 
becomes more significant when Sox2 is removed from the analysis. Interestingly, although many of 
the genes targeted by these pluripotent factors are actively expressed in ES cells, those that are also 
associated with a bivalent domain tend to be silenced (p < 5 x 10-3). This suggests that the bivalent 
domains may override any activation potential these TFs might have, but also raises the possibility 
that the pluripotent TFs may help keep these genes in a poised state. Notably, a full 50% of bivalent 
domains are not associated with any of the three pluripotent TFs. It will be interesting to see if these 
coincide with binding sites of other important TFs. 
 
Discussion 
Our results shed light on chromatin structure in ES cells and raise intriguing hypotheses about its 
establishment and function during development. The bivalent domains reported here have many 
notable features: they combine both ‘repressive’ and ‘activating’ modifications; they are highly 
enriched in ES cells relative to differentiated cells; and they are associated with genes encoding TFs 
with roles in embryonic development and lineage specification. In differentiated cells, these TF 
genes instead tend to be associated with large regions carrying either an activating or a repressive 
methylation mark. We propose that bivalent domains silence developmental genes in ES cells, 
while preserving their potential to become activated upon initiation of specific differentiation 
programs. Bivalent domains may be related to a phenomenon observed at the bithorax complex in 
early fly development, where silenced polycomb response elements are nonetheless associated with 
trithorax-group proteins and low-level transcription. Remarkably, both of these activities appear to 
be required for subsequent gene activation during development (Orlando et al., 1998; Schmitt et al., 
2005). By analogy, H3K4me3 within bivalent domains and associated trithorax activities may keep 
silenced developmental genes poised in ES cells. Our analyses of differentiated cells suggest that 
bivalent domains largely resolve during differentiation into large regions of either H3K27me3 or 
H3K4me3. These modified regions may provide a robust epigenetic memory to maintain lineage- 
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TSSs of all genes (blue) and genes with H3K27me3 domains in ES cells
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 specific expression or repression of these critical genes. Their large size would ensure that each 
daughter chromosome would likely inherit a substantial proportion of the modified histones, which 
could then promote similar modification of new histones in the immediate vicinity (Henikoff et al., 
2004; van Steensel, 2005). 
A fundamental issue remains to understand the mechanism by which the initial conditions 
are established in ES cells. The analysis here suggests that some of the answer can be read directly 
from the genome sequence. The strong association of H3K4me3 with CpG islands may well be 
directly causal, inasmuch as H3K4me3 methylases are known to associate with CpG-rich DNA 
(Ayton et al., 2004; Lee and Skalnik, 2005). The strong association of H3K27me3 with transposon-
poor zones may instead reflect strong evolutionary pressure against the presence of transposon-
derived sequence in these regions. Repetitive sequences are subject to repressive epigenetic 
modifications (Arnaud et al., 2000; Lippman et al., 2004; Martens et al., 2005), which might 
interfere with the function of the bivalent domains and thus be eliminated by selection. It has been 
reported previously that imprinted loci, while significantly depleted for short interspersed 
transposable elements (SINEs), are permissive to L1 long interspersed transposable elements 
(LINEs) (Greally, 2002). In contrast, we find that both classes of transposons tend to be excluded 
from regions associated with H3K27me3 or bivalent domains in ES cells. The direct signal for 
H3K27me3 remains unclear (although we cannot exclude the possibility that the deficit of 
transposon-related chromatin modifications in some fashion promotes the recruitment of 
H3K27me3 methylases). The correlations between the histone modifications and the genomic 
features are notably weaker in differentiated cells (Bernstein et al., 2005).  We suggest that, while 
the embryonic state may be largely defined by DNA sequence, it is subsequently altered in response 
to lineage-specific transcriptional programs and environmental cues, and epigenetically maintained.  
Our study was motivated by the suspicion that HCNE-rich regions might be particularly 
fruitful targets for studying chromatin structure in ES cells; this has indeed been borne out. 
However, the results here do not explain the functional role of the HCNEs themselves. Although 
HCNEs are markedly enriched at many of the H3K27me3 and H3K4me3 sites in both ES and 
differentiated cells, they tend overall to be distributed across much larger regions. One possibility is 
that some of the HCNEs dictate chromosome conformation or nuclear localization in a manner that 
facilitates robust gene regulation and/or epigenetic switching (Chambeyron and Bickmore, 2004; 
Kosak and Groudine, 2004). 
Further studies will be needed to define bivalent domains and related features. It will be 
important to examine the entire genome in ES cells, as well as to follow their fate during 
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 development and differentiation. In particular, it will be interesting to determine whether the 
bivalent domains that persist following ES cell differentiation correspond to genes that remain 
poised for later induction. In addition, it will be valuable to characterize the bivalent domains with 
respect to other epigenetic modifications and the binding sites of additional TFs. We note that 
preliminary studies of H3 Lys9 methylation show no evidence of association with bivalent domains. 
A deeper understanding of bivalent domains may shed light on mechanisms that underlie 
the maintenance of pluripotency in ES cells and lineage fidelity in differentiated cells. Moreover, a 
comprehensive inventory of the presence or absence of bivalent domains over key developmental 
genes may provide valuable markers of cell identity and differentiation potential, both in normal 
and pathologic states. 
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 Methods 
 
Cell culture. The first source of ES cells (ES1 above) were V6.5 murine ES cells (genotype 
129SvJae x C57BL/6; male; passages 10-15). They were cultivated in 5% CO2 at 37 degrees on 
irradiated MEFs in DMEM containing 15% FCS, leukemia-inhibiting factor, 
penicillin/streptomycin, L-glutamine, and nonessential amino acids (Rideout et al., 2000). At least 
2-3 passages under feeder-free conditions on 0.2% gelatin were used to exclude feeder 
contamination. The second source of ES cells (ES2 above, used for micrococcal nuclease-digestion 
ChIP) were SF1-1 murine ES cells (genotype C57BL/6 x M. spretus F1; male; passages 11-16) 
grown in the absence of feeder cells on gelatinized plates as described previously (Umlauf et al., 
2004). Primary mouse lung fibroblasts (ATCC: # CCL-206), mouse embryonic fibroblasts (10.5 
p.c.) immortalized with polyoma virus, C2C12 myoblasts (ATCC #CRL-1772) and Neuro2a 
neuroblastoma cells (ATCC #CCL-131) were grown in DMEM with 10% fetal bovine serum and 
penicillin/streptomycin at 37 degrees, 5% CO2. ES1 cells were differentiated into pan-neural 
precursor cells through embryoid body formation for 4 days and selection in ITSFn media for 5-7 
days (Okabe et al., 1996) and maintained  in FGF2 and EGF2 (both from R&D Systems) 
containing, chemically defined media as described (Conti et al., 2005). These cells uniformly 
express nestin and Sox2 and upon growth factor withdrawal differentiate into neurons, astrocytes 
and oligodendrocytes (Brustle et al., 1999; Conti et al., 2005). 
Chromatin immunoprecipitation. ChIP experiments for all cells except ES2 were carried out 
essentially as described in ref. (Bernstein et al., 2005) and at http://www.upstate.com. Briefly, ~5 x 
107 cells were trypsinized, fixed with 1% formaldehyde, resuspended in Lysis Buffer and sonicated 
with a Branson 250 Sonifier to fragment chromatin to a size range of 200 to 1000 bases. Solubilized 
chromatin was diluted 10-fold in ChIP dilution buffer and, after removal of a control aliquot (whole 
cell extract), incubated at 4°C overnight with antibodies against H3K4me3 (Abcam #8580), 
H3K27me3 (Upstate #07-449). Immune complexes were precipitated with Protein A-sepharose, 
washed sequentially with Low Salt Immune Complex Wash, LiCl Immune Complex Wash, and TE, 
and then eluted in Elution Buffer. After cross-link reversal and Proteinase K treatment, ChIP and 
control DNA samples were extracted with phenol-chloroform, precipitated under ethanol, treated 
with RNase and Calf Intestinal Alkaline Phosphatase, and then purified with a MinElute Kit 
(Qiagen). 
Micrococcal nuclease-ChIP. Chromatin fragments of one to six nucleosomes were prepared from 
unfixed chromatin from ES2 cells by micrococcal nuclease digestion, and immunoprecipitated 
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 using antibody against H3K27me3 (Plath et al., 2003) or H3K4me2 (Upstate #07-030) as described 
(Umlauf et al., 2004). Immunoprecipitated DNA fractions and a control DNA sample enriched 
using unrelated antisera (against chicken antibodies) were extracted and purified as described above 
for the immunoprecipitated cross-linked chromatin. 
Sequential ChIP. Cross-linked chromatin from ES cells was immunoprecipitated with antibody 
against H3K27me3 as described above (see “Chromatin immunoprecipitation”) with the exception 
that chromatin was eluted from beads with a modified elution buffer containing 30mM DTT, 
500mM NaCl and 0.1% SDS at 37 degrees. Eluted chromatin was diluted 50-fold, subjected to a 
second immunoprecipitation with antibody against tri-methyl H3K4me3, and eluted with standard 
Elution Buffer. Thus isolated DNA and unenriched control DNA were extracted and purified as 
described above. In addition, a ‘reverse’ sequential ChIP was carried out as above, except that 
chromatin was immunoprecipitated first with antibody against H3K4me3 and then with antibody 
against H3K27me3. 
Real-time PCR. PCR primers were designed to amplify fragments 150 to 200 base pairs in size 
from the indicated genomic regions. Real-time PCR was carried out using Quantitect SYBR green 
PCR mix (Qiagen) in an MJ Research Opticon Instrument. For ChIP experiments, fold-enrichments 
were determined in real-time PCR reactions using either 0.5 ng ChIP DNA or 0.5 ng control DNA 
as template by the 2-ΔCT method described in the Applied Biosystems User Bulletin. For sequential 
ChIP experiments, 2 μl sequential ChIP DNA or 2 μl of a 1:100 dilution of control DNA were used 
as template, and relative fold-enrichments were determined by the 2-ΔΔCT method, using HoxA3 Ups 
as the normalizer. Each ratio was determined from two independent ChIP or sequential ChIP assays, 
each evaluated in duplicate by real-time PCR. Primers corresponding to the TSSs of Irx2, Dlx1 and 
Hlxb9 were used to test for enrichment of lysine 9 di- and tri-methylation, relative to a Gapdh 
control. RT-PCR was used to measure gene expression in ES cells and neural precursor cells. 
Briefly, RNA was isolated using an RNeasy mini kit (Qiagen), reverse transcribed and quantified on 
the 7000 ABI detection system using SYBR green PCR master mix. 
Region selection and array design. We previously reported the identification of 204 HCNE-rich 
loci on the basis of sequence comparisons across the human, mouse and dog genomes (Lindblad-
Toh et al., 2005). For the current study, we selected 56 HCNE-rich loci, including all four Hox 
clusters, as well as 5 control loci that do not show unusual HCNE density (ACTA locus, 
chromosome 19 gene desert, CD33r locus, BRCA1 locus, cytokine cluster). Each region was 
mapped to the mouse genome using coordinates from version mm5. Custom tiling arrays for these 
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 regions were obtained from Affymetrix Inc. (Santa Clara, CA). These contain approximately 1.3 
million probe pairs, each consisting of perfect match (PM) and single base mismatch (MM) 25-mer 
oligonucleotides, designed to interrogate the unique sequence in these regions at approximately 30 
base intervals (Kapranov et al., 2002).  
DNA amplification and array hybridization. ChIP and control DNA samples were amplified by 
in vitro transcription, converted into double-stranded cDNA with random primers, fragmented with 
DNase I, and end-labeled with biotin as described (Bernstein et al., 2005; Cawley et al., 2004; 
Kapranov et al., 2002). ChIP and control samples (5-10 μg) were hybridized to separate 
oligonucleotide arrays. Arrays were hybridized 16-18 hours at 45°C, washed, stained, and scanned 
using an Affymetrix GeneChip Scanner 3000 7G as described in the Affymetrix Expression 
Analysis Technical Manual. 
Analysis of ChIP tiling array data. Raw array data were quantile-normalized, scaled and analyzed 
as described  (Bernstein et al., 2005; Cawley et al., 2004). Briefly, (PM, MM) intensity pairs were 
mapped to the genome using exact 25-mer matching to mm5. A Wilcoxon Rank Sum test was 
applied to the transformation log2(max(PM-MM,1)) for data from the ChIP and control (whole cell 
extract) arrays within a window of ±500 base pairs, testing the null hypothesis that ChIP and control 
data come from the same probability distribution. Genomic positions belonging to enriched regions 
were defined by applying a high P-value cutoff of 10-4. These regions were extended locally by 
merging adjacent windows with P-values of at least 10-2, and resultant positions separated by < 2 kb 
were merged to form a predicted H3K4me3 or H3K27me3 site. We defined bivalent domains to be 
H3K27me3 methylated sites of at least 5 kb that overlap H3K4me3 sites of at least 1 kb.  
Genomic analysis. We manually collated a list of known TSSs based on RefSeq and Genbank 
mRNAs aligned to the examined regions in mouse (mm5) and the orthologous regions in human 
(hg17; alignments obtained from the UCSC genome browser). The methylation status of each TSS 
was based on the presence of significantly enriched H3K4me3 or H3K27me3 sites, or bivalent 
domains within 2 kb upstream or downstream. The expected density of CpG and transposable 
elements at methylated sites were determined from random intervals of the same size, anchored in 
non-repetitive sequence. CpG islands were defined as in (Takai and Jones, 2002). TEZs 
(Transposon exclusion zones) were defined as regions satisfying one of two criteria: (a) regions of 
at least 10 kb without any transposable elements; (b) regions of at least 15 kb with no more than 
250 bases annotated as transposable elements. Identified regions were then merged together as one 
TEZ if they were within distance of 1kb. For the genome-wide search, only criterion (a) was used.  
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Chapter 7: Genome-wide maps of histone methylation 
 
In this chapter, we describe one of the first application of single molecule-based sequencing to 
generate genome-wide chromatin state maps for a mammalian species. 
This work was first published as 
Mikkelsen, T. S. et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed 
cells. Nature 448, 553-560 (2007). 
This publication is attached as Appendix 6. Supplementary notes  can be found at the 
end of the chapter. Supplementary data is available online from http://www.nature.com/nature 
 297
 [This page is intentionally left blank] 
 298
We report the application of single molecule-based sequencing technology for high-
throughput profiling of histone modifications in mammalian cells. By obtaining over 4 billion 
bases of sequence from chromatin immunoprecipitated DNA, we generated genome-wide 
chromatin state maps of mouse embryonic stem cells, neural progenitor cells and embryonic 
fibroblasts. We find that lysine 4 and lysine 27 tri-methylation effectively discriminate genes 
that are expressed, poised for expression, or stably repressed, and therefore reflect cell state 
and lineage potential. Lysine 36 tri-methylation marks primary coding and non-coding 
transcripts, facilitating gene annotation. Lysine 9 and lysine 20 tri-methylation are detected at 
satellite, telomeric and active long-terminal repeats, and can spread into proximal unique 
sequences. Lysine 4 and lysine 9 tri-methylation mark imprinting control regions. Finally, we 
show that chromatin state can be read in an allele-specific manner by using single nucleotide 
polymorphisms. This study provides a framework for the application of comprehensive 
chromatin profiling towards characterization of diverse mammalian cell populations. 
One of the fundamental mysteries of biology is the basis of cellular state. Although their 
genomes are essentially identical, cell types in a multicellular organism maintain strikingly different 
behaviors that persist over extended periods. The most extreme case is lineage-commitment during 
development, where cells progress from totipotency to pluripotency to terminal differentiation; each 
step involves establishment of a stable state encoding specific developmental commitments that can 
be faithfully transmitted to daughter cells. Considerable evidence suggests that cellular state may be 
closely related to ‘chromatin state’ – that is, modifications to histones and other proteins that 
package the genome1-3. Accordingly, it would be desirable to construct ‘chromatin state maps’ for a 
wide variety of cell types, showing the genome-wide distribution of important chromatin 
modifications.  
 Chromatin state can be studied by chromatin immunoprecipitation (ChIP), in which an 
antibody is used to enrich DNA from genomic regions carrying a specific epitope. The major 
challenge to generating genome-wide chromatin state maps lies in characterizing these enriched 
regions in a scalable manner. Enrichment at individual loci is commonly assayed by PCR, but this 
method does not scale efficiently. A more recent approach has been ChIP-chip, in which enriched 
DNA is hybridized to a microarray4,5. This technique has been successfully used to study large 
genomic regions. However, ChIP-chip suffers from inherent technical limitations: (i) it requires 
large amounts (several micrograms) of DNA and thus involves extensive amplification, which 
introduces bias; (ii) it is subject to cross-hybridization which hinders study of repeated sequences  
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Figure 1. Comparison of ChIP-Seq and ChIP-chip data. Direct comparison of 
H3K4me3 (green) and H3K27me3 (red) ChIP data across a 300 kb region in mouse 
ESCs from independent experiments assayed by SMS (absolute fragment counts) 
or tiling arrays (log p-values for enrichment relative to whole-cell extracts [15]).
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Figure 2. Cumulative distributions of fragment densities (averaged over 1-kb windows) 
across the mouse genome are shown for ES cell ChIPs of pan-H3 (blue), H3K4me3 
(green) and H3K27me3 (red), and for unenriched whole-cell extracts (brown). The black 
curves show the distributions obtained from randomized placements of the of the same 
reads. The observed distributions for pan-H3 ChIP and whole-cell extract are virtually 
identical to the randomized distributions, indicating that ChIP-Seq generates unbiased 
data from unenriched samples. In contrast, the observed distributions for H3K4me3 
and H3K27me3 enriched samples show clear excess of extreme values.
and allelic variants; and (iii) it is currently expensive to study entire mammalian genomes. Given 
these issues, only a handful of whole-genome ChIP-chip studies in mammals have been reported. 
In principle, chromatin could be readily mapped across the genome by sequencing ChIP 
DNA and identifying regions that are over-represented among these sequences. Importantly, 
sequence-based mapping could require relatively small quantities of DNA and provide nucleotide-
level discrimination of similar sequences, thereby maximizing genome coverage. The major 
limitation has been that high-resolution mapping requires millions of sequences (Supplementary 
Note). This is cost-prohibitive with traditional technology, even with concatenation of multiple 
sequence tags6. However, recent advances in single molecule-based sequencing (SMS) technology 
promise to dramatically increase throughput and decrease costs7. In the approach developed by 
Illumina/Solexa, DNA molecules are arrayed across a surface, locally amplified, subjected to 
successive cycles of primer-mediated single-base extension (using fluorescently-labeled reversible 
terminators) and imaged after each cycle to determine the inserted base. The ‘read length’ is short 
(25-50 bases), but tens of millions of DNA fragments may be read simultaneously. 
Here, we report the development of a method for mapping ChIP enrichment by sequencing 
(ChIP-Seq) and describe its application to create chromatin-state maps for pluripotent and lineage-
committed mouse cells. The resulting data (1) define three broad categories of promoters based on 
their chromatin state in ES cells, including a larger than anticipated set of ‘bivalent’ promoters; (2) 
reveal that lineage commitment is accompanied by characteristic chromatin changes at bivalent 
promoters that parallel changes in gene expression and transcriptional competence; (3) demonstrate 
the potential for using ChIP for genome-wide annotation of novel promoters and primary 
transcripts, active transposable elements, imprinting control regions and allele-specific 
transcription. This study provides a technological framework for comprehensive characterization of 
chromatin-state across diverse mammalian cell populations.        
 
Genome-wide chromatin state maps 
We created genome-wide chromatin state maps for three mouse cell types: ES cells, neural 
progenitor cells (NPCs)8 and embryonic fibroblasts (MEFs). For each cell type, we prepared and 
sequenced ChIP DNA samples for some or all of the following features: pan-H3, H3K4me3, 
H3K9me3, H3K27me3, H3K36me3, H4K20me3 and RNA polymerase II.  
In each case, we sequenced nanogram quantities of DNA fragments (~300 bp) on a Solexa 
1GGA sequencer. We obtained an average of 10 million successful reads, consisting of the terminal 
27-36 bases of each fragment. The reads were mapped to the genome and used to determine the  
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Figure 3. A representative comparison of ChIP-Seq fragment densities across a 
500 kb interval on mouse chromosome 1. Rectangles beneath each density plot 
indicate significantly enriched intervals at the p < 10e-5 threshold (see Methods). 
Black bars at the top indicate the fraction of unique positions within 1kb windows 
at which ChIP-Seq reads can be uniquely aligned (at k = 27, d = 2; see Methods).
number of ChIP fragments overlapping any given position (Figure 1). Enriched intervals were 
defined as regions where this number exceeded a threshold defined by randomization (see 
Methods). The full data set consists of 18 chromatin-state maps, containing ~140 million uniquely 
aligned reads, representing over 4 billion bases of sequence. 
We validated the chromatin state maps by computational analysis and by comparison to 
previous methods. ChIP-Seq maps of specific histone modifications show marked enrichment at 
specific locations in the genome, while the pan-H3 and unenriched samples show relatively uniform 
distributions (Figure 2, 3). The maps show close agreement with our previously reported ChIP-chip 
data from ~2.5% of the mouse genome9 (Figure 1). Also, ChIP-PCR assays of 50 sites chosen to 
represent a range of ChIP-Seq fragment counts showed 98% concordance and a strong, quantitative 
correlation (Figure 4). 
 
Promoter state in ES and lineage-committed cells 
We began our analysis by studying H3K4me3 and H3K27me3 patterns at known promoters. 
H3K4me3 is catalyzed by trithorax-group (trxG) proteins and associated with activation, while 
H3K27me3 is catalyzed by Polycomb-group (PcG) proteins and associated with silencing10,11. 
Recently, we and others observed that some promoters in ES cells carry both H3K4me3 and 
H3K27me39,12. We termed this novel combination a ‘bivalent’ chromatin mark and proposed that it 
serves to poise key developmental genes for lineage-specific activation or repression.  
 We studied 17,762 promoters inferred from full-length cDNAs. Mammalian RNA 
Polymerase II promoters are known to occur in at least two major forms13,14. CpG-rich promoters 
are associated with both ubiquitously expressed ‘housekeeping’ genes, and genes with more 
complex expression patterns, particularly those expressed during embryonic development. CpG-
poor promoters are generally associated with highly tissue-specific genes. Accordingly, we divided 
our analysis to focus on high CpG promoters (HCP; n=11,410) and low CpG promoters (LCP; 
n=3,014) separately. To ensure a clean separation, we defined a set of intermediate CpG content 
promoters (ICP; n=3,338); this class shows properties consistent with being a mixture of the two 
major classes.  
High CpG promoters in ES cells. Virtually all HCPs (99%) are associated with intervals 
of significant H3K4me3 enrichment in ES cells (Figure 5a). The modified histones are typically 
confined to a punctate interval of 1-2 kb (Figure 6). As observed previously15,16, there is a strong 
correlation between the intensity of H3K4me3 and the expression level of the associated genes 
(Spearman’s ρ=0.67). However, not all promoters associated with H3K4me3 are active. 
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Figure 4. ChIP-Seq fragment densities (y-axis) are plotted against RT-PCR 
fold-enrichment (x-axis) for H3K4me3 (green) and H3K27me3 (red) at 60 
selected sites in mouse ES cells. Notably 28 out of 29 sites (97%) identified 
as significantly enriched for one of the two modifications by ChIP-Seq were 
clearly differentiated from unenriched sites by RT-PCR, and 31 of 31 sites 
(100%) with no ChIP-Seq enrichment had no RT-PCR enrichment either.
C
hI
P
-S
eq
C
hI
P
-S
eq
The chromatin state maps reveal that ~22% of HCPs (n=2,525) are actually bivalent, 
exhibiting both H3K4me3 and H3K27me3 (Figure 5a). A minority (n=564) are ‘wide’ bivalent sites 
in which H3K27me3 extends over a region of at least 5 kb and resemble those described 
previously9. The majority (n=1,961) are ‘narrow’ bivalent sites, with more punctate H3K27me3, 
that correspond to many additional PcG target promoters17-19. Bivalent promoters show low activity 
despite the presence of H3K4me3, suggesting that the repressive effect of PcG activity is generally 
dominant over the ubiquitous trxG activity (Figure 7).  
The different types of chromatin marks at HCP promoters are closely related to the nature 
of the associated genes. Monovalent promoters (H3K4me3) generally regulate genes with 
‘housekeeping’ functions including replication and basic metabolism. By contrast, bivalent 
promoters are associated with genes with more complex expression patterns, including key 
developmental transcription factors, morphogens and cell surface molecules. In addition, several 
bivalent promoters appear to regulate transcripts for lineage-specific microRNAs. 
High CpG promoters in NPCs and MEFs. The vast majority of HCPs marked with 
H3K4me3 alone in ES cells retain this mark both in NPCs and MEFs (92% in each; Figure 
5b,5c,8a). This is consistent with the tendency for this sub-class of promoters to regulate ubiquitous 
housekeeping genes. A small proportion (~4%) of these promoters have H3K27me3 in MEFs, and 
are thus bivalent or marked by H3K27me3 alone. This correlates with lower expression levels and 
may reflect active recruitment of PcG proteins to new genes during differentiation20. An example is 
the transcription factor Sox2, where the promoter is marked by H3K4me3 alone in ES cells and 
NPCs, but H3K27me3 alone in MEFs. Notably, this locus is flanked by CpG islands with bivalent 
markings in ES cells (see below), suggesting the locus may be poised for repression upon 
differentiation. 
The majority of HCPs with bivalent marks in ES cells resolve to a monovalent status in the 
committed cells. In NPCs, 46% resolve to H3K4me3 only and these genes show increased 
expression (Figure 5b,5d,8b). Of the remaining promoters, 14% resolve to H3K27me3 alone and 
32% lose both marks, with both outcomes being associated with low levels of expression. 
Importantly, 8% remain bivalent and these genes also continue to be repressed (Figure 5b,5d,8c). A 
somewhat less resolved pattern is seen in MEFs, with 32% marked by H3K4me3 alone, 22% 
marked by H3K27me3 alone, 3% without both marks, and the remaining (43%) still bivalent 
(Figure 5c). The relatively high number of bivalent promoters in MEFs may reflect a less 
differentiated state and/or heterogeneity in the population.  
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Figure 5. Histone tri-methylation state predicts expression of HCP and LCP 
promoters. (a) Mammalian promoters can be readily classified into sets with 
high (HCPs), intermediate (ICPs) or low (LCPs) CpG-content. In ES cells (ESCs), 
virtually all HCPs are marked by H3K4me3, either alone (green) or in combination 
with H3K27me3 (yellow). In contrast, most LCPs have neither mark (grey). Few 
promoters are only enriched for H3K27me3 (red). (b) Tri-methylation states of 
HCPs and LCPs in NPCs (indicated by colors), conditional on their ESC state 
(indicated below each bar). HCPs marked by H3K4me3 only in ESCs tend to 
retain this mark. HCPs marked by H3K4me3 and H3K27me3 tend to lose one 
or both marks, although some remain bivalent. Small, partially overlapping 
subsets of LCPs are marked by H3K4me3. (c) Tri-methylation states of HCPs 
and LCPs in MEFs. (d) Changes in expression levels of HCP genes with 
H3K4me3 alone (left) or also with H3K27me3 (right) upon differentiation to NPCs. 
Resolution of bivalent promoters to H3K4me3 is associated with increased 
expression. Boxplots show median (red bar), 25th and 75th percentile expression 
levels in ESCs. Whiskers show 2.5th and 97.5th percentiles. Asterisks indicate 
classes with less than 15 genes. (e) Changes in expression levels of LCP genes 
with H3K4me3 (left) or no mark (right) upon differentiation to NPCs. Gain of 
H3K4me3 is associated with increased expression.
Distinct regulation of Low CpG Promoters. The LCPs show a strikingly different pattern 
than the HCPs. Only a small minority (6.5%, n=207) of LCPs have significant H3K4me3 in ES 
cells and virtually none have H3K27me3 (Figure 5a). Most of these promoters have lost H3K4me3 
in NPCs and MEFs, while a small number of other LCPs (1.5% and 2.6%, respectively) have gained 
the mark (Figure 5b,5c,8e). In all three cell types, the expression levels of the associated genes 
strongly correlate with presence or absence of H3K4me3 (Figure 5e, 7).  
The genes with LCPs marked by H3K4me3 are closely related to tissue-specific functions. 
In NPCs, they include genes encoding several known markers of neural progenitors in vivo (such as 
Fabp7, Cp, Gpr56). In MEFs, they include genes encoding extracellular matrix components and 
growth factors (such as Col3a1, Col6a1, Postn, Aspn, Hgf, Figf), consistent with the mesenchymal 
origin of these cells (see below).  
We conclude that HCPs and LCPs are subject to distinct modes of regulation. In ES cells, 
all HCPs appear to be targets of trxG activity, and may therefore drive transcription unless actively 
repressed by PcG proteins. In committed cell types, a subset of HCPs appear to lose the capacity to 
recruit trxG activity (possibly due to other epigenetic modifications, such as DNA methylation21). In 
contrast, CpG-poor promoters appear to be inactive by default, independent of repression by PcG 
proteins, and may instead be selectively activated by cell type- or tissue-specific factors.  
Alternative promoter use. We note that genes with alternative promoters may have 
multiple, distinct chromatin states. An ‘active’ state at any one of these may be sufficient to drive 
expression. A common situation involves genes with one major HCP and one or more alternative 
LCPs. An example is the transcription factor Foxp2, which is expressed at moderate levels in both 
NPCs and MEFs (Figure 8f,g). The Foxp2 HCP is marked by H3K4me3 in NPCs, but is bivalent in 
MEFs. However, an alternative LCP is marked by H3K4me3 exclusively in MEFs. The 
protocadherin-γ (Pcdh-γ) locus is a more extreme case: the N-terminal variable regions of this gene 
are transcribed from at least 20 different HCPs in neurons22, all of which carry bivalent chromatin 
marks in ES cells. Pcdh-γ expression is nevertheless detected by microarrays, possibly due to a 
single promoter in front of the C-terminal constant region marked by H3K4me3 alone (Figure 8h).  
Although only ~10% of the genes analyzed here have more than one known promoter, 
recent ‘cap-trapping’ studies suggest that alternative promoter use may be substantially more 
common23. The ability of ChIP-Seq to assess chromatin state at known promoters, as well as to 
identify novel promoters (see below), should prove valuable in analysis of transcriptional networks. 
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Figure 6. Composite profile of HCP promoters. Plots show mean ChIP-Seq 
fragment densities (scaled for comparison) of H3K4me3, H3K36me3, pan-H3 
and RNA Polymerase II ChIP-Seq fragments over all analyzed high-CpG 
promoters. H3K4me3 marks a punctate interval peaking just downstream of 
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H3K36me3 increasing in the negative direction likely represent bidirectional 
promoter activity.
Promoter state reflects lineage commitment and potential 
Given their association with epigenetic memory, we next examined whether the patterns of 
H3K4me3 and H3K27me3 can reflect developmental potential. Both of the committed cell types 
studied here have been shown to be multipotent ex vivo. NPCs can be differentiated to glial and 
neuronal lineages8, while primary MEFs have been differentiated into adipocytes24, chondrocytes25 
and osteoblast-like cells26.  
 Lineage-specific resolution and retention of bivalent marks. We first examined a set of 
genes involved in in vivo differentiation pathways known to be, at least partially, recapitulated by 
MEFs, NPCs or neither. These genes all have bivalent promoters in ES cells. We found that their 
resolution in lineage-committed cells is closely related to their demonstrated developmental 
potential: 
• Genes restricted to regulation or specialized functions in unrelated lineages, such as 
hematopoietic (Cdx4, PU.1), epithelial (Cncf, Krt2-4), endoderm (Gata6, Pdx1) or germ line (Tenr, 
Ctcfl), have generally resolved to monovalent H3K27me3 or carry neither mark in both NPCs and 
MEFs. 
• Genes related to adipogenesis and chondro/osteogenesis often remain bivalent in MEFs, 
but not in NPCs. Examples include Ppar-γ, which is a key regulator of apipogenesis, and Sp7, 
which promotes chondro/osteogenic pathways. Early mesenchymal markers, such as Runx1 and 
Sox9 resolved to H3K4me3 alone in MEFs.  
• Genes related to gliogenesis and neurogenesis often resolve to H3K4me3 alone or remain 
bivalent in NPCs, while resolving to H3K27me3 alone in the MEFs. Gliogenesis and neurogenesis 
are thought to be mutually opposing pathways27, and we find that genes promoting gliogenesis are 
more likely to resolve to H3K4me3 in NPCs. Examples include Bmp2 and the miRNA mir-9-3, 
which promotes glial but inhibits neuronal differentiation28. Several genes known to promote 
neuronal differentiation, such as Neurog1 and Neurog2, remain bivalent while others, such as 
Bmp6, appear to resolve to H3K27me3 alone. The NPCs differentiate to astrocytes with 
significantly higher efficiency than to neurons (M. Wernig, unpublished data). The observed 
chromatin patterns may reflect this gliogenic bias.   
 Correlation with expression in adult tissues. We next analyzed gene expression in adult 
tissues with major contributions from neuroectodermal or mesenchymal lineages. We reasoned that 
if H3K4me3 is generally not restored once lost, then differential loss of H3K4me3 at promoters 
early in these lineages (as represented by NPCs and MEFs, respectively) might be reflected in 
differential gene expression patterns in related adult tissues. 
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Strikingly, we observed a clear bias in relative expression levels between relevant adult 
tissues for genes that retain H3K4me3 in NPCs only versus genes that retain H3K4me3 in MEFs 
only. The former are strongly biased toward higher expression in various brain sections, while the 
latter are biased towards higher expression in bone, adipose and other mesenchyme-rich tissues 
(Figure 9).  
 These analyses are of course limited by alternative promoter usage, the cell models used, 
and the heterogeneity of the adult tissues. Nonetheless, the data show clear trends that support an 
important role for retention and resolution of bivalent chromatin in the regulation of hierarchical 
lineage commitment. 
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Figure 8. Cell type-specific chromatin marks at promoters. (a) Multiple ‘housekeeping 
genes’, such as DNA Polymerase mu (Polm), are associated with HCPs marked by 
H3K4me3 in all cell types. (b) The neural transcription factor gene Olig1 (HCP) is 
bivalent in ESCs, but resolves to H3K4me3 in NPCs and H3K27me3 in MEFs. 
(c) The neurogenesis transcription factor gene Neurog1 (HCP) remains bivalent 
upon differentiation to NPCs, but resolves to H3K27me3 in MEFs. (d) The 
adipogenesis transcription factor gene Ppar-? (HCP) remains bivalent in MEFs, 
but loses both marks in NPCs. (e) The neural progenitor marker gene Fabp7 (LCP) 
is marked by H3K4me3 in NPCs only. (f) The brain and lung expressed transcription 
factor gene Foxp2 is associated with an HCP that is bivalent in ES cells, but resolves 
to H3K4me3 in NPCs and remains bivalent in MEFs. (g) Foxp2 also has an LCP 
marked by H3K4me3 in MEFs only. (h) Multiple, distinct bivalent chromatin marks 
at the variable region promoters of protocadherin-gamma. A promoter proximal to the 
constant region exons (*) is marked by H3K4me3 only.
Genome-wide annotation of promoters and primary transcripts 
We next considered genome-wide maps of H3K36me3. This mark has been linked to transcriptional 
elongation and may serve to prevent aberrant initiation within gene bodies29-33. Our chromatin maps 
reveal a global pattern of H3K36me3 in mammals similar to that previously observed in yeast29.  
In all three cell types, H3K36me3 is strongly enriched across the transcribed regions of 
active genes (Figure 10a), beginning immediately after the promoter H3K4me3 signal. The level of 
H3K36me3 is strongly correlated with the level of gene expression (Spearman’s ρ=0.77), although 
the dynamic range is compressed (1-2 orders of magnitude for H3K36me3 vs 3-4 for expression 
levels; Figure 11). Genes with bivalent promoters rarely show H3K36me3, consistent with their low 
expression. Notably, there is essentially no overlap between intervals significantly enriched for 
H3K36me3 and for H3K27me3, consistent with a role for PcG complexes in the exclusion of 
polymerases11.  
The vast majority of intervals significantly enriched for H3K36me3 is associated with 
known genes (~92% in ESCs), but there are at least ~500 additional regions across the genome 
(median size ~2 kb), with most being adjacent to sites of H3K4me3. Inspection revealed a number 
of interesting cases, falling into three categories. 
The first category corresponds to H3K36me3 that extends significantly upstream from the 
annotated start of a known gene, often until an H3K4me3 site. These appear to reflect the presence 
of unannotated alternate promoters. A notable example is the Foxp1 locus. In ES cells, one 
annotated Foxp1 promoter is marked by H3K4me3 and another CpG-rich region located ~500 kb 
upstream carries a bivalent mark. In MEFs, this CpG island is marked by H3K4me3 only, and 
H3K36me3 extends from this site to the 3’ end of Foxp1 (Figure 10a). Although no transcript 
extending across this entire region has been reported in mouse, the orthologous position in human 
has been shown to act as a promoter for the orthologous gene. The ChIP-Seq data contain many 
other examples where the combination of H3K36me3 and H3K4me3 appear to reveal novel 
promoters. 
The second category corresponds to H3K36me3 that extends significantly downstream of a 
known gene. An example is the Sox2 locus, which encodes a pluripotency-associated transcription 
factor that also functions during neural development. In ES cells, Sox2 has an unusually large 
region of H3K4me3 (>20 kb) accompanied by H3K36me3 extending far beyond the annotated 3’-
end (>15 kb); non-coding transcription throughout the locus has been noted previously34 and may 
serve a regulatory role (Figure 10b).  
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Figure 9. Correlation between chromatin state changes and lineage expression. 
Relative expression levels across adult mouse brain (frontal and cerebral cortex, 
substantia nigra, cerebellu, amygdale, hypothalamus, hippocampus) and 
relatively mesenchyme-rich tissues (bone, white fat, brown fat, trachea, digits, 
lung, bladder, uterus, umbilical cord) are shown for genes with bivalent chromatin 
marks in ES cells that retain H3K4me3 in NPCs but lose this mark in MEFs 
(n=62) or vice versa (n=160). Red, white and blue indicates higher, equal and 
lower relative expression, respectively.
The third category appears to reflect transcription of non-coding RNA genes. For example, 
two regions with H3K36me3 and adjacent H3K4me3 correspond to recently discovered nuclear 
transcripts with possible functions in mRNA processing35 (Figure 10c). In addition, a number of 
these presumptive transcriptional units overlap microRNAs (Figure 10d). A striking example is a 
>200 kb interval within the Dlk1-Dio3 imprinted locus (Figure 12a). This region harbors over 40 
non-coding RNAs, including clusters of microRNAs and small nucleolar RNAs36. The ChIP-Seq 
data suggest that the entire region is transcribed as a single unit that initiates at an H3K4me3 
marked HCP.  
These findings suggest that genome-wide maps of H3K4me3 and H3K36me3 may provide 
a general tool for defining novel transcription units. The capacity to define the origins and extents 
of primary transcripts will be of particular value for characterizing the regulation of microRNAs 
and other non-coding RNAs that are rapidly processed from long precursors37. Finally, the relatively 
narrow dynamic range of H3K36me3 may offer advantages over RNA-based approaches in 
assessing gene expression and defining cellular states. 
 
H3K9 and H4K20 tri-methylation associated with specific repetitive elements 
We next studied H3K9me3 and H4K20me3, both of which have been associated with silencing of 
centromeres, transposons and tandem repeats38-40. We sought first to assess the relative enrichments 
of H3K9me3 and H4K20me3 across different types of repetitive elements by aligning ChIP-Seq 
reads directly to consensus sequences for various repeat families (~40 million reads could be 
aligned this way).  
H3K9me3 and H4K20me3 show nearly identical patterns of enrichment in ES cells. The 
strongest enrichments are observed for telomeric, satellite, and long terminal repeats (LTRs). The 
LTR signal primarily reflects enrichment of intracisternal A-particles (IAP), early transposon (ETn) 
elements, and the LTRIS sub-family (Figure 13).  
IAP and ETn elements are active in murine ES cells and produce double-stranded 
RNAs41,42. RNA has also been implicated in maintaining satellite and telomeric heterochromatin38. 
Hence, these enrichment data are consistent with a global role for RNA in targeting repressive 
chromatin marks in mammalian ES cells, analogous to that observed in lower eukaryotes38,39.  
We next examined the distributions of H3K9me3 and H4K20me3 across unique sequence 
in the mouse genome. We identified ~1800 H3K9me3 sites (median size ~300 bp) in ES cells, with 
the vast majority also showing H4K20me3. Fully 78% of the sites lie within two kb of a satellite  
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Figure 10. H3K4me3 and H3K36me3 annotate genes and non-coding RNA 
transcripts. (a) Foxp1 has two annotated promoters (based on RefSeq and 
UCSC Known Genes), only one of which shows H3K4me3 in ES cells. The 
corresponding transcriptional unit is marked by H3K36me3. In MEFs, 
H3K36me3 extends an additional 500 kb upstream to an H3K4me3 site that 
appears to reflect an alternate promoter (this site is bivalent in ES cells). 
(b) H3K36me3 enrichment extends significantly downstream of Sox2. 
Though highly active in ES cells, Sox2 is flanked by two bivalent CpG islands 
that may poise it for repression. (c) H3K4me3 and H3K36me3 indicate two 
highly expressed non-coding RNAs, and (d) the putative primary transcript 
(dashed line) for a single annotated microRNA.
repeat or LTR (primarily IAP and ETn elements). This suggests that repressive marks are capable of 
spreading from repeat insertions and could potentially regulate proximal unique sequence. 
Recent studies have described a handful of active genes with H3K9me3 and H4K20me3, 
raising the possibility that these ‘repressive’ marks also function in transcriptional activation31,32. 
One-third of the ~1800 H3K9me3 enriched sites reside within an annotated gene, which is roughly 
the proportion expected by chance. However, H3K9me3 sites that are larger and/or more distant 
from LTRs are more likely to occur within genes. The largest genic site in ES cells (~6 kb) 
coincides with the Polrmt gene (Figure 12d). This case is notable because the downstream gene 
(Hcn2) is convergent and contains a CpG island at its 3’ end. Transcription from 3’ promoters has 
been proposed as a potential mechanism of transcriptional interference by producing antisense 
transcripts23. This example may therefore reflect a link between transcriptional interference and 
H3K9me3, as has been suggested for a few other mammalian loci43,44. Our results thus confirm that 
the presence of H3K9me3 within genes is a general phenomenon, although the functional 
implications remain to be elucidated.  
 
Imprinting control regions show overlapping H3K4 and H3K9 tri-methylation 
We next studied chromatin marks associated with imprinting. This epigenetic process typically 
involves allele-specific DNA methylation of CpG-rich imprinting control regions (ICRs)45. Several 
reports have also described allele-specific chromatin modification at a handful of ICRs, with 
H3K9me3 and H4K20me3 on the DNA methylated allele and H3K4me3 on the opposite allele46,47. 
We searched for regions showing overlapping H3K9me3 and H3K4me3 in ES cells. 
Strikingly, 13 of the top 20 sites, as ranked by enrichment of the two marks, are located within 
known imprinted regions, coincident with ICRs or imprinted gene promoters. An example is the 
Peg13 promoter (Fig. 12c). Conversely, of the ~20 known and putative autosomal imprinted loci 
that contain ICRs, 17 have at least one with the overlapping chromatin marks. We conclude that 
overlapping H3K9me3 and H3K4me3 is a common signature of ICRs in ES cells. 
 
Allele-specific histone methylation 
To explore the feasibility of inferring allele-specific chromatin states, we constructed chromatin-
state maps in male ES cells derived from a more distant cross (129 (maternal) x M. castaneus 
(paternal)), and used a catalog of ~3.5 million SNPs to assign ChIP-Seq reads to one of the two 
parental alleles. 
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Figure 11. Scatter plot of H3K36me3 density across transcripts versus their 
expression levels as measured by Affymetrix GeneChips. The lower left-hand 
cluster corresponds to largely inactive genes.The range of H3K36me3 densities 
across most actively expressed genes spans ~1 order of magnitude, compared 
to ~3 for expression levels.
As a positive control, we first compared results for chromosome X and the autosomes for 
reads derived by H3K4me3 ChIP. Virtually all (97%) of ~3700 informative reads on chromosome 
X, and roughly half (57%) of the 178,000 informative reads on the autosomes, were assigned to the 
129 strain. These proportions correspond roughly to the expected 100% and 50%.  
We then examined the allelic distribution at overlapping H3K4me3 and H3K9me3 sites 
coincident with putative ICRs (see above). Six of the ICRs had enough reads (≥10) containing SNPs 
to assess allelic bias. In every case, the SNPs showed significant bias in the expected direction 
(p<0.02; Figure 12c).  
We applied the same approach to search for allelic imbalance in intervals with significant 
H3K36me3 enrichment, which would predict differential transcription of the two alleles. A striking 
interval corresponds to a microRNA cluster within the Dlk1-Dio3 locus known to be imprinted in 
the embryo proper36 (Fig. 12a-b). Of the additional imprinted genes with H3K36me3 enrichment, 
four (Snrpn, Grb10, Impact, Peg3) had enough reads containing SNPs to assess allelic bias. In every 
case, the data showed significant bias in the expected direction (p<0.02). The data also revealed 
novel instances of allele-specific transcription. For example, a transcript of unknown function 
(BC054101), first identified in trophoblast stem cells48, showed highly significant maternal bias for 
H3K36me3, as well as H3K4me3 (p<10-15; Figure 14).  
The results suggest that, with sufficiently deep coverage and dense SNP maps, ChIP-Seq 
will provide a powerful means for identifying allele-specific chromatin modifications. With data 
from reciprocal crosses, it should be possible to discriminate novel cases of imprinting from strain-
specific differences. 
 
Conclusion 
Genome-wide chromatin-state maps provide a rich source of information about cellular state, 
yielding insights beyond what is typically obtained by RNA expression profiling. Analysis of 
H3K4me3 and H3K36me3 allows recognition of promoters together with their complete 
transcription units. This should help define alternative promoters and their usage in specific cell 
types; identify the structure of genes encoding non-coding RNAs; detect gene expression (given the 
narrower dynamic range); and detect detecting allele-specific transcription. In addition, analysis of 
H3K9me3 and H4K20me3 should facilitate study of heterochromatin, spreading and imprinting 
mechanisms. 
 Most interestingly, analysis of H3K4me3 and H3K27me3 provides a rich description of 
cellular state. Our results suggest that promoters may be classified as active, repressed or poised for  
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Figure 12. Allele-specific histone methylation and genic H3K9me3/H4K20me3 
(a) H3K4me3 and H3K36me3 indicate a primary microRNA transcript in the 
Dlk1-Dio3 locus. The allele-specificity of this transcript is read out using 
ChIP-Seq data for hybrid ES cells and a SNP catalogue. The H3K36me3 
reads overwhelmingly correspond to maternal 129 alleles, consistent with 
the known maternal expression of these microRNAs36. (b) In contrast, a 
non-imprinted transcript shows roughly equal proportions of reads assigned 
to 129 and castaneus alleles. (c) Peg13 is marked by H3K4me3 and H3K9me3 
in ES cells; 19 of 21 H3K4me3 reads correspond to the paternal castaneus 
allele, while 6 of 6 H3K9me3 reads correspond to the maternal 129 allele, 
consistent with paternal expression of this gene. (d) H3K9 me3 and H4K20me3 
enrichment evident at the Polrmt gene may reflect transcriptional interference 
due to antisense transcription from the 3’ UTR CpG island of Hcn2 (see text).
alternative developmental fates. Conceivably, chromatin state at key regulatory genes may suffice 
to describe developmental commitment and potential. 
Given the technical features of ChIP-Seq (high throughput, low cost and input 
requirement), it is now appropriate to contemplate projects to generate catalogs of chromatin-state 
maps representing a wide range of human and mouse cell types. These should include varied 
developmental stages and lineages, from totipotent to terminally differentiated, with the aim of 
precisely defining cellular states at the epigenetic level and observing how they change over the 
course of normal development. Chromatin-state maps should also be systematically cataloged from 
situations of abnormal development. Cancer cells are the most obvious targets, as they are 
frequently associated with epigenetic defects and many appear to have acquired characteristics of 
earlier developmental stages. A comprehensive public database of chromatin-state maps would be a 
valuable resource for the scientific community.   
 322
ba
Figure 13. (a)   Simple telomeric repeats, satellite repeats, and class II endogenous retroviruses 
(LTR ERV2) all show significant enrichment for H3K9me3 in ES cells (blue). A weaker signal 
is seen for class I endogenous retroviruses (LTR ERV1). Both ERV1 and ERV2 elements lose 
the H3K9me3 marking in MEFs (red) and NPCs (green). The dashed line indicates twofold 
enrichment; values below 1 indicate depletion. Error bars show the difference in signal observed 
between sample runs. Inset: Intracisternal A particles (ERV2 IAP) and Early Transposon 
associated elements (ERV2 ETn), both known to be active in mice, are largely responsible for 
the enrichment of H3K9me3 observed for ERV2s in ES cells. (b) H3K9me3 and H4K20me3 
exhibit similar distribution at repeats, and are strongly enriched in active ERVs. 
Methods 
 
Cell Culture. V6.5 murine ES cells (genotype 129SvJae x C57BL/6; male; passages 10–15) and 
hybrid murine ES cells (genotype 129SvJae x M. castaneus F1; male; passages 4-6) were cultivated 
in 5% CO2 at 37º on irradiated MEFs in DMEM containing 15% FCS, leukemia-inhibiting factor, 
penicillin/streptomycin, L-glutamine, nonessential amino acids and 2-mercaptoethanol. Cells were 
subject to at least two to three passages on 0.2% gelatin under feeder-free conditions to exclude 
feeder contamination. V6.5 ES cells were differentiated into neural precursor cells (NPCs) through 
embryoid body formation for 4 days and selection in ITSFn media for 5–7 days, and maintained in 
FGF2 and EGF2 (R&D Systems) as described8. The cells uniformly express nestin and Sox2 and 
can differentiate into neurons, astrocytes and oligodendrocytes. Mouse embryonic fibroblasts 
(genotype 129SvJae x C57BL/6; male; d13.5; passages 4-6), were grown in DMEM with 10% fetal 
bovine serum and penicillin/streptomycin at 37º, 5% CO2.  
Chromatin Immunoprecipitation (ChIP). ChIP experiments were carried out as described in 
Bernstein et al., 2005 and at www.upstate.com. Briefly, chromatin from fixed cells was fragmented 
to a size range of 200 to 700 bases with a Branson 250 Sonifier or a Diagenode Bioruptor. 
Solubilized chromatin was immunoprecipitated with antibody against H3K4me3 (Abcam #8580), 
H3K9me3 (Abcam #8898), H3K27me3 (Upstate #07-449), H3K36me3 (Abcam #9050), 
H4K20me3 (Upstate #07-463), pan-H3 (Abcam #1791) or RNA polymerase II (Covance MMS-
126R). Antibody-chromatin complexes were pulled-down using Protein A-sepharose (or anti-IgM 
conjugated agarose for RNA polymerase II), washed and then eluted. After cross-link reversal and 
Proteinase K treatment, immunoprecipitated DNA was extracted with phenol-chloroform, ethanol 
precipitated, and treated with RNase. ChIP DNA was quantified using PicoGreen. 
Library Preparation and Solexa sequencing. One to ten nanograms of ChIP DNA (or unenriched 
whole cell extract) were prepared for Solexa sequencing as follows: DNA fragments were repaired 
to blunt ends by T4 DNA polymerase and phosphorylated with T4 Polynucleotide kinase using the 
END-IT kit (Epicentre). Then, a single ‘A’ base was added to 3’ ends with Klenow (3’Æ5’ exo-, 0.3 
U/μl). Double-stranded Solexa adaptors (75 bp with a ‘T’ overhang) were ligated to the fragments 
with DNA ligase (0.05 U/μl). Ligation products between 275 and 700 base pairs were gel purified 
on 2% agarose to remove unligated adaptors, and subjected to 18 PCR cycles. Completed libraries 
were quantified with PicoGreen. 
DNA sequencing was carried out using Illumina’s Solexa sequencing system. Cluster 
amplification, linearization, blocking and sequencing primer reagents were provided in the Solexa  
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Figure 14. A transcribed region that exhibits allelic bias in the ChIP-Seq data from 
129/castaneus hybrid ES cells is a candidate for imprinted or strain-specific expression. 
An interval of H3K36me3 enrichment (red bar) overlapping the transcript of unknown 
function BC054101. Of the 69 aligned reads within the enriched interval at the center of 
the locus, 64 were classified as 129 (maternal). Of the 61 aligned H3K4me3 reads in the
same interval, 59 were classified as 129. This suggests near exclusive maternal 
transcription. 
Cluster Amplification kits and were used according to the manufacturer’s specifications as 
described here. To obtain single strand templates, the sample prep was first denatured in NaOH 
(0.1N final concentration) and diluted in Solexa hybridization buffer (4oC) to a final concentration 
of either 2 or 4pM. Sample loading was carried out as follows. A template sample was loaded into 
each lane of a Solexa flowcell mounted on a Solexa cluster station on which all subsequent steps 
were performed. The temperature was increased to 95oC for 1min and slowly decreased to 40oC to 
allow for annealing onto complementary adapter oligos on the flowcell surface. Cluster formation 
was then carried out as follows. The template strands were extended with Taq polymerase 
(0.25U/ul) to generate a fixed copy of the template on the flowcell. The samples were then 
denatured with formamide (Sigma-Aldrich, F-5786, >99.5% (GC)) and washed (Solexa Wash 
buffer) to remove the original captured template leaving behind a single stranded template ready for 
amplification. Clusters were then amplified under isothermal conditions (60oC) for 30 cycles using 
Solexa Amplification mix containing Bst I DNA polymerase (0.08U/ul). After each amplification 
cycle, the templates were denatured with formamide (as above). Fresh amplification mix was added 
after each denaturation step. Following amplification, the clusters were linearized with Solexa 
Linearization mix, and any unextended flowcell surface capture oligos were blocked with ddNTPs 
(2.4uM mix in the presence of 0.25U/ul terminal transferase). The linearized clusters were then 
denatured (0.1N NaOH) to remove and wash away the linearized strands. The single-stranded 
templates in the cluster were then annealed with the Solexa sequencing primer (10uM). The 
flowcells were removed from the cluster station and then transferred onto the 1G Genetic Analyzer 
which performed the sequencing according to its own standard protocols. We followed the protocol 
without any modifications. 
Read alignment and generation of density maps and modified intervals. Sequence reads from 
each ChIP library are compiled, post-processed and aligned to the reference genome sequence using 
a general purpose computational pipeline. We first pre-compute a table that associates each possible 
12-mer with all of its occurrences in the reference genome. Then, for each k-bp read, we scan both 
it and its reverse complement, and for each of its constituent 12-mers, we find each potential start 
point on the reference genome, and then compute the number of mismatches in the corresponding 
alignment. These computations are dynamically terminated so that only "unique" alignments are 
reported, according to the following rule: if an alignment A has only x mismatches, and if there is 
no alternative alignment having ≤ x + 2 mismatches, then we call A unique.  
For each ChIP (or control) experiment, we next estimate the number of end-sequenced 
ChIP fragments that overlap any given nucleotide position in the reference genome (here, at 25-bp 
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resolution). For each position, we count the number of aligned reads that are oriented towards it and 
closer than the average length of a library fragment (~300 bp).  
To identify the portion of the mouse genome that can be interrogated with SMS reads of a 
given length (k) and alignment stringency, we aligned every k-mer that occurs in the reference 
sequence (mm8) using the same pipeline as for SMS reads. Nucleotide positions in the reference 
genome where less than 50% of the 200 flanking k-mers on each side had “unique” alignments, 
were masked as repetitive and disregarded from further analysis (<28% of the genome). Although 
we analyzed reads spanning 27-36 bp, all data were conservatively masked at k=27. 
We identified genomic intervals enriched with a specific chromatin mark from the mean 
fragment count in 1kb sliding windows. To account for varying read numbers and lengths, we 
generated sample-specific expected distributions of fragment counts under the null hypothesis of no 
enrichment by moving each aligned read to a randomly chosen, “unique” position on the same 
chromosome. Nominal p-values for enrichment at a particular position were obtained by 
comparison to a randomized version of the same dataset (due to the large number of reads, multiple 
randomizations gave identical results). Genome-wide maps of enriched sites were created by 
identification of windows where the nominal p-value fell below 10-5, and merging any enriched 
windows that were less than 1 kb apart, into continuous intervals. To improve sensitivity to the 
more diffuse enrichment observed from H3K9me3 and H4K20me3 near repetitive regions and from 
H3K36me3 across large transcripts, we also developed a Hidden Markov Model (HMM) to segment 
the reference genome into ‘enriched’ and ‘unenriched’ intervals (Koche, R. unpublished). The 
observed fragment densities were discretized to four categories, in a sample dependent manner 
(‘masked, ‘sub-threshold’, ‘near-threshold’ and ‘above threshold’). Emission and transition 
probabilities were fitted using supervised learning on limited intervals (~10 Mb total) chosen to 
reflect diverse chromatin landscapes, and the resultant models were applied genome-wide. 
Validation of ChIP-Seq by comparison to ChIP-chip and real-time PCR. ChIP-Seq data for 
H3K4me3 and H3K27me3 in ES cells were compared to published ChIP-chip profiles across ~2% 
of the mouse genome9. Significantly enriched sites in the ChIP-chip data were defined using a 
previously validated p-value threshold of 10-4, and compared to the ChIP-Seq sites. In addition, a 
set of 50 PCR primer pairs was designed to amplify 100-140 bp fragments from genomic regions 
showing a wide range of signal for H3K4me3 and H3K27me3 by ChIP-Seq. Real-time PCR was 
carried out using Quantitect SYBR green PCR mix (Qiagen) on a 7000 ABI detection system, using 
0.25 ng ChIP or WCE DNA as template. Fold-enrichments reflect two independent ChIP assays, 
each evaluated in duplicate by real-time PCR. 
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Promoter classification and definition of gene and transcript intervals. The analyzed promoters 
were based on transcription start sites inferred from full-length mouse RefSeqs (downloaded from 
the UCSC Genome Brower April 02, 2007). Promoters containing a 500 bp interval within -0.5 kb 
to +2 kb with a (G+C)-fraction ≥ 0.55 and a CpG observed to expected ratio (O/E) ≥ 0.6 were 
classified as HCPs. Promoters containing no 500 bp interval with CpG O/E ≥ 0.4 were classified as 
LCPs. The remainder were classified as ICPs. The chromatin states of promoters were determined 
by overlap with cell type specific H3K4me3 and H3K27me3 intervals. For comparison with 
expression levels, the chromatin states of genes with more than one known promoter were classified 
according to the most ‘active’ mark (i. e. a gene with an H3K4me3 marked promoter and a bivalent 
promoter, would be classified as ‘H3K4me3’). Correlation between H3K4me3 enrichment and 
expression levels was calculated from the mean fragment density over promoter from -0.5 kb to +1 
kb. Correlation between H3K36 me3 and expression levels was calculated from the mean fragment 
density over each RefSeq transcript. 
Expression data. RNA expression data for ES cells, NPCs and MEFs were generated from polyA 
RNA using GeneChip Mouse Genome 430 2.0 Arrays (Affymetrix). Expression data for adult 
tissues were downloaded from the Novartis Gene Expression Atlas at expression.gnf.org. Pre-
processing, normalization (GC-RMA) and hierarchical clustering (Pearson, log-transformed, row-
centered values) were performed using GenePattern [www.broad.mit.edu/cancer/software/].  
Analysis of repetitive elements. Chromatin state at repetitive elements was evaluated by aligning 
SMS reads directly to a library of repetitive element consensus sequences [http://www.girinst.org]. 
The proportion of reads aligning to each class was calculated for H3K9me3 and H4K20me3, and 
enrichment determined by comparison to WCE and pan-H3. We also applied an orthogonal 
approach based on HMM intervals of H3K9me3 in unique sequence (see above). For each repetitive 
element type or class, we calculated the number of occurrences within 1 kb of a unique H3K9me3 
site, controlling against a set of randomly placed sites of the same length distribution. 
Allele-specific histone methylation. Mouse SNP between the 129 and M. castaneus strains were 
obtained from Perlegen at mouse.perlegen.com. Allele specific bias was evaluated by a binomial 
test of the null hypothesis that ChIP fragments were drawn uniformly from both alleles.(H3K4me3 
and H3K9me3 reads were pooled prior to the test). We note that the 129 strain is closer to the B6-
derived reference genome, and this may cause a slight bias towards assigning aligned reads to this 
strain. 
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Supplementary Note: ChIP-Seq read requirement, genome coverage and accuracy 
 
The number of sequence reads required to map a chromatin feature can be estimated from a simple 
model. Suppose that the genome is divided into N non-overlapping bins of fixed size, that a fraction 
f of these bins contain a particular chromatin feature and that one performs ChIP-Seq with an 
antibody that enriches the sequence in these bins by a factor of e. If one collects a total of R 
sequence reads, the number of reads in a bin should approximately follow a Poisson distribution 
with mean eM for bins containing the feature and M for the other bins, where M = R/N(ef+(1-f)).  
Theoretical specificity and sensitivity of ChIP-Seq, conditional on the number of reads, can 
be estimated from the overlap of the two distributions. For example, suppose that an epitope is 
present across 1% of the genome, and can be enriched 20-fold by an antibody. Mapping this epitope 
with 95% specificity and 95% sensitivity into bins of 500 bp would require ~2 million reads. 
Increasing the resolution to 200 base pairs would require ~5 million reads. Epitopes that enrich less 
efficiently require more reads (e.g. 10-fold enrichment and 200 base pair resolution would require 
~10 million reads). 
How much of the mouse genome can be interrogated by ChIP-Seq SMS reads? The 
proportion depends on the read length k and the mismatch tolerance d (where optimal read 
alignments are kept for analysis if they have no alternative alignment with ≤ d additional  
mismatches). In this report, we used k=27 and d=2 (although the actual read lengths varied from 27-
36 bp). If we consider 500-bp windows in which at least half of the 27-mers are unique, then ~70% 
of all windows can be interrogated. Notably, this includes ~20% of all nucleotides in annotated 
interspersed repeats. Longer read lengths can provide over 80% theoretical coverage. 
Moreover, the specificity of SMS read alignments is also high in practice: When reads from 
individual BAC clones are mapped onto the whole genome using our pipeline, >98% of mappable 
reads are placed correctly (at k=27, d=2). This implies that ChIP-Seq can accurately interrogate 
~70% of the mammalian genome. By comparison, ChIP-chip yields data for at most ~50% because 
most repeats are ignored due to the problem of cross-hybridization.  
 
 
 
 
 
 Chapter 8: Genome-scale maps of DNA methylation 
 
In this chapter, we describe the application of single molecule-based sequencing to generate 
genome-scale maps of DNA methylation for a mammalian species. 
This work was first published as 
Meissner, A.*, Mikkelsen, T. S.* et al. Genome-scale DNA methylation maps of pluripotent and 
differentiated cells. Nature 454, 766-770 (2008). 
This publication is attached as Appendix 7. Supplementary notes can be found at the end of the 
chapter. Supplementary data is available online from http://www.nature.com/nature 
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We report the generation and analysis of genome-scale DNA methylation profiles at 
nucleotide resolution in mammalian cells. Using high-throughput Reduced Representation 
Bisulfite Sequencing (RRBS) and single-molecule-based sequencing, we generated DNA 
methylation maps covering the vast majority of CpG islands, and a representative sampling of 
conserved non-coding elements, transposons and other genomic features, for murine 
embryonic stem (ES) cells, ES-derived and primary neural cells, and eight other primary 
tissues. Several key findings emerge from the data. First, DNA methylation patterns are better 
correlated with histone methylation patterns than with the underlying genome sequence 
context. Second, methylation of CpGs are dynamic epigenetic marks that undergo extensive 
changes during cellular differentiation, particularly in regulatory regions outside of core 
promoters. Third, analysis of ES-derived and primary cells reveals that ‘weak’ CpG islands 
associated with a specific set of developmentally regulated genes undergo aberrant 
hypermethylation during extended proliferation in vitro, in a pattern reminiscent of that 
reported in some primary tumors. More generally, the results establish RRBS as a powerful 
technology for epigenetic profiling of cell populations relevant to developmental biology, 
cancer and regenerative medicine. 
Covalent epigenetic modifications to chromatin are thought to be essential for maintaining 
gene expression patterns and cellular states during development 1-3. Methylation of cytosines in 
CpG dinucleotides is generally associated with repressive chromatin contexts and stably propagated 
through cell division by DNA methyl-transferases (DNMTs). DNA methylation has been implicated 
in X inactivation, imprinting, silencing of germline-specific genes in somatic cells and transposon 
defense 1,2,4,5. Moreover, malignant cells frequently display seemingly aberrant DNA methylation 
patterns, including hypermethylation of CpG islands 6-9. 
 Despite being the most extensively studied epigenetic modification in mammals, relatively 
little is known about the genome-wide distribution of DNA methylation, how it changes during 
cellular differentiation or how it relates to histone methylation and other chromatin modifications. 
Concerns have also been raised about discrepancies in methylation patterns of cells in vivo and cells 
propagated in vitro 10-12. Accordingly, a catalog of high-resolution DNA methylation maps from 
cells at different developmental stages and growth conditions would be a valuable resource for 
defining normal and abnormal patterns, and for elucidating their functional relevance. 
 Methylation can be detected by sequencing genomic DNA that has been treated with 
sodium bisulfite, which converts unmethylated cytosines to uracils by deamination 13. The 
traditional approach has been to PCR-amplify targeted loci, using redundant sequence coverage to 
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estimate the methylation level of each cytosine in a cell population 14-16. It has been impractical, 
however, to apply bisulfite sequencing at a genome-wide scale because PCR-based approaches are 
too labor intensive and whole-genome shotgun sequencing, while feasible for small genomes 17, is 
currently too expensive for comparative analysis across multiple cell states in large mammalian 
genomes.  
To facilitate comparative analysis of nucleotide-resolution DNA methylation levels across 
cell types, we recently developed Reduced Representation Bisulfite Sequencing (RRBS) 18. This 
approach relies on restriction digestion and size-selection to isolate and sequence a defined fraction 
of a large genome. By choosing an enzyme with a recognition site including a CpG dinucleotide, 
one can enrich for ‘CpG islands’ while also sampling the remainder of the genome. Computational 
analysis indicated that digesting genomic DNA with the methylation-insensitive restriction enzyme 
MspI (recognition site: C/CGG), selecting fragments in the range 40-220 bp, and performing 36-bp 
end-sequencing would cover ~1 million distinct CpG dinucleotides (4.8% of all CpGs in the mouse 
genome) with roughly half located within CpG islands (including sequence from 90% of all 
annotated CpG islands in the mouse genome) and the rest distributed between other relatively CpG-
poor sequence features (Figure 1; Table1). Notably, while CpGs are not distributed uniformly in the 
genome, every RRBS sequence read includes at least one informative CpG position (from the 
recognition site; Figure 2), making the approach highly efficient. 
 
High-throughput bisulfite sequencing 
We validated high-throughout RRBS by sequencing MspI fragments from wild-type (V6.5; 
129SvJae/C57/B6 male) and methylation deficient (Dnmt[1kd,3a-/-,3b-/-]) ES cells 18, using an 
Illumina Genome Analyzer. We generated an initial set of ~21 million high quality, aligned RRBS 
reads. The reads from each cell type included ~97% of the predicted non-repetitive MspI fragments 
(median coverage 12x and 8x, respectively). This demonstrates that MspI based RRBS library 
construction is relatively unbiased (Figure 3) and insensitive to genome-wide CpG methylation 
levels (estimated by nearest-neighbor analysis (NNA) as 72% and 0.5%, respectively). Reads from 
methylation deficient cells showed 99% bisulfite conversion of CpGs, and reads from both cell 
types showed near complete (>99%) bisulfite conversion of non-CpG cytosines.  
 To investigate cell type-specific DNA methylation patterns, we generated 140 million 
additional RRBS reads (5.8 Gb of total sequence) from ES-derived neural precursor cells (NPCs) 
and various primary cell populations described below (Table 2). To study the relationship of DNA 
methylation and histone methylation patterns, we also generated new chromatin-state maps of H3 
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Figure 1. Reduced Representation Bisulfite Sequencing. a, Schematic overview of 
the RRBS approach. Genomic DNA is digested with methylation-insensitive MspI. 
Fragments between 40-220 bp are selected, treated with sodium bisulfite and 5’ end-
sequenced (see Figure 2 for more details). CpGs are represented as open 
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reads overlapping that site. The inferred methylation level is shown below each CpG 
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methylation). b, The MspI-based reduced representation fraction contains ~4.8% of 
all CpGs in the mouse genome, but is significantly enriched for HCPs and other CpG-
rich sequence features.
  
 
Table 1: RRBS coverage as a function of size selection 
 
RR digest: Mouse (mm8) Coverage CpG islands Enrichmentb 
Enzyme Range Fragments  Mba CpGs All ≥10 
CpGs 
CpG 
islands  
TSS Exons+
Introns 
MspI 40-120 186,429 13.4 853,075 13,105 12,303 63.1 7.8 1.4
MspI 100-220 185,349 13.3 700,518 12,152 10,492 31.0 5.1 1.3
MspI 220-400 144,683 10.4 472,895 7,840 3,783 11.7 3.6 1.4
MspI 40-220 333,104 24.0 1,383,382 14,353 13,633 47.5 6.5 1.3
MspI 40-400 476,883 34.3 1,853,073 15,015 14,200 36.7 5.6 1.3
 
The RRBS strategy can be applied to any mammalian genome. Due to the higher CpG and CpG 
island content of the human genome, the same size fractions will result in approximately twice as 
many fragments: 
 
RR digest: Human (hg18) Coverage CpG islands Enrichmentb 
Enzyme Range Fragments  Mba CpGs All ≥10 
CpGs 
CpG 
islands  
TSS  Exons+
Introns 
MspI 40-120 369,554 23.4 1,808,076 22,434 21,069 41.7 6.9 1.5
MspI 100-
220 
337,756 24.3 1,463,283 21,064 18,206 19.2 5.3 1.4
MspI 220-
400 
232,189 16.7 843,688 14,415 7,542 8.6 3.8 1.4
MspI 40-220 647,902 43.5 2,985,666 24,633 23,303 30.0 6.9 1.5
MspI 40-400 878,491 60.1 3,823,195 25,783 24,336 24.1 6.1 1.4
 
a Total unique and repetitive sequence covered, assuming 36 bp end reads 
b Relative to complete genome sequence 
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Table 2: RRBS libraries sequenced in this study 
 
RRBS Library source 
Analyzed 
(aligned, 
high-
quality) 
reads 
Distinct 
CpGs 
Median 
coverage 
(x) 
Median 
CpG 
methylation 
level (%) 
Astrocytes (in vitro, P18) 9,037,586 951,422 7 70 
Astrocytes (primary, 
P11) 9,638,968 928,227 10 42 
Astrocytes (primary, P2) 9,783,816 919,407 10 25 
B cells 6,416,120 894,879 7 17 
Brain 11,472,495 906,010 14 10 
CD4+ T cells 7,312,532 874,811 9 11 
CD8+ T cells 5,540,188 821,388 6 10 
ES cells 13,298,707 950,671 12 14 
ES cells (Dnmt deficient) 8,062,719 908,483 8 0 
Liver 7,983,808 668,614 8 9 
Lung 9,017,768 796,645 6 8 
Embryonic fibroblasts 9,289,500 903,921 8 23 
NPC (P18) 9,118,163 921,136 9 40 
NPC (P9) 11,150,501 912,408 9 55 
Sox1+ 11,314,731 972,024 11 29 
Sox1+-derived NPCs 12,872,974 996,991 11 35 
Tail-tip fibroblasts 10,571,236 948,249 9 11 
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Figure 3. RRBS Library representation from ES cells. a, The majority (97%) of non-
repetitive MspI fragment ends were observed at least once among 13 million 
aligned reads, and the median coverage was 12X. b, Median coverage was relatively 
similar for fragments of different lengths. 
lysine 4 mono- and di-methylation (H3K4me1 and H3K4me2) from ES cells, NPCs and whole 
brain tissue, using ChIP-Seq 19. 
 
DNA methylation correlates with histone methylation 
We began by analyzing the distribution of DNA methylation in wild-type ES cells. As the 
pluripotent in vitro counterpart of the inner cell mass, ES cells represent a key reference point for 
epigenomic studies 3,19-21.  
The methylation levels of CpG dinucleotides display a bimodal distribution (Figure 4), with 
the vast majority being either ‘largely unmethylated’ (<20% of reads showing methylation) or 
‘largely methylated’ (>80% of reads). As expected 1,15,22, CpGs in regions of high CpG density 
(>7% in a 300-bp window) tend to be unmethylated, while CpGs in low density regions (<5%) tend 
to be methylated. However, we noted that DNA methylation is not perfectly predicted by CpG 
density, particularly in regions of low density: ~10% of CpGs in low density regions were 
unmethylated, while ~0.3% of CpGs in high density regions were methylated. Because genomic 
features tend to be associated with distinct histone methylation patterns 19, we analyzed these 
features separately. We found that DNA methylation patterns were better explained by histone 
methylation patterns than by CpG density. 
High CpG-density promoters. In mammalian genomes, the vast majority of CpG islands 
are associated with two classes of genes: ‘housekeeping’ genes with ubiquitous expression and ‘key 
developmental’ genes with complex expression patterns 23. In ES cells, high CpG-density promoters 
(HCPs) at housekeeping genes are enriched with the transcription initiation mark H3K4me3 
(‘univalent’) and are highly expressed, or at least primed for rapid activation, while those at 
developmental genes are enriched with both H3K4me3 and the repressive mark H3K27me3 
(‘bivalent’) and are expressed at low levels 19,21. Both types of promoters are also enriched with 
H3K4me2, which is associated with an open chromatin confirmation. Of the 10,299 HCPs sampled 
(on average, 19 distinct CpGs per promoter), we found that virtually all contain at least a core 
region of unmethylated CpGs, regardless of their level of expression or H3K27me3 enrichment 
(Figures 4 and 5a); this is consistent with previous reports 21,22,24.  
Low CpG-density promoters. In contrast to HCPs, low CpG-density promoters (LCPs) are 
generally associated with highly tissue-specific genes. In ES cells, only a small subset of LCPs are 
enriched with H3K4me3 (~7%) or H3K4me2 (~3%), and essentially none are enriched with 
H3K27me3 19. We found that while most CpGs located in sampled LCPs (990 sites with ≥10X  
  342
0 50 100
All (≥10X)
n=543,678
0 50 100
HCP
n=193,531
0 50 100
LCP
n=990
0 50 100
HCNE
n=13,596
0 50 100
DMR
n=179
0 50 100
LTR
n=19,146
0 50 100
SINE
n=17,502
0 50 100
Other
n=202,533
n=442,171 n=165,096 n=792 n=10,772 n=143 n=14,737 n=12,638 n=156,998
<1
<3
<5
<7
<9
≥10
<1
<3
<5
<7
<9
≥10
20
40
60
0
20
40
60
0
Methylation level (%)
C
pG
s 
(%
) E
S
 c
el
ls
N
P
C
s
E
S
 c
el
ls
N
P
C
s
C
pG
 d
en
si
ty
 (%
)
Figure 4. CpG methylation levels in ES cells and NPCs. Distribution of inferred 
methylation levels for all CpGs with ≥10X coverage in either ES cells or NPCs. 
The top histograms show the distribution of methylation levels (%) across all 
CpGs, high CpG density promoters (HCP), low CpG density promoters (LCP), 
highly conserved non-coding elements (HCNE), differentially methylated regions 
(DMR), long terminal repeats (LTR), short interspersed elements (SINE) and 
other genomic features (n gives the number of CpGs in each category). 
Methylation levels are bimodal (except at DMRs), and correlate with sequence 
features and local CpG density. The bottom box plots show the distribution of 
methylation levels conditional on local CpG density (defined as fraction of CpGs 
in a 300-bp window; %). The red lines denote medians, notches the standard 
errors, boxes the interquartile ranges, and whiskers the 2.5th and 97.5th 
percentiles.
coverage from 392 promoters) are methylated, those in LCPs enriched with H3K4me3 or H3K4me2 
have significantly reduced methylation levels (Figure 6). 
 Distal regulatory regions. Establishment of correct gene expression patterns in 
mammalian cells often requires multiple cis-regulatory elements, such as enhancers, silencers and 
boundary elements 25. Cis-regulatory elements active in a particular cell type are often associated 
with markers of open chromatin, such as H3K4me2 or H3K4me1 26,27. Using our new ES cell 
chromatin state maps, we identified 25,051 punctuate sites of H3K4me2 enrichment in ES cells 
from 1 to >100 kb away from known promoters (the majority of these sites were also enriched with 
H3K4me1, but not with H3K4me3). We found that the CpGs sampled at the H3K4me2 enriched 
sites (outside of promoters and CpG islands) had significantly lower methylation levels than those 
at unenriched sites (Figure 5b). Interestingly, this relationship was particularly strong for CpGs 
located in highly conserved non-coding elements (HCNEs; Figure 5c).  
Imprinting control regions. The epigenetic process of imprinting typically involves allele-
specific histone and DNA methylation of CpG-rich regulatory elements known as imprinting 
control regions (ICRs) 28. Our RRBS library included sequence from 13 of the ~20 known ICRs (on 
average, 13 distinct CpGs per ICR). CpGs within these elements display a unimodal distribution of 
methylation levels, with a median close to 50%, which is consistent with hypomethylation of the 
active allele marked with H3K4me3 and hypermethylation of the silenced allele marked with 
H3K9me3 (Figure 4) 19. The 50:50 ratio at ICRs also demonstrates the quantitative nature of RRBS. 
Interspersed repeats. DNA methylation has been proposed to contribute to genome 
stability by suppressing the mobility of retrotransposons and other repetitive elements 1,29. Repeat 
families differ in their chromatin structure, with H3K9me3 enriched at active long terminal repeat 
(LTRs) and to a lesser extent long interspersed elements (LINEs), but not at short interspersed 
elements (SINEs). Notably, CpGs located in LTRs and LINEs are generally hypermethylated even 
in CpG-rich contexts (Figure 4). By contrast CpGs in SINEs show a correlation between 
methylation levels and CpG density that is comparable to non-repetitive sequences.  
 We conclude that the presence of H3K4 methylation and absence of H3K9 methylation are 
better predictors of unmethylated CpGs than sequence context alone. This is consistent with models 
where de novo methyl-transferases either specifically recognize sites with unmethylated H3K4 30 or 
are excluded by H3K4 methylation or associated factors. Similarly, H3K9me3 or associated factors 
may recruit DNMTs at ICRs and repetitive elements 31,32. 
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Figure 5. Correlation between DNA and histone methylation. a, Mean methylation 
levels across CpGs within each profiled HCP (requiring ≥5X coverage of ≥5 CpGs 
within the CpG island), conditional on their histone methylation state in ES cells 
and NPCs (n denotes the number of HCPs in each category; HCPs classified as 
enriched with H3K4me3 are generally also enriched for H3K4me2, but not vice 
versa). Loss of H3K4 methylation, and to a lesser extent H3K27me3, is strongly 
correlated with gain of DNA methylation. b, Methylation levels of individual CpGs 
outside of HCPs, conditional on overlapping enrichment of H3K4me2 (n denotes 
the number of distinct sites in each category). Changes in histone methylation 
state is strongly correlated with an inverse change in DNA methylation. 
c, Methylation levels of CpGs in HCNEs that do not overlap CpG islands, 
conditional on overlapping enrichment of H3K4me2. The red lines denote medians, 
notches the standard errors, boxes the interquartile ranges, and whiskers the 2.5th 
and 97.5th percentiles. All pair-wise comparisons of methylation levels at sites with 
changing chromatin states are significant (p < 10e-20; Mann-Whitney U test).
Dynamic changes in DNA methylation during differentiation 
We next used RRBS to analyze how patterns of DNA methylation change when ES cells are 
differentiated in vitro into a homogeneous population of neural precursor cells (NPCs) 33. While 
CpG methylation levels are highly correlated between the two cell types (ρ=0.81), there were clear 
differences: ~8% of CpGs unmethylated in ES cells became largely methylated in NPCs, while ~2% 
of CpGs largely methylated in ES cells became unmethylated. We found that the changes in CpG 
methylation upon differentiation were strongly correlated with changes in histone methylation 
patterns. 
 High CpG-density promoters. At both univalent and bivalent HCPs, we found that the 
vast majority of CpGs remained unmethylated upon differentiation, particularly within their core 
CpG island, but that loss of H3K4me3 and retention of H3K4me2 or H3K27me3 correlated with 
partial increase in DNA methylation levels (median ~25%; 2.9% and 12% of univalent and bivalent 
HCPs, respectively) and complete loss of H3K4 and H3K27 methylation correlated with DNA 
hypermethylation (median ~75%; 2.8% and 32% of univalent and bivalent HCPs, respectively; 
Figure 5).  
Low CpG-density promoters. Most LCPs marked by H3K4 methylation in ES cells lose 
this mark in NPCs; while LCPs associated with key genes expressed in NPCs (such as Fabp7 and 
Gpr56) gain this mark. Loss or gain of H3K4 methylation is a strong predictor of inverse changes in 
CpG methylation levels at these promoters (Figure 6), resulting in methylation patterns that are cell-
type specific. 
Distal regulatory elements. Our chromatin state maps revealed that 18,899 (75%) of non-
promoter sites enriched with H3K4me2 in ES cells lost this mark in NPCs, while 20,088 new 
H3K4me2 sites appeared, often in HCNE-rich regions surrounding activated developmental genes 
(Figure 7). Loss or gain of H3K4 methylation again correlated with a significant increase and 
decrease in CpG methylation levels, respectively (Figure 5b,c). In fact, these regions account for the 
majority of observed de-methylation events. Unlike for HCPs, the presence of H3K27me3 alone did 
not correlate with lower methylation levels in CpG-poor regions (Figure 8). 
 The data support the notion that CpG-rich and -poor regulatory elements undergo distinct 
modes of epigenetic regulation during cellular differentiation 1,19,22. The vast majority (>95%) of 
HCPs appear to be constitutively unmethylated and regulated by trithorax-group (trxG; associated 
with H3K4me3) and/or Polycomb-group (PcG; associated with H3K27me3) proteins, which may be  
recruited in part via non-specific unmethylated-CpG binding domains 34. Hypermethylation of these 
CpG-dense regions leads to exclusion of trxG/PcG activity, heterochromatin formation and
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Figure 6. Distribution of CpG methylation levels for (a) intermediate CpG-
density promoters (ICPs) and (b) low CpG-density promoters (LCPs), conditional 
on histone methylation states in ES cells and neural progenitor cells (NPCs). 
Changes in H3K4 methylation are significant correlated with inverse changes in 
DNA methylation levels (Mann-Whitney’s U test).
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essentially irreversible gene silencing 1,4. In contrast, promoters and other regulatory elements in 
CpG-poor sequence contexts appear to undergo extensive and dynamic methylation and de-
methylation. Hence, methylation of isolated CpGs may contribute to chromatin condensation or 
directly interfere with transcription factor binding 1,3,4, but do not necessarily prevent chromatin 
remodeling in response to activating signals.  
 
Comparison of in vitro and in vivo DNA methylation patterns 
As noted above, a small set of HCPs (n=252; ~3%) became hypermethylated (>75% mean 
methylation across sampled CpGs) upon in vitro differentiation of ES cells to NPCs. Because the 
role of HCP hypermethylation in normal development remains unclear 1, we next investigated 
whether the observed pattern reflects an in vivo regulatory mechanism (Figure9a-f).  
 We isolated NPCs from E13.5 embryos and differentiated them into Gfap-positive 
astrocytes (with no more than two passages in vitro). We similarly differentiated the in vitro–
derived NPCs into astrocytes (with these cells having undergone at least 18 passage since isolation 
from embryoid bodies). We then compared the in vivo- and in vitro-derived astrocyte populations, 
using RRBS. 
The methylation levels of CpGs were highly correlated (rho=0.85), but astrocytes obtained 
from in vivo NPCs displayed substantially less HCP hypermethylation than those obtained from ES 
cells (Figure 9a). The in vivo-derived astrocytes showed hypermethylation only at 30 HCPs, largely 
associated with germline-specific genes (including testis-specific transcription factors and meiosis-
related genes such as Dazl, Hormad1, Sycp1, Sycp2 and Taf7l), several of which showed partial 
methylation even in ES cells. In contrast, the in vitro-derived astrocytes showed hypermethylation 
of ~305 additional HCPs, in addition to the germline-specific genes. This set includes some genes 
known to be expressed by at least some in vivo astrocytes (including Isyna1, Gsn and Cldn5; 35), but 
which were silent in the ES-cell derived astrocytes. However, the hypermethylated HCPs are 
significantly enriched for genes not normally expressed in neural progenitors or the astrocyte 
lineage (Tables 3-6). They include genes involved in neuronal (Lhx8, Lhx9, Moxd1, Htf1, Slit1) or 
ependymal (Otx2, Kl) differentiation and function, as well as developmental genes associated with 
unrelated lineages (muscle-specific Myod1, Sertoli- and Schwann cell-specific Dhh and prostate-
specific Nkx3-1). In fact, we found that ‘key developmental’ HCPs that are bivalent in ES cells are 
six times more likely to be included in the hypermethylated set, compared to univalent 
‘housekeeping’ HCPs. Moreover, univalent genes in the hypermethylated set are expressed at 
significantly lower levels in both ES cells and primary astrocytes, compared to those that remained  
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Figure 7. Developmentally regulated de-methylation of highly conserved non-coding 
elements. Comparison of histone and DNA methylation levels across the Olig1/2 
neural-lineage transcription factor locus. Chip-Seq tracks for H3K4me1/2/3 and 
H3K27me3 in ES and NPCs are shown. The unmethylated CpG-rich promoters 
are bivalent and inactive in ES cells and resolve to univalent H3K4me3 as the genes 
are activated in NPCs. Several regions of H3K4me2 enrichment appear over HCNEs 
distal to the two genes, and this correlates with CpG de-methylation. Inferred 
methylation values for selected CpGs (40 out of 215 sampled by RRBS in the 
region) are shown and color-coded (red indicates largely methylated (>80%); green 
indicates largely unmethylated (<20%).
Table 3: GO Categories enriched for HCPs with > 75% mean methylation in 
ES-derived astrocytes 
 
GO 
category 
Description p-
valuea 
Genes associated with methylated HCPsb 
GO:0007126 Meiosis 6.19E-
05 
Msh4,Sycp3,Sycp2,Spo11,Syce2,Sycp1,Dmc1 
GO:0007155 Cell adhesion 0.00014
1 
Dsc2,Cd97,Dsg2,Nlgn2,Cpxm2,Gp1bb,Lamc2, 
Scarf2,Pkp1,Pgm5,Ctgf,Col9a3,Parvb,Aebp1, 
Itga4,Col2a1,Cldn11 
GO:0007165 Signal transduction 0.00151
7 
Cd97,Gpr176,Cspg4,F2rl1,Lep,Gpr64,Ptger2, 
Plcd1,Sstr1,Oxtr,Tnfrsf25,Fgfr4,Galr2,Fgf20, 
Sstr4,Gpr83,Irak3,Fgf17,Prokr1,Prlhr,Stat5a, 
... 
GO:0007283 Spermatogenesis 0.00259
2 
Taf7l,Sycp3,Spag6,Dazl,Dmc1,D1Pas1,Msh4, 
Cldn11,Spag16 
GO:0009190 Cyclic nucleotide 
biosynthetic 
process 
0.00590
6 
Gucy2e,Npr1,Adcy7 
GO:0006811 Ion transport 0.00692
2 
Scnn1b,Grin2a,Clic6,Grik2,Atp2a3,Kcnj10, 
Slc34a2,Trpm6,Kcng1,Slc13a3,Kcna6,Bspry, 
Slc5a5,Pllp,Kcnb1,Tmem37,Mcoln2 
GO:0001541 Ovarian follicle 
development 
0.00788
7 
Msh4,Dmc1,Spo11 
GO:0006508 Proteolysis 0.00819
3 
Mmp2,Ccdc79,Mmp23,A530088I07Rik,Agbl2, 
Mmp14,Casp8,Wdr31,Pgm5,Aebp1,Dhh, 
Adamts5,Npepl1 
GO:0007275 Multicellular 
organismal 
development 
0.00848 Taf7l,Cspg4,Myod1,Dkk3,Nnat,Hoxd12, 
Sema4b,Nodal,Lect1,Pgf,Dazl,Dhh,Amn,Dll3, 
Tnfaip2,Ddx4,Slit1,Nsd1,Hhat,Cdx1,Nkx3.1, 
... 
GO:0007218 Neuropeptide 
signaling pathway 
0.01128
3 
Npb,Sstr1,Gal,Gpr64,Cd97 
GO:0001525 Angiogenesis 0.01441
9 
Ctgf,Casp8,Tnfaip2,Pgf,Cspg4,Plcd1 
GO:0007517 Muscle 
development 
0.03182
6 
Des,Ky,Myod1 
GO:0016477 Cell migration 0.03212 Ctgf,Mmp14,Nodal,Itga4 
GO:0006836 Neurotransmitter 
transport 
0.03672 Slc18a2,Slc6a2,Slc6a11 
 
a Nominal p-value of set enrichment based on Fisher’s exact test (two-tailed) 
b Based on GO annotations obtained form http://geneontoloy.org 
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Figure 8. Correlations between histone methylation, expression levels and CpG 
methylation levels outside of annotated promoters and CpG islands in ES cells. 
a, H3K4me3 or H3K4me2 are  correlated with low DNA methylation, whereas 
H3K36me3 and H3K27me3 alone is correlated with high DNA methylation levels. 
b, Distribution of methylation levels for CpGs overlapping known genes (excluding 
promoter regions), conditional on expression levels. Low = normalized absolute 
expression level < 50; Med >= 50 and < 200; High >= 200.
Table 4: GO Categories enriched for HCPs with > 50% mean methylation in 
ES-derived astrocytes 
 
GO 
category 
Description p-value a Genes associated with methylated HCPsb 
GO:0007165 Signal 
transduction 
7.01E-06 Gpr37,Edaradd,Cd97,Grm8,Fgf15,Gpr176, 
Gpr101,Cspg4,F2rl1,Wnt3,Lep,Gpr64,Edg3, 
Ptger2,Plcd1,Gpr12,Sstr1,Oxtr,Grb10,Tnfrsf25,
Gm266,Ltb4r2,Fgfr4,Galr2,Drd5,Gpr156,Hif3a, 
... 
GO:0007155 Cell adhesion 2.82E-05 Dsc2,Nlgn1,Cd97,Itgb4,Dsg2,Nlgn2,Cpxm2, 
Gp1bb,Lamc2,Pcdhac1,Scarf2,Sdk2,Pkp1, 
Pgm5,Ctgf,Col9a3,Parvb,Col18a1,Aebp1,Perp,
... 
GO:0007275 Multicellular 
organismal 
development 
2.82E-05 Ndrg2,Edaradd,Taf7l,Vamp5,Itgb4,Cspg4, 
Myod1,Lmx1b,Dkk3,Wnt3,Churc1,Nnat, 
Hoxd12,Bmp3,Sema4b,Snai1,Boll,Bmp8b, 
... 
GO:0006817 Phosphate 
transport 
6.48E-05 Scara3,Col2a1,Emid1,Col25a1,Col18a1, 
Col12a1,Slc34a2,Gldn,Emid2 
GO:0007126 Meiosis 0.00013 Msh4,Sycp3,Sycp2,Spo11,Syce2,Smc1b, 
Sycp1,Dmc1,Boll 
GO:0006811 Ion transport 0.00115 Scnn1b,Kcnf1,Grin2a,Clic6,Grik2,Atp2a3, 
P2rx5,Kcnj10,Slc34a2,Kcnk13,Trpm6,Kcng1, 
Kcnc4,Slc13a3,Slc39a8,Kcna6,Bspry,Slc5a5, 
... 
GO:0030199 Collagen fibril 
organization 
0.01084 Col2a1,Tnxb,Lox,Lmx1b 
GO:0001525 Angiogenesis 0.01566 Ctgf,Col18a1,Casp8,Tnfaip2,Sox18,Htatip2, 
Pgf,Cspg4,Plcd1 
GO:0051216 Cartilage 
development 
0.01936 Bmp3,Gnas,Bmp8b,Lect1 
GO:0007268 Synaptic 
transmission 
0.02197 Chrna3,Grin2a,P2rx2,Nrxn2,Grik2,Grm8 
GO:0001501 Skeletal 
development 
0.02207 Rai1,Dll3,Hoxd10,Gnas,Hoxa11,Hoxd12,Pthlh 
GO:0006629 Lipid metabolic 
process 
0.02731 Fads3,Srebf1,Pcsk9,Acot12,Mlstd1,Slc27a3, 
Tnxb,Lep,Acot6,Slc27a2,Plcd1 
GO:0006508 Proteolysis 0.02961 Ctsf,Mmp2,Gpr26,Dnahc11,Ccdc79,Mmp23, 
A530088I07Rik,Agbl2,Mmp14,Casp8,Wdr31, 
Pgm5,Aebp1,Pcsk9,Dhh,St14,Adamts5,Ctsh, 
... 
GO:0007283 Spermatogenesis 0.04606 Boll,Bmp8b,Taf7l,Sycp3,Spag6,Dazl,Dmc1, 
D1Pas1,Msh4,Cldn11,Spag16 
GO:0007517 Muscle 
development 
0.04622 Des,Ky,Tagln2,Myod1 
GO:0001541 Ovarian follicle 
development 
0.04828 Msh4,Dmc1,Spo11 
 
a Nominal p-value of set enrichment based on Fisher’s exact test (two-tailed) 
b Based on GO annotations obtained form http://geneontoloy.org 
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Figure 9. HCP hypermethylation of cultured cells. Inferred mean methylation levels 
(%) across autosomal HCPs (requiring ≥5X coverage of ≥5 CpGs within the CpG 
island) are compared between different cell populations. a, ES-derived astrocytes 
contains roughly 10 times more hypermethylated HCPs than primary astrocytes 
after 2 passages in culture. b, Continued passage of primary astrocytes lead to 
gradual hypermethylation of many of the same HCPs as in ES-derived astrocytes. 
c, Only a handful of mainly germ line-specific HCPs display significant methylation 
levels in a whole brain tissue sample. d, The vast majority of HCPs are unmethylated 
in ES cells, but a small subset gain significant methylation upon differentiation to 
NPCs. e, Continued proliferation of NPCs leads to additional HCPs becoming 
hypermethylated after 18 passages. f, Differentiation of late-stage NPCs into 
astrocytes by growth factor withdrawal does not lead to additional HCP 
hypermethylation. g, Expression levels of genes associated with profiled HCPs for 
ES cells, ES-derived astrocytes (A), primary neocortical (AN) and cerebellar (AC) 
astrocytes. Hypermethylation of HCPs is strongly correlated with low expression 
levels in ES-derived astrocytes. HCPs that are univalent in ES cells and become 
hypermethylated in ES-derived astrocytes are associated with lower expression levels 
in both ES cells and primary astrocytes. h, The maximal CpG density (300 bp window) 
of hypermethylated HCPs in ES cell or ES-derived astrocytes is significantly lower 
than for unmethylated HCPs. The red lines denote medians, notches the standard 
errors, boxes the interquartile ranges, and whiskers the 2.5th and 97.5th percentiles.
  
 
Table 5: GO Categories depleted for HCPs with > 75% mean methylation in 
ES-derived astrocytes 
 
GO 
category 
Description p-value a Genes associated with methylated HCPsb 
GO:0006512 Ubiquitin cycle 0.000243 Parc 
GO:0015031 Protein transport 0.001639 Lin7b,Rasef 
GO:0006412 Translation 0.010517 Eef1a2 
GO:0006886 Intracellular 
protein transport 
0.016169  
GO:0008380 RNA splicing 0.023412  
GO:0006397 mRNA processing 0.031508 Papolb 
 
a Nominal p-value of set enrichment based on Fisher’s exact test (two-tailed) 
b Based on GO annotations obtained form http://geneontoloy.org 
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Figure 10. Distribution of CpG methylation levels inferred from a whole brain RRBS 
library. a, Distribution of inferred methylation levels for all CpGs with ≥10X coverage 
in either ES cells or NPCs. The top histograms show and the distribution of 
methylation levels (%) across all CpGs, high CpG density promoters (HCP), 
intermediate CpG density promoters (ICP), low CpG density promoters (LCP), highly 
conserved non-coding elements (HCNE), differentially methylated regions (DMR), 
long terminal repeats (LTR), short interspersed elements (SINE) and other genomic 
features (n gives the number of CpGs in each category).The distribution of methylation 
levels is bimodal and correlated with CpG density and genomic features in a pattern 
similar to the observed in ES cells. b, The distribution of CpG and histone methylation 
states for HCPs in ES cells and whole brain. The vast majority of HCPs that are 
univalent (H3K4me3) in ES cells also show this state in the brain sample. The vast 
majority of HCPs that are bivalent in ES cells, retain at least one of these marks in 
the brain sample (enrichment of H3K4me3 and H3K27me3 may not represent 
bivalency due to heterogeneity). The absence of both H3K4me3 and H3K27me3 
correlates with hypermethylation. The red lines denote medians, notches the standard 
errors, boxes the interquartile ranges, and whiskers the 2.5th and 97.5th percentiles.
 
 
 
Table 6: GO Categories depleted for HCPs with > 50% mean methylation in 
ES-derived astrocytes 
 
GO 
category 
Description p-value a Genes associated with methylated HCPsb 
GO:0006512 ubiquitin cycle 7.33E-08 Fbxo17,Parc 
GO:0015031 protein transport 9.07E-06 Rab3b,Pitpnm1,Lin7b,Sec31b,Rasef 
GO:0006412 translation 0.0001 Rps20,Eef1a2 
GO:0006397 mRNA processing 0.00014 Papolb 
GO:0008380 RNA splicing 0.00023  
GO:0006886 intracellular 
protein transport 
0.001 Rab3b 
GO:0006281 DNA repair 0.00444 Mpg 
GO:0006974 response to DNA 
damage stimulus 
0.00448 Mpg 
GO:0006457 protein folding 0.0091  
GO:0042254 ribosome 
biogenesis and 
assembly 
0.0141  
GO:0016568 chromatin 
modification 
0.02006 Nsd1 
GO:0051726 regulation of cell 
cycle 
0.02915 Cdkl1 
GO:0006511 ubiquitin-
dependent protein 
catabolic process 
0.03008 Parc 
GO:0051301 cell division 0.03397 Sycp3,Sycp1,Syce2,Sycp2 
 
a Nominal p-value of set enrichment based on Fisher’s exact test (two-tailed) 
b Based on GO annotations obtained form http://geneontoloy.org 
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Figure 11. Inferred mean methylation levels (%) of autosomal HCPs compared 
across different primary and ES-derived cell populations. a-e, primary cell types 
contain only ~20-30 hypermethylated HCPs, largely associated with germline-
specific genes. f-h, Progressive hypermethylation of HCPs during continued 
proliferation of Sox1+ progentior cells. Sox1+ is the earliest known marker of 
neural progenitors and therefore allows isolation of a differentiated ES-derived 
population after minimal time in culture. There is initially little methylation in these 
cells, but after 11 passages in culture, many of the same HCPs that were 
methylated in the original NPC populations have also become methylated in 
Sox1+-derived NPCs.
ba
ed
c
gf h
hypomethylated (Figure 9g). We also found that the hypermethylated HCPs tend to have a 
somewhat lower CpG density (~15% lower; Figure 9h). 
To further investigate the differences between in vitro and in vivo cell populations, we also 
constructed RRBS and ChIP-Seq libraries directly from whole brain tissue (representing cells of 
mainly glial origin). We found that virtually all (>99%) of sampled HCPs were unmethylated 
(Figure 9c) and enriched with H3K4me3 and/or H3K27me3 (Figure 10), with ~20 germline-specific 
HCPs being the only clear exceptions. RRBS libraries from other in vivo sources (CD4+ and CD8+ 
T-cells, B-cells, lung, liver, and embryonic and tail-tip fibroblasts) also showed low levels of 
hypermethylated promoters (Figure 11). This strongly suggests that – apart from silencing germ-
line specific genes 22, imprinted genes and X-inactivated (Figure 12) genes in somatic tissues – 
hypermethylation of HCPs is not a major mechanisms of normal developmental regulation in vivo.  
To test for a correlation between passage number and HCP hypermethylation, we examined 
cell populations derived from intermediate degrees of passage in vitro. We studied independently 
derived, early stage NPCs collected after only 9 passages; these cells displayed HCP 
hypermethylation at approximately half of the HCPs that are hypermethylated in the late stage 
NPCs (Figure 9d,e). To further reduce time in culture, we used a Sox1-GFP knock-in ES cell line 
(Sox1-GFP 129/129) 36. Sox1 is the earliest known marker for neural progenitors and allows 
isolation by FACS of a homogenous population of very early progenitor cells. These cells initially 
displayed virtually no HCP hypermethylation. However, after continued culturing they acquired 
hypermethylation at many of the same HCPs as the previous NPC populations (Figure 11). Finally, 
we grew the in vivo-derived astrocyte population discussed above for 11 passages in vitro and then 
examined its methylation pattern. Strikingly, these cells had also begun to acquire hypermethylation 
at a largely similar set of HCPs (Figure 9a,b). 
These results imply that independently derived NPC populations from both in vitro and in 
vivo sources and different genetic backgrounds reproducibly undergo hypermethylation at a 
characteristic set of HCPs, with the process beginning gradually and becoming more prominent 
with increased passage number.   
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Figure 12. Comparison of methylation levels (%) for CpGs within and 
outside of HCPs in male and female cell populations (ES-derived and 
primary astrocytes, respectively). CpG islands show an average of ~50% 
methylation in the female population, consistent with hypermethylation of 
HCPs on the inactivated X-chromosome.
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Discussion 
The RRBS method makes it feasible to perform genome-wide bisulfite sequencing on large-
mammalian genomes, providing a valuable tool for epigenetic profiling of cell populations. 
Bisulfite sequencing is highly reproducible and provides absolute quantitation of methylation levels 
at nucleotide resolution. As sequencing capacity increases, genome coverage can be readily scaled 
in step by adding additional restriction enzymes or increasing the selected size range. 
Comparative analysis of DNA and histone methylation profiles in ES cells and NPCs 
reveals novel insights into the relationship between these epigenetic marks and the genome 
sequence. While various studies have attempted to predict DNA methylation levels from sequence 
context 37,38, we find that cell type-specific histone H3K4 methylation is a significantly better 
predictor of DNA methylation levels. In regions where H3K4 methylation levels change upon 
differentiation from ES cells to NPCs, CpG methylation shows a significant inverse correlation. 
Notably, while all previous genome-scale DNA methylation analyses have focused on CpG islands 
or promoter regions, our analysis reveals that the majority of differentiation-associated changes take 
place in relatively low CpG density distal regulatory regions. 
Comparison of in vitro and in vivo cell populations show that key developmental regulators 
that are bivalent in ES cells and expressed at low levels in the cell type or lineage studied, and also 
HCPs that have lower than average CpG density, are particularly susceptible to culture-induced 
hypermethylation. These observations have several implications. 
First, generating cellular models by directed differentiation of pluripotent cells is of central 
interest for developmental biology and regenerative medicine. Aberrant epigenetic regulation in 
culture have raised concern over the accuracy of such models 10-12. For example, it is well known 
that both primary and transformed cell lines often lose developmental potency after continued 
proliferation in culture 10. The efficiency of neuronal differentiation of the multipotent NPC 
populations studied here declines with increased passage number 19,39,40. Susceptibility to 
hypermethylation at key regulatory genes that are normally activated upon differentiation could 
explain this phenomenon.  
Second, malignant cells are often found to harbor hypermethylated CpG islands 7-9. 
Recently, genes known to undergo frequent hypermethylation in adult cancers were noted to be 
significantly enriched for genes with bivalent promoters in ES cells 41-43. It was therefore suggested 
that hypermethylation of genes during tumorigenesis may be initiated by the presence of Polycomb 
group proteins (associated with H3K27 methylation), although functional studies have been 
inconclusive 44. The similarities between hypermethylation both in culture and in cancer (and 
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potentially aging 9) may provide a useful in vitro model for studying a common underlying 
mechanism. 
Finally, the gradual hypermethylation of lower density HCPs hints at underlying kinetics. 
Since H3K4 methylases are targeted to HCPs, at least in part by non-specific CpG-binding domains 
34, lower CpG density likely contributes to a lower rate of H3K4 methylation. Such HCPs may 
therefore be particularly sensitive to imbalanced chromatin modifying factors or other culture-
induced perturbations. 
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Methods 
 
Cell culture and ES cell differentiation. V6.5 ES cells and Sox1-EGFP ES cells 36 were expanded 
on γ-irradiated mouse embryonic fibroblasts in DMEM plus 15% fetal bovine serum (FBS; 
Hyclone) supplemented with 1x MEM-nonessential amino acids (Life Technologies), 0.1mM 2-
mercaptoethanol, and 103U/ml leukemia inhibitory factor (LIF). After passaging onto gelatin-coated 
dishes (0.1% gelatin; Sigma), ES cells were trypsinized and transferred to bacterial dishes allowing 
embryoid body (EB) formation. EBs were propagated for 4 days in the same medium in the absence 
of LIF and subsequently plated onto tissue culture dishes. One day after plating, the medium was 
replaced by ITSFn, i.e. DMEM/F12 (Life Technologies) supplemented with 5 µg/ml insulin, 50 
µg/ml human APO transferrin, 30 nM sodium selenite (all Sigma), 2.5 µg/ml fibronectin and 
penicillin/streptomycin (both Life Technologies). After 5-7 days, cells were trypsinized, triturated 
to a single cell suspension, replated on laminin-coated dishes (1µg/ml; Life Technologies) and 
further propagated in N3 medium composed of DMEM/F12, 25 µg/ml insulin, 50 µg/ml transferrin, 
30 nM sodium selenite, 20 nM progesterone, 100 nM putrescine (Sigma), 10 ng/ml FGF2 (R&D 
Systems, Wiesbaden-Nordenstadt, Germany) and penicillin/streptomycin. Neural precursor cell 
proliferation was maintained by daily additions of FGF2. Sox1-EGFP positive neural precursors 
were isolated and FACS-purified (FACS Aria, Becton Dickinson) either from ITSFn cultures or 
after short-term expansion in FGF2. Growth factor withdrawal of these cultures results in terminal 
differentiation into primarily neuronal cell populations 45. Neural precursor cell lines were obtained 
by sequential passaging and propagation in the presence of 20ng/ml EGF and 10 ng/ml FGF2 (both 
R&D Systems). Differentiation into astrocytes was induced by growth factor withdrawal and 
addition of 5% FBS for 5 days. 
Primary tissues and cell types. Primary tissues were isolated from 4-6 week old male 
129SvJae/C57/B6 mice. Mouse embryonic fibroblasts (MEFs) and primary neural precursors were 
isolated from 129SvJae/C57/B6 E14.5 embryos. MEFs were generated according to standard 
protocols. In vivo neural precursors were isolated by disaggregating the whole brain and plating the 
suspension under the conditions described above. Established lines were differentiated into 
astrocytes by growth factor withdrawal and addition of serum (see above). 
MspI RRBS library construction. 1-10 µg mouse genomic DNA was digested with 10-100 U of 
MspI (NEB) in a 30-500 µl reaction overnight at 37ºC. Digested DNA was phenol extracted, 
ethanol precipitated and size selected on a 4% NuSieve 3:1 Agarose gel (Lonza). DNA marker lanes 
were excised from the gel and stained with SYBR Green (Invitrogen). For each sample, two slices 
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containing DNA fragments of approximately 40-120 bp and 120-220bp, respectively, were excised 
from the unstained preparative portion of the gel. DNA was recovered using Easy Clean DNA spin 
filters (Primm labs, Boston, MA, USA), phenol extracted and ethanol precipitated. The two size 
fractions were kept apart throughout the procedure including the final sequencing. Size-selected 
MspI fragments were filled in and 3’-terminal A extended in a 50µl reaction containing 20 U 
Klenow exo- (NEB), 0.4 mM dATP, 0.04 mM dGTP, and 0.04 mM 5-methyl-dCTP (Roche) in 1X 
NEB buffer 2 (15 min at room temperature followed by 15 min at 37ºC), phenol extracted and 
ethanol precipitated with 10 µg glycogen (Roche) as a carrier. Ligation to pre-annealed Illumina 
adapters containing 5’-methyl-cytosine instead of cytosine (Illumina) was performed using the 
Illumina DNA preparation kit and protocol. QIAquick (QIAGEN) cleaned-up, adapter-ligated 
fragments were bisulfite-treated using the EpiTect Bisulfite Kit (QIAGEN) with minor 
modifications: The bisulfite conversion time was increased to approximately 14 hours by adding 3 
cycles (5 min of denaturation at 95ºC followed by 3 hours at 60 ºC). After bisulfite conversion, the 
single-stranded uracil-containing DNA was eluted in 20 µl of EB buffer. Analytical (25 µl) PCR 
reactions containing 0.5 µl of bisulfite-treated DNA, 5 pmol each of genomic PCR primers 1.1 and 
2.1 (Illumina) and 2.5 U PfuTurboCx Hotstart DNA polymerase (Stratagene) were set up to 
determine the minimum number of PCR cycles required to recover enough material for sequencing. 
Preparative scale (8 x 25 µl) PCR was performed using the same PCR profile: 5 min at 95ºC, n x 
(30 s at 95ºC, 20 s at 65ºC, 30 s at 72 ºC) followed by 7 min at 72ºC, with n ranging from 18 to 24 
cycles. QIAquick purified PCR products were subjected to a final size selection on a 4% NuSieve 
3:1 Agarose gel. SYBR Green-stained gel slices containing adapter-ligated fragments of 130-210 bp 
or 210-310 bp in size were excised. RRBS library material was recovered from the gel (QIAquick) 
and sequenced on an Illumina 1G Genome Analyzer. 
Sequence alignments and data analysis. Sequence reads from bisulfite-treated Solexa libraries 
were analyzed using a custom computational pipeline. Residual Cs in each read were first converted 
to Ts, with each such conversion noted for subsequent analysis. A reference sequence database was 
constructed from the 36 bp ends of each computationally predicted MspI fragment in the 40-220 bp 
size range. All Cs in each fragment end was then converted to Ts (only the C-poor strands are 
sequenced in the RRBS process; Figure 2).  
The converted reads were aligned to the converted reference by finding all 12 bp perfect 
matches and then extending to both ends of the treated read, not allowing gaps (reverse complement 
alignments are not considered). The number of mismatches in the induced alignment were then 
counted between the unconverted read and reference, ignoring cases where a T in the unconverted 
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read is matched to a C in the unconverted reference. For a given read, the best alignment was kept if 
the second best alignment had ≥2 more mismatches, otherwise the read was discarded as non-
unique. Low quality reads were identified and discarded if 1010 1000
q
q Q∈
>∑ , where Q denotes the 
read quality scores at each mismatched position. The methylation level of each sampled cytosine 
was estimated as the number of reads reporting a C, divided by the total number of reads reporting a 
C or T, counting only reads with quality scores of ≥20 at the position. 
 HCP, ICP and LCP annotations were taken from 19. CpG island and other annotations were 
downloaded from the UCSC browser (mm8). Estimation of methylation levels from individual 
CpGs was limited to those with ≥10X coverage. The methylation level of an HCP promoter was 
estimated as the mean methylation level across all CpGs with ≥5X coverage overlapping the 
annotated CpG island(s) in the promoter, requiring at least 5 such CpGs. HCPs were classified as 
hypermethylated if this mean methylation level was ≥75%. 
Chromatin immunoprecipitation. H3K4me1 (ab8895), H3K4me2 (ab7766) and H3K4me3 
(ab8580) antibodies were purchased from Abcam. ChIP experiments on mouse ES cells 
(H3K4me1/2), NPCs (H3K4me1/2) and whole brain tissue (H3K4me1/2/3), Illumina/Solexa 
sequencing, alignments and identification of significantly enriched regions (using 1 kb sliding 
windows and correction for alignability) were carried out as described previously 19.  
Expression data. RNA expression for ES-derived astrocytes were generated as described 
previously 19. Primary astrocyte data was obtained from 35. 
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Chapter 9: Integrative analysis of cellular reprogramming 
 
In this chapter, we describe an integrative analysis of changes in gene expression, histone 
methylation and DNA methylation during direct reprogramming of somatic cells to a pluripotent 
state. 
This work was first published as 
Mikkelsen, T. S. et al. Dissecting direct reprogramming through integrative genomic analysis 
Nature 454, 49-55 (2008). 
This publication is attached as Appendix 8. Supplementary notes can be found at the end of the 
chapter. Supplementary data is available online from http://www.nature.com/nature 
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 Somatic cells can be reprogrammed to a pluripotent state through the ectopic expression of 
defined transcription factors. Understanding the mechanism and kinetics of this remarkable 
transformation may shed light on the nature of developmental potency and suggest strategies 
with improved efficiency or safety. Here we report an integrative genomic analysis of 
reprogramming of murine fibroblasts and B lymphocytes. Lineage-committed cells show a 
complex response to the ectopic expression involving induction of genes downstream of 
individual reprogramming factors. Fully reprogrammed cells show gene expression and 
epigenetic states that are highly similar to embryonic stem cells. In contrast, stable partially 
reprogrammed cell lines show reactivation of a distinctive subset of stem cell-related genes, 
incomplete repression of lineage-specifying transcription factors, and DNA hypermethylation 
at pluripotency-related loci. These observations suggest that (i) some cells may become 
trapped in partially reprogrammed states due to incomplete repression of transcription 
factors, and (ii) DNA de-methylation is an inefficient step in the transition to pluripotency. We 
demonstrate that RNA inhibition of transcription factors can facilitate reprogramming, and 
that treatment with DNA methyltransferase inhibitors can improve the overall efficiency of 
the reprogramming process.  
Mouse and human cells can be reprogrammed to pluripotency through ectopic expression of 
defined transcription factors 1-8 (“direct reprogramming”). Generation of such induced pluripotent 
stem (iPS) cells may provide an attractive source of patient-specific stem cells 2,4,6,7,9 (reviewed in 
refs. 10,11). However, the mechanism and nature of molecular changes underlying the process of 
direct reprogramming remain largely mysterious 11. It is a slow and inefficient process that currently 
requires weeks, with the vast majority of cells failing to reprogram 2,9,12-14. A clearer understanding 
of the process would enable development of safer and more efficient reprogramming strategies, and 
it might shed light on fundamental questions concerning the establishment of cellular identity.  
 To identify possible obstacles to reprogramming and to use this knowledge to devise ways 
to accelerate the transition to full pluripotency, we undertook a comprehensive genomic 
characterization of cells at various stages of the reprogramming process. The characterization 
involved gene expression profiling, chromatin state maps of key activating and repressive marks 
(histone H3 K4me3 and K27me3), and DNA methylation analysis. 
 
  371
10 0 10 1 10 2 10 3 10 4
FL1-H
100 101 10 2 10 3 104
FL1-H
100 101 102 10 3 10 4
FL1-H
100 101 102 10 3 10 4
FL1-H
100 10 1 102 10 3 104
FL1-H
Day 0 Day 4 Day 8
Day 12 Day 16
SSEA1
1.2%22%10.2% 0.6%
0.04%2.9%0%0% 0%0%
Figure 1. Nanog-GFP MEFs were induced with doxycycline and monitored 
without passaging (parallel plates were induced and harvested at different time 
points). At day 8, SSEA1 positive cells and some GFP postive cells appear. At 
day 16, about 22% of the cells had become SSEA1 positive and around 1.2% 
SSEA1/GFP double positive.
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
     GFP (Nanog)
S
S
E
A
1
 Response to reprogramming factors in lineage-committed cells 
We first studied the response of lineage-committed cells to ectopic expression of the four 
reprogramming factors Oct4, Sox2, Klf4 and c-Myc. Because the vast majority of induced cells fail 
to achieve successful reprogramming, we reasoned that genomic characterization might yield 
insights into the basis of the low overall efficiency of the method. 
To eliminate heterogeneity due to differential viral integration, we studied mouse 
embryonic fibroblasts (MEFs) isolated from chimeric mice that had been generated from an iPS cell 
line, carrying integrated doxycycline (Dox)-inducible lentiviral vectors with the four 
reprogramming factors and a Nanog-GFP reporter gene 13,15. We induced the expression of the 
reprogramming factors and obtained gene expression profiles at days 4, 8, 12 and 16. Fluorescence 
activated cell sorting (FACS) analysis on day 16 showed that ~20% of the cells stained positive for 
the stem-cell marker SSEA1, but only ~1.2% had achieved complete reprogramming, as indicated 
by activation of the Nanog-GFP reporter (Figure 1) and consistent with previous reports 13,14. 
The immediate response to induction of the reprogramming factors (>3-fold change by day 
4) is characterized by de-differentiation from the wild-type MEF state and up-regulation of 
proliferative genes. De-differentiation is evident in significant decrease (5-40 fold) in expression 
levels of typical mesenchymal genes expressed in MEFs (for example, Snai1, Snai2). The 
proliferative response is evident in up-regulation of genes with functions such as DNA replication 
(Poli, Rfc4, Mcm5) and cell cycle progression (Ccnd1, Ccnd2); this response may be consistent with 
expression of reprogramming factor c-Myc 10,16. 
We also detect a significant increase in expression of stress-induced and anti-proliferative 
genes. In particular, we detect a sustained 5-10 fold up-regulation of Cdkn1a and Cdkn2a, which 
encode cyclin-dependent kinase (CDK) inhibitors that are key effectors of multiple differentiation 
and tumor suppressor pathways. Cdkn1a is a downstream target of the reprogramming factor Klf4 
17, while Cdkn2a is known to be activated by deregulated c-Myc expression 18. This response was 
followed by gradual up-regulation of genes associated with differentiating MEFs (Pparg, Fabp4, 
Mgp) on days 12-16. This suggests that induction of the reprogramming factors triggers normal 
‘fail-safe’ mechanisms that act to prevent uncontrolled proliferation, which may prevent the 
majority of cells from reaching a stably de-differentiated state. 
Interestingly, we also detect strong up-regulation of lineage-specific genes from unrelated 
lineages. These include axon guidance factors (Epha7, Ngef), epidermal (Krt14, Krt16, Ivl, Sprr1a) 
and glomerular proteins (Podxl). We speculate that this gene activation reflects responses to the  
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Figure 2. Gene expression profiling. Relative expression levels across differentiated, 
partially reprogrammed and pluripotent cell populations. The dendrogram was 
generated by complete linkage hierarchical clustering using Pearson correlation on 
all measured genes. Only genes with at least 2-fold difference between any pair of 
samples from different classes are shown in the heatmap. Red, white and blue 
indicate higher, identical and lower relative expression, respectively.
 reprogramming factors Sox2 and Klf4, which, independent of their roles in ES cell regulation, 
function in neural, epidermal and kidney differentiation 10,17. 
 
Pluripotent cell lines 
We next studied the changes to gene expression patterns and epigenetic states seen in successfully 
reprogrammed iPS cells. We analyzed three cell lines: MEF derived iPS cells carrying an Oct4-GFP 
reporter (MCV8.1; corresponding to subclone 8.1 in 12); mature B lymphocyte-derived iPS cells 
carrying a Nanog-GFP reporter (B-iPS) 15; and wild-type ES cells (V6.5) 19.  
We found that the genome-wide expression profiles of Oct4- or Nanog-iPS cells derived 
from different cell types and systems are highly similar, but not identical, to wild-type ES cells 
(Figure 2), consistent with recent studies of independent cell lines 2,4,9,20. For example, the iPS and 
ES cell lines share high expression levels of genes related to maintenance of pluripotency and self-
renewal such as Oct4, Sox2, Nanog, Lin28, Zic3, Fgf4, Tdgf1 and Rex1, and low expression levels 
for most lineage-specifying transcription factors and other developmental genes. Consistent with the 
characteristically short cell cycle of ES cells, the iPS cells show low expression of cyclin D (Ccnd1, 
Ccnd2) 21. 
 To determine whether iPS cells have also regained ES cell-like chromatin states, we 
generated genome-wide maps showing the location of H3K4me3 and H3K27me3 from the MEF-
derived MCV8.1 cell line, using ChIP-Seq. We previously described the differences in these 
chromatin modifications between wild-type ES cells and MEFs 22. In ES cells, virtually all high-
CpG promoters (HCPs) are enriched with H3K4me3; a subset of these HCPs, associated with 
repressed developmental genes, are also enriched with H3K27me3 (‘bivalent’). In MEFs, the 
majority of HCPs that are bivalent in ES cells resolve to become monovalent (H3K4me3- or 
H3K27me3-only). Some pluripotency- and germline-specific genes show loss of both H3K4me3 
and H3K27me3 in somatic cells and this correlates with DNA hypermethylation 23,33. 
The chromatin state maps of the iPS cell line MCV8.1 are strikingly similar to those of ES 
cells both near promoters and in intergenic regions (Figures 3-5). The vast majority (>97%) of 
HCPs that lack H3K4me3-enrichment in MEFs have regained this mark in MCV8.1 cells. At all 
pluripotency- and germline-specific genes examined, the promoters have regained H3K4me3-
enrichment and show DNA hypomethylation (Figure 6). At genes encoding lineage-specific 
transcription factors that are bivalent and transcriptionally silent in ES cells, the bivalent pattern is 
typically re-established (~80% of HCPs classified as bivalent in wild-type ES cells; and ~95% of 
loci encoding key developmental transcription factors; Figure 3b-d,g). 
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Figure 3. Chromatin state maps. a, Loss of H3K4me3 correlates with inactivation 
of MEF-specific low-CpG promoters (LCPs) during reprogramming. b, The 
transcription factor Zeb2 is marked by H3K4me3 and expressed in MEFs, but 
gains H3K27me3 and is silenced in partially and fully reprogrammed cells. 
c, The mesoderm/neural-crest transcription factor Sox9 is marked by H3K4me3 
only and remains active in MCV6. d, The endodermal transcription factor Gata6 
inappropriately lost H3K27me3 and is activated in MCV6 cells. e, The autocrine 
growth factor Fgf4 loses H3K27me3, gains H3K4me3 and becomes highly 
expressed in both partially and fully reprogrammed cells. f, The pluripotency 
gene Nanog gains H3K4me3 and is active only in iPS cells. g, The germline-
specific gene Ddx4 gains H3K4me3 and H3K27me3 in iPS cells only, and 
remains poised for activation in germ cells. h, Chromatin states for high-CpG 
promoters (HCPs) in MEFs and reprogrammed cells, conditional on their state 
in ES cells. i, Fraction of genes with HCPs expressed in ES cells, but not wild-
type MEFs, that have been re-activated in cells at various stages of reprogramming, 
conditional on their chromatin state in MEFs. Most HCPs marked by H3K27me3 
only or neither mark are not re-actived in partially reprogrammed cells.
 We conclude that direct reprogramming to a pluripotent state involves re-activation of 
endogeneous pluripotency-related genes, establishment of an ‘open’ chromatin state (as indicated 
by genome-wide H3K4me3 enrichment and DNA de-methylation), and comprehensive Polycomb-
mediated repression of lineage-specifying genes (as indicated by bivalent chromatin states 
involving H3K27me3-enrichment).  
 
Partially reprogrammed cell lines 
Only a subset of the stably de-differentiated cells obtained in the absence of drug selection show 
evidence of complete reprogramming to a pluripotent state. We previously derived clonal cell lines 
that can be maintained in relatively stable, “partially reprogrammed” states in the absence of drug 
selection 12. We reasoned that characterizing such cells might help identify key barriers in the late 
stages of the process. Accordingly, we studied three partially reprogrammed independent cell lines 
established during attempts to reprogram MEFs or mature B lymphocytes (Figures 2-6).  
MCV8. This cell line, which corresponds to subclone 8 from 12, was established during our 
attempt to reprogram MEFs carrying an Oct4-GFP reporter with constitutive retroviruses. It 
produces heterogeneous cultures of cells with mainly fibroblast-like morphology, with ~20-30% 
positive for the stem cell marker SSEA1 (Figure 7, 8), and occasional interspersed ES-like colonies 
at late passages. Multiple secondary subclones from these ES-like colonies have been shown to 
establish homogeneous GFP positive iPS cell lines (including the MCV8.1 line characterized above 
12). Proviral integration patterns showed that the same parental cells in the MCV8 population gave 
rise to both GFP-positive and -negative cells, suggesting that complete reprogramming depends on 
stochastic epigenetic events 11,12. 
The gene expression patterns of MCV8 cells are clearly distinct from both MEFs and iPS 
cells (Figure 2). MCV8 cultures show significant down-regulation of both structural genes (Col1a1, 
Col1a2) and regulatory factors (Snai1, Snai2, Zeb2) expressed in MEFs, up-regulation of some 
lineage-specific genes with neural, epidermal or endodermal functions (presumably as a 
consequence of Sox2 and Klf4 expression), and particularly high expression of proliferative genes. 
Interestingly, high levels of expression can also be detected for several of the CDK inhibitors 
(Cdkn1a, Cdkn2a) induced by the reprogramming factors. It is unclear how the partially 
reprogrammed cells have escaped the presumed anti-proliferative effects of these genes, but 
possible explanations include compensation by overexpression of proliferative genes, repression of 
differentiation pathways (MCV8 is cultured in the presence of the differentiation inhibitor LIF and  
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 expresses the LIF receptor at 2-3-fold higher levels than ES cells), or transformation (but we note 
that MCV8 cells have not lost the ability to re-differentiate, see below). 
The pattern of gene re-activation of genes expressed in ES cells in MCV8 is strongly 
correlated with chromatin state in MEFs (Figure 3i). Several genes related to self-renewal and 
proliferation of embryonic and adult stem cells show re-activation, including the autocrine growth 
factor Fgf4 24 and the transcription factor Zic3 25, but genes directly related to pluripotency show 
low or undetectable expression.  Of HCPs that are enriched with H3K4me3 in MEFs but not 
expressed at detectable levels, the majority (~70%) are re-activated in MCV8. In contrast, 
transcriptionally silent HCPs that are enriched in MEFs for H3K27me3 only or neither mark are 
significantly less likely to be re-activated (~35% and ~20%, respectively; PFisher < 10-6).  
There are notable differences in the chromatin states of MCV8, MEFs and MCV8.1 iPS 
cells (Figure 3). Examining HCPs that are bivalent in ES cells, MCV8 cells show bivalent 
chromatin structures at 70% more of these loci (n=1,467) than seen in the MEFs (n=859), but ~40% 
fewer than in MCV8.1 iPS cells (n=2,360), which is consistent with partial de-differentiation (~88% 
of the bivalent loci in MCV8 are also bivalent in MCV8.1). There are many more HCPs that lack 
H3K4me3 and H3K27me3 in MCV8 than in MCV8.1 (n=311 vs. 31), and these genes include the 
majority of pluripotency- and germ cell-specific loci. Using bisulfite sequencing, we confirmed that 
this chromatin state correlates with DNA hypermethylation (Figure 6). 
We note that we initially sorted MCV8 cells into SSEA1-positive and –negative cells and 
analyzed them separately. However, we found no major differences in expression levels or DNA 
methylation patterns between the two fractions (Figure 2, 6). Moreover, when the two 
subpopulations were cultured separately, both reverted to a heterogeneous state within 1-2 passages. 
Similar results were obtained from sorting by MHC surface expression, which decreases upon 
reprogramming. Thus, while these surface markers may provide some enrichment for cells that are 
amenable to full reprogramming 14, they do not appear to discriminate between significantly 
different cell states within MCV8 cultures. 
MCV6. This cell line was also established during our attempt to reprogram Oct4-GFP 
MEFs (subclone 6 from 12). It produces homogeneous cultures with compact colonies and ES cell-
like morphology (Figure 8). It differs from MCV8 in that it has different proviral integrations and 
has never spontaneously given rise to fully reprogrammed cells (Figure 7).  
 The gene expression profile and chromatin state maps from MCV6 are largely similar to 
MCV8, but we found two notable differences. First, MCV6 has fewer genes with bivalent 
chromatin signatures, and a disproportionately large fraction of HCPs without neither H3K4me3- or  
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 H3K27me3-enrichment (7% vs. ~2.5% in MEFs and MCV8). Second, MCV6 expresses high levels 
of several lineage-specifying transcription factors that are expressed at low or undetectable levels in 
MCV8 or iPS cells, including Sox9 (Figure 3c), and Gata6 (Figure 3d). The latter observation 
suggests that MCV6 may have become trapped in more differentiated state than MCV8. 
BIV1. This cell line was established during our attempt to reprogram B lymphocytes with 
inducible lentiviral vectors 15. It had lost surface expression of all common lymphoid markers and 
did not require any lymphoid cytokines for growth, but also showed no evidence of achieving 
complete reprogramming during 50 days of continuous Dox-mediated viral expression (as judged 
by the absence of SSEA1 or GFP-positive cells). After Dox withdrawal and loss of any detectable 
viral expression (see below), the cells continued to proliferate with a more fibroblast-like 
morphology and, after more than 10 additional days in culture, spontaneously gave rise to some 
GFP positive ES-like colonies, but at a lower frequency than MCV8 (Figure 8, 9). 
 The gene expression profile and chromatin state maps from BIV1 cells grown with Dox 
show striking similarities to those of MCV8, including: down-regulation of lineage-specific genes, 
such as the B lymphocyte master regulator Pax5; high expression of proliferative genes; activation 
of neural and epidermal genes; low levels of H3K4me3 and H3K27me3 enrichment relative to ES 
cells, consistent with DNA hypermethylation (see below); and incomplete activation of 
pluripotency-related loci (Figures 2-6). Notably, the expression profiles of BIV1, MCV8 and 
MCV6 are more similar to each other (r2 > 0.9 for any pair) than to the lineage-committed cell types 
from which they originated or to any of the pluripotent cell types (r2 < 0.8 for any pair; Figure 2). 
This suggests that the three cell lines may represent relatively common intermediate states induced 
by the four reprogramming factors. (The three lines also show expression of Fbx15, suggesting that 
they may be similar to the Fbx15-selected cells obtained during initial attempts to generate iPS cells 
7.) 
Comparing the expression profiles of BIV1 cultures before and after Dox withdrawal, we 
found that Dox withdrawal resulted in: up-regulation of mesenchymal extracellular matrix genes 
(Col1a1, Col2a1), consistent with the shift to a more fibroblast-like morphology; down-regulation 
of most inappropriately expressed neural and epidermal genes, which is consistent with these genes 
being induced by over-expression of Sox2 or Klf4; and up-regulation of some iPS/ES-specific 
genes (Dppa5, Lin28, Dnmt3l), which is consistent with the eventual emergence of rare GFP 
positive colonies. Thus, continuous over-expression of the reprogramming factors may 
paradoxically have stabilized BIV1 cells in its partially reprogrammed state. 
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 In summary, the three partially reprogrammed cell lines appear to represent similar (but 
distinct) cell states that emerge at an intermediate stage in the direct reprogramming process. The 
states are characterized by re-activation of genes related to stem cell renewal and maintenance, but 
not pluripotency; incomplete repression of lineage-specific transcription factors; and incomplete 
epigenetic remodeling, including persistent DNA hypermethylation.  
 
Inhibition of DNA methyltransferase accelerates reprogramming  
Because the partially reprogrammed cell lines show DNA hypermethylation at pluripotency-related 
genes, we hypothesized that loss of DNA methylation (or a closely linked epigenetic mark, such as 
H3K9 methylation 26) is a critical and inefficient step in the transition from a partially 
reprogrammed state to pluripotency.  
Overcoming the block in partially reprogrammed cell lines. We tested this notion by 
treating cells with the DNA methyltransferase inhibitor 5-aza-cytidine (AZA) and found that it 
induced a rapid and stable transition to a fully reprogrammed iPS state. We initially studied SSEA1-
positive MCV8 cells, treating them with AZA for 48 hours and monitoring the subsequent 
appearance of GFP-positive cells (Figure 7, 10). GFP-positive cells appeared at a frequency of 7.5% 
after one passage, compared to 0.25% in untreated cells. After five passages, GFP-positive cells 
comprised 77.8% of the treated population, while the proportion in untreated cells remained stably 
low (0.41%). We obtained similar results when treating the SSEA1-negative fraction. (When 
untreated cells from the fifth passage were subsequently treated with AZA, GFP-positive cells 
appeared at a similar rate as in the initial treatment; Figure 10b). We also found robust induction of 
the GFP reporter after AZA treatment of BIV1 (-Dox) cells (Figure 10a, 11). 
We evaluated the cellular state and developmental potency of the GFP-positive MCV8 and 
BIV1 cells obtained after AZA treatment and FACS. Both populations stained positive for the stem-
cell marker SSEA1. Combined bisulfite restriction analysis (COBRA) revealed significant de-
methylation of CpGs near the pluripotency-related genes Dppa5, Nanog and Utf1 (Figure 12), 
implying that re-activation was not limited to the GFP-tagged reporters. The viral transgenes 
showed low or undetectable expression levels (Figure 10c,d) indicating that AZA treatment did not 
interfere with viral silencing, which is required for full reprogramming 9, and that the emergence of 
GFP-positive cells was not caused by viral re-activation. Finally, subcutaneous injection into severe 
combined immunodeficiency (SCID) mice led to teratoma formation in 3-4 weeks (Figure 10e), 
demonstrating that the GFP-positive cells had undergone a stable transition to the pluripotent state. 
(Untreated MCV8 or BIV1 cells did not generate teratomas in the same timeframe). 
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Figure 8. a, Morphology of the three partially reprogrammed cell lines (MCV8, 
MCV6 and BIV1). After extended passaging we observed positive colonies in 
MCV8 at very low frequencies, but never in MCV6. b, BIV1 -Dox (but not BIV1 
+Dox) yielded a few ES like colonies after extensive culturing. In total we were 
able to isolate 5 Nanog-GFP positive cell lines from this clone (although we 
cannot rule out that all of them are identical due to the passaging). Using this 
inducible secondary system, Hanna et al. were able to generate additional 
B lymphocyte-derived iPS lines at much higher frequencies by adding an 
additional transcription factor (Hanna et al., 2008).
 To exclude nonspecific effects of AZA we treated MCV8 cells with siRNAs or lentiviral 
shRNAs against Dnmt1, which also led to the appearance GFP-positive cells within one passage (up 
to 1.7%; Figure 11b,c,d). We conclude that transient inhibition of DNA methyltransferase is 
sufficient to rapidly transition MCV8 and BIV1 cells from a partially reprogrammed state to a 
pluripotent state. 
 Populations of lineage-committed cells. We next used the chimera-derived Nanog-GFP 
MEFs (described above) to test whether AZA treatment could increase the overall reprogramming 
efficiency. The cells were grown in the presence of Dox from day 1, and AZA was administered for 
48 hours starting on day 4, 6, or 8. The reprogramming efficiency was determined by counting ES-
like colonies at day 14 (Figure 10f,g).  
We found that starting AZA treatment on days 4 and 6 led to high cell death and no overall 
gain in efficiency. The cell death may reflect the fact that most cells are still in a differentiated state: 
genome-wide hypomethylation is known to induce apoptosis in differentiated cells, while ES cells 
are resistant 27, 28, 29. 
In contrast, there was a consistent 4-fold increase in the number of ES-like colonies in the 
cultures treated with AZA starting on day 8 (PT < 0.007). Moreover, the vast majority (>95%) of the 
ES-like colonies were GFP-positive in the treated cells, whereas only a minority (<25%) were GFP-
positive in the untreated controls (a proportion consistent with 9,12-14). While early AZA treatment is 
counter productive to reprogramming, there may be a sufficient number of partially reprogrammed 
cells in the population to outweigh its cytotoxic effect. 
We conclude that de-methylation of one or more (unknown) loci is a critical step in the late 
stages of direct reprogramming, and that inhibition of DNA methyltransferase lowers this kinetic 
barrier, thereby facilitating transition to pluripotency. A similar role for DNA demethylation has 
been recently reported during in vivo reprogramming in the germ line 30. 
 
Transcription factor knockdown facilitates reprogramming 
In contrast to the other partially reprogrammed cell lines, MCV6 did not respond to AZA treatment 
(Figure 7). We also noted above that MCV6 cells never show spontaneous appearance of GFP-
positive colonies. We hypothesized that expression of one or more lineage-specifying transcription 
factors may have stabilized these cells in a more differentiated state than MCV8 or BIV1. 
To test this hypothesis, we studied our genome-wide maps and identified lineage-specifying 
transcription factors that are expressed at low or undetectable levels in MCV8 or iPS cell 
populations. We transfected MCV6 cells with siRNAs against four transcription factors with >5- 
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 fold higher expression in MCV6 relative to MCV8 (Gata6, Pax7, Pax3 and Sox9). This resulted in 
no significant response. However, when transfection of siRNA targeting any one of the factors was 
followed by treatment with AZA for 48 hours, GFP-positive cells appeared at a significant 
frequency in all examined populations (16 independent transfections; Figure 13, 14). For example, 
targeting the primitive endoderm marker Gata6 31 generated ~2% GFP-positive cells within one 
passage of the subsequent AZA treatment. By contrast, no GFP-positive cells appeared in 
populations transfected with negative control siRNAs, or siRNAs targeted against transcription 
factors not expressed in MCV6 (Zic1, Meox2) or against Dnmt1 (7 control populations; PMWU < 
4x10-4). 
We conclude that re-activation or incomplete repression of lineage-specifying transcription 
factors during the reprogramming process blocks activation of the endogenous pluripotency 
regulatory network in MCV6. Transient silencing of one or more of these factors, combined with 
inhibition of DNA methyltransferase, appears to shift the regulatory balance towards the pluripotent 
state, which may then be stabilized by autoregulatory feedback 11. 
 
Discussion 
Several insights emerge from our integrative genomic analyses. First, the Oct4/Sox2/Klf4/c-Myc-
based reprogramming process appears to be fairly general, with two independent strategies 
(constititutive retrovirus or inducible lentivirus) and two distinct cell types (MEFs and B 
lymphocytes) yielding similar immediate responses, partially reprogrammed states and a similar 
mechanism for the final transition to pluripotency. Second, cells may fail to successfully reprogram 
for several apparent reasons: the cells may induce anti-proliferative genes in response to 
proliferative stress; they may inappropriately activate or fail to repress endogenous or ectopic 
transcription factors, and become ‘trapped’ in differentiated states; and they may fail to reactivate 
hypermethylated pluripotency genes. Third, complete reprogramming can be facilitated by direct 
intervention against these failure modes, such as transient inhibition of DNA methyltransferase and 
expressed transcription factors. 
 We expect that further characterization of intermediate states and alternative small molecule 
treatments will yield critical insights that help facilitate the desired transitions, making 
reprogramming efficient and safe for use in regenerative medicine. More generally, our data are 
consistent with a model of development where cellular states are defined by transcription factors 
and stabilized by epigenetic remodeling. Integrative gene expression and epigenomic profiling 
provides a powerful tool for defining and guiding directed transitions between these states.
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Figure 10. Inhibition of DNMT1 accelerates the transition to pluripotency. a, MCV8 
and BIV1 (-Dox) cells were sorted by FACS on SSEA1 status and either exposed 
to AZA for 48 hours (green) or kept in regular ES medium (grey). The number of 
Oct4-GFP-positive cells was analyzed over multiple passages (P) by FACS. 
b, Untreated MCV8 control cells from passage 5 were subsequently subjected to 
AZA treatment for 48 (+) or 120 hours (++), and resulting Oct4-GFP positive cells 
were counted after one passage. c, AZA treatment does not influence retroviral 
expression levels. d, AZA treatment has no influence on lentiviral expression in 
uninduced or induced BIV1 cells. e, Pluripotency of all AZA treated lines and 
MCV8.1 was demonstrated by teratoma formation. ECT, ectoderm; MES, 
mesoderm; END, endoderm. f, Overall efficiency of AZA treatment. Nanog-GFP 
MEFs were plated on 6-well plates (4 wells per time point with Dox and 2 wells 
without). Cells were treated with AZA during one of the indicated intervals. On 
day 14, colony formation was analyzed by fluorescence microscopy (representative 
panels are show). g, Number of AP-positive, ES-like colonies obtained from each 
treatment. AZA treatment during days 8-10 resulted in a ~4-fold increase in efficiency 
over untreated controls. For a, c, d and g, error bars show standard deviations 
(n = 2, 2, 2 and 4, respectively).
 Methods 
 
Viral infections and cell lines: MEFs used to derive primary iPS cell lines by infections with 
inducible lentiviruses were harvested at 13.5dpc from F1 matings between ROSA26-M2rtTA mice 
32 and Nanog-GFP mice 13. Secondary Nanog-GFP MEFs were isolated using neomycin selection. 
Lentiviral preparation and infection with Doxycycline inducible lentiviruses encoding Oct4, Klf4, 
c-Myc and Sox2 cDNA driven by the TetO/CMV promoter, were previously described 13. MCV6 
and MCV8 were generated by retroviral infection of Oct4-GFP MEFs as described previously 12. 
Cell culture: Infected MEFs or secondary inducible MEFs 15 were cultured and expanded in 
standard ES medium and conditions 12. Culture and viral induction was done as described 13,15 and 
BIV1 was obtained as a stable line and grown under regular ES conditions in the presence or 
absence of 2 μg/ml of Doxycycline. AZA treatment was performed for 48 hours or as indicated at a 
concentration of 0.5μM. Higher doses showed similar effects but increased toxicity. 
Expression profiling: RNA was isolated using TRIZOL followed by a second round of purification 
using RNeasy Columns (Qiagen). RNA was then processed and analyzed as described elsewhere 22. 
Absolute expression values were RMA normalized, truncated to ≥20, and visualized using 
GenePattern (http://www.broad.mit.edu/cancer/software/genepattern/).  
Chromatin IP and Illumina/Solexa Sequencing. Cells were harvested and cross-linked with 
formaldehyde (final concentration 1%) for 10 min at 37°C. Washed twice with cold PBS (plus 
Protease inhibitors), frozen and kept at –80°C. Chromatin IP, library construction, sequencing, 
identification of enriched intervals and chromatin state classification was done as described 
previously 22. 
Bisulfite Sequencing and COBRA: Genomic DNA was isolated and bisulfite conversion was 
performed in a thermocycler using the Qiagen EpiTect Kit according to manufacturers instructions 
with two additional cycles (5min 99°C and 3h 60°C) at the end. When using 2µg genomic DNA as 
starting material, converted DNA was eluted in 40µl EB (Qiagen) and 2µl were used and amplified 
with previously described primer sets 23 and the following additional primer pairs (CyctF: 
GAAGGATTAAATAGATGTATAAGAAAATAT; CyctR: 
AAACCCTAATTATAAACAAATACAAC; Sox2F: GGTTTAGGAAAAGGTTGGGAATA; 
Sox2R: AACCAAAATAAAACAAAACCCATAA). PCR was done in 25µl reactions using 
EpiTect MSP Kit (Qiagen) mastermix according to manufactures instructions with a 45sec 
annealing step at 50°C (35cycles). PCR products were gel purified, TOPO cloned (Invitrogen) and 
sequenced. Combined bisulfite restriction analysis (COBRA) for Dppa5, Nanog and UTF1 was  
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Figure 12. Combined Bisulfite Restriction Analysis (COBRA) of CpG dinucleotides 
near Dppa5, Nanog and Utf1. The bisulfite treated and PCR amplified product of 
Dppa5 was digested with Taq1 (TCGA). The products for Nanog and Utf1 were 
digested with HpyCHIV (ACGT). The top band indicates unmethylated (uncut; U) 
CpGs and the lower band(s) methylated CpGs in the recognition sequence of the 
respective enzyme. The left panel shows several donor, partially reprogrammed 
and reprogrammed cell lines, including the BIV1 +/-Dox. As can be seen in lane 6, 
simply withdrawing doxycycline (Dox) resulted in further reprogramming and
loss of methylation, in particular at Utf1. Nanog however did not change, which is 
consistent with the fact that these cells remain Nanog-GFP negative. Notably, 
MEFs often show mixed methylation patterns (compare Figure 6 and (Imamura 
et al. 2006)). The right panel shows analysis of the GFP positive and negative 
fractions post AZA treatment. Clear loss of methylation can be seen in the positive 
fraction, but not in the negative fraction. A10 is a subclone picked from the SSEA1 
positive fraction prior to AZA treatment.
Lane 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
 done using 15µl of the gel purified DNA. Dppa5 was digested for 4h at 65°C with Taq1 (TCGA). 
Nanog and UTF1 were digested with HpyCHIV (ACGT) for 4h at 37°C. Digested products were 
run on2% agarose gels. 
Knockdown of transcription factors and Dnmt1: Reverse transfections were done in 24 well 
dishes according to manufacturers instructions using the siPORT NeoFX Transfection Agent 
(Ambion). The following Silencer Select (Ambion/ABI) siRNAs were used: Negative Control 
siRNA (#4390843), positive control Cy3 GAPDH siRNA (#AM4649), Pax 3 siRNA (s71259, 
s71260), Pax 7 siRNA (s71271, s71272), Gata6 siRNA (s66489, s66490), Sox9 siRNA (s74192, 
s74193), Meox2 siRNA (s69792, s69793), Zic1 siRNA (s76384, s76385) and Dnmt1 siRNA 
(s65071, s65072). Dnmt1 was stably knocked down using five independent shRNAs from the RNAi 
consortium (TRC; http://www.broad.mit.edu/genome_bio/trc/). shRNA1 (TRCN0000039024; 
target: GCTGACACTAAGCTGTTTGTA), shRNA2 (TRCN0000039025; target: 
GCCTTTACTTTCAACATCAAA), shRNA3 (TRCN0000039026; target: 
CCGCACTTACTCCAAGTTCAA), shRNA4 (TRCN0000039027; target: 
CCCGAAGATCAACTCACCAAA) and shRNA5 (TRCN0000039028; target: 
GCAAAGAGTATGAGCCAATAT). MCV8 cells were infected overnight and selected in 
puromycin (final: 2µg/ml) for 48h.  
Quantitative RT-PCR. Total RNA was isolated using Rneasy Kit (Qiagen). Three micrograms of 
total RNA was treated with DNase I to remove potential contamination of genomic DNA using a 
DNA Free RNA kit (Zymo Research, Orange, CA). Retroviral expression levels were determined as 
described previously 9. For inducible lentiviral expression one microgram of DNase I-treated RNA 
was reverse transcribed using a First Strand Synthesis kit (Invitrogen) and ultimately resuspended in 
100 μl of water. Quantitative PCR analysis was performed in triplicate using 1/50 of the reverse 
transcription reaction in an ABI Prism 7000 (Applied Biosystems, Foster City, CA) with Platinum 
SYBR green qPCR SuperMix-UDG with ROX (Invitrogen). Primers used for amplification were as 
follows: c-Myc: F, 5’-ACCTAACTCGAGGAGGAGCTGG-3’ and R, 5’-
TCCACATAGCGTAAAAGGAGC-3’; Klf4: F, 5’-ACACTGTCTTCCCACGAGGG-3’and R, 5’-
GGCATTAAAGCAGCGTATCCA-3’; Sox2: F, 5’-CATTAACGGCACACTGCCC-3’ and R, 5’-
GGCATTAAAGCAGCGTATCCA-3’; Oct4: F, 5’-AGCCTGGCCTGTCTGTCACTC-3’ and R, 
5’-GGCATTAAAGCAGCGTATCCA-3’. To ensure equal loading of cDNA into RT reactions, 
GAPDH mRNA was amplified using the following primers: F, 5’-
TTCACCACCATGGAGAAGGC-3’; and R, 5’-CCCTTTTGGCTCCACCCT-3’. Data were 
extracted from the linear range of amplification. All graphs of qRT-PCR data shown represent  
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Figure 13. Transcription factor knockdown facilitates reprogramming. MCV6 
cells were plated onto 24-well dishes and transfected with siRNAs targeting 
expressed (Pax7, Pax3, Gata6, Sox9) or non-expressed (Zic1, Meox2) 
transcription factors. One plate was kept in ES medium and the second 
was exposed to AZA for 48 hours. Two independent siRNA sequences 
were used for duplicate experiments (red and green). FACS analysis was 
performed 48 hours after AZA treatment (96 hours after transfection) without 
passaging. The transfection efficiency was estimated as ~20% using Cy3-
coupled GADPH control siRNA.
 samples of RNA that were DNase treated, reverse transcribed, and amplified in parallel to avoid 
variation inherent in these procedures.  
Flow cytometry analysis and cell sorting. The following fluorescently conjugated antibodies (PE, 
FITC, Cy-Chrome or APC labeled) were used for FACS analysis and cell sorting: anti-SSEA1 
(RnD systems), anti-Igκ, anti-Igλ1,2,3, anti-CD19, anti-B220, anti-sIgM, anti-sIgD (all obtained 
from BD-Biosciences). Cell sorting was performed by using FACS-Aria (BD-Biosciences), and 
consistently achieved cell sorting purity of >97%. For determining GFP-positive cell numbers by 
FACS we counted >50,000 cells. 
 
  394
10 0 10 1 10 2 10 3 10 4
FL1-H
R1
10 0 101 102 103 10 4
FL1-H
R1
10 0 101 102 103 10 4
FL1-H
R1
10 0 101 10 2 103 10 4
FL1-H
R1
10 0 101 10 2 103 10 4
FL1-H
R1
10 0 10 1 10 2 10 3 10 4
FL1-H
R1
10 0 101 102 103 10 4
FL1-H
R1
100 101 102 103 104
FL1-H
R1
100 101 102 103 10 4
FL1-H
R1
10 0 101 102 103 104
FL1-H
R1
100 101 102 103 10 4
FL1-H
R1
100 101 10 2 103 104
FL1-H
R1
0.0% 1.2% 1.9% 2.2% 1.6% 2.7%
1.9% 2.0% 0.0% 0.0% 0.0% 1.8%
Dnmt1
Control Pax3 Pax7 Gata6 Sox9 Pax3 + Pax7
Gata6 + Sox9 Pax7 + Gata6
+ Sox9
Zic1 Meox2 All
100 10 1 102 10 3 104
FL1-H
R1
100 10 1 10 2 103 104
FL1-H
R1
10 0 10 1 10 2 10 3 10 4
FL1-H
R1
10 0 10 1 102 10 3 10 4
FL1-H
R1
100 101 102 103 104
FL1-H
R1
100 101 102 103 104
FL1-H
R1
100 101 102 103 104
FL1-H
R1
10 0 10 1 10 2 10 3 10 4
FL1-H
R1
100 101 102 103 104
FL1-H
R1
10 0 10 1 10 2 10 3 10 4
FL1-H
R1
100 101 102 103 104
FL1-H
R1
100 101 102 103 104
FL1-H
R1
0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Dnmt1
Control Pax3 Pax7 Gata6 Sox9 Pax3 + Pax7
Gata6 + Sox9 Pax7 + Gata6
+ Sox9
Zic1 Meox2 All
 AZA (48 hours)
Control
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
100 101 102 103 104 100 101 102 103 104 100 101 102 103 104 10
0 101 102 103 104 100 101 102 103 104 100 101 102 103 104
100 101 102 103 104 100 101 102 103 104 100 101 102 103 104 100 101 102 103 104 100 101 102 103 104 10
0 101 102 103 104
100 101 102 103 104 100 101 102 103 104 100 101 102 103 104 10
0 101 102 103 104 100 101 102 103 104 100 101 102 103 104
100 101 102 103 104 10
0 101 102 103 104 100 101 102 103 104 100 101 102 103 104 10
0 101 102 103 104 100 101 102 103 104
Figure 14. FACS analysis for GFP positive cells after siRNA-mediated transcription 
factor knockdown. Top panels show transfections with the indicated single siRNAs 
or combinations 96 hours after transfection and 48 hours after AZA treatment. The 
percent GFP positive cells are shown in the gate. Bottom panel shows that the 
same siRNAs without the subsequent AZA treatment show no GFP positive cells. 
While Pax3, Pax7, Gata6 and Sox9 are expressed in MCV6, Zic1 and Meox2 are 
not. The lack of GFP positive cells in the latter wells serves as an additional control.
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The contributions described in this thesis suggest several future directions for research on the 
structure, evolution and function of the human genome. 
Our comparative analysis of mammalian genome sequences suggest that the rate of 
turnover of ancestral functional elements has been low within the infraclass of eutherian mammals. 
Sequencing additional eutherian genomes should therefore yield increasing specificity for detection 
of functional elements without a significant loss of sensitivity. The highly correlated and nearly-
neutral patterns of evolution in protein-coding sequences also suggest that new methods for 
detecting positive selection in regulatory elements must be developed to help define the molecular 
basis of morphological evolution. Moreover, the significant contribution of transposon-derived 
sequences to the evolution of eutheria-specific conserved elements suggests that primate- or human-
specific regulatory elements might have similar origins. Development of new analysis methods 
might be required to study these highly repetitive sequences. 
Our studies on genome-wide patterns of chromatin modifications provide a framework for 
comprehensive characterization of chromatin state across a variety of mammalian cell populations. 
We focused on DNA methylation and a small number of relatively well-understood histone lysine 
methylation marks. The genome-wide distributions of additional histone modifications, such as 
acetylation, ubiquitination, arginine methylation, as well as the use of histone variants, remain to be 
explored. Generating a more comprehensive compendium of chromatin state maps should help 
define signatures that clearly differentiate between pluripotent and differentiated cells or between 
‘normal’ and ‘abnormal’ epigenetic regulation. 
Projects devoted to sequencing additional mammalian genomes and generating chromatin 
state maps from various mammalian cell and tissue types are already in progress. It is important to 
note, however, that comparative sequence analysis is largely limited to detecting the location of 
functional sequence elements; similarly, generation of chromatin state maps is largely limited to 
detecting the location of specific chromatin modifications. Understanding the function or specific 
role of each sequence element or chromatin mark requires directed experimentation in relevant 
biological contexts. Here, we describe a few potential research projects designed to assign specific 
biological functions to sequence elements involved in morphological development or cellular 
differentiation, and to further explore the direct relationship between chromatin state and cell state. 
 
Dissect the regulatory architecture of key developmental loci 
Embryonic patterning and morphological development is driven, at least in part, by combinatorial 
expression of transcription factors and signaling molecules. Our results show that more than half of 
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highly conserved non-coding sequences, and more than a quarter of all conserved non-coding 
sequences, in mammalian genomes are clustered in long ‘gene deserts’ surrounding ~200 coding 
sequences for transcription factors, signaling molecules and axon guidance receptors. It seems 
reasonable to hypothesize that many of these conserved non-coding sequences are regulatory 
elements that control the complex developmental expression patterns of the nearby coding 
sequences. If this is the case, associating each discrete functional element in these regions with the 
anatomical location or developmental stage at which they influence gene expression would be a 
major step towards describing how morphology is encoded in our genome sequence. 
 Understanding the architecture of these loci would be critical to designing an effective 
experimental strategy. Regulatory elements might act independently to activate gene expression at 
specific anatomical locations or developmental stages; multiple redundant or mutually reinforcing 
elements might be required to activate expression; or gene expression levels might be determined 
by the sum of interactions of multiple synergistic and antagonistic elements spread across the locus. 
Regulatory elements on one allele might also influence the promoter and protein-coding sequences 
on the other allele through transvection. 
 Systematic functional studies in the context of human development is intractable. It seems 
likely that the basic regulatory architecture of these regions are conserved and amenable to rapid 
dissection in vertebrate model systems such as zebrafish and frog. However, the low sensitivity of 
non-coding sequence alignments between mammals and non-mammalian vertebrates and the 
presumed high rate of evolutionary innovation across these loci suggest that studies in distantly 
related vertebrates would not be effective for uncovering the specific functions of most regulatory 
elements found in the mammalian genomes. Focusing on mouse development might therefore be 
the best trade-off between evolutionary divergence and experimental tractability. 
 The ease and high efficiency of genetic engineering in murine ES cells suggest a general 
experimental approach. An appropriate reporter gene can first be inserted into a locus of interest 
using homologous recombination. Embryos at different stages of development can then be 
generated from clonal ES cells containing the reporter (“unmodified clones”), potentially using 
tetraploid complementation. The expression pattern of the reporter can be determined using high-
resolution in situ hybridization on tissue sections or on whole specimens using optical projection 
tomography. A second round of recombination can then be used to generate a series of sub-clones 
with deletions across the flanking regulatory regions (“deletion clones”). Tiling 20 kb deletions with 
10 kb overlap would require a few hundred successful targeting events to cover a typical locus. 
Obtaining heterozygous deletions linked to the reporter gene should be sufficient,  but homozygous 
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deletions could be generated if transvection occurs. In parallel, each of the deleted regions can be 
inserted along with a reporter gene at a different chromosomal location (“insertion clones”). 
Embryos can then be generated from each of these modified clones and the expression patterns of 
their reporter genes can be compared to that of the unmodified clone to infer regulatory activities 
and architecture. For example, if regulatory elements act independently, a deletion clone should 
show loss of reporter expression at a particular location, while a corresponding insertion clone 
should show specific expression at the same location. If there are redundant regulatory elements, a 
deletion clone might show no change in reporter expression, while the corresponding insertion 
clone should still show specific expression. 
Once a course-grained map of regulatory elements and their interactions across a locus has 
been generated, regions of particular interest could be fine-mapped to identify and study the 
minimal sequences required for their regulatory activities. Sequence analysis and perturbation 
experiments can be used to identify the trans-acting factors that interact with each element. Regions 
that appear to control anatomical structures that differ significantly between mice and humans can 
be replaced with orthologous human DNA to test whether it can induce a more ‘human-like’ 
expression pattern in the mouse background. 
If pilot studies on one or a small number of loci turn out to be informative, this approach 
can in principle be extended to all key developmental loci in the mammalian genome. Covering 200 
loci at 10 kb resolution would require generation of ~40,000 insertion and deletion clones, which is 
not much different from the scale of ongoing efforts to generate comprehensive gene-trap or 
knockout clone collections. 
 
Dissect regulatory networks that control cellular differentiation 
Once cells have organized themselves in anatomical structures, they differentiate into the 
specialized cell types that make up our various tissues. Cellular differentiation typically involves (1) 
induction of tissue-specific effector genes and (2) silencing of genes that drive cell growth and 
proliferation. In each cell type, these processes are controlled by specialized transcriptional 
regulatory networks that are composed of trans-acting proteins or RNA molecules and cis-acting 
regulatory elements.  
 Cellular differentiation is, at least in some cases, simpler to study than developmental 
patterning and morphology. Good in vitro models have been developed for several differentiation 
processes in both human and mouse, such as adipogenesis, myogenesis and some variations of 
neurogenesis. These models can be used to obtain relatively homogeneous cell populations from 
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multiple stages of the differentiation process. Comparison of in vitro differentiated cells to their in 
vivo equivalents should help to filter out any cell culture-related artifacts in the models. In some 
cases, such as hematopoiesis, cells at different stages can also be sorted directly from tissue 
samples. Over the last few decades, candidate gene studies and expression profiling have 
successfully identified key transcription factors and other trans-acting factors in all of these 
differentiation processes. Identification of the cis-regulatory elements they interact with have been 
significantly more challenging, however. The methods developed in this thesis, in particular ChIP-
Seq, have the potential to accelerate identification and functional annotation of differentiation-
related regulatory elements. 
Our results show that ChIP-Seq can be used to generate chromatin state maps from cell 
populations at different stages of a differentiation process. If enough stages are covered, these maps  
should locate essentially all cis-regulatory elements utilized in the process. In principle, ChIP-Seq 
can also be used to map all binding sites for every expressed sequence-specific transcription factor. 
Combining data from such experiments with genome-wide expression profiling using microarrays 
or RNA sequencing should yield an essentially complete inventory of the trans- and cis-acting 
components of the regulatory network. 
 Once all trans- and cis-acting components of the regulatory network have been identified, 
standard techniques can be used to define their specific functions and interactions. RNA 
interference, over-expression and knockouts can be use to examine the role of individual trans-
acting factors. Transfection of reporter constructs or modification of the endogenous loci can be 
used to examine the function and composition of individual cis-regulatory elements. Most of these 
techniques should be amenable to high-throughput experimentation and allow efficient interrogation 
of every component and interaction in a regulatory network. 
 
Probe the relationship between chromatin state and cell state 
The regulatory networks that control morphology and differentiation are specified by the genome 
sequence, but various evidence suggest that chromatin structure can influence when and where 
individual components of these networks are accessible. Nuclear transfer and direct reprogramming 
experiments have demonstrated that differentiation-induced changes in chromatin state are, within 
the resolution of our assays, completely reversible given the right signals. However, the relatively 
low efficiency of these methods and the observation that inhibiting chromatin modifying enzymes 
can improve the efficiency suggest that chromatin modifications can contribute to stabilizing a 
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differentiated cell state. A key open question is whether knowing the chromatin state of a cell can 
help predict how it will respond to new environmental signals or other perturbations. 
Our results show that, in any given cell type, gene promoters display one of a limited 
number of distinct chromatin states. CpG-rich promoters display at least four different states: H3K4 
methylated, H3K27 methylated, bivalent or DNA methylated. CpG-poor promoters display at least 
two different states: H3K4 methylated or DNA methylated. Additional states involving H3K9 
methylation and other modifications might also exist. These states are closely correlated with gene 
expression levels and cellular differentiation – but do they also predict how genes respond to new 
regulatory signals? For example, if cells committed to muscle differentiation are exposed to a signal 
that induces pluripotent cells to commit to a neural fate, will genes with H3K27 methylated 
promoters be less responsive to this signal than genes with H3K4 methylated or bivalent promoters? 
Will DNA hypermethylated promoters be less responsive than H3K27 methylated promoters? Will 
there be differences in the responsiveness of genes with CpG-rich and CpG-poor promoters? And if 
there are any such differences, are they a direct consequence of differences in chromatin 
accessibility? Our analysis of direct reprogramming suggest positive answers the these questions, 
but more systematic investigations are needed to establish the generality of these results. 
One experimental approach to these questions would be to subject cells with different 
chromatin states to identical perturbations and then measure the resulting changes in gene 
expression patterns or chromatin states. Perturbations might involve introducing ectopic 
transcription factors or changing the extracellular environment. If chromatin accessibility is a 
critical factor in stabilizing gene expression patterns, there should be a statistical correlation 
between the magnitude or kinetics of the response of each gene and its pre-perturbation chromatin 
state across different cell types. If a correlation is detected, repeating the experiment while 
interfering with the implicated regulatory pathways should help differentiate between direct and 
indirect effects. For example, if bivalent promoters are found to be less responsive than H3K4 
methylated promoters, one might predict that interfering with the function of Polycomb group 
proteins should result in an increased response from genes in the former state. Small molecules have 
been or are being developed to inhibit various families of chromatin modifying and remodeling 
enzymes. RNA interference and genetic ablation can also be used to control specific enzymes. 
 A variation on this approach would be to introduce ectopic transcription factors and directly 
assay their binding sites across the genome using ChIP-Seq. If a correlation between differential 
binding sites and chromatin states across different cell types is detected, small molecules or RNA 
interference could again be used to gauge whether it represents a direct effect. A related experiment 
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would be to examine correlations between retro- or lentiviral integration patterns and chromatin 
state, which would be of relevance to gene therapy and related applications. 
 There are at least three potential technical challenges to this approach. First, chromatin state 
maps generated by ChIP-Seq are generated by averaging signals from a relatively large population 
of cells (at least several hundred thousand). Any variation in chromatin state between cells in the 
population, due to cell cycle progression, cryptic differentiation, stochastic effects or other causes, 
would introduce noise and reduce any observable correlation with perturbation responses. It will 
therefore be critical to develop quantitative models to estimate and control for population 
heterogeneity. Second, differences in the expression of signaling receptors or transcriptional co-
factors between different cell types can be expected to influence their gene expression responses, 
independent of any effect of chromatin accessibility. It might therefore be important to choose 
perturbations for which such dependencies are well-understood. Finally, because the same 
regulatory pathways often control both differentiation- and growth-related genes, it can be difficult 
to interfere with chromatin modifying pathways without compromising the viability or well-being 
of the perturbed cells. The development of methods for modulating chromatin state at specific loci 
would therefore be highly desirable. If these challenges can be overcome, integrated analysis of 
gene expression patterns and chromatin state maps before and after relevant cellular perturbations 
should become a powerful tool for elucidating the direct, functional relationship between chromatin 
state and cell state. 
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Initial sequence of the chimpanzee
genome and comparison with the human
genome
The Chimpanzee Sequencing and Analysis Consortium*
Here we present a draft genome sequence of the common chimpanzee (Pan troglodytes). Through comparison with the
human genome, we have generated a largely complete catalogue of the genetic differences that have accumulated since
the human and chimpanzee species diverged from our common ancestor, constituting approximately thirty-five million
single-nucleotide changes, five million insertion/deletion events, and various chromosomal rearrangements. We use this
catalogue to explore the magnitude and regional variation of mutational forces shaping these two genomes, and the
strength of positive and negative selection acting on their genes. In particular, we find that the patterns of evolution in
human and chimpanzee protein-coding genes are highly correlated and dominated by the fixation of neutral and slightly
deleterious alleles. We also use the chimpanzee genome as an outgroup to investigate human population genetics and
identify signatures of selective sweeps in recent human evolution.
More than a century ago Darwin1 and Huxley2 posited that humans
share recent common ancestors with the African great apes. Modern
molecular studies have spectacularly confirmed this prediction and
have refined the relationships, showing that the common chimpan-
zee (Pan troglodytes) and bonobo (Pan paniscus or pygmy chimpan-
zee) are our closest living evolutionary relatives3. Chimpanzees are
thus especially suited to teach us about ourselves, both in terms of
their similarities and differences with human. For example, Goodall’s
pioneering studies on the common chimpanzee revealed startling
behavioural similarities such as tool use and group aggression4,5. By
contrast, other features are obviously specific to humans, including
habitual bipedality, a greatly enlarged brain and complex language5.
Important similarities and differences have also been noted for the
incidence and severity of several major human diseases6.
Genome comparisons of human and chimpanzee can help to reveal
themolecular basis for these traits aswell as the evolutionary forces that
have moulded our species, including underlying mutational processes
and selective constraints. Early studies sought to draw inferences from
sets of a few dozen genes7–9, whereas recent studies have examined
larger data sets such as protein-coding exons10, random genomic
sequences11,12 and an entire chimpanzee chromosome13.
Here we report a draft sequence of the genome of the common
chimpanzee, and undertake comparative analyses with the human
genome. This comparison differs fundamentally from recent com-
parative genomic studies of mouse, rat, chicken and fish14–17. Because
these species have diverged substantially from the human lineage, the
focus in such studies is on accurate alignment of the genomes and
recognition of regions of unusually high evolutionary conservation
to pinpoint functional elements. Because the chimpanzee lies at such
a short evolutionary distance with respect to human, nearly all of the
bases are identical by descent and sequences can be readily aligned
except in recently derived, large repetitive regions. The focus thus
turns to differences rather than similarities. An observed difference at
a site nearly always represents a single event, not multiple indepen-
dent changes over time. Most of the differences reflect random
genetic drift, and thus they hold extensive information about muta-
tional processes and negative selection that can be readily mined with
current analytical techniques. Hidden among the differences is a
minority of functionally important changes that underlie the phe-
notypic differences between the two species. Our ability to dis-
tinguish such sites is currently quite limited, but the catalogue of
human–chimpanzee differences opens this issue to systematic inves-
tigation for the first time.We would also hope that, in elaborating the
few differences that separate the two species, we will increase pressure
to save chimpanzees and other great apes in the wild.
Our results confirm many earlier observations, but notably chal-
lenge some previous claims based on more limited data. The
genome-wide data also allow some questions to be addressed for
the first time. (Here and throughout, we refer to chimpanzee–human
comparison as representing hominids and mouse–rat comparison as
representing murids—of course, each pair covers only a subset of the
clade.) The main findings include:
. Single-nucleotide substitutions occur at a mean rate of 1.23%
between copies of the human and chimpanzee genome, with 1.06%
or less corresponding to fixed divergence between the species.
. Regional variation in nucleotide substitution rates is conserved
between the hominid and murid genomes, but rates in subtelomeric
regions are disproportionately elevated in the hominids.
. Substitutions at CpG dinucleotides, which constitute one-quarter
of all observed substitutions, occur at more similar rates in male and
female germ lines than non-CpG substitutions.
. Insertion and deletion (indel) events are fewer in number than
single-nucleotide substitutions, but result in ,1.5% of the euchro-
matic sequence in each species being lineage-specific.
. There are notable differences in the rate of transposable element
insertions: short interspersed elements (SINEs) have been threefold
more active in humans, whereas chimpanzees have acquired two new
families of retroviral elements.
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. Orthologous proteins in human and chimpanzee are extremely
similar, with ,29% being identical and the typical orthologue
differing by only two amino acids, one per lineage.
. The normalized rates of amino-acid-altering substitutions in the
hominid lineages are elevated relative to the murid lineages, but close
to that seen for common human polymorphisms, implying that
positive selection during hominid evolution accounts for a smaller
fraction of protein divergence than suggested in some previous
reports.
. The substitution rate at silent sites in exons is lower than the rate at
nearby intronic sites, consistent with weak purifying selection on
silent sites in mammals.
. Analysis of the pattern of human diversity relative to hominid
divergence identifies several loci as potential candidates for strong
selective sweeps in recent human history.
In this paper, we begin with information about the generation,
assembly and evaluation of the draft genome sequence. We then
explore overall genome evolution, with the aim of understanding
mutational processes at work in the human genome. We next focus
on the evolution of protein-coding genes, with the aim of character-
izing the nature of selection. Finally, we briefly discuss initial insights
into human population genetics.
In recognition of its strong community support, we will refer to
chimpanzee chromosomes using the orthologous numbering
nomenclature proposed by ref. 18, which renumbers the chromo-
somes of the great apes from the International System for Human
Cytogenetic Nomenclature (ISCN; 1978) standard to directly corre-
spond to their human orthologues, using the terms 2A and 2B for the
two ape chromosomes corresponding to human chromosome 2.
Genome sequencing and assembly
We sequenced the genome of a single male chimpanzee (Clint; Yerkes
pedigree number C0471; Supplementary Table S1), a captive-born
descendant of chimpanzees from the West Africa subspecies Pan
troglodytes verus, using a whole-genome shotgun (WGS)
approach19,20. The data were assembled using both the PCAP and
ARACHNE programs21,22 (see Supplementary Information ‘Genome
sequencing and assembly’ and Supplementary Tables S2–S6). The
former was a de novo assembly, whereas the latter made limited use of
human genome sequence (NCBI build 34)23,24 to facilitate and
confirm contig linking. The ARACHNE assembly has slightly greater
continuity (Table 1) and was used for analysis in this paper. The draft
genome assembly—generated from ,3.6-fold sequence redundancy
of the autosomes and ,1.8-fold redundancy of both sex chromo-
somes—covers,94% of the chimpanzee genome with.98% of the
sequence in high-quality bases. A total of 50% of the sequence (N50)
is contained in contigs of length greater than 15.7 kilobases (kb) and
supercontigs of length greater than 8.6megabases (Mb). The assem-
bly represents a consensus of two haplotypes, with one allele from
each heterozygous position arbitrarily represented in the sequence.
Assessment of quality and coverage. The chimpanzee genome
assembly was subjected to rigorous quality assessment, based on
comparison to finished chimpanzee bacterial artificial chromosomes
(BACs) and to the human genome (see Supplementary Information
‘Genome sequencing and assembly’ and Supplementary Tables
S7–S16).
Nucleotide-level accuracy is high by several measures. About 98%
of the chimpanzee genome sequence has quality scores25 of at least 40
(Q40), corresponding to an error rate of#1024. Comparison of the
WGS sequence to 1.3Mb of finished BACs from the sequenced
individual is consistent with this estimate, giving a high-quality
discrepancy rate of 3 £ 1024 substitutions and 2 £ 1024 indels,
which is no more than expected given the heterozygosity rate (see
below), as 50% of the polymorphic alleles in the WGS sequence will
differ from the single-haplotype BACs. Comparison of protein-
coding regions aligned between the WGS sequence, the recently
published sequence of chimpanzee chromosome 21 (ref. 13; formerly
chromosome 22 (ref. 18)) and the human genome also revealed no
excess of substitutions in the WGS sequence (see Supplementary
Information ‘Genome sequencing and assembly’). Thus, by restrict-
ing our analysis to high-quality bases, the nucleotide-level accuracy
of theWGS assembly is essentially equal to that of ‘finished’ sequence.
Structural accuracy is also high based on comparisonwith finished
BACs from the primary donor and other chimpanzees, although the
relatively low level of sequence redundancy limits local contiguity.
On the basis of comparisons with the primary donor, some small
supercontigs (most ,5 kb) have not been positioned within large
supercontigs (,1 event per 100 kb); these are not strictly errors but
nonetheless affect the utility of the assembly. There are also small,
undetected overlaps (all ,1 kb) between consecutive contigs (,1.2
events per 100 kb) and occasional local misordering of small contigs
(,0.2 events per 100 kb). No misoriented contigs were found.
Comparison with the finished chromosome 21 sequence yielded
similar discrepancy rates (see Supplementary Information ‘Genome
sequencing and assembly’).
The most problematic regions are those containing recent seg-
mental duplications. Analysis of BAC clones from duplicated
(n ¼ 75) and unique (n ¼ 28) regions showed that the former
tend to be fragmented into more contigs (1.6-fold) and more
supercontigs (3.2-fold). Discrepancies in contig order are also
more frequent in duplicated than unique regions (,0.4 versus
,0.1 events per 100 kb). The rate is twofold higher in duplicated
regions with the highest sequence identity (.98%). If we restrict the
analysis to older duplications (#98% identity) we find fewer assem-
bly problems: 72% of those that can be mapped to the human
genome are shared as duplications in both species. These results are
consistent with the described limitations of current WGS assembly
for regions of segmental duplication26. Detailed analysis of these
rapidly changing regions of the genome is being performed with
more directed approaches27.
Chimpanzee polymorphisms.The draft sequence of the chimpanzee
genome also facilitates genome-wide studies of genetic diversity
among chimpanzees, extending recent work28–31. We sequenced and
analysed sequence reads from the primary donor, four other West
African and three central African chimpanzees (Pan troglodytes
troglodytes) to discover polymorphic positions within and between
these individuals (Supplementary Table S17).
A total of 1.66 million high-quality single-nucleotide polymorph-
isms (SNPs) were identified, of which 1.01 million are heterozygous
within the primary donor, Clint. Heterozygosity rates were estimated
to be 9.5 £ 1024 for Clint, 8.0 £ 1024 among West African chim-
panzees and 17.6 £ 1024 among central African chimpanzees, with
the variation between West and central African chimpanzees being
19.0 £ 1024. The diversity in West African chimpanzees is similar to
that seen for human populations32, whereas the level for central
African chimpanzees is roughly twice as high.
The observed heterozygosity in Clint is broadly consistent with
West African origin, although there are a small number of regions of
distinctly higher heterozygosity. These may reflect a small amount of
central African ancestry, but more likely reflect undetected regions of
segmental duplications present only in chimpanzees.
Table 1 | Chimpanzee assembly statistics
Assembler PCAP ARACHNE
Major contigs* 400,289 361,782
Contig length (kb; N50)† 13.3 15.7
Supercontigs 67,734 37,846
Supercontig length (Mb; N50) 2.3 8.6
Sequence redundancy: all bases (Q20) 5.0 £ (3.6 £ ) 4.3 £ (3.6 £ )
Physical redundancy 20.7 19.8
Consensus bases (Gb) 2.7 2.7
*Contigs .1 kb.
†N50 length is the size x such that 50% of the assembly is in units of length at least x.
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Genome evolution
We set out to study the mutational events that have shaped the
human and chimpanzee genomes since their last common ancestor.
We explored changes at the level of single nucleotides, small inser-
tions and deletions, interspersed repeats and chromosomal
rearrangements. The analysis is nearly definitive for the smallest
changes, but is more limited for larger changes, particularly lineage-
specific segmental duplications, owing to the draft nature of the
genome sequence.
Nucleotide divergence. Best reciprocal nucleotide-level alignments
of the chimpanzee and human genomes cover,2.4 gigabases (Gb) of
high-quality sequence, including 89Mb from chromosome X and
7.5Mb from chromosome Y.
Genome-wide rates.We calculate the genome-wide nucleotide diver-
gence between human and chimpanzee to be 1.23%, confirming
recent results from more limited studies12,33,34. The differences
between one copy of the human genome and one copy of the
chimpanzee genome include both the sites of fixed divergence
between the species and some polymorphic sites within each species.
By correcting for the estimated coalescence times in the human and
chimpanzee populations (see Supplementary Information ‘Genome
evolution’), we estimate that polymorphism accounts for 14–22% of
the observed divergence rate and thus that the fixed divergence is
,1.06% or less.
Nucleotide divergence rates are not constant across the genome, as
has been seen in comparisons of the human and murid gen-
omes16,17,24,35,36. The average divergence in 1-Mb segments fluctuates
with a standard deviation of 0.25% (coefficient of variation ¼ 0.20),
which is much greater than the 0.02% expected assuming a uniform
divergence rate (Fig. 1a; see also Supplementary Fig. S1).
Regional variation in divergence could reflect local variation in
either mutation rate or other evolutionary forces. Among the latter,
one important force is genetic drift, which can cause substantial
differences in divergence time across loci when comparing closely
related species, as the divergence time for orthologues is the sum of
two terms: t1, the time since speciation, and t2, the coalescence time
for orthologues within the common ancestral population37. Whereas
t1 is constant across loci (,6–7million years38), t2 is a random
variable that fluctuates across loci (with a mean that depends on
population size and here may be on the order of 1–2million years39).
However, because of historical recombination, the characteristic
scale of such fluctuations will be on the order of tens of kilobases,
which is too small to account for the variation observed for 1-Mb
regions40 (see Supplementary Information ‘Genome evolution’).
Other potential evolutionary forces are positive or negative selection.
Although it is more difficult to quantify the expected contributions
of selection in the ancestral population41–43, it is clear that the effects
would have to be very strong to explain the large-scale variation
observed across mammalian genomes16,44. There is tentative evidence
from in-depth analysis of divergence and diversity that natural
selection is not the major contributor to the large-scale patterns of
genetic variability in humans45–47. For these reasons, we suggest that
the large-scale variation in the human–chimpanzee divergence rate
primarily reflects regional variation in mutation rate.
Chromosomal variation in divergence rate. Variation in divergence
rate is evident even at the level of whole chromosomes (Fig. 1b). The
most striking outliers are the sex chromosomes, with a mean
divergence of 1.9% for chromosome Y and 0.94% for chromosome
X. The likely explanation is a higher mutation rate in the male
compared with female germ line48. Indeed, the ratio of the male/
female mutation rates (denoted a) can be estimated by comparing
the divergence rates among the sex chromosomes and the autosomes
and correcting for ancestral polymorphism as a function of popu-
lation size of the most recent common ancestor (MRCA; see
Supplementary Information ‘Genome evolution’). Estimates for a
range from 3 to 6, depending on the chromosomes compared and the
assumed ancestral population size (Supplementary Table S18). This
is significantly higher than recent estimates of a for the murids
(,1.9) (ref. 17) and resolves a recent controversy based on smaller
data sets12,24,49,50.
The higher mutation rate in the male germ line is generally
attributed to the 5–6-fold higher number of cell divisions undergone
by male germ cells48. We reasoned that this would affect mutations
resulting from DNA replication errors (the rate should scale with the
number of cell divisions) but not mutations resulting from DNA
damage such as deamination of methyl CpG to TpG (the rate should
scale with time). Accordingly, we calculated a separately for CpG
sites, obtaining a value of ,2 from the comparison of rates between
autosomes and chromosome X. This intermediate value is a compo-
site of the rates of CpG loss and gain, and is consistent with roughly
equal rates of CpG to TpG transitions in the male and female germ
line51,52.
Significant variation in divergence rates is also seen among
autosomes (Fig. 1b; P , 3 £ 10215, Kruskal–Wallis test over 1-Mb
windows), confirming earlier observations based on low-coverage
WGS sampling12. Additional factors thus influence the rate of
divergence between chimpanzee and human chromosomes. These
factors are likely to act at length scales significantly shorter than a
chromosome, because the standard deviation across autosomes
(0.21%) is comparable to the standard deviation seen in 1-Mb
windows across the genome (0.13–0.35%). We therefore sought to
Figure 1 | Human-chimpanzee divergence in 1-Mb segments across the
genome. a, Distribution of divergence of the autosomes (blue), the X
chromosome (red) and the Y chromosome (green). b, Distribution of
variation by chromosome, shown as a box plot. The edges of the box
correspond to quartiles; the notches to the standard error of the median; and
the vertical bars to the range. The X and Y chromosomes are clear outliers,
but there is also high local variation within each of the autosomes.
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understand local factors that contribute to variation in divergence
rate.
Contribution of CpG dinucleotides. Sites containing CpG dinucleo-
tides in either species show a substantially elevated divergence rate of
15.2% per base; they account for 25.2% of all substitutions while
constituting only 2.1% of all aligned bases. The divergence at CpG
sites represents both the loss of ancestral CpGs and the creation of
new CpGs. The former process is known to occur at a rapid rate per
base due to frequent methylation of cytosines in a CpG context and
their frequent deamination53,54, whereas the latter process probably
proceeds at a rate more typical of other nucleotide substitutions.
Assuming that loss and creation of CpG sites are close to equilibrium,
themutation rate for bases in a CpG dinucleotidemust be 10–12-fold
higher than for other bases (see Supplementary Information ‘Gen-
ome evolution’ and ref. 51).
Because of the high rate of CpG substitutions, regional divergence
rates would be expected to correlate with regional CpG density. CpG
density indeed varies across 1-Mb windows (mean ¼ 2.1%, coeffi-
cient of variation ¼ 0.44 compared with 0.0093 expected under a
Poisson distribution), but only explains 4% of the divergence rate
variance. In fact, regional CpG and non-CpG divergence is highly
correlated (r ¼ 0.88; Supplementary Fig. S2), suggesting that higher-
order effects modulate the rates of two very different mutation
processes (see also ref. 47).
Increased divergence in distal regions. The most striking regional
pattern is a consistent increase in divergence towards the ends of
most chromosomes (Fig. 2). The terminal 10Mb of chromosomes
(including distal regions and proximal regions of acrocentric
chromosomes) averages 15% higher divergence than the rest of the
genome (Mann–Whitney U-test; P , 10230), with a sharp increase
towards the telomeres. The phenomenon correlates better with
physical distance than relative position along the chromosomes
and may partially explain why smaller chromosomes tend to have
higher divergence (Supplementary Fig. S3; see also ref. 15). These
observations suggest that large-scale chromosomal structure, directly
or indirectly, influences regional divergence patterns. The cause of
this effect is unclear, but these regions (,15% of the genome) are
notable in having high local recombination rate, high gene density
and high G þ C content.
Correlation with chromosome banding. Another interesting pattern is
that divergence increases with the intensity of Giemsa staining in
cytogenetically defined chromosome bands, with the regions corre-
sponding to Giemsa dark bands (G bands) showing 10% higher
divergence than the genome-wide average (Mann–Whitney U-test;
P , 10214) (see Fig. 2). In contrast to terminal regions, these regions
(17% of the genome) tend to be gene poor, (G þ C)-poor and low in
recombination55,56. The elevated divergence seen in two such differ-
ent types of regions suggests that multiple mechanisms are at work,
and that no single known factor, such as G þ C content or recombi-
nation rate, is an adequate predictor of regional variation in the
mammalian genome by itself (Fig. 3). Elucidation of the relative
contributions of these and other mechanisms will be important for
formulating accurate models for population genetics, natural selec-
tion, divergence times and the evolution of genome-wide sequence
composition57.
Correlation with regional variation in the murid genome. Given that
sequence divergence shows regional variation in both hominids
(human–chimpanzee) and murids (mouse–rat), we asked whether
the regional rates are positively correlated between orthologous
regions. Such a correlation would suggest that the divergence rate
is driven, in part, by factors that have been conserved over the ,75
million years since rodents, humans and apes shared a common
ancestor. Comparative analysis of the human and murid genomes
has suggested such a correlation58–60, but the chimpanzee sequence
provides a direct opportunity to compare independent evolutionary
processes between two mammalian clades.
We compared the local divergence rates in hominids and murids
across major orthologous segments in the respective genomes
(Fig. 4). For orthologous segments that are non-distal in both
hominids and murids, there is a strong correlation between the
divergence rates (r ¼ 0.5, P , 10211). In contrast, orthologous
segments that are centred within 10Mb of a hominid telomere
have disproportionately high divergence rates and G þ C content
relative to the murids (Mann–Whitney U-test; P , 10211 and
Figure 2 | Regional variation in divergence rates. Human–chimpanzee
divergence (blue), G þ C content (green) and human recombination rates173
(red) in sliding 1-Mb windows for human and chimpanzee chromosome 1.
Divergence and G þ C content are noticeably elevated near the 1p telomere,
a trend that holds for most subtelomeric regions (see text). Internally on the
chromosome, regions of low G þ C content and high divergence often
correspond to the dark G bands.
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P , 1024), implying that the elevation in these regions is, at least
partially, lineage specific. The same general effect is observed (albeit
less pronounced) if CpG dinucleotides are excluded (Supplementary
Fig. S4). Increased divergence and G þ C contentmight be explained
by ‘biased gene conversion’61 due to the high hominid recombination
rates in these distal regions. Segments that are distal in murids do not
show elevated divergence rates, which is consistent with this model,
because the recombination rates of distal regions are not as elevated
in mouse and rat62.
Taken together, these observations suggest that sequence diver-
gence rate is influenced by both conserved factors (stable across
mammalian evolution) and lineage-specific factors (such as proxi-
mity to the telomere or recombination rate, which may change with
chromosomal rearrangements).
Insertions and deletions.We next studied the indel events that have
occurred in the human and chimpanzee lineages by aligning the
genome sequences to identify length differences. We will refer below
to all events as insertions relative to the other genome, although they
may represent insertions or deletions relative to the genome of the
common ancestor.
The observable insertions fall into two classes: (1) ‘completely
covered’ insertions, occurring within continuous sequence in both
species; and (2) ‘incompletely covered’ insertions, occurring within
sequence containing one or more gaps in the chimpanzee, but
revealed by a clear discrepancy between the species in sequence
length. Different methods are needed for reliable identification of
modest-sized insertions (1 base to 15 kb) and large insertions
(.15 kb), with the latter only being reliably identifiable in the
human genome (see Supplementary Information ‘Genome evol-
ution’).
The analysis ofmodest-sized insertions reveals,32Mb of human-
specific sequence and ,35Mb of chimpanzee-specific sequence,
contained in ,5million events in each species (Supplementary
Information ‘Genome evolution’ and Supplementary Fig. S5). Nearly
all of the human insertions are completely covered, whereas only half
of the chimpanzee insertions are completely covered. Analysis of the
completely covered insertions shows that the vast majority are small
(45% of events cover only 1 base pair (bp), 96% are ,20 bp and
98.6% are ,80 bp), but that the largest few contain most of the
sequence (with the,70,000 indels larger than 80 bp comprising 73%
of the affected base pairs) (Fig. 5). The latter indels .80 bp fall into
three categories: (1) about one-quarter are newly inserted transpo-
sable elements; (2) more than one-third are due to microsatellite and
satellite sequences; (3) and the remainder are assumed to be mostly
deletions in the other genome.
The analysis of larger insertions (.15 kb) identified 163 human
regions containing 8.3Mb of human-specific sequence in total
(Fig. 6). These cases include 34 regions that involve exons from
known genes, which are discussed in a subsequent section. Although
we have no direct measure of large insertions in the chimpanzee
genome, it appears likely that the situation is similar.
On the basis of this analysis, we estimate that the human and
chimpanzee genomes each contain 40–45Mb of species-specific
euchromatic sequence, and the indel differences between the gen-
omes thus total ,90Mb. This difference corresponds to ,3% of
both genomes and dwarfs the 1.23% difference resulting from
nucleotide substitutions; this confirms and extends several recent
studies63–67. Of course, the number of indel events is far fewer than
the number of substitution events (,5 million compared with ,35
million, respectively).
Transposable element insertions. We next used the catalogue of
lineage-specific transposable element copies to compare the activity
of transposons in the human and chimpanzee lineages (Table 2).
Endogenous retroviruses. Endogenous retroviruses (ERVs) have
become all but extinct in the human lineage, with only a single
retrovirus (human endogenous retrovirus K (HERV-K)) still active24.
HERV-K was found to be active in both lineages, with at least 73
human-specific insertions (7 full length and 66 solo long terminal
repeats (LTRs)) and at least 45 chimpanzee-specific insertions (1 full
length and 44 solo LTRs). A few other ERV classes persisted in the
human genome beyond the human–chimpanzee split, leaving ,9
human-specific insertions (all solo LTRs, including five HERV9
elements) before dying out.
Against this background, it was surprising to find that the
chimpanzee genome has two active retroviral elements (PtERV1
and PtERV2) that are unlike any older elements in either genome;
Figure 3 |Divergence rates versus G 1 C content for 1-Mb segments across
the autosomes. Conditional on recombination rate, the relationship
between divergence and G þ C content varies. In regions with
recombination rates less than 0.8 cM Mb21 (blue), there is an inverse
relationship, where high divergence regions tend to be (G þ C)-poor and
low divergence regions tend to be (G þ C)-rich. In regions with
recombination rates greater than 2.0 cM Mb21, whether within 10 Mb (red)
or proximal (green) of chromosome ends, both divergence and G þ C
content are uniformly high.
Figure 4 | Disproportionately elevated divergence and G 1 C content near
hominid telomeres. Scatter plot of the ratio of human–chimpanzee
divergence over mouse–rat divergence versus the ratio of human G þ C
content over mouse G þ C content across 199 syntenic blocks for which
more than 1 Mb of sequence could be aligned between all four species.
Blocks for which the centre is within 10 Mb of a telomere in hominids only
(green) or in hominids and murids (magenta), but not in murids only (light
blue), show a significant trend towards higher ratios than internal blocks
(dark blue). Blocks on the X chromosome (red) tend to show a lower
divergence ratio than autosomal blocks, consistent with a smaller difference
between autosomal and X divergence in murids than in hominids (lower a).
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these must have been introduced by infection of the chimpanzee
germ line. The smaller family (PtERV2) has only a few dozen copies,
which nonetheless represent multiple (,5–8) invasions, because the
sequence differences among reconstructed subfamilies are too great
(,8%) to have arisen bymutation since divergence from human. It is
closely related to a baboon endogenous retrovirus (BaEV, 88%ORF2
product identity) and a feline endogenous virus (ECE-1, 86% ORF2
product identity). The larger family (PtERV1) is more homogeneous
and has over 200 copies. Whereas older ERVs, like HERV-K, are
primarily represented by solo LTRs resulting from LTR–LTR recom-
bination, more than half of the PtERV1 copies are still full length,
probably reflecting the young age of the elements. PtERV1-like
elements are present in the rhesus monkey, olive baboon and African
great apes but not in human, orang-utan or gibbon, suggesting
separate germline invasions in these species68.
Higher Alu activity in humans. SINE (Alu) elements have been
threefold more active in humans than chimpanzee (,7,000 com-
pared with ,2,300 lineage-specific copies in the aligned portion),
refining the rather broad range (2–7-fold) estimated in smaller
studies13,67,69. Most chimpanzee-specific elements belong to a sub-
family (AluYc1) that is very similar to the source gene in the common
ancestor. By contrast, most human-specific Alu elements belong to
two new subfamilies (AluYa5 andAluYb8) that have evolved since the
chimpanzee–human divergence and differ substantially from the
ancestral source gene69. It seems likely that the resurgence of Alu
elements in humans is due to these potent new source genes.
However, based on an examination of available finished sequence,
the baboon shows a 1.6-fold higher Alu activity relative to human
new insertions, suggesting that there may also have been a general
decline in activity in the chimpanzee67.
Some of the human-specific Alu elements are highly diverged (92
with .5% divergence), which would seem to suggest that they are
much older than the human–chimpanzee split. Possible explanations
include: gene conversion by nearby older elements; processed pseu-
dogenes arising from a spurious transcription of an older element;
precise excision from the chimpanzee genome; or high local
mutation rate. In any case, the presence of such anomalies suggests
that caution is warranted in the use of single-repeat elements as
homoplasy-free phylogenetic markers.
New Alu elements target (A þT)-rich DNA in human and chimpanzee
genomes. Older SINE elements are preferentially found in gene-rich,
(G þ C)-rich regions, whereas younger SINE elements are found in
gene-poor, (A þ T)-rich regions where long interspersed element
(LINE)-1 (L1) copies also accumulate24,70. The latter distribution is
consistent with the fact that Alu retrotransposition is mediated by L1
(ref. 71). Murid genomes revealed no change in SINE distribution
with age17.
The human pattern might reflect either preferential retention of
SINEs in (G þ C)-rich regions, due to selection or mutation bias, or
a recent change in Alu insertion preferences. With the availability of
the chimpanzee genome, it is possible to classify the youngest Alu
copies more accurately and thus begin to distinguish these
possibilities.
Analysis shows that lineage-specific SINEs in both human and
chimpanzee are biased towards (A þ T)-rich regions, as opposed to
even the most recent copies in the MRCA (Fig. 7). This indicates that
SINEs are indeed preferentially retained in (G þ C)-rich DNA, but
comparison with a more distant primate is required to formally rule
out the possibility that the insertion bias of SINEs did not change just
before speciation.
Equal activity of L1 in both species. The human and chimpanzee
genomes both show,2,000 lineage-specific L1 elements, contrary to
previous estimates based on small samples that L1 activity is 2–3-fold
higher in chimpanzee72.
Transcription from L1 source genes can sometimes continue into
3
0
flanking regions, which can then be co-transposed73,74. Human–
chimpanzee comparison revealed that ,15% of the species-specific
insertions appear to have carried with them at least 50 bp of flanking
sequence (followed by a poly(A) tail and a target site duplication). In
principle, incomplete reverse transcription could result in insertions
of the flanking sequence only (without any L1 sequence), mobilizing
gene elements such as exons, but we found no evidence of this.
Retrotransposed gene copies. The L1 machinery also mediates retro-
transposition of host messenger RNAs, resulting in many intronless
(processed) pseudogenes in the human genome75–77. We identified
163 lineage-specific retrotransposed gene copies in human and 246 in
chimpanzee (Supplementary Table S19). Correcting for incomplete
sequence coverage of the chimpanzee genome, we estimate that there
are ,200 and ,300 processed gene copies in human and chimpan-
zee, respectively. Processed genes thus appear to have arisen at a rate
of ,50 per million years since the divergence of human and
chimpanzee; this is lower than the estimated rate for early primate
evolution75, perhaps reflecting the overall decrease in L1 activity. As
expected78, ribosomal protein genes constitute the largest class in
both species. The second largest class in chimpanzee corresponds to
zinc finger C2H2 genes, which are not a major class in the human
genome.
Figure 5 | Length distribution of small indel events, as determined using
bounded sequence gaps. Sequences present in chimpanzee but not in
human (blue) or present in human but not in chimpanzee (red) are shown.
The prominent spike around 300 nucleotides corresponds to SINE insertion
events. Most of the indels are smaller than 20 bp, but larger indels account
for the bulk of lineage-specific sequence in the two genomes.
Figure 6 | Length distribution of large indel events (>15 kb), as determined
using paired-end sequences from chimpanzee mapped against the human
genome. Both the total number of candidate human insertions/chimpanzee
deletions (blue) and the number of bases altered (red) are shown.
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The retrotransposon SVA and distribution of CpG islands by transpo-
sable elements. The third most active element since speciation has
been SVA, which created about 1,000 copies in each lineage. SVA is a
composite element (,1.5–2.5 kb) consisting of two Alu fragments, a
tandem repeat and a region apparently derived from the 3
0
end of a
HERV-K transcript; it is probably mobilized by L1 (refs 79, 80). This
element is of particular interest because each copy carries a sequence
that satisfies the definition of a CpG island81 and contains potential
transcription factor binding sites; the dispersion of 1,000 SVA copies
could therefore be a source of regulatory differences between chim-
panzee and human (Supplementary Table S20). At least three human
genes contain SVA insertions near their promoters (Supplementary
Table S21), one of which has been found to be differentially expressed
between the two species82,83, but additional investigations will be
required to determine whether the SVA insertion directly caused this
difference.
Homologous recombination between interspersed repeats. Human–
chimpanzee comparison also makes it possible to study homologous
recombination between nearby repeat elements as a source of
genomic deletions. We found 612 deletions (totalling 2Mb) in the
human genome that appear to have resulted from recombination
between two nearby Alu elements present in the common ancestor;
there are 914 such events in the chimpanzee genome. (The events are
not biased to (A þ T)-rich DNA and thus would not explain the
preferential loss of Alu elements in such regions discussed above.)
Similarly, we found 26 and 48 instances involving adjacent L1 copies
and 8 and 22 instances involving retroviral LTRs in human and
chimpanzee, respectively. None of the repeat-mediated deletions
removed an orthologous exon of a known human gene in
chimpanzee.
The genome comparison allows one to estimate the dependency of
homologous recombination on divergence and distance. Homolo-
gous recombination seems to occur between quite (.25%) diverged
copies (Fig. 8), whereas the number of recombination events (n)
varies inversely with the distance (d, in bases) between the copies (as
n < 6 £ 106 d21.7; r2 ¼ 0.9).
Large-scale rearrangements. Finally, we examined the chimpanzee
genome sequence for information about large-scale genomic altera-
tions. Cytogenetic studies have shown that human and chimpanzee
chromosomes differ by one chromosomal fusion, at least nine
pericentric inversions, and in the content of constitutive hetero-
chromatin84. Human chromosome 2 resulted from a fusion of two
ancestral chromosomes that remained separate in the chimpanzee
lineage (chromosomes 2A and 2B in the revised nomenclature18,
formerly chimpanzee chromosomes 12 and 13); the precise fusion
point has been mapped and its duplication structure described in
detail85,86. In accord with this, alignment of the human and chim-
panzee genome sequences shows a break in continuity at this point.
We searched the chimpanzee genome sequence for the precise
locations of the 18 breakpoints corresponding to the 9 pericentric
inversions (Supplementary Table S22). By mapping paired-end
sequences from chimpanzee large insert clones to the human
genome, we were able to identify 13 of the breakpoints within the
assembly from discordant end alignments. The positions of five
breakpoints (on chromosomes 4, 5 and 12) were tested by fluor-
escence in situ hybridization (FISH) analysis and all were confirmed.
Also, the positions of three previously mapped inversion breakpoints
(on chromosomes 15 and 18) matched closely those found in the
assembly87,88. The paired-end analysis works well in regions of unique
sequence, which constitute the bulk of the genome, but is less
effective in regions of recent duplication owing to ambiguities in
mapping of the paired-end sequences. Beyond the known inversions,
we also found suggestive evidence of many additional smaller
inversions, as well as older segmental duplications (,98% identity;
Supplementary Fig. S6). However, both smaller inversions and more
recent segmental duplications will require further investigations.
Gene evolution
We next sought to use the chimpanzee sequence to study the role of
natural selection in the evolution of human protein-coding genes.
Genome-wide comparisons can shed light on many central issues,
including: the magnitude of positive and negative selection; the
variation in selection across different lineages, chromosomes, gene
families and individual genes; and the complete loss of genes within a
lineage.
We began by identifying a set of 13,454 pairs of human and
chimpanzee genes with unambiguous 1:1 orthology for which it was
possible to generate high-quality sequence alignments covering
virtually the entire coding region (Supplementary Information
‘Gene evolution’ and Table S23). The list contains a large fraction
of the entire complement of human genes, although it under-
represents gene families that have undergone recent local expansion
(such as olfactory receptors and immunoglobulins). To facilitate
comparison with the murid lineage, we also compiled a set of 7,043
human, chimpanzee, mouse and rat genes with unambiguous 1:1:1:1
orthology and high-quality sequence alignments (Supplementary
Table S24).
Average rates of evolution. To assess the rate of evolution for each
gene, we estimated KA, the number of coding base substitutions that
result in amino acid change as a fraction of all such possible sites (the
non-synonymous substitution rate). Because the background
Table 2 | Transposable element activity in human and chimpanzee lineages
Element Chimpanzee* Human*
Alu 2,340 (0.7Mb) 7,082 (2.1Mb)
LINE-1 1,979 (.5Mb) 1,814 (5.0Mb)
SVA 757 (.1Mb) 970 (1.3Mb)
ERV class 1 234 (.1Mb)† 5 (8 kb)‡
ERV class 2 45 (55 kb)§ 77 (130 kb)§
(Micro)satellite 7,054 (4.1Mb) 11,101 (5.1Mb)
*Number of lineage-specific insertions (with total size of inserted sequences indicated in
brackets) in the aligned parts of the genomes.
†PtERV1 and PtERV2.
‡HERV9.
§Mostly HERV-K.
Figure 7 | Correlation of Alu age and distribution by G 1 C content. Alu
elements that inserted after human–chimpanzee divergence are densest in
the (G þ C)-poor regions of the genome (peaking at 36–40% G þ C),
whereas older copies, common to both genomes, crowd (G þ C)-rich
regions. The figure is similar to figure 23 of ref. 24, but the use of chimpanzee
allows improved separation of young and old elements, leading to a sharper
transition in the pattern.
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mutation rate varies across the genome, it is crucial to normalize KA
for comparisons between genes. A striking illustration of this
variation is the fact that the mean KA is 37% higher in the rapidly
diverging distal 10Mb of chromosomes than in the more proximal
regions. Classically, the background rate is estimated by KS, the
synonymous substitution rate (coding base substitutions that,
because of codon redundancy, do not result in amino acid change).
Because a typical gene has only a few synonymous changes between
humans and chimpanzees, and not infrequently is zero, we exploited
the genome sequence to estimate the local intergenic/intronic sub-
stitution rate, K I, where appropriate. KA and KS were also estimated
for each lineage separately using mouse and rat as outgroups (Fig. 9).
The KA/KS ratio is a classical measure of the overall evolutionary
constraint on a gene, where KA/KS ,, 1 indicates that a substantial
proportion of amino acid changes must have been eliminated by
purifying selection. Under the assumption that synonymous substi-
tutions are neutral, KA/KS . 1 implies, but is not a necessary
condition for, adaptive or positive selection. The KA/K I ratio has
the same interpretation. The ratios will sometimes be denoted below
by q with an appropriate subscript (for example, qhuman) to indicate
the branch of the evolutionary tree under study.
Evolutionary constraint on amino acid sites within the hominid lineage.
Overall, human and chimpanzee genes are extremely similar, with the
encoded proteins identical in the two species in 29% of cases. The
median number of non-synonymous and synonymous substitutions
per gene are two and three, respectively. About 5% of the proteins
show in-frame indels, but these tend to be small (median ¼ 1 codon)
and to occur in regions of repeated sequence. The close similarity of
human and chimpanzee genes necessarily limits the ability to make
strong inferences about individual genes, but there is abundant data
to study important sets of genes.
The KA/KS ratio for the human–chimpanzee lineage (qhominid) is
0.23. The value is much lower than some recent estimates based on
limited sequence data (ranging as high as 0.63 (ref. 7)), but is
consistent with an estimate (0.22) from random expressed-sequence-
tag (EST) sequencing45. Similarly, KA/K I was also estimated as 0.23.
Under the assumption that synonymous mutations are selectively
neutral, the results imply that 77% of amino acid alterations in
hominid genes are sufficiently deleterious as to be eliminated by
natural selection. Because synonymous mutations are not entirely
neutral (see below), the actual proportion of amino acid alterations
with deleterious consequences may be higher. Consistent with
previous studies8, we find that KA/KS of human polymorphisms
with frequencies up to 15% is significantly higher than that of
human–chimpanzee differences and more common polymorphisms
(Table 3), implying that at least 25% of the deleterious amino acid
alterations may often attain readily detectable frequencies and thus
contribute significantly to the human genetic load.
Evolutionary constraint on synonymous sites within hominid lineage.
We next explored the evolutionary constraints on synonymous sites,
specifically fourfold degenerate sites. Because such sites have no effect
on the encoded protein, they are often considered to be selectively
neutral in mammals.
We re-examined this assumption by comparing the divergence at
fourfold degenerate sites with the divergence at nearby intronic sites.
Although overall divergence rates are very similar at fourfold degen-
erate and intronic sites, direct comparison is misleading because the
former have a higher frequency of the highly mutable CpG dinucleo-
tides (9% compared with 2%). When CpG and non-CpG sites are
considered separately, we find that both CpG sites and non-CpG sites
show markedly lower divergence in exonic synonymous sites than in
introns (,50% and ,30% lower, respectively). This result resolves
recent conflicting reports based on limited data sets45,89 by showing
that such sites are indeed under constraint.
The constraint does not seem to result from selection on the usage
of preferred codons, which has been detected in lower organisms90
such as bacteria91, yeast92 and flies93. In fact, divergence at fourfold
Figure 8 | Dependency of homologous recombination between Alu
elements on divergence and distance. a, Whereas homologous
recombination occurs between quite divergent (Smith–Waterman score
,1,000), closely spaced copies, more distant recombination seems to favour
a better match between the recombining repeats. b, The frequency of Alu–
Alu-mediated recombination falls markedly as a function of distance
between the recombining copies. The first three points (magenta) involve
recombination between left or right arms of one Alu inserted into another.
The high number of occurrences at a distance of 300–400 nucleotides is due
to the preference of integration in the A-rich tail; exclusion of this point does
not change the parameters of the equation.
Figure 9 | Human–chimpanzee–mouse–rat tree with branch-specific KA/KS
(q) values. a, Evolutionary tree. The branch lengths are proportional to the
absolute rates of amino acid divergence. b, Maximum-likelihood estimates
of the rates of evolution in protein-coding genes for humans, chimpanzees,
mice and rats. In the text, qhominid is the KA/KS of the combined human and
chimpanzee branches and qmurid of the combined mouse and rat branches.
The slight difference between qhuman and q chimpanzee is not statistically
significant; masking of some heterozygous bases in the chimpanzee
sequence may contribute to the observed difference (see Supplementary
Information ‘Gene evolution’).
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degenerate sites increases slightly with codon usage bias (Kendall’s
t ¼ 0.097, P , 10214). Alternatively, the observed constraint at
synonymous sites might reflect ‘background selection’—that is, the
indirect effect of purifying selection at amino acid sites causing
reduced diversity and thereby reduced divergence at closely linked
sites42. Given the low rate of recombination in hominid genomes (a
1 kb region experiences only,1 crossover per 100,000 generations or
2million years), such background selection should extend beyond
exons to include nearby intronic sites94. However, when the diver-
gence rate is plotted relative to exon–intron boundaries, we find that
the rate jumps sharply within a short region of ,7 bp at the
boundary (Fig. 10). This pattern strongly suggests that the action
of purifying selection at synonymous sites is direct rather than
indirect, suggesting that other signals, for example those involved
in splice site selection, may be embedded in the coding sequence and
therefore constrain synonymous sites.
Comparison with murids. An accurate estimate of KA/KS makes it
possible to study how evolutionary constraint varies across clades. It
was predicted more than 30 years ago95 that selection against deleter-
ious mutations would depend on population size, with mutations
being strongly selected only if they reduce fitness by s .. 1/4N
(where N is effective population size). This would predict that
genes would be under stronger purifying selection in murids than
hominids, owing to their presumed larger population size. Initial
analyses (involving fewer than 50 genes96) suggested a strong effect,
but the wide variation in estimates of KA/KS in hominids
7,8,97 and
murids98 has complicated this analysis45.
Using the large collection of 7,043 orthologous quartets, we
calculated mean KA/KS values for the various branches of the four-
species evolutionary tree (human, chimpanzee, mouse and rat;
Fig. 9). The KA/KS ratio for hominids is 0.20. (This is slightly lower
than the value of 0.23 obtained with all human–chimpanzee ortho-
logues, probably reflecting slightly greater constraint on the class of
proteins with clear orthologues across hominids and murids.)
The KA/KS ratio is markedly lower for murids than for hominids
(qmurid < 0.13 compared with q hominid < 0.20) (Fig. 9). This
implies that there is an ,35% excess of the amino-acid-changing
mutations in the two hominids, relative to the two murids. Excess
amino acid divergence may be explained by either increased adaptive
evolution or relaxation of evolutionary constraints. As shown in the
next section, the latter seems to be the principal explanation.
Relaxed constraints in human evolution. The KA/KS ratio can be used
to make inferences about the role of positive selection in human
evolution99,100. Because alleles under positive selection spread rapidly
through a population, they will be found less frequently as common
human polymorphisms than as human–chimpanzee differences8.
Positive selection can thus be detected by comparing the KA/KS
ratio for common human polymorphisms with the KA/KS ratio for
hominid divergence. These ratios have been estimated as
qpolymorphism < 0.20 based on an initial collection of common
SNPs in human genes and qdivergence < 0.34 based on comparison
of human and Old World monkey genes8. Thus, the proportion of
amino acid changes attributable to positive selection was inferred to
be ,35% (ref. 8). This would imply a huge quantitative role for
positive selection in human evolution.
With the availability of extensive data for both human polymorph-
ism and human–chimpanzee divergence, we repeated this analysis
(using the same set of genes for both estimates). We find that
qpolymorphism < 0.21–0.23 and qdivergence < 0.23 are statistically
indistinguishable (Table 3). Although some of the amino acid
substitutions in human and chimpanzee evolution must surely
reflect positive selection, the results indicate that the proportion of
changes fixed by positive selection seems to be much lower than the
previous estimate8. (Because the previous results involved compari-
son to Old World monkeys, it is possible that they reflect strong
positive selection earlier in primate evolution; however, we suspect
that they reflect the fact that relatively few genes were studied and
that different genes were used to study polymorphism and diver-
gence.)
Relaxed negative selection pressures thus primarily explain the
excess amino acid divergence in hominid genes relative to murids.
Moreover, because both qhuman and q chimpanzee are similarly elevated
this explanation applies equally to both lineages.
We next sought to study variation in the evolutionary rate of genes
within the hominid lineage by searching for unusually high or low
levels of constraint for genes and sets of genes.
Rapid evolution in individual genes. We searched for individual
genes that have accumulated amino acid substitutions faster than
expected given the neutral substitution rate; we considered these
genes as potentially being under strong positive selection. A total of
585 of the 13,454 human–chimpanzee orthologues (4.4%) have
observed KA/K I . 1 (see Supplementary Information ‘Gene evol-
ution’). However, given the low divergence, the KA/K I statistic has
large variance. Simulations show that estimates of KA/K I . 1 would
be expected to occur simply by chance in at least 263 cases if purifying
selection is allowed to act non-uniformly across genes (Supplemen-
tary Fig. S7).
Nonetheless, this set of 585 genes may be enriched for genes that
are under positive selection. The most extreme outliers include
glycophorin C, which mediates one of the Plasmodium falciparum
invasion pathways in human erythrocytes101; granulysin, which
mediates antimicrobial activity against intracellular pathogens such
asMycobacterium tuberculosis102; as well as genes that have previously
been shown to be undergoing adaptive evolution, such as the
protamines and semenogelins involved in reproduction103 and the
Mas-related gene family involved in nociception104. With similar
Table 3 | Comparison of KA/KS for divergence and human diversity
Substitution type DA DS KA/KS Per cent excess* Confidence interval†
Human–chimpanzee divergence 38,773 61,737 0.23 – –
HapMap (European ancestry)‡
Rare derived alleles (,15%) 1,614 1,540 0.39 67 [59, 75]
Common alleles 1,199 1,907 0.23 0 [25, 6]
Frequent derived alleles (.85%) 209 356 0.22 27 [219, 7]
HapMap (African ancestry)‡
Rare derived alleles (,5%) 849 842 0.36 61 [50, 72]
Common alleles 495 803 0.22 22 [210, 7]
Frequent derived alleles (.85%) 59 82 0.26 15 [211, 48]
Affymetrix 120K (multi-ethnic)§
Rare derived alleles (,15%) 74 82 0.33 44 [14, 80]
Common alleles 77 137 0.21 211 [228, 12]
Frequent derived alleles (.85%) 10 15 0.25 6 [242, 95]
DA, Number of observed non-synonymous substitutions. DS, Number of observed synonymous substitutions.
*A negative value indicates excess of non-synonymous divergence over polymorphism.
†95% confidence intervals assuming non-synonymous substitutions are Poisson distributed.
‡Source: http://www.hapmap.org (Public Release no. 13).
§Source: http://www.affymetrix.com.
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follow-up studies on candidates from this list, one may be able to
draw conclusions about positive selection on other individual genes.
In subsequent sections, we examine the rate of divergence for sets of
related genes with the aim of detecting subtler signals of accelerated
evolution.
Variation in evolutionary rate across physically linked genes. We
explored how the rate of evolution varies regionally across the
genome. Several studies of mammalian gene evolution have noted
that the rate of amino acid substitution shows local clustering, with
proteins encoded by nearby genes evolving at correlated rates16,105–107.
Variation across chromosomes. On the basis of an analysis of ,100
genes108, it was recently reported that the normalized rate of protein
evolution is greater on the nine chromosomes that underwent major
structural rearrangement during human evolution (chromosomes 1,
2, 5, 9, 12, 15, 16, 17 and 18); it was suggested that such rearrange-
ments led to reduced gene flow and accelerated adaptive evolution. A
subsequent study of a collection of chimpanzee ESTs gave contra-
dictory results109,110. With our larger data set, we re-examined this
issue and found no evidence of accelerated evolution on chromo-
somes with major rearrangements, even if we considered each
rearrangement separately (Supplementary Table S25).
Among all hominid chromosomes, the most extreme outlier is
chromosome X with a mean KA/K I of 0.32. The higher mean seems
to reflect a skewed distribution at both high and low values, with the
median value (0.17) being more in line with other chromosomes
(0.15). The excess of low valuesmay reflect greater purifying selection
at some genes, owing to the hemizygosity of chromosome X inmales.
The excess of high values may reflect increased adaptive selection also
resulting from hemizygosity, if a considerable proportion of advan-
tageous alleles are recessive111. Interestingly, the higher KA/K I value
on the X chromosome versus autosomes is largely restricted to genes
expressed in testis83.
Variation in local gene clusters. We next searched for genomic
neighbourhoods with an unusually high density of rapidly evolving
genes. Specifically, we calculated the median KA/K I for sliding
windows of ten orthologues and identified extreme outliers
(P , 0.001 compared to random ordering of genes; see Supplemen-
tary Information ‘Gene evolution’). A total of 16 such neighbour-
hoodswere found,whichgreatlyexceeds randomexpectation(Table4).
Repeating the analysis with larger windows (25, 50 and 100 ortho-
logues) did not identify additional rapidly diverging regions.
In nearly all cases, the regions contain local clusters of phylogen-
etically and functionally related genes. The rapid diversification of
gene families, postulated by ref. 112, can thus be readily discerned
even at the relatively close distance of human–chimpanzee diver-
gence. Most of the clusters are associated with functional categories
such as host defence and chemosensation (see below). Examples
include the epidermal differentiation complex encoding proteins
that help form the cornified layer of the skin barrier (Supplementary
Fig. S8), the WAP-domain cluster encoding secreted protease inhibi-
tors with antibacterial activity, and the Siglec cluster encodingCD33-
related genes. Rapid evolution in these clusters does not seem to be
unique to either human or chimpanzee113,114.
Variation in evolutionary rate across functionally related genes.
We next studied variation in the evolutionary rate of functional
categories of genes, based on the Gene Ontology (GO) classifi-
cation115.
Rapidly and slowly evolving categories within the hominid lineage.We
started by searching for sets of functionally related genes with
exceptionally high or low constraint in humans and chimpanzees.
For each of the 809 categories with at least 20 genes, KA/KS was
calculated by concatenating the gene sequences. The category-
specific ratios were compared to the average across all orthologues
to identify extreme outliers using a metric based on the binomial test
(Supplementary Information ‘Gene evolution’ and Supplementary
Tables S26–S29). The numbers of observed outliers below a specific
threshold (test statistic,0.001) were then compared to the expected
distribution of outliers given randomly permuted annotations.
A total of 98 categories showed elevated KA/KS ratios at the
specified threshold (Table 5). Only 30 would be expected by chance,
indicating that most (but not all) of these categories undergo
significantly accelerated evolution relative to the genome-wide aver-
age (P , 1024). The rapidly evolving categories within the hominid
lineage are primarily related to immunity and host defence, repro-
duction, and olfaction, which are the same categories known to be
undergoing rapid evolution within the broader mammalian lineage,
as well as more distantly related species15,16,116. Hominids thus seem
to be typical of mammals in this respect (but see below).
A total of 251 categories showed significantly low KA/KS ratios
(comparedwith,32 expected by chance; P , 1024). These include a
wide range of processes including intracellular signalling, metab-
olism, neurogenesis and synaptic transmission, which are evidently
under stronger-than-average purifying selection. More generally,
genes expressed in the brain show significantly stronger average
constraint than genes expressed in other tissues83.
Differences between hominid and murid lineages. Having found gene
categories that show substantial variation in absolute evolutionary
rate within hominids, we next examined variation in relative rates
Figure 10 | Purifying selection on synonymous sites. Mean divergence
around exon boundaries at non-CpG, exonic, fourfold degenerate sites and
intronic sites, relative to the closest mRNA splice junction. The divergence
rate at exonic, fourfold degenerate sites is significantly lower than at nearby
intronic sites (Mann–Whitney U-test; P , 10227), suggesting that purifying
selection limits the rate of synonymous codon substitutions.
Table 4 | Rapidly diverging gene clusters in human and chimpanzee
Location
(human) Cluster Median KA/K I*
1q21 Epidermal differentiation complex 1.46
6p22 Olfactory receptors and HLA-A 0.96
20p11 Cystatins 0.94
19q13 Pregnancy-specific glycoproteins 0.94
17q21 Hair keratins and keratin-associated proteins 0.93
19q13 CD33-related Siglecs 0.90
20q13 WAP domain protease inhibitors 0.90
22q11 Immunoglobulin-l/breakpoint critical region 0.85
12p13 Taste receptors, type 2 0.81
17q12 Chemokine (C-C motif) ligands 0.81
19q13 Leukocyte-associated immunoglobulin-like receptors 0.80
5q31 Protocadherin-b 0.77
1q32 Complement component 4-binding proteins 0.76
21q22 Keratin-associated proteins and uncharacterized ORFs 0.76
1q23 CD1 antigens 0.72
4q13 Chemokine (C-X-C motif) ligands 0.70
*Maximum median KA/K I if the cluster stretched over more than one window of ten genes.
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between murids and hominids. The KA/K S of each of the GO
categories are highly correlated between the hominid and murid
orthologue pairs, suggesting that the selective pressures acting on
particular functional categories have been largely proportional in
recent hominid and recent murid evolution (Fig. 11). However, there
are several categories with significantly accelerated non-synonymous
divergence on each of the lineages, which might represent functions
that have undergone lineage-specific positive selection or a lineage-
specific relaxation of constraint (Supplementary Information ‘Gene
evolution’ and Supplementary Tables S30–S39).
A total of 59 categories (compared with 11 expected at random,
P , 0.0003) show evidence of accelerated non-synonymous diver-
gence in the murid lineage. These are dominated by functions and
processes related to host defence, such as immune response and
lymphocyte activation. Examples include genes encoding interleu-
kins and various T-cell surface antigens (Cd4,Cd8,Cd80). Combined
with the recent observation that genes involved in host defence have
undergone gene family expansion inmurids16,17, this suggests that the
immune system has undergone extensive lineage-specific innovation
in murids. Additional categories that also show relative acceleration
in murids include chromatin-associated proteins and proteins
involved in DNA repair. These categories may have similarly under-
gone stronger adaptive evolution in murids or, alternatively, they
may contain fewer sites for mutations with slightly deleterious effects
(with the result that the KA/K S ratios are less affected by the
differences in population size96,117).
Another 58 categories (versus 14 expected at random, P , 0.0005)
show evidence of accelerated evolution in hominids, with the set
dominated by genes encoding proteins involved in transport (for
example, ion transport), synaptic transmission, spermatogenesis and
perception of sound (Table 6). Notably, some outliers include genes
with brain-related functions, compatible with a recent finding118.
Potential positive selection on spermatogenesis genes in the homi-
nids was also recently noted119. However, as above, it is possible that
these categories could have more sites for slightly deleterious
mutations and thus be more affected by population size differences.
Sequence information from more species and from individuals
within species will be necessary to distinguish between the possible
explanations.
Differences between the human and chimpanzee lineage. One of the
most interesting questions is perhaps whether certain categories have
undergone accelerated evolution in humans relative to chimpanzees,
because such genes might underlie unique aspects of human
evolution.
As was done for hominids and murids above, we compared non-
synonymous divergence for each category to search for relative
acceleration in either lineage (Fig. 12). Seven categories show signs
of accelerated evolution on the human lineage relative to chimpan-
zee, but this is only slightly more than the four expected at random
(P , 0.22). Intriguingly, the single strongest outlier is ‘transcription
factor activity’, with the 348 human genes studied having accumu-
lated 47% more amino acid changes than their chimpanzee ortho-
logues. Genes with accelerated divergence in human include
homeotic, forkhead and other transcription factors that have key
roles in early development. However, given the small number of
changes involved, additional data will be required to confirm this
trend. There was no excess of accelerated categories on the chim-
panzee lineage.
We also compared human genes with and without disease associ-
ations, including mental retardation, for differences in mutation rate
when compared to chimpanzee. Briefly, no significant differences
were observed in either the background mutation rate or in the ratio
of human-specific changes to chimpanzee-specific amino acid
changes (see Supplementary Information ‘Gene evolution’ and
Supplementary Tables S40 and S41).
We thus findminimal evidence of acceleration unique to either the
human or chimpanzee lineage across broad functional categories.
This is not simply due to general lack of power resulting from the
small number of changes since the divergence of human and
chimpanzee, because one can detect acceleration of categories in
either hominid relative to either murid. For example, 29 accelerated
categories versus 9 expected at random (P , 0.02) can be detected on
the human lineage, and 40 categories versus 11 expected at random
(P , 0.007) on the chimpanzee lineage, relative to mouse. But the
Table 5 | GO categories with the highest divergence rates in hominids
GO categories within ‘biological process’ Number of orthologues Amino acid divergence KA/KS
GO:0007606 sensory perception of chemical stimulus 59 0.018 0.590
GO:0007608 perception of smell 41 0.018 0.521
GO:0006805 xenobiotic metabolism 40 0.013 0.432
GO:0006956 complement activation 22 0.013 0.428
GO:0042035 regulation of cytokine biosynthesis 20 0.011 0.402
GO:0007565 pregnancy 34 0.014 0.384
GO:0007338 fertilization 24 0.010 0.371
GO:0008632 apoptotic programme 36 0.010 0.358
GO:0007283 spermatogenesis 80 0.008 0.354
GO:0000075 cell cycle checkpoint 27 0.006 0.354
Listed are the ten categories in the taxonomy biological process with the highest KA/KS ratios, which are not significant solely due to significant subcategories.
Table 6 | GO categories with accelerated divergence rates in hominids relative to murids
GO categories within ‘biological process’ Number of orthologues
Amino acid divergence in
hominids
Amino acid divergence in
murids KA/KS in hominids KA/KS in murids
GO:0007283 spermatogenesis 43 0.0075 0.054 0.323 0.188
GO:0006869 lipid transport 22 0.0081 0.051 0.306 0.120
GO:0006865 amino acid transport 24 0.0058 0.033 0.218 0.084
GO:0015698 inorganic anion transport 29 0.0061 0.027 0.195 0.072
GO:0006486 protein amino acid glycosylation 50 0.0056 0.040 0.166 0.100
GO:0019932 second-messenger-mediated signalling 58 0.0049 0.036 0.159 0.083
GO:0007605 perception of sound 28 0.0052 0.033 0.158 0.085
GO:0016051 carbohydrate biosynthesis 27 0.0047 0.028 0.147 0.067
GO:0007268 synaptic transmission 93 0.0040 0.025 0.126 0.069
GO:0006813 potassium ion transport 65 0.0035 0.022 0.113 0.056
Listed are the ten categories in the taxonomy biological process with the strongest evidence for accelerated evolution in hominids relative to murids, which are not significant solely due to
significant subcategories.
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outliers are largely the same for both human and chimpanzee,
indicating that the fraction of amino acid mutations that have
contributed to human- and chimpanzee-specific patterns of evol-
ution must be small relative to the fraction that have contributed to a
common hominid and, to a large extent, mammalian pattern of
evolution.
It was recently reported10 that several functional categories are
enriched for genes with evidence of positive selection in the human
lineage or the chimpanzee lineage, and that these categories are
largely different between the two lineages. These results and ours
differ in ways that will require further investigation. With the
potential exception of some developmental regulators, the categories
that ref. 10 reported as showing the strongest enrichment of positive
selection in one lineage (including cell adhesion, ion transport and
perception of sound) are among those that we show as having
accelerated divergence in both human and chimpanzee. This suggests
that positive selection and relaxation of constraints may be corre-
lated, or alternatively, that the results of ref. 10 may be enriched for
false positives in categories that have experienced particularly strong
relaxation of constraints in the hominids. Data from additional
primates, as well as advances in analytical methods, will be necessary
to distinguish between these alternatives. At present, strong evidence
of positive selection unique to the human lineage is thus limited to a
handful of genes120.
Our analysis above largely omitted genes belonging to large gene
families, because gene family expansion makes it difficult to define
1:1:1:1 orthologues across hominids and murids. One of the largest
such families, the olfactory receptors, is known to be undergoing
rapid divergence in primates. Directed study of these genes in the
draft assembly has suggested that more than 100 functional human
olfactory receptors are likely to be under no evolutionary con-
straint121. Our analysis also omitted the majority of very recently
duplicated genes owing to their lower coverage in the current
chimpanzee assembly. However, recent human-specific duplications
can be readily identified from the finished human genome sequence,
and have previously been shown to be highly enriched for the same
categories found to have high absolute rates of evolution in 1:1
orthologues here; that is, olfaction, immunity and reproduction23.
Gene disruptions in human and chimpanzee. Whereas most genes
have undergone only subtle substitutions in their amino acid
sequence, a few dozen have suffered more marked changes. We
found a total of 53 known or predicted human genes that are either
deleted entirely (36) or partially (17) in chimpanzee (Supplementary
Table S42). We have so far tested and confirmed 15 of these cases by
polymerase chain reaction (PCR) or Southern blotting. An
additional eight genes have sustained large deletions (.15 kb)
entirely within an intron. Some genes may have been missed in this
count owing to limitations of the draft genome sequence. In
addition, some genesmay have suffered chain terminationmutations
or altered reading frames in chimpanzee, but accurate identification
of these will require higher-quality sequence. The sensitivity of the
reciprocal analysis of genes disrupted in human is currently limited
by the small number of independently predicted gene models for the
chimpanzee. Some of the gene disruptions may be related to inter-
esting biological differences between the species, as discussed below.
Genetic basis for human- and chimpanzee-specific biology. Given
the substantial number of neutral mutations, only a small subset of
the observed gene differences is likely to be responsible for the key
phenotypic changes in morphology, physiology and behavioural
complexity between humans and chimpanzees. Determining which
differences are in this evolutionarily important subset and inferring
their functional consequences will require additional types of evi-
dence, including information from clinical observations and model
systems122. We describe some novel examples of genetic changes for
which plausible functional or physiological consequences can be
suggested.
Apoptosis. Mouse and human are known to differ with respect to an
important mediator of apoptosis, caspase-12 (refs 123–125). The
protein triggers apoptosis in response to perturbed calcium homeo-
stasis in mice, but humans seem to lack this activity owing to several
mutations in the orthologous gene that together affect the protein
produced by all known splice forms; the mutations include a
premature stop codon and a disruption of the SHG box required
for enzymatic activity of caspases. By contrast, the chimpanzee gene
encodes an intact open reading frame and SHG box, indicating that
the functional loss occurred in the human lineage. Intriguingly, loss-
of-function mutations in mice confer increased resistance to amy-
loid-induced neuronal apoptosis without causing obvious develop-
mental or behavioural defects126. The loss of function in humansmay
contribute to the human-specific pathology of Alzheimer’s disease,
which involves amyloid-induced neurotoxicity and deranged cal-
cium homeostasis.
Inflammatory response. Human and chimpanzee show a notable
difference with respect to important mediators of immune and
inflammatory responses. Three genes (IL1F7, IL1F8 and ICEBERG)
Figure 11 | Hominid and murid KA/KS (q) in GO categories with more than
20 analysed genes. GO categories with putatively accelerated (test statistic
,0.001; see Methods) non-synonymous divergence on the hominid lineages
(red) and on the murid lineages (orange) are highlighted. Owing to the
hierarchical nature of GO, the categories do not all represent independent
data points. A non-redundant list of significant categories is provided in
Table 8 and a complete list in Supplementary Table S30.
Figure 12 | Human and chimpanzee KA/KS (q) in GO categories with more
than 20 analysed genes. GO categories with putatively accelerated (test
statistic ,0.001; see Methods) non-synonymous divergence on the human
lineage (red) and on the chimpanzee lineage (orange) are highlighted. The
variance of these estimates is larger than that seen in the hominid–murid
comparison owing to the small number of lineage-specific substitutions.
Owing to the hierarchical nature of the GO ontology, the categories do not
all represent independent data points. A complete list of categories is
provided in Supplementary Table S30.
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that act in a common pathway involving the caspase-1 gene all appear
to be deleted in chimpanzee. ICEBERG is thought to repress caspase-
1-mediated generation of pro-inflammatory IL1 cytokines, and its
absence in chimpanzee may point to species-specific modulation of
the interferon-g- and lipopolysaccharide-induced inflammatory
response127.
Parasite resistance. Similarly, we found that two members of the
primate-specific APOL gene cluster (APOL1 and APOL4) have been
deleted from the chimpanzee genome. The APOL1 protein is
associated with the high-density lipoprotein fraction in serum and
has recently been proposed to be the lytic factor responsible for
resistance to certain subspecies of Trypanosoma brucei, the parasite
that causes human sleeping sickness and the veterinary disease
nagana128. The loss of the APOL1 gene in chimpanzees could thus
explain the observation that human, gorilla and baboon possess the
trypanosome lytic factor, whereas the chimpanzee does not129.
Sialic acid biology related proteins. Sialic acids are cell-surface sugars
that mediate many biological functions130. Of 54 genes involved in
sialic acid biology, 47 were suitable for analysis. We confirmed and
extended findings on several that have undergone human-specific
changes, including disruptions, deletions and domain-specific func-
tional changes113,131,132. Human- and chimpanzee-specific changes
were also found in otherwise evolutionarily conserved sialyl motifs in
four sialyl transferases (ST6GAL1, ST6GALNAC3, ST6GALNAC4 and
ST8SIA2), suggesting changes in donor and/or acceptor binding130.
Lineage-specific changes were found in a complement factor H
(HF1) sialic acid binding domain associated with human disease133.
Human SIGLEC11 has undergone gene conversion with a nearby
pseudogene, correlating with acquisition of human-specific brain
expression and altered binding properties134.
Human disease alleles. We next sought to identify putative func-
tional differences between the species by searching for instances in
which a human disease-causing allele appears to be the wild-type
allele in the chimpanzee. Starting from 12,164 catalogued disease
variants in 1,384 human genes, we identified 16 cases in which the
altered sequence in a disease allele matched the chimpanzee
sequence, and had plausible support in the literature (Table 7; see
also Supplementary Table S43). Upon re-sequencing in seven chim-
panzees, 15 cases were confirmed homozygous in all individuals,
whereas one (PON1 I102V) appears to be a shared polymorphism
(Supplementary Table S44).
Six cases represent de novo human mutations associated with
simple mendelian disorders. Similar cases have also been found in
comparisons of more distantly related mammals135, as well as
between insects136, and have been interpreted as a consequence of a
relatively high rate of compensatory mutations. If compensatory
mutations are more likely to be fixed by positive selection than by
neutral drift136, then the variants identified here might point towards
adaptive differences between humans and chimpanzees. For ex-
ample, the ancestral Thr 29 allele of cationic trypsinogen (PRSS1)
causes autosomal dominant pancreatitis in humans137, suggesting
that the human-specific Asn 29 allele may represent a digestion-
related molecular adaptation138.
The remaining ten cases represent common human polymorph-
isms that have been reported to be associated with complex traits,
including coronary artery disease and diabetes mellitus. In all of these
cases we confirmed that the disease-associated allele in humans is
indeed the ancestral allele by showing that it is carried not only by
chimpanzee but also by outgroups such as the macaque. These
ancestral alleles may thus have become human-specific risk factors
due to changes in human physiology or environment, and the
polymorphisms may represent ongoing adaptations. For example,
PPARG Pro 12 is the wild-type allele in chimpanzee but has been
clearly associated with increased risk of type 2 diabetes in human139.
It is tempting to speculate that this allele may represent an ancestral
‘thrifty’ genotype140.
The current results must be interpreted with caution, because few
complex disease associations have been firmly established. The fact
that the human disease allele is the wild-type allele in chimpanzee
may actually indicate that some of the putative associations are
spurious and not causal. However, this approach can be expected to
become increasingly fruitful as the quality and completeness of the
disease mutation databases improve.
Human population genetics
The chimpanzee has a special role in informing studies of human
population genetics, a field that is undergoing rapid expansion and
acquiring new relevance to human medical genetics141. The chim-
panzee sequence allows recognition of those human alleles that
represent the ancestral state and the derived state. It also allows
estimates of local mutation rates, which serve as an important
baseline in searching for signs of natural selection.
Ancestral and derived alleles. Of,7.2million SNPs mapped to the
human genome in the current public database, we could assign the
alleles as ancestral or derived in 80% of the cases according to which
allele agrees with the chimpanzee genome sequence142 (see Sup-
plementary Information ‘Human population genetics’). For the
remaining cases, no assignment could be made because of the
following: the orthologous chimpanzee base differed from both
human alleles (1.2%); was polymorphic in the chimpanzee sequences
obtained (0.4%); or could not be reliably identified with the current
draft sequence of the chimpanzee (18.8%), with many of these
occurring in repeated or segmentally duplicated sequence. The first
two cases arise presumably because a second mutation occurred in
the chimpanzee lineage. It should be possible to resolve most of these
cases by examining a close outgroup such as gorilla or orang-utan.
Mutations in the chimpanzee may also lead to the erroneous
assignment of human alleles as derived alleles. This error rate can be
estimated as the probability of a second mutation resulting in the
chimpanzee sequence matching the derived allele (see Supplementary
Information ‘Human population genetics’). The estimated error rate
for typical SNPs is 0.5%, owing to the low nucleotide substitution rate.
The exceptions are those SNPs forwhich thehumanalleles areCpGand
TpG and the chimpanzee sequence is TpG. For these, a non-negligible
fraction may have arisen by two independent deamination events
within an ancestral CpG dinucleotide, which are well-known muta-
tional hotspots51 (also see above). Human SNPs in a CpG context for
which the orthologous chimpanzee sequence is TpG account for 12%
of the total, and have an estimated error rate of 9.8%. Across all SNPs,
the average error rate, 1, is thus estimated to be,1.6%.
We compared the distribution of allele frequencies for ancestral
Table 7 | Candidate human disease variants found in chimpanzee
Gene Variant* Disease association Ancestral† Frequency‡
AIRE P252L159 Autoimmune syndrome Unresolved 0
MKKS R518H160 Bardet–Biedl syndrome Wild type 0
MLH1 A441T161 Colorectal cancer Wild type 0
MYOC Q48H162 Glaucoma Wild type 0
OTC T125M163 Hyperammonaemia Wild type 0
PRSS1 N29T137 Pancreatitis Disease 0
ABCA1 I883M164 Coronary artery disease Unresolved 0.136
APOE C130R165 Coronary artery disease and
Alzheimer’s disease
Disease 0.15
DIO2 T92A166 Insulin resistance Disease 0.35
ENPP1 K121Q167 Insulin resistance Disease 0.17
GSTP1 I105V168 Oral cancer Disease 0.348
PON1§ I102V169 Prostate cancer Wild type 0.016
PON1 Q192R170 Coronary artery disease Disease 0.3
PPARG A12P139 Type 2 diabetes Disease 0.85
SLC2A2 T110I171 Type 2 diabetes Disease 0.12
UCP1 A64T172 Waist-to-hip ratio Disease 0.12
*This takes the following format: benign variant, codon number, disease/chimpanzee variant.
†Ancestral variant as inferred from closest available primate outgroups (Supplementary
Information).
‡Frequency of the disease allele in human study population.
§Polymorphic in chimpanzee.
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and derived alleles using a database of allele frequencies for,120,000
SNPs (see Supplementary Information ‘Human population gen-
etics’). As expected, ancestral alleles tend to have much higher
frequencies than derived alleles (Supplementary Fig. S9). None-
theless, a significant proportion of derived alleles have high frequen-
cies: 9.1% of derived alleles have frequency $80%.
An elegant result in population genetics states that, for a randomly
interbreeding population of constant size, the probability that an
allele is ancestral is equal to its frequency143.We explored the extent to
which this simple theoretical expectation fits the human population.
We tabulated the proportion p a(x) of ancestral alleles for various
frequencies of x and compared this with the prediction p a(x) ¼ x
(Fig. 13).
The data lie near the predicted line, but the observed slope (0.83) is
substantially less than 1. One explanation for this deviation is that
some ancestral alleles are incorrectly assigned (an error rate of 1
would artificially decrease the slope by a factor of 1–21). However,
with 1 estimated to be only 1.6%, errors can only explain a small part
of the deviation. The most likely explanation is the presence of
bottlenecks during human history, which tend to flatten the distri-
bution of allele frequencies. Theoretical calculations indicate that a
recent bottleneck would decrease the slope by a factor of (1 2 b),
where b is the inbreeding coefficient induced by the bottleneck (see
Supplementary Information ‘Human population genetics’ and Sup-
plementary Fig. S10). This suggests thatmeasurements of the slope in
different human groups may shed light on population-specific
bottlenecks. Consistent with this, preliminary analyses of allele
frequencies in several regions for SNPs obtained by systematic
uniform sampling indicate that the slope is significantly lower than
1 in European and Asian samples and close to 1 in an African sample
(see Supplementary Information ‘Human population genetics’ and
Supplementary Fig. S11).
Signatures of strong selective sweeps in recent human history. The
pattern of human genetic variation holds substantial information
about selection events that have shaped our species. Strong positive
selection creates the distinctive signature of a ‘selective sweep’,
whereby a rare allele rapidly rises to fixation and carries the haplotype
on which it occurs to high frequency (the ‘hitchhiking’ effect). The
surrounding region should show two distinctive signatures: a sig-
nificant reduction of overall diversity, and an excess of derived alleles
with high frequency in the population owing to hitchhiking of
derived alleles on the selected haplotype (see Supplementary Infor-
mation ‘Human population genetics’). The pattern might be detect-
able for up to 250,000 years after a selective sweep has ended144.
Notably, the chimpanzee genome provides crucial baseline infor-
mation required for accurate assessment of both signatures.
The size of the interval affected by a selective sweep is expected to
scale roughly with s, the selective advantage due to the mutation.
Simulations can be used to study the distribution of the interval size
(see Supplementary Information ‘Human population genetics’).
With s ¼ 1%, the interval over which heterozygosity falls by 50%
has a modal size of 600 kb and a probability of greater than 10% of
exceeding 1Mb.
We undertook an initial scan for large regions (.1Mb) with the
two signatures suggestive of strong selective sweeps in recent human
history. We began by identifying regions in which the observed
human diversity rate was much lower than the expectation based
on the observed divergence rate with chimpanzee. The human
diversity rate was measured as the number of occurrences from a
database of 1.92million SNPs identified by shotgun sequencing in a
panel of African–American individuals (see Supplementary Infor-
mation ‘Genome sequencing and assembly’). The comparison with
the chimpanzee eliminates regions in which low diversity simply
reflects a low mutation rate in the region. Regions were identified
based on a simple statistical procedure (see Supplementary Infor-
mation ‘Human population genetics’). Six genomic regions stand
out as clear outliers that show significantly reduced diversity relative
to divergence (Table 8; see also Supplementary Fig. S12).
We next tested whether these six regions show a high proportion of
SNPs with high-frequency derived alleles (defined here as alleles with
frequency $80%). Within each region, we focused on the 1-Mb
interval with the greatest discrepancy between diversity and diver-
gence and compared it to 1-Mb regions throughout the genome. For
the database of 120,000 SNPs with allele frequencies discussed above,
the typical 1-Mb region in the human genome contains ,40 SNPs,
and the proportion ph of SNPs with high-frequency derived alleles is
,9.1%. All six regions identified by our scan for reduced diversity
have a higher than average fraction of high-frequency derived alleles;
all six fall within the top 10% genome-wide and three fall within the
top 1%. Although this is not definitive evidence for any particular
region, the joint probability of all six regions randomly scoring in the
top 10% is 1026. The results indicate that the six regions are
candidates for strong selective sweeps during the past
250,000 years144. The regions differ notably with respect to gene
content, ranging from one containing 57 annotated genes (chromo-
some 22) to another with no annotated genes whatsoever (chromo-
some 4). We have no evidence to implicate any individual functional
element as a target of recent selection at this point, but the regions
contain a number of interesting candidates for follow-up studies.
Intriguingly, the chromosome 4 gene desert, which flanks a proto-
cadherin gene and is conserved across vertebrates15, has been impli-
cated in two independent studies as being associated with obes-
ity145,146.
In addition to the six regions, one further genomic region deserves
mention: an interval of 7.6Mb on chromosome 7q (see Supplemen-
tary Information ‘Human population genetics’). The interval con-
tains several regions with high scores in the diversity-divergence
analysis (including the seventh highest score overall) as well as in the
proportion of high-frequency derived alleles. The region contains the
FOXP2 and CFTR genes. The former has been the subject of much
interest as a possible target for selection during human evolution147
and the latter as a target of selection in European populations148.
Convincing proof of past selection will require careful analysis of
the precise pattern of genetic variation in the region and the
identification of a likely target of selection. Nonetheless, our findings
suggest that the approach outlined here may help to unlock some of
the secrets of recent human evolution through a combination of
within-species and cross-species comparison.
Figure 13 | The observed fraction of ancestral alleles in 1% bins of observed
frequency. The solid line shows the regression (b ¼ 0.83). The dotted line
shows the theoretical relationship pa(x) ¼ x. Note that because each variant
yields a derived and an ancestral allele, the data are necessarily symmetrical
about 0.5.
ARTICLES NATURE|Vol 437|1 September 2005
82
© 2005 Nature Publishing Group 
 
Discussion
Our knowledge of the human genome is greatly advanced by the
availability of a second hominid genome. Some questions can be
directly answered by comparing the human and chimpanzee
sequences, including estimates of regional mutation rates and aver-
age selective constraints on gene classes. Other questions can be
addressed in conjunction with other large data sets, such as issues in
human population genetics for which the chimpanzee genome
provides crucial controls. For still other questions, the chimpanzee
genome simply provides a starting point for further investigation.
The hardest such question is: whatmakes us human? The challenge
lies in the fact that most evolutionary change is due to neutral drift.
Adaptive changes comprise only a small minority of the total genetic
variation between two species. As a result, the extent of phenotypic
variation between organisms is not strictly related to the degree of
sequence variation. For example, gross phenotypic variation between
human and chimpanzee is much greater than between the mouse
species Mus musculus and Mus spretus, although the sequence
difference in the two cases is similar. On the other hand, dogs
show considerable phenotypic variation despite having little overall
sequence variation (,0.15%). Genomic comparison markedly
narrows the search for the functionally important differences
between species, but specific biological insights will be needed to
sift the still-large list of candidates to separate adaptive changes from
neutral background.
Our comparative analysis suggests that the patterns of molecular
evolution in the hominids are typical of a broader class of mammals
in many ways, but distinctive in certain respects. As with the murids,
the most rapidly evolving gene families are those involved in
reproduction and host defence. In contrast to the murids, however,
hominids appear to experience substantially weaker negative selec-
tion; this probably reflects their smaller population size. Conse-
quently, hominids accumulate deleterious mutations that would be
eliminated by purifying selection in murids. This may be both an
advantage and a disadvantage. Although decreased purifying selec-
tion may tend to erode overall fitness, it may also allow hominids to
‘explore’ larger regions of the fitness landscape and thereby achieve
evolutionary adaptations that can only be reached by passing
through intermediate states of inferior fitness149,150.
Although the analyses presented here focus on protein-coding
sequences, the chimpanzee genome sequence also allows systematic
analysis of the recent evolution of gene regulatory elements for the
first time. Initial analysis of both gene expression patterns and
promoter regions suggest that their overall patterns of evolution
closely mirror that of protein-coding regions. In an accompanying
paper83, we show that the rates of change in gene expression among
different tissues in human and chimpanzee correlate with the
nucleotide divergence in the putative proximal promoters and even
more interestingly with the average level of constraint on proteins in
the same tissues. Another study151 has similarly used the chimpanzee
sequence described here to show that gene promoter regions are also
evolving under markedly less constraint in hominids than in murids.
The draft chimpanzee sequence here is sufficient for initial
analyses, but it is still imperfect and incomplete. Definitive studies
of gene and genome evolution—including pseudogene formation,
gene family expansion and segmental duplication—will require high-
quality finished sequence. In this regard, we note that efforts are
already underway to construct a BAC-based physical map and to
increase the shotgun sequence coverage to approximately sixfold
redundancy. The added coverage alone will not affect the analysis
greatly, but plans are in place to produce finished sequence for
difficult to sequence and important segments of the genome.
Our close biological relatedness to chimpanzees not only allows
unique insights into human biology, it also creates ethical obli-
gations. Although the genome sequence was acquired without harm
to chimpanzees, the availability of the sequence may increase
pressure to use chimpanzees in experimentation. We strongly oppose
reducing the protection of chimpanzees and instead advocate the
policy positions suggested by an accompanying paper152. Further-
more, the existence of chimpanzees and other great apes in their
native habitats is increasingly threatened by human civilization.
More effective policies are urgently needed to protect them in the
wild. We hope that elaborating how few differences separate our
species will broaden recognition of our duty to these extraordinary
primates that stand as our siblings in the family of life.
METHODS
Sequencing and assembly. Approximately 22.5 million sequence reads were
derived fromboth ends of inserts (paired end reads) from4-, 10-, 40- and 180-kb
clones, all prepared from primary blood lymphocyte DNA. Genomic resources
available from the source animal include a lymphoid cell line (S006006) and
genomic DNA (NS06006) at Coriell Cell Repositories (http://locus.umdnj.edu/
ccr/), as well as a BAC library (CHORI-251)153 (see also Supplementary
Information ‘Genome sequencing and assembly’).
Genome alignment. BLASTZ154 was used to align non-repetitive chimpanzee
regions against repeat-masked human sequence. BLAT155 was subsequently used
to align the more repetitive regions. The combined alignments were chained156
and only best reciprocal alignments were retained for further analysis.
Insertions and deletions. Small insertion/deletion (indel) events (,15 kb) were
parsed directly from the BLASTZ genome alignment by counting the number
and size of alignment gaps between bases within the same contig. Sites of large-
scale indels (.15 kb) were detected from discordant placements of paired
sequence reads against the human assembly. Size thresholds were obtained
from both human fosmid alignments on human sequence (40 ^ 2.58 kb) and
chimpanzee plasmid alignments against human chromosome 21
(4.5 ^ 1.84 kb). Indels were inferred by two or more pairs surpassing these
thresholds by more than two standard deviations and the absence of sequence
data within the discordancy.
Gene annotation. A total of 19,277 human RefSeq transcripts157, representing
16,045 distinct genes, were indirectly aligned to the chimpanzee sequence via the
genome alignment. After removing low-quality sequences and likely alignment
artefacts, an initial catalogue containing 13,454 distinct 1:1 human–chimpanzee
orthologues was created for the analyses described here. A subset of 7,043 of
these genes with unambiguous mouse and rat orthologues were realigned using
Clustal W158 for the lineage-specific analyses. Updated gene catalogues can be
obtained from http://www.ensembl.org.
Rates of divergence. Nucleotide divergence rates were estimated using baseml
with the REV model. Non-CpG rates were estimated from all sites that did not
overlap a CG dinucleotide in either human or chimpanzee. KA and KS were
estimated jointly for each orthologue using codeml with the F3x4 codon
frequency model and no additional constraints, except for the comparison of
divergent and polymorphic substitutions where KA/KS for both was estimated as
(DA/NA)/(DS/NS), with NS/NA, the ratio of synonymous to non-synonymous
sites, estimated as 0.36 fromtheorthologue alignments.Unless otherwise specified,
KA/KS for a set of genes was calculated by summing the number of substitutions
and the number of sites to obtainKA andKS for the concatenated set before taking
Table 8 | Human regions with strongest signal of selection based on diversity relative to divergence
Chromosome Start (Mb) End (Mb) Regression log-score Skew P-value Genes
1 48.58 52.58 103.3 0.071 Fourteen known genes from ELAVL4 to GPX7
2 144.35 148.47 84.8 0.074 ARHGAP15 (partial), GTDC1 and ZFHX1B
22 36.15 40.22 81.8 0.00022 Fifty-seven known genes from CARD10 to PMM1
12 84.69 89.01 80.9 0.031 Ten known genes from PAMCI to ATP2B1
8 34.91 37.54 76.9 0.00032 UNC5D and FKSG2
4 32.42 35.62 55.9 0.00067 No known genes or Ensembl predictions
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the ratio. Hominid and murid pairwise rates were estimated independently from
codons aligned across all four species.Human and chimpanzee lineage-specificKA
and KS were estimated on an unrooted tree with both mouse and rat included.
Lineage-specific rates were also estimated by parsimony, with essentially identical
results (see Supplementary Information). K I was estimated from all interspersed
repeats within 250 kb of the mid-point of each gene.
Accelerated evolution in GO categories. The binomial probability of observing
X or more non-synonymous substitutions, given a total of X þ Y substitutions
and the expected proportion x from all orthologues, was calculated by summing
substitutions across the orthologues in each GO category. For the absolute rate
test, Y ¼ the number of synonymous substitutions in orthologues in the same
category. For the relative rate tests, Y ¼ the number of non-synonymous
substitutions on the opposite lineage. Note that this binomial probability is
simply a metric designed to identify potentially accelerated categories, it is not a
P-value that can be used to reject directly the null hypothesis of no acceleration in
that particular category. For each test, the observed number of categories with a
binomial probability less than 0.001 was compared to the expected distribution
of such outliers by repeating the procedure 10,000 times on randomly permuted
GO annotations. The significance of the number of observed outliers n was
estimated as the proportion of random trials yielding n or more outliers.
Detection of selective sweeps.The observed number of human SNPs, u i, human
bases, m i, human–chimpanzee substitutions, v i, and chimpanzee bases, n i,
within each set of non-overlapping 1-Mb windows along the human genome
were used to generate two random numbers, x i (adjusted human diversity) and
y i (adjusted human–chimpanzee divergence), from the two beta-distributions:
xi < Betaðui þ a; mi2 ui þ bÞ
yi < Betaðvi þ c; ni2 vi þ dÞ
where a ¼ 1, b ¼ 1,000, c ¼ 1 and d ¼ 100. These numbers were then fit to a
linear regression:
xjy<Nða0 þa1y; b2Þ
A P-value for each window was calculated for each window based on (x i, y i) and
the regression line. This was repeated 100 times and the average of the P-values
taken as the P-value for diversity given divergence in each window. Overlapping
windows with P , 0.1 containing at least one window of P , 0.05 were
coalesced and scored as the sum of their 2log(p) scores.
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Genome sequence, comparative analysis
and haplotype structure of the domestic
dog
Kerstin Lindblad-Toh1, Claire M Wade1,2, Tarjei S. Mikkelsen1,3, Elinor K. Karlsson1,4, David B. Jaffe1,
Michael Kamal1, Michele Clamp1, Jean L. Chang1, Edward J. Kulbokas III1, Michael C. Zody1, Evan Mauceli1,
Xiaohui Xie1, Matthew Breen5, Robert K. Wayne6, Elaine A. Ostrander7, Chris P. Ponting8, Francis Galibert9,
Douglas R. Smith10, Pieter J. deJong11, Ewen Kirkness12, Pablo Alvarez1, Tara Biagi1, William Brockman1,
Jonathan Butler1, Chee-Wye Chin1, April Cook1, James Cuff1, Mark J. Daly1,2, David DeCaprio1, Sante Gnerre1,
Manfred Grabherr1, Manolis Kellis1,13, Michael Kleber1, Carolyne Bardeleben6, Leo Goodstadt8, Andreas Heger8,
Christophe Hitte9, Lisa Kim7, Klaus-Peter Koepfli6, Heidi G. Parker7, John P. Pollinger6, Stephen M. J. Searle14,
Nathan B. Sutter7, Rachael Thomas5, Caleb Webber8, Broad Institute Genome Sequencing Platform*
& Eric S. Lander1,15
Here we report a high-quality draft genome sequence of the domestic dog (Canis familiaris), together with a dense map
of single nucleotide polymorphisms (SNPs) across breeds. The dog is of particular interest because it provides important
evolutionary information and because existing breeds show great phenotypic diversity for morphological, physiological
and behavioural traits. We use sequence comparison with the primate and rodent lineages to shed light on the structure
and evolution of genomes and genes. Notably, the majority of the most highly conserved non-coding sequences in
mammalian genomes are clustered near a small subset of genes with important roles in development. Analysis of SNPs
reveals long-range haplotypes across the entire dog genome, and defines the nature of genetic diversity within and
across breeds. The current SNP map now makes it possible for genome-wide association studies to identify genes
responsible for diseases and traits, with important consequences for human and companion animal health.
Man’s best friend, Canis familiaris, occupies a special niche in
genomics. The unique breeding history of the domestic dog provides
an unparalleled opportunity to explore the genetic basis of disease
susceptibility, morphological variation and behavioural traits. The
position of the dog within the mammalian evolutionary tree also
makes it an important guide for comparative analysis of the human
genome.
The history of the domestic dog traces back at least 15,000 years,
and possibly as far back as 100,000 years, to its original domestication
from the grey wolf in East Asia1–4. Dogs evolved through a mutually
beneficial relationship with humans, sharing living space and food
sources. In recent centuries, humans have selectively bred dogs that
excel at herding, hunting and obedience, and in this process have
created breeds rich in behaviours that both mimic human behaviours
and support our needs. Dogs have also been bred for desired physical
characteristics such as size, skull shape, coat colour and texture5,
producing breeds with closely delineated morphologies. This evolu-
tionary experiment has produced diverse domestic species, harbour-
ing more morphological diversity than exists within the remainder of
the family Canidae6.
As a consequence of these stringent breeding programmes and
periodic population bottlenecks (for example, during the World
Wars), many of the ,400 modern dog breeds also show a high
prevalence of specific diseases, including cancers, blindness, heart
disease, cataracts, epilepsy, hip dysplasia and deafness7,8. Most of
these diseases are also commonly seen in the human population, and
clinical manifestations in the two species are often similar9. The high
prevalence of specific diseases within certain breeds suggests that a
limited number of loci underlie each disease, making their genetic
dissection potentially more tractable in dogs than in humans10.
Genetic analysis of traits in dogs is enhanced by the close
relationship between humans and canines in modern society.
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Through the efforts of the American Kennel Club (AKC) and similar
organizations worldwide, extensive genealogies are easily accessible
for most purebred dogs. With the exception of human, dog is the
most intensely studied animal in medical practice, with detailed
family history and pathology data often available8. Using genetic
resources developed over the past 15 years11–16, researchers have
already identified mutations in genes underlying ,25 mendelian
diseases17,18. There are also growing efforts to understand the genetic
basis of phenotypic variation such as skeletal morphology10,19.
The dog is similarly important for the comparative analysis of
mammalian genome biology and evolution. The four mammalian
genomes that have been intensely analysed to date (human20–22,
chimpanzee23, mouse24 and rat25) represent only one clade
(Euarchontoglires) out of the four clades of placental mammals.
The dog represents the neighbouring clade, Laurasiatheria26. It thus
serves as an outgroup to the Euarchontoglires and increases the total
branch length of the current tree of fully sequenced mammalian
genomes, thereby providing additional statistical power to search for
conserved functional elements in the human genome24,27–33. It also
helps us to draw inferences about the common ancestor of the two
clades, called the boreoeutherian ancestor, and provides a bridge to
the two remaining clades (Afrotheria and Xenarthra) that should be
helpful for anchoring low-coverage genome sequence currently being
produced from species such as elephant and armadillo28.
Here we report a high-quality draft sequence of the dog genome
covering ,99% of the euchromatic genome. The completeness,
nucleotide accuracy, sequence continuity and long-range connec-
tivity are extremely high, exceeding the values calculated for
the recent draft sequence of the mouse genome24 and reflecting
improved algorithms, higher-quality data, deeper coverage and
intrinsic genome properties. We have also created a tool for the
formal assessment of assembly accuracy, and estimate that.99% of
the draft sequence is correctly assembled.
We also report an initial compendium of SNPs for the dog
population, containing .2.5 million SNPs derived primarily from
partial sequence comparison of 11 dog breeds to a reference
sequence. We characterized the polymorphism rate of the SNPs
across breeds and the long-range linkage disequilibrium (LD) of
the SNPs within and across breeds.
We have analysed these data to study genome structure, gene
evolution, haplotype structure and phylogenetics of the dog. Our key
findings include:†The evolutionary forces molding the mammalian genome differ
among lineages, with the average transposon insertion rate being
lowest in dog, the deletion rate being highest in mouse and the
nucleotide substitution rate being lowest in human.†Comparison between human and dog shows that ,5.3% of the
human genome contains functional elements that have been under
purifying selection in both lineages. Nearly all of these elements are
confined to regions that have been retained in mouse, indicating
that they represent a common set of functional elements across
mammals.† Fifty per cent of the most highly conserved non-coding sequence in
the genome shows striking clustering in ,200 gene-poor regions,
most of which contain genes with key roles in establishing or
maintaining cellular identity, such as transcription factors or axon
guidance receptors.† Sets of functionally related genes show highly similar patterns of
evolution in the human and dog lineages. This suggests that we
should be careful about interpreting accelerated evolution in
human relative to mouse as representing human-specific innovations
(for example, in genes involved in brain development), because
comparable acceleration is often seen in the dog lineage.†Analysis across the entire genome of the sequenced boxer and
across 6% of the genome in ten additional breeds shows that linkage
disequilibrium (LD) within breeds extends over distances of several
megabases, but LD across breeds only extends over tens of kilobases.
These LD patterns reflect two principal bottlenecks in dog history:
early domestication and recent breed creation.†Haplotypes within breeds extend over long distances, with ,3–5
alleles at each locus. Portions of these haplotypes, as large as
100 kilobases (kb), are shared across multiple breeds, although they
are present at widely varying frequencies. The haplotype structure
suggests that genetic risk factors may be shared across breeds.†The current SNP map has sufficient density and an adequate
within-breed polymorphism rate (,1/900 base pairs (bp) between
breeds and,1/1,500 bp within breeds) to enable systematic associa-
tion studies to map genes affecting traits of interest. Genotyping of
,10,000 SNPs should suffice for most purposes.†The genome sequence can be used to select a small collection of
rapidly evolving sequences, which allows nearly complete resolution
of the evolutionary tree of nearly all living species of Canidae.
Generating a draft genome sequence
We sequenced the genome of a female boxer using the whole-
genome shotgun (WGS) approach22,24 (see Methods and Supplemen-
tary Table S1). A total of 31.5 million sequence reads, providing
,7.5-fold sequence redundancy, were assembled with an improved
version of the ARACHNE program34, resulting in an initial assembly
(CanFam1.0) used for much of the analysis below, and an updated
assembly (CanFam2.0) containing minor improvements (Table 1
and Supplementary Table S2).
Genome assembly. The recent genome assembly spans a total
distance of 2.41 Gb, consisting of 2.38 Gb of nucleotide sequence
with the remaining 1% in captured gaps. The assembly has extremely
high continuity. The N50 contig size is 180 kb (that is, half of all bases
reside in a contiguous sequence of 180 kb or more) and the N50
supercontig size is 45.0 Mb (Table 1). In particular, this means that
most genes should contain no sequence gaps and that most canine
chromosomes (mean size 61 Mb) have nearly all of their sequence
ordered and oriented within one or two supercontigs (Supplemen-
tary Table S2). Notably, the sequence contigs are,50-fold larger than
the earlier survey sequence of the standard poodle16.
The assembly was anchored to the canine chromosomes using data
from both radiation hybrid and cytogenetic maps11,13,14. Roughly
97% of the assembled sequence was ordered and oriented on the
chromosomes, showing an excellent agreement with the two maps.
There were only three discrepancies, which were resolved by obtain-
ing additional fluorescence in situ hybridization (FISH) data from
the sequenced boxer. The 3% of the assembly that could not be
anchored consists largely of highly repetitive sequence, including
eight supercontigs of 0.5–1.0 Mb composed almost entirely of
satellite sequence.
The nucleotide accuracy and genome coverage of the assembly is
high (Supplementary Table S3). Of the bases in the assembly,
98% have quality scores exceeding 40, corresponding to an error
rate of less than 1024 and comparable to the standard for the
finished human sequence35. When we directly compared the assem-
bly to 760 kb of finished sequence (in regions where the boxer is
Table 1 | Assembly statistics for CanFam1.0 and 2.0
CanFam1.0 CanFam2.0
N50 contig size 123 kb 180 kb
N50 supercontig size 41.2 Mb 45.0 Mb
Assembly size (total bases) 2.360 Gb 2.385 Gb
Number of anchored supercontigs 86 87
Percentage of genome in anchored supercontigs 96 97
Sequence in anchored bases 2.290 Gb 2.309 Gb
Percentage of assembly in gaps 0.9 0.8
Estimated genome size* 2.411 Gb 2.445 Gb
Percentage of assembly in ‘certified regions’,
without assembly inconsistency
99.3 99.6
*Includes anchored bases, spanned gaps (21 Mb in CanFam1.0, 18 Mb in CanFam2.0) and
centromeric sequence (3 Mb for each chromosome).
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homozygous, to eliminate differences attributable to polymorphisms;
see below), we found that the draft genome sequence covers 99.8% of
the finished sequence and that bases with quality scores exceeding
40 have an empirical error rate of 2 £ 1025 (Supplementary Table S3).
Explaining the high sequence continuity.The dog genome assembly
has superior sequence continuity (180 kb) than the WGS assembly of
the mouse genome (25 kb) obtained several years ago24. At least three
factors contribute to the higher connectivity of the dog assembly (see
Supplementary Information). First, we used a new version of
ARACHNE with improved algorithms. Assembling the dog genome
with the previous software version decreased N50 contig size from
180 kb to 61 kb, and assembling the mouse genome with the new
version increased N50 contig size from 25 kb to 35 kb. Second, the
amount of recently duplicated sequence is roughly twofold lower in
dog than mouse (Supplementary Table S4); this improves contiguity
because sequence gaps in both organisms tend to occur in recently
duplicated sequence. Third, the dog sequence data has both higher
redundancy (7.5-fold versus 6.5-fold) and higher quality (in terms of
read length, pairing rate and tight distribution of insert sizes) com-
pared with mouse. The contig size for the dog genome drops by about
32% when the data redundancy is decreased from 7.5-fold to 6.5-
fold. A countervailing influence is that the dog genome contains
polymorphism, whereas the laboratory mouse is completely inbred.
Assembly certification. Although ‘quality scores’ have been devel-
oped to indicate the nucleotide accuracy of a draft genome
sequence36, no analogous measures have been developed to reflect
the long-range assembly accuracy. We therefore sought to develop
such a measure on the basis of two types of internal inconsistencies
(see Supplementary Information). The first is haplotype incon-
sistency, involving clear evidence of three or more distinct haplotypes
within an assembled region from a single diploid individual. The
second is linkage inconsistency, involving a cluster of reads for which
the placement of the paired-end reads is illogical. This includes
cases in which: (1) one end cannot be mapped to the region, (2) the
linkage relationships are inconsistent with the sequence within
contigs, or (3) distance constraints imply overlap between non-
overlapping sequence contigs. The linkage inconsistency tests are
most powerful when read pairs are derived from clone libraries
with tight constraints on insert size. A region of assembly is
defined as ‘certified’ if it is free of inconsistencies, and is otherwise
‘questionable’.
Approximately 99.6% of the assembly resides in certified regions,
with the N50 size of certified regions being ,12 Mb or about one-
fifth of a chromosome. The remaining questionable regions are
typically small (most are less than 40 kb), although there are a
handful of regions of several hundred kilobases (Supplementary
Fig. S1 and Supplementary Tables S5, S6). The questionable regions
typically contain many inconsistencies, probably reflecting mis-
assembly or overcollapse owing to segmental duplication. Chromo-
somes 2, 11 and 16 have 1.0–2.0% of their sequence in questionable
regions. The certified and questionable regions are annotated in
the public release of the dog genome assembly. With the concept
of assembly certification, the scientific community can have
appropriate levels of confidence in the draft genome sequence.
Genome landscape and evolution
Our understanding of the evolutionary processes that shape
mammalian genomes has greatly benefited from the comparative
analysis of sequenced primate21,23 and rodent24,25 genomes. However,
the rodent genome is highly derived relative to that of the common
ancestor of the eutherian mammals. As the first extensive sequence
from an outgroup to the clade that includes primates and rodents, the
dog genome offers a fresh perspective on mammalian genome evol-
ution. Accordingly, we examined the rates and correlations of large-
scale rearrangement, transposon insertion, deletion and nucleotide
divergence across three major mammalian orders (primates, rodents
and carnivores).
Conserved synteny and large-scale rearrangements. We created
multi-species synteny maps from anchors of unique, unambiguously
aligned sequences (see Supplementary Information), showing
regions of conserved synteny among dog, human, mouse and rat
genomes. Approximately 94% of the dog genome lies in regions of
conserved synteny with the three other species (Supplementary
Figs S2–S4 and Supplementary Table S7).
Given a pair of genomes, we refer to a ‘syntenic segment’ as a
region that runs continuously without alterations of order and
orientation, and a ‘syntenic block’ as a region that is contiguous in
two genomes but may have undergone internal rearrangements.
Syntenic breakpoints between blocks reflect primarily interchromo-
somal exchanges, and breakpoints between syntenic segments reflect
intrachromosomal rearrangements. In the analysis below, we focus
on syntenic segments of at least 500 kb.
We identified a total of 391 syntenic breakpoints across dog,
human, mouse and rat genomes (Fig. 1 and Supplementary
Figs S2, S5). With data for multiple species, it is possible to assign
events to specific lineages (Fig. 1 and Supplementary Table S8). We
counted the total number of breakpoints along the human, dog,
mouse and rat lineages, with the values for each rodent lineage
reflecting all breakpoints since the common ancestor with human
(Fig. 1). The total number of breakpoints in the human lineage is
substantially smaller than in the dog, mouse or rat lineages (83 versus
100, 161 or 176, respectively). However, there are more intra-
chromosomal breakpoints in the human lineage than in dog (52
versus 33).
Although the overall level of genomic rearrangement has been
much higher in rodent than in human, comparison with dog shows
that there are regions where the opposite is true. In particular, of the
many intrachromosomal rearrangements previously observed
between human chromosome 17 and the orthologous mouse
Figure 1 | Conserved synteny among the human, dog, mouse and rat
genomes. a, Diagram of syntenic blocks (.500 kb) along dog
chromosomes (Chr) 15, 16 and 31, with colours indicating the chromosome
containing the syntenic region in other species. Synteny breakpoints were
assigned to one of five lineages: dog (D), human (H), mouse (M), rat (R) or
the common rodent ancestor (Ro). b, Lineage-specific intrachromosomal
and interchromosomal breaks displayed on phylogenetic trees.
Intrachromosomal breaks are seen more frequently in the human lineage
than in mouse and rat, whereas interchromosomal breaks are somewhat
more common in dog and considerably more common in rodents than in
humans.
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sequence24, most have occurred in the human lineage (see Supple-
mentary Information). Human chromosome 17 is rich in segmental
duplications and gene families21, which may contribute to its
genomic fragility37,38.
Genomic insertion and deletion. The euchromatic genome of the
dog is ,150 Mb smaller than in mouse, and ,500 Mb smaller than
in human. The smaller total size is reflected at the local level, with
100-kb blocks of conserved synteny in dog corresponding to regions
for which the median size is,3% larger in mouse and,15% larger
in human.
To understand the balance of forces that determine genome size,
we studied the alignments of the human, mouse and dog genomes
(Fig. 2). In particular, we identified the lineage-specific interspersed
repeats within each genome, which consist of particular families of
short interspersed elements (SINEs), long interspersed elements
(LINEs) and other transposable elements that are readily recognized
by sequence analysis (Supplementary Tables S9, S10). The remaining
sequence was annotated as ‘ancestral’, consisting of both ancestral
unique sequence and ancestral repeat sequence; these two categories
were combined because the power to recognize ancient transposon-
derived sequences degrades with repeat age, particularly in the
rapidly diverging mouse lineage24.
This comparative analysis indicates that different forces account
for the smaller genome sizes in dog and mouse relative to human.
The smaller size of the dog genome is primarily due to the presence of
substantially less lineage-specific repeat sequence in dog (334 Mb)
than in human (609 Mb) or mouse (954 Mb). This reflects a lower
activity of endogenous retroviral and DNA transposons (,26,000
extant copies in dog versus ,183,000 in human), as well as the fact
that the SINE element in dog is smaller than in human (although of
similar length to that in mouse). As a consequence, the total
proportion of repetitive elements (both lineage-specific and ances-
tral) recognizable in the genome is lower for dog (34%) than for
mouse (40%) or human (46%). In contrast, the smaller size of the
mouse genome is primarily due to a higher deletion rate. Specifically,
the amount of extant ‘ancestral sequence’ is much lower in mouse
(1,474 Mb) than in human (2,216 Mb) or dog (1,997 Mb). Assuming
an ancestral genome size of 2.8 Gb (ref. 24) and also that deletions
occur continuously, we suggest that the rate of genomic deletion in
the rodent lineage has been approximately 2.5-fold higher than in the
dog and human lineages (see Supplementary Information). As a
consequence, the human genome shares ,650 Mb more ancestral
sequence with dog than with mouse, despite our more recent
common ancestor with the latter.
Active SINE family. Despite its relatively low proportion of trans-
posable element-derived sequence, the dog genome contains a highly
active carnivore-specific SINE family (defined as SINEC_Cf; RepBase
release 7.11)16. The element is so active that many insertion sites are
still segregating polymorphisms that have not yet reached fixation.
Of ,87,000 young SINEC_Cf elements (defined by low divergence
from the consensus sequence), nearly 8% are heterozygous within the
draft genome sequence of the boxer. Moreover, comparison of the
boxer and standard poodle genome sequences reveals more than
10,000 insertion sites that are bimorphic, with thousands more
certain to be segregating in the dog population16,39. In contrast, the
number of polymorphic SINE insertions in the human genome is
estimated to be fewer than 1,000 (ref. 40).
The biological effect of these segregating SINE insertions is
unknown. SINE insertions can be mutagenic through direct disrup-
tion of coding regions or through indirect effects on regulation and
processing of messenger RNAs39. Such SINE insertions have already
been shown to be responsible for two diseases in dog: narcolepsy
and centronuclear myopathy41,42. It is conceivable that the genetic
variation resulting from these segregating SINE elements has pro-
vided important raw material for the selective breeding programmes
that have produced the wide phenotypic variations among modern
dog breeds16,43.
Sequence composition. The human and mouse genomes differ
markedly in sequence composition, with the human genome having
slightly lower average GþC content (41% versus 42% in mouse) but
much greater variation across the genome. The dog genome closely
resembles the human genome in its distribution of GþC content
(Fig. 3a; Spearman’s rho ¼ 0.85 for dog–human and 0.76 for dog–
mouse comparisons), even if we consider only nucleotides that can be
aligned across all three species (Supplementary Fig. S6). The wider
distribution of GþC content in human and dog is thus likely to
reflect the boreoeutherian ancestor44,45, with the more homogeneous
composition in rodents having arisen primarily through lineage-
specific changes in substitution patterns46,47 rather than deletion of
sequences with high GþC content.
Rate of nucleotide divergence. We estimated the mean nucleotide
divergence rates in 1-Mb windows along the dog, human and mouse
lineages on the basis of alignments of all ancestral repeats, using the
consensus sequence for the repeats as a surrogate outgroup (Fig. 3b;
see also Supplementary Information).
The dog lineage has diverged more rapidly than the human
lineage (median relative divergence rate of 1.18, longer branch length
in 95% of windows), but at only half the rate of the mouse lineage
(median relative rate of 0.48, shorter branch length in 100% of
windows). The absolute divergence rates are somewhat sensitive to
the evolutionary model used and the filtering of alignment artefacts
(data not shown), but the relative rates appear to be robust and are
consistent with estimates from smaller sequence samples with
multiple outgroups28,48,49. The lineage-specific divergence rates
(human , dog , mouse) are probably explained by differences
in metabolic rates50,51 or generation times52,53, but the relative
contributions of these factors remain unclear49.
Correlation in nucleotide divergence. As seen in other mammalian
genomes23–25, the average nucleotide divergence rate across 1-Mb
windows varies significantly across the dog genome (coefficient of
variation 0.11, compared with 0.024 expected under a uniform
distribution). This regional variation shows significant correlation
in orthologous windows across the dog, human and mouse genomes,
but the strength of the correlation seems to decrease with total
branch length (pair-wise correlation for orthologous 1-Mb windows:
Spearman’s rho ¼ 0.49 for dog–human and 0.24 for dog–mouse
comparisons). Lineage-specific variation in the regional divergence
Figure 2 | Venn diagram showing the total lengths of aligned and unique
sequences in the euchromatic portions of the dog, human and mouse
genomes. Lengths shown in Mb, as inferred from genome-wide BLASTZ
alignments (see Methods and Supplementary information). Overlapping
partitions represent orthologous ancestral sequences. Each lineage-specific
partition is further split into the total length of sequence classified as either
lineage-specific interspersed repeats (red) or ancestral sequence (black). The
latter is assumed to primarily represent ancestral sequences deleted in the
two other species.
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rates may be coupled with changes in factors such as sequence
composition or chromosomal position23,54. Consistent with this,
the ratios of lineage-specific divergence rates in orthologous win-
dows are positively correlated with the ratios of current GþC content
in the same windows (Spearman’s rho ¼ 0.16 for dog–human, 0.24
for dog–mouse).
Male mutation bias. Comparison of autosomal and X chromosome
substitution rates can be used to estimate the relative mutation rates
in the male and female germ lines (a), because the X chromosome is
present in females twice as often as in males. Using the lineage-
specific rates from ancestral repeats, we estimate a as 4.8 for the
lineage leading to human, and 2.8 for the lineages leading to both
mouse and dog. These values fall between recent estimates from
murids24,25 and from hominids23, and suggest that male mutation
bias may have increased in the lineage leading to humans.
Mutational hotspots and chromosomal fission. Genome compari-
sons of human with both chicken55 and chimpanzee23 have previously
revealed that sequences close to a telomere tend to have increased
divergence rates and G þ C content relative to interstitial sequences.
It has been unclear whether these increases are inherent character-
istics of the subtelomeric sequence itself or derived characteristics
causally connected with its chromosomal position. We find a similar
increase in both divergence (median increase 15%, P , 1025; Mann-
Whitney U-test) and GþC content (median increase 9%, P , 1029)
for subtelomeric regions along the dog lineage, with a sharp increase
towards the telomeres (Supplementary Fig. S7).
This phenomenon is manifested at other synteny breaks, not only
those at telomeres. We also observed a significant increase in
divergence and GþC content in interstitial regions that are sites of
syntenic breakpoints54,56 (Supplementary Fig. S7). These properties
therefore seem correlated with the susceptibility of regions to
chromosomal breakage.
Proportion of genome under purifying selection
One of the striking discoveries to emerge from the comparison of the
human and mouse genomes21,24 was the inference that,5.2% of the
human genome shows greater-than-expected evolutionary conserva-
tion (compared with the background rate seen in ancestral repeat
elements, which are presumed to be nonfunctional). This proportion
greatly exceeds the 1–2% that can be explained by protein-coding
regions alone. The extent and function of the large fraction of non-
coding conserved sequence remain unclear57, but this sequence is
likely to include regulatory elements, structural elements and RNA
genes.
Low turnover of conserved elements. We repeated the analysis of
conserved elements using the human and dog genomes. Briefly, the
analysis involves calculating a conservation score SHD, normalized by
the regional divergence rate, for every 50-bp window in the human
genome that can be aligned to dog. The distribution of conservation
scores for all genomic sequences is compared to the distribution in
ancestral repeat sequences (which are presumed to diverge at the
local neutral rate), showing a clear excess of sequences with high
conservation scores. By subtracting a scaled neutral distribution from
the total distribution, one can estimate the distribution of conserva-
tion scores for sequences under purifying selection. Moreover, for a
given sequence with conservation score SHD, one can also assign a
probability P selection(SHD) that the sequence is under purifying
selection (see ref. 24 and Supplementary Information).
The human–dog genome comparison indicates that,5.3% of the
human genome is under purifying selection (Fig. 4a), which is
equivalent to the proportion estimated from human–rodent analysis.
The obvious question is whether the bases conserved between human
and dog coincide with the bases conserved between humans and
rodents25,58. Because the conservation scores do not unambiguously
assign sequences as either selected or neutral (but instead only assign
probability scores for selection), we cannot directly compare the
conserved bases. We therefore devised the following alternative
approach.
We repeated the human–dog analysis, dividing the 1462 Mb of
orthologous sequence between human and dog into those regions
with (812 Mb) or without (650 Mb) orthologous sequence in mouse
(Fig. 2). The first set shows a clear excess of conservation relative
to background, corresponding to ,5.2% of the human genome
(Fig. 4b). In contrast, the second set shows little or no excess
conservation, corresponding to at most 0.1% of the human genome
(Fig. 4c). This implies that hardly any of the functional elements
conserved between human and dog have been deleted in the mouse
lineage (see also Supplementary Information).
The results strongly suggest that there is a common set of
functional elements across all three mammalian species, correspond-
ing to ,5% of the human genome (,150 Mb). These functional
elements reside largely within the 812 Mb of ancestral sequence
common to human, mouse and dog. If we eliminate ancestral repeat
elements within this shared sequence as largely non-functional, most
functional elements can be localized to 634 Mb, and constitute
approximately 24% of this sequence.
It should be noted that the estimate of,5% pertains to conserved
elements across distantly related mammals. It is possible that there
are additional weakly constrained or recently evolved elements
within narrow clades (for example, primates) that can only be
detected by genomic sequencing of more closely related species29.
Clustering of highly conserved non-coding elements. We next
Figure 3 | Sequence composition and divergence rates. a, Distribution of
G þ C content in 10-kb windows across the genome in dog (green), human
(red) and mouse (blue). b, Median lineage-specific substitution rates based
on analysis of ancestral repeats aligning across all three genomes. Analysis
was performed in non-overlapping 1-Mb windows across the dog genome
that contained at least 2 kb of aligned ancestral repeat sequence (median
8.8 kb). The tree was rooted with the consensus sequences from the ancestral
repeats. Numbers in parentheses give the 20–80th percentile range across the
windows studied.
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explored the distribution of conserved non-coding elements (CNEs)
across mammalian genomes. For this purpose, we calculated a
conservation score SHMD based on simultaneous conservation
across all three species (see Methods). We defined highly conserved
non-coding elements (HCNEs) to be 50-bp windows that do not
overlap coding regions and for which P selection(SHMD), the
probability of being under purifying selection given the conserva-
tion score, is at least 95%. We identified ,140,000 such windows
(6.5 Mb total sequence), comprising ,0.2% of the human genome
and representing the most conserved ,5% of all mammalian
CNEs.
The density of HCNEs shows striking peaks when plotted in 1-Mb
windows across the genome (Fig. 4d and Supplementary Figs S8 and
S9), with 50% lying in 204 regions that span less than 14% of the
human genome (Supplementary Table S11). These regions are
generally gene-poor, together containing only ,6% of all protein-
coding sequence.
The genes contained within these gene-poor regions are of
particular interest. At least 182 of the 204 regions contain genes
with key roles in establishing or maintaining cellular ‘state’. At least
156 of the regions contain one or, in a few cases, several transcription
factors involved in differentiation and development59. Another 26
regions contain a gene important for neuronal specialization and
growth, including several axon guidance receptors. The proportion
of developmental regulators is far greater than expected by chance
(P , 10231; see Supplementary Information).
We then tested whether the HCNEs within these regions tend to
cluster around the genes encoding regulators of development.
Analysis of the density of HCNEs in the intronic and intergenic
sequences flanking every gene in the 204 regions revealed that the
197 genes encoding developmental regulators show an average of
,10-fold enrichment for HCNEs relative to the full set of 1,285 genes
in the regions (Fig. 4e and Supplementary Fig. S10). The enrichment
sometimes extends into the immediately flanking genes.
We note that the 204 regions include nearly all of the recently
identified clusters of conserved elements between distantly related
vertebrates such as chicken and pufferfish55,59–62. For example, they
overlap 56 of the 57 large intervals containing conserved non-coding
sequence identified between human and chicken55. The mammalian
analysis, however, detects vastly more CNEs (.100-fold more
sequence than with pufferfish59 and 2–3-fold more than with
chicken) and identifies many more clusters. The limited sensitivity
of these more distant vertebrate comparisons may reflect the diffi-
culty of aligning short orthologous elements across such large
evolutionary distances or the emergence of mammal-specific regu-
latory elements. In any case, mammalian comparative analysis may
be a more powerful tool for elucidating the regulatory controls across
these important regions.
Although the function of conserved non-coding elements is
unknown, on the basis of recent studies59,63–66 it seems likely that
many regulate gene expression. If so, the above results suggest that
,50% of all mammalian HCNEs may be devoted to regulating,1%
of all genes. In fact, the distribution may be even more skewed, as
there are additional genomic regions with only slightly lower HCNE
density than the 204 studied above (Supplementary Fig. S8). All of
these regions clearly merit intensive investigation to assess indicators
of regulatory function. We speculate that these regions may harbour
characteristic chromatin structure and modifications that are poten-
tially involved in the establishment or maintenance of cellular state.
Genes
Accurate identification of the protein-coding genes in mammalian
genomes is essential for understanding the human genome, includ-
ing its cellular components, regulatory controls and evolutionary
Figure 4 | Conservation of orthologous sequence between human and
dog. a, Histogram of conservation scores, S, for all 50-bp windows across
the human genome with at least 20 bases of orthologous sequence aligning
to the dog genome, for all aligning sequences (red) and for ancestral repeat
sequence only (blue). b, Conservation scores for the subset of windows that
also have at least 20 bases of orthologous sequence aligning to the mouse
genome. c, Conservation scores of the complementary subset of windows
lacking such orthologous sequence in mouse. d, Density of 50-bp windows
not overlapping known coding regions, for which Pselection(S) . 95%, based
on comparisons between human and dog (HD), human and mouse (HM),
or between human, mouse and dog (HMD), and the density of known genes,
all in 1-Mb sliding windows across human chromosome 3. e, Enrichment of
HCNEs in the immediate neighbourhood of genes encoding developmental
regulators in the 204 highly conserved regions. The histogram shows the
median number of HCNE bases in the intronic and surrounding intergenic
sequence, for the 197 known or putative development regulators (indicated
by top of red bar) and for all of the 1,285 genes (blue bar). The histogram is
centred at the 5 0 -end of the gene (marked 0) and each bin corresponds to half
of the normalized distance to the flanking consecutive upstream genes
(marked 21, 22 and 23) or consecutive downstream genes (1, 2 and 3) as
indicated. The sequences surrounding the developmental genes are typically
longer, have more HCNE sequence and have a higher density of HNCE
sequence than other genes in the regions (see Supplementary Information).
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constraints. The number of protein-coding genes in human has been
a topic of considerable debate, with estimates steadily falling from
,100,000 to 20,000–25,000 over the past decade21,22,67–70. We ana-
lysed the dog genome in order to refine the human gene catalogue
and to assess the evolutionary forces shaping mammals. (In the
Genes section, ‘gene’ refers only to a protein-coding gene.)
Gene predictions in dog and human.We generated gene predictions
for the dog genome using an evidence-based method (see Sup-
plementary Information). The resulting collection contains 19,300
dog gene predictions, with nearly all being clear homologues of
known human genes.
The dog gene count is substantially lower than the ,22,000-gene
models in the current human gene catalogue (EnsEMBL build 26).
For many predicted human genes, we find no convincing evidence of
a corresponding dog gene. Much of the excess in the human gene
count is attributable to spurious gene predictions in the human
genome (M. Clamp, personal communication).
Gene duplications. Gene duplication is thought to contribute
substantially to functional innovation69,71. We identified 216 gene
duplications that are specific to the dog lineage and 574 that are
specific to the human lineage, using the synonymous substitution
rate K S as a distance metric and taking care to discard likely
pseudogenes. (The CanFam 2.0 assembly contains approximately
24 additional gene duplications, mostly olfactory receptors.) Human
genes are thus 2.7-fold more likely to have undergone duplication
than are dog genes over the same time period. This may reflect
increased repeat-mediated segmental duplication in the human
lineage72.
Although gene duplication has been less frequent in dog than
human, the affected gene classes are very similar. Prominent among
the lineage-specific duplicated genes are genes that function in
adaptive immunity, innate immunity, chemosensation and repro-
duction, as has been seen for other mammalian genomes24,25,69,71.
Reproductive competition within the species and competition
against parasites have thus been major driving forces in gene family
expansion.
The two gene families with the largest numbers of dog-specific
genes are the histone H2B family and the a-interferons, which cluster
in monophyletic clades when compared to their human homologues.
This is particularly notable for the a-interferons, for which the gene
families within the six species (human, mouse, rat, dog, cat and
horse) are apparently monophyletic. This may be due either to
coincidental independent gene duplication in each of the six lineages
or to ongoing gene conversion events that have homogenized
ancestral gene duplicates73.
Evolution of orthologous genes across three species. The dog
genome sequence allows us for the first time to characterize the
large-scale patterns of evolution in protein-coding genes across three
major mammalian orders. We focused on a subset of 13,816 human,
mouse and dog genes with 1:1:1 orthology. For each, we inferred the
number of lineage-specific synonymous (KS) and non-synonymous
(KA) substitutions along each lineage and calculated the KA/KS ratio
(Table 2 and Supplementary Information), a traditional measure
of the strength of selection (both purifying and directional) on
proteins74.
The median KA/KS ratio differs sharply across the three lineages
(P , 10244, Mann-Whitney U-test), with the dog lineage falling
between mouse and human. Population genetic theory predicts75
that the strength of purifying selection should increase with effective
population size (Ne). The observed relationship (mouse , dog ,
human) is thus consistent with the evolutionary prediction, given the
expectation that smaller mammals tend to have larger effective
population sizes76.
We next searched for particular classes of genes showing deviations
from the expected rate of evolution for a species. Such variation in
rate (heterotachy) may point to lineage-specific positive selection or
relaxation of evolutionary constraints77. We developed a statistical
method similar to the recently described Gene Set Enrichment
Analysis (GSEA)78–80 to detect evidence of heterotachy for sets of
functionally related genes (see Supplementary Information). Briefly,
the approach involves ranking all genes by KA/KS ratio, testing
whether the set is randomly distributed along the list and assessing
the significance of the observed deviations by comparison with
randomly permuted gene sets. In contrast to previous studies,
which focused on small numbers of genes with prior hypotheses of
selection, this approach detects signals of lineage-specific evolution
in a relatively unbiased manner and can provide context to the results
of more limited studies.
A total of 4,950 overlapping gene sets were studied, defined by such
criteria as biological function, cellular location or co-expression (see
Supplementary Information). Overall, the deviations between the
three lineages are small, and median KA/KS ratios for particular gene
sets are highly correlated for each pair of species (Supplementary
Fig. S11). However, there is greater relative variation in human–
mouse and dog–mouse comparisons than in human–dog compari-
sons (Supplementary Fig. S12).
This suggests that observed heterotachy between human and
mouse must be interpreted with caution. For example, there is a
great interest in the identification of genetic changes underlying the
unique evolution of the human brain. A recent study81 highlighted 24
genes involved in brain development and physiology that show signs
of accelerated evolution in the lineage leading from ancestral
primates to humans when compared to their rodent orthologues.
We observe the same trend for the 18 human genes that overlap
with the genes studied here, but find at least as many genes with
higher relative acceleration in the dog lineage (see Supplementary
Information). Heterotachy relative to mouse therefore does not
appear to be a distinctive feature of the human lineage. It may reflect
decelerated evolution in the rodent lineage, or possibly independent
adaptive evolution in the human and dog lineages82.
A small number of gene sets show evidence of significantly
accelerated evolution in the human lineage, relative to both mouse
and dog (32 sets at z $ 5.0 versus zero sets expected by chance,
P , 1024; Fig. 5a). These sets fall into two categories: genes expressed
exclusively in testis, and (nuclear) genes encoding subunits of
the mitochondrial electron transport chain (ETC) complexes. The
former are believed to undergo rapid evolution as a consequence of
sperm competition across a wide range of species83–85, and lineage-
specific acceleration suggests that sexual selection may have been a
particularly strong force in primate evolution. The selective forces
acting on the latter category are less obvious. Because of the
importance of mitochondrial ATP generation for sperm motility86,
and the potentially antagonistic co-evolution of these genes with
maternally inherited mitochondrial DNA-encoded subunits87, we
Table 2 | Evolutionary rates for 1:1:1 orthologues among dog, mouse and human
Median (20–80th percentile range) Spearman’s rho
Dog* Mouse Human Dog–human Dog–mouse Human–mouse
KS 0.210 (0.138–0.322) 0.416 (0.310–0.558) 0.139 (0.0928–0.214) 0.47 0.50 0.52
KA 0.021 (0.006–0.051) 0.038 (0.013–0.087) 0.017 (0.005–0.040) 0.87 0.87 0.86
KA/KS 0.095 (0.030–0.221) 0.088 (0.031–0.197) 0.112 (0.034–0.272) 0.80 0.85 0.82
*Estimates are based on unrooted tree. The dog branch thus includes the branch from the boreoeutherian ancestor to the primate–rodent split.
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propose that sexual selection may also be the primary force behind
the rapid evolution of the primate ETC genes. Given the ubiquitous
role of mitochondrial function, however, such sexual selection may
have led to profound secondary effects on physiology88.
We found no gene sets with comparably strong evidence for dog-
specific accelerated evolution. There is, however, a small excess of sets
with moderately high acceleration scores (19 sets at z $ 3.0 versus 5
sets expected by chance, P , 0.02; Fig. 5b). These sets, which are
primarily related to metabolism, may contain promising candidates
for follow-up studies of molecular adaptation in carnivores.
Polymorphism and haplotype structure in the domestic dog
The modern dog has a distinct population structure with hundreds
of genetically isolated breeds, widely varying disease incidence and
distinctive morphological and behavioural traits89,90. Unlocking the
full potential of the dog genome for genetic analysis requires a dense
SNP map and an understanding of the structure of genetic variation
both within and among breeds.
Generating a SNPmap. We generated a SNP map of the dog genome
containing .2.5 million distinct SNPs mapped to the draft genome
sequence, corresponding to an average density of approximately
one SNP per kb (Table 3). The SNPs were discovered in three
complementary ways (see Supplementary Information). (1) We
identified SNPs within the sequenced boxer genome (set 1;
,770,000 SNPs) by searching for sites at which alternative alleles
are supported by at least two independent reads each. We tested a
subset (n ¼ 40 SNPs) by genotyping and confirmed all as hetero-
zygous sites. (2) We compared the 1.5£ sequence from the standard
poodle16 with the draft genome sequence from the boxer (set 2;
,1,460,000 SNPs). (3) We generated shotgun sequence data from
nine diverse dog breeds (,100,000 reads each, 0.02£ coverage), four
grey wolves and one coyote (,22,000 reads each, 0.004£ coverage)
and compared it to the boxer (set 3; ,440,000 SNPs). We tested a
subset (n ¼ 1,283 SNPs) by genotyping and confirmed 96% as true
polymorphisms.
The SNP rate between the boxer and any of the different breeds is
one SNP per ,900 bp, with little variation among breeds (Table 3).
The only outlier (,1/790 bp) is the Alaskan malamute, which is the
only breed studied that belongs to the Asian breed cluster91. The grey
wolf (,1/580 bp) and coyote (,1/420 bp) show greater variation
when compared with the boxer, supporting previous evidence of a
bottleneck during dog domestication, whereas that the SNP rate is
lower in the grey wolf than in the coyote reflects the closer relation-
ship of the grey wolf to the domestic dog1–3,92 (see section ‘Resolving
canid phylogeny’).
The observed SNP rate within the sequenced boxer assembly is
,1/3,000 bp. This underestimates the true heterozygosity owing to
the conservative criterion used for identifying SNPs within the boxer
assembly (requiring two reads containing each allele); correcting
for this leads to an estimate of ,1/1,600 bp (see Supplementary
Information). This low rate reflects reduced polymorphism within a
breed, compared with the greater variation of ,1/900 bp between
breeds.
To assess the utility of the SNPs for dog genetics, we genotyped a
subset from set 3a (n ¼ 1,283) in 20 dogs from each of ten breeds
(Supplementary Table S16). Within a typical breed, ,73% of the
SNPs were polymorphic. The polymorphic SNPs have minor allele
frequencies that are approximately evenly distributed between 5%
and 50% (allele frequencies less than 5% are not reliable with only 40
chromosomes sampled). In addition, the SNPs from sets 2 and 3 have
a roughly uniform distribution across the genome (Fig. 6a, see below
concerning set 1). The SNP map thus has high density, even
distribution and high cross-breed polymorphism, indicating that it
should be valuable for genetic studies.
Expectations for linkage disequilibrium and haplotype structure.
Modern dog breeds are the product of at least two population
bottlenecks, the first associated with domestication from wolves
(,7,000–50,000 generations ago) and the second resulting from
intensive selection to create the breed (,50–100 generations ago).
This population history should leave distinctive signatures on the
patterns of genetic variation both within and across breeds. We might
expect aspects of both the long-range LD seen in inbred mouse strains,
with strain-specific haplotypes extending over multiple megabases,
and the short-range LD seen in humans, with ancestral haplo-
type blocks typically extending over tens of kilobases. Specifically,
Figure 5 | Gene sets showing accelerated evolution along the human and
dog lineages. a, Distribution of acceleration scores along the human lineage
relative to both mouse and dog, observed for 4,950 gene sets (red). The
expected distribution based on 10,000 randomized trials is shown in blue.
The dotted line shows the acceleration score for which the probability of
observing even a single set by random chance (out of the 4,950 sets tested) is
less than 1%. In fact, 32 sets show acceleration scores on the human lineage
exceeding this threshold. b, The observed (red) and expected (blue)
distribution of acceleration scores for the dog lineage, relative to both
human and mouse.
Table 3 | SNPs discovered in dogs, wolves and coyotes compared to the
boxer assembly
Set number Breed or species Number of
SNPs
SNP rate
(one per x bases)
1 Boxer versus boxer 768,948 3,004 (observed)
1,637 (corrected)
2 Boxer versus poodle 1,455,007 894
3a Boxer versus breeds*
German shepherd 45,271 900
Rottweiler 44,097 917
Bedlington terrier 44,168 913
Beagle 42,572 903
Labrador retriever 40,730 926
English shepherd 40,935 907
Italian greyhound 39,390 954
Alaskan malamute 45,103 787
Portuguese water dog 45,457 896
Total distinct SNPs 373,382 900
3b Boxer versus Canids†
China grey wolf 12,182 580
Alaska grey wolf 13,888 572
India grey wolf 14,510 573
Spanish grey wolf 10,349 587
California coyote 20,270 417
Total distinct SNPs 71,381
3 Set 3 total distinct SNPs 441,441
Total Total distinct SNPs 2,559,519
*Based on ,100,000 sequence reads per breed.
†Based on ,20,000 sequence reads per wolf.
ARTICLES NATURE|Vol 438|8 December 2005
810
© 2005 Nature Publishing Group 
 
long-range LD would be expected within dog breeds and short-range
LD across breeds.
Preliminary evidence of long-range LD within breeds has been
reported90. Five genome regions were examined (,1% of the
genome) in five breeds using ,200 SNPs with high minor allele
frequency. LD seemed to extend 10–100-fold further in dog than in
human, with relatively few haplotypes per breed.
With the availability of a genome sequence and a SNP map, we
sought to undertake a systematic analysis of LD and haplotype
structure in the dog genome.
Haplotype structure within the boxer assembly. We first analysed
the structure of genetic variation within the sequenced boxer genome
by examining the distribution of the ,770,000 SNPs detected
between homologous chromosomes. Strikingly, the genome is a
mosaic of long, alternating regions of near-total homozygosity and
high heterozygosity (Fig. 6b, c), with observed SNP rates of,14 per
Mb and ,850 per Mb, respectively. (The latter is close to that seen
within breeds and is indistinguishable when one corrects for the
conservative criterion used to identify SNPs within the boxer
assembly; see Supplementary Information.) The homozygous
regions have an N50 size of 6.9 Mb and cover 62% of the genome,
and the heterozygous regions have an N50 size of 1.1 Mb and cover
38% of the genome. The results imply that the boxer genome is
largely comprised of vast haplotype blocks. The long stretches of
homozygosity indicate regions in which the sequenced boxer genome
carries the same haplotype on both chromosomes. The proportion of
homozygosity (,62%) reflects the limited haplotype diversity within
breeds.
Long-range haplotypes in different breeds. We sought to determine
whether the striking haplotype structure seen in the boxer genome is
representative of most dog breeds. To this end, we randomly selected
ten regions of 15 Mb each (,6% of the genome) and examined
linkage disequilibrium in these regions in a collection of 224 dogs,
consisting of 20 dogs from each of ten breeds and one dog from each
of 24 additional breeds (see Supplementary Tables S17–S19).
The ten breeds were chosen to represent all four clusters described
in ref. 91. The selected breeds have diverse histories, with varying
population size and bottleneck severity. For example, the Basenji is an
ancient breed from Africa that has a small breeding population in the
United States descending from dogs imported in the 1930s–1940s
(refs 93, 94). The Irish wolfhound suffered a severe bottleneck two
centuries ago, with most dogs today being descendents of a single dog
in the early 1800s (refs 5, 94). In contrast, the Labrador retriever and
golden retriever have long been, and remain, extremely popular dogs
Figure 6 | The distribution of SNPs is fairly uniform across breeds, but
non-uniform within the sequenced boxer assembly. a, SNPs across
chromosome 3, generated by comparing the boxer assembly withWGS reads
fromnine breeds. b, The SNPs on chromosome 3 of the boxer assembly show
an uneven distribution (plotted in 500-kb windows). Note that boxer SNPs
were identified using a more conservative method, lowering the observed
SNP rate by roughly twofold. c, An alternating pattern of large homozygous
(light blue,,62%of genome;N50 size 6.9Mb) and large heterozygous (dark
blue ,38% of genome; N50 size 1.1Mb) blocks indicates large identical or
divergent haplotypes across the boxer genome. White indicates centromeric
sequence.
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(with ,150,000 and ,50,000 new puppies registered annually,
respectively). They have not undergone such recent severe bottle-
necks, but some lines have lost diversity because of the repeated use of
popular sires89. The Glen of Imaal terrier represents the opposite end
of the popularity spectrum, with fewer than 100 new puppies
registered with the American kennel Club each year.
The 224 dogs were genotyped for SNPs across each of the ten
regions, providing 2,240 cases in which to assess long-range LD. The
SNPs (n ¼ 1,219; Supplementary Table S19) were distributed along
the regions to measure the fall-off of genetic correlation, with higher
density at the start of the region and lower densities at further
distances (Fig. 7a). In 645 cases, we also examined the first 10 kb in
Figure 7 | Homozygous regions and linkage disequilibrium are nearly
100-fold longer within dog breeds than across the dog or human
populations. a, Sampling design for ten random regions of 15Mb each,
used to assess the haplotype structure of ,6% of the genome (see
Supplementary Information). For each region, we examined the first 10 kb
through resequencing and dense genotyping. To detect long haplotypes, we
genotyped SNPs distributed throughout the next 1Mb and sampled SNPs at
intervals of 1Mb for the next 14Mb. In total we genotyped 1,219 SNPs
across the ten regions in a collection of 224 dogs (20 dogs from each of 10
breeds and one dog from each of 24 breeds). b, Conditional on a dog being
homozygous for the initial 10-kb region (n ¼ 245), we assessed the
probability that the dog was homozygous for all SNPs within a given
distance. The average proportion remaining homozygous is compared for
the various breeds (green), for the boxer when sampled in the same ways as
the breeds (blue) and for the boxer using all SNPs found in the genome
sequence (red). About 50% of the individuals seem to be homozygous
throughout 1Mb both in the boxer and other breeds, indicating that other
breeds have comparable long-range homozygosity. c, Linkage
disequilibrium (LD) as a function of distance is shown as the r2 statistic
within individual breeds (red), across various breeds (blue) and a human
population (black) taken from the CEPH collection genotyped as part of the
ENCODE component of the International HapMap Project118. For the
overall dog and human populations, LD falls rapidly, reaching the baseline
level seen for unlinked loci by,200 kb. In contrast, LD for individual breeds
falls initially but then stays at a moderately high level across several
megabases. d, The LD curves are broadly similar for most breeds, but the
proportion of long-range LD is correlated with known breed history. e, The
observed within-breed LD curve (averaged across breeds) is well fitted by a
simple model with a domestication bottleneck 10,500 generations ago and a
breed-creation bottleneck occurring 50 generations ago (see Supplementary
Information). f, LD curves for individual dog breeds can be fitted by models
with different breed-creation bottlenecks. The poorest fit is obtained for the
akita, the breeding history of which is known to involve two separate breed-
creation bottlenecks.
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greater detail by denser genotyping (with ,2 SNPs per kb) in 405
cases and complete resequencing in 240 cases. The resequencing data
yielded a heterozygosity rate of ,1 SNP per 1,500 bp, essentially
equivalent to the rate seen in the sequenced boxer genome.
On the basis of examining the first 10 kb, we found that ,38% of
instances seem to be completely homozygous and that all dogs seem
to be homozygous for at least one of the ten regions. We then
measured the distance over which homozygosity persisted. Of
instances homozygous in the initial 10-kb segment, 46% were
homozygous across 1 Mb and 17% were still homozygous across
10 Mb (Fig. 7b). The fall-off in homozygosity is essentially identical
to that seen in the boxer genome, provided that the boxer data are
sampled in an equivalent manner (see Supplementary Information).
This indicates that the long-range haplotype structure seen in the
boxer is typical of most dog breeds, although the precise haplotypes
vary with breed and the locations of homozygous regions vary
between individuals.
We also assessed long-range correlations by calculating r 2,
a traditional measure of LD, across the 15-Mb regions. The r2
curve representing the overall dog population (one dog from each
of 24 breeds) drops rapidly to background levels. This is in sharp
contrast to the r2 curves within each breed. Within breeds, LD is
biphasic, showing a sharp initial drop within,90 kb followed by an
extended shoulder that gradually declines to the background
(unlinked) level by 5–15 Mb in most breeds (Fig. 7c). The basic
pattern is similar in all ten regions (Supplementary Fig. S13) and in
all breeds (Fig. 7d). (Labrador retrievers show the shortest LD,
probably due to their mixed aetiology and large population size.)
The biphasic r2 curves within each breed thus consist of two
components (Fig. 7e), at scales differing by ,100-fold. The first
component matches the fall-off in the general dog population and is
likely to represent the short-range de-correlation of local haplotype
blocks in the ancestral dog population. The second component
represents long-range breed-specific haplotypes (Fig. 8a). Notably,
the first component falls off nearly twice as quickly as the LD in the
human population (,200 kb), and the second component falls off
slightly slower than seen in laboratory mouse strains95.
Modelling the effects of population history. We tested this
interpretation by performing mathematical simulations on a dog
population that underwent an ancient bottleneck and recent breed-
creation bottlenecks, using the coalescent approach96 (see Sup-
plementary Information). Our experimental results were well fitted
by models assuming an ancient bottleneck (effective domesticated
population size 13,000, inbreeding coefficient F ¼ 0.12) occurring
,9,000 generations ago (corresponding to ,27,000 years) and
subsequent breed-creation bottlenecks of varying intensities occur-
ring 30–90 generations ago97 (Supplementary Fig. S14). The model
closely reproduces the observed r2 curves and the observed poly-
morphism rates within breeds, among breeds and between dog and
grey wolf. The model also yields estimates of breed-specific bottle-
necks that are broadly consistent with known breed histories. For
example, Labrador retrievers, and to a lesser extent golden retrievers
and English springer spaniels, show less severe bottlenecks.
Deterministically modelled results (Fig. 7e, f) indicate that a
simple, two-bottleneck model provides a close fit to the data for
the breeds. They do not rule out a more complex population history,
such as multiple domestication events, low levels of continuing gene
flow between domestic dog and grey wolf97,98 or multiple bottlenecks
within breeds. Notably, the akita yields the poorest fit to the model,
with an r2 curve that appears to be triphasic. This may reflect the
initial creation of the breed as a hunting dog in Japan ,450
generations ago, and a consecutive bottleneck associated with its
introduction into the United States during the 1940s (ref. 99).
Haplotype diversity. We next studied haplotype diversity within and
among breeds, using the dense genotypes from the 10-kb regions.
Across the 645 cases examined, there is an average of ,10 distinct
haplotypes per region. Within a breed, we typically see four of
these haplotypes, with the average frequency of the most common
haplotype being 55% and the average frequency of the two most
common being 80% (Fig. 8c and Supplementary Fig. S18). The
haplotypes and their frequencies differ sharply across breeds. None-
theless, 80% of the haplotypes seen with a frequency of at least 5%
in one breed are found in other breeds as well (Supplementary
Table S26). This extends previous observations of haplotype sharing
across breeds90. In particular, the inclusion of all SNPs with a minor
allele frequency $5% across all breeds provides a more accurate
picture of haplotype sharing, because the analysis includes haplo-
types that are rare within a single breed but more common across the
population.
We then inferred the ancestral haplotype block structure in the
ancestral dog population (before the creation of modern breeds) by
combining the data across breeds and applying methods similar to
those used for haplotype analysis in the human genome100 (see
Supplementary Information). In the 10-kb regions studied, one or
two haplotype blocks were typically observed. Additional data across
100-kb regions suggest that the ancestral blocks have an average size
of ,10 kb. The blocks typically have ,4–5 distinct haplotypes
across the entire dog population (Fig. 8b). The overall situation
closely resembles the structure for the human genome, although
with slightly smaller block size (Supplementary Figs S15–S19 and
Supplementary Table S24–26).
Ancestral and breed-specific haplotypes. A clear picture of the
population genetic history of dogs emerges from the results detailed
above:†The ancestral dog population had short-range LD. The haplotype
blocks were somewhat shorter than in modern humans (,10 kb
versus,20 kb in human), consistent with the dog population being
somewhat older than the human population (,9,000 generations
versus,4,000 generations). Haplotype blocks at large distances were
essentially uncorrelated (Fig. 8a).†Breed creation introduced tight breed-specific bottlenecks, at least
for the breeds examined. From the great diversity of long-range
haplotype combinations carried in the ancestral population, the
founding chromosomes emerging from the bottleneck represented
only a small subset. These became long-range breed-specific haplo-
types (Fig. 8a).†Although the breed-specific bottlenecks were tight, they did not
cause massive random fixation of individual haplotypes. Only 13%
of the small ancestral haplotypes are monomorphic within a typical
breed, consistent with the estimated inbreeding coefficient of,12%.
Across larger regions ($100 kb), we observed no cases of complete
fixation within a breed (Supplementary Fig. S20).†There is notable sharing of 100-kb haplotypes across breeds, with
,60% seen in multiple breeds although with different frequencies.
On average, the probability of sampling the same haplotype on two
chromosomes chosen from different breeds is roughly twofold lower
than for chromosomes chosen within a single breed (Supplementary
Fig. S21).
Implications for genetic mapping. These results have important
implications for the design of dog genetic studies. Although early
efforts focused on cross-breeding of dogs for linkage analysis101–103, it
is now clear that within-breed association studies offer specific
advantages in the study of both monogenic and polygenic diseases.
First, they use existing dogs coming to medical attention and do not
require the sampling of families with large numbers of affected
individuals. Such studies should be highly informative, because
dog breeds have retained substantial genetic diversity. Moreover,
they will require a much lower density of SNPs than comparable
human association studies, because the long-range LD within breeds
extends ,50-fold further than in humans90,104,105.
Whereas human association studies require .300,000 evenly
spaced SNPs100,106,107, the fact that LD extends over at least 50-fold
greater distances in dog suggests that dog association studies would
require perhaps ,10,000 evenly spaced SNPs. To estimate the
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Figure 8 | Two bottlenecks, one old and one recent, have shaped the
haplotype structure and linkage disequilibrium of canine breeds.
a, Modern haplotype structure arose from key events in dog breeding
history. The domestic dog diverged from wolves 15,000–100,000 years
ago97,119, probably through multiple domestication events98. Recent dog
breeds have been created within the past few hundred years. Both
bottlenecks have influenced the haplotype pattern and LD of current breeds.
(1) Before the creation of modern breeds, the dog population had the short-
range LD expected on the basis of its large size and time since the
domestication bottleneck. (2) In the creation of modern breeds, a small
subset of chromosomes was selected from the pool of domestic dogs. The
long-range patterns that happened to be carried on these chromosomes
became common within the breed, thereby creating long-range LD. (3) In
the short time since breed creation, these long-range patterns have not yet
been substantially broken down by recombination. Long-range haplotypes,
however, still retain the underlying short-range ancestral haplotype blocks
from the domestic dog population, and these are revealed when one
examines chromosomes across many breeds. b, c, Distribution of ancestral
haplotype blocks in a 10-kb window on chromosome 6 at ,31.4Mb across
24 breeds (b) and within four breeds (c). Ancestral haplotype blocks are
5–15 kb in size (which is shorter than the ,25-kb blocks seen in humans)
and are shared across breeds. Typical blocks show a spectrum of ,5
haplotypes, with one common major haplotype. Blocks were defined using
the modified four-gamete rule (see Supplementary Information) and each
haplotype (minor allele frequency (maf) . 3%) within a block was given a
unique colour. d, e, Distribution of breed-derived haplotypes across a 10-kb
window on chromosome 6 at ,31.4Mb across 24 breeds (d) and within
four breeds (e). Each colour denotes a distinct haplotype (maf . 3%) across
11 SNPs in the 10-kb window for each of the analysed dogs. Pairs of
haplotypes have an average of 3.7 differences. Most haplotypes can be
definitively identified on the basis of homozygosity within individual dogs.
Grey denotes haplotypes that cannot be unambiguously phased owing to
rare alleles or missing data. Within each of the four breeds shown, there are
2–5 haplotypes, with one or two major haplotypes accounting for the
majority of the chromosomes. Across the 24 breeds, there are a total of seven
haplotypes. All but three are seen in multiple breeds, although at varying
frequencies.
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number of SNPs required, we generated SNP sets from ten 1-Mb
regions by coalescent simulations using the bottleneck parameters
that generate SNP rates and LD curves equivalent to the actual data
(Supplementary Fig. S14 and Supplementary Table S20). We then
selected individual SNPs as ‘disease alleles’ and tested our ability
to map them by association analysis with various marker densities
(Fig. 9a).
For disease alleles causing a simple mendelian dominant trait with
high penetrance and no phenocopies, there is overwhelming power
to map the locus (Fig. 9a). Using,15,000 evenly spaced SNPs and a
log likelihood odds ratio (LOD score) score threshold of 5, the
probability of detecting the locus is over 99% given a collection of
100 affected and 100 unaffected dogs. (The LOD score threshold
corresponds to a false positive rate of 3% loci per genome.)
For a multigenic trait, the power to detect disease alleles depends
on several factors, including the relative risk conferred by the allele,
the allele frequency and the interaction with other alleles. We
investigated a simple model of an allele that increases risk by a
multiplicative factor (l) of 2 or 5 (see Supplementary Information).
Using the above SNP density and LOD score threshold, the power to
detect a locus with a sample of 100 affected and 100 unaffected dogs is
97% for l ¼ 5 and 50% for l ¼ 2 (Fig. 9b, c). Although initial
mapping will be best done by association within breeds, subsequent
fine-structure mapping to pinpoint the disease gene will probably
benefit from cross-breed comparison. Given the genetic relationships
across breeds described above, it is likely that the same risk allele will
be carried in multiple breeds. By comparing risk-associated haplo-
types in multiple breeds, it should be possible to substantially narrow
the region containing the gene.
Resolving canid phylogeny
The dog family, Canidae, contains 34 closely related species that
diverged within the last,10 million years1. Resolving the evolution-
ary relationships of such closely related taxa has been difficult
because a great quantity of genomic sequence is typically required
to yield enough informative nucleotide sites for the unambiguous
reconstruction of phylogenetic trees. We sought to streamline the
process of evolutionary reconstruction by exploiting our knowledge
of the dog genome to select genomic regions that would maximize
the amount of phylogenetic signal per sequenced base. Specifically,
we sought regions of rapidly evolving, unique sequence.
We first compared the coding regions of 13,816 dog genes with
human–dog–mouse 1:1:1 orthologues to find those with high neutral
evolutionary divergence (comparing KS and KA/KS). We selected 12
exons (8,080 bp) for sequencing, based on the criteria that their
sequences (1) are consistent with the known phylogeny of human,
dog, mouse and rat, (2) have a high percentage of bases ($15%) that
are informative for phylogenetic reconstruction in the human, dog,
mouse and rat phylogenies, and (3) could be successfully amplified in
all canids. The chosen exons contain 3.3-fold more substitutions than
random exonic sequence. Using our SNP database, we also evaluated
introns to identify those with high variation between dog and coyote.
We selected four introns (3,029 bp) that contained ,5-fold more
SNPs than the background frequency. We sequenced these exons and
introns (11,109 bp) in 30 out of 34 living wild canids, and we
combined the data with additional sequences (3,839 bp) from recent
studies3,92.
The resulting evolutionary tree has a high degree of statistical
support (Fig. 10), and uniquely resolves the topology of the dog’s
closest relatives. Grey wolf and dog are most closely related (0.04%
and 0.21% sequence divergence in nuclear exon and intron
sequences, respectively), followed by a close affiliation with coyote,
golden jackal and Ethiopian wolf, three species that can hybridize
with dogs in the wild (Fig. 10). Closest to this group are the dhole and
African wild dog, two species with a uniquely structured meat-slicing
tooth, suggesting that this adaptation was later lost. The molecular
tree supports an African origin for the wolf-like canids, as the two
African jackals are the most basal members of this clade. The two
other large groupings of canids are (1) the South American canids,
which are clearly rooted by the two most morphologically divergent
canids, the maned wolf and bush dog; and (2) the red fox-like canids,
which are rooted by the fennec fox and Blanford’s fox, but now also
include the raccoon dog and bat-eared fox with higher support.
Together, these three clades contain 93% of all living canids. The grey
fox lineage seems to be the most primitive and suggests a North
American origin of the living canids about 10 million years ago1.
These results demonstrate the close kinship of canids. Their
limited sequence divergence suggests that many molecular tools
developed for the dog (for example, expression microarrays) will
be useful for exploring adaptation and evolutionary divergence in
other canids as well.
Conclusions
Genome comparison is a powerful tool for discovery. It can reveal
unknown—and even unsuspected—biological functions, by sifting
the records of evolutionary experiments that have occurred over 100
years or over 100 million years. The dog genome sequence illustrates
the range of information that can be gleaned from such studies.
Mammalian genome analysis is helping to develop a global picture
of gene regulation in the human genome. Initial comparison with
rodents revealed that,5% of the human genome is under purifying
selection, and that the majority of this sequence is not protein-
Figure 9 | Power to detect a disease locus by association mapping. One
SNP was designated as a disease allele under one of three genetic models: (a)
simple mendelian dominant, (b) fivefold multiplicative increase in risk and
(c) twofold multiplicative increase in risk. SNP genotypes across
surrounding chromosomal regions of 1Mb were simulated, using the
coalescent model corresponding to observed within-breed variation (see
text). Diploid genotypes across the chromosomal region were then
generated for 100 affected and 100 unaffected dogs, based on the disease
model, and association analysis was performed to detect the presence of the
disease allele. The distribution of the maximum LOD score across the 1-Mb
region is shown for analyses based on multi-SNP haplotypes (solid lines)
with SNP densities equivalent to a genome-wide map with a total of 7,500
(red), 15,000 (green) or 30,000 (blue) SNPs. Dotted curves show the null
distribution for a genome-wide search in which no disease locus is present
(see Supplementary Information). A LOD score of 5 corresponds to ,3%
chance of a false positive across the genome. For this threshold, the power to
detect a disease allele that increases risk by twofold using haplotype analysis
and a map with 15,000 SNPs is ,50%.
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coding. The dog genome is now further clarifying this picture, as our
data suggest that this ,5% represents functional elements common
to all mammals. The distribution of these elements relative to genes is
highly heterogeneous, with roughly half of the most highly conserved
non-coding elements apparently devoted to regulating ,1% of
human genes; these genes have important roles in development,
and understanding the regulatory clusters that surround them may
reveal how cellular states are established and maintained. In recent
papers32,108, the dog genome sequence has been used to greatly
expand the catalogue of mammalian regulatory motifs in promoters
and 3
0
-untranslated regions. The dog genome sequence is also being
used to substantially revise the human gene catalogue. Despite these
advances, it is clear that mammalian comparative genomics is still in
its early stages. Progress will be markedly accelerated by the avail-
ability of many additional mammalian genome sequences, initially
with light coverage28 but eventually with near-complete coverage.
In addition to its role in studies of mammalian evolution, the dog
has a special role in genomic studies because of the unparalleled
phenotypic diversity among closely related breeds. The dog is a
testament to the power of breeding programmes to select naturally
occurring genetic variants with the ability to shape morphology,
physiology and behaviour. Genome comparison within and across
breeds can reveal the genes that underlie such traits, informing basic
research on development and neurobiology. It can also identify
disease genes that were carried along in breeding programmes.
Potential benefits include insights into disease mechanism, and the
possibility of clinical trials in disease-affected dogs to accelerate new
therapeutics that would improve health in both dogs and humans.
The SNP map of the dog genome confirms that dog breeds show
the long-range haplotype structure expected from recent intensive
breeding. Moreover, our analysis shows that the current collection of
.2.5 million SNPs should be sufficient to allow association studies of
Figure 10 | Phylogeny of canid species. The phylogenetic tree is based on
,15 kb of exon and intron sequence (see text). Branch colours identify the
red-fox-like clade (red), the South American clade (green), the wolf-like
clade (blue) and the grey and island fox clade (orange). The tree shown was
constructed using maximum parsimony as the optimality criterion and is
the single most parsimonious tree. Bootstrap values and bayesian posterior
probability values are listed above and below the internodes, respectively;
dashes indicate bootstrap values below 50% or bayesian posterior
probability values below 95%. Horizontal bars indicate indels, with the
number of indels shown in parentheses if greater than one. Underlined
species names are represented with corresponding illustrations. (Copyright
permissions for illustrations are listed in the Supplementary Information.)
Divergence time, in millions of years (Myr), is indicated for three nodes as
discussed in ref. 1. For scientific names and species descriptions of canids,
see ref. 119. A tree based on bayesian inference differs from the tree shown in
two respects: it groups the raccoon dog and bat-eared fox as sister taxa, and
groups the grey fox and island fox as basal to the clade containing these sister
taxa. However, neither of these topological differences is strongly supported
(see text and Supplementary Information).
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nearly any trait in any breed. Realizing the full power of dog genetics
now awaits the development of appropriate genotyping tools, such as
multiplex ‘SNP chips’109—this is already underway. For millennia,
dogs have accompanied humans on their travels. It is only fitting that
the dog should also be a valued companion on our journeys of
scientific discovery.
METHODS
Detailed descriptions of all methods are provided in the Supplementary
Information. Links to all of the data can be obtained via the Broad Institute
website (http://www.broad.mit.edu/tools/data.html).
WGS sequencing and assembly. Approximately 31.5 million sequence reads
were derived from both ends of inserts (paired-end reads) from 4-, 10-, 40- and
200-kb clones, all prepared from primary blood lymphocyte DNA from a single
female boxer. This particular animal was chosen for sequencing because it had
the lowest heterozygosity rate among ,120 dogs tested at a limited set of loci;
subsequent analysis showed that the genome-wide heterozygosity rate in this
boxer is not substantially different from other breeds91. The assembly was carried
out using an interim version of ARACHNE2þ (http://www.broad.mit.edu/wga/).
Genome alignment and comparison. Synteny maps were generated using
standard methods24 from pair-wise alignments of repeat masked assemblies
using PatternHunter110 on CanFam2.0. All other comparative analyses were
performed on BLASTZ/MULTIZ111,112 genome-wide alignments obtained from
the UCSC genome browser (http://genome.ucsc.edu), based on CanFam1.0.
Known interspersed repeats were identified and dated using RepeatMasker and
DateRepeats113. The numbers of orthologous nucleotides were counted directly
from the alignments using human (hg17) as the reference sequence for all
overlaps except the dog–mouse overlap, for which pair-wise (CanFam1.0, mm5)
alignments were used.
Divergence rate estimates. Orthologous ancestral repeats were excised from the
genome alignment and realigned with the corresponding RepBase consensus
using ClustalW. Nucleotide divergence rates were estimated from concatenated
repeat alignments using baseml with the REV substitution model114. Ortholo-
gous coding regions were excised from the genome alignments using the
annotated human coding sequences (CDS) from Ensembl and the UCSC
browser Known Genes track (October 2004) as reference. KA and KS were
estimated for each orthologue triplet using codeml with the F3 £ 4 codon
frequency model and no additional constraints.
Detection and clustering of sequence conservation. Pair-wise conservation
scores and the fraction of orthologous sequences under purifying selection were
estimated as in ref. 24. The three-way conservation score SHMD was defined as
SHMD ¼ ðp2 uÞ=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃðuð12 uÞ=np ; where n is the number of nucleotides aligned
across all three genomes (human, mouse, dog) for each non-overlapping 50-bp
window with more than 20 aligned bases, p is the fraction of nucleotides identical
across all three genomes, and u is the mean identity of ancestral repeats within
500 kb of the window. HCNEs were defined as windows with SHMD . 5.4 that
did not overlap a coding exon, as defined by the UCSC Known Genes track, and
HCNE clusters were defined as all runs of overlapping 1-Mb intervals (50-kb step
size) across the human genome with HCNE densities in the 90th percentile.
Gene set acceleration scores. Gene annotation was performed on CanFam1.0. A
set of 13,816 orthologous human, mouse and dog genes were identified and
compiled into 4,950 gene sets containing genes related by functional annotations
or microarray gene expression data. For each gene set S, the acceleration score
A(S) along a lineage is defined by (1) ranking all genes based on KA/KS within a
lineage, (2) calculating the rank-sum statistic for the set along each lineage
(denoted adog(S), amouse(S), ahuman(S)), (3) calculating the rank-sum for
the lineage minus the maximum rank-sum the other lineages, for example,
ahuman(S)–max(adog(S), amouse(S)) and (4) converting this rank-sum difference
to a z-score by comparing it to the mean and standard deviation observed in
10,000 random sets of the same size. The expected number of sets at a given
z-score threshold was estimated by repeating steps (1)–(4) 10,000 times for
groups of 4,950 randomly permuted gene sets.
SNP discovery. The SNP discovery was performed on CanFam2.0. Set 1 SNPs
were discovered by comparison of the two haplotypes derived from the boxer
assembly using only high-quality discrepancies supported by two reads. SNPs in
sets 2 and 3 were discovered by aligning reads or contigs to the boxer assembly
and using the SSAHA SNP algorithm115.
Haplotype structure. The SNPs within the sequenced boxer genome
(CanFam2.0) were assigned to homozygous or heterozygous regions using a
Viterbi algorithm116. To determine whether the haplotype structure seen in the
boxer is representative of most dog breeds, we randomly selected ten regions of
15 Mb each (,6% of the CanFam2.0 genome) and examined the extent of
homozygosity and linkage disequilibrium in these regions in a collection of 224
dogs, consisting of 20 dogs from each of 10 breeds (akita, basenji, bullmastiff,
English springer spaniel, Glen of Imaal terrier, golden retriever, Irish wolfhound,
Labrador retriever, pug and rottweiler) and one dog from each of 24 additional
breeds (see Supplementary Information). For each instance in which a dog was
homozygous in a particular 10-kb region, we measured the distance from
the beginning of the 10-kb region to the first heterozygous SNP in the adjoining
100-kb, 1-Mb and 15-Mb data. This distance was used as the extent of
homozygosity. The boxer sequence was sampled in an identical manner to the
actual breed data. Linkage disequilibrium (represented by r2) across the ten
15-Mb regions was assessed using Haploview117.
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We report a high-quality draft of the genome sequence of the grey, short-tailed opossum (Monodelphis domestica). As the
first metatherian (‘marsupial’) species to be sequenced, the opossum provides a unique perspective on the organization and
evolution of mammalian genomes. Distinctive features of the opossum chromosomes provide support for recent theories
about genome evolution and function, including a strong influence of biased gene conversion on nucleotide sequence
composition, and a relationship between chromosomal characteristics and X chromosome inactivation. Comparison of
opossum and eutherian genomes also reveals a sharp difference in evolutionary innovation between protein-coding and
non-coding functional elements. True innovation in protein-coding genes seems to be relatively rare, with lineage-specific
differences being largely due to diversification and rapid turnover in gene families involved in environmental interactions. In
contrast, about 20%of eutherian conserved non-coding elements (CNEs) are recent inventions that postdate the divergence
of Eutheria and Metatheria. A substantial proportion of these eutherian-specific CNEs arose from sequence inserted by
transposable elements, pointing to transposons as a major creative force in the evolution of mammalian gene regulation.
Metatherians (‘marsupials’) comprise one of the three major groups
ofmodernmammals and represent the closest outgroup to the euthe-
rian (‘placental’) mammals (Supplementary Fig. 1). Metatherians
and eutherians diverged ,180million years (Myr) ago, long before
the radiation of the extant eutherian clades ,100Myr ago1,2.
Although the metatherian lineage originally radiated from North
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America, only one extant species can be found there (the Virginia
opossum), whereas all other species are found in South America
(including more than 65 species of opossums and shrew opossums)
and Australasia (,200 species, including possums, kangaroos, koalas
and many small insectivores and carnivores)3.
All sequenced mammalian genomes until now have come from
eutherian species. Although metatherians and eutherians (together,
‘therians’) share many ancient mammalian characteristics, they have
each evolved distinctive morphological and physiological traits.
Metatherians are particularly noted for the birth of young at a very
early stage of development, followed by a lengthy and complex lacta-
tional period. Genomic analysis will help reveal the genetic innova-
tions that underlie the distinctive traits of each lineage4–6.
Equally important, metatherian genomes can shed light on the
human genome. Comparative analysis of eutherians has greatly
improved our understanding of the architecture and functional
organization of mammalian genomes7–10. Identification of sequence
elements thought to be under purifying selection, on the basis of
cross-species sequence conservation, has led to increasingly refined
inventories of protein-coding genes11,12, proximal and distal regula-
tory elements13,14 and putative RNA genes15. Yet, we still know rela-
tively little about the evolutionary dynamics of these and other
functional elements: how stable is the complement of protein-coding
genes? How rapidly do regulatory sequences appear and disappear?
From what substrate do they evolve?
Comparison of the human genome with genomes from distant
outgroups such as birds (divergence ,310Myr ago) or fish
(,450Myr ago) has provided valuable information.When similarity
between sequences from such distantly related genomes can be
detected, it surely signals functional importance; but the high spe-
cificity of these signals16 is offset by dramatically reduced sensitiv-
ity10,17,18. Simulations have shown that the feasibility of aligning
orthologous genomic sequences declines rapidly once their mean
genetic distance exceeds 1 substitution per site19. The genome of
chicken, the most closely related non-mammalian amniote genome
available, is separated from the human genome by approximately 1.7
substitutions per site in orthologous, neutrally evolving sequences20.
Even moderately constrained functional elements may therefore be
difficult to detect. In contrast, metatherian mammals are well posi-
tioned to address this issue: because unconstrained regions of their
genomes are separated from that of human by only ,1 substitution
per site (see below), most orthologous, constrained sequence should
be readily aligned.
Herewe report the first high-quality draft of ametatherian genome
sequence, which was derived from a female, grey, short-tailed opos-
sum—Monodelphis domestica. The species was chosen chiefly on
the availability and utility of the organism for research purposes.
M. domestica is a small rapidly breeding South American species
that has been raised in pedigreed colonies for more than 25 years
and developed as one of only two laboratory bred metatherians21,22.
M. domestica is being actively used as a model system for investi-
gations in mechanisms of imprinting23–25, immunogenetics26–28, neu-
robiology, neoplasia and developmental biology (reviewed in ref. 6).
For example, newborn opossums are remarkable in that they can heal
complete transections of the spinal cord29. Elucidation of themolecu-
lar mechanisms underlying this ability promise important insights
relevant to regenerative medicine concerning spinal cord or peri-
pheral nerve injuries. Other than human, M. domestica is also the
only mammal known in which ultraviolet radiation is a complete
carcinogen for malignant melanoma30, and this has led to its estab-
lishment as a unique neoplasia model. All of these investigations will
directly benefit from the development of genomic resources for this
species.
Below we describe the generation of the draft sequence of the
opossum genome, analyse its large-scale characteristics, and compare
it to previously sequenced amniote genomes. Our key findings
include:
$ The distinctive features of the opossum genome provide an
informative test of current models of genome evolution and support
the hypothesis that biased gene conversion has a key role in deter-
mining overall nucleotide composition.
$ The evolution of random inactivation of the X chromosome in
eutherians correlates with acquisition of X-inactive-specific tran-
script (XIST), elevation in long interspersed element (LINE)/L1 den-
sity and suppression of large-scale rearrangements.
$ The opossum genome seems to contain 18,000–20,000 protein-
coding genes, the vast majority of which have eutherian orthologues.
Lineage-specific genes largely originate from expansion and rapid
turnover in gene families involved in immunity, sensory perception
and detoxification.
$ Identification of orthologues of highly divergent immune genes
and a novel T-cell receptor isotype challenge previous claims that
metatherians possess a ‘primitive’ immune system.
$ Of the non-coding sequences conserved among eutherians,
,20% seem to have evolved after the divergence from metatherians.
Of protein-coding sequences conserved among eutherians, only
,1% seems to be absent in opossum.
$ At least 16% of eutherian-specific conserved non-coding ele-
ments are clearly derived from transposons, implicating these ele-
ments as an important creative force in mammalian evolution.
Extensions to these findings, as well as additional topics, are
reported in a series of companion papers31–41.
Genome assembly and single nucleotide polymorphism discovery
We sequenced the genome of a partially inbred female opossumusing
the whole-genome shotgun (WGS) method7,42. The resulting WGS
assembly has a total length of 3,475megabases (Mb), consistent with
size estimates based on flow cytometry (,3.5–3.6 Gb; Supplementary
Notes 1–2 and Supplementary Fig. 2). Approximately 97% of the
assembled sequence has been anchored to eight large autosomes
and one sex chromosome on the basis of genetic markers mapped
by linkage analysis38 or fluorescence in situ hybridization43 (FISH;
Supplementary Note 3). The draft genome sequence has high con-
tinuity, coverage and accuracy (Table 1; Supplementary Note 4 and
Supplementary Tables 1–7).
To enable genetic mapping studies of opossum, we also created a
large catalogue of candidate single nucleotide polymorphisms
(SNPs). We identified ,775,000 SNPs within the sequenced indi-
vidual by analysing assembled sequence reads.We identified an addi-
tional ,510,000 SNPs by generating and comparing ,300,000
sequence reads from three individuals from distinct, partially
outbred laboratory stocks maintained at the Southwest Foundation
for Biomedical Research (San Antonio, Texas)22,44 (Supplemen-
tary Note 5). The SNP rates between the different stocks range from
Table 1 | Genome assembly characteristics
WGS assembly (monDom5)
Number of sequence reads 38.83 106
Sequence redundancy (Q20 bases) 6.83
Contig length (kb; N50*) 108
Scaffold length (Mb; N50) 59.8
Anchored bases in the assembly (Mb) 3,412
Estimated euchromatic genome size{ (Mb) 3,475
Integration of physical mapping data
Scaffolds anchored on chromosomes 216
Fraction of genome in anchored and oriented scaffolds (%) 91
Fraction of genome in anchored, but unoriented, scaffolds (%) 6
Quality control
Bases with quality score$40 (%) 98
Empirical error rate for bases with quality score$40{ (%) 33 1025
Empirical euchromatic sequence coverage{ (%) 99
Bases in regions with low probability of structural error1 (%) 98
*N50 is the size x such that 50%of the assembly reside in contigs/scaffolds of length at least x.
{ Includes anchored bases and spanned gaps (,2%).
{Based on comparison with 1.66Mb of finished bacterial artificial chromosome (BAC)
sequence.
1Based on ARACHNE assembly certification (see Supplementary Note 4).
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1 per 360 to 1 per 140 bases and correlate with the distance between
their geographical origins (Supplementary Table 8–10 and Supple-
mentary Fig. 3).
The data from this study, including the draft genome assembly and
SNPs, are freely available on our website (http://www.broad.mit.edu/
mammals/opossum/) and have been deposited in appropriate public
databases.
Genome landscape
The opossum genome has certain unusual properties that provide an
opportunity to test recentmodels of genome evolution. The opossum
autosomes are extremely large: they range from 257Mb to 748Mb,
with the smallest being larger than the largest chromosome prev-
iously sequenced in any amniote (human chromosome 1). In con-
trast, the X chromosome is only ,76Mb long; this is substantially
less than the size of the X chromosome in any sequenced eutherian.
Studies of G-banding and chromosome painting have also shown
that karyotypes and basic chromosomal organization are extraord-
inarily conserved throughout Metatheria, even between the distantly
related American and Australasian lineages (,55–80Myr ago)5,45.
Sequence composition. Recent analyses have uncovered two major
trends in the evolution of sequence composition in amniote gen-
omes: first, most modern lineages seem to be experiencing a gradual
decline in total G1C content relative to their common ancestors46;
second, the local rate of recombination is positively correlated with
local G1C content and, even more strongly, with the local density of
CpG dinucleotides20,47. These observations have led to a proposed
model48 whereby sequence composition reflects the balance between
a genome-wide, (A1T)-biased mutation process and a localized
recombination-mediated (G1C)-biased gene conversion process.
This model predicts that the sequence composition of a genomic
region is a function of its historical rate of recombination, with the
frequency of hypermutable CpG dinucleotides being a particularly
sensitive indicator.
The opossum genome fits the predictions of this model well (see
also refs 34, 35). Current linkage data38 show that the average recom-
bination rate for the autosomes (,0.2–0.3 cMMb21) is lower than in
other sequenced amniotes (0.5–.3 cMMb21). Consistent with the
proposed model, the mean autosomal G1C content (37.7%) is also
lower than in other sequenced amniotes (40.9–41.8%) and, in par-
ticular, the mean autosomal density of CpGs (0.9%) is twofold lower
than in other amniotes (1.7–2.2%). Because large-scale patterns of
recombination seem to be relatively stable in the absence of chromo-
somal rearrangements49,50, the stability of the opossum karyotype
suggests that the majority of the genome has experienced low re-
combination rates over an extended period. Indeed, the sequence
composition is also more homogeneous than seen in other amniotes
(Fig. 1).
The subtelomeric regions of autosomes are notable outliers with
respect to sequence composition in the opossum genome, provid-
ing additional support for the biased gene conversion hypothesis.
Cytological studies in opossum51,52 suggest that the rate of chiasmata
formation (and hence meiotic recombination) is relatively uniform
across each autosome in males, whereas it is strongly biased to sub-
telomeric regions in females. Consistent with a higher sex-averaged
rate of recombination,meanG1C-content (41.6%) andCpGdensity
(1.9%) are significantly elevated within,10Mb of the chromosome
ends (Supplementary Fig. 4).
Similarly, the very short X chromosome also supports the biased
gene conversion hypothesis. Although few linkage data are currently
available for opossum X chromosome, the average effective recom-
bination rate must be at least 0.44 cMMb21, and thus larger than for
the autosomes. (This estimate follows from the requirement of at
least one meiotic crossover per bivalent in the female germ-line53,54.)
The mean G1C content (40.9%) and CpG density (1.4%) of the
X chromosome are substantially higher than for any of the autosomes
(Supplementary Table 11). The opossum pattern is thus the opposite
of that seen in eutherians, in which the X chromosome has low
recombination and low G1C content and CpG density (Table 2).
Segmental duplication. In human and other eutherians, segmental
duplications (defined as pairs of regions with$90% sequence sim-
ilarity over$1 kb) are associated with chromosomal fragility and
syntenic breakpoints55,56. The relative karyotypic stability of meta-
therians therefore indicated that they might have a low proportion of
segmental duplications.
The overall proportion of segmental duplication in opossum
(1.7%) is indeed substantially lower than in other sequenced
amniotes (2.5–5.3%). The segmental duplications are also relatively
short: only 22 exceed 100 kb in opossum as compared with 483 in
human (Supplementary Table 12). Additionally, the segmental
duplications aremore locally distributed: 76% are intrachromosomal
(versus 46% for human) and the median distance between related
duplications is 175 kb (versus 2.2Mb for human).We find no indica-
tion that correction for over-collapsed duplications in the assembly
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Figure 1 | Sequence composition in the opossum genome. Distribution of
G1C content in 10-kb windows across the genome in opossum (blue),
human (red), mouse (black), dog (green) and chicken (purple).
Table 2 | Comparative analysis of genome landscape in opossumand other
amniotes
Opossum Human Mouse Dog Chicken
Euchromatic genome size (Mb) 3,475 2,880 2,550 2,330 1,050
Karyotype
Haploid number 9 23 20 39 33
Autosomal size range (Mb) 258–748 47–247 61–197 27–125 5–201
X chromosome size (Mb) 76 155 167 127 NA
Segmental duplications
Autosomal (%) 1.7 5.2 5.3 2.5 10.4
Intrachromosomal duplications (%) 76 46 84 ND ND
Median length between
duplications (Mb)
0.18 2.2 1.6 0.33 0.03
X chromosome (%) 3.3 4.1 13 1.7 NA
Interspersed repeats (%)
Total 52.2 45.5 40.9 35.5 9.4
LINE/non-LTR retrotransposon 29.2 20.0 19.6 18.2 6.5
SINE 10.4 12.6 7.2 10.2 NA
Endogenous retrovirus 10.6 8.1 9.8 3.7 1.3
DNA transposon 1.7 2.8 0.8 1.9 0.8
G1C content (%)
Autosomal 37.7 40.9 41.8 41.1 41.5
X chromosome 40.9 39.5 39.2 40.2 NA
CpG content (%)
Autosomal 0.9 2.0 1.7 2.2 2.1
X chromosome 1.4 1.7 1.2 1.9 NA
Recombination rate (cMMb21)
Autosomal* ,0.2–0.3 1–2 0.5–1 1.3–3.4{ 2.5–21
X chromosome{ $0.441 0.8 0.3 ND NA
NA, not applicable; ND, no or insufficient data.
* Range of chromosome-averaged recombination rates.
{ See Æhttp://www.vgl.ucdavis.edu/research/canine/projects/linkage_map/data/æ
{ Estimated as 2/3 of the female rate.
1 See text.
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would significantly alter these estimates (Supplementary Note 6 and
Supplementary Table 13).
Transposable elements. Metatherian transposable elements largely
belong to families also found in eutherians, but can be divided into
more than 500 subfamilies, many of which are lineage specific (cata-
logued in Repbase57). At least 52% of the opossum genome can be
recognized as transposable elements and other interspersed repeats
(Table 2)33,35, which is more than in any of the other sequenced
amniotes (34–43%).Notably, theopossumgenome is significantly en-
riched in non-long terminal repeat (LTR) retrotransposons (LINEs,
29%), comprising copies of various LINE subfamilies. Given the low
abundance of segmental duplications, accumulation of transposable
elements seems to be the primary reason for the relatively large opos-
sum genome size. The total euchromatic sequence that is not re-
cognized as transposable elements is rather similar in opossum and
human (1638Mb versus 1568Mb, respectively). The enrichment of
LINEs may be related to the overall low recombination rate in opos-
sum, inasmuch as studies of eutherian genomes have shown that
LINEs occur at elevated densities in regions with low local recombina-
tion rates47.
Conserved synteny
Identification of syntenic segments between related genomes can
facilitate reconstruction of chromosomal evolution and identifica-
tion of orthologous functional elements. Starting from nucleotide-
level, reciprocal-best alignments (‘synteny anchors’), we found that
the opossum and human genomes can be subdivided (at a resolution
of 500 kb) into 510 collinear segments with anN50 length (size x such
that 50% of the assembly is in units of length at least x) of 19.7Mb,
which cover 93% of the opossum genome (Supplementary Fig. 5). If
local rearrangements are disregarded, these segments can be further
grouped into 372 blocks of large-scale, conserved synteny.
Extending this analysis to additional eutherians (mouse, rat and
dog), with chicken as an additional outgroup, we created a high-
resolution synteny map that reveals 616 blocks of conserved synteny
across the five fully sequenced mammals (Supplementary Note 7,
Supplementary Figs 6–7 and Supplementary Table 14). Because the
majority of synteny breakpoints between human, mouse, rat and dog
are clearly lineage specific (see also ref. 10), genomic regions that were
probably contiguous in the last common boreoeutherian ancestor
can be inferred by parsimony (Supplementary Note 8). We found
that themammalian synteny blocks can be used to infer 43 connected
groups in the ancestral boreoeutherian genome (Supplementary Fig.
8). In fact, the largest 30 groups cover 95% of the human genome (see
also ref. 58).
The resulting synteny map can be used to clarify chromosomal
rearrangements during early mammalian evolution. For example,
limited comparative mapping previously revealed that the eutherian
X chromosome contains an ‘X-conserved region’ (XCR) that corre-
sponds to the ancestral therian X chromosome, and an ‘X-added
region’ (XAR), which was translocated from an autosome after the
split from Metatheria59,60. The exact extent of the XCR has been
unclear, however, owing to unclear synteny with non-mammalian
out-groups at its boundary61. Using our high-resolution syntenymap
we can now confidently map the XAR–XCR fusion point to 46.85Mb
on human chromosome band Xp11.3 (Fig. 2).
X chromosome inactivation
In opossum and other metatherian mammals, dosage compensation
for X-linked genes is achieved through inactivity of the paternally
derived X chromosome in females62. In contrast, eutherian dosage
compensation involves inactivation of the paternal X chromosome
at spermatogenesis, reactivation in the early embryo, followed
by random and clonally stable inactivation of one of the two
X chromosomes in each cell of female embryos63. The random in-
activation step is controlled by a complex locus known as the
X inactivation centre (XIC). In the early female embryo, the non-
coding XIST gene is transcribed from the XIC and coats one chro-
mosome, in cis, to initiate silencing of the majority of its genes. It has
been proposed that paternal X chromosome inactivation represents
the ancestral therian dosage compensation system, and that random
X chromosome inactivation is a recent innovation in the eutherian
lineage64,65. The opossum genome sequence provides the first oppor-
tunity to test major hypotheses about the evolution of this system.
No XIST homologue in opossum. We searched all assembled and
unassembled opossum WGS sequence for homology to the human
and mouse XIC non-coding genes but, in agreement with a recent
report66, did not find any significant alignments. (In particular, we
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found no match to the highly conserved 150-bp region overlapping
the critical exon 4 of XIST; this region is so strongly conserved in the
Eutheria that it should be readily detectable if present40.) Analysis of
synteny in the regions surrounding the eutherian XIC also revealed
that it has been disrupted by large-scale rearrangements (Fig. 2)40,41.
In eutherians, the XIC is flanked by the ancient protein-coding genes
CDX4–CHIC1 on one side and SLC16A2–RNF12 on the other side. In
both chicken and frog these four genes are clustered in autosomal
XIC homologous regions (which do not contain homologues of the
XIC non-coding genes66). On the opossumX chromosome, however,
these two pairs of genes are separated by ,29Mb (compared with
,750 Kb in human). Taken together, the evidence strongly suggests
that XIST is specific to eutherians40,41,66.
The Lyon repeat hypothesis. LINE/L1 elements are of particular
interest to the study of X chromosome inactivation. These transpos-
able elements have been proposed to act as ‘boosters’ for the spread of
X chromosome inactivation in cis from the XIC (reviewed in ref. 67).
This hypothesis is supported in part by the observation that in
human, LINE/L1 density is significantly elevated in the XCR
(33%), where nearly all genes are inactivated, but approximates the
autosomal density in the XAR (19%), where many genes escape
inactivation (Fig. 3)61,68. In mouse, we found that the LINE/L1 den-
sity is elevated in both the XCR (35%) and the XAR (32%), which is
consistent with the observation that genes that escape inactivation on
the human XAR are often inactivated in mouse69. As previously
observed in human68, the LINE/L1 elevation in mouse is particularly
dramatic among recent, lineage-specific subfamilies (Supplementary
Fig. 9).
In contrast to human and mouse, the LINE/L1 density on the
opossum X chromosome (22%) is significantly lower than in the
eutherianXCR, and is in fact slightly less than in the autosomal regions
homologous to the eutherian XAR (23%). This difference between
metatherian and eutherianX chromosomes is not readily explainedby
any simple correlation between LINE/L1 density, recombination or
mutation rates. We therefore conclude that LINE/L1 density is
unlikely to be a critical factor for X chromosome inactivation in the
metatherian lineage, and that the approximately twofold increase on
the eutherianX chromosomemaybedirectly related to the acquisition
of XIST and random X chromosome inactivation.
Suppression of large-scale rearrangements. Comparative analyses
have revealed that the structure of the human X chromosome has
remained essentially unchanged since the eutherian radiation10,20,61. A
possible reason is that the requirement for XIST transcripts to spread
across the chromosome from a central location has led to selection
against structural rearrangements. For example, translocation of
LINE/L1-poor XAR segments into the XCR could potentially disrupt
inactivation at more distal loci. Consistent with this hypothesis, our
syntenymap reveals that the XAR andXCRhomologous regions have
experienced several major rearrangements both in the opossum lin-
eage (,15 lineage-specific synteny breakpoints) and in the eutherian
lineage before the eutherian radiation (,9 lineage-specific break-
points; Supplementary Table 15). The low rate of rearrangements
in the human lineage is therefore unlikely to be due to functions or
sequences that were present on the ancestral therian X chromosome,
or in early eutherian evolution.
We note that unlike in human, the mouse X chromosome has
experienced several rearrangements (with 15 lineage-specific synteny
breakpoints), such that the XAR and XCR are no longer two separate
segments. This would be consistent with the more comprehensive
inactivation in themouse imposing weaker constraints on rearrange-
ment. Although little is known about the extent of X chromosome
inactivation in dog or rat, their X chromosomes are also consistent
with this hypothesis. The dogX chromosome is collinear with human
and is enriched for LINE/L1 only in the XCR (33.4% versus 16.8%
for the XAR). The rat X chromosome has accumulated ,4 lineage-
specific synteny breakpoints after the divergence from mouse61, and
is similarly enriched for LINE/L1 in both the XCR (36.7%) and the
XAR (34.5%).
Genes
The gene content of metatherian and eutherian genomes provides
key information about biological functions. We analysed the gene
content of the opossum genome and compared it with that of the
human genome. We focused on instances of rapid divergence and
duplication of protein-coding genes, which have led to lineage-spe-
cific gene complements70.
Gene catalogue. We generated an initial catalogue of 18,648 pre-
dicted protein-coding genes and 946 non-coding genes (primarily
small nuclear RNA, small nucleolar RNA, microRNA and ribosomal
RNA) in opossum34 (Supplementary Note 9 and Supplementary
Data). Regularly updated annotations can be obtained from public
databases (http://www.ensembl.org and http://genome.ucsc.edu).
We next characterized orthology and paralogy relationships
between predicted protein-coding genes in opossum and human11
(Table 3). We could identify unambiguous human orthologues for
15,320 (82%) of the opossum predicted genes, with 12,898 cases
having a single copy in each species (1:1 orthologues). Notably, we
identified orthologues of key T-cell lineage markers such as CD4 and
CD8, which had not been successfully identified by cloning in
metatherian species39. Most (2,704) of the remaining genes are
homologous to human genes, but could not be assigned to ortholo-
gous groups with certainty.
A small number (624) of predicted opossum genes have no clear
homologue among the human gene predictions. Inspection revealed
that most of these are short (median length of 120 amino acids,
compared with 445 for 1:1 orthologues) and probably originate from
pseudogenes or spurious open reading frames. Only eight currently
have strong evidence of representing functional genes without homo-
logues in humans (Supplementary Table 16). These include CPD-
photolyase, which is part of an ancestral photorepair system still
active in opossum71, malate synthase72 and inosine/uridine hydro-
lase. The latter two are ancient genes not previously identified in a
mammalian species.
Conversely, approximately,1,100 current gene predictions from
human have no clear homologue in the initial opossum catalogue
(Supplementary Data). Of these, ,620 can be at least partially
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Figure 3 | Enrichment of LINE/L1 correlates with random Xchromosome
inactivation. Box plot of LINE/L1 density in 500-kb intervals across the
autosomes (A), the X-added region (XAR) and its homologous regions in
opossum, and the X conserved region (XCR). Red bar, median; box edges,
25th and 75th percentiles; whiskers, range.
Table 3 | Opossumand human gene predictions and projected gene counts
Protein-coding genes Opossum
Initial predictions 18,648
Orthologues in human* 15,320
1:1 12,898
Many:1 1,016
1:Many 451
Many:Many 582
Homologues in human, but unclear orthology{ 2,704
No predicted homologues in human 624
Projected total{ 18,000–20,000
* Includes some cases where multiple transcripts have inconsistent phylogenies, or where the
predicted orthologue is a putative pseudogene.
{ Includes members of highly duplicated gene families.
{Accounting for missed annotations in opossum and removal of probable pseudogenes.
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aligned to the opossum genome and may not have been annotated as
genes owing to imperfections in the draft assembly or high sequence
divergence. In particular, manual re-annotation identified ortholo-
gues of several rapidly evolving cytokines39. The remaining predic-
tions are dominated by gene families known to have undergone
expansion and rapid evolution in the human lineage, such as
b-defensins and cancer-testis antigens. On the basis of our compar-
ison, we conclude that the opossum genome probably contains
,18,000–20,000 protein-coding genes, with the vast majority having
eutherian orthologues.
Divergence rates among orthologues. We calculated the synonym-
ous substitution rate (KS; substitutions that do not result in amino
acid change because of codon redundancy) of 1:1 opossum–human
orthologues to approximate the unconstrained divergence rate
between the species7,10. The median value of KS is 1.02. Consistent
with expectation, this value is substantially smaller than the chicken–
human KS value (1.7), with the ratio being very close to the ratio of
prior estimates of the divergence times for the two lineages
(,180Myr ago for opossum and ,310Myr ago for chicken).
Notably, the median KS for orthologues located on the XCR is
significantly elevated relative to orthologues located on autosomes
in both species (1.2 versus 1.0; P, 1023; see also refs 34, 35). This is
the opposite to what is observed within Eutheria10, but is consistent
with the expectation that the higher G1C-content and recombina-
tion rate on the opossum X chromosome relative to its autosomes
implies a higher rate of mutation47. A similar elevation can also be
detected in subtelomeric regions34.
Innovation and turnover in gene families. We next studied the
evolution of gene family expansions in the metatherian lineage.
The opossum gene catalogue contains 2,743 (15%) genes that have
probably been involved in one or more duplication or gene conver-
sion event since the last common ancestor with eutherian mammals,
as inferred from low KS between the copies (median5 0.41). The
number of duplications is one-third fewer than the number of
human lineage-specific duplications (4,037; 20%), which may reflect
the lower rate of segmental duplication in the opossum genome.
We found a large number of lineage-specific copies of genes
involved in sensory perception, such as the c-crystallin family of
eye lens proteins73, and taste, odorant74 and pheromone receptors.
Other major lineage-specific duplications were found in the rapidly
evolving KRAB zinc-finger family, and in genes related to toxin
degradation and dietary adaptations, including cytochrome P450
and various gastric enzymes (see also ref. 34).
Innovation in the innate and adaptive immune systems is visible
through substantial duplication or gene conversion involving the
leukocyte receptor and natural killer complexes, immunoglobulins,
type I interferons and defensins32,39. The opossum genome also con-
tains a newT-cell receptor isotype that is expressed early in ontogeny,
before conventional T-cell receptors, andmay provide early immune
function in the altricial young37.
The opossum also shows some surprising gene family expansions
that are without precedent in other vertebrates. Notable among these
are multiple duplications of the nonsense-mediated decay factors
SMG5 and SMG6, and the pre-mRNA splicing factors, KIAA1604
and PRP18. The opossum genome also harbours two adjacent para-
logous copies of DNA (cytosine-5)-methyltransferase 1 (DNMT1),
which catalyses methylation of CpG dinucleotides. It will be inter-
esting to discover if specialized functions have been adopted by these
paralogous genes.
The patterns of evolution among duplicated genes largely mirror
those observed in eutherians34,70. The set of opossum paralogues
is strongly biased towards recent duplications (KS, 0.1) and in gen-
eral have accumulated a disproportionately high number of non-
synonymous mutations (Fig. 4). The median intraspecies ratio of
nonsynonymous to synonymous substitution rates (KA/KS) between
paralogues is 0.51, which is sixfold higher than the interspecies ratio
seen for 1:1 orthologues (0.086). This is consistent with the rapid
gene birth and death model75, which predicts that duplicated genes
either undergo functional divergence in response to positive selection
or rapidly degenerate owing to lack of evolutionary benefit.
Conserved sequence elements
The most surprising discovery to emerge from comparative analyses
of eutherian genomes is the finding that the majority of evolution-
arily conserved sequence does not represent protein-coding genes,
but rather are conserved non-coding elements (CNEs)7,10. The opos-
sum genome provides a well-positioned outgroup to study the origin
and evolution of these elements.
For simplicity, we will refer to sequence elements as ‘amniote
conserved elements’ if they are conserved between chicken and at
least one of opossum or human; ‘eutherian conserved elements’ if
they are conserved between human and at least one of mouse, rat or
dog; and ‘eutherian-specific elements’ if they are eutherian conserved
sequence absent from both opossum and chicken. (‘Metatherian-
specific elements’ surely also exist, but cannot be identified without
additional metatherian genomes.)
Loss of amniote conserved elements in mammals.We first studied
the extent to which amniote conserved elements have been lost in
the human lineage. We focused on ,133,000 conserved intervals
between opossum and chicken (68Mb), ,50% of which overlaps
protein-coding regions (Supplementary Data).
Nearly all (97.5%) of these amniote conserved elements can be
aligned to the human genome (Fig. 5a). We reasoned that some of
the remainder might be orthologous to sequence that lies within gaps
in the current human assembly, or which had been missed by the
initial genome-wide alignment. We therefore repeated the analysis,
focusing only on amniote elements present in opossum and occur-
ring in ‘ungapped intervals’ (that is, syntenic intervals between
human and opossum that have no sequence gaps); the ungapped
intervals contain 63% of all conserved elements.
We found that 99.0% of amniote elements in ungapped intervals
could be unambiguously aligned to the human genome. The remain-
ing 1.0% of amniote elements could not be found even by a more
sensitive alignment algorithm (Fig. 5b), and thus seem to have been
lost in the human lineage.
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We also performed the converse analysis, by aligning the human
and chicken genomes to identify amniote conserved elements poten-
tially lost in opossum. The results were similar, with 99.4% of ele-
ments in ungapped intervals being readily aligned to opossum.
We conclude that the vast majority of amniote conserved elements
encode such fundamental functions that they cannot be lost in either
eutherians or metatherians. Nonetheless, the small fractions that
have been lost correspond to more than 1,400 elements in total; it
will be interesting to investigate their function and the consequence
of their loss. Notably, although protein-coding sequence comprises
50% of all amniote conserved elements, they comprise only 4% of the
elements lost in one of the lineages.
Eutherian-specific conserved elements. We next explored the
appearance of novel conserved elements in the lineage leading from
the common therian ancestor to the boreoeutherian ancestor, which
could shed light on theorigin of such elements in general.We identified
a collection of eutherian conserved elements that cover 104Mb (3.7%)
of the human genome, using the phylo-HMM approach14; ,29% of
them overlap protein-coding sequence (Supplementary Data).
Only a small proportion of human conserved protein-coding
sequences could not be aligned to the opossum genome (1.1% in
ungapped regions; Fig. 5c). In contrast, a much larger proportion
of human non-coding elements seem to be eutherian specific (20.5%
in ungapped regions). Taking the results from ungapped syntenic
intervals as a conservative estimate for the proportion of total
innovation, we conclude that approximately 14.8Mb (1.1% of
30Mb of coding sequence and 20.5% of 74Mb of CNEs) of the
eutherian conserved elements are eutherian specific.
The amount of apparent innovation is highest among short and
moderately conserved elements (median length of 37 bp; median
log2-odds score5 22), probably reflecting, in part, that shorter ele-
ments maymore readily diverge beyond recognition (see also refs 36,
76). Nonetheless, substantial innovation is apparent even among
elements that are relatively long and unambiguously conserved
within Eutheria. For example, the proportion of eutherian-specific
elements is 8.1% among CNEswith log2-odds score$ 60, which have
a median length of 197 bp (Fig. 5d).
Lineage-specific CNEs correspond to functional elements. To
establish the biological relevance of lineage-specific CNEs, we exam-
ined the overlap of eutherian and amniote CNEs with two disparate
sets of experimentally identified functional elements. If the euther-
ian-specific CNEs were enriched for false-positive predictions, we
would expect them to be substantially under-represented among
these functional elements.
We first considered a set of known human microRNAs
(miRNAs)77. Of the 51 miRNAs that overlap amniote CNEs, only
one (hsa-mir-194-1; ref. 78) seems to have been lost in opossum
(Fig. 5e). (The mature form of this miRNA is identical to a second
conserved miRNA, hsa-mir-194-2, which does have an opossum
orthologue; this apparent redundancy may have made it more sus-
ceptible to lineage-specific loss.) Of the 183 miRNAs that overlap
eutherian CNEs in ungapped syntenic regions, 27 (15%) correspond
to eutherian-specific elements (Supplementary Data). An example is
an 87-bp eutherian-specific CNE corresponding to hsa-mir-28; it has
previously been detected by northern blot analysis in human and
mouse, but not in any non-mammalian species79.
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Figure 5 | Lineage-specific conserved sequence elements. a, Phylogenetic
distribution of amniote conserved elements. b, Distribution for alignment
scores of amniote elements, represented by opossum (human), to ungapped
syntenic intervals in the human (opossum) genome, for shared (purple) and
lineage-specific (orange) elements, and randomly permuted sequences of the
same length and base composition (green). Ungapped syntenic intervals are
flanked by two synteny anchors (white) and contain no assembly gaps
(inset). Md, Monodelphis domestica; Hs, Homo sapiens; Gg, Gallus
gallus. c, Phylogenetic distribution of eutherian conserved elements.
d, Distribution of alignment scores for eutherian CNEs (log2-odds
score$ 60), represented by human, to ungapped syntenic intervals in the
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(green). The bimodal distribution of scores confirms that highly conserved
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(purple). f, A eutherian-specific CNE in the intron of the BCL2 gene (red)
overlaps a DNase hypersensitive site in human lymphocytes (black).
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Wenext considered a genome-wide set ofDNase hypersensitive sites
from human lymphocytes, which represent a variety of putative reg-
ulatory elements80. Of the 290 sites that overlap amniote CNEs present
in human, none overlaps instances that are lost in opossum. Of the
2,041 sites that overlap eutherian CNEs in ungapped syntenic regions,
407 (20%) exclusively overlap eutherian-specific elements (Supplem-
entary Data). An example is a 269-bp eutherian-specific CNE in
intron 2 of the apoptosis regulator BCL2, which overlaps a DNase
hypersensitive site, suggesting it has a cis-regulatory function (Fig. 5f).
The fraction of eutherian CNEs overlapping DNase hypersensitive
sites that are eutherian specific is strikingly similar to the fraction of
all conserved non-coding sequence that is eutherian specific (20.5%).
The fraction of miRNAs that correspond to eutherian-specific CNEs
is slightly lower (15%), which is consistent with their higher average
conservation scores. In particular, the results provide strong evidence
that the majority of eutherian-specific CNEs are likely to be genuine
functional elements.
Lineage-specific CNEs associated with key developmental genes.
Wenext explored the distribution of lineage-specific CNEs across the
human genome. Overall, there is a strong regional correlation
between the density of eutherian CNEs shared with opossum and
the density of eutherian-specific CNEs (Spearman’s r5 0.82 for
1-Mb windows; Fig. 6). The densities of amniote CNEs present or
lost in opossum are also positively correlated (Spearman’s r5 0.30).
Previous studies have shown that both eutherian and amniote
CNEs are enriched in certain large, gene-poor regions surrounding
genes that have key roles in development, primarily encoding tran-
scription factors, morphogens and axon guidance receptors10,81,82.
For example, 35% of all eutherian CNEs and 49% of all amniote
CNEs (in ungapped syntenic regions) lie within the 204 largest clus-
ters of CNEs in the human genome (described in ref. 10). The,240
key developmental genes in these regions have relatively low rates
of amino acid divergence (median KA/KS5 0.03) and show little
evidence of lineage-specific loss or duplications. In contrast, we
found that the rate of gain and loss of CNEs in the same regions is
only moderately (,30%) lower than elsewhere in the genome.
Indeed, we identified more than 37,000 lineage-specific CNEs in
these developmentally important regions.
Because experimental studies of CNEs in these regions have fre-
quentlyuncovered cis-regulatory functions affecting thenearbydevelop-
mental genes16,82–85, the substantial innovations in these regions are
candidates for genetic changes underlying differential morphological
andneurological evolution inmammalian lineages. This patternwould
be consistent with the notion that modification of regulatory networks
has been a major force in the evolution of animal diversity86–88.
Eutherian-specific CNEs derived from transposable elements. In
general, each eutherian-specific element must have arisen by one of
three mechanisms: (1) divergence of an ancestral functional element
to such an extent that its similarity is no longer detectable; (2)
duplication of an ancestral functional element giving rise to an ele-
ment without a 1:1 orthologue in other clades; or (3) evolution of a
novel functional element from sequence that was absent or non-
functional in the ancestral genome.
The first mechanism is not likely to account formost of the euther-
ian-specific CNE sequence, at least among those with high conser-
vation scores—if an ancient functional element underwent such
rapid divergence at some point in the eutherian lineage that it is no
longer detectable, then there should be concomitant ‘loss’ of an
amniote conserved element. But, lineage-specific loss seems to be
relatively rare for both amniote elements, as shown above, and for
eutherian elements10.The majority of eutherian-specific conserved
elements therefore probably arose after the metatherian divergence,
either by adaptive evolution of new or previously non-functional
sequence, or by duplication of ancestral elements.
One intriguing source for eutherian-specific CNEs is transposable
elements. A number of researchers have argued that transposable
elements offer an obvious and ideal substrate for the evolution of
lineage-specific functions89–93. Transposable elements contain a vari-
ety of functional subunits that can be exapted and modified by the
host genome89,91, and they can mediate duplication of existing CNEs
to distant genomic locations through transduction or chimaerism92.
Individual instances of CNEs derived from transposable elements
have been described previously14,94,95. However, these cases together
comprise only a trivial fraction of the CNEs in the human genome. It
has thus been unclear whether the evolution of CNEs from transpos-
able elements represents a general mechanism or a rare exception.
When we examined the set of eutherian-specific CNEs, we found a
striking overlap with transposable elements. In ungapped syntenic
intervals, at least 16% of eutherian-specific CNEs overlap currently
recognized transposable elements in human. The fraction is similar
(14%) if we focus only on the most highly conserved elements
(phylo-HMM log2-odds score)$ 60, see above). The overlapping
transposable elements originate from most major transposon fam-
ilies found in eutherians (Table 4), and are not clearly differentiated
from other CNEs in terms of distribution across the genome. This
implies that transposable-element-mediated evolution has been a
significant creative force in the emergence of recent CNEs. The fact
that sequences from transposable elements themselves can be iden-
tified within these CNEs also implies that exaptation of at least a
portion of the transposable element, rather than simply incidental
transduction of adjacent sequence, has been a frequent occurrence.
In contrast, the eutherian CNEs that are present in opossum (and
thus are more ancient) only rarely show overlap with recognizable
transposable elements (,0.7%). We speculate that many of these
CNEs also arose from transposable elements, but that they are difficult
to recognize as suchowing to substantial divergence. In fact, three large
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Figure 6 | Lineage-specific CNEs near key developmental genes. The
densities of eutherian CNEs present (blue) or absent (red) in opossum are
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families of ancient paralogous CNEs have recently been discovered
that were clearly distributed around the genome as parts of transpos-
able elements96–98. In each case, only aminority of the family members
still retain evidence of transposon-like features. We also previously
described,100 smaller CNE families that pre-date the eutherian radi-
ation, butwhich had nomembers associatedwith known transposable
elements98. For all but two of these families, we can find orthologues in
the opossum genome for the majority of their members (Supplemen-
tary Note 10 and Supplementary Fig. 10). Moreover, closer inspection
reveals previously unrecognized transposon-like features in several of
these and other ancient CNE families33.
Strikingly, the proportion of eutherian-specific CNEs recognizable
as transposable-element-derived (16%) is very similar to the propor-
tion of the total aligned sequence between the human, mouse and dog
genomes recognizable as ancestral transposable elements (,17% of
,812Mb; the vast majority of which is inactive)10. It is widely sus-
pected that the latter proportion is a significantunderestimate owing to
the difficulty of recognizing transposable elements that inserted more
than,100–200Myr ago7,33. In cases where the transposable-element-
related sequence hallmarks are not essential to the subsequent CNE, or
where evolution of a new function did not follow immediately after the
transposable element insertion, exapted sequences would be expected
to have diverged to the point that they can no longer be readily recog-
nized at a rate similar to inactive insertions. Because this seems to have
occurred formost of the families of ancient CNEs described above, it is
likely that the proportion of all eutherian (not just eutherian-specific)
CNEs derived from transposable elements is substantially higher than
the observed proportion of 16%.
Conclusions
The generation of the first complete genome sequence for a marsupial,
Monodelphis domestica, provides an important resource for genetic
analysis in this unique model organism, as well as the first reference
sequence for metatherian mammals. Our initial results demonstrate
the usefulness of this sequence for comparative analyses of the archi-
tecture and functional organization of mammalian genomes.
The relationship of sequence composition, segmental duplications
and transposable element density with the large and stable karyotype
of the opossum genome has provided new support for an emerging,
general model of chromosome evolution in mammals. In addition,
comparison of the opossum and eutherian X chromosomes revealed
that the evolution of random X chromosome inactivation correlates
with acquisition of XIST, elevation in LINE/L1 density and suppres-
sion of large-scale rearrangements.
Comparative analysis of protein-coding genes showed that the
eutherian complement is largely conserved in opossum. Lineage-
specific genes seem to be largely limited to gene families that are
rapidly turning over in all mammals, although improved annotations
that do not rely on homology to distant species will be required to
complete the opossum gene catalogue. Identification of a wide array
of both conserved and lineage-specific immune genes is particularly
notable because limited success in isolating these genes by cloning has
led to claims that the metatherian immune system is relatively ‘prim-
itive’. Availability of the genome sequence now facilitates more sys-
tematic study of the metatherian immune response39.
At timescales longer than the characteristic time of loss for gene
duplications, it is clear that innovation in non-coding elements
has been substantially more common relative to protein-coding
sequences, at least during eutherian evolution. The opossum genome
sequence has provided the first estimate of the genome-wide rate of
CNE innovation in eutherian evolution, as well as identification of
tens of thousands of lineage-specific elements. It has also provided
evidence that exaptation of transposable elements has a much
greater role in the evolution of novel CNEs than has been previously
realized.
Sequencing of additional metatherian genomes would be helpful
for extending our results by allowing detection of metatherian-
specific coding and non-coding elements. In addition, sampling of
both the American and Australasian lineages would allow the recon-
struction of the genome of their common ancestor, which would
complement ongoing efforts for the boreoeutherian ancestral gen-
ome58. The shorter genetic distance between the ancestral metather-
ian and boreoeutherian genomes (,0.6–0.7 substitutions per site)
would facilitate a more comprehensive analysis of short and weakly
conserved functional elements, for which the phylogenetic distri-
bution and evolutionary origins are still difficult to ascertain.
METHODS SUMMARY
WGS sequencing and assembly. Approximately 38.8million high-quality
sequence reads were assembled using an interim version of ARACHNE21
(http://www.broad.mit.edu/wga/).
SNP discovery. The SNP discovery was performed using ARACHNE and
SSAHA-SNP99. Linkage disequilibrium was assessed using Haploview100.
Genome alignment and comparisons. Synteny maps were generated using
standard methods7,10.
Gene prediction and phylogeny.Opossumprotein-coding andnon-codingRNA
genes were predicted using a modified version of the Ensembl genebuild pipe-
line101, followed by several rounds of refinement using Exonerate102 and manual
curation. Orthology and paralogy were inferred using the PhyOP pipeline11,34.
Conserved element prediction. Amniote conserved elements were inferred
from pairwise BLASTZ alignment blocks with more than 75% identity
for$100 bp. Eutherian conserved elements were inferred using phastCons14.
Eutherian elements that did not fall within a 10-kilobase or longer synteny
‘net’103 were ignored.
Phylogeny of conserved elements. For amniote conserved elements, pairwise
best-in-genome BLASTZ alignments of opossum to human and vice versa were
used to infer their phylogenetic distributions. For eutherian conserved elements,
concomitant BLASTZ/MULTIZ alignments to opossum and chicken were used.
A conserved element was called absent from a species if it was not covered by a
single aligned nucleotide in the relevant alignment.
Correction for assembly gaps and initial alignment artefacts. A conserved
element was considered to be in an ungapped syntenic interval if it was flanked
by two synteny anchorswithin 200 kb on the same contigs in both the human and
opossum assemblies. All conserved elements in ungapped syntenic intervals were
realigned using water (http://emboss.sourceforge.net). Putatively eutherian-
specific elements, including XIST, were also searched against all opossum
sequencing reads using MegaBLAST.
Table 4 | Eutherian-specific conserved non-coding elements derived from
transposons
Transposon family All log2-odds score$ 60
Number of
CNEs*
Overlapped
length (kb){
Number of
CNEs*
Overlapped
length (kb){
SINE/MIR 9,617 364 363 49
LINE/L1 6,619 286 194 36
LINE/L2 7,616 303 290 47
LINE/CR1 2,520 136 203 36
LINE/RTE 867 48 56 11
LTR/MaLR 1,995 65 25 3.7
LTR/ERV1 140 5.1 1 0.2
LTR/ERVL 992 36 12 2.8
DNA/Tip100 242 9.3 2 0.6
DNA/MER1_type 2,427 93 54 9
DNA/MER2_type 113 5.3 4 0.9
DNA/Tc2 162 8.5 6 1.4
DNA/Mariner 250 14.6 20 3.3
DNA/AcHobo 151 5.1 3 0.3
Unknown (MER121) 49 4 10 1.6
Total 33,760 1,383 1,243 203
Fraction of overlapped CNEs 16% 14%
*Number of eutherian-specific CNEs in ungapped syntenic regions overlapping annotated
transposable elements.
{Total length of annotated transposable element sequence overlapping the CNEs (this is less
than the total length of CNEs overlapping transposable element sequence).
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Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
WGS sequencing and assembly. Approximately 38.8million high-quality
sequence reads were derived from paired-end reads of 4- and 10-kb plasmids,
fosmid and BAC clones, prepared from primary tissue DNA from a single female
opossum. The reads were assembled using an interim version of ARACHNE21
(http://www.broad.mit.edu/wga/). No comparative data were used in the assem-
bly process. An intermediate assembly (monDom4) was used for the majority of
the analyses reported here. The most recent version (monDom5) has identical
sequence content and scaffold structure, but includes additional FISH data as
described in Supplementary Note 2.
SNP discovery. The SNP discovery was performed using ARACHNE by com-
parison of the two haplotypes derived from the opossum assembly using only
high-quality discrepancies supported by two or more reads each. Sequence reads
from three additional individuals were also aligned to the reference assembly,
and SNPs were discovered using SSAHA-SNP99. Linkage disequilibrium was
assessed using Haploview100.
Genome alignment and comparisons. The assembly versions used in all com-
parative analyseswere hg17 or hg18 (human),mm8 (mouse), rn4 (rat), canFam2
(dog), monDom4 ormonDom5 (opossum) and galGal3 (chicken). The number
of aligned nucleotides was counted directly from unfiltered, pairwise BLASTZ
alignments (obtained from http://genome.ucsc.edu). Synteny maps were gener-
ated using standard methods7,10, starting from 320,000 reciprocal-best syntenic
anchors identified by PatternHunter104 (see SupplementaryNote 7). Reconstruc-
tion of the boreoeutherian ancestral karyotype is described in Supplementary
Note 8.
Gene prediction and phylogeny. Opossum protein-coding and non-coding
RNA genes were predicted using a modified version of the Ensembl genebuild
pipeline101, followed by several rounds of refinement using Exonerate102 and
manual curation. Orthology and paralogy were inferred using the PhyOP pipe-
line with all predicted opossum and human (Ensembl v40) gene transcripts as
input andKS as the distancemetric
11,34. Coding regionswere aligned according to
their amino acid sequences using BLASTP. KA and KS were estimated using the
codeml program105, with default settings and the F3X4 codon frequency model.
Functional categories were identified using the Gene Ontology106.
Conserved element prediction. Amniote conserved elements were inferred
directly from pairwise BLASTZ alignments of chicken to opossum or human.
Every alignment blockwithmore than 75% identity for$100 bpwas classified as
an amniote conserved element. Eutherian conserved elements were inferred
using phastCons14 on BLASTZ/MULTIZ107,108 alignments of human to mouse,
rat and dog. The nonconserved model was fitted to fourfold degenerate sites
from 15,900 human RefSeqs projected onto the same alignments, using phyloFit
and REV. A separate model was fitted for the X chromosome. The scaling para-
meter for the conservedmodel was estimated by phastCons. Target coverage and
expected element length were set to 12.5% and 12 bp, respectively. Predicted
eutherian conserved elements that did not fall within a 10-kb or longer synteny
‘net’103 between human, mouse and dog were ignored. The coding status of each
element was inferred from$1 nucleotide overlap with entries in the UCSC
human ‘known genes’ track109. Proportions are reported out of the total length
of the elements considered. Eutherian CNEs were classified as transposable-
element-derived if they showed more than 20% nucleotide overlap (med-
ian5 100% for all elements, 54% for elements with log2-odds score$ 60) with
human RepeatMasker annotations.
Phylogeny of conserved elements. For amniote conserved elements, pairwise
best-in-genome BLASTZ alignments of opossum to human and vice versa were
used to infer their phylogenetic distributions. For eutherian conserved elements,
concomitant BLASTZ/MULTIZ alignments to opossum and chicken were used.
A conserved element was called absent from a species if it was not covered by a
single aligned nucleotide in the relevant BLASTZ alignment.
Correction for assembly gaps and initial alignment artefacts. A conserved
element was considered to be in an ungapped syntenic interval if it was flanked
by two PatternHunter synteny anchors within 200-kb of each other on the same
contigs in both the human and opossum assemblies. All conserved elements
(represented by human or opossum, as appropriate) in ungapped syntenic inter-
vals were realigned to the unmasked genome sequence (in opossum or human)
using the water program (http://emboss.sourceforge.net) with default para-
meters and a gap extension penalty of 4. A randomly permuted version of each
element was also realigned. For amniote conserved elements, only the longest
interval with$75% identity from within the originating alignment block (see
above) was realigned. Amniote elements were called lost, and eutherian elements
were called eutherian-specific if their Smith–Waterman realignment score,
divided by the length of the element, did not exceed the corresponding score
for the permuted element plus one. (Conservatively calling an element found if
its score simply exceeded the score of the permuted element resulted in 15% of
eutherian CNEs in ungapped regions and 8% of those with log2-odds score$ 60
being called eutherian-specific.) Putatively eutherian-specific elements, includ-
ing XIST, were also searched against all opossum sequencing reads using dis-
contiguous MegaBLAST.
104.Ma, B., Tromp, J. & Li, M. PatternHunter: faster and more sensitive homology
search. Bioinformatics 18, 440–445 (2002).
105. Yang, Z. PAML: a program package for phylogenetic analysis by maximum
likelihood. Comput. Appl. Biosci. 13, 555–556 (1997).
106. Ashburner, M. et al. Gene ontology: tool for the unification of biology. Nature
Genet. 25, 25–29 (2000).
107. Blanchette, M. et al. Aligning multiple genomic sequences with the threaded
blockset aligner. Genome Res. 14, 708–715 (2004).
108. Schwartz, S. et al. Human-mouse alignments with BLASTZ. Genome Res. 13,
103–107 (2003).
109. Hsu, F. et al. The UCSC known genes. Bioinformatics 22, 1036–1046
(2006).
doi:10.1038/nature05805
Nature  ©2007 Publishing Group
Systematic discovery of regulatory motifs in conserved
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Conserved noncoding elements (CNEs) constitute the majority of
sequences under purifying selection in the human genome, yet their
function remains largely unknown. Experimental evidence suggests
that many of these elements play regulatory roles, but little is known
about regulatory motifs contained within them. Here we describe a
systematic approach to discover and characterize regulatory motifs
within mammalian CNEs by searching for long motifs (12–22 nt) with
significant enrichment in CNEs and studying their biochemical and
genomic properties. Our analysis identifies 233 long motifs (LMs),
matching a total of 60,000 conserved instances across the human
genome. These motifs include 16 previously known regulatory ele-
ments, such as the histone 3-UTR motif and the neuron-restrictive
silencer element, as well as striking examples of novel functional
elements. The most highly enriched motif (LM1) corresponds to the
X-box motif known from yeast and nematode. We show that it is
bound by the RFX1 protein and identify thousands of conserved motif
instances, suggesting a broad role for the RFX family in gene regu-
lation. A second group of motifs (LM2*) does not match any previ-
ously known motif. We demonstrate by biochemical and computa-
tional methods that it defines a binding site for the CTCF protein,
which is involved in insulator function to limit the spread of gene
activation. We identify nearly 15,000 conserved sites that likely serve
as insulators, and we show that nearby genes separated by predicted
CTCF sites show markedly reduced correlation in gene expression.
These sites may thus partition the human genome into domains of
expression.
comparative genomics  conserved noncoding element
Comparative analysis of the human and several other mamma-lian genomes has revealed that 5% of the human genome is
under purifying selection, with less than one-third of the sequences
under selection encoding proteins. The vast majority lies in hun-
dreds of thousands of conserved noncoding elements (CNEs). The
functional significance of these CNEs is largely unknown. It seems
likely that many are involved in gene regulation, and transgenic
experiments have identified some CNEs that are capable of driving
highly specific spatiotemporal gene expression patterns (1–4).
However, little is known about regulatory motifs contained within
CNEs or proteins that recognize these elements.
We and others have previously undertaken large-scale efforts to
discover conserved motifs in limited subsets of the human genome
(5–8), specifically, gene promoters and 3-UTRs. The approach has
been to search for motifs that are preferentially conserved in these
regions by using syntenic alignments of human, mouse, rat, and dog
sequences (5). Using this approach we have discovered 174 motifs
in promoter regions (within 2 kb of the transcriptional start), most
of which are involved in transcriptional regulation and in tissue-
specific gene expression control, and 105 motifs in 3-UTRs,
implicated in posttranscriptional regulation with half related to
microRNA targeting. These studies were limited in scope because
gene promoters and 3-UTRs contain only a small fraction (6%)
of the CNEs in the genome. In addition, they were limited in power
because they involved comparison with only three non-human
mammals.
Hereweuse the recent availability of sequences of 12mammalian
genomes to extend our motif discovery efforts to the entire human
genome. We focus specifically on long regulatory motifs, between
12 and 22 nt, which provide a strong signal for motif discovery. We
searched for motifs that are enriched in CNE regions relative to the
rest of the genome.
We discovered200motifs showing striking enrichment in CNE
regions. The analysis automatically rediscovered a dozen previously
known regulatory elements. More importantly, most of the discov-
ered motifs are new and show properties distinct from typical
promoter elements. In particular, one of the novel motifs defines
15,000 potential insulator elements in the human genome, high-
lighting the diverse role of the CNEs in gene regulation.
Results
Creating a Motif Catalog. We began by compiling a data set of
829,730CNEs in the human genome (totaling 62Mbor2%of the
euchromatic genome), consisting of sequences showing strong
conservation in syntenic regions in comparisons involving 12 mam-
malian genomes [see supporting information (SI) Text]. The vast
majority of these elements are located at a considerable distance
from the transcriptional start sites (TSS) of protein-coding genes
(SI Fig. 4). Approximately 95% are located 2 kb away from the
TSS of any gene, and half are 100 kb from a TSS. This suggests
that only a small portion of the CNEs serve functions specific to
core or proximal promoters.
We sought to create a catalog of sequence motifs enriched in the
CNEs (SI Fig. 5). We began by identifying k-mers (for k 12) that
occur at a significantly higher frequency in theCNE sequences than
in the remainder of the genome.We focused only on relatively long
k-mers, because the expected number N of random occurrences in
the entire CNE database is small (for example, n  8 for k  12;
SI Fig. 6). We identified a total of 69,810 enriched k-mers. An
example is 5-GTTGCCATGGAAAC-3, which appears 698 times
in the CNE data set, whereas only 27 sites are expected based on
its genome-wide frequency (26-fold enrichment). We noticed that
many of enriched k-mers were closely related; therefore, we clus-
tered them based on sequence similarity. The 69,810 enriched
k-mers collapsed into 233 distinct groups, denoted LM1, LM2, etc.
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for ‘‘long motif.’’ For each of these motifs we derived a positional
weight matrix (PWM) representation reflecting the distribution of
4 nt at each position. The enrichment of eachmotif in theCNEdata
set was expressed in an enrichment score (seeMethods). The top 50
motifs are shown in Table 1, and a full list of 233 motifs is given in
SI Table 3. The motifs range in size from 12 to 22 bases.
For each of 233 discoveredmotifs, we searched the entire human
genome to identify conserved instances; that is, we identified all
human sites matching the PWM and then found those sites that
show clear cross-species conservation (see SI Text). We found a
total of 60,019 conserved instances, with roughly half residing
within the CNE data set and roughly half in the remainder of the
genome. Importantly, the approach of focusing on motifs enriched
in the CNE data set identified many motif instances elsewhere in
the genome.
To assess the significance of these results, the procedure was
repeated with matched control motifs. For each of the 233 motifs
we created a control motif by permuting the columns of the PWM
while preserving the occurrence of CpG dinucleotides. These
control motifs have only 3,081 conserved instances, which is 20-fold
lower than for the discoveredmotifs. These results indicate that only
a small fraction of the 60,019 instances of the discovered motifs are
likely to have occurred purely by chance.
The number of conserved instances is highly uneven across the
motifs (range 37–7,549, with mean of 266 and median of 61). Most
motifs (67%) have 100 conserved instances (SI Table 3). But,
remarkably, the two motifs with the highest enrichment scores,
LM1 andLM2, both have5,000 conserved instances in the human
genome (Table 2), suggesting a widespread functional role for these
elements.
Characterizing the Discovered Motifs. Known regulatory elements.
Among the 233 discovered motifs, 16 match known regulatory
elements (Table 1). For example, the LM9 motif is nearly identical
Table 1. List of top 50 most highly enriched motifs
ID k-mer sequence
No. of allowed
mismatches
No. of initial
sites in CNEs
Fold
enrichment Z-score
Known
motif
LM1 GTTGCCATGGAAAC 1 698 25.9 130.0 X-box
LM2 ACCACTAGATGGCA 1 305 22.9 80.4
LM3 GTTGCTAGGCAACC 1 204 30.7 76.9
LM4 GCCTGCTGGGAGTTGTAGTT 3 143 26.3 59.2
LM5 AACTCCCATTAGCGTTAATGG 3 43 68.1 53.5
LM6 AAAGGCCCTTTTAAGGGCCAC 3 48 46.2 46.3 Histone 3-UTR
LM7 CAGCAGATGGCGCTGTT 2 97 22.1 44.4
LM8 ATGAATTATTCATG 1 280 8.8 44.3
LM9 TCAGCACCACGGACAG 1 82 25.6 44.2 NRSE
LM10 CTGTTTCCTTGGAAACCAG 3 165 9.3 35.2
LM11 GAAATGCTGACAGACCCTTAA 3 41 30.7 34.5
LM12 TGGCCTGAAAGAGTTAATGCA 3 51 22.8 32.7
LM13 TGCTAATTAGCA 0 82 13.1 30.4 CHX10
LM14 ATCCAGATGTTTGGCA 1 33 27.0 28.9 RP58
LM15 CATTTGCATGCAAATGA 2 124 8.5 28.8
LM16 TTGAGATCCTTAGATGAAAG 3 64 14.6 28.6
LM17 CATCTGGTTTGCAT 1 117 8.8 28.5
LM18 CATTTGCATCTGATTTGCAT 3 80 11.8 28.2
LM19 TGCTAATTAGCAGC 1 88 10.8 28.1
LM20 TGACAGCTGTCAAA 1 118 8.5 28.0
LM21 ATTTGCATCTCATTTGC 2 123 8.2 27.9
LM22 CAGCTGTTAAACAGCTG 2 80 11.4 27.6
LM23 AGCACCACCTGGTGGTA 2 65 13.4 27.5
LM24 AGAACAGATGGC 0 70 12.1 26.8 TAL1BETAITF2
LM25 AAAAGCAATTTCCT 1 202 5.3 26.7
LM26 TAAACACAGCTG 0 83 10.2 26.3
LM27 CATTTGCATCTCATTAGCA 3 110 8.0 26.1
LM28 AGAACATCTGTTTC 1 144 6.3 25.5
LM29 GCTAATTGCAAATG 1 98 8.4 25.3
LM30 CTTTGAAATGTCAA 1 182 5.3 25.3
LM31 CTTTTCATCTTCAAAGCACTT 3 57 13.0 25.2
LM32 CTGACATTTCCAAA 1 174 5.4 25.0
LM33 GTAATTGGAAACAGCTG 2 69 10.7 24.8
LM34 GATTTGCATTGCAAATG 2 84 8.8 24.1
LM35 ACTTCAAAGGGAGC 1 87 8.5 24.1
LM36 GAAATGCAATTTGC 1 125 6.4 24.1
LM37 ATGCAAATGAGCCC 1 85 8.5 23.9
LM38 GCAAATTAGCAGCT 1 82 8.5 23.4
LM39 GTCTCCTAGGAAAC 1 84 8.4 23.4
LM40 TCCCATTGACTTCAATGGGA 3 44 14.2 23.4
LM41 TTTGAAATGCTAATG 1 80 8.6 23.2
LM42 AAGCCTAATTAGCA 1 69 9.6 23.1
LM43 CAGGAAATGAAA 0 141 5.6 23.1
LM44 GTGTAATTGGAAACAGCTG 3 75 8.9 23.0
LM45 GCTAATTGGATTTG 1 76 8.7 22.9
LM46 AACAGCTGTTGAAA 1 128 5.9 22.9
LM47 AGAGTGCCACCTACTGAAT 3 65 9.8 22.7
LM48 TAATGAGCTCATTA 1 108 6.5 22.6
LM49 GTAATTAGCAGCTG 1 68 9.3 22.5
LM50 TGGGTAATTACATTCTG 2 65 9.6 22.5
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to the consensus sequence of the neuron-restrictive silencer ele-
ment (NRSE). The NRSE is recognized by the transcription factor
REST (RE1 silencing transcription factor), which plays a pivotal
role in repressing the expression of neuronal genes in nonneuronal
tissues (9–11). Between 800 and 1,900 NRSE sites have been
estimated to exist in the human genome (12, 13), which is consistent
with our count of the number of conserved instances (1,443). It is
reassuring to note that our procedure identified the LM9 motif
without any prior knowledge, recovering the correct size of NRSE
and showing nearly perfect similarity to NRSE along all of its 21
positions (SI Fig. 7).
Another example is LM6, which is a well studied RNAmotif that
is present exclusively in the 3-UTRs of genes encoding histone
proteins. In histone mRNAs this sequence is known to fold into a
stem-loop structure involved in posttranscriptional regulation, play-
ing a role similar to poly(A) tails on typical mRNAs (14, 15).
Conservation properties. The discovered motifs have two notable
conservation properties. First, they show a much higher conserva-
tion rate than the control motifs, even outside the CNEs where they
were discovered. The conservation rate was defined as the ratio of
conserved instances to total instances in the human genome. All of
the discovered motifs have a conservation rate that is 2-fold higher
than for their matched controls, and 65% have a rate that is 5-fold
higher (SI Table 4). If the conservation rate is computed based only
on motif instances outside the CNEs, 96% of the discovered motifs
have a conservation rate that is 2-fold higher than for their controls,
and 63% have a rate that is 5-fold higher.
Second, the motifs show similar patterns of cross-species con-
servation and within-species conservation (Fig. 1 a and b). For each
motif we asked whether the most conserved positions across the
various motif instances within human (and thus those most likely to
be involved in motif recognition) are also the positions within
individual instances that show the highest conservation across
species (and thus are most constrained in their evolution). To
measure the within-species conservation of a motif we used the
information content (Ik) of its PWM at the position k. To quantify
its cross-species conservation we identified its instances located
within the CNEs and calculated the proportion (Mk) of the in-
stances with bases not mutated in the orthologous regions of the
mouse or dog genomes at position k of the motif. The correlation
coefficient between I and M for each of the discovered motifs is
shown in Fig. 1c. We found that nearly all motifs (95%) show a
positive correlation, and 53% have correlation coefficient 0.5.
This suggests that the discovered motifs are indeed functional. The
results also suggest that these motifs retain similar recognition
properties across species.
Table 2. Properties of the top 10 discovered motifs
ID Motif profile
No. of
conserved
instances
False
positive
rate*
Conservation
rate,† %
Fold increase
in
conservation
rate‡
Correlation between
cross-species
conservation and
motif profile
Positional
bias
around
TSS§
LM1 5,332 0.050 29.3 9.5 0.92
LM2 7,549 0.048 29.4 14.0 0.91
LM3 844 0.048 40.1 14.3 0.94
LM4 1,877 0.046 20.3 13.5 0.89 20.3
LM5 224 0.042 19.4 16.3 0.87
LM6 79 0.026 20.1 10.1 0.81 25.5
LM7 6,302 0.048 21.6 10.3 0.72
LM8 608 0.047 17.2 9.6 0.68
LM9 1,443 0.039 11.8 8.4 0.90 6.1
LM10 5,914 0.050 14.5 6.6 0.77
*The proportion of conserved instances expected to have occurred by chance.
†The proportion of instances detected in human that are also conserved in orthologous regions of other mammals.
‡Compared to the conservation rates of control motifs.
§Fold enrichment on the number of motif sites located within 1 kb of TSS over those for control motifs. Only motifs with fold enrichment above 4 are shown.
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Palindromes. A significant proportion (17%) of the 233 motifs are
palindromes, forming perfect or nearly perfect matches to their
reverse complement over nearly their entire length. For example,
LM3 consists ofGTTGCY juxtaposedwith its reverse complement,
RGCAAC, with a central W, itself a self-palindrome (W  A/T).
The proportion of palindromes is much higher than for random
control sequences (0.13%) (see SI Text) and is similar to the
proportion seen for the 16 known motifs (18%). The enrichment is
especially pronounced among the 20 top-scoring motifs, with 45%
being palindromic. Notably, the palindromic motifs are also sym-
metric in the information content of each base, andweakly specified
positions are symmetrically placed with weakly specified positions
on the two motif halves. Palindromicity can be indicative of DNA
sequences that bind by a protein homodimer. Alternatively, palin-
dromicity can sometimes reflect RNA sequences that form stem-
loop structures, as illustrated by the LM6 motif in the 3-UTRs of
histone genes.
Distance from transcriptional starts. Most of the discovered motifs
show little or no enrichment near genes. More than 93% have 80%
of their conserved instances located10 kb away from the TSS of
any gene (Fig. 1d). A typical example is the LM2 motif (Fig. 1e).
Most of these motifs are likely not to be related to core and
proximal promoter functions, but may instead encode distal regu-
lators, insulators, or other functions.
There are five cases, however, with a strong preference for being
located near gene starts. A striking example is the LM4 motif, for
which 60% of the conserved instances lie within 1 kb of the TSS
(26-fold enriched over randomexpectation) and themodal distance
is 75 bases upstream of the TSS (Fig. 1f). Another example is
LM100, a palindromic sequence for which 45% of conserved
instances lie within 2 kb of a TSS. These motifs are likely to be
related to core and proximal promoter functions.
Local conservation context. We studied the conservation context of
the discoveredmotifs. BecauseCNE sequences used to discover the
motifs tend to occur in large blocks (N50 length 110 bases, where
N50 length is the length x such that 50% of all CNE bases lie in
CNEs with the size x), conserved motif occurrences lying within
CNEs would be expected to be embedded within blocks of con-
served sequence. This is indeed the case. For each motif M we
examined the block of conserved sequence surrounding the each
conserved occurrence in a CNE and defined d1(M) to be the N50
length of the block. The median value of d1(M) is 112 bases, with
an interquartile range of 88–140 bases.
More revealingly, we examined the corresponding value d2(M)
defined for conserved motif instances that lie outside the CNEs
data set. Themedian value of d2(M) is 96 bases (interquartile range
of 61–133 bases), which is similar to d1(M). This indicates that the
discovered motifs typically function as part of regulatory modules
containing many other regulatory elements. These results suggest
that CNE motifs here may provide a useful initial entry point for
studying the function of diverse large CNEs, including ultra-
conserved elements that have been shown to have enhancer
function.
Although most motifs appear to function in concert with others,
we found eight striking examples among the 233 motifs that appear
to act in isolation. This is true both for conserved occurrences
within and outside the CNE data set. These motifs are LM9
(NRSE), LM6 (the histone 3-UTR element), LM4 (a promoter-
proximal motif), and four unknown motifs: LM2, LM7, LM23, and
LM194. (We show below that LM2, LM7, and LM23 correspond to
CTCF binding sites.) Themedian lengths of surrounding conserved
sequences for these motifs are all less than five flanking bases on
each side. For example, LM2 has only a median two flanking
conserved bases on each side (Fig. 1g), whereas LM1 (Fig. 1h) has
a median of 31 flanking conserved bases on each side.
LM1 Defines RFX Binding Sites. Themost highly enrichedmotif LM1
is similar to the X-box motif, which has been extensively studied in
yeast and nematodes (16–18). In yeast, more than three dozen
X-box sites have been identified, and these sites have been shown
to be bound by the Crt1 protein, an effector of the DNA damage
checkpoint pathway (19). In Caenorhabditis elegans, 700 X-box
sites have been computationally predicted, and several dozen of
these sites have been demonstrated to be recognized by theDAF-19
protein, which is known to regulate genes involved in the develop-
ment of sensory cilia (16, 18).
Individual instances of the X-box motif in vertebrates have been
reported, but no systematic survey of X-box motifs in the human
genome has been conducted. Approximately three dozen such sites
have been reported to be bound by RFX family proteins, which are
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Fig. 1. A summary on properties of the discovered motifs. (a and b) Motif profile within species and variability across species for LM1 (a) and LM2 (b). Positions
with high information content are less variable than those with low information content in cross-species comparison. (c) The correlation coefficients between
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homologous to both Crt1 and DAF-19 and contain a highly
conserved winged helix DNA binding domain. The biochemically
characterized consensus sequence forRFXbinding shows similarity
to the LM1 motif (20), although it contains less information.
To test whether LM1 binds RFX proteins, we performed an
affinity-capture experiment (see SI Text). A biotinylated double-
stranded DNA probe containing multiple copies of the LM1 motif
was incubated with HeLa cell nuclear extract and then captured
with streptavidin. The bound protein was electrophoresed, blotted,
and probed with an antibody against RFX1, a prototypical member
of the RFX family, revealing that the protein indeed specifically
binds LM1 (Fig. 2a).
LM2 Defines a Common Insulator Site Across the Human Genome.The
most interesting case among the 233 discovered motifs is LM2. It
has the largest number of conserved instances (7,549) in the
genome, with the vast majority being located far from TSSs (Fig.
1e). The LM2 motif is 19 bases in length and does not match the
reported consensus sequence of any known motif.
We obtained a hint regarding the possible function of the LM2
motif by using proteomic experiments in which HeLa cell nuclear
extract was subjected to affinity capture with a biotinylated double-
stranded DNA probe containing multiple copies of the LM2motif,
and the resulting material was analyzed by protease digestion and
mass spectrometry. These affinity-capture experiments suggested
that the CTCF protein binds the LM2 motif (unpublished data).
CTCF, a protein containing 11 zinc-finger domains, is a major
factor implicated in vertebrate insulator activities (21–23). An
insulator is a DNA sequence element that prevents a regulatory
protein binding to the control region of one gene from influencing
the transcription of neighboring genes. When placed between an
enhancer and a promoter, an insulator can block the interaction
between the two. Several dozen insulator sites have been charac-
terized, and almost all have been shown to contain CTCF binding
sites. In some cases, the CTCF site has been directly shown to be
both necessary and sufficient for enhancer blocking activities in
heterologous settings. The known CTCF sites show considerable
sequence variation, and no clear consensus sequence has been
derived (22). The well studied CTCF sites in the IGF2/H19 locus
show similarity to the LM2motif (24), although the similarity score
is below our threshold used for detecting LM2 sites.
To test directly whether CTCF binds the LM2motif we analyzed
thematerial obtained by affinity capturewith a biotinylated double-
stranded DNA probe containing multiple copies of the LM2 motif
by immunoblotting with an antibody against the human CTCF
protein (see SI Text). The results confirmed that CTCF does indeed
bind the LM2motif (Fig. 2). By contrast, mutation of the three core
positions with the highest information content (positions 5, 10, and
13 of LM2) (Fig. 1b) completely abolished the binding of the CTCF
protein.
Given the sequence diversity among reported CTCF sites, we
searched for additional motifs in our catalog that show substantial
similarity to LM2. The motifs LM7 and LM23 are nearly identical
in their first 14 positions, diverging only in the last four or five bases
(SI Fig. 8). The two additional motifs also have an unusually large
number of conserved instances (6302 for LM7 and 3758 for LM23).
Affinity-capture experiments using probes containing copies of the
LM7 and LM23 motifs demonstrated that both motifs bind CTCF,
whereas mutation of the three core positions with the highest
information content completely abolish binding (Fig. 2b). The three
motifs, LM2, LM7, andLM23, will be referred to as a ‘‘supermotif,’’
LM2*.
Altogether the LM2*motif has 14,987 conserved instances in the
human genome (which is 20-fold higher than for the corresponding
controlmotifs). Strikingly, this comprises approximately one-fourth
of the 60,019 sites for the complete catalog of 233 motifs. We
propose that the vast majority of these sites are CTCF-binding sites
and function as insulators.
Although the predicted CTCF sites tend to be located far from
gene starts, they are not randomly distributed across the genome.
Instead, their distribution closely follows the distribution of genes,
with a correlation coefficient of 0.6 (SI Fig. 9). This is consistent
with the notion that the sites are related to gene regulation, rather
than, for example, chromosomal structure.
We sought to test whether the predicted CTCF sites actually
serve as functional insulators. Although it is possible to perform
insulator assays on individual instances in a heterologous context,
we were interested to assess the function of many CTCF sites in
their natural context. If the predicted CTCF sites actually function
as insulators, we reasoned that the presence of aCTCF site between
two genes might ‘‘decouple’’ their gene expression.
It is known that divergent gene pairs, transcribed in opposite
directions with transcription start sites close to each other, tend to
show correlated gene expression patterns (25, 26). We therefore
assembled a data set of 963 divergent gene pairs with intergene
distance 20 kb and with expression values measured across 75
human tissues (27). As expected, the divergent gene pairs are more
closely correlated in gene expression than randomly chosen gene
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Fig. 2. Confirmation of CTCF and RFX1 binding by in vitro affinity capture.
(a) CTCF was specifically captured by probes LM2a and LM2b constructed for
the LM2 motif, whereas RFX1 was specifically captured by probes LM1a and
LM1b constructed for the LM1 motif. (b) The binding of CTCF to LM2, LM7, and
LM23 (Left), but not to their corresponding mutant motifs with three core
bases altered (Right). See Methods for probes used in the experiments.
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pairs (Fig. 3). When the cases are divided into gene pairs separated
by a CTCF site (CTCF pairs, 80 cases) and those not separated by
a CTCF site (non-CTCF pairs, 883 cases), the former show corre-
lations that are essentially equivalent to the random background.
Overall, 37% of non-CTCF pairs are strongly correlated (correla-
tion coefficient   0.3). This proportion is 2-fold higher than the
proportion of random genes pairs (12%) showing similarly strong
correlation. By contrast, the proportion of CTCF pairs with simi-
larly strong correlation is 16%, which is close to that seen for
random gene pairs. This difference persists after correcting for
small difference in the lengths of CTCF-containing and CTCF-
non-containing intergenic regions (SI Fig. 10). This provides strong
evidence that the majority of the predicted CTCF sites do indeed
function as insulators.
Finally, we examined the frequency of the CTCF motif LM2*
across various vertebrate genomes. The three motifs all occurred
frequently in all eutherian mammals, opossum, chicken, and the
pufferfish Tetraodon. The motif shows a similar total number of
instances across all vertebrate species despite a 5-fold variation in
genome size (SI Fig. 11). This is consistent with the LM2* motif
being related to gene number (which is fairly constant across these
species) rather than genome size.
Discussion
Our analysis provided an initial systematic catalog of regulatory
motifs in the conserved regions of the entire human genome. The
233 discovered motifs are highly enriched in the CNE sequence,
with all being at least 5-fold enriched relative to the rest of the
genome. These motifs match 60,019 conserved instances in the
human genome, with a typical motif having 100 conserved
instances. Among the 233 discovered motifs, only 16 could be
recognized as previously known regulatory elements, indicating
that much more still remains to be learned about the function
of CNE.
The most interesting unknown motif is LM2, which has 7,500
conserved instances in the genome, more abundant than any other
discovered motif. We used affinity-capture assays to demonstrate
that LM2, as well as two other closely related motifs, LM7 and
LM23, are specifically bound by the CTCF protein, which is
involved in insulator function. Together, the three motifs match
nearly 15,000 conserved instances in the human genome, corre-
sponding to approximately one-fourth of all matching instances for
the entire set of discoveredmotifs.Althoughwe cannot rule out that
CTCF protein can also bind to other, highly dissimilar sites, our
findings suggest that a few dominant CTCF motifs are extremely
enriched throughout the human genome.
The results here are, of course, only a step toward comprehensive
catalog of regulatory motifs across the human genome. In partic-
ular, our analysis used stringent threshold to identify only the most
highly enriched motifs in the CNEs and therefore have omitted
short motifs (e.g., 6–8 nt). Additionally, the current study focused
primarily on motifs present in most mammals, and therefore many
lineage-specific motifs, such as those unique to primates, still
remain to be discovered. The power of motif discovery can be
boosted not just by considering the enrichment of sequences in the
human CNEs, but by exploiting their detailed conservation pattern
across different species. With the availability of genome sequences
from an increasing number of related mammals, it should be
possible to create a complete dictionary of human motifs in the
years ahead.
Methods
We started by enumerating a list of candidate k-mers with 12 
k 22 and counting the number (C) of matching instances of each
k-mer present in the CNE data set (SI Fig. 5). A sequence was
declared a match to a k-mer if the number of mismatches between
the sequence and the k-merwas less than a thresholdM (whereM
0 for k  13;M  1 for k  14, 15, or 16;M  2 for k  17 or 18;
and M  3 for k  19). For k-mers with C  30 we identified all
matching instances in the entire human genome and assessed their
enrichment in the CNEs using two scores: (i) fold enrichment:
SNR  C/; and (ii) Z-score  (C  )/sqrt(), quantifying the
significance of the enrichment. Here,  is the expected number of
matching instances within the CNE data set based on the observed
frequency of matches in the overall genome. Finally, we collected
all k-mers with SNR  5 and Z-score  10, resulting in a total of
69,810 k-mers significantly enriched in the CNEs. The probability
of a k-mer having aZ-score10 at random is2 1012, and, after
Bonferroni correction, the expected number of such k-mers is
104. These k-mers were further clustered and grouped into 233
distinct motifs according to the procedure described in ref. 5. For
each motif we selected the k-mer with the highest Z-score to
represent the motif.
Please see SI Text for additional methods.
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The most highly conserved noncoding ele-
ments (HCNEs) in mammalian genomes cluster
within regions enriched for genes encoding de-
velopmentally important transcription factors
(TFs). This suggests that HCNE-rich regions
may contain key regulatory controls involved
in development. We explored this by examining
histone methylation in mouse embryonic stem
(ES) cells across 56 large HCNE-rich loci. We
identified a specific modification pattern,
termed ‘‘bivalent domains,’’ consisting of large
regions of H3 lysine 27 methylation harboring
smaller regions of H3 lysine 4methylation. Biva-
lent domains tend to coincide with TF genes ex-
pressed at low levels. We propose that bivalent
domains silence developmental genes in ES
cells while keeping them poised for activation.
We also found striking correspondences be-
tween genome sequence and histone methyla-
tion in ES cells, which become notably weaker
in differentiated cells. These results highlight
the importance of DNA sequence in defining
the initial epigenetic landscape and suggest
a novel chromatin-based mechanism for main-
taining pluripotency.
INTRODUCTION
Epigenetic regulation of gene expression is mediated in
part by posttranslational modifications of histone proteins,which in turn modulate chromatin structure (Jenuwein and
Allis, 2001; Margueron et al., 2005). The core histones
H2A, H2B, H3, and H4 are subject to dozens of different
modifications, including acetylation, methylation, and
phosphorylation. Histone H3 lysine 4 (Lys4) and lysine
27 (Lys27) methylation are of particular interest as these
modifications are catalyzed, respectively, by trithorax-
and Polycomb-group proteins, which mediate mitotic in-
heritance of lineage-specific gene expression programs
and have key developmental functions (Ringrose and
Paro, 2004). Lys4 methylation positively regulates tran-
scription by recruiting nucleosome remodeling enzymes
and histone acetylases (Santos-Rosa et al., 2003; Pray-
Grant et al., 2005; Sims et al., 2005; Wysocka et al.,
2005), while Lys27 methylation negatively regulates tran-
scription by promoting a compact chromatin structure
(Francis et al., 2004; Ringrose et al., 2004).
Various observations suggest that chromatin undergoes
important alterations during mammalian development
(Delaval and Feil, 2004; Margueron et al., 2005; Sado and
Ferguson-Smith, 2005). Embryonic stem (ES) cell differen-
tiation is accompanied by changes in chromatin accessi-
bility at several key developmental genes, including a
large-scale opening of the HoxB locus (Chambeyron and
Bickmore, 2004; Perry et al., 2004). Furthermore, Poly-
comb-group proteins play an essential role in maintaining
the pluripotent state of ES cells and show markedly re-
duced expression upon differentiation (O’Carroll et al.,
2001; Silva et al., 2003; Valk-Lingbeek et al., 2004). How-
ever, little is known about the overall structure of ES cell
chromatin, how it is established, or how it contributes to
the maintenance of pluripotency (Szutorisz and Dillon,
2005).
Large-scale studies of mammalian chromatin have
recently become possible with the combination ofCell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc. 315
chromatin immunoprecipitation (ChIP) and DNA microar-
rays. Initial studies in primary fibroblasts revealed thou-
sands of genomic sites associated with Lys4 methylation
(Bernstein et al., 2005; Kim et al., 2005). The vast majority
show a ‘‘punctate’’ pattern, typically occurring at sites of
1-2 kb near promoters of active genes. Lys27 methyla-
tion is implicated in X chromosome inactivation and im-
printing (Plath et al., 2003; Umlauf et al., 2004). However,
little is known about the overall genomic distribution of this
repressive mark. Gene-specific and limited microarray
studies have reported that Lys27 methylation tends to oc-
cur at punctate sites near promoters of repressed genes
(Cao and Zhang, 2004; Kimura et al., 2004; Kirmizis
et al., 2004; Koyanagi et al., 2005). Based on such studies,
the distributions of Lys4 and Lys27methylation have been
thought to be nonoverlapping.
A notable exception to the punctate pattern of histone
modifications is evident at the Hox gene clusters: These
loci contain large, cell type-specific Lys4 methylated re-
gions, up to 60 kb in length, that overlay multiple Hox
genes (Bernstein et al., 2005; Guenther et al., 2005). These
regions likely reflect accessible chromatin domains estab-
lished during embryonic development to maintain Hox
gene expression programs (Chambeyron and Bickmore,
2004). However, the extent to which large domains of
chromatin modifications represent a general feature of
mammalian genomes remains unclear.
Recent studies have revealed that the most highly
conserved noncoding elements (HCNEs) in mammalian
genomes cluster within 200 HCNE-rich genomic loci,
which include all four Hox clusters (Nobrega et al., 2003;
Bejerano et al., 2004; Lindblad-Toh et al., 2005; Woolfe
et al., 2005). These regions tend to be gene-poor but are
highly enriched for genes encoding transcription factors
(TFs) implicated in embryonic development.
These findings suggest that the HCNE-rich regions or
the TF genes within them may contain key epigenetic reg-
ulatory controls involved in development. We explored
this by mapping histone methylation patterns in mouse
ES cells across 61 large regions (2.5% of the genome).
The results reveal a novel chromatin modification pattern
that we term ‘‘bivalent domains,’’ consisting of large re-
gions of Lys27 methylation harboring smaller regions of
Lys4 methylation. In ES cells, bivalent domains frequently
overlay developmental TF genes expressed at very low
levels. Bivalent domains tend to resolve during ES cell dif-
ferentiation and, in differentiated cells, developmental
genes are typically marked by broad regions selectively
enriched for either Lys27 or Lys4 methylation. We suggest
that bivalent domains silence developmental genes in ES
cells while keeping them poised for activation. Finally, we
analyzed the relationship between histone methylation
and the underlying DNA sequence in both ES and differen-
tiated cells. This analysis suggests that DNA sequence
largely defines the initial epigenetic state in ES cells, which
is subsequently altered upon differentiation, presumably
in response to lineage-specific gene expression programs
and environmental cues.316 Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc.RESULTS
Bivalent Domains in ES Cells Contain Repressive
and Activating Histone Modifications
Histone H3 Lys4 and Lys27 methylation patterns in ES
cells were examined across a subset of HCNE-rich loci us-
ing a combination of ChIP and tiling oligonucleotide ar-
rays. The arrays tile 61 large genomic regions, totaling
60.3 Mb, at a density of approximately one probe per 30
bases (Table S1). The regions consist of the four Hox clus-
ters (1.3 Mb encoding 43 genes), 52 additional HCNE-rich
regions (55 Mb encoding 169 genes), and five ‘‘control’’
regions that do not show high HCNE density (4 Mb encod-
ing 95 genes). We isolated genomic DNA associated with
either trimethylated Lys4 or trimethylated Lys27 by immu-
noprecipitating cross-linked chromatin, and we then hy-
bridized these DNA fractions to the tiling arrays (see Ex-
perimental Procedures). We identified regions of Lys4 or
Lys27 methylation by comparing these hybridization re-
sults to those obtained for total genomic DNA. Experi-
ments were performed in duplicate and analyzed using
previously validated criteria (Bernstein et al., 2005). The
resulting maps of ES cell chromatin (Figures 1 and S1)
show a number of important features, many of which
were unexpected.
We found a total of 343 sites of Lys4 methylation, rang-
ing in size from 1 kb to 14 kb with a median size of 3.4 kb
(Table S2). Of these, 63%correspond to transcription start
sites (TSSs) of known genes. Conversely, 80%of the TSSs
are covered by Lys4 sites. Because Lys4 sites and TSSs
each cover only2%of the genomic regions, this concor-
dance is highly significant. We and others have previously
noted a global concordance between Lys4-methylated
sites and TSSs in differentiated mammalian cells (Bern-
stein et al., 2005; Kim et al., 2005).
We also found 192 Lys27-methylated sites across these
regions. These tend to affect much larger genomic regions
than the Lys4 sites. The median Lys27 site is smaller in the
control regions (5 kb) but twice as large in the HCNE-rich
regions (10 kb) and still larger in the Hox regions (18 kb).
Overall, 75%of Lys27 sites are larger than 5 kb.Wewill re-
fer to these large regions as ‘‘Lys27 domains.’’ There are
123 in the HCNE regions, 14 in the Hox regions, and 7 in
the control regions (Table S2).
Comparison of the two datasets revealed many in-
stances of a previously undescribed pattern of chromatin
modifications: Three-quarters of the Lys27 domains con-
tain Lys4 sites within them. These regions thus harbor
both a ‘‘repressive’’ and an ‘‘activating’’ chromatin modifi-
cation; we therefore termed them ‘‘bivalent domains.’’
There are 95 in the HCNE regions, 9 in the Hox regions,
and 5 in the control regions (Table S2).
Bivalent Domains Overlay Developmentally
Important TF Genes in HCNE-Rich Regions
Roughly three-quarters of the bivalent domains in the
HCNE regions (69/95) overlap TSSs of known genes,
with the Lys4 sites typically positioned directly at the
Figure 1. Representative Views of Histone Methylation Patterns across HCNE-Rich Regions in ES and Differentiated Cells
(A)Dlx1-Dlx2genecluster (Region47,112kb). Foreachcell type, tracksshowregionsassociatedwithLys27methylation (yellow), Lys4methylation (green),
orbothmodifications (red).ForEScells only, the rawp-valuesignals for Lys27 (yellow) andLys4methylation (green)arealsoshown.Genes (TSSs indicated
by long vertical lines; exons indicated as dark), CpG islands, HCNEs (Lindblad-Toh et al., 2005), and transposable elements are also shown.
(B) En2, Shh, Hlxb9 (Region 48, 1.5 MB). Expanded views show 75 kb around each gene.
(C) Ebf1 (Region 31, 497 kb). Note expansive Lys27 methylated region in the Neuro2a cells.Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc. 317
Figure 2. Histone Methylation Status of
Transcription Start Sites
Methylation status is shown for the 332 known
TSSs in the 61 examined regions in ES cells,
C2C12 myoblasts, Neuro2a neuroblastoma
cells, mouse embryonic fibroblasts (MEF),
and mouse lung fibroblasts (MLF). Red indi-
cates the presence of a bivalent domain; yellow
indicates Lys27 methylation only; green indi-
cates Lys4 methylation only; and black indi-
cates no detected methylation. Blue rows in
the three rightmost columns indicate TSSs
that correspond to TF genes, contain CpG is-
lands, or coincide with transposon-exclusion
zones (TEZs). This figure and the correspond-
ing Table S3 show the strong correlation
among bivalent domains, TF genes, CpG
islands, and TEZs.TSS. Of these, a full 93% (64/69) occur at genes that en-
code TFs, including Sox, Fox, Pax, Irx, and Pou gene fam-
ily members, even though TF genes make up only half of
the genes in the regions examined (Figure 2). The 26 biva-
lent domains that do not occur at known TSSs are also of
interest: Four occur at the 30-ends of developmental genes
(Npas3, Meis2, Pax2, and Wnt8b), and ten occur in loca-
tions that show strong evidence of encoding transcripts
(including the presence ofmRNA transcripts, CpG islands,
and high levels of sequence conservation). Among the
nonTF genes associated with bivalent domains are genes
implicated in neural development, such as Fgf8 and
Prok1. In the Hox regions, the observed bivalent domains
are especially large and overlap multiple TSSs of known
genes, all of which are TFs. The five bivalent domains in
the control regions are quite short; they all overlap gene
starts, although these genes do not encode TFs.318 Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc.The chromatin analysis thus reveals that ES cells con-
tain many bivalent domains. In HCNE-rich regions, these
domains are particularly large and highly enriched at de-
velopmentally important genes that establish cell identity.
The bivalent nature of this novel epigenetic pattern raises
the possibility that the associated genes are poised in a bi-
potential state, which may be resolved differently in differ-
ent cell lineages. This hypothesis predicts that differenti-
ated cells would contain few, if any, bivalent domains.
In Differentiated Cells, TF Genes Are Marked
by Either Repressive or Activating Modifications
We next examined Lys4 and Lys27 methylation patterns
across these same regions in a collection of differentiated
cell types, including mouse embryonic fibroblasts (MEFs),
mouse primary lung fibroblasts (MLFs), C2C12myoblasts,
and Neuro2a neuroblastoma cells. We identified multiple
Lys4 and Lys27methylated sites in each cell type, many of
which are large. However, in marked contrast to the ES
cell data, we found few bivalent domains in the differenti-
ated cells (6 in MEFs, 1 inMLFs, 13 in myoblasts, and 12 in
the neuroblastoma cells).
Thus, the majority of TSSs that show bivalent domains
in ES cells do not show bivalent domains in the differenti-
ated cells. The vast majority of these (93/97) instead show
either a Lys27- or a Lys4-methylated site in at least one of
the differentiated cell types (Figure 2 and Table S3). These
‘‘monovalent’’ sites tend to be large, with median sizes of
19.4 kb and 7.4 kb for Lys27 and Lys4, respectively (com-
pared to 6.7 kb and 3.4 kb over all sites in the differentiated
cells). Thus, bivalent domains appear largely specific to
ES cells and, in differentiated cells, developmental genes
are instead frequently organized within expansive regions
showing either repressive or activating modifications.
Bivalent Modification Patterns in ES Cells Confirmed
by Alternate Techniques
Given the novel nature of the bivalent domains, we sought
to confirm our results using completely different reagents
and protocols (see Experimental Procedures). Specifi-
cally, we used an independent source of ES cellswith a dif-
ferent genotype; we refer to the first source as ES1 and the
second as ES2. We also used an alternative ChIP proce-
dure carried out onmicrococcal nuclease-digested nucle-
osomes that had not been subjected to cross-linking and
performed the immunoprecipitation with antisera from dif-
ferent sources. This alternative ChIP technique controls
for nucleosome occupancy and is not subject to potential
artifacts of cross-linking and sonication (O’Neill and
Turner, 2003). The ES2 data also show a large number
of bivalent domains, and these correspond closely to
those seen in the ES1 data. Importantly, 94 of the 95 biva-
lent domains in the ES2 data correspond to bivalent do-
mains in the ES1 cells.
We next sought to test whether the observed bivalent
domain structure truly reflects the simultaneous presence
of both Lys4 and Lys27 methylation on the same physical
chromosomes. It is formally possible that the bivalent do-
mains could instead reflect the presence of either two
subpopulations with distinct character or one population
alternating between two states. To rule out this possibility,
we carried out a sequential ChIP in which ES cell chroma-
tin was immunoprecipitated first with Lys27 tri-methyl an-
tibody and second with Lys4 tri-methyl antibody. This se-
quential purification is designed to retain only chromatin
that concomitantly carries both kinds of modifications.
Using real-time PCR, we tested three TSSs associated
with bivalent domains (Irx2, Dlx1, and Hlxb9). Each was
significantly enriched relative to the controls (genes en-
riched for only Lys27 or only Lys4) (see Figure 3 and Ex-
perimental Procedures). For example, Irx2 is enriched
10-fold in the primary (Lys27) ChIP and further enriched
>30-fold (relative to control) in the secondary (Lys4) ChIP.
This shows that a large proportion of Irx2 chromatin that
contains Lys27 methylation also contains Lys4 methyla-tion—at least 30-fold more than the control. (Of course,
the technique cannot prove that 100% of all Irx2 species
in ES cells carry both modifications because of inherent
limitations due to background). We also tested the Irx2
TSS by repeating the sequential ChIP with the order of
the immunoprecipitations reversed and again found sig-
nificant enrichment (see Experimental Procedures). To-
gether, the experiments above suggest that the bivalent
domains accurately represent the epigenetic state at
many TF genes in ES cells.
Bivalent Domains Are Associated with Low Levels
of Gene Expression
To gain insight into the functional significance of bivalent
domains, we examined gene expression patterns across
the three cell types with at least ten bivalent domains (ES
cells, C2C12, andNeuro2a) (Mogass et al., 2004; Tomczak
et al., 2004; Perez-Iratxeta et al., 2005). Within each cell
type, we found that genes marked by Lys4 methylation
tend to be expressed at significantly higher levels than
those associated with Lys27 methylation (Figure 4). A
good example is the Ebf1 gene, which encodes a TF impli-
cated in multiple differentiation pathways: In MEFs, MLFs,
and myoblasts, it is expressed at relatively high levels
(Schraets et al., 2003; Koli et al., 2004) and is associated
with relatively large Lys4 sites (>5 kb), while in neuroblas-
toma cells it is expressed at an essentially undetectable
level and is associated with an expansive Lys27 domain.
We next examined the expression levels of genes
marked by bivalent domains. These show low levels of ex-
pression, with the overall distribution being similar to that
for genes marked by Lys27 methylation alone (Figure 4).
Thus, the presence of Lys4 methylation at a TSS is typi-
cally associated with high gene activity when it occurs in
the absence of Lys27 methylation but with low gene activ-
ity when it occurs together with Lys27 methylation (that is,
the repressive effect of Lys27 appears to be epistatic to
the activating effect of Lys4 methylation in a bivalent do-
main). These results raise the possibility that bivalent do-
mains function to silence developmental genes in ES cells
while keeping them poised for induction upon initiation of
specific developmental pathways.
Resolution of Bivalent Domains during ES
Cell Differentiation
Our analysis of ES cells and four differentiated cell types
suggests that bivalent domains are characteristic of plu-
ripotent cells, that they silence developmental genes while
keeping them poised, and that they tend to resolve upon
ES cell differentiation into Lys4 or Lys27 methylation, in
accordance with associated changes in gene expression.
We sought to study whether the resolution of bivalent do-
mains can be observed soon after ES cell differentiation
by examining a differentiated cell type obtained directly
from ES cells. Specifically, we differentiated ES cells along
a neural pathway in serum-free culture and generated
a homogenous population of multipotent neural precursor
cells maintained in FGF2- and EGF-containing media, asCell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc. 319
Figure 3. Characterization of the Irx2 Bivalent Domain
ChIP and sequential ChIP were used to examine the methylation status of the Irx2 TSS (bivalent), the Tcf4 TSS (Lys4 only), and a site upstream of
HoxA3 (Lys27 only).
(A) Real-time PCR ratios reflect the enrichment of indicated sites when ES cells are subjected to ChIP with trimethyl Lys4 antibody or trimethyl Lys27
antibody.
(B) Corresponding data for mouse lung fibroblasts.
(C) Real-time PCR ratios reflect the relative enrichment of indicated sites after sequential immunoprecipitations with trimethyl Lys27 antibody and
then trimethyl Lys4 antibody (see Experimental Procedures).
(D) PCRproducts amplified from control (input) DNA, Lys27ChIP DNA, and Lys27-Lys4 sequential ChIP DNA are shown; the same sampleswere used
as real-time PCR template in (C). The sequential ChIP results indicate that, in ES cells, the Irx2 TSS is associatedwith chromatinmarked by both Lys27
and Lys4 methylation.described previously (Conti et al., 2005). We focused on
seven genes associated with bivalent domains in ES cells
(Figure 5). These include three genes that are markedly in-
duced during differentiation (Nkx2.2, Sox21, and Zfpm2),
one that is weakly induced (Dlx1), and three that are not in-
duced (Pax5, Lbx1h, and Evx1). Using ChIP and real-time
PCR, we first confirmed that the TSS of each gene is in-
deed associated with both Lys4 and Lys27 methylation
in the original ES cells, and we then examined the methyl-
ation status of these genes in the neural precursor cells.
For the three genes whose expression is markedly in-
duced, the TSS becomes specifically associated with
Lys4methylation in these differentiated cells. For the three
genes that are not induced, the TSS becomes specifically
associated with Lys27 methylation. Interestingly, the TSS
of the weakly induced gene, Dlx1, remains associated
with both methylation marks in the neural precursor cells,
although the Lys4 signal is significantly stronger. These320 Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc.data support a model in which bivalent domains are
largely specific to ES cells and tend to resolve upon ES
cell differentiation according to pathway-specific gene
expression programs.
Epigenetic Modifications in ES Cells Strongly
Correlate with Underlying DNA Sequence
Because the Lys4- and Lys27-methylated sites in ES cells
seem to represent important initial conditions for develop-
ment, we searched for DNA sequence features that might
underlie or predict the establishment of these epigenetic
marks across the genome.
We found a strong positive correlation between the
presence of Lys4 methylation in ES cells and the density
of CpG dinucleotides in the underlying DNA sequence
(median 8% versus 2% expected) (Figure S2). Strikingly,
95% of TSSs with Lys4 sites have CpG islands, and
91% of TSSs with CpG islands also have Lys4 sites
(rphi = 0.73) (see Table S4 and Experimental Procedures).
Moreover, the lengths of the two features are significantly
correlated where they overlap (r = 0.50). By contrast, the
correlation is weaker in the differentiated cells; this is pri-
marily due to loss of Lys4 methylation at 20%–35% of
CpG islands (rphi = 0.40 for MLFs) (Table S4). We note
that a recent genome-wide study (Roh et al., 2005) of his-
tone H3 acetylation in T cells observed a correlation with
CpG islands at a similar level to that seen in the differenti-
ated cells examined here.
Figure 4. Gene Expression as a Function of Histone Methyla-
tion Status
Box plot showing 25th, 50th, and 75th percentile expression levels in ES
cells, myoblasts, and neuroblastoma cells for genes associated with
no histone methylation, Lys27 methylation, bivalent domains, or Lys4
methylation. Whiskers show 2.5th and 97.5th percentiles. Expression
data (y axis) were determined from published expression profiles (Mo-
gass et al., 2004; Tomczak et al., 2004; Perez-Iratxeta et al., 2005), uni-
formly normalized to a mean of 0 and a standard deviation of 1 for all
probes on each array.
Figure 5. Resolution of Bivalent Domains during ES Cell
Differentiation
ES cells were differentiated along a neural pathway in serum-free cul-
ture, and a homogenous population of multipotent neural precursor
cells were maintained in FGF2- and EGF-containing media, as de-
scribed in Conti et al., 2005. Several loci showing bivalent domains
in ES cells were examined in the differentiated cells.
(A) Expression levels (relative to Gapdh) were determined by
RT-PCR for the indicated genes in ES cells and in neural precursors.
The methlyation states of the indicated genes were determined by
ChIP and real-time PCR in ES cells (B) and in neural precursors
(C). The data suggest that bivalent domains tend to resolve during
ES cell differentiation in accordance with associated changes in
gene expression.Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc. 321
Wealso found that Lys27-methylated regions in ES cells
show a strikingly low density of transposon-derived se-
quence (median 6% versus 22% expected) (Figures S2
and S3). The most extreme example is found at the Hox
clusters, which are known to have the lowest density of
transposon-derived sequence in the mouse and human
genomes (Lander et al., 2001; Waterston et al., 2002)
and which have the largest Lys27 domains (up to 141
kb) in our sample. Most of the Lys27 domains contain
long stretches (>10 kb) with little or no identifiable transpo-
son-derived sequence. We defined such regions as
‘‘transposon exclusion zones’’ (TEZs) (see Experimental
Procedures). Within the loci examined here, 89% of
TSSs with a TEZ have a Lys27 domain in ES cells, and
73% of TSSs with a Lys27 domain have a TEZ (rphi =
0.69) (Table S4). The lengths of these two features are sig-
nificantly correlated where they overlap (r = 0.78). Interest-
ingly, we note that the small number of Lys27 domains
found only in differentiated cells does not appear to over-
lap particularly transposon-poor sequence (Figure 1C and
Table S4).
We tested if the TEZs represent conserved genomic
features by examining the orthologous sequence in the
human and dog genome. The frequency of lineage-spe-
cific repeats provides an independent test of whether
transposons are tolerated in these regions. The TEZs
show a clear deficit of lineage-specific repeats in both hu-
man (1.3% versus 15.2%expected) and dog (1.0% versus
9.1% expected), confirming that this property is strongly
conserved across mammals.
We then searched for TEZs across the entire mouse ge-
nome. We identified 710 TEZs, of which 328 overlap TSSs
of known genes (Table S5). Strikingly, the vast majority of
these genes encode developmental and tissue-specific
TFs (189), proteins involved in axon guidance and neuro-
nal function (65), and other cell signaling-related proteins
such as growth factors (25), including Fgf8, Fgf10,
Fgf14, and the imprinted gene Igf2. Notably, they include
70% of the developmental regulators previously identi-
fied within 204 HCNE-rich loci (Lindblad-Toh et al.,
2005). We predict that most of these genes will harbor
Lys27 domains or bivalent domains in ES cells.
Colocalization of Bivalent Domains with Oct4
and Nanog
Finally, we examined the relationship of bivalent domains
to the reported binding sites of certain pluripotent TFs. A
recent genomic analysis in human ES cells found that
Oct4, Nanog, and Sox2 are frequently associated with de-
velopmentally important genes (Boyer et al., 2005). We
mapped the Oct4, Nanog, and Sox2 binding sites re-
ported in that study to orthologous positions in the mouse
genome and examined their overlap with bivalent do-
mains. About 50%of bivalent domains coincide with bind-
ing sites of at least one of the pluripotent TFs, a highly sig-
nificant correspondence (p < 109). The correlation is
primarily due to Oct4 and Nanog and actually becomes
more significant when Sox2 is removed from the analysis.322 Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc.Interestingly, although many of the genes targeted by
these pluripotent factors are actively expressed in ES
cells, those that are also associated with a bivalent do-
main tend to be silenced (p < 5  103). This suggests
that the bivalent domains may override any activation po-
tential these TFs might have but also raises the possibility
that the pluripotent TFs may help keep these genes in
a poised state. Notably, a full 50% of bivalent domains
are not associated with any of the three pluripotent TFs.
It will be interesting to see if these coincide with binding
sites of other important TFs.
DISCUSSION
Our results shed light on chromatin structure in ES cells
and raise intriguing hypotheses about its establishment
and function during development. The bivalent domains
reported here have many notable features: They combine
both ‘‘repressive’’ and ‘‘activating’’ modifications; they are
highly enriched in ES cells relative to differentiated cells;
and they are associated with genes encoding TFs with
roles in embryonic development and lineage specification.
In differentiated cells, these TF genes instead tend to be
associated with large regions carrying either an activating
or a repressive methylation mark. We propose that biva-
lent domains silence developmental genes in ES cells
while preserving their potential to become activated
upon initiation of specific differentiation programs. Biva-
lent domains may be related to a phenomenon observed
at the bithorax complex in early fly development, where si-
lenced Polycomb response elements are nonetheless as-
sociated with trithorax-group proteins and low-level tran-
scription. Remarkably, both of these activities appear to
be required for subsequent gene activation during devel-
opment (Orlando et al., 1998; Schmitt et al., 2005). By
analogy, Lys4methylation within bivalent domains and as-
sociated trithorax activities may keep silenced develop-
mental genes poised in ES cells. Our analyses of differen-
tiated cells suggest that bivalent domains largely resolve
during differentiation into large regions of either Lys27 or
Lys4 methylation. These modified regions may provide
a robust epigenetic memory to maintain lineage-specific
expression or repression of these critical genes. Their
large size would ensure that each daughter chromosome
would likely inherit a substantial proportion of themodified
histones, which could then promote similarmodification of
new histones in the immediate vicinity (Henikoff et al.,
2004; van Steensel, 2005).
A fundamental issue that remains is to understand the
mechanism by which the initial conditions are estab-
lished in ES cells. The analysis here suggests that
some of the answer can be read directly from the ge-
nome sequence. The strong association of Lys4 methyl-
ation with CpG islands may well be directly causal, inas-
much as the trithorax complexes that methylate Lys4 are
reported to associate with CpG-rich DNA (Ayton et al.,
2004; Lee and Skalnik, 2005). The strong association of
Lys27 methylation with transposon-exclusion zones
may instead reflect strong evolutionary pressure against
the presence of transposon-derived sequence in these
regions. Repetitive sequences are subject to repressive
epigenetic modifications (Arnaud et al., 2000; Lippman
et al., 2004; Martens et al., 2005), which might interfere
with the function of the bivalent domains and thus be
eliminated by selection. It has been reported previously
that imprinted loci, while significantly depleted for short
interspersed transposable elements (SINEs), are permis-
sive to L1 long interspersed transposable elements
(LINEs) (Greally, 2002). In contrast, we find that both
classes of transposons tend to be excluded from regions
associated with Lys27 methylation or bivalent domains in
ES cells. The direct signal for Lys27 methylation remains
unclear (although we cannot exclude the possibility that
the deficit of transposon-related chromatin modifications
in some fashion promotes the association of the Poly-
comb complex that methylates Lys27). The correlations
between the histone modifications and the genomic fea-
tures are notably weaker in differentiated cells (Bernstein
et al., 2005). We suggest that while the embryonic state
may be largely defined by DNA sequence, it is subse-
quently altered in response to lineage-specific transcrip-
tional programs and environmental cues and epigeneti-
cally maintained.
Our study was motivated by the suspicion that HCNE-
rich regions might be particularly fruitful targets for study-
ing chromatin structure in ES cells; this has indeed been
borne out. However, the results here do not explain the
functional role of the HCNEs themselves. Although
HCNEs are markedly enriched at many of the Lys27 and
Lys4 sites in both ES and differentiated cells, they tend
overall to be distributed across much larger regions.
One possibility is that some of the HCNEs dictate chromo-
some conformation or nuclear localization in a manner
that facilitates robust gene regulation and/or epigenetic
switching (Chambeyron and Bickmore, 2004; Kosak and
Groudine, 2004).
Further studies will be needed to define bivalent do-
mains and related features. It will be important to examine
the entire genome in ES cells as well as to follow their fate
during development and differentiation. In particular, it will
be interesting to determine whether the bivalent domains
that persist following ES cell differentiation correspond to
genes that remain poised for later induction. In addition, it
will be valuable to characterize the bivalent domains with
respect to other epigenetic modifications and the binding
sites of additional TFs. We note that preliminary studies of
H3 Lys9methylation show no evidence of association with
bivalent domains.
A deeper understanding of bivalent domains may shed
light on mechanisms that underlie the maintenance of plu-
ripotency in ES cells and lineage fidelity in differentiated
cells. Moreover, a comprehensive inventory of the pres-
ence or absence of bivalent domains over key develop-
mental genesmay provide valuablemarkers of cell identity
and differentiation potential, both in normal and patho-
logic states.EXPERIMENTAL PROCEDURES
Cell Culture
The first source of ES cells (ES1) were V6.5 murine ES cells (genotype
129SvJae C57BL/6; male; passages 10–15). They were cultivated in
5% CO2 at 37º on irradiated MEFs in DMEM containing 15% FCS, leu-
kemia-inhibiting factor, penicillin/streptomycin, L-glutamine, and non-
essential amino acids (Rideout et al., 2000). At least two to three pas-
sages under feeder-free conditions on 0.2% gelatin were used to
exclude feeder contamination. The second source of ES cells (ES2,
used for micrococcal nuclease-ChIP) was SF1-1 murine ES cells (ge-
notype C57BL/6  M. spretus F1; male; passages 11–16) grown in
the absence of feeder cells on gelatinized plates as described previ-
ously (Umlauf et al., 2004). Primary mouse lung fibroblasts (ATCC
#CCL-206), mouse embryonic fibroblasts (10.5 p.c.) immortalized
with polyoma virus, C2C12 myoblasts (ATCC #CRL-1772), and Neu-
ro2a neuroblastoma cells (ATCC #CCL-131) were grown in DMEM
with 10% fetal bovine serum and penicillin/streptomycin at 37º, 5%
CO2. ES1 cells were differentiated into pan-neural precursor cells
through embryoid body formation for 4 days and selection in ITSFn
media for 5–7 days (Okabe et al., 1996), and they were maintained in
FGF2 and EGF2 (both from R&D Systems) containing chemically de-
fined media as described (Conti et al., 2005). These cells uniformly ex-
press nestin and Sox2 and upon growth factor withdrawal differentiate
into neurons, astrocytes, and oligodendrocytes (Brustle et al., 1999;
Conti et al., 2005).
Chromatin Immunoprecipitation
ChIP experiments for all cells except ES2 were carried out as de-
scribed in Bernstein et al., 2005 and at http://www.upstate.com.
Briefly, 5  107 cells were trypsinized, fixed with 1% formaldehyde,
resuspended in Lysis Buffer, and fragmented with a Branson 250 So-
nifier to a size range of 200 to 1,000 bases. Solubilized chromatin was
diluted 10-fold in ChIP dilution buffer and, after removal of a control al-
iquot, incubated at 4ºC overnight with antibody against trimethyl Lys4
(Abcam #8580) or trimethyl Lys27 (Upstate #07-449). Immune com-
plexes were precipitated with Protein A-sepharose, washed sequen-
tially with Low Salt Immune Complex Wash, LiCl Immune Complex
Wash, and TE, and then eluted in Elution Buffer. After cross-link rever-
sal and Proteinase K treatment, ChIP and control DNA samples were
extracted with phenol-chloroform, precipitated under ethanol, treated
with RNase and Calf Intestinal Alkaline Phosphatase, and purified with
a MinElute Kit (Qiagen).
Micrococcal Nuclease-ChIP
Chromatin fragments of one to six nucleosomes were prepared from
unfixed chromatin from ES2 cells by micrococcal nuclease digestion
and immunoprecipitated using antibody against trimethyl Lys27 (Plath
et al., 2003) or dimethyl Lys4 (Upstate #07-030) as described (Umlauf
et al., 2004). Immunoprecipitated DNA fractions and a control DNA
sample enriched using unrelated antisera (against chicken antibodies)
were extracted and purified as described above.
Sequential ChIP
Cross-linked chromatin from ES cells was immunoprecipitated with
antibody against trimethyl Lys27 as described above (see ‘‘Chromatin
Immunoprecipitation’’) except that chromatin was eluted in a solution
of 30 mM DTT, 500 mM NaCl, and 0.1% SDS at 37º. Eluted chromatin
was diluted 50-fold, subjected to a second immunoprecipitation with
antibody against trimethyl Lys4, and then eluted with standard Elution
Buffer. The isolated DNA was extracted and purified as above. In ad-
dition, a ‘‘reverse’’ sequential ChIP was carried out in which chromatin
was immunoprecipitated first with antibody against trimethyl Lys4 and
then with antibody against trimethyl Lys27.Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc. 323
Real-Time PCR
PCR primers for evaluating ChIP assayswere designed to amplify 150–
200 base pair fragments from the indicated genomic regions. Real-
time PCR was carried out using Quantitect SYBR green PCRmix (Qia-
gen) in an MJ Research Opticon Instrument. For ChIP experiments,
either 0.5 ng ChIP DNA or 0.5 ng control DNA was used as template,
and fold-enrichments were determined by the 2-DCTmethod described
in the Applied Biosystems User Bulletin. For sequential ChIP experi-
ments, 2 ml sequential ChIP DNA or 2 ml of a 1:100 dilution of input
DNA was used as template, and relative fold-enrichments were deter-
mined by the 2-DDCT method, using HoxA3 Ups as the normalizer.
Ratios were determined from two independent ChIP or sequential
ChIP assays, each evaluated in duplicate by real-time PCR. Primers
corresponding to the Irx2, Dlx1, or Hlxb9 TSSs were used to test for
enrichment of Lys9 methylation (see Supplemental Data). RT-PCR
was used to measure gene expression in ES cells and neural precursor
cells. Briefly, RNA was isolated using an RNeasy mini kit (Qiagen),
reverse transcribed, and quantified using SYBR green PCR master
mix on a 7000 ABI detection system. Primer sequences are available
in Supplemental Data.
Region Selection and Array Design
The identification of 204 HCNE-rich loci on the basis of sequence com-
parisons across the human, mouse, and dog genomes was reported
previously (Lindblad-Toh et al., 2005). For the current study, we se-
lected 56 HCNE-rich loci, including all four Hox clusters, as well as 5
control loci that do not show unusual HCNE density (ACTA locus, chro-
mosome 19 gene desert, CD33r locus, BRCA1 locus, cytokine cluster).
Each region was mapped to the mouse genome using mm5 coordi-
nates (Table S1). Custom tiling arrays for these regions were obtained
from Affymetrix Inc. (Santa Clara, CA). They contain approximately 1.3
million probe pairs, each consisting of perfect match (PM) and single
basemismatch (MM) 25-mer oligonucleotides, designed to interrogate
the unique sequence in these regions at approximately 30 base inter-
vals (Kapranov et al., 2002).
DNA Amplification and Array Hybridization
ChIP and control DNA samples were amplified by in vitro transcription,
converted into double-stranded cDNA with random primers, frag-
mented with DNase I, and end-labeled with biotin as described (Kap-
ranov et al., 2002; Liu et al., 2003; Cawley et al., 2004; Bernstein et al.,
2005). ChIP and control samples (5–10 mg) were hybridized to separate
oligonucleotide arrays. Arrays were hybridized 16–18 hr at 45ºC,
washed, stained, and scanned using an Affymetrix GeneChip Scanner
3000 7G as described in the Affymetrix Expression Analysis Technical
Manual.
Analysis of ChIP Tiling Array Data
Raw array data were quantile-normalized, scaled, and analyzed as de-
scribed (Cawley et al., 2004; Bernstein et al., 2005). Enrichment was
quantified using a Wilcoxon Rank Sum test applied to the transforma-
tion log2(max[PM-MM,1]) for data from ChIP and control arrays within
a window of ±500 base pairs, testing the null hypothesis that ChIP and
control data come from the same probability distribution. Genomic po-
sitions belonging to enriched regions were defined by applying a high
P-value cutoff of 104. These regions were extended locally by merg-
ing adjacent windows with P-values of at least 102, and resultant po-
sitions separated by <2 kb were merged to form a predicted Lys4 or
Lys27 methylated site. Bivalent domains were defined as Lys27 meth-
ylated regions > 5 kb that overlap Lys4 sites > 1 kb. Histone methyla-
tion data are available as interactive tracks at: http://www.broad.mit.
edu/cell/hcne_chromatin.
Genomic Analysis
We collated a list of known TSSs based on RefSeq and Genbank
mRNAs aligned to the examined regions in mouse (mm5) and the or-
thologous regions in human (hg17; alignments obtained from the324 Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc.UCSC genome browser). The methylation status of each TSS was
based on the presence of significantly enriched Lys4 or Lys27 sites
or bivalent domains within 2 kb upstream or downstream. The ex-
pected density of CpG and transposable elements at methylated sites
was determined from random intervals of the same size, anchored in
nonrepetitive sequence. CpG islands were defined as in Takai and
Jones, 2002. TEZs (transposon exclusion zones) were defined as re-
gions satisfying one of two criteria: (1) regions of at least 10 kb without
any transposable elements; (2) regions of at least 15 kb with no more
than 250 bases annotated as transposable elements. Identified
regions were then merged together as one TEZ if they were within
1kb. For the genome-wide search, only criterion (1) was used. Supple-
mental Data are available at: http://www.broad.mit.edu/cell/hcne_
chromatin.
Supplemental Data
Supplemental Data include three figures and five tables and can be
found with this article online at http://www.cell.com/cgi/content/full/
125/2/315/DC1/.
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Genome-wide maps of chromatin state in
pluripotent and lineage-committed cells
Tarjei S. Mikkelsen1,2, Manching Ku1,4, David B. Jaffe1, Biju Issac1,4, Erez Lieberman1,2, Georgia Giannoukos1,
Pablo Alvarez1, William Brockman1, Tae-Kyung Kim5, Richard P. Koche1,2,4, William Lee1, Eric Mendenhall1,4,
Aisling O’Donovan4, Aviva Presser1, Carsten Russ1, Xiaohui Xie1, Alexander Meissner3, Marius Wernig3,
Rudolf Jaenisch3, Chad Nusbaum1, Eric S. Lander1,3* & Bradley E. Bernstein1,4,6*
We report the application of single-molecule-based sequencing technology for high-throughput profiling of histone
modifications in mammalian cells. By obtaining over four billion bases of sequence from chromatin immunoprecipitated
DNA, we generated genome-wide chromatin-state maps of mouse embryonic stem cells, neural progenitor cells and
embryonic fibroblasts. We find that lysine 4 and lysine 27 trimethylation effectively discriminates genes that are expressed,
poised for expression, or stably repressed, and therefore reflect cell state and lineage potential. Lysine 36 trimethylation
marks primary coding and non-coding transcripts, facilitating gene annotation. Trimethylation of lysine 9 and lysine 20 is
detected at satellite, telomeric and active long-terminal repeats, and can spread into proximal unique sequences. Lysine 4
and lysine 9 trimethylation marks imprinting control regions. Finally, we show that chromatin state can be read in an
allele-specific manner by using single nucleotide polymorphisms. This study provides a framework for the application of
comprehensive chromatin profiling towards characterization of diverse mammalian cell populations.
One of the fundamental mysteries of biology is the basis of cellular
state. Although they have essentially identical genomes, the different
cell types in a multicellular organism maintain markedly different
behaviours that persist over extended periods. Themost extreme case
is lineage commitment during development, where cells progress
from totipotency to pluripotency to terminal differentiation; each
step involves establishment of a stable state encoding specific
developmental commitments that can be faithfully transmitted to
daughter cells. Considerable evidence suggests that cellular state
may be closely related to ‘chromatin state’—that is, modifications
to histones and other proteins that package the genome1–3.
Accordingly, it would be desirable to construct ‘chromatin-state
maps’ for a wide variety of cell types, showing the genome-wide
distribution of important chromatin modifications.
Chromatin state can be studied by chromatin immunoprecipita-
tion (ChIP), in which an antibody is used to enrich DNA from
genomic regions carrying a specific epitope. The major challenge to
generating genome-wide chromatin-state maps lies in characterizing
these enriched regions in a scalable manner. Enrichment at indi-
vidual loci is commonly assayed by polymerase chain reaction
(PCR), but this method does not scale efficiently. A more recent
approach has been ChIP-chip, in which enriched DNA is hybridized
to a microarray4,5. This technique has been successfully used to study
large genomic regions. However, ChIP-chip suffers from inherent
technical limitations: (1) it requires large amounts (several micro-
grams) of DNA and thus involves extensive amplification, which
introduces bias; (2) it is subject to cross-hybridization, which hinders
the study of repeated sequences and allelic variants; and (3) it is
currently expensive to study entiremammalian genomes. Given these
issues, only a handful of whole-genome ChIP-chip studies in mam-
mals have been reported.
In principle, chromatin could be readily mapped across the
genome by sequencing ChIP DNA and identifying regions that are
over-represented among these sequences. Notably, sequence-based
mapping could require relatively small quantities of DNA and pro-
vide nucleotide-level discrimination of similar sequences, thereby
maximizing genome coverage. The major limitation has been that
high-resolution mapping requires millions of sequences (Supple-
mentary Note 1). This is cost-prohibitive with traditional techno-
logy, even with concatenation of multiple sequence tags6. However,
recent advances in single-molecule-based sequencing (SMS) techno-
logy promise to increase throughput and decrease costsmarkedly7. In
the approach developed by Illumina/Solexa, DNA molecules are
arrayed across a surface, locally amplified, subjected to successive
cycles of primer-mediated single-base extension (using fluorescently
labelled reversible terminators) and imaged after each cycle to deter-
mine the inserted base. The ‘read length’ is short (25–50 bases), but
tens of millions of DNA fragments may be read simultaneously.
Here, we report the development of a method for mapping ChIP
enrichment by sequencing (ChIP-Seq) and describe its application to
create chromatin-state maps for pluripotent and lineage-committed
mouse cells. The resulting data define three broad categories of pro-
moters based on their chromatin state in embryonic stem (ES) cells,
including a larger than anticipated set of ‘bivalent’ promoters; reveal
that lineage commitment is accompanied by characteristic chromatin
changes at bivalent promoters that parallel changes in gene expression
and transcriptional competence; and demonstrate the potential for
using ChIP for genome-wide annotation of novel promoters and
primary transcripts, active transposable elements, imprinting control
regions and allele-specific transcription. This study provides a tech-
nological framework for comprehensive characterization of chro-
matin state across diverse mammalian cell populations.
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Genome-wide chromatin-state maps
We created genome-wide chromatin-state maps for three mouse
cell types: ES cells, neural progenitor cells (NPCs)8 and embryonic
fibroblasts (MEFs). For each cell type, we prepared and sequenced
ChIP DNA samples for some or all of the following features: pan-
H3, trimethylated histone H3 lysine 4 (H3K4me3), H3K9me3,
H3K27me3, H3K36me3, H4K20me3 and RNA polymerase II
(Supplementary Table 1).
In each case, we sequenced nanogram quantities of DNA frag-
ments (,300 base pairs (bp)) on an Illumina/Solexa sequencer. We
obtained an average of 10million successful reads, consisting of
the terminal 27–36 bases of each fragment. The reads were mapped
to the genome and used to determine the number of ChIP fragments
overlapping any given position (Fig. 1). Enriched intervals were
defined as regions where this number exceeded a threshold defined
by randomization (see Methods). The full data set consists of 18
chromatin-state maps, containing ,140million uniquely aligned
reads, representing over 4 billion bases of sequence.
We validated the chromatin-state maps by computational analysis
and by comparison to previous methods. ChIP-Seq maps of specific
histone modifications show marked enrichment at specific locations
in the genome, whereas the pan-H3 and unenriched samples show
relatively uniform distributions (Supplementary Figs 1 and 2). The
maps show close agreement with our previously reported ChIP-chip
data from ,2.5% of the mouse genome9 (Fig. 1). Also, ChIP-PCR
assays of 50 sites chosen to represent a range of ChIP-Seq fragment
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counts showed 98% concordance and a strong, quantitative correla-
tion (Supplementary Fig. 3 and Supplementary Table 2).
Promoter state in ES and lineage-committed cells
We began our analysis by studying H3K4me3 andH3K27me3 patterns
at known promoters. H3K4me3 is catalysed by trithorax-group (trxG)
proteins andassociatedwith activation,whereasH3K27me3 is catalysed
by polycomb-group (PcG) proteins and associated with silencing10,11.
Recently, we and others observed that some promoters in ES cells carry
bothH3K4me3 andH3K27me39,12. We termed this novel combination
a ‘bivalent’ chromatin mark and proposed that it serves to poise key
developmental genes for lineage-specific activation or repression.
We studied 17,762 promoters inferred from full-length transcripts
(Supplementary Table 3). Mammalian RNA polymerase II pro-
moters are known to occur in at least two major forms13,14 (Sup-
plementary Fig. 4). CpG-rich promoters are associated with both
ubiquitously expressed ‘housekeeping’ genes, and genes with more
complex expression patterns, particularly those expressed during
embryonic development. CpG-poor promoters are generally assoc-
iated with highly tissue-specific genes. Accordingly, we divided our
analysis to focus on ‘high’ CpG promoters (HCP; n5 11,410) and
‘low’ CpG promoters (LCP; n5 3,014) separately. To ensure a clean
separation, we defined a set of intermediate CpG content promoters
(ICP; n5 3,338); this class shows properties consistent with being a
mixture of the two major classes.
High CpG promoters in ES cells. Virtually all HCPs (99%) are
associated with intervals of significant H3K4me3 enrichment in ES
cells (Fig. 2a). The modified histones are typically confined to a
punctate interval of 1–2 kilobases (kb) (Supplementary Fig. 5). As
observed previously15,16, there is a strong correlation between the
intensity ofH3K4me3 and the expression level of the associated genes
(Spearman’s r5 0.67). However, not all promoters associated with
H3K4me3 are active.
The chromatin-state maps reveal that,22% of HCPs (n5 2,525)
are actually bivalent, exhibiting both H3K4me3 and H3K27me3
(Fig. 2a). A minority of these (n5 564) are ‘wide’ bivalent sites in
which H3K27me3 extends over a region of at least 5 kb and resemble
those described previously9. The majority (n5 1,961) are ‘narrow’
bivalent sites, with more punctate H3K27me3, that correspond to
many additional PcG target promoters17–19. Bivalent promoters show
low activity despite the presence of H3K4me3, suggesting that the
repressive effect of PcG activity is generally dominant over the ubi-
quitous trxG activity (Supplementary Fig. 6 and Supplementary
Table 4).
The different types of chromatin marks at HCPs are closely related
to the nature of the associated genes (Supplementary Table 5).
Monovalent promoters (H3K4me3) generally regulate genes with
‘housekeeping’ functions including replication and basic metabol-
ism. By contrast, bivalent promoters are associated with genes with
more complex expression patterns, including key developmental
transcription factors, morphogens and cell surface molecules. In
addition, several bivalent promoters appear to regulate transcripts
for lineage-specific microRNAs.
High CpG promoters in NPCs and MEFs.Most HCPs marked with
H3K4me3 alone in ES cells retain this mark both in NPCs and MEFs
(92% in each; Figs 2b, c and 3a). This is consistent with the tendency
for this sub-class of promoters to regulate ubiquitous house-
keeping genes. A small proportion (,4%) of these promoters have
H3K27me3 in MEFs, and are thus bivalent or marked by H3K27me3
alone. This correlates with lower expression levels and may reflect
active recruitment of PcG proteins to new genes during differenti-
ation20. An example is the transcription factor gene Sox2, where the
promoter is marked by H3K4me3 alone in ES cells and NPCs, but
H3K27me3 alone in MEFs. Notably, this locus is flanked by CpG
islands with bivalent markings in ES cells (see below), suggesting that
the locus may be poised for repression upon differentiation.
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The majority of HCPs with bivalent marks in ES cells resolve to a
monovalent status in the committed cells. In NPCs, 46% resolve to
H3K4me3 only and these genes show increased expression (Figs 2b, d
and 3b). Of the remaining promoters, 14% resolve to H3K27me3
alone and 32% lose bothmarks, with both outcomes being associated
with low levels of expression. Notably, 8% remain bivalent and these
genes also continue to be repressed (Figs 2b, d and 3c). A less resolved
pattern is seen in MEFs, with 32% marked by H3K4me3 alone, 22%
marked by H3K27me3 alone, 3% without both marks, and the
remaining (43%) still bivalent (Fig. 2c). The relatively high number
of bivalent promoters in MEFs may reflect a less differentiated state
and/or heterogeneity in the population.
Distinct regulation of low CpG promoters. The LCPs show a very
different pattern than the HCPs. Only a small minority (6.5%,
n5 207) of LCPs have significant H3K4me3 in ES cells and virtually
none have H3K27me3 (Fig. 2a). Most of these promoters have lost
H3K4me3 inNPCs andMEFs, whereas a small number of other LCPs
(1.5% and 2.6%, respectively) have gained the mark (Figs 2b, c and
3e). In all three cell types, the expression levels of the associated genes
strongly correlate with the presence or absence of H3K4me3 (Fig. 2e
and Supplementary Fig. 6).
The genes with LCPs marked by H3K4me3 are closely related to
tissue-specific functions. In NPCs, they include genes encoding sev-
eral known markers of neural progenitors in vivo (such as Fabp7, Cp,
Gpr56). In MEFs, they include genes encoding extracellular matrix
components and growth factors (such asCol3a1,Col6a1, Postn,Aspn,
Hgf, Figf), consistent with the mesenchymal origin of these cells (see
below).
We conclude that HCPs and LCPs are subject to distinct modes of
regulation. In ES cells, all HCPs seem to be targets of trxG activity,
and may therefore drive transcription unless actively repressed by
PcG proteins. In committed cell types, a subset of HCPs appears to
lose the capacity to recruit trxG activity (possibly due to other epi-
genetic modifications, such as DNA methylation21). In contrast,
CpG-poor promoters seem to be inactive by default, independent
of repression by PcG proteins, and may instead be selectively acti-
vated by cell-type- or tissue-specific factors.
Alternative promoter use.We note that genes with alternative pro-
moters may have multiple, distinct chromatin states. An ‘active’ state
at any one of these promoters may be sufficient to drive expression. A
common situation involves genes with one major HCP and one or
more alternative LCPs. An example is the transcription factor Foxp2,
which is expressed atmoderate levels in bothNPCs andMEFs (Fig. 3f,
g). The Foxp2HCP ismarked byH3K4me3 inNPCs, but is bivalent in
MEFs. However, an alternative LCP is marked by H3K4me3 exclu-
sively inMEFs. The protocadherin-c (Pcdhg) locus is a more extreme
case: the amino-terminal variable regions of this gene are transcribed
from at least 20 different HCPs in neurons22, all of which carry biva-
lent chromatin marks in ES cells. Pcdhg expression is nevertheless
detected bymicroarrays, possibly owing to a single promoter in front
of the carboxy-terminal constant region marked by H3K4me3 alone
(Fig. 3h).
Although only ,10% of the genes analysed here have more than
one known promoter, recent ‘cap-trapping’ studies suggest that
alternative promoter use may be substantially more common23.
The ability of ChIP-Seq to assess chromatin state at known promo-
ters, as well as to identify novel promoters (see below), should prove
valuable in analysis of transcriptional networks.
Promoter state reflects lineage commitment and potential
Given their association with epigenetic memory, we next examined
whether the patterns of H3K4me3 and H3K27me3 can reflect
developmental potential. Both of the committed cell types studied
here have been shown to be multipotent ex vivo. NPCs can be differ-
entiated to glial and neuronal lineages8, whereas primary MEFs have
been differentiated into adipocytes24, chondrocytes25 and osteoblast-
like cells26.
Lineage-specific resolution and retention of bivalent marks. We
first examined a set of genes involved in in vivo differentiation path-
ways known to be, at least partially, recapitulated by MEFs, NPCs, or
neither. These genes all have bivalent promoters in ES cells.We found
that their resolution in lineage-committed cells is closely related to
their demonstrated developmental potential (Supplementary Table
6): (1) genes restricted to regulation or specialized functions in
unrelated lineages, such as haematopoietic (Cdx4, PU.1 (also called
Sfpi1)), epithelial (Cnfn, Krt2-4), endoderm (Gata6, Pdx1) or germ
line (Tenr (Adad1), Ctcfl), generally resolved to monovalent
H3K27me3 or carry neither mark in both NPCs and MEFs. (2)
Genes related to adipogenesis and chondro/osteogenesis often
remain bivalent in MEFs, but not in NPCs. Examples include
Pparg, which is a key regulator of adipogenesis, and Sp7, which pro-
motes chondro/osteogenic pathways. Early mesenchymal markers,
such as Runx1 and Sox9, resolved to H3K4me3 alone in MEFs. (3)
Genes related to gliogenesis and neurogenesis often resolved to
H3K4me3 alone or remain bivalent in NPCs, whereas they resolved
to H3K27me3 alone in the MEFs. Gliogenesis and neurogenesis are
thought to be mutually opposing pathways27, and we find that genes
promoting gliogenesis are more likely to resolve to H3K4me3 in
NPCs. Examples include Bmp2 and the microRNA mir-9-3, which
promotes glial but inhibits neuronal differentiation28. Several genes
known to promote neuronal differentiation, such as Neurog1 and
Neurog2, remain bivalent whereas others, such as Bmp6, appear to
resolve to H3K27me3 alone. In our hands, the NPCs differentiate to
astrocytes with significantly higher efficiency than to neurons (M.W.,
unpublished data). The observed chromatin patterns may reflect this
gliogenic bias.
Correlation with expression in adult tissues.Wenext analysed gene
expression in adult tissues with major contributions from neuroec-
todermal or mesenchymal lineages. We reasoned that if H3K4me3 is
generally not restored once lost, then differential loss of H3K4me3 at
promoters early in these lineages (as represented by NPCs andMEFs,
respectively) might be reflected in differential gene expression pat-
terns in related adult tissues.
Notably, we observed a clear bias in relative expression levels
between relevant adult tissues for genes that retain H3K4me3 in
NPCs only versus genes that retain H3K4me3 in MEFs only. The
former are strongly biased towards higher expression in various brain
sections, whereas the latter are biased towards higher expression in
bone, adipose and other mesenchyme-rich tissues (Fig. 4).
These analyses are limited by alternative promoter usage, the cell
models used, and the heterogeneity of the adult tissues. Nonetheless,
the data show clear trends that support an important role for reten-
tion and resolution of bivalent chromatin in the regulation of hier-
archical lineage commitment.
Genome-wide annotation of promoters and primary transcripts
We next considered genome-wide maps of H3K36me3. This mark
has been linked to transcriptional elongation and may serve to pre-
vent aberrant initiation within gene bodies29–33. Our chromatin maps
reveal a global pattern of H3K36me3 in mammals similar to that
previously observed in yeast29.
In all three cell types, H3K36me3 is strongly enriched across the
transcribed regions of active genes (Fig. 5a), beginning immediately
after the promoter H3K4me3 signal. The level of H3K36me3 is
strongly correlated with the level of gene expression (Spearman’s
r5 0.77), although the dynamic range is compressed (1–2 orders
of magnitude for H3K36me3 versus 3–4 for expression levels;
Supplementary Fig. 7). Genes with bivalent promoters rarely show
H3K36me3, consistent with their low expression. Notably, there is
essentially no overlap between intervals significantly enriched for
H3K36me3 and for H3K27me3, consistent with a role for PcG com-
plexes in the exclusion of polymerases11.
The vastmajority of intervals significantly enriched forH3K36me3
is associated with known genes (,92% in ES cells), but there are
ARTICLES NATURE |Vol 448 |2 August 2007
556
Nature  ©2007 Publishing Group
at least ,500 additional regions across the genome (median size
,2 kb), with most being adjacent to sites of H3K4me3. Inspection
revealed a number of interesting cases, falling into three categories.
The first category corresponds to H3K36me3 that extends signifi-
cantly upstream from the annotated start of a known gene, often until
an H3K4me3 site. These seem to reflect the presence of unannotated
alternative promoters. A notable example is the Foxp1 locus. In ES
cells, one annotated Foxp1 promoter is marked by H3K4me3 and
another CpG-rich region located,500 kb upstream carries a bivalent
mark. In MEFs, this CpG island is marked by H3K4me3 only, and
H3K36me3 extends from this site to the 39 end of Foxp1 (Fig. 5a).
Although no transcript extending across this entire region has been
reported in mouse, the orthologous position in human has been
shown to act as a promoter for the orthologous gene. The ChIP-
Seq data contain many other examples where the combination of
H3K36me3 and H3K4me3 seems to reveal novel promoters.
The second category corresponds to H3K36me3 that extends sig-
nificantly downstream of a known gene. An example is the Sox2
locus, which encodes a pluripotency-associated transcription factor
that also functions during neural development. In ES cells, Sox2 has
an unusually large region of H3K4me3 (.20 kb) accompanied by
H3K36me3 extending far beyond the annotated 39 end (.15 kb);
non-coding transcription throughout the locus has been noted prev-
iously34 and may serve a regulatory role (Fig. 5b).
The third category seems to reflect transcription of non-coding
RNA genes. For example, two regions with H3K36me3 and adjacent
H3K4me3 correspond to recently discovered nuclear transcripts with
possible functions in messenger RNA processing35 (Fig. 5c). In addi-
tion, a number of these presumptive transcriptional units overlap
microRNAs (Fig. 5d). A striking example is a.200-kb interval
within theDlk1–Dio3 imprinted locus (Fig. 6a). This region harbours
over 40 non-coding RNAs, including clusters of microRNAs and
small nucleolar RNAs36. The ChIP-Seq data suggest that the entire
region is transcribed as a single unit that initiates at a H3K4me3-
marked HCP.
These findings suggest that genome-wide maps of H3K4me3 and
H3K36me3 may provide a general tool for defining novel transcrip-
tion units. The capacity to define the origins and extents of primary
transcripts will be of particular value for characterizing the regulation
ofmicroRNAs and other non-coding RNAs that are rapidly processed
from long precursors37. Finally, the relatively narrowdynamic range of
H3K36me3 may offer advantages over RNA-based approaches in
assessing gene expression and defining cellular states.
H3K9 andH4K20 trimethylationmark specific repetitive elements
We next studied H3K9me3 andH4K20me3, both of which have been
associated with silencing of centromeres, transposons and tandem
repeats38–40. We sought first to assess the relative enrichments of
H3K9me3 and H4K20me3 across different types of repetitive ele-
ments by aligning ChIP-Seq reads directly to consensus sequences
for various repeat families (,40million reads could be aligned this
way).
H3K9me3 and H4K20me3 show nearly identical patterns of
enrichment in ES cells. The strongest enrichments are observed for
telomeric, satellite and long terminal repeats (LTRs). The LTR signal
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primarily reflects enrichment of intracisternal A-particle (IAP) and
early transposon (ETn) elements (Supplementary Fig. 8).
IAP and ETn elements are active in murine ES cells and produce
double-stranded RNAs41,42. RNA has also been implicated in main-
taining satellite and telomeric heterochromatin38. Hence, these
enrichment data are consistent with a global role for RNA in targeting
repressive chromatinmarks inmammalian ES cells, analogous to that
observed in lower eukaryotes38,39.
We next examined the distributions of H3K9me3 and H4K20me3
across unique sequences in the mouse genome. We identified,1,800
H3K9me3 sites (median size,300 bp) in ES cells, with the vastmajor-
ity also showing H4K20me3. Fully 78% of the sites lie within 2 kb of a
satellite repeat or LTR (primarily IAP andETn elements). This suggests
that repressive marks are capable of spreading from repeat insertions
and could potentially regulate proximal unique sequence.
Recent studies have described a handful of active genes with
H3K9me3 and H4K20me3, raising the possibility that these ‘repres-
sive’ marks also function in transcriptional activation31,32. One-third
of the ,1,800 H3K9me3-enriched sites reside within an annotated
gene, which is roughly the proportion expected by chance. However,
H3K9me3 sites that are larger and/or more distant from LTRs are
more likely to occur within genes (Supplementary Fig. 9). The largest
genic site in ES cells (,6 kb) coincides with the Polrmt gene (Fig. 6d).
This case is notable because the downstream gene (Hcn2) is conver-
gent and contains a CpG island at its 39 end. Transcription from 39
promoters has been proposed as a potential mechanism of transcrip-
tional interference by producing antisense transcripts23. This
example may therefore reflect a link between transcriptional inter-
ference and H3K9me3, as has been suggested for a few other mam-
malian loci43,44. Our results thus confirm the presence of H3K9me3
within a subset of genes, although the functional implications remain
to be elucidated.
H3K4 and H3K9 trimethylation at imprinted loci
We next studied chromatin marks associated with imprinting. This
epigenetic process typically involves allele-specific DNAmethylation
of CpG-rich imprinting control regions45. Several reports have also
described allele-specific chromatin modification at a handful of
imprinting control regions, with H3K9me3 and H4K20me3 on the
DNA methylated allele and H3K4me3 on the opposite allele46,47.
We searched for regions showing overlapping H3K9me3 and
H3K4me3 in ES cells. Notably, 13 of the top 20 sites, as ranked by
enrichment of the two marks, are located within known imprinted
regions, coincident with imprinting control regions or imprinted
gene promoters. An example is the Peg13 promoter (Fig. 6c). Con-
versely, of the ,20 known and putative autosomal imprinted loci
that contain imprinting control regions, 17 have at least one with the
overlapping chromatin marks (Supplementary Table 7). We con-
clude that overlapping H3K9me3 and H3K4me3 is a common sig-
nature of imprinting control regions in ES cells.
Allele-specific histone methylation
To explore the feasibility of inferring allele-specific chromatin states,
we constructed chromatin-state maps in male ES cells derived from a
more distant cross (129SvJae (maternal) x Mus musculus castaneus
(paternal)), and used a catalogue of ,3.5million single nucleotide
polymorphisms (SNPs) to assign ChIP-Seq reads to one of the two
parental alleles.
As a positive control, we first compared results for chromosome X
and the autosomes for reads derived by H3K4me3 ChIP. Virtually all
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read out using ChIP-Seq data for hybrid ES cells and a SNP catalogue. The
H3K36me3 reads overwhelmingly correspond to maternal 129SvJae alleles,
consistent with the known maternal expression of these microRNAs36. b, In
contrast, a non-imprinted transcript shows roughly equal proportions of
reads assigned to 129SvJae andM.m. castaneus alleles. c, Peg13 is marked by
H3K4me3 and H3K9me3 in ES cells; 19 out of 21 H3K4me3 reads
correspond to the paternal M. m. castaneus allele, whereas 6 out of 6
H3K9me3 reads correspond to the maternal 129SvJae allele, consistent with
paternal expression of this gene. d, H3K9me3 and H4K20me3 enrichment
evident at the Polrmt gene may reflect transcriptional interference owing to
antisense transcription from the 39 UTR CpG island of Hcn2 (see text).
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(97%) of,3,700 informative reads on chromosome X, and roughly
half (57%) of the 178,000 informative reads on the autosomes, were
assigned to the 129SvJae strain. These proportions correspond
roughly to the expected 100% and 50%.
We then examined the allelic distribution at overlapping
H3K4me3 and H3K9me3 sites coincident with putative imprinting
control regions (see above). Six of the imprinting control regions had
enough reads ($10) containing SNPs to assess allelic bias. In every
case, the SNPs showed significant bias in the expected direction
(P, 0.02; Fig. 6c and Supplementary Table 7).
We applied the same approach to search for allelic imbalance in
intervals with significant H3K36me3 enrichment, which would pre-
dict differential transcription of the two alleles. A striking interval
corresponds to a microRNA cluster within the Dlk1–Dio3 locus
known to be imprinted in the embryo proper36 (Fig. 6a, b). Of the
additional imprinted genes with H3K36me3 enrichment, four
(Snrpn, Grb10, Impact, Peg3) had enough reads containing SNPs to
assess allelic bias. In every case, the data showed significant bias in the
expected direction (P, 0.02). The data also revealed novel instances
of allele-specific transcription. For example, a transcript of unknown
function (BC054101), first identified in trophoblast stem cells48,
showed highly significant maternal bias for H3K36me3, as well as
H3K4me3 (P, 10215; Supplementary Fig. 10).
The results suggest that, with sufficiently deep coverage and dense
SNP maps, ChIP-Seq will provide a powerful means for identifying
allele-specific chromatin modifications. With data from reciprocal
crosses, it should be possible to discriminate novel cases of imprint-
ing from strain-specific differences.
Discussion
Genome-wide chromatin-state maps provide a rich source of
information about cellular state, yielding insights beyond what is
typically obtained by RNA expression profiling. Analysis of
H3K4me3 and H3K36me3 allows recognition of promoters together
with their complete transcription units. This should help to define
alternative promoters and their usage in specific cell types; identify
the primary structure of genes encoding non-coding RNAs; detect
gene expression (given the narrower dynamic range); and detect
allele-specific transcription. In addition, analysis of H3K9me3 and
H4K20me3 should facilitate the study of heterochromatin, spreading
and imprinting mechanisms.
Most interestingly, analysis of H3K4me3 andH3K27me3 provides
a rich description of cellular state. Our results suggest that promoters
may be classified as active, repressed or poised for alternative devel-
opmental fates. Conceivably, chromatin state at key regulatory genes
may suffice to describe developmental commitment and potential.
Given the technical features of ChIP-Seq (high throughput, low
cost and input requirement), it is now appropriate to contemplate
projects to generate catalogues of chromatin-state maps representing
a wide range of human and mouse cell types. These should include
varied developmental stages and lineages, from totipotent to termin-
ally differentiated, with the aim of precisely defining cellular states at
the epigenetic level and observing how they change over the course of
normal development. Chromatin-state maps should also be system-
atically catalogued from situations of abnormal development. Cancer
cells are the most obvious targets, as they are frequently associated
with epigenetic defects and many appear to have acquired character-
istics of earlier developmental stages. A comprehensive public data-
base of chromatin-state maps would be a valuable resource for the
scientific community.
METHODS SUMMARY
Murine V6.5 ES cells (129SvJae3C57BL/6; male), hybrid ES cells (129SvJae3
M.m. castaneus F1; male) andNPCs were cultured as described
8,9. PrimaryMEFs
(129SvJae 3 C57BL/6; male) were obtained at embryonic day (E)13.5.
ChIP experiments were carried out as described15. Sequencing libraries were
generated from1–10 ng ofChIPDNAby adaptor ligation, gel purification and 18
cycles of PCR. Sequencing was carried out using the Illumina/Solexa Genome
Analyzer system according to the manufacturer’s specifications.
Reads were aligned to the reference genome, and the fragment count at any
given position (25-bp resolution) was estimated as the number of uniquely
aligned reads oriented towards it and within 300 bp. Enriched intervals were
identified by comparison of the mean fragment count in 1-kb windows against
a sample-specific expected distribution estimated by randomization (H3K4me3,
H3K27me3), or using a supervised Hidden Markov Model (H3K36me3,
H3K9me3, H4K20me3).
Promoters were inferred from full-length mouse RefSeqs. HCPs contain a
500-bp interval within 20.5 kb to 12 kb with a (G1C)-fraction$0.55 and a
CpG observed to expected ratio (O/E)$0.6. LCPs contain no 500-bp interval
with CpGO/E$0.4. Chromatin states of promoters were determined by overlap
with H3K4me3- and H3K27me3-enriched intervals. Correlations with express-
ion levels were calculated from the mean fragment count over each promoter or
transcript.
ES cell, NPC andMEF expression data were generated using GeneChip arrays
(Affymetrix) and GenePattern (http://www.broad.mit.edu/cancer/software/).
Expression data for adult tissues were downloaded from Novartis (http://
symatlas.gnf.org).
Repeat class enrichments were determined by aligning reads to consensus
sequences (http://www.girinst.org). Mouse SNP maps were obtained from
Perlegen (http://mouse.perlegen.com). Allele-specific bias was evaluated by a
binomial test of the null hypothesis that ChIP fragments were drawn uniformly
from both alleles.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Cell culture. V6.5 murine ES cells (genotype 129SvJae 3 C57BL/6; male; pas-
sages 10–15) and hybrid murine ES cells (genotype 129SvJae3M. m. castaneus
F1; male; passages 4–6) were cultivated in 5% CO2 at 37 uC on irradiated MEFs
in DMEM containing 15% FCS, leukaemia-inhibiting factor, penicillin/
streptomycin, L-glutamine, nonessential amino acids and 2-mercaptoethanol.
Cells were subjected to at least two to three passages on 0.2% gelatin under
feeder-free conditions to exclude feeder contamination. V6.5 ES cells were dif-
ferentiated into neural progenitor cells (NPCs) through embryoid body forma-
tion for 4 days and selection in ITSFn media for 5–7 days, and maintained in
FGF2 and EGF2 (R&D Systems) as described8. The cells uniformly express nestin
and Sox2 and can differentiate into neurons, astrocytes and oligodendrocytes.
Mouse embryonic fibroblasts (genotype 129SvJae3 C57BL/6; male; E13.5; pas-
sages 4–6), were grown in DMEM with 10% fetal bovine serum and penicillin/
streptomycin at 37u, 5% CO2.
Chromatin immunoprecipitation. ChIP experiments were carried out as
described previously15 and at http://www.upstate.com. Briefly, chromatin from
fixed cells was fragmented to a size range of 200–700 bases with a Branson 250
Sonifier or a Diagenode Bioruptor. Solubilized chromatin was immunoprecipi-
tated with antibody against H3K4me3 (Abcam 8580), H3K9me3 (Abcam 8898),
H3K27me3 (Upstate 07-449), H3K36me3 (Abcam 9050), H4K20me3 (Upstate
07-463), pan-H3 (Abcam 1791) or RNA polymerase II (Covance MMS-126R).
Antibody–chromatin complexes were pulled-down using protein A-sepharose
(or anti-IgM-conjugated agarose for RNA polymerase II), washed and then
eluted. After cross-link reversal and proteinase K treatment, immunoprecipi-
tated DNA was extracted with phenol-chloroform, ethanol precipitated, and
treated with RNase. ChIP DNA was quantified using PicoGreen.
Library preparation and Solexa sequencing. One to ten nanograms of ChIP
DNA (or unenriched whole-cell extract) were prepared for Solexa sequencing as
follows: DNA fragments were repaired to blunt ends by T4DNA polymerase and
phosphorylatedwith T4polynucleotide kinase using the END-IT kit (Epicentre).
Then, a single ‘A’ base was added to 39 ends with Klenow (39R59 exo2,
0.3U ml21). Double-stranded Solexa adaptors (75 bp with a ‘T’ overhang) were
ligated to the fragments with DNA ligase (0.05U ml21). Ligation products
between 275 and 700 bp were gel purified on 2% agarose to remove unligated
adaptors, and subjected to 18 PCR cycles. Completed libraries were quantified
with PicoGreen.
DNA sequencing was carried out using the Illumina/Solexa Genome Analyzer
sequencing system. Cluster amplification, linearization, blocking and sequen-
cing primer reagents were provided in the Solexa Cluster Amplification kits and
were used according to the manufacturer’s specifications as described here. To
obtain single strand templates, the sample preparation was first denatured in
NaOH (0.1N final concentration) and diluted in Solexa hybridization buffer
(4 uC) to a final concentration of either 2 or 4 pM. Sample loading was carried
out as follows. A template sample was loaded into each lane of a Solexa flowcell
mounted on a Solexa cluster station on which all subsequent steps were per-
formed. The temperature was increased to 95 uC for 1min and slowly decreased
to 40 uC to allow for annealing onto complementary adaptor oligonucleotides on
the flowcell surface. Cluster formation was then carried out as follows. The
template strands were extended with Taq polymerase (0.25U ml21) to generate
a fixed copy of the template on the flowcell. The samples were then denatured
with formamide (Sigma-Aldrich, F-5786,.99.5% (GC)) and washed (Solexa
Wash buffer) to remove the original captured template, leaving behind a sin-
gle-stranded template ready for amplification. Clusters were then amplified
under isothermal conditions (60 uC) for 30 cycles using Solexa amplification
mix containing BstI DNA polymerase (0.08Uml21). After each amplification
cycle, the templates were denaturedwith formamide (as above). Fresh amplifica-
tionmix was added after each denaturation step. After amplification, the clusters
were linearized with Solexa linearization mix, and any unextended flowcell sur-
face capture oligonucleotides were blocked with ddNTPs (2.4mM mix in the
presence of 0.25Uml21 terminal transferase). The linearized clusters were then
denatured (0.1N NaOH) to remove and wash away the linearized strands. The
single-stranded templates in the cluster were then annealed with the Solexa
sequencing primer (10 mM). The flowcells were removed from the cluster station
and then transferred onto the 1GGenetic Analyser which performed the sequen-
cing according to its own standard protocols. We followed the protocol without
any modifications.
Read alignment and generation of density maps and modified intervals.
Sequence reads from eachChIP library are compiled, post-processed and aligned
to the reference genome sequence using a general purpose computational pipe-
line.We first pre-compute a table that associates each possible 12-mer with all of
its occurrences in the reference genome. Then, for each SMS read, we scan both it
and its reverse complement, and for each of its constituent 12-mers, we find each
potential start point on the reference genome, and then compute the number of
mismatches in the corresponding alignment. These computations are dynam-
ically terminated so that only ‘unique’ alignments are reported, according to the
following rule: if an alignment A has only x mismatches, and if there is no
alternative alignment having#x 1 2 mismatches, then we call A unique. To
minimize the risk of amplification bias, only one read was kept if multiple reads
aligned to the same start point.
For each ChIP (or control) experiment, we next estimate the number of end-
sequenced ChIP fragments that overlap any given nucleotide position in the
reference genome (here, at 25-bp resolution). For each position, we count the
number of aligned reads that are oriented towards it and closer than the average
length of a library fragment (,300 bp).
To identify the portion of the mouse genome that can be interrogated with
SMS reads of a given length (k) and alignment stringency, we aligned every k-mer
that occurs in the reference sequence (mm8) using the same pipeline as for SMS
reads. Nucleotide positions in the reference genome where less than 50% of the
200 flanking k-mers on each side had ‘unique’ alignments were masked as repet-
itive and disregarded from further analysis (,28% of the genome). Although we
analysed reads spanning 27–36 bp, all data were conservativelymasked at k5 27.
We identified genomic intervals enrichedwith a specific chromatinmark from
the mean fragment count in 1-kb sliding windows. To account for varying read
numbers and lengths, we generated sample-specific expected distributions of
fragment counts under the null hypothesis of no enrichment by moving each
aligned read to a randomly chosen ‘unique’ position on the same chromosome.
Nominal P-values for enrichment at a particular position were obtained by
comparison to a randomized version of the same data set (due to the large
number of reads, multiple randomizations gave identical results). Genome-wide
maps of enriched sites were created by identification of windows where the
nominal P-value fell below 1025, and merging any enriched windows that were
less than 1-kb apart into continuous intervals. To improve sensitivity to themore
diffuse enrichment observed from H3K9me3 and H4K20me3 near repetitive
regions and from H3K36me3 across large transcripts, we also developed a
HiddenMarkovModel (HMM) to segment the reference genome into ‘enriched’
and ‘unenriched’ intervals (R.P.K., manuscript in preparation). The observed
fragment densities were divided into four categories, in a sample-dependent
manner (‘masked’, ‘sub-threshold’, ‘near-threshold’ and ‘above threshold’).
Emission and transition probabilities were fitted using supervised learning on
limited intervals (,10Mb total) chosen to reflect diverse chromatin landscapes,
and the resultant models were applied genome wide.
Validation of ChIP-Seq by comparison to ChIP-chip and real-time PCR.
ChIP-Seq data for H3K4me3 and H3K27me3 in ES cells were compared to
published ChIP-chip profiles across ,2% of the mouse genome9. Significantly
enriched sites in the ChIP-chip data were defined using a previously validated
P-value threshold of 1024, and compared to the ChIP-Seq sites. In addition, a set
of 50 PCR primer pairs (Supplementary Table 2) was designed to amplify 100–
140-bp fragments from genomic regions showing a wide range of signals for
H3K4me3 and H3K27me3 by ChIP-Seq. Real-time PCR was carried out using
Quantitect SYBR green PCRmix (Qiagen) on a 7000ABI detection system, using
0.25 ng ChIP orWCEDNA as template. Fold enrichments reflect two independ-
ent ChIP assays, each evaluated in duplicate by real-time PCR.
Promoter classification and definition of gene and transcript intervals. The
analysed promoters were based on transcription start sites inferred from full-
length mouse RefSeqs (downloaded from the UCSC Genome Brower 2 April
2007). Promoters containing a 500-bp interval within 20.5 kb to 12 kb with a
(G1C)-fraction$0.55 and a CpG observed to expected ratio (O/E)$0.6 were
classified as HCPs. Promoters containing no 500-bp interval with CpGO/E$0.4
were classified as LCPs. The remainder were classified as ICPs. The chromatin
states of promoters were determined by overlap with cell-type-specific
H3K4me3 and H3K27me3 intervals. For comparison with expression levels,
the chromatin states of genes with more than one known promoter were clas-
sified according to the most ‘active’ mark (that is, a gene with an H3K4me3
marked promoter and a bivalent promoter would be classified as ‘H3K4me3’).
Correlation between H3K4me3 enrichment and expression levels was calculated
from the mean fragment density over each promoter from 20.5 kb to 11 kb.
Correlation between H3K36me3 and expression levels was calculated from the
mean fragment density over each RefSeq transcript.
Expression data. RNA expression data for ES cells, NPCs and MEFs were gen-
erated from polyA RNA using GeneChip Mouse Genome 430 2.0 Arrays
(Affymetrix). Expression data for adult tissues were downloaded from the
Novartis Gene Expression Atlas at http://symatlas.gnf.org. Pre-processing, nor-
malization (GC-RMA) and hierarchical clustering (Pearson, log-transformed,
row-centred values) were performed using GenePattern (http://www.broad.
mit.edu/cancer/software/).
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Analysis of repetitive elements. Chromatin state at repetitive elements was
evaluated by aligning SMS reads directly to a library of repetitive element
consensus sequences (http://www.girinst.org). The proportion of reads aligning
to each class was calculated for H3K9me3 and H4K20me3, and enrichment
determined by comparison toWCE and pan-H3.We also applied an orthogonal
approach based on HMM intervals of H3K9me3 in unique sequences (see
above). For each repetitive element type or class, we calculated the number of
occurrences within 1 kb of a unique H3K9me3 site, controlling against a set of
randomly placed sites of the same length distribution.
Allele-specific histone methylation. SNPs between the 129S1/SvlmJ (used as
proxy for 129SvJae) and M. m. castaneus mouse strains were obtained from
Perlegen at http://mouse.perlegen.com. Allele-specific bias was evaluated by a
binomial test of the null hypothesis that ChIP fragments were drawn uniformly
from both alleles. (H3K4me3 and H3K9me3 reads were pooled before the test,
see Supplementary Table 7.) We note that the 129SvJae strain is closer to the
C57BL/6-derived reference genome, and this may cause a slight bias towards
assigning aligned reads to this strain. To minimize this bias, aligned reads were
kept for analysis if no alternative alignment had the same number of mismatches
to the reference sequence.
doi:10.1038/nature06008
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LETTERS
Genome-scale DNA methylation maps of pluripotent
and differentiated cells
Alexander Meissner1,2,3*, Tarjei S. Mikkelsen2,4*, Hongcang Gu2, Marius Wernig1, Jacob Hanna1,
Andrey Sivachenko2, Xiaolan Zhang2, Bradley E. Bernstein2,5,6, Chad Nusbaum2, David B. Jaffe2, Andreas Gnirke2,
Rudolf Jaenisch1,7 & Eric S. Lander1,2,7,8
DNA methylation is essential for normal development1–3 and has
been implicated in many pathologies including cancer4,5. Our
knowledge about the genome-wide distribution of DNA methyla-
tion, how it changes during cellular differentiation and how it
relates to histone methylation and other chromatin modifications
in mammals remains limited. Here we report the generation and
analysis of genome-scale DNA methylation profiles at nucleotide
resolution in mammalian cells. Using high-throughput reduced
representation bisulphite sequencing6 and single-molecule-based
sequencing, we generated DNA methylation maps covering most
CpG islands, and a representative sampling of conserved non-cod-
ing elements, transposons and other genomic features, for mouse
embryonic stem cells, embryonic-stem-cell-derived and primary
neural cells, and eight other primary tissues. Several key findings
emerge from the data. First, DNA methylation patterns are better
correlated with histone methylation patterns than with the under-
lying genome sequence context. Second, methylation of CpGs are
dynamic epigenetic marks that undergo extensive changes during
cellular differentiation, particularly in regulatory regions outside
of core promoters. Third, analysis of embryonic-stem-cell-derived
and primary cells reveals that ‘weak’ CpG islands associated with a
specific set of developmentally regulated genes undergo aberrant
hypermethylation during extended proliferation in vitro, in a pat-
tern reminiscent of that reported in some primary tumours. More
generally, the results establish reduced representation bisulphite
sequencing as a powerful technology for epigenetic profiling of cell
populations relevant to developmental biology, cancer and regen-
erative medicine.
DNA methylation can be detected by sequencing genomic DNA
that has been treated with sodium bisulphite7. It has been impractical
to apply bisulphite sequencing at a genome-wide scale because poly-
merase chain reaction (PCR)-based8 and whole-genome shotgun9
approaches are currently too inefficient for comparative analysis
across multiple cell states in large mammalian genomes. However,
reduced representations can be generated to sequence a defined frac-
tion of a large genome6,10. Computational analysis indicated that
digesting mouse genomic DNA with the methylation-insensitive
restriction enzyme MspI, selecting 40–220-base pair (bp) fragments,
and performing 36-bp end-sequencing would cover ,1million dis-
tinct CpG dinucleotides (4.8% of all CpGs), with roughly half located
within ‘CpG islands’ (including sequences from 90% of all CpG
islands) and the rest distributed between other relatively CpG-poor
sequence features (Supplementary Fig. 1 and Supplementary Table
1). Notably, although CpGs are not distributed uniformly in the
genome, every MspI reduced representation bisulphite sequencing
(RRBS) sequence read includes at least one informative CpG position
(Supplementary Fig. 2), making the approach highly efficient.
We validated high-throughout RRBS by sequencing MspI frag-
ments from wild-type and methylation-deficient embryonic stem
(ES) cells6, using an Illumina Genome Analyser. We generated an
initial set of,21million high quality, aligned RRBS reads. The reads
from each cell type included ,97% of the predicted non-repetitive
MspI fragments (12-fold and 8-fold median coverage, respectively).
This demonstrates that RRBS library construction is relatively
unbiased (Supplementary Fig. 3) and is insensitive to genome-wide
CpG methylation levels (estimated by nearest-neighbour analysis as
72% and 0.5%, respectively). Reads from both cell types showed near
complete (.99%) bisulphite conversion of non-CpG cytosines.
To investigate cell-type-specific DNA methylation patterns, we
generated 140million additional RRBS reads (5.8 gigabase (Gb);
Supplementary Information) from ES-derived neural precursor cells
(NPCs) and various primary cell populations (Supplementary Table
2). We also generated new chromatin-state maps of H3 lysine 4
mono- and di-methylation (H3K4me1 andH3K4me2) from ES cells,
NPCs and whole brain tissue (Supplementary Table 3 and
Supplementary Information), using chromatin immunoprecipita-
tion followed by high-throughput sequencing (ChIP-Seq)11.
The methylation levels of CpG dinucleotides in wild-type ES cells
display a bimodal distribution (Fig. 1), withmost being either ‘largely
unmethylated’ (,20% of reads showing methylation) or ‘largely
methylated’ (.80% of reads). As expected2,8,12, CpGs in regions of
high CpG density (.7% over 300 bp) tend to be unmethylated,
whereas CpGs in low-density regions (,5%) tend to be methylated.
However, we noted that,10% of CpGs in low-density regions were
unmethylated, whereas,0.3% of CpGs in high-density regions were
methylated. We found that DNA methylation patterns were better
explained by histone methylation patterns than by CpG density.
Because genomic features tend to be associated with distinct histone
methylation patterns11, we analysed these features separately.
High-CpG-density promoters (HCPs) are associated with two
classes of genes: ubiquitous ‘housekeeping’ genes and highly regu-
lated ‘key developmental’ genes13. In ES cells, HCPs at housekeeping
genes are enriched with the transcription initiation mark H3K4me3
(‘univalent’) and are generally highly expressed, whereas those at
developmental genes are enriched with both H3K4me3 and the
repressive mark H3K27me3 (‘bivalent’) and are generally silent11,14.
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Massachusetts 02129, USA. 6Department of Pathology, HarvardMedical School, Boston,Massachusetts 02115, USA. 7Department of Biology,Massachusetts Institute of Technology,
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Both types of promoters are also enriched with H3K4me2, which is
associated with an open chromatin confirmation. Out of the 10,299
HCPs sampled (on average, 19 distinct CpGs per promoter), we
found that virtually all contain a core region of unmethylated
CpGs, regardless of their level of expression or H3K27me3 enrich-
ment (Figs 1 and 2a)12,14,15.
Low-CpG-density promoters (LCPs) are generally associated with
tissue-specific genes. In ES cells, a small subset of LCPs are enriched
withH3K4me3 (,7%) orH3K4me2 (,3%), and essentially none are
enriched with H3K27me3 (ref. 11). We found that whereas most
CpGs located in sampled LCPs (990 sites from 392 promoters) are
methylated, those in LCPs enriched with H3K4me3 or H3K4me2
have significantly reducedmethylation levels (Supplementary Fig. 4).
Distal regulatory regions such as enhancers, silencers and bound-
ary elements are often required to establish correct gene expression
patterns in mammalian cells16. Cis-regulatory elements active in a
particular cell type are often associated with markers of open chro-
matin, such as H3K4me2 or H3K4me1 (refs 17, 18). We identified
25,051 sites of H3K4me2 enrichment in ES cells from 1 kb to.100 kb
away from known promoters (most were also enriched with
H3K4me1, but not with H3K4me3). CpGs sampled at H3K4me2-
enriched sites (outside of promoters and CpG islands) had signifi-
cantly lower methylation levels than those at unenriched sites
(Fig. 2b). This relationship was particularly strong for CpGs located
in highly conserved non-coding elements (HCNEs; Fig. 2c).
Imprinting control regions (ICRs) are CpG-rich regulatory
regions that display allele-specific histone and DNA methylation19.
Our RRBS library included sequences from 13 of ,20 known ICRs
(on average, 13 distinct CpGs per ICR). CpGs within these elements
display a unimodal distribution of methylation levels, with a median
close to 50%, which is consistent with hypomethylation of the active
allele marked with H3K4me3 and hypermethylation of the silenced
allele marked with H3K9me3 (Fig. 1)11.
Interspersed repeat families differ in their chromatin structure,
with H3K9me3 enriched at active long terminal repeats (LTRs) and
to a lesser extent at long interspersed elements (LINEs), but not at
short interspersed elements (SINEs). Notably, CpGs located in LTRs
and LINEs are generally hypermethylated, even in CpG-rich contexts
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Figure 1 | CpG methylation levels in ES cells and NPCs for CpGs with$10-
fold coverage. The top histograms show the distribution of methylation
levels (%) across all CpGs, HCPs, LCPs, HCNEs, differentially methylated
regions (DMRs), LTRs, SINEs and other genomic features (n, number of
CpGs). Methylation levels are bimodal (except at DMRs, which have a
unimodal distribution largely consistent with uniform sampling from the
maternal and paternal alleles in ES cells and partial hypermethylation in
NPCs). The bottom box plots show the distribution of methylation levels
conditional on local CpG density (defined as fraction of CpGs in a 300-bp
window; shown as percentage). The red lines denote medians, notches the
standard errors, boxes the interquartile ranges, and whiskers the 2.5th and
97.5th percentiles.
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Figure 2 | Correlation between DNA and histone methylation. a, Mean
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coverage of$5 CpGs), conditional on their histone methylation state in ES
cells and NPCs (n, number of HCPs; those enriched with H3K4me3 are
generally also enriched for H3K4me2, but not vice versa). Loss of H3K4
methylation, and to a lesser extent of H3K27me3, is correlated with gain of
DNA methylation. b, Methylation levels of individual CpGs outside of
HCPs, conditional on enrichment of H3K4me2 (n, number of distinct sites
in each category). Changes in histone methylation state are inversely
correlated with changes in DNA methylation. c, Methylation levels of CpGs
in HCNEs not overlapping CpG islands, conditional on H3K4me2
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(Fig. 1). In contrast, CpGs in SINEs show a correlation between
methylation levels and CpG density that is comparable to non-
repetitive sequences.
We conclude that in ES cells the presence ofH3K4methylation and
the absence of H3K9 methylation are better predictors of unmethy-
lated CpGs than sequence context alone. This is consistent with
models in which de novomethyl-transferases either specifically recog-
nize sites with unmethylated H3K4 (ref. 20) or are excluded by H3K4
methylation or associated factors. Similarly, H3K9me3 or associ-
ated factors may recruit methyl-transferases at ICRs and repetitive
elements21.
We next used RRBS to analyse how DNA methylation patterns
change when ES cells are differentiated in vitro into a homogeneous
population of NPCs (Supplementary Fig. 4)22. Whereas CpG methy-
lation levels are highly correlated between the two cell types
(rho5 0.81), there were clear differences: ,8% of CpGs unmethy-
lated in ES cells became largely methylated in NPCs, whereas,2% of
CpGs methylated in ES cells became unmethylated; these changes
were strongly correlated with changes in histone methylation
patterns.
At both univalent and bivalent HCPs, we found that most CpGs
remained unmethylated on differentiation, particularly within their
core CpG island, but that loss of H3K4me3 and retention of
H3K4me2 or H3K27me3 correlated with a partial increase in DNA
methylation levels (median, ,25%; 2.9% and 32% of univalent and
bivalent HCPs, respectively) and complete loss of H3K4 and H3K27
methylation correlated with DNA hypermethylation (median,
,75%; 2.8% and 16% of univalent and bivalent HCPs, respectively;
Fig. 2).
Most LCPs marked by H3K4methylation in ES cells lose this mark
in NPCs; however, LCPs associated with genes expressed in NPCs
gain this mark. Loss or gain of H3K4 methylation is a strong pre-
dictor of inverse changes in CpG methylation levels at these promo-
ters (Supplementary Fig. 5).
Our chromatin-state maps revealed that 18,899 (75%) of putative
distal regulatory elements enriched with H3K4me2 in ES cells lost
this mark in NPCs, whereas 20,088 new H3K4me2 sites appeared,
often in HCNE-rich regions surrounding activated developmental
genes (Fig. 3). Loss or gain of H3K4methylation were again inversely
correlated with CpG methylation levels (Fig. 2b, c). In fact, these
regions account for most observed de-methylation events. The pres-
ence of H3K27me3 alone did not correlate with lower methylation
levels in CpG-poor regions (Supplementary Fig. 6).
The data support the notion that CpG-rich and -poor regulatory
elements undergo distinct modes of epigenetic regulation2,11,12. Most
(.95%)HCPs seem to be constitutively unmethylated and regulated
by trithorax-group (trxG; associated with H3K4me3) and/or
Polycomb-group (PcG; associated with H3K27me3) proteins, which
may be recruited in part by means of non-specific unmethylated-
CpG binding domains23. Hypermethylation of these CpG-dense
regions leads to exclusion of trxG/PcG activity, heterochromatin
formation and essentially irreversible gene silencing2. In contrast,
regulatory elements in CpG-poor sequence contexts seem to undergo
extensive and dynamic methylation and de-methylation. Hence,
methylation of isolated CpGs may contribute to chromatin con-
densation or directly interfere with transcription factor binding2,
but does not necessarily prevent chromatin remodelling in response
to activating signals.
As noted above, a small set of HCPs (n5 252; ,3%) became
hypermethylated (.75% mean methylation across sampled CpGs)
on in vitro differentiation of ES cells to NPCs. To investigate whether
the observed pattern reflects an in vivo regulatory mechanism, we
isolated NPCs from embryonic day (E)13.5 embryos and differen-
tiated them into glial fibrillary acidic protein (Gfap)-positive astro-
cytes (with no more than two passages in vitro). We similarly
differentiated the in vitro-derived NPCs into astrocytes (with these
cells having undergone at least 18 passages; Supplementary Fig. 4),
and compared the two populations using RRBS (Fig. 4a–f).
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Figure 3 | Developmentally regulated de-methylation of highly conserved
non-coding elements. Comparison of histone and DNA methylation levels
across the Olig1/Olig2 neural-lineage transcription factor locus. ChIP-Seq
tracks for H3K4me1/2/3 and H3K27me3 in ES cells and NPCs are shown.
The unmethylated CpG-rich promoters are bivalent and inactive in ES cells
and resolve to univalent H3K4me3 on activation in NPCs. H3K4me2
enrichment appears over HCNEs distal to the two genes, and this correlates
with CpG de-methylation. Inferred methylation levels for 40 out of 215
sampled CpGs are shown and colour-coded. Red indicates largely
methylated (.80%); green indicates largely unmethylated (,20%), and
orange indicates intermediate levels (>20% and(80%).
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The methylation levels of CpGs were highly correlated
(rho5 0.85), but astrocytes obtained from in vivo NPCs displayed
substantially less HCP hypermethylation than those obtained from
ES cells (Fig. 4a). The in vivo-derived astrocytes showed hypermethy-
lation at only 30 HCPs, largely associated with germline-specific
genes (including Dazl, Hormad1, Sycp1, Sycp2 and Taf7l), several
of which also showed partial methylation in ES cells. In contrast,
the in vitro-derived astrocytes showed hypermethylation of these
and ,305 additional HCPs. This set includes some genes known to
be expressed by at least some in vivo astrocytes (including Isyna1,Gsn
and Cldn5; ref. 24) but that were silent in the ES-cell-derived astro-
cytes (Supplementary Information). However, the hypermethylated
HCPs are significantly enriched for genes not expressed inNPCs or in
the astrocyte lineage (Supplementary Tables 4–7). They include genes
involved in development and differentiation of neuronal (Lhx8,
Lhx9, Moxd1, Htr1f and Slit1), ependymal (Otx2 and Kl) and unre-
lated lineages (includingMyod1,Dhh andNkx3-1). In fact, we found
that ‘key developmental’ HCPs that are bivalent in ES cells are six
times more likely to be included in the hypermethylated set com-
pared to univalent HCPs. Moreover, univalent genes in the hyper-
methylated set are expressed at significantly lower levels in both ES
cells and primary astrocytes, compared to those that remained hypo-
methylated (Fig. 4g). We also found that the hypermethylated HCPs
tend to have a ,15% lower CpG density (Fig. 4h).
To investigate further the differences between in vitro and in vivo
cell populations, we analysed whole brain tissue (representing cells of
mainly glial origin). Virtually all (.99%) of sampled HCPs were
unmethylated (Fig. 4c) and enriched with H3K4me3 and/or
H3K27me3 (Supplementary Fig. 7), with ,20 germline-specific
HCPs being the only clear exceptions. RRBS libraries from other in
vivo sources (T cells, B cells, spleen, lung, liver and fibroblasts) also
showed few hypermethylated HCPs (Supplementary Fig. 8). This
suggests that—apart from silencing germline-specific12, imprinted
and X-inactivated (Supplementary Fig. 9) genes in somatic tis-
sues—hypermethylation ofHCPs is not amajormechanism of devel-
opmental regulation in vivo.
To test for a correlation between passage number and HCP hyper-
methylation, we examined independently derived in vitro NPCs col-
lected after only 9 passages. These cells displayed hypermethylation at
approximately half of the HCPs that are hypermethylated in the
NPCs after 18 passages (Fig. 4d, e). To reduce time in culture further,
we used Sox1–GFP (green fluorescent protein) ES cells25 to isolate
very early NPCs. These cells initially displayed virtually no HCP
hypermethylation. However, after continued culturing they acquired
hypermethylation at many of the same HCPs as the previous NPC
populations (Supplementary Fig. 8). Finally, we grew the in vivo-
derived NPCs for 11 passages in vitro, differentiated them into astro-
cytes and then examined themethylation pattern. Notably, these cells
had also begun to acquire hypermethylation at a largely similar set of
HCPs (Fig. 4a, b).
These results show that independently derived NPC populations
from both in vitro and in vivo sources and different genetic back-
grounds reproducibly undergo gradual hypermethylation at a char-
acteristic set of HCPs. These observations have several implications.
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Figure 4 | HCP hypermethylation of cultured cells. Inferred mean
methylation levels (%) across autosomal HCPs (requiring$5-fold coverage
of $5 CpGs within the CpG island). a, ES-derived astrocytes contains
roughly 10 times more hypermethylated HCPs than primary NPC-derived
astrocytes after two passages (P) in culture. b, Continued passage of the
primary cells lead to gradual hypermethylation of many of the same HCPs.
c, Only a handful of mainly germline-specific HCPs display
hypermethylation in a whole brain tissue sample. d, Most HCPs are
unmethylated in ES cells, but a small subset gain significant methylation on
differentiation to NPCs. e, Continued proliferation of NPCs leads to
additional HCPs becoming hypermethylated after 18 passages.
f, Differentiation of late-stage NPCs into astrocytes by growth factor
withdrawal does not lead to additionalHCPhypermethylation.g, Expression
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First, aberrant epigenetic regulation in culture has raised concern
over the accuracy of cellular models generated by in vitro differenti-
ation or manipulation26–28. Both primary and transformed cell lines,
including ES-derived NPC populations, tend to lose developmental
potency after continued proliferation in culture26,29. Susceptibility to
hypermethylation at key regulatory genes that are normally activated
on differentiation could explain this phenomenon. Second, malig-
nant cells are often found to harbour hypermethylated CpG islands4,5.
Recently, genes known to undergo frequent hypermethylation in
adult cancers were noted to be significantly enriched for genes with
bivalent promoters in ES cells (reviewed in ref. 30). The similarities
between hypermethylation in culture and in cancer may provide a
useful in vitromodel for studying a common underlying mechanism.
Finally, the gradual hypermethylation of ‘weak’ HCPs hints at under-
lying kinetics. Because H3K4 methylases are targeted, at least in part,
by non-specific CpG-binding domains23, such HCPs may be particu-
larly sensitive to imbalanced chromatin-modifying factors or other
cancer- or culture-related perturbations.
More generally, RRBS makes it feasible to perform genome-scale
bisulphite sequencing on large-mammalian genomes, providing a
valuable tool for epigenetic profiling of cell populations. As sequen-
cing capacity increases, genome coverage can be readily scaled in step
by adding restriction enzymes, increasing the selected size range or
using hybridization-based reduced representation strategies.
METHODS SUMMARY
ES cells and ES-derived neural cells were cultured as described previously11,25.
Primary tissues were isolated from 4–6-week-old male 129SvJae/C57/B6 mice.
Mouse embryonic fibroblasts (MEFs) and primary neural precursors were iso-
lated from 129SvJae/C57/B6 E14.5 embryos.
RRBS libraries were prepared from 1–10mg mouse genomic DNA digested
with 10–100Units MspI (NEB). Size-selected MspI fragments (40–120 bp and
120–220 bp) were filled in and 39-terminal-A extended, extracted with phenol
and precipitated with ethanol. Ligation to pre-annealed adapters containing 59-
methyl-cytosine instead of cytosine (Illumina)was performed using the Illumina
DNA preparation kit and protocol. QIAquick (Qiagen) cleaned-up, adaptor-
ligated fragments were bisulphite-treated using the EpiTect Bisulphite Kit
(Qiagen). Preparative-scale PCR was performed and QIAquick-purified PCR
products were subjected to a final size selection on a 4% NuSieve 3:1 agarose
gel. SYBR-green-stained gel slices containing adaptor-ligated fragments of 130–
210 bp or 210–310 bp in size were excised. Library material was recovered from
the gel (QIAquick) and sequenced on an Illumina 1G genome analyser.
Sequence reads from bisulphite-treated Solexa libraries were identified using
standard Illumina base-calling software and then analysed using a custom com-
putational pipeline. ChIP-Seq experiments, sequencing, alignments and iden-
tification of significantly enriched regions were carried out as described
previously11.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Cell culture and ES cell differentiation. V6.5 (129/B6), Sox1–EGFP knock-in
(Sox1–GFP 129/129)25 and methylation-deficient (Dnmt[1kd,3a2/2,3b2/2]) ES
cells were expanded on c-irradiated MEFs in DMEM plus 15% fetal bovine
serum (FBS, Hyclone) supplemented with 13 MEM-nonessential amino acids
(Life Technologies), 0.1mM 2-mercaptoethanol and 103Unitsml21 leukaemia
inhibitory factor (LIF). After passaging onto gelatin-coated dishes (0.1% gelatin,
Sigma), ES cells were trypsinized and transferred to bacterial dishes allowing
embryoid body formation. Embryoid bodies were propagated for 4 days in the
same medium in the absence of LIF and subsequently plated onto tissue culture
dishes. One day after plating, the medium was replaced by ITSFn; that is,
DMEM/F12 (Life Technologies) supplemented with 5 mgml21 insulin,
50 mgml21 human APO transferrin, 30 nM sodium selenite (all Sigma),
2.5mgml21 fibronectin and penicillin/streptomycin (both Life Technologies).
After 5–7 days, cells were trypsinized, triturated to a single cell suspension,
replated on laminin-coated dishes (1mgml21, Life Technologies) and further
propagated in N3 medium composed of DMEM/F12, 25mgml21 insulin,
50 mgml21 transferrin, 30 nM sodium selenite, 20 nM progesterone, 100 nM
putrescine (Sigma), 10 ngml21 Fgf2 (R&D Systems) and penicillin/streptomy-
cin. Neural precursor cell proliferation was maintained by daily additions of
Fgf2. Sox1–EGFP-positive neural precursors were isolated and FACS-purified
(FACS Aria, Becton Dickinson) either from ITSFn cultures or after short-term
expansion in Fgf2. Growth factor withdrawal of these cultures results in terminal
differentiation into primarily neuronal cell populations. Neural precursor cell
lines were obtained by sequential passaging and propagation in the presence of
20 ngml21 Egf and 10 ngml21 Fgf2 (both R&D Systems). Differentiation into
astrocytes was induced by growth factor withdrawal and addition of 5% FBS for
5 days.
Primary tissues and cell types.Primary tissues were isolated from 4–6-week-old
male 129SvJae/C57/B6 mice. MEFs and primary neural precursors were isolated
from129SvJae/C57/B6 E14.5 embryos.MEFswere generated according to stand-
ard protocols. In vivoneural precursorswere isolated by disaggregating thewhole
brain and plating the suspension under the conditions described previously.
Established lines were differentiated into astrocytes by growth factor withdrawal
and addition of serum (see previously).
MspI RRBS library construction. 1–10mg mouse genomic DNA was digested
with 10–100Units of MspI (NEB) in a 30–500ml reaction 16–20 h at 37 uC.
Digested DNA was extracted with phenol, precipitated with ethanol and size-
selected on a 4% NuSieve 3:1 agarose gel (Lonza). DNA marker lanes were
excised from the gel and stainedwith SYBRGreen (Invitrogen). For each sample,
two slices containing DNA fragments of approximately 40–120 bp and 120–
220 bp, respectively, were excised from the unstained preparative portion of
the gel. DNA was recovered using Easy Clean DNA spin filters (Primm Labs),
extracted with phenol and precipitated with ethanol. The two size fractions were
kept apart throughout the procedure, including during the final sequencing.
Size-selected MspI fragments were filled in and 39-terminal A extended in a
50 ml reaction containing 20U Klenow exo2 (NEB), 0.4mM dATP, 0.04mM
dGTP and 0.04mM 5-methyl-dCTP (Roche) in 13 NEB buffer 2 (15min at
25 uC followed by 15min at 37 uC), extracted with phenol and precipitated with
ethanol using 10mg glycogen (Roche) as a carrier. Ligation to pre-annealed
Illumina adapters containing 59-methyl-cytosine instead of cytosine
(Illumina) was performed using the IlluminaDNApreparation kit and protocol.
QIAquick (Qiagen) cleaned-up, adaptor-ligated fragments were bisulphite-
treated using the EpiTect Bisulphite Kit (Qiagen) with minor modifications:
the bisulphite conversion time was increased to approximately 14 h by adding
three cycles (5min of denaturation at 95 uC followed by 3 h at 60 uC). After
bisulphite conversion, the single-stranded uracil-containing DNA was eluted
in 20ml of elution buffer. Analytical (25ml) PCR reactions containing 0.5ml of
bisulphite-treated DNA, 5 pmol each of genomic PCR primers 1.1 and 2.1
(Illumina) and 2.5U PfuTurboCx Hotstart DNA polymerase (Stratagene) were
set up to determine the minimum number of PCR cycles required to recover
enough material for sequencing. Preparative-scale (83 25 ml) PCR was per-
formed using the same PCR profile: 5min at 95 uC, n3 (30 s at 95 uC, 20 s at
65 uC, 30 s at 72 uC), followed by 7min at 72 uC, with n ranging from 18 to 24
cycles. QIAquick-purified PCR products were subjected to a final size selection
on a 4% NuSieve 3:1 agarose gel. SYBR-green-stained gel slices containing
adaptor-ligated fragments of 130–210 bp or 210–310 bp in size were excised.
RRBS library material was recovered from the gel (QIAquick) and sequenced
on an Illumina 1G genome analyser.
Sequence alignments and data analysis. Sequence reads frombisulphite-treated
Solexa libraries were identified using standard Illumina base-calling software and
then analysed using a custom computational pipeline. Residual cytosines (Cs) in
each readwere first converted to thymines (Ts), with each such conversion noted
for subsequent analysis. A reference sequence database was constructed from the
36-bp ends of each computationally predicted MspI fragment in the 40–220-bp
size range. All Cs in each fragment end were then converted to Ts (only the
C-poor strands are sequenced in the RRBS process; Supplementary Fig. 2).
The converted reads were aligned to the converted reference by finding all 12-
bp perfect matches and then extending to both ends of the treated read, not
allowing gaps (reverse complement alignments were not considered). The num-
ber of mismatches in the induced alignment was then counted between the
unconverted read and reference, ignoring cases in which a T in the unconverted
read is matched to a C in the unconverted reference. For a given read, the best
alignment was kept if the second-best alignment had $2 more mismatches,
otherwise the read was discarded as non-unique. Low-quality reads were iden-
tified and discarded if
P
q[Q
10
q=10w1,000, whereQ denotes the read quality scores
at eachmismatched position. Themethylation level of each sampled cytosinewas
estimated as the number of reads reporting a C, divided by the total number of
reads reporting a C or T, counting only reads with quality scores of $20 at the
position.
HCP, ICP and LCP annotations were taken from ref. 11. CpG island and other
annotations were downloaded from the UCSC browser (mm8). Estimation of
methylation levels from individual CpGs was limited to those with $10-fold
coverage. The methylation level of an HCP promoter was estimated as the mean
methylation level across all CpGs with$5-fold coverage overlapping the anno-
tated CpG island(s) in the promoter, requiring at least 5 such CpGs. HCPs were
classified as hypermethylated if this mean methylation level was $75%.
Chromatin immunoprecipitation. H3K4me1 (ab8895), H3K4me2 (ab7766)
and H3K4me3 (ab8580) antibodies were purchased from Abcam. ChIP experi-
ments on mouse ES cells (H3K4me1/2), NPCs (H3K4me1/2) and whole brain
tissue (H3K4me1/2/3), Illumina/Solexa sequencing, alignments and identifica-
tion of significantly enriched regions (using 1 kb sliding windows and correction
for alignability) were carried out as described previously11.
Expression data. RNA expression data for ES-derived astrocytes were generated
as described previously11 and analysed using GenePattern (http://www.broad.-
mit.edu/cancer/software/genepattern/). Primary astrocyte data were obtained
from ref. 24.
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ARTICLES
Dissecting direct reprogramming through
integrative genomic analysis
Tarjei S. Mikkelsen1,2, Jacob Hanna4, Xiaolan Zhang1, Manching Ku5, Marius Wernig4, Patrick Schorderet4,
Bradley E. Bernstein1,5,6, Rudolf Jaenisch3,4, Eric S. Lander1,3,4,7 & Alexander Meissner1,8
Somatic cells can be reprogrammed to a pluripotent state through the ectopic expression of defined transcription factors.
Understanding the mechanism and kinetics of this transformation may shed light on the nature of developmental potency
and suggest strategies with improved efficiency or safety. Here we report an integrative genomic analysis of reprogramming
of mouse fibroblasts and B lymphocytes. Lineage-committed cells show a complex response to the ectopic expression
involving induction of genes downstream of individual reprogramming factors. Fully reprogrammed cells show gene
expression and epigenetic states that are highly similar to embryonic stem cells. In contrast, stable partially reprogrammed
cell lines show reactivation of a distinctive subset of stem-cell-related genes, incomplete repression of lineage-specifying
transcription factors, and DNA hypermethylation at pluripotency-related loci. These observations suggest that some cells
may become trapped in partially reprogrammed states owing to incomplete repression of transcription factors, and that
DNA de-methylation is an inefficient step in the transition to pluripotency. We demonstrate that RNA inhibition of
transcription factors can facilitate reprogramming, and that treatment with DNA methyltransferase inhibitors can improve
the overall efficiency of the reprogramming process.
Mouse and human cells can be reprogrammed to pluripotency
through ectopic expression of defined transcription factors1–9 (‘direct
reprogramming’). Generation of such induced pluripotent stem
(iPS) cells may provide an attractive source of patient-specific stem
cells (reviewed in refs 10, 11). However, themechanism and nature of
molecular changes underlying the process of direct reprogramming
remain largely mysterious11. It is a slow and inefficient process that
currently requires weeks, with most cells failing to repro-
gramme2,9,12–14. A clearer understanding of the process would enable
development of safer and more efficient reprogramming strategies,
andmight shed light on fundamental questions concerning the estab-
lishment of cellular identity.
To identify possible obstacles to reprogramming and to use this
knowledge to devise ways to accelerate the transition to full pluripo-
tency, we undertook a comprehensive genomic characterization of
cells at various stages of the reprogramming process. The character-
ization involved gene expression profiling, chromatin state maps of
key activating and repressive marks (histone H3 K4me3 and
K27me3) and DNA methylation analysis.
Response to reprogramming factors
We first studied the response of lineage-committed cells to ectopic
expression of the four reprogramming factors Oct4 (also known as
Pou5f1), Sox2, Klf4 and c-Myc. Because most induced cells fail to
achieve successful reprogramming, we reasoned that genomic char-
acterization might yield insights into the basis of the low overall
efficiency of the method.
To eliminate heterogeneity caused by differential viral integration,
we studied mouse embryonic fibroblasts (MEFs) isolated from chi-
maeric mice that had been generated from an iPS cell line carrying
integrated doxycycline (Dox)-inducible lentiviral vectors with the
four reprogramming factors and a Nanog–GFP (green fluorescent
protein) reporter gene13,15. We induced the expression of the repro-
gramming factors and obtained gene expression profiles at days 4, 8,
12 and 16 (Supplementary Data). Fluorescence-activated cell sorting
(FACS) analysis on day 16 showed that ,20% of the cells stained
positive for the stem-cell marker SSEA1, but only ,1.2% had
achieved complete reprogramming, as indicated by activation of
the Nanog–GFP reporter (Supplementary Fig. 1) and consistent with
previous reports13,14.
The immediate response to induction of the reprogramming fac-
tors (.3-fold change by day 4) is characterized by de-differentiation
from the wild-typeMEF state and upregulation of proliferative genes.
De-differentiation is evident in a significant decrease (5–40-fold) in
expression levels of typical mesenchymal genes expressed in MEFs
(for example, Snai1 and Snai2). The proliferative response is evident
in upregulation of genes with functions such as DNA replication
(Poli, Rfc4 and Mcm5) and cell cycle progression (Ccnd1 and
Ccnd2); this response may be consistent with expression of repro-
gramming factor c-Myc10,16.
We also detected a strong increase in the expression of stress-
induced and anti-proliferative genes. In particular, we detected a sus-
tained 5–10-fold upregulation of Cdkn1a and Cdkn2a, which encode
cyclin-dependent kinase (CDK) inhibitors that are key effectors of
multiple differentiation and tumour suppressor pathways. Cdkn1a
is a downstream target of the reprogramming factor Klf4 (ref. 17),
whereas Cdkn2a is known to be activated by deregulated c-Myc
expression18. This response was followed by gradual upregulation of
genes associatedwithdifferentiatingMEFs (Pparg,Fabp4 andMgp) on
days 12–16.This suggests that inductionof the reprogramming factors
1Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA. 2Division of Health Sciences and Technology, 3Department of Biology,
Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. 4Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts
02142, USA. 5Molecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA. 6Department of Pathology,
HarvardMedical School, Boston,Massachusetts 02115, USA. 7Department of SystemsBiology, HarvardMedical School, Boston,Massachusetts 02114, USA. 8Department of StemCell
and Regenerative Biology, Harvard University, Cambridge, Massachusetts 02138, USA.
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triggers normal ‘fail-safe’ mechanisms that act to prevent uncon-
trolled proliferation, which may prevent the majority of cells from
reaching a stably de-differentiated state.
We also detected strong upregulation of lineage-specific genes
from unrelated lineages. These include axon guidance factors
(Epha7 and Ngef), epidermal proteins (Krt14, Krt16, Ivl and
Sprr1a) and glomerular proteins (Podxl). We speculate that this gene
activation reflects responses to the reprogramming factors Sox2 and
Klf4, which, independent of their roles in embryonic stem cell regu-
lation, function in neural, epidermal and kidney differentiation10,17.
Pluripotent cell lines
We next studied the changes to gene expression patterns and epige-
netic states seen in successfully reprogrammed iPS cells. We analysed
three cell lines: MEF-derived iPS cells carrying anOct4–GFP reporter
(MCV8.1; corresponding to subclone 8.1 in ref. 12); mature-B-
lymphocyte-derived iPS cells carrying a Nanog–GFP reporter (B-
iPS)15; and wild-type embryonic stem cells (V6.5)19.
We found that the genome-wide expression profiles of Oct4- or
Nanog-iPS cells derived from different cell types and systems are
highly similar, but not identical, to wild-type embryonic stem cells
(Fig. 1), consistent with recent studies of independent cell lines2,4,9,20.
For example, the iPS and embryonic stem cell lines share high
expression levels of genes related to maintenance of pluripotency
and self-renewal such as Oct4, Sox2, Nanog, Lin28, Zic3, Fgf4, Tdgf1
and Rex1 (also known as Zfp42), and low expression levels for most
lineage-specifying transcription factors and other developmental
genes. Consistent with the characteristically short cell cycle of embry-
onic stem cells, the iPS cells show low expression of cyclin D (Ccnd1
and Ccnd2)21.
To determine whether iPS cells have also regained embryonic-
stem-cell-like chromatin states, we generated genome-wide maps
showing the location of H3K4me3 and H3K27me3 from the MEF-
derived MCV8.1 cell line using ChIP-Seq. Previously we described
the differences in these chromatin modifications between wild-type
embryonic stem cells and MEFs22. In embryonic stem cells, virtually
all high-CpG promoters (HCPs) are enriched with H3K4me3; a sub-
set of theseHCPs, associated with repressed developmental genes, are
also enriched with H3K27me3 (‘bivalent’). InMEFs, most HCPs that
are bivalent in embryonic stem cells resolve to become monovalent
(H3K4me3- orH3K27me3-only). Some pluripotency- and germline-
specific genes show loss of bothH3K4me3 andH3K27me3 in somatic
cells, and this correlates with DNA hypermethylation (ref. 23, and
A.M. et al., unpublished observations).
The chromatin statemaps of the iPS cell lineMCV8.1 aremarkedly
similar to those of embryonic stem cells both near promoters and in
intergenic regions (Fig. 2 and Supplementary Figs 2–6). Most
(.97%) HCPs that lack H3K4me3-enrichment in MEFs have
regained this mark in MCV8.1 cells. At all pluripotency- and germ-
line-specific genes examined, the promoters have regained
H3K4me3-enrichment and show DNA hypomethylation (Fig. 3).
At genes encoding lineage-specific transcription factors that are biva-
lent and transcriptionally silent in embryonic stem cells, the bivalent
pattern is typically re-established (,80% of HCPs classified as biva-
lent in wild-type embryonic stem cells, and ,95% of loci encoding
key developmental transcription factors; Fig. 2b–d, g).
We conclude that direct reprogramming to a pluripotent state
involves re-activation of endogeneous pluripotency-related genes,
establishment of an ‘open’ chromatin state (as indicated by gen-
ome-wide H3K4me3 enrichment and DNA de-methylation), and
comprehensive Polycomb-mediated repression of lineage-specifying
genes (as indicated by bivalent chromatin states involving
H3K27me3-enrichment).
Partially reprogrammed cell lines
Only a subset of the stably de-differentiated cells obtained in the
absence of drug selection show evidence of complete reprogramming
to a pluripotent state. Previously we derived clonal cell lines that can
be maintained in relatively stable ‘partially reprogrammed’ states in
the absence of drug selection12. We reasoned that characterizing such
cells might help to identify key barriers in the late stages of the
process. Accordingly, we studied three partially reprogrammed inde-
pendent cell lines established during attempts to reprogrammeMEFs
or mature B lymphocytes (Figs 1–3).
MCV8. This cell line, which corresponds to subclone 8 from ref. 12,
was established during our attempt to reprogramme MEFs carrying
an Oct4–GFP reporter with constitutive retroviruses. It produces
heterogeneous cultures of cells with mainly fibroblast-like mor-
phology, with ,20–30% positive for the stem cell marker SSEA1
(Supplementary Figs 7 and 8) and occasional interspersed
embryonic-stem-cell-like colonies at late passages. Multiple second-
ary subclones from these embryonic-stem-cell-like colonies have
been shown to establish homogeneous GFP-positive iPS cell lines
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Figure 1 | Gene expression profiling. Relative expression levels across
differentiated, partially reprogrammed and pluripotent cell populations.
The dendrogram was generated by complete linkage hierarchical clustering
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shown in the heat map. Red, white and blue indicate higher, identical and
lower relative expression, respectively. ES cells, embryonic stem cells.
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(including the MCV8.1 line characterized above12). Proviral integ-
ration patterns showed that the same parental cells in the MCV8
population gave rise to both GFP-positive and -negative cells, sug-
gesting that complete reprogramming depends on stochastic epige-
netic events11,12.
The gene expression patterns of MCV8 cells are clearly distinct
from both MEFs and iPS cells (Fig. 1). MCV8 cultures show down-
regulation of both structural genes (Col1a1 and Col1a2) and regula-
tory factors (Snai1, Snai2 and Zeb2) expressed inMEFs, upregulation
of some lineage-specific genes with neural, epidermal or endodermal
functions (presumably as a consequence of Sox2 and Klf4 express-
ion), and particularly high expression of proliferative genes.
Interestingly, high levels of expression can also be detected for several
of the CDK inhibitors (Cdkn1a and Cdkn2a) induced by the repro-
gramming factors. It is unclear how the partially reprogrammed cells
have escaped the presumed anti-proliferative effects of these genes,
but possible explanations include compensation by overexpression
of proliferative genes, repression of differentiation pathways (MCV8
is cultured in the presence of the differentiation inhibitor LIF and
expresses the LIF receptor at 2–3-fold higher levels than embryonic
stem cells) or transformation (but we note that MCV8 cells have not
lost the ability to re-differentiate, see below).
The pattern of re-activation of genes expressed in embryonic stem
cells in MCV8 is strongly correlated with chromatin state in MEFs
(Fig. 2i). Several genes related to self-renewal and proliferation of
embryonic and adult stem cells show re-activation, including the
autocrine growth factor Fgf4 (ref. 24) and the transcription factor
Zic3 (ref. 25), but genes directly related to pluripotency show low or
undetectable expression. Of HCPs that are enriched with H3K4me3
in MEFs but are not expressed at detectable levels, most (,70%) are
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Figure 3 | DNA methylation analysis. Bisulphite sequencing of promoters
or enhancers with Oct4/Sox2 binding sites near pluripotency-related and
germ-cell-specific (Stella and Cyct) genes, as catalogued in ref. 23. Empty
squares indicate unmethylated and filled squares methylated CpG
dinucleotides. Most assayed sites are hypermethylated in differentiated and
partially reprogrammed cells. Sox2 is enriched with H3K27me3 in non-
pluripotent cells and accordingly hypomethylated in all cell types. Triangles
show sites used for COBRA analysis (see text).
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re-activated in MCV8. In contrast, transcriptionally silent HCPs that
are enriched in MEFs for H3K27me3 only or for neither mark are
significantly less likely to be re-activated (,35% and,20%, respect-
ively; PFisher, 10
26).
There are notable differences in the chromatin states of MCV8,
MEFs and MCV8.1 iPS cells (Fig. 2). Examining HCPs that are biva-
lent in embryonic stem cells demonstrates that MCV8 cells show
bivalent chromatin structures at 70% more of these loci
(n5 1,467) than seen in the MEFs (n5 859), but at ,40% fewer
than in MCV8.1 iPS cells (n5 2,360); this is consistent with partial
de-differentiation (,88% of the bivalent loci in MCV8 are also biva-
lent inMCV8.1). There aremanymoreHCPs that lackH3K4me3 and
H3K27me3 inMCV8 than inMCV8.1 (n5 311 versus 31), and these
genes include the majority of pluripotency- and germ-cell-specific
loci. Using bisulphite sequencing, we confirmed that this chromatin
state correlates with DNA hypermethylation (Fig. 3).
We initially sorted MCV8 cells into SSEA1-positive and -negative
cells and analysed them separately. However, we found no major
differences in expression levels or DNA methylation patterns
between the two fractions (Figs 1 and 3; Supplementary Data).
Moreover, when the two subpopulations were cultured separately,
both reverted to a heterogeneous state within 1–2 passages
(Supplementary Fig. 9). Similar results were obtained from sorting
by major histocompatibility complex surface expression, which
decreases on reprogramming (Supplementary Fig. 10;
Supplementary Data). Thus, although these surface markers may
provide some enrichment for cells that are amenable to full repro-
gramming14, they do not seem to discriminate between significantly
different cell states within MCV8 cultures.
MCV6. This cell line was also established during our attempt to
reprogrammeOct4–GFPMEFs (subclone 6 from ref. 12). It produces
homogeneous cultures with compact colonies and embryonic-stem-
cell-like morphology (Supplementary Fig. 8). It differs from MCV8
in that it has different proviral integrations and has never sponta-
neously given rise to fully reprogrammed cells (Supplementary Fig.
7).
The gene expression profile and chromatin statemaps fromMCV6
are largely similar to those of MCV8, but we found two notable
differences. First, MCV6 has fewer genes with bivalent chromatin
signatures, and a disproportionately large fraction of HCPs with
neither H3K4me3- nor H3K27me3-enrichment (7% versus ,2.5%
in MEFs and MCV8). Second, MCV6 expresses high levels of several
lineage-specifying transcription factors that are expressed at low or
undetectable levels inMCV8 or iPS cells, including Sox9 (Fig. 2c) and
Gata6 (Fig. 2d). The latter observation suggests thatMCV6may have
become trapped in a more differentiated state than MCV8.
BIV1. This cell line was established during our attempt to repro-
gramme B lymphocytes with inducible lentiviral vectors15. It had lost
surface expression of all common lymphoid markers and did not
require any lymphoid cytokines for growth, but also showed no
evidence of achieving complete reprogramming during 50 days of
continuous Dox-mediated viral expression (as judged by the absence
of SSEA1- or GFP-positive cells). After Dox withdrawal and loss of
any detectable viral expression (see below), the cells continued to
proliferate with a more fibroblast-like morphology and, after more
than ten additional days in culture, spontaneously gave rise to some
GFP-positive embryonic-stem-cell-like colonies, but at a lower fre-
quency than MCV8 (Supplementary Figs 8 and 11).
The gene expression profile and chromatin state maps from BIV1
cells grown with Dox show notable similarities to those of MCV8,
including: downregulation of lineage-specific genes, such as the B
lymphocyte master regulator Pax5; high expression of proliferative
genes; activation of neural and epidermal genes; low levels of
H3K4me3 and H3K27me3 enrichment relative to embryonic stem
cells, consistent with DNA hypermethylation (see below); and
incomplete activation of pluripotency-related loci (Fig. 1;
Supplementary Figs 2–6 and 12). Notably, the expression profiles
of BIV1, MCV8 and MCV6 are more similar to each other
(r2. 0.9 for any pair) than to the lineage-committed cell types from
which they originated or to any of the pluripotent cell types (r2, 0.8
for any pair; Fig. 1). This suggests that the three cell lines may rep-
resent relatively common intermediate states induced by the four
reprogramming factors (Oct4, Sox2, Klf4 and c-Myc). (The three
lines also show expression of Fbx15, suggesting that they may be
similar to the Fbx15-selected cells obtained during initial attempts
to generate iPS cells7.)
By comparing the expression profiles of BIV1 cultures before and
after Dox withdrawal, we found that Dox withdrawal resulted in:
upregulation of mesenchymal extracellular matrix genes (Col1a1
and Col2a1), consistent with the shift to a more fibroblast-like mor-
phology; downregulation of most inappropriately expressed neural
and epidermal genes, which is consistent with these genes being
induced by overexpression of Sox2 or Klf4; and upregulation of some
iPS and embryonic-stem-cell-specific genes (Dppa5 (also known as
Dppa5a), Lin28 and Dnmt3l), which is consistent with the eventual
emergence of rare GFP-positive colonies. Thus, continuous overex-
pression of the reprogramming factors may paradoxically have sta-
bilized BIV1 cells in its partially reprogrammed state.
In summary, the three partially reprogrammed cell lines appear to
represent similar (but distinct) cell states that emerge at an inter-
mediate stage in the direct reprogramming process. The states are
characterized by: re-activation of genes related to stem cell renewal
and maintenance, but not pluripotency; incomplete repression of
lineage-specific transcription factors; and incomplete epigenetic
remodelling, including persistent DNA hypermethylation.
Inhibition of Dnmt1 accelerates reprogramming
Because the partially reprogrammed cell lines show DNA hyper-
methylation at pluripotency-related genes, we hypothesized that loss
of DNA methylation (or a closely linked epigenetic mark, such as
H3K9 methylation26) is a critical and inefficient step in the transition
from a partially reprogrammed state to pluripotency.
Partially reprogrammed cell lines.We tested this notion by treating
cells with the DNAmethyltransferase inhibitor 5-aza-cytidine (AZA)
and found that it induced a rapid and stable transition to a fully
reprogrammed iPS state. We initially studied SSEA1-positive
MCV8 cells, treating them with AZA for 48 h and monitoring the
subsequent appearance of GFP-positive cells (Fig. 4a and
Supplementary Fig. 7). GFP-positive cells appeared at a frequency
of 7.5% after one passage, compared to 0.25% in untreated cells. After
five passages, GFP-positive cells comprised 77.8% of the treated
population, whereas the proportion in untreated cells remained sta-
bly low (0.41%). We obtained similar results when treating the
SSEA1-negative fraction. (When untreated cells from the fifth pas-
sage were subsequently treated with AZA, GFP-positive cells
appeared at a similar rate as in the initial treatment; Fig. 4b.) We also
found robust induction of the GFP reporter after AZA treatment of
BIV1 (2Dox) cells (Fig. 4a and Supplementary Fig. 13a).
We evaluated the cellular state and developmental potency of the
GFP-positive MCV8 and BIV1 cells obtained after AZA treatment
and FACS. Both populations stained positive for the stem-cell marker
SSEA1. Combined bisulphite restriction analysis (COBRA) revealed
significant de-methylation of CpGs near the pluripotency-related
genesDppa5,Nanog andUtf1 (Supplementary Fig. 14), implying that
re-activation was not limited to the GFP-tagged reporters. The viral
transgenes showed low or undetectable expression levels (Fig. 4c, d)
indicating that AZA treatment did not interfere with viral silencing,
which is required for full reprogramming9, and that the emergence of
GFP-positive cells was not caused by viral re-activation. Finally, sub-
cutaneous injection into severe combined immunodeficiency (SCID)
mice led to teratoma formation in 3–4weeks (Fig. 4e), demonstrating
that the GFP-positive cells had undergone a stable transition to the
pluripotent state. (Untreated MCV8 or BIV1 cells did not generate
teratomas in the same time frame.)
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To exclude nonspecific effects of AZA, we treated MCV8 cells with
small interfering RNAs (siRNAs) or lentiviral short hairpin RNAs
(shRNAs) against Dnmt1, which also led to the appearance GFP-
positive cells within one passage (up to 1.7%; Supplementary Fig.
13b–d). We conclude that transient inhibition of Dnmt1 is sufficient
to transition MCV8 and BIV1 cells rapidly from a partially repro-
grammed state to a pluripotent state.
Populations of lineage-committed cells. We next used the chi-
maera-derived Nanog–GFP MEFs (described previously) to test
whether AZA treatment could increase the overall reprogramming
efficiency. The cells were grown in the presence of Dox from day 1,
and AZA was administered for 48 h starting on day 4, 6 or 8. The
reprogramming efficiency was determined by counting embryonic-
stem-cell-like colonies at day 14 (Fig. 4f, g).
We found that starting AZA treatment on days 4 and 6 led to high
cell death and no overall gain in efficiency. The cell death may reflect
the fact that most cells are still in a differentiated state: genome-wide
hypomethylation is known to induce apoptosis in differentiated cells,
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Figure 4 | Inhibition of Dnmt1 accelerates the transition to pluripotency.
a, MCV8 (sorted by FACS using a SSEA1-specific antibody) and BIV1
(2Dox) were either exposed to AZA for 48 h (green) or kept in regular
embryonic stem cell medium (grey). The number of Oct4–GFP-positive cells
was analysed over multiple passages (P) by FACS. b, Untreated MCV8
control cells from passage 5 were subsequently subjected to AZA treatment
for 48 h (1) or 120 h (11), and resulting Oct4–GFP-positive cells were
counted after one passage. P6/P1, total passage 6/passage 1 after AZA
treatment. c, AZA treatment does not influence retroviral expression levels.
d, AZA treatment has no influence on lentiviral expression in uninduced or
induced BIV1 cells. e, Pluripotency of all AZA-treated lines andMCV8.1 was
demonstrated by teratoma formation. ECT, ectoderm; END, endoderm;
MES, mesoderm. f, Overall efficiency of AZA treatment. Nanog–GFPMEFs
were plated on 6-well plates (4 wells per time point with Dox, and 2 wells
without). Cells were treated with AZA during one of the indicated intervals.
On day 14, colony formation was analysed by fluorescence microscopy
(representative panels are shown). g, Number of alkaline-phosphatase-
positive, embryonic-stem-cell-like colonies obtained from each treatment.
AZA treatment during days 8–10 resulted in a,4-fold increase in efficiency
over untreated controls. For a, c, d and g, error bars show standard
deviations (n5 2, 2, 2 and 4, respectively).
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whereas embryonic stem cells are resistant27–29. In contrast, there was
a consistent fourfold increase in the number of embryonic-stem-cell-
like colonies in the cultures treated with AZA starting on day 8
(P, 0.007; t-test). Moreover, most (.95%) embryonic-stem-cell-
like colonies were GFP-positive in the treated cells, whereas only a
minority (,25%) were GFP-positive in the untreated controls (a
proportion consistent with refs 9, 12–14). Whereas early AZA treat-
ment is counter-productive to reprogramming, there may be a suf-
ficient number of partially reprogrammed cells in the population to
outweigh its cytotoxic effect.
We conclude that de-methylation of one or more (unknown) loci
is a critical step in the late stages of direct reprogramming, and that
inhibition of Dnmt1 lowers this kinetic barrier, thereby facilitating
the transition to pluripotency. A similar role for DNA demethyla-
tion has been reported recently during in vivo reprogramming in the
germ line30.
Transcription-factor-knockdown
In contrast to the other partially reprogrammed cell lines, MCV6 did
not respond toAZA treatment (Supplementary Fig. 7).We also noted
previously that MCV6 cells never show spontaneous appearance of
GFP-positive colonies. We hypothesized that expression of one or
more lineage-specifying transcription factor may have stabilized
these cells in a more differentiated state than MCV8 or BIV1.
To test this hypothesis, we studied our genome-wide maps and
identified lineage-specifying transcription factors that are expressed
at low or undetectable levels in MCV8 or iPS cell populations. We
transfected MCV6 cells with siRNAs against four transcription fac-
tors with.5-fold higher expression inMCV6 than inMCV8 (Gata6,
Pax7, Pax3 and Sox9). This resulted in no significant response.
However, when transfection of siRNA targeting any one of the factors
was followed by treatment with AZA for 48 h, GFP-positive cells
appeared at a significant frequency in all examined populations (16
independent transfections; Fig. 5 and Supplementary Fig. 15). For
example, targeting the primitive endoderm marker Gata6 (ref. 31)
generated ,2% GFP-positive cells within one passage of the sub-
sequent AZA treatment. In contrast, no GFP-positive cells appeared
in populations transfected with negative control siRNAs, or siRNAs
targeted against transcription factors not expressed in MCV6 (Zic1
andMeox2) or against Dnmt1 (7 control populations; P, 43 1024;
Mann–Whitney U-test).
We conclude that re-activation or incomplete repression of lin-
eage-specifying transcription factors during the reprogramming pro-
cess blocks activation of the endogenous pluripotency regulatory
network in MCV6. Transient silencing of one or more of these fac-
tors, combined with inhibition of Dnmt1, seems to shift the regula-
tory balance towards the pluripotent state, which may then be
stabilized by autoregulatory feedback11.
Discussion
Several insights emerge from our integrative genomic analyses. First,
the Oct4/Sox2/Klf4/c-Myc-based reprogramming process appears to
be fairly general, with two independent strategies (constititutive ret-
rovirus or inducible lentivirus) and two distinct cell types (MEFs and
B lymphocytes) yielding similar immediate responses, partially
reprogrammed states and a similarmechanism for the final transition
to pluripotency. Second, cells may fail to reprogramme successfully
for several apparent reasons: the cells may induce anti-proliferative
genes in response to proliferative stress; they may inappropriately
activate or fail to repress endogenous or ectopic transcription factors,
and become ‘trapped’ in differentiated states; and they may fail to
reactivate hypermethylated pluripotency genes. Third, complete
reprogramming can be facilitated by direct intervention against these
failure modes, such as transient inhibition of Dnmt1 and expressed
transcription factors.
We expect that further characterization of intermediate states and
alternative small molecule treatments will yield critical insights that
will help facilitate the desired transitions, making reprogramming
efficient and safe for use in regenerative medicine. More generally,
our data are consistent with amodel of development inwhich cellular
states are defined by transcription factors and stabilized by epigenetic
remodelling. Integrative gene expression and epigenomic profiling
provides a powerful tool for defining and guiding directed transitions
between these states.
Note added in proof: The work by A.M. et al. cited in the text as
unpublished observations has now been accepted for publication32.
METHODS SUMMARY
Embryonic stem and iPS cells were cultivated on irradiated MEFs. MEFs were
infected for 16–20 h with the Moloney-based retroviral vector pLIB (Clontech)
containing the complementary DNAs of Oct4, Sox2, Klf4 and c-Myc. Cell lines
containing the inducible lentiviruses and a ROSA26-targeted M2rtTA were
induced with 2 mgml21 of Dox. AZA treatment was performed for 48 h or as
indicated at a concentration of 0.5mM.
Bisulphite treatment was performed with the Qiagen EpiTect Kit. For chro-
matin immunoprecipiation, cells were harvested and cross-linked with form-
aldehyde (final concentration 1%) for 10min at 37 uC, were washed twice with
cold PBS (plus protease inhibitors), frozen and kept at –80 uC. Chromatin
immunoprecipiation, library construction, sequencing, identification of
enriched intervals and chromatin state classification were performed as
described previously22. RNA was isolated using Trizol followed by a second
round of purification using RNeasy columns (Qiagen). RNAwas then processed
and analysed as described elsewhere22.
Reverse transfections were performed in 24-well dishes according to manu-
facturer’s instructions using the siPORT NeoFX transfection agent (Ambion)
and Silencer Select (Ambion/ABI) siRNAs for the respective targets.
Fluorescently conjugated antibodies were used for FACS analysis and cell
sorting. Cell sorting was performed by using FACS-Aria (BD-Biosciences),
and consistently achieved cell sorting purity of .97%. For determining GFP-
positive cell numbers by FACS, we counted .50,000 cells.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Viral infections and cell lines. MEFs used to derive primary iPS cell lines by
infections with inducible lentiviruses were harvested at 13.5 days post coitum
from F1 matings between ROSA26–M2rtTA mice
33 and Nanog–GFP mice13.
Secondary Nanog–GFP MEFs were isolated using neomycin selection.
Lentiviral preparation and infection with Dox-inducible lentiviruses encoding
Oct4,Klf4, c-Myc and Sox2 cDNAdriven by the tetracycline operator (TetO) and
a minimal cytomegalovirus (CMV) promoter were described previously13.
MCV6 and MCV8 were generated by retroviral infection of Oct4–GFP MEFs
as described previously12.
Cell culture. Infected MEFs or secondary inducible MEFs15 were cultured and
expanded in standard embryonic stem medium and conditions12. Culture and
viral induction were performed as described13,15 and BIV1 was obtained as a
stable line and grown under regular embryonic stem cell conditions in the
presence or absence of 2 mgml21 Dox. AZA treatment was performed for 48 h
or as indicated at a concentration of 0.5mM.Higher doses showed similar effects
but increased toxicity.
Expression profiling.RNAwas isolated using Trizol followed by a second round
of purification using RNeasy Columns (Qiagen). RNA was then processed and
analysed as described elsewhere22. Absolute expression values were Robust
Multi-Array (RMA)-normalized, truncated to absolute intensity values $20,
and visualized using GenePattern (http://www.broad.mit.edu/cancer/software/
genepattern/).
Chromatin immunoprecipitation and Illumina/Solexa sequencing. Cells were
harvested and cross-linked with formaldehyde (final concentration 1%) for
10min at 37 uC. They were washed twice with cold PBS (plus protease inhibi-
tors), frozen and kept at –80 uC. Chromatin immunoprecipitation, library con-
struction, sequencing, identification of enriched intervals and chromatin state
classification were performed as described previously22.
Bisulphite sequencing and COBRA.Genomic DNAwas isolated and bisulphite
conversion was performed in a thermocycler using the Qiagen EpiTect Kit
according to manufacturer’s instructions with two additional cycles (5min at
99 uC and 3 h at 60 uC) at the end. When using 2 mg genomic DNA as starting
material, converted DNA was eluted in 40ml elution buffer (Qiagen) and 2 ml
were used and amplified with previously described primer sets23 and the follow-
ing additional primer pairs (CyctF: GAAGGATTAAATAGATGTATAAGA
AAATAT; CyctR: AAACCCTAATTATAAACAAATACAAC; Sox2F: GGTTTA
GGAAAAGGTTGGGAATA; Sox2R: AACCAAAATAAAACAAAACCCATAA).
PCR was performed in 25-ml reactions using EpiTect MSP Kit (Qiagen) mas-
termix according to the manufacturer’s instructions with a 45 s annealing step at
50 uC (35 cycles). PCR products were gel-purified, TOPO-cloned (Invitrogen)
and sequenced. COBRA forDppa5,Nanog andUtf1was performed using 15 ml of
the gel-purified DNA. Dppa5 was digested for 4 h at 65 uC with Taq1 (TCGA).
Nanog andUtf1were digested with HpyCHIV (ACGT) for 4 h at 37 uC. Digested
products were run on 2% agarose gels.
Knockdown of transcription factors and Dnmt1. Reverse transfections were
performed in 24-well dishes according to the manufacturer’s instructions using
the siPORT NeoFX transfection agent (Ambion). The following Silencer Select
(Ambion/ABI) siRNAs were used (the sequence shown is the sense strand):
negative control siRNA (4390843: sequence not provided), positive control
Cy3 GAPDH siRNA (AM4649: sequence not provided), Pax3 siRNA (s71259,
GCCCACGUCUAUUCCACAA; s71260, GCUCCGAUAUUGACUCUGA),
Pax7 siRNA (s71271, CCCUCAGUGAGUUCGAUUA; s71272, CCACAUCC
GUCACAAGAUA), Gata6 siRNA (s66489, CAAAAAUACUUCUCCUUCU;
s66490, CCUCUGCACGCUUUCCCUA), Sox9 siRNA (s74192, AGACU
CACAUCUCUCCUAA; s74193, AAGUUGAUCUGAAGCGAGA), Meox2
siRNA (s69792, GCAGUGAAUCUAGACCUCA; s69793, GCCCAUCAU
AAUUAUCUGA), Zic1 siRNA (s76384, CAAAAAGUCGUGCAACAAA;
s76385, GGGACUUUCUGUUCCGCA) and Dnmt1 siRNA (s65071, GGU
AGAGAGUUACGACGAA; s65072, CAACGGAUCCUAUCACACU). Dnmt1
was stably knocked down using five independent shRNAs from the RNA inter-
ference consortium (TRC; http://www.broad.mit.edu/genome_bio/trc/).
shRNA1 (TRCN0000039024; target: GCTGACACTAAGCTGTTTGTA),
shRNA2 (TRCN0000039025; target: GCCTTTACTTTCAACATCAAA),
shRNA3 (TRCN0000039026; target: CCGCACTTACTCCAAGTTCAA),
shRNA4 (TRCN0000039027; target: CCCGAAGATCAACTCACCAAA) and
shRNA5 (TRCN0000039028; target: GCAAAGAGTATGAGCCAATAT).
MCV8 cells were infected overnight and selected in puromycin (final, 2 mgml21)
for 48 h.
Quantitative RT–PCR. Total RNA was isolated using RNeasy Kit (Qiagen).
Three micrograms of total RNA was treated with DNase I to remove potential
contamination of genomic DNA using a DNA-Free RNA kit (Zymo Research).
Retroviral expression levels were determined as described previously9. For indu-
cible lentiviral expression, 1 mg of DNase I-treated RNA was reverse transcribed
using a First Strand Synthesis kit (Invitrogen) and ultimately resuspended in
100ml of water. Quantitative PCR analysis was performed in triplicate using 1/50
of the reverse transcription reaction in an ABI Prism 7000 (Applied Biosystems)
with Platinum SYBR green qPCR SuperMix-UDG with ROX (Invitrogen).
Primers used for amplification were as follows: c-Myc: F, 59-
ACCTAACTCGAGGAGGAGCTGG-39, and R, 59-TCCACATAGCGTAAA
AGGAGC-39; Klf4: F, 59-ACACTGTCTTCCCACGAGGG-39, and R, 59-
GGCATTAAAGCAGCGTATCCA-39; Sox2: F, 59-CATTAACGGCACACTG
CCC-39, and R, 59-GGCATTAAAGCAGCGTATCCA-39; Oct4: F, 59-
AGCCTGGCCTGTCTGTCACTC-39, and R, 59-GGCATTAAAGCAGC
GTATCCA-39. To ensure equal loading of cDNA into qRT–PCR reactions,
GAPDH messenger RNA was amplified using the following primers: F, 59-
TTCACCACCATGGAGAAGGC-39, and R, 59-CCCTTTTGGCTCCACCCT-39.
Data were extracted from the linear range of amplification. All graphs
of qRT–PCR data shown represent samples of RNA that were DNase-
treated, reverse transcribed, and amplified in parallel to avoid variation
inherent in these procedures.
Flow cytometry analysis and cell sorting. The following fluorescently conju-
gated antibodies (PE, FITC, Cy-Chrome or APC-labelled) were used for FACS
analysis and cell sorting: anti-SSEA1 (RnD Systems), anti-Igk, anti-Igl1,2,3,
anti-CD19, anti-B220, anti-sIgM and anti-sIgD (all obtained from BD-
Biosciences). Cell sorting was performed by using FACS-Aria (BD-
Biosciences), and consistently achieved cell sorting purity of .97%. For deter-
mining GFP-positive cell numbers by FACS, we counted .50,000 cells.
33. Beard, C. et al. Efficient method to generate single-copy transgenic mice by site-
specific integration in embryonic stem cells. Genesis 44, 23–28 (2006).
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